country,term,count
AX,OXYGEN SATURATION DECREASED,1
AL,ACUTE MYOCARDIAL INFARCTION,1
AL,CHEST PAIN,1
AL,DYSPNOEA,1
AL,PALPITATIONS,1
AL,RALES,1
AL,VASCULITIS,1
DZ,ASTHENIA,1
DZ,BLOOD CREATININE ABNORMAL,1
DZ,BLOOD UREA ABNORMAL,1
DZ,BRADYCARDIA,1
DZ,BRONCHIAL HYPERREACTIVITY,1
DZ,DYSPNOEA,1
DZ,ERYSIPELAS,1
DZ,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
DZ,GENERAL PHYSICAL HEALTH DETERIORATION,1
DZ,HAEMOGLOBIN DECREASED,1
DZ,HYPOXIA,1
DZ,INFLUENZA,1
DZ,LOSS OF CONSCIOUSNESS,1
DZ,MITRAL VALVE DISEASE,1
DZ,ORTHOPNOEA,1
DZ,PLATELET COUNT DECREASED,1
DZ,PULMONARY FUNCTION TEST ABNORMAL,1
DZ,PYREXIA,1
DZ,RENAL FAILURE,1
DZ,RESPIRATORY DISTRESS,1
DZ,RESPIRATORY FAILURE,1
DZ,SYNCOPE,1
DZ,WHITE BLOOD CELL COUNT DECREASED,1
AR,CARDIAC FAILURE,8
AR,RENAL FAILURE,8
AR,CARDIO-RESPIRATORY ARREST,7
AR,HYPOTENSION,7
AR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,7
AR,PNEUMONIA,7
AR,SYNCOPE,7
AR,ANAEMIA,6
AR,GASTROINTESTINAL HAEMORRHAGE,5
AR,HYPERTENSION,5
AR,BLOOD PRESSURE DECREASED,4
AR,CARDIAC DISORDER,4
AR,MALAISE,4
AR,PULMONARY OEDEMA,4
AR,RENAL FAILURE ACUTE,4
AR,SEPSIS,4
AR,THROMBOSIS,4
AR,ABDOMINAL PAIN,3
AR,ARRHYTHMIA,3
AR,CHRONIC KIDNEY DISEASE,3
AR,DIABETES MELLITUS,3
AR,DIABETIC FOOT,3
AR,DISEASE PROGRESSION,3
AR,DYSPNOEA,3
AR,GENERAL PHYSICAL HEALTH DETERIORATION,3
AR,PLEURAL EFFUSION,3
AR,PRESCRIBED UNDERDOSE,3
AR,TUMOUR LYSIS SYNDROME,3
AR,ACUTE KIDNEY INJURY,2
AR,AGITATION,2
AR,ASCITES,2
AR,BILE DUCT OBSTRUCTION,2
AR,BLOOD ALKALINE PHOSPHATASE INCREASED,2
AR,BLOOD CREATININE INCREASED,2
AR,BLOOD LACTATE DEHYDROGENASE INCREASED,2
AR,CELLULITIS,2
AR,CEREBROVASCULAR ACCIDENT,2
AR,CONDITION AGGRAVATED,2
AR,COUGH,2
AR,DEATH,2
AR,DEHYDRATION,2
AR,DIARRHOEA,2
AR,DRUG DOSE OMISSION,2
AR,DRUG INEFFECTIVE,2
AR,FLUID OVERLOAD,2
AR,FLUID RETENTION,2
AR,GASTRIC HAEMORRHAGE,2
AR,HAEMORRHAGIC STROKE,2
AR,INCORRECT DOSE ADMINISTERED,2
AR,INFARCTION,2
AR,INFECTION,2
AR,JAUNDICE,2
AR,JOINT SWELLING,2
AR,LOSS OF CONSCIOUSNESS,2
AR,LOWER GASTROINTESTINAL HAEMORRHAGE,2
AR,LUNG DISORDER,2
AR,NEPHROCALCINOSIS,2
AR,PAIN,2
AR,PANCREATIC NEOPLASM,2
AR,PERIPHERAL VASCULAR DISORDER,2
AR,PORTAL HYPERTENSION,2
AR,RENAL IMPAIRMENT,2
AR,SKIN NECROSIS,2
AR,SKIN ULCER,2
AR,THROMBOCYTOPENIA,2
AR,UNDERDOSE,2
AR,UPPER GASTROINTESTINAL HAEMORRHAGE,2
AR,VOMITING,2
AR,WEIGHT INCREASED,2
AR,ABASIA,1
AR,ABDOMINAL DISCOMFORT,1
AR,ABDOMINAL DISTENSION,1
AR,ABORTION SPONTANEOUS,1
AR,ACUTE ABDOMEN,1
AR,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
AR,ACUTE PULMONARY OEDEMA,1
AR,ADENOCARCINOMA PANCREAS,1
AR,AGGRESSION,1
AR,ALANINE AMINOTRANSFERASE INCREASED,1
AR,ANGINA PECTORIS,1
AR,ANGIOPLASTY,1
AR,ANXIETY,1
AR,APHASIA,1
AR,ARTERIAL DISORDER,1
AR,ASPARTATE AMINOTRANSFERASE INCREASED,1
AR,ASPHYXIA,1
AR,ASPIRATION,1
AR,ASTHENIA,1
AR,ATRIAL FIBRILLATION,1
AR,ATRIOVENTRICULAR BLOCK COMPLETE,1
AR,BLISTER,1
AR,BLOOD CREATININE ABNORMAL,1
AR,BLOOD GLUCOSE INCREASED,1
AR,BLOOD LACTATE DEHYDROGENASE DECREASED,1
AR,BLOOD OSMOLARITY INCREASED,1
AR,BLOOD PRESSURE ABNORMAL,1
AR,BLOOD PRESSURE INCREASED,1
AR,BLOOD URINE PRESENT,1
AR,BRADYARRHYTHMIA,1
AR,BRAIN DEATH,1
AR,BRONCHOSPASM,1
AR,CARDIAC ARREST,1
AR,CARDIAC FAILURE ACUTE,1
AR,CARDIAC FAILURE CONGESTIVE,1
AR,CARDIOMYOPATHY,1
AR,CATARACT,1
AR,CHOLELITHIASIS,1
AR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
AR,COAGULOPATHY,1
AR,CONCOMITANT DISEASE AGGRAVATED,1
AR,CONCOMITANT DISEASE PROGRESSION,1
AR,CONGENITAL CYSTIC KIDNEY DISEASE,1
AR,CYSTIC FIBROSIS,1
AR,DECREASED APPETITE,1
AR,DEPRESSED LEVEL OF CONSCIOUSNESS,1
AR,DEPRESSED MOOD,1
AR,DERMATITIS EXFOLIATIVE,1
AR,DEVICE ISSUE,1
AR,DIABETES MELLITUS INADEQUATE CONTROL,1
AR,DIABETIC FOOT INFECTION,1
AR,DISORIENTATION,1
AR,DIZZINESS,1
AR,DUODENAL ULCER,1
AR,DYSPEPSIA,1
AR,DYSPNOEA AT REST,1
AR,EJECTION FRACTION DECREASED,1
AR,ERYTHEMA,1
AR,ERYTHRODERMIC PSORIASIS,1
AR,EXPOSURE DURING PREGNANCY,1
AR,EXTREMITY NECROSIS,1
AR,FACE INJURY,1
AR,FAECAL INCONTINENCE,1
AR,FALL,1
AR,FATIGUE,1
AR,FIRST TRIMESTER PREGNANCY,1
AR,FOETAL EXPOSURE DURING PREGNANCY,1
AR,GANGRENE,1
AR,GASTROENTERITIS,1
AR,GENERALISED OEDEMA,1
AR,GENERALISED TONIC-CLONIC SEIZURE,1
AR,GINGIVAL BLEEDING,1
AR,HAEMATOCHEZIA,1
AR,HAEMATOCRIT ABNORMAL,1
AR,HAEMATOCRIT INCREASED,1
AR,HAEMATOMA,1
AR,HAEMATURIA,1
AR,HAEMODYNAMIC INSTABILITY,1
AR,HAEMOGLOBIN ABNORMAL,1
AR,HAEMOGLOBIN DECREASED,1
AR,HAEMOLYSIS,1
AR,HAEMORRHAGE URINARY TRACT,1
AR,HAEMORRHAGIC ANAEMIA,1
AR,HAEMORRHAGIC DIATHESIS,1
AR,HAEMORRHAGIC TRANSFORMATION STROKE,1
AR,HALLUCINATION,1
AR,HEADACHE,1
AR,HEART RATE ABNORMAL,1
AR,HEART RATE DECREASED,1
AR,HEART RATE INCREASED,1
AR,HEPARIN-INDUCED THROMBOCYTOPENIA,1
AR,HEPATIC ENZYME INCREASED,1
AR,HEPATIC STEATOSIS,1
AR,HEPATITIS,1
AR,HEPATOCELLULAR CARCINOMA,1
AR,HIP FRACTURE,1
AR,HYPERAESTHESIA,1
AR,HYPERHIDROSIS,1
AR,HYPERSPLENISM,1
AR,HYPERTENSIVE CRISIS,1
AR,HYPOGLYCAEMIA,1
AR,HYPOVOLAEMIC SHOCK,1
AR,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,1
AR,IMPAIRED HEALING,1
AR,INGUINAL HERNIA,1
AR,INSOMNIA,1
AR,INTESTINAL PERFORATION,1
AR,ISCHAEMIC STROKE,1
AR,KIDNEY ENLARGEMENT,1
AR,LARGE INTESTINE PERFORATION,1
AR,LARGE INTESTINE POLYP,1
AR,LIVER DISORDER,1
AR,LOW BIRTH WEIGHT BABY,1
AR,MALIGNANT MELANOMA,1
AR,MATERNAL EXPOSURE DURING PREGNANCY,1
AR,MELAENA,1
AR,MEMORY IMPAIRMENT,1
AR,MOBILITY DECREASED,1
AR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
AR,MUSCLE NECROSIS,1
AR,MYALGIA,1
AR,MYOCARDIAL INFARCTION,1
AR,MYOPATHY,1
AR,NASOPHARYNGITIS,1
AR,NEONATAL RESPIRATORY DISTRESS SYNDROME,1
AR,NEPHROLITHIASIS,1
AR,NEPHROTIC SYNDROME,1
AR,NEUTROPENIA,1
AR,NO THERAPEUTIC RESPONSE,1
AR,OCULAR HYPERAEMIA,1
AR,OEDEMA,1
AR,OEDEMA PERIPHERAL,1
AR,PAIN IN EXTREMITY,1
AR,PALLOR,1
AR,PARKINSON^S DISEASE,1
AR,PERICARDIAL EFFUSION,1
AR,PERIPHERAL SWELLING,1
AR,PERIPHERAL VENOUS DISEASE,1
AR,PERITONITIS,1
AR,PETECHIAE,1
AR,PHARYNGEAL HAEMORRHAGE,1
AR,PLATELET COUNT ABNORMAL,1
AR,PLATELET COUNT INCREASED,1
AR,POLYMYOSITIS,1
AR,POOR PERIPHERAL CIRCULATION,1
AR,PORTAL VEIN THROMBOSIS,1
AR,POST PROCEDURAL COMPLICATION,1
AR,POST PROCEDURAL INFECTION,1
AR,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
AR,PREMATURE BABY,1
AR,PREMATURE LABOUR,1
AR,PREMATURE RUPTURE OF MEMBRANES,1
AR,PRESCRIBED OVERDOSE,1
AR,PRESYNCOPE,1
AR,PRODUCT USE ISSUE,1
AR,PROSTATITIS,1
AR,PRURIGO,1
AR,PRURITUS,1
AR,PULMONARY ARTERIAL HYPERTENSION,1
AR,PULMONARY EMBOLISM,1
AR,PULMONARY HAEMORRHAGE,1
AR,PULMONARY HYPERTENSION,1
AR,PYREXIA,1
AR,RASH,1
AR,RED BLOOD CELL COUNT DECREASED,1
AR,RENAL DISORDER,1
AR,RENAL FAILURE CHRONIC,1
AR,RESPIRATORY DISORDER,1
AR,RESPIRATORY DISTRESS,1
AR,RESPIRATORY FAILURE,1
AR,SEPTIC SHOCK,1
AR,SKELETAL INJURY,1
AR,SKIN EXFOLIATION,1
AR,SLEEP APNOEA SYNDROME,1
AR,SOFT TISSUE INFECTION,1
AR,SPINAL CORD COMPRESSION,1
AR,SPLENOMEGALY,1
AR,STAPHYLOCOCCAL INFECTION,1
AR,STAPHYLOCOCCAL SEPSIS,1
AR,STRESS,1
AR,SUPRAVENTRICULAR TACHYCARDIA,1
AR,TESTICULAR PAIN,1
AR,THERAPY CESSATION,1
AR,THROMBOTIC MICROANGIOPATHY,1
AR,TOXICITY TO VARIOUS AGENTS,1
AR,TREATMENT FAILURE,1
AR,URINARY INCONTINENCE,1
AR,URINARY RETENTION,1
AR,URINARY TRACT INFECTION BACTERIAL,1
AR,URINARY TRACT OBSTRUCTION,1
AR,URINE OUTPUT DECREASED,1
AR,UTERINE CYST,1
AR,UTERINE LEIOMYOMA,1
AR,VARICELLA,1
AR,VASCULAR GRAFT OCCLUSION,1
AR,VENTRICULAR EXTRASYSTOLES,1
AR,VISION BLURRED,1
AR,VISUAL IMPAIRMENT,1
AR,VOLVULUS,1
AR,WHITE BLOOD CELL DISORDER,1
AR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
AM,CARDIAC FAILURE,3
AM,ASTHENIA,2
AM,COUGH,2
AM,DYSPNOEA,2
AM,PULMONARY TUBERCULOSIS,2
AM,LOSS OF CONSCIOUSNESS,1
AM,MEDICATION ERROR,1
AM,RESPIRATORY FAILURE,1
AW,BLOOD COUNT ABNORMAL,1
AW,DIARRHOEA,1
AW,GENERAL PHYSICAL HEALTH DETERIORATION,1
AW,LIVER FUNCTION TEST ABNORMAL,1
AW,PLATELET COUNT INCREASED,1
AW,VENTRICULAR TACHYCARDIA,1
AU,ACUTE KIDNEY INJURY,56
AU,DYSPNOEA,43
AU,HYPOTENSION,42
AU,HYPERKALAEMIA,39
AU,CARDIAC FAILURE,34
AU,FALL,33
AU,NAUSEA,32
AU,INCORRECT DOSE ADMINISTERED,29
AU,RENAL IMPAIRMENT,28
AU,DIZZINESS,25
AU,ANAEMIA,23
AU,CARDIAC FAILURE CONGESTIVE,23
AU,CHEST PAIN,22
AU,PNEUMONIA,22
AU,DIARRHOEA,21
AU,ATRIAL FIBRILLATION,20
AU,RHABDOMYOLYSIS,20
AU,CONFUSIONAL STATE,19
AU,FATIGUE,19
AU,MALAISE,19
AU,CONDITION AGGRAVATED,18
AU,OEDEMA PERIPHERAL,18
AU,SYNCOPE,17
AU,VOMITING,17
AU,RENAL FAILURE ACUTE,16
AU,HYPONATRAEMIA,15
AU,PLEURAL EFFUSION,15
AU,DEATH,14
AU,ORTHOSTATIC HYPOTENSION,14
AU,ELECTROCARDIOGRAM QT PROLONGED,13
AU,MYOCARDIAL INFARCTION,13
AU,PULMONARY ARTERIAL HYPERTENSION,13
AU,RASH,13
AU,ASTHENIA,12
AU,DEHYDRATION,12
AU,DISEASE PROGRESSION,12
AU,PYREXIA,12
AU,WEIGHT DECREASED,12
AU,ACUTE MYOCARDIAL INFARCTION,11
AU,BRADYCARDIA,11
AU,DECREASED APPETITE,11
AU,DEPRESSION,11
AU,HYPOCALCAEMIA,11
AU,ANGIOEDEMA,10
AU,BLOOD CREATININE INCREASED,10
AU,CONGESTIVE CARDIOMYOPATHY,10
AU,COUGH,10
AU,LOWER RESPIRATORY TRACT INFECTION,10
AU,MALIGNANT NEOPLASM PROGRESSION,10
AU,PAIN,10
AU,RENAL FAILURE,10
AU,RESPIRATORY FAILURE,10
AU,SEPSIS,10
AU,URINARY TRACT INFECTION,10
AU,CARDIAC ARREST,9
AU,DRUG INEFFECTIVE,9
AU,FEBRILE NEUTROPENIA,9
AU,HEADACHE,9
AU,HYPERTENSION,9
AU,MELAENA,9
AU,TOXICITY TO VARIOUS AGENTS,9
AU,CYANOSIS,8
AU,DEEP VEIN THROMBOSIS,8
AU,GASTROINTESTINAL HAEMORRHAGE,8
AU,HYPOGLYCAEMIA,8
AU,LETHARGY,8
AU,MUSCULAR WEAKNESS,8
AU,PERICARDIAL EFFUSION,8
AU,PSEUDOPORPHYRIA,8
AU,PULMONARY EMBOLISM,8
AU,RIGHT VENTRICULAR FAILURE,8
AU,WEIGHT INCREASED,8
AU,ABDOMINAL DISTENSION,7
AU,ARTHRALGIA,7
AU,BACK PAIN,7
AU,CHRONIC KIDNEY DISEASE,7
AU,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,7
AU,CONTUSION,7
AU,DEAFNESS,7
AU,FLUID OVERLOAD,7
AU,GAMMA-GLUTAMYLTRANSFERASE INCREASED,7
AU,HAEMOGLOBIN DECREASED,7
AU,HEPATIC FAILURE,7
AU,HYPOMAGNESAEMIA,7
AU,INTESTINAL ISCHAEMIA,7
AU,OEDEMA,7
AU,PAIN IN EXTREMITY,7
AU,PNEUMONIA HAEMOPHILUS,7
AU,PULMONARY HYPERTENSION,7
AU,PULMONARY OEDEMA,7
AU,RECTAL HAEMORRHAGE,7
AU,SKIN ULCER,7
AU,SUICIDE ATTEMPT,7
AU,ABDOMINAL PAIN,6
AU,ATYPICAL FEMUR FRACTURE,6
AU,C-REACTIVE PROTEIN INCREASED,6
AU,CEREBROVASCULAR ACCIDENT,6
AU,CHILLS,6
AU,CIRCULATORY COLLAPSE,6
AU,DELIRIUM,6
AU,ERYTHEMA,6
AU,FLUID RETENTION,6
AU,GLOMERULAR FILTRATION RATE DECREASED,6
AU,INTENTIONAL SELF-INJURY,6
AU,MENTAL DISORDER,6
AU,MOBILITY DECREASED,6
AU,MYOCARDIAL ISCHAEMIA,6
AU,PERSONALITY DISORDER,6
AU,UROSEPSIS,6
AU,ABDOMINAL DISCOMFORT,5
AU,ACUTE PULMONARY OEDEMA,5
AU,ARRHYTHMIA,5
AU,ATRIAL FLUTTER,5
AU,CELLULITIS,5
AU,DIABETIC KETOACIDOSIS,5
AU,EJECTION FRACTION DECREASED,5
AU,EPISTAXIS,5
AU,FEMUR FRACTURE,5
AU,GAIT DISTURBANCE,5
AU,GENERAL PHYSICAL HEALTH DETERIORATION,5
AU,HAEMORRHAGE,5
AU,HEPATIC ENCEPHALOPATHY,5
AU,HYPERGLYCAEMIA,5
AU,INFECTION,5
AU,INSOMNIA,5
AU,LIVER FUNCTION TEST ABNORMAL,5
AU,METABOLIC ACIDOSIS,5
AU,MYALGIA,5
AU,OVERDOSE,5
AU,PRURITUS,5
AU,THROMBOCYTOPENIA,5
AU,TRANSAMINASES INCREASED,5
AU,TRANSFUSION,5
AU,TREMOR,5
AU,URINARY RETENTION,5
AU,VISUAL IMPAIRMENT,5
AU,WRONG DRUG ADMINISTERED,5
AU,ABDOMINAL PAIN UPPER,4
AU,ANAPHYLACTIC REACTION,4
AU,ASCITES,4
AU,ASTHMA,4
AU,BACTERAEMIA,4
AU,BLISTER,4
AU,BLOOD ALKALINE PHOSPHATASE INCREASED,4
AU,BLOOD CALCIUM DECREASED,4
AU,BLOOD GLUCOSE INCREASED,4
AU,BLOOD LACTIC ACID INCREASED,4
AU,CHEST DISCOMFORT,4
AU,COLITIS,4
AU,COLON CANCER,4
AU,CONSTIPATION,4
AU,DIABETES MELLITUS,4
AU,DRY MOUTH,4
AU,DYSPNOEA EXERTIONAL,4
AU,ENCEPHALOPATHY,4
AU,EXERCISE TOLERANCE DECREASED,4
AU,FLUSHING,4
AU,HAEMATEMESIS,4
AU,HAEMATURIA,4
AU,HYPERCALCAEMIA,4
AU,HYPOPHAGIA,4
AU,INFLUENZA LIKE ILLNESS,4
AU,INTERNATIONAL NORMALISED RATIO INCREASED,4
AU,INTERSTITIAL LUNG DISEASE,4
AU,IRON DEFICIENCY ANAEMIA,4
AU,JOINT SWELLING,4
AU,LACTIC ACIDOSIS,4
AU,LEUKOCYTOSIS,4
AU,LOSS OF CONSCIOUSNESS,4
AU,MENINGIOMA,4
AU,METASTASES TO LIVER,4
AU,NEUTROPENIA,4
AU,OSTEOARTHRITIS,4
AU,PARAESTHESIA,4
AU,RENAL FAILURE CHRONIC,4
AU,RESPIRATORY TRACT INFECTION,4
AU,SEPTIC SHOCK,4
AU,SKIN CANCER,4
AU,SKIN DISCOLOURATION,4
AU,SPLENOMEGALY,4
AU,URINE OUTPUT DECREASED,4
AU,VIRAL INFECTION,4
AU,WHITE BLOOD CELL COUNT INCREASED,4
AU,WOUND,4
AU,ACTIVITIES OF DAILY LIVING IMPAIRED,3
AU,ADVERSE DRUG REACTION,3
AU,ANGINA PECTORIS,3
AU,ANXIETY,3
AU,ARTHROPATHY,3
AU,ATRIOVENTRICULAR BLOCK COMPLETE,3
AU,BLOOD UREA INCREASED,3
AU,CARDIAC FAILURE ACUTE,3
AU,CARDIO-RESPIRATORY ARREST,3
AU,CATARACT,3
AU,CATHETER SITE INFECTION,3
AU,CHOLANGITIS,3
AU,CHOLESTASIS,3
AU,COGNITIVE DISORDER,3
AU,CRYPTOCOCCOSIS,3
AU,DEAFNESS BILATERAL,3
AU,DRUG HYPERSENSITIVITY,3
AU,DUODENAL ULCER HAEMORRHAGE,3
AU,DYSPEPSIA,3
AU,ENDOMETRIOSIS,3
AU,FEELING ABNORMAL,3
AU,GOUT,3
AU,HAEMATOCRIT DECREASED,3
AU,HAEMORRHOIDS,3
AU,HEAD INJURY,3
AU,HERPES ZOSTER,3
AU,HOSPITALISATION,3
AU,HYPERBILIRUBINAEMIA,3
AU,HYPOAESTHESIA,3
AU,HYPOPHOSPHATAEMIA,3
AU,HYPOXIA,3
AU,INTESTINAL PERFORATION,3
AU,LACERATION,3
AU,LIMB INJURY,3
AU,LIVER DISORDER,3
AU,MEMORY IMPAIRMENT,3
AU,METHAEMOGLOBINAEMIA,3
AU,MULTI-ORGAN FAILURE,3
AU,MUSCLE SPASMS,3
AU,MUSCULOSKELETAL CHEST PAIN,3
AU,NEUTROPHIL COUNT INCREASED,3
AU,NIGHT SWEATS,3
AU,OSTEOMYELITIS,3
AU,OXYGEN SATURATION DECREASED,3
AU,PALPITATIONS,3
AU,PANCYTOPENIA,3
AU,PERIPHERAL SWELLING,3
AU,PNEUMOCYSTIS JIROVECII PNEUMONIA,3
AU,PNEUMONIA ASPIRATION,3
AU,PRESYNCOPE,3
AU,PSYCHOTIC DISORDER,3
AU,PURPURA,3
AU,RASH PRURITIC,3
AU,RENAL DISORDER,3
AU,SOMNOLENCE,3
AU,STAPHYLOCOCCAL INFECTION,3
AU,STAPHYLOCOCCUS TEST POSITIVE,3
AU,SUBDURAL HAEMORRHAGE,3
AU,SWELLING,3
AU,THORACIC VERTEBRAL FRACTURE,3
AU,THROMBOTIC MICROANGIOPATHY,3
AU,TREATMENT FAILURE,3
AU,URINARY INCONTINENCE,3
AU,ACUTE ABDOMEN,2
AU,ACUTE HEPATIC FAILURE,2
AU,ACUTE RESPIRATORY FAILURE,2
AU,ADRENAL INSUFFICIENCY,2
AU,AGITATION,2
AU,ALANINE AMINOTRANSFERASE INCREASED,2
AU,ALOPECIA,2
AU,APHASIA,2
AU,ARTHRITIS,2
AU,ATAXIA,2
AU,BACTERIAL SEPSIS,2
AU,BLOOD CHOLESTEROL DECREASED,2
AU,BLOOD CHOLESTEROL INCREASED,2
AU,BLOOD GLUCOSE DECREASED,2
AU,BLOOD IRON DECREASED,2
AU,BLOOD LACTATE DEHYDROGENASE INCREASED,2
AU,BLOOD POTASSIUM DECREASED,2
AU,BLOOD PRESSURE DECREASED,2
AU,BLOOD PRESSURE FLUCTUATION,2
AU,BLOOD PRESSURE INCREASED,2
AU,BREAST CANCER METASTATIC,2
AU,CALCIPHYLAXIS,2
AU,CARDIAC DISORDER,2
AU,CARDIAC FAILURE CHRONIC,2
AU,CARDIAC TAMPONADE,2
AU,CARDIOGENIC SHOCK,2
AU,CEREBRAL HAEMORRHAGE,2
AU,CEREBRAL INFARCTION,2
AU,CLAVICLE FRACTURE,2
AU,COLON ADENOMA,2
AU,CONCOMITANT DISEASE AGGRAVATED,2
AU,CONCOMITANT DISEASE PROGRESSION,2
AU,CONTRAINDICATED PRODUCT ADMINISTERED,2
AU,CONVULSION,2
AU,CORONARY ARTERY DISEASE,2
AU,CREATININE RENAL CLEARANCE DECREASED,2
AU,DEAFNESS NEUROSENSORY,2
AU,DELUSION,2
AU,DEMENTIA,2
AU,DERMATITIS BULLOUS,2
AU,DEVICE MALFUNCTION,2
AU,DIABETIC ULCER,2
AU,DIVERTICULITIS,2
AU,DIVERTICULUM INTESTINAL HAEMORRHAGIC,2
AU,DRUG ABUSE,2
AU,DRUG DOSE OMISSION,2
AU,DRUG INTOLERANCE,2
AU,DRUG PRESCRIBING ERROR,2
AU,DRUG-INDUCED LIVER INJURY,2
AU,DYSGEUSIA,2
AU,DYSPHONIA,2
AU,ELECTROCARDIOGRAM QT INTERVAL ABNORMAL,2
AU,EOSINOPHILIA,2
AU,ESCHERICHIA SEPSIS,2
AU,FAECES DISCOLOURED,2
AU,FALSE POSITIVE INVESTIGATION RESULT,2
AU,FOETAL EXPOSURE DURING PREGNANCY,2
AU,GASTRIC ULCER,2
AU,GASTRITIS,2
AU,GASTROENTERITIS,2
AU,GASTROINTESTINAL DISORDER,2
AU,HAEMORRHAGIC STROKE,2
AU,HALLUCINATION,2
AU,HEMIPLEGIA,2
AU,HEPATIC CIRRHOSIS,2
AU,HEPATIC HYDROTHORAX,2
AU,HEPATITIS,2
AU,HEPATITIS C,2
AU,HYDRONEPHROSIS,2
AU,HYPERHIDROSIS,2
AU,HYPOKALAEMIA,2
AU,HYPOKINESIA,2
AU,ILL-DEFINED DISORDER,2
AU,IMPAIRED HEALING,2
AU,INFLAMMATION,2
AU,INFLUENZA,2
AU,INSULIN C-PEPTIDE DECREASED,2
AU,INTERNATIONAL NORMALISED RATIO ABNORMAL,2
AU,IRON DEFICIENCY,2
AU,ISCHAEMIC CARDIOMYOPATHY,2
AU,JAUNDICE,2
AU,JOINT INJURY,2
AU,LEFT VENTRICULAR DYSFUNCTION,2
AU,LUNG INFECTION,2
AU,LUNG NEOPLASM MALIGNANT,2
AU,MALIGNANT MELANOMA,2
AU,MENTAL IMPAIRMENT,2
AU,METRORRHAGIA,2
AU,MUSCULOSKELETAL PAIN,2
AU,MUSCULOSKELETAL STIFFNESS,2
AU,MYOCLONUS,2
AU,MYOPATHY,2
AU,NASOPHARYNGITIS,2
AU,NEPHROPATHY,2
AU,NERVOUSNESS,2
AU,NEURALGIA,2
AU,NON-CARDIAC CHEST PAIN,2
AU,NORMOCHROMIC NORMOCYTIC ANAEMIA,2
AU,OPTIC ISCHAEMIC NEUROPATHY,2
AU,OROPHARYNGEAL PAIN,2
AU,ORTHOPNOEA,2
AU,PERIPHERAL COLDNESS,2
AU,PHOTOPHOBIA,2
AU,PLASMACYTOMA,2
AU,PNEUMONIA BACTERIAL,2
AU,PNEUMONITIS,2
AU,POST PROCEDURAL HAEMORRHAGE,2
AU,PRODUCT PHYSICAL ISSUE,2
AU,PRODUCT USE IN UNAPPROVED INDICATION,2
AU,PROTEIN TOTAL DECREASED,2
AU,PROTHROMBIN TIME PROLONGED,2
AU,RED BLOOD CELL COUNT DECREASED,2
AU,RENAL CYST,2
AU,RESPIRATORY DISTRESS,2
AU,RIB FRACTURE,2
AU,SCHIZOPHRENIA,2
AU,SCIATICA,2
AU,SERUM FERRITIN ABNORMAL,2
AU,SINUS BRADYCARDIA,2
AU,SINUS TACHYCARDIA,2
AU,SKIN NEOPLASM EXCISION,2
AU,SLEEP DISORDER,2
AU,SPINAL COLUMN STENOSIS,2
AU,SPINAL OSTEOARTHRITIS,2
AU,SPUTUM DISCOLOURED,2
AU,SQUAMOUS CELL CARCINOMA OF SKIN,2
AU,STRESS CARDIOMYOPATHY,2
AU,STRESS FRACTURE,2
AU,SYSTEMIC SCLEROSIS,2
AU,TACHYCARDIA,2
AU,THERAPY CESSATION,2
AU,THERAPY CHANGE,2
AU,TOXIC EPIDERMAL NECROLYSIS,2
AU,TRANSIENT ISCHAEMIC ATTACK,2
AU,TROPONIN INCREASED,2
AU,UNDERDOSE,2
AU,UNEVALUABLE EVENT,2
AU,UPPER GASTROINTESTINAL HAEMORRHAGE,2
AU,URTICARIA,2
AU,VAGINAL HAEMORRHAGE,2
AU,VENTRICULAR FIBRILLATION,2
AU,VENTRICULAR TACHYCARDIA,2
AU,VIRAL UPPER RESPIRATORY TRACT INFECTION,2
AU,VISION BLURRED,2
AU,ABASIA,1
AU,ABNORMAL BEHAVIOUR,1
AU,ABNORMAL LOSS OF WEIGHT,1
AU,ACCIDENTAL EXPOSURE TO PRODUCT,1
AU,ACCIDENTAL OVERDOSE,1
AU,ACIDOSIS,1
AU,ACUTE CORONARY SYNDROME,1
AU,ACUTE LYMPHOCYTIC LEUKAEMIA,1
AU,ACUTE MYELOID LEUKAEMIA,1
AU,ACUTE PSYCHOSIS,1
AU,ALLERGIC OEDEMA,1
AU,AMNESIA,1
AU,ANAEMIA POSTOPERATIVE,1
AU,ANAPHYLACTIC SHOCK,1
AU,ANAPHYLACTOID REACTION,1
AU,ANION GAP INCREASED,1
AU,ANKLE FRACTURE,1
AU,ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC,1
AU,AORTIC ANEURYSM,1
AU,AORTIC STENOSIS,1
AU,AORTIC VALVE REPLACEMENT,1
AU,APLASIA PURE RED CELL,1
AU,APPETITE DISORDER,1
AU,ARRHYTHMIA SUPRAVENTRICULAR,1
AU,ARTERIAL HAEMORRHAGE,1
AU,ARTERIAL STENOSIS,1
AU,ARTERIOGRAM CORONARY ABNORMAL,1
AU,ARTERIOSCLEROSIS,1
AU,ARTHRITIS INFECTIVE,1
AU,ASPARTATE AMINOTRANSFERASE INCREASED,1
AU,ASPIRATION,1
AU,AUTOIMMUNE HAEMOLYTIC ANAEMIA,1
AU,AUTOIMMUNE HEPATITIS,1
AU,BACK INJURY,1
AU,BALANOPOSTHITIS,1
AU,BASAL CELL CARCINOMA,1
AU,BILIARY SEPSIS,1
AU,BILIRUBIN CONJUGATED INCREASED,1
AU,BIPOLAR DISORDER,1
AU,BLADDER CANCER,1
AU,BLADDER DISORDER,1
AU,BLEEDING TIME PROLONGED,1
AU,BLINDNESS,1
AU,BLOOD ALBUMIN DECREASED,1
AU,BLOOD BICARBONATE INCREASED,1
AU,BLOOD BILIRUBIN INCREASED,1
AU,BLOOD CHLORIDE INCREASED,1
AU,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
AU,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,1
AU,BLOOD CULTURE POSITIVE,1
AU,BLOOD FOLATE DECREASED,1
AU,BLOOD GLUCOSE ABNORMAL,1
AU,BLOOD GLUCOSE FLUCTUATION,1
AU,BLOOD LACTATE DEHYDROGENASE DECREASED,1
AU,BLOOD MAGNESIUM DECREASED,1
AU,BLOOD PHOSPHORUS INCREASED,1
AU,BLOOD POTASSIUM INCREASED,1
AU,BLOOD PRESSURE SYSTOLIC INCREASED,1
AU,BLOOD TRIGLYCERIDES INCREASED,1
AU,BLOOD URIC ACID INCREASED,1
AU,BODY MASS INDEX DECREASED,1
AU,BODY TEMPERATURE INCREASED,1
AU,BONE CANCER METASTATIC,1
AU,BONE LESION,1
AU,BOWEL MOVEMENT IRREGULARITY,1
AU,BOWEN^S DISEASE,1
AU,BRACHIOCEPHALIC VEIN THROMBOSIS,1
AU,BRAIN MIDLINE SHIFT,1
AU,BRAIN NATRIURETIC PEPTIDE INCREASED,1
AU,BRAIN NEOPLASM,1
AU,BREAST CANCER,1
AU,BRONCHIECTASIS,1
AU,BRONCHITIS,1
AU,BRONCHOSCOPY,1
AU,BUNDLE BRANCH BLOCK RIGHT,1
AU,BURNING SENSATION,1
AU,BURSITIS,1
AU,C-KIT GENE MUTATION,1
AU,CACHEXIA,1
AU,CANCER SURGERY,1
AU,CANDIDA INFECTION,1
AU,CARBOHYDRATE ANTIGEN 15-3 INCREASED,1
AU,CARCINOEMBRYONIC ANTIGEN INCREASED,1
AU,CARCINOID TUMOUR,1
AU,CARDIAC MURMUR,1
AU,CARDIAC OUTPUT DECREASED,1
AU,CARDIAC PACEMAKER INSERTION,1
AU,CARDIOMEGALY,1
AU,CARDIOMYOPATHY,1
AU,CARDIOPULMONARY FAILURE,1
AU,CATARACT OPERATION,1
AU,CATHETER MANAGEMENT,1
AU,CATHETER SITE CELLULITIS,1
AU,CATHETER SITE DISCHARGE,1
AU,CATHETER SITE HAEMORRHAGE,1
AU,CATHETERISATION CARDIAC,1
AU,CENTRAL VENOUS CATHETERISATION,1
AU,CEREBRAL ARTERY THROMBOSIS,1
AU,CHEST INJURY,1
AU,CHOLANGITIS ACUTE,1
AU,CHOLECYSTECTOMY,1
AU,CHOLECYSTITIS,1
AU,CHOLECYSTITIS ACUTE,1
AU,CHOLELITHIASIS,1
AU,COLITIS ISCHAEMIC,1
AU,COLONOSCOPY,1
AU,COMA,1
AU,CORONARY ANGIOPLASTY,1
AU,CORONARY ARTERY BYPASS,1
AU,CORONARY ARTERY OCCLUSION,1
AU,CORONARY ARTERY THROMBOSIS,1
AU,CORTISOL INCREASED,1
AU,CORYNEBACTERIUM TEST POSITIVE,1
AU,CREPITATIONS,1
AU,CROHN^S DISEASE,1
AU,CUSHINGOID,1
AU,CYANOSIS CENTRAL,1
AU,CYST,1
AU,CYSTITIS,1
AU,CYTOMEGALOVIRUS COLITIS,1
AU,CYTOMEGALOVIRUS VIRAEMIA,1
AU,CYTOPENIA,1
AU,DEPRESSED LEVEL OF CONSCIOUSNESS,1
AU,DEVICE DIFFICULT TO USE,1
AU,DEVICE DISLOCATION,1
AU,DEVICE PACING ISSUE,1
AU,DEVICE RELATED INFECTION,1
AU,DEVICE RELATED SEPSIS,1
AU,DIABETES INSIPIDUS,1
AU,DIABETIC COMA,1
AU,DIABETIC COMPLICATION,1
AU,DIABETIC FOOT,1
AU,DIALYSIS,1
AU,DIFFUSE LARGE B-CELL LYMPHOMA,1
AU,DILATATION VENTRICULAR,1
AU,DISEASE RECURRENCE,1
AU,DIVERTICULAR PERFORATION,1
AU,DIZZINESS EXERTIONAL,1
AU,DRUG ADMINISTRATION ERROR,1
AU,DRUG DISPENSING ERROR,1
AU,DRUG EFFECT DECREASED,1
AU,DRUG EFFECT INCOMPLETE,1
AU,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
AU,DRUG WITHDRAWAL MAINTENANCE THERAPY,1
AU,DUODENAL ULCER,1
AU,DUODENITIS,1
AU,DYSARTHRIA,1
AU,DYSPHAGIA,1
AU,DYSURIA,1
AU,EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED,1
AU,ECCHYMOSIS,1
AU,ECZEMA,1
AU,EGFR GENE MUTATION,1
AU,ELECTROCARDIOGRAM ABNORMAL,1
AU,EMBOLISM,1
AU,EMPHYSEMA,1
AU,ENCEPHALITIS,1
AU,ENCOPRESIS,1
AU,ENDOSCOPY UPPER GASTROINTESTINAL TRACT,1
AU,ENDOTRACHEAL INTUBATION,1
AU,ENTEROCOCCAL INFECTION,1
AU,EOSINOPHIL COUNT INCREASED,1
AU,ERUCTATION,1
AU,EXERCISE TEST ABNORMAL,1
AU,EYE OEDEMA,1
AU,EYELID OEDEMA,1
AU,FACE INJURY,1
AU,FACE OEDEMA,1
AU,FAECAL INCONTINENCE,1
AU,FAECES HARD,1
AU,FEAR OF INJECTION,1
AU,FEELING JITTERY,1
AU,FIBROMYALGIA,1
AU,FLATULENCE,1
AU,FOOT FRACTURE,1
AU,FUNGAL OESOPHAGITIS,1
AU,GASTRIC MUCOSAL HYPERTROPHY,1
AU,GASTRIC PH DECREASED,1
AU,GASTRIC ULCER HAEMORRHAGE,1
AU,GASTRITIS EROSIVE,1
AU,GASTROENTERITIS SALMONELLA,1
AU,GASTROINTESTINAL CANCER METASTATIC,1
AU,GASTROINTESTINAL CARCINOMA,1
AU,GASTROINTESTINAL SOUNDS ABNORMAL,1
AU,GASTROINTESTINAL TUBE INSERTION,1
AU,GASTROINTESTINAL ULCER,1
AU,GASTROOESOPHAGEAL REFLUX DISEASE,1
AU,GLAUCOMA,1
AU,GLOBULINS DECREASED,1
AU,GLOBULINS INCREASED,1
AU,GLOMERULAR FILTRATION RATE ABNORMAL,1
AU,GLUCOSE TOLERANCE IMPAIRED,1
AU,GRAFT VERSUS HOST DISEASE,1
AU,GRIEF REACTION,1
AU,GROIN PAIN,1
AU,H1N1 INFLUENZA,1
AU,HAEMATOCHEZIA,1
AU,HAEMATOMA,1
AU,HAEMODYNAMIC INSTABILITY,1
AU,HAEMOLYTIC URAEMIC SYNDROME,1
AU,HAEMOPTYSIS,1
AU,HAEMORRHAGE INTRACRANIAL,1
AU,HAEMORRHAGIC ANAEMIA,1
AU,HAEMORRHAGIC TRANSFORMATION STROKE,1
AU,HAEMORRHOIDAL HAEMORRHAGE,1
AU,HEARING IMPAIRED,1
AU,HEART RATE DECREASED,1
AU,HEART RATE INCREASED,1
AU,HEART SOUNDS ABNORMAL,1
AU,HEAT STROKE,1
AU,HEMIPARESIS,1
AU,HEPATIC FUNCTION ABNORMAL,1
AU,HEPATOCELLULAR CARCINOMA,1
AU,HEPATOTOXICITY,1
AU,HERNIA,1
AU,HERPES SIMPLEX,1
AU,HIP FRACTURE,1
AU,HOMELESS,1
AU,HOT FLUSH,1
AU,HYPERCOAGULATION,1
AU,HYPERLACTACIDAEMIA,1
AU,HYPERSENSITIVITY,1
AU,HYPOCHROMIC ANAEMIA,1
AU,HYPOVOLAEMIA,1
AU,IDIOPATHIC PULMONARY FIBROSIS,1
AU,ILEUS PARALYTIC,1
AU,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
AU,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
AU,INCORRECT DOSAGE ADMINISTERED,1
AU,INCREASED APPETITE,1
AU,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,1
AU,INFUSION,1
AU,INFUSION RELATED REACTION,1
AU,INFUSION SITE PAIN,1
AU,INGUINAL HERNIA,1
AU,INJURY,1
AU,INTENTIONAL PRODUCT MISUSE,1
AU,INTENTIONAL PRODUCT USE ISSUE,1
AU,INTERMITTENT CLAUDICATION,1
AU,INTERNATIONAL NORMALISED RATIO FLUCTUATION,1
AU,INTERVERTEBRAL DISC PROTRUSION,1
AU,INTERVERTEBRAL DISC SPACE NARROWING,1
AU,INTESTINAL OBSTRUCTION,1
AU,INTRADUCTAL PROLIFERATIVE BREAST LESION,1
AU,INTRAMEDULLARY ROD INSERTION,1
AU,ISCHAEMIC CEREBRAL INFARCTION,1
AU,ISCHAEMIC HEPATITIS,1
AU,JOINT DISLOCATION,1
AU,JOINT STIFFNESS,1
AU,JUGULAR VEIN DISTENSION,1
AU,KIDNEY INFECTION,1
AU,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
AU,LARGE INTESTINAL STENOSIS,1
AU,LARGE INTESTINE POLYP,1
AU,LEFT VENTRICULAR FAILURE,1
AU,LEG AMPUTATION,1
AU,LEUKOPENIA,1
AU,LIGAMENT INJURY,1
AU,LIMB DISCOMFORT,1
AU,LIMB OPERATION,1
AU,LIPASE INCREASED,1
AU,LISTLESS,1
AU,LIVER FUNCTION TEST INCREASED,1
AU,LIVER TRANSPLANT,1
AU,LOCAL SWELLING,1
AU,LOCALISED INFECTION,1
AU,LOW DENSITY LIPOPROTEIN INCREASED,1
AU,LOWER LIMB FRACTURE,1
AU,LUNG DISORDER,1
AU,LYMPHOCYTE COUNT DECREASED,1
AU,LYMPHOEDEMA,1
AU,LYMPHOPENIA,1
AU,MACROCYTOSIS,1
AU,MACULAR DEGENERATION,1
AU,MALIGNANT HYPERTENSION,1
AU,MALIGNANT MELANOMA IN SITU,1
AU,MALNUTRITION,1
AU,MEAN CELL VOLUME ABNORMAL,1
AU,MEAN CELL VOLUME INCREASED,1
AU,MEDIASTINUM NEOPLASM,1
AU,MEDICAL DEVICE CHANGE,1
AU,MENISCUS INJURY,1
AU,METASTASES TO GASTROINTESTINAL TRACT,1
AU,METASTASES TO LYMPH NODES,1
AU,METASTASES TO SPINE,1
AU,METASTATIC GASTRIC CANCER,1
AU,METASTATIC MALIGNANT MELANOMA,1
AU,METASTATIC SQUAMOUS CELL CARCINOMA,1
AU,MICROANGIOPATHY,1
AU,MINERAL SUPPLEMENTATION,1
AU,MINI MENTAL STATUS EXAMINATION ABNORMAL,1
AU,MOTION SICKNESS,1
AU,MOUTH HAEMORRHAGE,1
AU,MOUTH ULCERATION,1
AU,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
AU,MUSCLE RUPTURE,1
AU,MYELOCYTE COUNT INCREASED,1
AU,MYELODYSPLASTIC SYNDROME,1
AU,MYOCARDIAL STRAIN,1
AU,MYOCARDITIS,1
AU,MYOGLOBINURIA,1
AU,MYOSITIS,1
AU,NECK PAIN,1
AU,NEOPLASM PROGRESSION,1
AU,NEPHRITIS,1
AU,NERVE INJURY,1
AU,NERVE ROOT COMPRESSION,1
AU,NEUTROPENIC INFECTION,1
AU,NEUTROPENIC SEPSIS,1
AU,NO ADVERSE EVENT,1
AU,NO THERAPEUTIC RESPONSE,1
AU,NOCTURIA,1
AU,NODULE,1
AU,NON-HODGKIN^S LYMPHOMA,1
AU,NON-SMALL CELL LUNG CANCER STAGE IV,1
AU,NYSTAGMUS,1
AU,OBSESSIVE-COMPULSIVE DISORDER,1
AU,OBSTRUCTIVE AIRWAYS DISORDER,1
AU,OCCULT BLOOD POSITIVE,1
AU,OESOPHAGEAL PERFORATION,1
AU,OESOPHAGEAL VARICES HAEMORRHAGE,1
AU,OESOPHAGITIS ULCERATIVE,1
AU,OLIGODENDROGLIOMA,1
AU,OLIGURIA,1
AU,OROANTRAL FISTULA,1
AU,OSTEOLYSIS,1
AU,OSTEONECROSIS OF JAW,1
AU,OSTEOPOROSIS POSTMENOPAUSAL,1
AU,OSTEOPOROTIC FRACTURE,1
AU,OVARIAN CYST,1
AU,PACKED RED BLOOD CELL TRANSFUSION,1
AU,PAIN IN JAW,1
AU,PALLOR,1
AU,PANCREATIC CARCINOMA,1
AU,PANCREATIC CYST,1
AU,PANCREATITIS ACUTE,1
AU,PANCREATITIS VIRAL,1
AU,PARAESTHESIA ORAL,1
AU,PARALYSIS,1
AU,PATHOLOGICAL FRACTURE,1
AU,PELVIC FRACTURE,1
AU,PELVIC HAEMATOMA,1
AU,PENILE BLISTER,1
AU,PEPTIC ULCER HAEMORRHAGE,1
AU,PERICARDITIS,1
AU,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
AU,PERIPHERAL ISCHAEMIA,1
AU,PERIPHERAL VASCULAR DISORDER,1
AU,PHARYNGEAL OEDEMA,1
AU,PHOBIA,1
AU,PHOTOSENSITIVITY REACTION,1
AU,PIGMENTATION DISORDER,1
AU,PITUITARY-DEPENDENT CUSHING^S SYNDROME,1
AU,PLASMA CELL MYELOMA,1
AU,PLATELET COUNT ABNORMAL,1
AU,PNEUMOTHORAX,1
AU,POLLAKIURIA,1
AU,POLYURIA,1
AU,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,1
AU,PROCEDURAL HAEMORRHAGE,1
AU,PROCEDURAL INTESTINAL PERFORATION,1
AU,PRODUCT DIFFICULT TO SWALLOW,1
AU,PRODUCT PACKAGING ISSUE,1
AU,PRODUCT QUALITY ISSUE,1
AU,PROSTATIC OPERATION,1
AU,PSEUDOMONAS INFECTION,1
AU,PUBIS FRACTURE,1
AU,PULMONARY ARTERIAL PRESSURE INCREASED,1
AU,PULMONARY FIBROSIS,1
AU,PULMONARY HAEMORRHAGE,1
AU,PULMONARY MASS,1
AU,PULMONARY SEPSIS,1
AU,PULMONARY THROMBOSIS,1
AU,PULSE ABSENT,1
AU,PURULENT DISCHARGE,1
AU,PYELONEPHRITIS,1
AU,RADIUS FRACTURE,1
AU,RALES,1
AU,RASH ERYTHEMATOUS,1
AU,RASH MACULO-PAPULAR,1
AU,RASH VESICULAR,1
AU,REACTION TO DRUG EXCIPIENTS,1
AU,REBOUND EFFECT,1
AU,RECTAL ADENOCARCINOMA,1
AU,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
AU,REMOVAL OF INTERNAL FIXATION,1
AU,RENAL GRAFT INFECTION,1
AU,RENAL SURGERY,1
AU,RENAL TRANSPLANT FAILURE,1
AU,RESPIRATORY DISORDER,1
AU,RESTLESSNESS,1
AU,RESTRICTIVE CARDIOMYOPATHY,1
AU,RETINAL VEIN OCCLUSION,1
AU,RETINOPATHY,1
AU,RETROPERITONEAL LYMPHADENOPATHY,1
AU,RETROPERITONEAL MASS,1
AU,RHINORRHOEA,1
AU,RIGHT VENTRICULAR DYSFUNCTION,1
AU,RIGHT VENTRICULAR HYPERTROPHY,1
AU,ROAD TRAFFIC ACCIDENT,1
AU,SCOLIOSIS,1
AU,SEASONAL ALLERGY,1
AU,SEIZURE,1
AU,SEROTONIN SYNDROME,1
AU,SERUM FERRITIN DECREASED,1
AU,SHORT-BOWEL SYNDROME,1
AU,SJOGREN^S SYNDROME,1
AU,SKIN EXFOLIATION,1
AU,SKIN GRAFT INFECTION,1
AU,SKIN HAEMORRHAGE,1
AU,SKIN INFECTION,1
AU,SKIN INJURY,1
AU,SKIN OEDEMA,1
AU,SKULL FRACTURE,1
AU,SPINAL COLUMN INJURY,1
AU,SPINAL COMPRESSION FRACTURE,1
AU,SPINAL CORD COMPRESSION,1
AU,STATUS EPILEPTICUS,1
AU,STENOSIS,1
AU,STENOTROPHOMONAS INFECTION,1
AU,STREPTOCOCCAL SEPSIS,1
AU,STUPOR,1
AU,SUBACUTE ENDOCARDITIS,1
AU,SUBDURAL HAEMATOMA,1
AU,SUBRETINAL FLUID,1
AU,SUDDEN CARDIAC DEATH,1
AU,SUDDEN DEATH,1
AU,SUPERINFECTION,1
AU,SURGERY,1
AU,SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT,1
AU,SWELLING FACE,1
AU,SYSTEMIC LUPUS ERYTHEMATOSUS,1
AU,SYSTEMIC MASTOCYTOSIS,1
AU,SYSTEMIC-PULMONARY ARTERY SHUNT,1
AU,TACHYPNOEA,1
AU,TEMPORAL ARTERITIS,1
AU,TERMINAL STATE,1
AU,TESTICULAR SWELLING,1
AU,THERAPEUTIC EMBOLISATION,1
AU,THIRST,1
AU,THROMBOSIS IN DEVICE,1
AU,THYROID NEOPLASM,1
AU,TINNITUS,1
AU,TOOTH DISORDER,1
AU,TOOTH EXTRACTION,1
AU,TOOTHACHE,1
AU,TORSADE DE POINTES,1
AU,TRANSFERRIN SATURATION DECREASED,1
AU,TRANSPLANT DYSFUNCTION,1
AU,TRANSPLANT REJECTION,1
AU,TRAUMATIC LUNG INJURY,1
AU,TRICUSPID VALVE INCOMPETENCE,1
AU,TROPONIN T INCREASED,1
AU,TRYPTASE INCREASED,1
AU,TUBULOINTERSTITIAL NEPHRITIS,1
AU,TUMOUR LYSIS SYNDROME,1
AU,TYPE 1 DIABETES MELLITUS,1
AU,TYPE 2 DIABETES MELLITUS,1
AU,TYPE I HYPERSENSITIVITY,1
AU,ULCER,1
AU,UNINTENTIONAL MEDICAL DEVICE REMOVAL,1
AU,UNRESPONSIVE TO STIMULI,1
AU,UPPER LIMB FRACTURE,1
AU,URETERIC OBSTRUCTION,1
AU,URETHRAL HAEMORRHAGE,1
AU,URINE FLOW DECREASED,1
AU,UTERINE LEIOMYOMA,1
AU,VASCULAR CALCIFICATION,1
AU,VASCULAR DEMENTIA,1
AU,VASCULAR RUPTURE,1
AU,VASCULITIS,1
AU,VENTRICULAR EXTRASYSTOLES,1
AU,VERTEBRAL FORAMINAL STENOSIS,1
AU,VERTIGO,1
AU,VITAMIN D DEFICIENCY,1
AU,VITREOUS FLOATERS,1
AU,VITREOUS HAEMORRHAGE,1
AU,VOLVULUS,1
AU,VULVOVAGINAL CANDIDIASIS,1
AU,WAIST CIRCUMFERENCE INCREASED,1
AU,WALKING DISTANCE TEST ABNORMAL,1
AU,WEIGHT ABNORMAL,1
AU,WEIGHT BEARING DIFFICULTY,1
AU,WHITE BLOOD CELL COUNT DECREASED,1
AU,WOUND INFECTION,1
AU,XANTHELASMA,1
AT,PNEUMONIA,28
AT,ANAEMIA,26
AT,DIARRHOEA,26
AT,CARDIAC FAILURE,25
AT,DYSPNOEA,21
AT,GENERAL PHYSICAL HEALTH DETERIORATION,21
AT,RENAL IMPAIRMENT,21
AT,HYPOKALAEMIA,20
AT,FATIGUE,19
AT,ACUTE KIDNEY INJURY,18
AT,GASTROINTESTINAL HAEMORRHAGE,16
AT,HYPONATRAEMIA,16
AT,NAUSEA,15
AT,OEDEMA PERIPHERAL,15
AT,PERICARDIAL HAEMORRHAGE,15
AT,VOMITING,15
AT,BLOOD CREATININE INCREASED,14
AT,DEHYDRATION,14
AT,DRUG INEFFECTIVE,14
AT,RHABDOMYOLYSIS,14
AT,WEIGHT DECREASED,14
AT,PLEURAL EFFUSION,13
AT,RENAL FAILURE,13
AT,ATRIAL FIBRILLATION,12
AT,THROMBOCYTOPENIA,12
AT,PYREXIA,11
AT,DEATH,10
AT,MELAENA,9
AT,URINARY TRACT INFECTION,9
AT,ASCITES,8
AT,BLOOD CREATINE PHOSPHOKINASE INCREASED,8
AT,HAEMOGLOBIN DECREASED,8
AT,LEUKOPENIA,8
AT,SYNCOPE,8
AT,ASTHENIA,7
AT,BLOOD LACTATE DEHYDROGENASE INCREASED,7
AT,CIRCULATORY COLLAPSE,7
AT,CONDITION AGGRAVATED,7
AT,ERYSIPELAS,7
AT,FALL,7
AT,HYPOTENSION,7
AT,INFECTION,7
AT,PULMONARY EMBOLISM,7
AT,SEPSIS,7
AT,CEREBRAL HAEMORRHAGE,6
AT,CEREBROVASCULAR ACCIDENT,6
AT,CORONARY ARTERY DISEASE,6
AT,DECREASED APPETITE,6
AT,DRUG ABUSE,6
AT,ELECTROCARDIOGRAM QT PROLONGED,6
AT,EPISTAXIS,6
AT,HYPERHIDROSIS,6
AT,HYPERKALAEMIA,6
AT,NEUROPATHY PERIPHERAL,6
AT,NEUTROPENIA,6
AT,PARALYSIS,6
AT,PERIPHERAL SWELLING,6
AT,RENAL FAILURE ACUTE,6
AT,VENTRICULAR FIBRILLATION,6
AT,ABDOMINAL PAIN UPPER,5
AT,BLOOD GLUCOSE INCREASED,5
AT,C-REACTIVE PROTEIN INCREASED,5
AT,CONVULSION,5
AT,GASTRITIS HAEMORRHAGIC,5
AT,GENERALISED TONIC-CLONIC SEIZURE,5
AT,ISCHAEMIC STROKE,5
AT,METABOLIC ALKALOSIS,5
AT,OEDEMA,5
AT,PAIN IN EXTREMITY,5
AT,PANCYTOPENIA,5
AT,POLYNEUROPATHY,5
AT,PRURITUS,5
AT,PULMONARY OEDEMA,5
AT,SINUS TACHYCARDIA,5
AT,UROSEPSIS,5
AT,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,4
AT,BLOOD PRESSURE INCREASED,4
AT,BONE PAIN,4
AT,BRADYCARDIA,4
AT,BRONCHITIS,4
AT,CARDIAC FAILURE CHRONIC,4
AT,CHEST PAIN,4
AT,CHRONIC GASTRITIS,4
AT,COUGH,4
AT,DIZZINESS,4
AT,DYSPNOEA EXERTIONAL,4
AT,EPIDIDYMITIS,4
AT,GASTRITIS EROSIVE,4
AT,HAEMATOMA,4
AT,HAEMORRHAGE,4
AT,HEADACHE,4
AT,HEPATOMEGALY,4
AT,HYPERKINESIA,4
AT,INTENTIONAL DRUG MISUSE,4
AT,INTESTINAL HAEMORRHAGE,4
AT,JAUNDICE,4
AT,MALAISE,4
AT,MITRAL VALVE INCOMPETENCE,4
AT,MYOCARDIAL INFARCTION,4
AT,PLATELET COUNT INCREASED,4
AT,RASH,4
AT,SPLENOMEGALY,4
AT,SUDDEN CARDIAC DEATH,4
AT,VENTRICULAR TACHYCARDIA,4
AT,VERTIGO,4
AT,WHITE BLOOD CELL COUNT INCREASED,4
AT,ACUTE MYELOID LEUKAEMIA,3
AT,ANAEMIA MACROCYTIC,3
AT,ANURIA,3
AT,AORTIC ARTERIOSCLEROSIS,3
AT,ARTHRALGIA,3
AT,ASPARTATE AMINOTRANSFERASE INCREASED,3
AT,BACK PAIN,3
AT,BLOOD BILIRUBIN INCREASED,3
AT,CARDIOGENIC SHOCK,3
AT,CLOSTRIDIUM DIFFICILE INFECTION,3
AT,DEEP VEIN THROMBOSIS,3
AT,DEPRESSION,3
AT,DRUG WITHDRAWAL SYNDROME,3
AT,DRUG-INDUCED LIVER INJURY,3
AT,DYSPHONIA,3
AT,ELECTROCARDIOGRAM ABNORMAL,3
AT,ELECTROCARDIOGRAM ST SEGMENT ABNORMAL,3
AT,ELECTROLYTE IMBALANCE,3
AT,FEBRILE NEUTROPENIA,3
AT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,3
AT,GASTRITIS,3
AT,GASTROENTERITIS,3
AT,HAEMATOCHEZIA,3
AT,HAEMODIALYSIS,3
AT,HEPATIC ENZYME INCREASED,3
AT,HYPERLACTACIDAEMIA,3
AT,HYPERVOLAEMIA,3
AT,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,3
AT,LEUKOCYTOSIS,3
AT,LIVER FUNCTION TEST INCREASED,3
AT,MALIGNANT NEOPLASM PROGRESSION,3
AT,MOBILITY DECREASED,3
AT,MULTI-ORGAN FAILURE,3
AT,MUSCLE SPASMS,3
AT,MUSCULAR WEAKNESS,3
AT,MYALGIA,3
AT,MYOCARDIAL ISCHAEMIA,3
AT,NEPHROPATHY,3
AT,OBESITY,3
AT,OLIGURIA,3
AT,OSTEITIS,3
AT,PALLOR,3
AT,PALPITATIONS,3
AT,PLATELET COUNT DECREASED,3
AT,PNEUMONITIS,3
AT,RENAL CYST,3
AT,RENAL CYST INFECTION,3
AT,RENAL CYST RUPTURED,3
AT,RENAL DISORDER,3
AT,RESPIRATORY FAILURE,3
AT,RIGHT VENTRICULAR FAILURE,3
AT,SUBDURAL HAEMATOMA,3
AT,THROMBOPHLEBITIS,3
AT,TOXICITY TO VARIOUS AGENTS,3
AT,VENTRICULAR ARRHYTHMIA,3
AT,ABDOMINAL PAIN,2
AT,ACUTE MYOCARDIAL INFARCTION,2
AT,ALANINE AMINOTRANSFERASE INCREASED,2
AT,APHASIA,2
AT,APLASTIC ANAEMIA,2
AT,ARRHYTHMIA,2
AT,ATELECTASIS,2
AT,ATRIOVENTRICULAR BLOCK COMPLETE,2
AT,BLOOD ALKALINE PHOSPHATASE INCREASED,2
AT,BLOOD CHOLESTEROL INCREASED,2
AT,BLOOD PHOSPHORUS DECREASED,2
AT,BLOOD POTASSIUM INCREASED,2
AT,BLOOD PRESSURE DECREASED,2
AT,BLOOD UREA INCREASED,2
AT,BLOOD URIC ACID INCREASED,2
AT,CARDIAC ARREST,2
AT,CARDIAC DISORDER,2
AT,CARDIOMYOPATHY,2
AT,CHEST DISCOMFORT,2
AT,CHOLECYSTITIS,2
AT,CHOLESTASIS,2
AT,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
AT,CONCOMITANT DISEASE AGGRAVATED,2
AT,CYTOMEGALOVIRUS INFECTION,2
AT,DIABETES MELLITUS,2
AT,DISEASE PROGRESSION,2
AT,DIVERTICULITIS,2
AT,DIVERTICULUM,2
AT,DRUG ERUPTION,2
AT,ERYTHEMA,2
AT,ESCHERICHIA BACTERAEMIA,2
AT,FEMUR FRACTURE,2
AT,FLUID OVERLOAD,2
AT,GASTRIC ULCER,2
AT,GASTROINTESTINAL DISORDER,2
AT,GENERALISED OEDEMA,2
AT,GLOMERULAR FILTRATION RATE DECREASED,2
AT,HAEMATEMESIS,2
AT,HAEMATOCRIT DECREASED,2
AT,HEART RATE INCREASED,2
AT,HYDRONEPHROSIS,2
AT,HYPERBILIRUBINAEMIA,2
AT,HYPERGLYCAEMIA,2
AT,HYPERPHOSPHATAEMIA,2
AT,HYPERTENSION,2
AT,HYPERTONIA,2
AT,HYPOACUSIS,2
AT,HYPOCHLORAEMIA,2
AT,INFLUENZA,2
AT,INSOMNIA,2
AT,JOINT SWELLING,2
AT,LARGE INTESTINE PERFORATION,2
AT,LEFT VENTRICULAR DYSFUNCTION,2
AT,LEFT VENTRICULAR HYPERTROPHY,2
AT,LIVER FUNCTION TEST ABNORMAL,2
AT,LOSS OF CONSCIOUSNESS,2
AT,MULTIPLE INJURIES,2
AT,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
AT,MYELOFIBROSIS,2
AT,MYOCLONUS,2
AT,NASOPHARYNGITIS,2
AT,NEOPLASM PROGRESSION,2
AT,NEPHRITIS,2
AT,NOCTURIA,2
AT,ORTHOPNOEA,2
AT,OSTEOARTHRITIS,2
AT,OSTEONECROSIS,2
AT,PAIN,2
AT,PERICARDIAL EFFUSION,2
AT,PLATELET ANISOCYTOSIS,2
AT,POST PROCEDURAL HAEMORRHAGE,2
AT,PRODUCT USE IN UNAPPROVED INDICATION,2
AT,PROSTATE CANCER RECURRENT,2
AT,PROTHROMBIN TIME SHORTENED,2
AT,RALES,2
AT,RECTAL HAEMORRHAGE,2
AT,RENAL FUNCTION TEST ABNORMAL,2
AT,RESPIRATORY DEPRESSION,2
AT,ROAD TRAFFIC ACCIDENT,2
AT,SEIZURE,2
AT,SEROTONIN SYNDROME,2
AT,SHOCK HAEMORRHAGIC,2
AT,SOMNOLENCE,2
AT,STAPHYLOCOCCAL INFECTION,2
AT,STAPHYLOCOCCAL SEPSIS,2
AT,SUBCUTANEOUS HAEMATOMA,2
AT,SUDDEN DEATH,2
AT,SYSTOLIC DYSFUNCTION,2
AT,TACHYCARDIA,2
AT,TONSILLITIS,2
AT,TRACHEAL PAIN,2
AT,TRANSFERRIN DECREASED,2
AT,TRANSPLANT REJECTION,2
AT,TYPE 2 DIABETES MELLITUS,2
AT,UNEVALUABLE EVENT,2
AT,UPPER GASTROINTESTINAL HAEMORRHAGE,2
AT,VIRAL LOAD INCREASED,2
AT,ABDOMINAL DISCOMFORT,1
AT,ABDOMINAL DISTENSION,1
AT,ABSCESS,1
AT,ABSCESS LIMB,1
AT,ACNE PUSTULAR,1
AT,ACTIVITIES OF DAILY LIVING IMPAIRED,1
AT,ACUTE HEPATIC FAILURE,1
AT,ADENOCARCINOMA,1
AT,ADENOCARCINOMA OF COLON,1
AT,ADJUSTMENT DISORDER,1
AT,ADRENOMEGALY,1
AT,AFFECT LABILITY,1
AT,AGEUSIA,1
AT,AMYLASE INCREASED,1
AT,ANAEMIA HAEMOLYTIC AUTOIMMUNE,1
AT,ANGIOEDEMA,1
AT,ANGIOPATHY,1
AT,ANGIOPLASTY,1
AT,ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC,1
AT,ANXIETY,1
AT,AORTIC ANEURYSM,1
AT,AORTIC DISORDER,1
AT,AORTIC STENOSIS,1
AT,APATHY,1
AT,APLASIA PURE RED CELL,1
AT,ARTERIAL THERAPEUTIC PROCEDURE,1
AT,ARTERIOSCLEROSIS,1
AT,ARTERIOSCLEROSIS CORONARY ARTERY,1
AT,ARTHRITIS,1
AT,ASTHMA,1
AT,ATRIAL ENLARGEMENT,1
AT,AUTOIMMUNE THROMBOCYTOPENIA,1
AT,BASAL GANGLIA HAEMORRHAGE,1
AT,BASOPHIL COUNT INCREASED,1
AT,BETA 2 MICROGLOBULIN INCREASED,1
AT,BILIRUBIN CONJUGATED INCREASED,1
AT,BLAST CELL COUNT INCREASED,1
AT,BLAST CELL CRISIS,1
AT,BLINDNESS UNILATERAL,1
AT,BLISTER,1
AT,BLOOD ALBUMIN DECREASED,1
AT,BLOOD BICARBONATE INCREASED,1
AT,BLOOD BILIRUBIN UNCONJUGATED INCREASED,1
AT,BLOOD CHOLINESTERASE DECREASED,1
AT,BLOOD CULTURE POSITIVE,1
AT,BLOOD PRESSURE ABNORMAL,1
AT,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
AT,BLOOD SODIUM DECREASED,1
AT,BLOOD URINE PRESENT,1
AT,BRAIN STEM HAEMORRHAGE,1
AT,BRAIN STEM INFARCTION,1
AT,BRONCHIAL OBSTRUCTION,1
AT,BRONCHOPULMONARY ASPERGILLOSIS,1
AT,CANDIDURIA,1
AT,CARCINOMA IN SITU,1
AT,CARDIAC FAILURE ACUTE,1
AT,CARDIAC FAILURE CONGESTIVE,1
AT,CARDIAC FIBRILLATION,1
AT,CARDIOMEGALY,1
AT,CARDIOPULMONARY FAILURE,1
AT,CD4 LYMPHOCYTES DECREASED,1
AT,CELLULITIS,1
AT,CEREBRAL INFARCTION,1
AT,CEREBRAL VENTRICLE COLLAPSE,1
AT,CHEYNE-STOKES RESPIRATION,1
AT,CHILLS,1
AT,CHOLELITHIASIS,1
AT,CHOREA,1
AT,CHRONIC KIDNEY DISEASE,1
AT,CHRONIC SINUSITIS,1
AT,COAGULOPATHY,1
AT,COLD SWEAT,1
AT,COLITIS,1
AT,COLITIS ISCHAEMIC,1
AT,COLITIS ULCERATIVE,1
AT,COLON ADENOMA,1
AT,COMPUTERISED TOMOGRAM HEAD ABNORMAL,1
AT,CONCOMITANT DISEASE PROGRESSION,1
AT,CONCUSSION,1
AT,CONTRAINDICATED PRODUCT ADMINISTERED,1
AT,CYTOMEGALOVIRUS VIRAEMIA,1
AT,DECREASED ACTIVITY,1
AT,DELIRIUM,1
AT,DEMENTIA,1
AT,DEPRESSED MOOD,1
AT,DERMATITIS ALLERGIC,1
AT,DEVICE MALFUNCTION,1
AT,DIABETIC FOOT INFECTION,1
AT,DIABETIC GASTROPATHY,1
AT,DIASTOLIC DYSFUNCTION,1
AT,DIFFUSE LARGE B-CELL LYMPHOMA,1
AT,DILATATION VENTRICULAR,1
AT,DISSEMINATED INTRAVASCULAR COAGULATION,1
AT,DISTURBANCE IN ATTENTION,1
AT,DIVERTICULAR PERFORATION,1
AT,DIZZINESS POSTURAL,1
AT,DRUG EFFECT INCOMPLETE,1
AT,DRUG HYPERSENSITIVITY,1
AT,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
AT,DRUG INTOLERANCE,1
AT,DRUG LEVEL INCREASED,1
AT,DRUG SPECIFIC ANTIBODY PRESENT,1
AT,DRUG USE DISORDER,1
AT,DUODENAL ULCER HAEMORRHAGE,1
AT,EAR HAEMORRHAGE,1
AT,ECZEMA,1
AT,ELECTROCARDIOGRAM U-WAVE ABNORMALITY,1
AT,EMOTIONAL DISTRESS,1
AT,ENDOCARDITIS,1
AT,ENTEROCOLITIS HAEMORRHAGIC,1
AT,EOSINOPHILIA,1
AT,EPILEPSY,1
AT,EYELID PTOSIS,1
AT,FAECES DISCOLOURED,1
AT,FAECES SOFT,1
AT,FEAR,1
AT,FISTULA,1
AT,FLUID IMBALANCE,1
AT,GAIT DISTURBANCE,1
AT,GASTRIC CYST,1
AT,GASTRIC MUCOSA ERYTHEMA,1
AT,GASTROENTERITIS RADIATION,1
AT,GASTROINTESTINAL PAIN,1
AT,GLIOSIS,1
AT,GRAFT LOSS,1
AT,GRAND MAL CONVULSION,1
AT,HAEMANGIOMA OF LIVER,1
AT,HAEMOGLOBIN ABNORMAL,1
AT,HAEMOLYSIS,1
AT,HAEMORRHAGE INTRACRANIAL,1
AT,HAEMORRHAGE SUBCUTANEOUS,1
AT,HAEMORRHAGIC ANAEMIA,1
AT,HAEMORRHOIDS,1
AT,HALLUCINATION,1
AT,HEAD INJURY,1
AT,HEART VALVE STENOSIS,1
AT,HEMIPARESIS,1
AT,HEPATIC CIRRHOSIS,1
AT,HEPATITIS,1
AT,HEPATITIS CHOLESTATIC,1
AT,HEPATORENAL SYNDROME,1
AT,HIATUS HERNIA,1
AT,HIP FRACTURE,1
AT,HOSPITALISATION,1
AT,HYPERCHOLESTEROLAEMIA,1
AT,HYPERLIPIDAEMIA,1
AT,HYPERPLASIA,1
AT,HYPERSENSITIVITY,1
AT,HYPERTENSIVE CRISIS,1
AT,HYPERTHYROIDISM,1
AT,HYPERURICAEMIA,1
AT,HYPOAESTHESIA,1
AT,HYPOCALCAEMIA,1
AT,HYPOPITUITARISM,1
AT,HYPOTHYROIDISM,1
AT,IMPAIRED WORK ABILITY,1
AT,INCORRECT DRUG ADMINISTRATION DURATION,1
AT,INCREASED APPETITE,1
AT,INFLAMMATION,1
AT,INFLAMMATORY MARKER INCREASED,1
AT,INJECTION SITE ERYTHEMA,1
AT,INJECTION SITE EXFOLIATION,1
AT,INJECTION SITE REACTION,1
AT,INJECTION SITE SWELLING,1
AT,INJURY,1
AT,INTENTIONAL PRODUCT MISUSE,1
AT,INTENTIONAL UNDERDOSE,1
AT,INTERSTITIAL LUNG DISEASE,1
AT,INTRACRANIAL LIPOMA,1
AT,INTRAVENTRICULAR HAEMORRHAGE,1
AT,ISCHAEMIA,1
AT,KIDNEY TRANSPLANT REJECTION,1
AT,LACRIMATION INCREASED,1
AT,LACTIC ACIDOSIS,1
AT,LARYNGEAL OEDEMA,1
AT,LEFT ATRIAL ENLARGEMENT,1
AT,LEFT VENTRICULAR FAILURE,1
AT,LEG AMPUTATION,1
AT,LETHARGY,1
AT,LEUKOENCEPHALOPATHY,1
AT,LIPASE INCREASED,1
AT,LOCALISED OEDEMA,1
AT,LOW DENSITY LIPOPROTEIN INCREASED,1
AT,LOWER GASTROINTESTINAL HAEMORRHAGE,1
AT,LOWER LIMB FRACTURE,1
AT,LUPUS-LIKE SYNDROME,1
AT,LYMPHADENOPATHY,1
AT,LYMPHOCELE,1
AT,LYMPHOCYTE COUNT DECREASED,1
AT,LYMPHOCYTE COUNT INCREASED,1
AT,LYMPHOPENIA,1
AT,MASTITIS,1
AT,MEAN CELL HAEMOGLOBIN DECREASED,1
AT,MEAN CELL VOLUME DECREASED,1
AT,MEDICAL DEVICE COMPLICATION,1
AT,METABOLIC ACIDOSIS,1
AT,METAMYELOCYTE COUNT INCREASED,1
AT,METASTASES TO LUNG,1
AT,METASTASIS,1
AT,METASTATIC BRONCHIAL CARCINOMA,1
AT,METASTATIC MALIGNANT MELANOMA,1
AT,MUSCLE HAEMORRHAGE,1
AT,MUSCLE HYPERTROPHY,1
AT,MUSCLE SWELLING,1
AT,MYELOCYTE COUNT INCREASED,1
AT,MYOCARDIAL NECROSIS MARKER INCREASED,1
AT,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED,1
AT,NEPHROTIC SYNDROME,1
AT,NERVOUS SYSTEM DISORDER,1
AT,NEUROMYOPATHY,1
AT,NO THERAPEUTIC RESPONSE,1
AT,NON-SMALL CELL LUNG CANCER,1
AT,OEDEMATOUS KIDNEY,1
AT,ONYCHOMYCOSIS,1
AT,OPTIC NEURITIS,1
AT,ORAL HERPES,1
AT,OSTEOMYELITIS,1
AT,OSTEONECROSIS OF JAW,1
AT,OXYGEN SATURATION DECREASED,1
AT,PANCREATIC CARCINOMA,1
AT,PANCREATITIS ACUTE,1
AT,PANIC REACTION,1
AT,PARESIS,1
AT,PARTIAL SEIZURES,1
AT,PCO2 DECREASED,1
AT,PELVIC HAEMORRHAGE,1
AT,PENETRATING AORTIC ULCER,1
AT,PERICARDIAL DRAINAGE,1
AT,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
AT,PERIPHERAL NERVE LESION,1
AT,PERIPHERAL VASCULAR DISORDER,1
AT,PERITONEAL DIALYSIS,1
AT,PERITONITIS,1
AT,PERONEAL NERVE PALSY,1
AT,PHLEBITIS,1
AT,PLEURAL DISORDER,1
AT,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
AT,PNEUMONIA KLEBSIELLA,1
AT,PNEUMONITIS CHEMICAL,1
AT,PNEUMOTHORAX TRAUMATIC,1
AT,POLYCYTHAEMIA,1
AT,PORPHYRIA NON-ACUTE,1
AT,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
AT,POSTOPERATIVE WOUND COMPLICATION,1
AT,POTENTIATING DRUG INTERACTION,1
AT,PRESCRIBED UNDERDOSE,1
AT,PRODUCT USE ISSUE,1
AT,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
AT,PROTEIN TOTAL DECREASED,1
AT,PROTHROMBIN TIME PROLONGED,1
AT,PSEUDOMONAS INFECTION,1
AT,PULMONARY ARTERIAL HYPERTENSION,1
AT,PULMONARY CONGESTION,1
AT,PULMONARY FIBROSIS,1
AT,PULMONARY INFARCTION,1
AT,PULMONARY VASCULAR DISORDER,1
AT,PULSE ABSENT,1
AT,RASH GENERALISED,1
AT,RASH PAPULAR,1
AT,RECTAL ULCER,1
AT,RED BLOOD CELL AGGLUTINATION,1
AT,RED BLOOD CELL COUNT INCREASED,1
AT,RED CELL DISTRIBUTION WIDTH INCREASED,1
AT,REFRACTORY CYTOPENIA WITH UNILINEAGE DYSPLASIA,1
AT,RENAL ANEURYSM,1
AT,RENAL CYST HAEMORRHAGE,1
AT,RENAL INJURY,1
AT,RESPIRATORY DISTRESS,1
AT,RESPIRATORY TRACT INFECTION,1
AT,RESTLESS LEGS SYNDROME,1
AT,RESTLESSNESS,1
AT,RETICULOCYTE COUNT DECREASED,1
AT,RETICULOCYTE COUNT INCREASED,1
AT,RETINAL HAEMORRHAGE,1
AT,RETINAL PIGMENT EPITHELIOPATHY,1
AT,RIGHT ATRIAL DILATATION,1
AT,RIGHT VENTRICULAR DILATATION,1
AT,RIGHT VENTRICULAR DYSFUNCTION,1
AT,RIGHT VENTRICULAR ENLARGEMENT,1
AT,SCOLIOSIS,1
AT,SECOND PRIMARY MALIGNANCY,1
AT,SECRETION DISCHARGE,1
AT,SEPTIC SHOCK,1
AT,SKIN DISORDER,1
AT,SKIN LESION,1
AT,SKIN NECROSIS,1
AT,SKIN ULCER,1
AT,SKIN WRINKLING,1
AT,SKULL FRACTURE,1
AT,SLEEP APNOEA SYNDROME,1
AT,SLEEP DISORDER,1
AT,SOFT TISSUE INJURY,1
AT,SPINAL PAIN,1
AT,SPLEEN DISORDER,1
AT,SPONTANEOUS HAEMATOMA,1
AT,STAPHYLOCOCCAL BACTERAEMIA,1
AT,STOMATITIS,1
AT,STRIDOR,1
AT,SUBARACHNOID HAEMORRHAGE,1
AT,SUBCUTANEOUS ABSCESS,1
AT,SUNBURN,1
AT,SUPRAVENTRICULAR TACHYCARDIA,1
AT,TENDON RUPTURE,1
AT,TERMINAL STATE,1
AT,THROMBOCYTOSIS,1
AT,THROMBOPHLEBITIS SUPERFICIAL,1
AT,THROMBOSIS,1
AT,TOE AMPUTATION,1
AT,TONSILLAR DISORDER,1
AT,TOOTH LOSS,1
AT,TOXIC SKIN ERUPTION,1
AT,TRICUSPID VALVE INCOMPETENCE,1
AT,TROPONIN INCREASED,1
AT,TROPONIN T INCREASED,1
AT,TUBERCULOUS PLEURISY,1
AT,TYPE 1 DIABETES MELLITUS,1
AT,UPPER LIMB FRACTURE,1
AT,UPPER RESPIRATORY TRACT INFECTION,1
AT,URETHRAL PROLAPSE,1
AT,URINE OUTPUT DECREASED,1
AT,URINE OUTPUT INCREASED,1
AT,UVEITIS,1
AT,VAGINAL HAEMORRHAGE,1
AT,VANISHING BILE DUCT SYNDROME,1
AT,VARICES OESOPHAGEAL,1
AT,VARICOSE VEIN,1
AT,VASCULITIS,1
AT,VENOOCCLUSIVE LIVER DISEASE,1
AT,VENOUS INSUFFICIENCY,1
AT,VENOUS RECANALISATION,1
AT,VENTRICULAR HYPOKINESIA,1
AT,VIRAL INFECTION,1
AT,VISION BLURRED,1
AT,VISUAL IMPAIRMENT,1
AT,VITAMIN D DEFICIENCY,1
AT,WEIGHT INCREASED,1
AT,WHITE MATTER LESION,1
AT,WITHDRAWAL SYNDROME,1
AT,WOUND,1
BS,DIABETES MELLITUS,1
BS,MITRAL VALVE INCOMPETENCE,1
BH,DRUG INEFFECTIVE,1
BH,PRODUCT QUALITY ISSUE,1
BH,THROMBOSIS IN DEVICE,1
BD,CARDIAC TAMPONADE,4
BD,PLEURAL EFFUSION,4
BD,PERICARDIAL EFFUSION,3
BD,ACUTE PULMONARY OEDEMA,2
BD,DRUG RESISTANCE,2
BD,ARTHRALGIA,1
BD,HAEMOTHORAX,1
BD,HYPOTENSION,1
BD,JUGULAR VEIN DISTENSION,1
BD,KWASHIORKOR,1
BD,OEDEMA,1
BD,PERICARDIAL HAEMORRHAGE,1
BD,PERICARDIAL RUB,1
BD,PURPURA,1
BD,RESPIRATORY DISTRESS,1
BD,RICKETTSIOSIS,1
BD,TACHYCARDIA,1
BD,VISCERAL LEISHMANIASIS,1
BB,PARAPSORIASIS,1
BB,RASH MACULO-PAPULAR,1
BB,SKIN HYPERPIGMENTATION,1
BY,ASCITES,1
BY,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
BY,BILIRUBIN CONJUGATED INCREASED,1
BY,BLOOD BILIRUBIN INCREASED,1
BY,CONDITION AGGRAVATED,1
BY,CYANOSIS,1
BY,DYSPNOEA,1
BY,HEART SOUNDS ABNORMAL,1
BY,HEPATOMEGALY,1
BY,HYDROTHORAX,1
BY,OEDEMA,1
BY,OEDEMA PERIPHERAL,1
BY,PERICARDIAL EFFUSION,1
BY,PNEUMONIA,1
BY,PULMONARY ARTERIAL HYPERTENSION,1
BY,SUPRAVENTRICULAR EXTRASYSTOLES,1
BY,WEIGHT DECREASED,1
BE,FATIGUE,21
BE,CARDIAC FAILURE,20
BE,DECREASED APPETITE,19
BE,DYSPNOEA,18
BE,ANAEMIA,17
BE,EPISTAXIS,17
BE,DIARRHOEA,16
BE,NAUSEA,15
BE,VOMITING,15
BE,WEIGHT DECREASED,15
BE,CONFUSIONAL STATE,14
BE,CONSTIPATION,14
BE,HYPERTENSION,14
BE,URINARY TRACT INFECTION,14
BE,DELIRIUM,13
BE,GENERAL PHYSICAL HEALTH DETERIORATION,13
BE,OEDEMA PERIPHERAL,13
BE,ASCITES,11
BE,FALL,11
BE,DEATH,10
BE,HYPOKALAEMIA,10
BE,NEUTROPENIA,10
BE,RENAL FAILURE,10
BE,ASTHENIA,9
BE,ATRIAL FIBRILLATION,9
BE,HYPOTENSION,9
BE,CARDIAC ARREST,8
BE,ENCEPHALOPATHY,8
BE,PLEURAL EFFUSION,8
BE,PRURITUS,8
BE,PYREXIA,8
BE,RENAL FAILURE ACUTE,8
BE,RHABDOMYOLYSIS,8
BE,DIZZINESS,7
BE,FEBRILE NEUTROPENIA,7
BE,HEPATIC FAILURE,7
BE,OEDEMA,7
BE,POLYNEUROPATHY,7
BE,RASH,7
BE,RENAL IMPAIRMENT,7
BE,SEPSIS,7
BE,TORSADE DE POINTES,7
BE,ABDOMINAL DISTENSION,6
BE,BRADYCARDIA,6
BE,CEREBRAL HAEMORRHAGE,6
BE,HEPATIC CIRRHOSIS,6
BE,INFLAMMATION,6
BE,METABOLIC ACIDOSIS,6
BE,PNEUMONIA,6
BE,THROMBOCYTOPENIA,6
BE,WEIGHT INCREASED,6
BE,ACUTE KIDNEY INJURY,5
BE,ALOPECIA,5
BE,CEREBROVASCULAR ACCIDENT,5
BE,DEEP VEIN THROMBOSIS,5
BE,HEADACHE,5
BE,HIP FRACTURE,5
BE,HYPOCALCAEMIA,5
BE,HYPONATRAEMIA,5
BE,LEUKOPENIA,5
BE,MUCOSAL INFLAMMATION,5
BE,PANCYTOPENIA,5
BE,PRODUCT USE ISSUE,5
BE,RECTAL HAEMORRHAGE,5
BE,TINNITUS,5
BE,TOOTHACHE,5
BE,ABDOMINAL PAIN,4
BE,AGITATION,4
BE,ALTERED STATE OF CONSCIOUSNESS,4
BE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,4
BE,DEPRESSION,4
BE,DRUG INEFFECTIVE,4
BE,DYSPEPSIA,4
BE,DYSPHONIA,4
BE,DYSPNOEA EXERTIONAL,4
BE,ELECTROCARDIOGRAM QT PROLONGED,4
BE,FOETAL EXPOSURE DURING PREGNANCY,4
BE,GAIT DISTURBANCE,4
BE,GASTROINTESTINAL HAEMORRHAGE,4
BE,GENERALISED OEDEMA,4
BE,HAEMANGIOMA,4
BE,HAEMORRHAGE,4
BE,HALLUCINATION_ VISUAL,4
BE,HYPOXIA,4
BE,LUNG INFECTION,4
BE,MALAISE,4
BE,MALIGNANT NEOPLASM PROGRESSION,4
BE,MYALGIA,4
BE,PERIPHERAL SENSORY NEUROPATHY,4
BE,PREMATURE BABY,4
BE,PSORIASIS,4
BE,PULMONARY ALVEOLAR HAEMORRHAGE,4
BE,PULMONARY EMBOLISM,4
BE,PULMONARY OEDEMA,4
BE,SEPTIC SHOCK,4
BE,SHOCK HAEMORRHAGIC,4
BE,SPEECH DISORDER,4
BE,STATUS EPILEPTICUS,4
BE,ABDOMINAL PAIN UPPER,3
BE,AMMONIA INCREASED,3
BE,ARRHYTHMIA,3
BE,ARTHRALGIA,3
BE,AXILLARY VEIN THROMBOSIS,3
BE,BLOOD PRESSURE DECREASED,3
BE,BRAIN OEDEMA,3
BE,CHEST PAIN,3
BE,COUGH,3
BE,DEHYDRATION,3
BE,DISEASE PROGRESSION,3
BE,DISTURBANCE IN ATTENTION,3
BE,DRUG INTOLERANCE,3
BE,DRUG-INDUCED LIVER INJURY,3
BE,DRY SKIN,3
BE,DYSGEUSIA,3
BE,ECCHYMOSIS,3
BE,FAECES DISCOLOURED,3
BE,FEELING ABNORMAL,3
BE,HAEMATOMA,3
BE,HEPATOCELLULAR CARCINOMA,3
BE,HYPERGLYCAEMIA,3
BE,HYPERHIDROSIS,3
BE,ISCHAEMIC STROKE,3
BE,JAUNDICE,3
BE,LIVER DISORDER,3
BE,MELAENA,3
BE,MUSCULAR WEAKNESS,3
BE,MYOCARDIAL INFARCTION,3
BE,MYOCLONUS,3
BE,OVERDOSE,3
BE,PARANOIA,3
BE,PNEUMONITIS,3
BE,PNEUMOTHORAX,3
BE,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,3
BE,SINUS TACHYCARDIA,3
BE,SOMNOLENCE,3
BE,SPLENOMEGALY,3
BE,SUBCLAVIAN VEIN THROMBOSIS,3
BE,TRANSIENT ISCHAEMIC ATTACK,3
BE,UROSEPSIS,3
BE,VARICES OESOPHAGEAL,3
BE,VENTRICULAR TACHYCARDIA,3
BE,VERTIGO,3
BE,ABNORMAL FAECES,2
BE,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,2
BE,ACUTE LUNG INJURY,2
BE,ACUTE PULMONARY OEDEMA,2
BE,AGGRESSION,2
BE,ALANINE AMINOTRANSFERASE INCREASED,2
BE,ALCOHOLISM,2
BE,AMYOTROPHY,2
BE,ANAEMIA MACROCYTIC,2
BE,ANURIA,2
BE,ANXIETY,2
BE,AORTIC VALVE INCOMPETENCE,2
BE,ASPARTATE AMINOTRANSFERASE INCREASED,2
BE,ATELECTASIS,2
BE,ATRIAL FLUTTER,2
BE,BLISTER,2
BE,BLOOD BILIRUBIN INCREASED,2
BE,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,2
BE,BLOOD CREATININE INCREASED,2
BE,BLOOD PRESSURE INCREASED,2
BE,BRONCHITIS,2
BE,CAMPYLOBACTER GASTROENTERITIS,2
BE,CANDIDA INFECTION,2
BE,CAPILLARY LEAK SYNDROME,2
BE,CARDIAC DISORDER,2
BE,CEREBRAL HAEMANGIOMA,2
BE,CHILLS,2
BE,CLOSTRIDIUM DIFFICILE INFECTION,2
BE,COAGULOPATHY,2
BE,COMA,2
BE,CONDITION AGGRAVATED,2
BE,CYSTITIS,2
BE,CYTOMEGALOVIRUS INFECTION,2
BE,DISORIENTATION,2
BE,DYSPHAGIA,2
BE,DYSSTASIA,2
BE,EJECTION FRACTION DECREASED,2
BE,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,2
BE,ENTEROCOLITIS,2
BE,ESCHERICHIA INFECTION,2
BE,EXTRASYSTOLES,2
BE,FAECES PALE,2
BE,GASTRIC ULCER,2
BE,GASTROOESOPHAGEAL REFLUX DISEASE,2
BE,HAEMATEMESIS,2
BE,HAEMATURIA,2
BE,HAEMORRHAGIC DIATHESIS,2
BE,HAEMOTHORAX,2
BE,HALLUCINATION_ AUDITORY,2
BE,HEART RATE INCREASED,2
BE,HEPATIC ENCEPHALOPATHY,2
BE,HEPATIC FIBROSIS,2
BE,HEPATIC FUNCTION ABNORMAL,2
BE,HEPATOMEGALY,2
BE,HIATUS HERNIA,2
BE,HYPERTRIGLYCERIDAEMIA,2
BE,HYPOALBUMINAEMIA,2
BE,HYPOPHAGIA,2
BE,HYPOPROTEINAEMIA,2
BE,HYPOVENTILATION,2
BE,ILEUS,2
BE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
BE,INSOMNIA,2
BE,INTERSTITIAL LUNG DISEASE,2
BE,IRRITABILITY,2
BE,LACTIC ACIDOSIS,2
BE,LEFT VENTRICULAR DYSFUNCTION,2
BE,LEUKOCYTOSIS,2
BE,LOCALISED INFECTION,2
BE,LOSS OF CONSCIOUSNESS,2
BE,LUNG DISORDER,2
BE,LYMPHORRHOEA,2
BE,MALNUTRITION,2
BE,MENTAL IMPAIRMENT,2
BE,MENTAL STATUS CHANGES,2
BE,MICROCYTIC ANAEMIA,2
BE,MITRAL VALVE INCOMPETENCE,2
BE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
BE,MUSCLE SPASMS,2
BE,MUSCULOSKELETAL CHEST PAIN,2
BE,MUSCULOSKELETAL PAIN,2
BE,MUSCULOSKELETAL STIFFNESS,2
BE,MYELODYSPLASTIC SYNDROME,2
BE,NECK PAIN,2
BE,NEUROPATHY PERIPHERAL,2
BE,OCULAR ICTERUS,2
BE,OESOPHAGEAL CANDIDIASIS,2
BE,OESOPHAGITIS,2
BE,OXYGEN SATURATION DECREASED,2
BE,PACKED RED BLOOD CELL TRANSFUSION,2
BE,PAIN IN EXTREMITY,2
BE,PALMAR ERYTHEMA,2
BE,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,2
BE,PARADOXICAL DRUG REACTION,2
BE,PAROTID GLAND ENLARGEMENT,2
BE,PERICARDIAL EFFUSION,2
BE,PNEUMONIA ASPIRATION,2
BE,POLYURIA,2
BE,PRODUCTIVE COUGH,2
BE,PROTEINURIA,2
BE,PYROGLUTAMATE INCREASED,2
BE,RALES,2
BE,RENAL FAILURE CHRONIC,2
BE,RESPIRATORY DISTRESS,2
BE,RHINORRHOEA,2
BE,SEIZURE,2
BE,SKIN REACTION,2
BE,STAPHYLOCOCCAL INFECTION,2
BE,STOMATITIS,2
BE,SYNCOPE,2
BE,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,2
BE,TOXIC ENCEPHALOPATHY,2
BE,TOXICITY TO VARIOUS AGENTS,2
BE,TROPONIN INCREASED,2
BE,URINE OSMOLARITY DECREASED,2
BE,VARICELLA,2
BE,ABDOMINAL WALL HAEMATOMA,1
BE,ABSCESS,1
BE,ACQUIRED DIAPHRAGMATIC EVENTRATION,1
BE,ACTIVATED PARTIAL THROMBOPLASTIN TIME ABNORMAL,1
BE,ACUTE CORONARY SYNDROME,1
BE,ACUTE HEPATIC FAILURE,1
BE,ACUTE RESPIRATORY DISTRESS SYNDROME,1
BE,ADENOCARCINOMA OF COLON,1
BE,ADVERSE EVENT,1
BE,ANAL FISSURE,1
BE,ANGIOEDEMA,1
BE,ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC,1
BE,APATHY,1
BE,APLASIA,1
BE,APLASIA PURE RED CELL,1
BE,ARTHRITIS,1
BE,ASTHMA,1
BE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
BE,ATYPICAL PNEUMONIA,1
BE,BACK PAIN,1
BE,BALANCE DISORDER,1
BE,BILE DUCT STENOSIS,1
BE,BLADDER CATHETERISATION,1
BE,BLADDER DILATATION,1
BE,BLAST CELL COUNT INCREASED,1
BE,BLOOD ALKALINE PHOSPHATASE INCREASED,1
BE,BLOOD BILIRUBIN ABNORMAL,1
BE,BLOOD GLUCOSE INCREASED,1
BE,BLOOD PRESSURE ABNORMAL,1
BE,BLOOD PRESSURE SYSTOLIC INCREASED,1
BE,BLOOD TEST ABNORMAL,1
BE,BODY TEMPERATURE INCREASED,1
BE,BONE MARROW FAILURE,1
BE,BOWEL MOVEMENT IRREGULARITY,1
BE,BRAIN HERNIATION,1
BE,BRAIN INJURY,1
BE,BREAST PAIN,1
BE,BRONCHIECTASIS,1
BE,BRONCHOPULMONARY ASPERGILLOSIS,1
BE,BUNDLE BRANCH BLOCK RIGHT,1
BE,BURSITIS INFECTIVE,1
BE,CARDIAC FAILURE CHRONIC,1
BE,CARDIAC MURMUR,1
BE,CARDIAC VALVE DISEASE,1
BE,CARDIOVASCULAR DISORDER,1
BE,CAROTID ARTERY OCCLUSION,1
BE,CATARACT,1
BE,CATHETER SITE VESICLES,1
BE,CHOLANGITIS,1
BE,CHOLELITHIASIS,1
BE,CHROMATURIA,1
BE,CHRONIC KIDNEY DISEASE,1
BE,CHRONIC SINUSITIS,1
BE,CIRCULATORY COLLAPSE,1
BE,CLONUS,1
BE,COLITIS,1
BE,COMA SCALE ABNORMAL,1
BE,COMPLICATIONS OF TRANSPLANTED KIDNEY,1
BE,CONJUNCTIVAL IRRITATION,1
BE,CONTUSION,1
BE,CORNEAL OPACITY,1
BE,CREPITATIONS,1
BE,DEAFNESS UNILATERAL,1
BE,DECUBITUS ULCER,1
BE,DELUSION,1
BE,DEMENTIA,1
BE,DEPRESSED MOOD,1
BE,DERMATITIS ACNEIFORM,1
BE,DERMATOSIS,1
BE,DIABETES MELLITUS,1
BE,DIABETES MELLITUS INADEQUATE CONTROL,1
BE,DIFFUSE LARGE B-CELL LYMPHOMA,1
BE,DILATATION VENTRICULAR,1
BE,DISSEMINATED INTRAVASCULAR COAGULATION,1
BE,DRUG EFFECT DECREASED,1
BE,DRUG EFFECT INCOMPLETE,1
BE,DRY MOUTH,1
BE,DUODENAL ULCER,1
BE,DYSARTHRIA,1
BE,ECZEMA,1
BE,ECZEMA ASTEATOTIC,1
BE,ELECTROCARDIOGRAM ABNORMAL,1
BE,ELECTROLYTE IMBALANCE,1
BE,EMBEDDED DEVICE,1
BE,ENTEROBACTER INFECTION,1
BE,ERYSIPELAS,1
BE,ERYTHEMA MULTIFORME,1
BE,ERYTHROPENIA,1
BE,ESCHERICHIA SEPSIS,1
BE,ESCHERICHIA URINARY TRACT INFECTION,1
BE,EYE OEDEMA,1
BE,EYELID OEDEMA,1
BE,FAECALOMA,1
BE,FAECES SOFT,1
BE,FEELING DRUNK,1
BE,FLATULENCE,1
BE,FLUSHING,1
BE,FOETOR HEPATICUS,1
BE,FOLLICULITIS,1
BE,FOOD CRAVING,1
BE,FOOT FRACTURE,1
BE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
BE,GASTRITIS,1
BE,GASTRITIS EROSIVE,1
BE,GASTROINTESTINAL DISORDER,1
BE,GASTROINTESTINAL INFECTION,1
BE,GASTROINTESTINAL PAIN,1
BE,GENERAL SYMPTOM,1
BE,GENITAL LESION,1
BE,GINGIVAL BLEEDING,1
BE,GOUTY ARTHRITIS,1
BE,GRAFT VERSUS HOST DISEASE,1
BE,GYNAECOMASTIA,1
BE,HAEMATOTOXICITY,1
BE,HAEMOGLOBIN DECREASED,1
BE,HAEMOLYTIC URAEMIC SYNDROME,1
BE,HAEMOPTYSIS,1
BE,HAEMORRHAGIC STROKE,1
BE,HAEMORRHOIDS,1
BE,HAIR TEXTURE ABNORMAL,1
BE,HALLUCINATION,1
BE,HEART RATE IRREGULAR,1
BE,HEMIPARESIS,1
BE,HEPATIC ENZYME INCREASED,1
BE,HEPATIC PAIN,1
BE,HEPATIC STEATOSIS,1
BE,HEPATITIS,1
BE,HEPATITIS B,1
BE,HILAR LYMPHADENOPATHY,1
BE,HISTIOCYTOSIS HAEMATOPHAGIC,1
BE,HOSPITALISATION,1
BE,HYPERAMMONAEMIC ENCEPHALOPATHY,1
BE,HYPERBILIRUBINAEMIA,1
BE,HYPERKALAEMIA,1
BE,HYPERLACTACIDAEMIA,1
BE,HYPERNATRAEMIA,1
BE,HYPERPARATHYROIDISM,1
BE,HYPERSENSITIVITY,1
BE,HYPERSENSITIVITY VASCULITIS,1
BE,HYPERTROPHIC CARDIOMYOPATHY,1
BE,HYPOCHROMIC ANAEMIA,1
BE,HYPOGLYCAEMIA,1
BE,HYPOKINESIA,1
BE,HYPOMAGNESAEMIA,1
BE,HYPOTHERMIA,1
BE,HYPOVITAMINOSIS,1
BE,HYPOVOLAEMIA,1
BE,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS,1
BE,IMPAIRED HEALING,1
BE,INFERIOR VENA CAVA STENOSIS,1
BE,INFLAMMATORY MARKER INCREASED,1
BE,INFLUENZA,1
BE,INFLUENZA LIKE ILLNESS,1
BE,INTENTIONAL OVERDOSE,1
BE,INTERNATIONAL NORMALISED RATIO INCREASED,1
BE,INTESTINAL OBSTRUCTION,1
BE,INTRAVENTRICULAR HAEMORRHAGE,1
BE,IRON DEFICIENCY ANAEMIA,1
BE,IRON OVERLOAD,1
BE,ISCHAEMIC HEPATITIS,1
BE,JOINT SWELLING,1
BE,KETOACIDOSIS,1
BE,KIDNEY TRANSPLANT REJECTION,1
BE,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
BE,LEFT VENTRICULAR HYPERTROPHY,1
BE,LEUKOCYTURIA,1
BE,LIMB DISCOMFORT,1
BE,LIVER FUNCTION TEST ABNORMAL,1
BE,LONG QT SYNDROME,1
BE,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
BE,LOWER RESPIRATORY TRACT INFECTION,1
BE,LUNG NEOPLASM MALIGNANT,1
BE,LYMPHADENOPATHY MEDIASTINAL,1
BE,LYMPHOEDEMA,1
BE,LYMPHOPENIA,1
BE,MATERNAL DRUGS AFFECTING FOETUS,1
BE,MEDICAL DEVICE CHANGE,1
BE,MEDICAL DEVICE SITE REACTION,1
BE,METASTASES TO BONE,1
BE,METASTASES TO LUNG,1
BE,MICTURITION DISORDER,1
BE,MOUTH HAEMORRHAGE,1
BE,MOUTH SWELLING,1
BE,MOVEMENT DISORDER,1
BE,MUCOUS MEMBRANE DISORDER,1
BE,MULTI-ORGAN FAILURE,1
BE,MUSCLE INJURY,1
BE,MUSCULOSKELETAL DISCOMFORT,1
BE,MYELOPROLIFERATIVE NEOPLASM,1
BE,NEOPLASM MALIGNANT,1
BE,NEPHROGENIC DIABETES INSIPIDUS,1
BE,NEPHROPATHY,1
BE,NEPHROTIC SYNDROME,1
BE,NERVOUSNESS,1
BE,NEUROENDOCRINE CARCINOMA OF THE SKIN,1
BE,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
BE,OBSTRUCTIVE UROPATHY,1
BE,ODYNOPHAGIA,1
BE,ORAL PAIN,1
BE,OROPHARYNGEAL PAIN,1
BE,OSTEOPOROSIS,1
BE,OTITIS MEDIA ACUTE,1
BE,OXYGEN SATURATION,1
BE,PACHYDERMOPERIOSTOSIS,1
BE,PAIN,1
BE,PALLOR,1
BE,PANCREATIC CARCINOMA METASTATIC,1
BE,PANCREATITIS ACUTE,1
BE,PARAESTHESIA,1
BE,PARKINSON^S DISEASE,1
BE,PARONYCHIA,1
BE,PCO2 DECREASED,1
BE,PERIARTHRITIS CALCAREA,1
BE,PERICARDIAL HAEMORRHAGE,1
BE,PERINEPHRIC COLLECTION,1
BE,PERIPHERAL COLDNESS,1
BE,PERIPHERAL MOTOR NEUROPATHY,1
BE,PERIPHERAL SWELLING,1
BE,PERIRENAL HAEMATOMA,1
BE,PERITONEAL HAEMORRHAGE,1
BE,PERITONITIS,1
BE,PLASMA CELL MYELOMA,1
BE,PLATELET COUNT DECREASED,1
BE,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
BE,PNEUMONIA PSEUDOMONAL,1
BE,PNEUMONIA STREPTOCOCCAL,1
BE,PNEUMOTHORAX TRAUMATIC,1
BE,POLLAKIURIA,1
BE,POLYARTHRITIS,1
BE,POST PROCEDURAL FISTULA,1
BE,POST PROCEDURAL HAEMATURIA,1
BE,PRESYNCOPE,1
BE,PROCEDURAL HAEMORRHAGE,1
BE,PROCTITIS,1
BE,PROPOFOL INFUSION SYNDROME,1
BE,PROSTATE CANCER,1
BE,PROTEUS TEST POSITIVE,1
BE,PROTHROMBIN LEVEL DECREASED,1
BE,PRURITUS GENERALISED,1
BE,PSEUDOMONAL SEPSIS,1
BE,PSYCHIATRIC DECOMPENSATION,1
BE,PSYCHOMOTOR HYPERACTIVITY,1
BE,PSYCHOMOTOR RETARDATION,1
BE,PULMONARY CONGESTION,1
BE,PULMONARY HAEMORRHAGE,1
BE,PULMONARY HYPERTENSION,1
BE,PYELONEPHRITIS,1
BE,PYURIA,1
BE,RASH MACULO-PAPULAR,1
BE,RECTAL ADENOCARCINOMA,1
BE,RENAL DISORDER,1
BE,RENAL INFARCT,1
BE,RENAL TRANSPLANT,1
BE,RENAL TUBULAR DISORDER,1
BE,RESPIRATORY ARREST,1
BE,RESPIRATORY DISORDER,1
BE,RESPIRATORY TRACT INFECTION,1
BE,SCAN ABNORMAL,1
BE,SHOCK,1
BE,SINUSITIS,1
BE,SKIN INDURATION,1
BE,SKIN INFECTION,1
BE,SLEEP APNOEA SYNDROME,1
BE,SMALL CELL LUNG CANCER,1
BE,SMALL INTESTINAL HAEMORRHAGE,1
BE,SMALL INTESTINE CARCINOMA,1
BE,SPLENIC HAEMATOMA,1
BE,SQUAMOUS CELL CARCINOMA,1
BE,SQUAMOUS CELL CARCINOMA OF SKIN,1
BE,STOMA SITE HYPERGRANULATION,1
BE,SUDDEN DEATH,1
BE,SUPRAVENTRICULAR TACHYCARDIA,1
BE,SUTURE RELATED COMPLICATION,1
BE,SUTURE RUPTURE,1
BE,SWELLING,1
BE,TACHYCARDIA,1
BE,TAKAYASU^S ARTERITIS,1
BE,THROMBOLYSIS,1
BE,THROMBOTIC STROKE,1
BE,TIBIA FRACTURE,1
BE,TONGUE DRY,1
BE,TRANSPLANT FAILURE,1
BE,TREATMENT NONCOMPLIANCE,1
BE,TRICUSPID VALVE INCOMPETENCE,1
BE,TUMOUR MARKER INCREASED,1
BE,UNEVALUABLE EVENT,1
BE,UNRESPONSIVE TO STIMULI,1
BE,UPPER GASTROINTESTINAL HAEMORRHAGE,1
BE,UPPER LIMB FRACTURE,1
BE,UPPER RESPIRATORY TRACT INFECTION,1
BE,URETERIC OBSTRUCTION,1
BE,URINARY INCONTINENCE,1
BE,URINE FLOW DECREASED,1
BE,URINE OUTPUT DECREASED,1
BE,URTICARIA,1
BE,VASODILATATION,1
BE,VASOPLEGIA SYNDROME,1
BE,VENTRICULAR ARRHYTHMIA,1
BE,VENTRICULAR FIBRILLATION,1
BE,VERTIGO POSITIONAL,1
BE,VIRAL INFECTION,1
BE,VISION BLURRED,1
BE,VISUAL ACUITY REDUCED,1
BE,VISUAL IMPAIRMENT,1
BE,VITAMIN D DEFICIENCY,1
BE,WHITE BLOOD CELL COUNT DECREASED,1
BE,WOUND DEHISCENCE,1
BE,WOUND EVISCERATION,1
BE,WOUND SECRETION,1
BE,WRIST FRACTURE,1
BE,YELLOW SKIN,1
BO,GASTROINTESTINAL HAEMORRHAGE,1
BO,HAEMORRHAGE,1
BO,HYPOVOLAEMIC SHOCK,1
BO,SEPTIC SHOCK,1
BO,WHITE BLOOD CELL COUNT INCREASED,1
BA,ALOPECIA,1
BA,ASCITES,1
BA,ASTHENIA,1
BA,BRADYCARDIA,1
BA,CARDIAC FAILURE,1
BA,CHEST PAIN,1
BA,CHRONIC GASTRITIS,1
BA,COLITIS,1
BA,DEATH,1
BA,DIARRHOEA,1
BA,DIVERTICULUM GASTRIC,1
BA,ERYTHEMA,1
BA,FATIGUE,1
BA,GASTRIC ULCER,1
BA,GASTROOESOPHAGEAL REFLUX DISEASE,1
BA,GENERAL PHYSICAL HEALTH DETERIORATION,1
BA,GINGIVAL BLEEDING,1
BA,HEPATIC FAILURE,1
BA,HOSPITALISATION,1
BA,HYPERVENTILATION,1
BA,JAUNDICE,1
BA,MELAENA,1
BA,NASAL INFLAMMATION,1
BA,NAUSEA,1
BA,PAIN OF SKIN,1
BA,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
BA,PORTAL VEIN THROMBOSIS,1
BA,SPLENOMEGALY,1
BA,SUDDEN DEATH,1
BA,THROMBOCYTOPENIA,1
BA,VARICES OESOPHAGEAL,1
BA,VOMITING,1
BR,DYSPNOEA,137
BR,MALAISE,118
BR,PNEUMONIA,113
BR,FATIGUE,98
BR,PAIN,94
BR,WEIGHT DECREASED,91
BR,ASTHENIA,85
BR,DRUG INEFFECTIVE,82
BR,CARDIAC DISORDER,78
BR,VOMITING,74
BR,PAIN IN EXTREMITY,73
BR,URINARY TRACT INFECTION,68
BR,ANAEMIA,64
BR,FALL,64
BR,ARTHRALGIA,61
BR,HYPERTENSION,61
BR,SWELLING,61
BR,CEREBROVASCULAR ACCIDENT,58
BR,NAUSEA,58
BR,PYREXIA,56
BR,GAIT DISTURBANCE,55
BR,CARDIAC FAILURE,54
BR,DIARRHOEA,54
BR,DIZZINESS,51
BR,INFLUENZA,50
BR,RENAL FAILURE,50
BR,BLOOD PRESSURE INCREASED,49
BR,COUGH,48
BR,HEADACHE,48
BR,FEELING ABNORMAL,46
BR,PERIPHERAL SWELLING,46
BR,CARDIAC ARREST,45
BR,DECREASED APPETITE,45
BR,DIABETES MELLITUS,44
BR,ARRHYTHMIA,43
BR,RENAL DISORDER,41
BR,INFARCTION,40
BR,RENAL IMPAIRMENT,40
BR,BLOOD GLUCOSE INCREASED,39
BR,MYOCARDIAL INFARCTION,39
BR,PULMONARY OEDEMA,39
BR,WEIGHT INCREASED,39
BR,MEMORY IMPAIRMENT,38
BR,DEATH,34
BR,HYPOGLYCAEMIA,33
BR,SYNCOPE,33
BR,DEPRESSION,32
BR,INSOMNIA,32
BR,HYPERGLYCAEMIA,31
BR,BLOOD PRESSURE DECREASED,30
BR,FLUID RETENTION,29
BR,VISUAL IMPAIRMENT,29
BR,HYPOTENSION,28
BR,CONDITION AGGRAVATED,27
BR,HYPERSENSITIVITY,27
BR,LUNG DISORDER,26
BR,RESPIRATORY FAILURE,26
BR,ERYTHEMA,25
BR,HAEMORRHAGE,25
BR,THROMBOSIS,25
BR,BACK PAIN,24
BR,OEDEMA PERIPHERAL,23
BR,PRURITUS,23
BR,SOMNOLENCE,23
BR,ABDOMINAL PAIN,22
BR,CHEST PAIN,22
BR,FEMUR FRACTURE,22
BR,HYPOAESTHESIA,22
BR,PRODUCT USE ISSUE,22
BR,INFECTION,21
BR,LIVER DISORDER,21
BR,MUSCULAR WEAKNESS,21
BR,TREMOR,21
BR,SEPSIS,20
BR,BLOOD CHOLESTEROL INCREASED,19
BR,CARDIO-RESPIRATORY ARREST,19
BR,COMA,19
BR,DRUG DOSE OMISSION,19
BR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,19
BR,INJECTION SITE PAIN,19
BR,PARAESTHESIA,19
BR,SEPTIC SHOCK,19
BR,ABASIA,18
BR,ANXIETY,18
BR,BLOOD CREATININE INCREASED,18
BR,BLOOD PRESSURE FLUCTUATION,18
BR,CATARACT,18
BR,WHEEZING,18
BR,ASTHMA,17
BR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,17
BR,DYSPHAGIA,17
BR,DYSPHONIA,17
BR,EMPHYSEMA,17
BR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,17
BR,CARDIAC FAILURE CONGESTIVE,16
BR,CONFUSIONAL STATE,16
BR,CONSTIPATION,16
BR,SKIN DISCOLOURATION,16
BR,ABDOMINAL DISTENSION,15
BR,ABDOMINAL PAIN UPPER,15
BR,ASCITES,15
BR,BLINDNESS,15
BR,BLOOD TRIGLYCERIDES INCREASED,15
BR,BRONCHITIS,15
BR,HYPERHIDROSIS,15
BR,HYPOACUSIS,15
BR,IMMUNODEFICIENCY,15
BR,JOINT SWELLING,15
BR,LIMB INJURY,15
BR,LOCAL SWELLING,15
BR,NERVOUSNESS,15
BR,PSORIASIS,15
BR,RASH,15
BR,RESPIRATORY DISORDER,15
BR,TACHYCARDIA,15
BR,ALOPECIA,14
BR,ASTHMATIC CRISIS,14
BR,CORONARY ARTERY OCCLUSION,14
BR,DISEASE PROGRESSION,14
BR,GASTRITIS,14
BR,LUNG INFECTION,14
BR,OSTEOARTHRITIS,14
BR,PULMONARY EMBOLISM,14
BR,RHEUMATOID ARTHRITIS,14
BR,VISION BLURRED,14
BR,ATRIAL FIBRILLATION,13
BR,CARDIOMEGALY,13
BR,CHRONIC KIDNEY DISEASE,13
BR,CONVULSION,13
BR,DYSURIA,13
BR,PRODUCT USE IN UNAPPROVED INDICATION,13
BR,SPEECH DISORDER,13
BR,SPINAL DISORDER,13
BR,ABDOMINAL DISCOMFORT,12
BR,ACUTE MYOCARDIAL INFARCTION,12
BR,HAEMOGLOBIN DECREASED,12
BR,INTENTIONAL PRODUCT MISUSE,12
BR,LOSS OF CONSCIOUSNESS,12
BR,MUSCLE SPASMS,12
BR,OSTEOPOROSIS,12
BR,OXYGEN SATURATION DECREASED,12
BR,PLEURAL EFFUSION,12
BR,ACUTE KIDNEY INJURY,11
BR,BLISTER,11
BR,BLOOD GLUCOSE DECREASED,11
BR,BODY HEIGHT DECREASED,11
BR,BONE PAIN,11
BR,CARDIOGENIC SHOCK,11
BR,DEHYDRATION,11
BR,ERYSIPELAS,11
BR,HEART RATE INCREASED,11
BR,NASOPHARYNGITIS,11
BR,PLATELET COUNT DECREASED,11
BR,PRODUCTIVE COUGH,11
BR,PULMONARY HYPERTENSION,11
BR,SPINAL PAIN,11
BR,SWELLING FACE,11
BR,THROAT IRRITATION,11
BR,WOUND,11
BR,BACTERIAL INFECTION,10
BR,BRADYCARDIA,10
BR,BRONCHOSPASM,10
BR,CARDIOVASCULAR DISORDER,10
BR,CHILLS,10
BR,DRUG ADMINISTRATION ERROR,10
BR,DRY SKIN,10
BR,EATING DISORDER,10
BR,GASTROOESOPHAGEAL REFLUX DISEASE,10
BR,GENERAL PHYSICAL HEALTH DETERIORATION,10
BR,HEART RATE DECREASED,10
BR,HOSPITALISATION,10
BR,MOVEMENT DISORDER,10
BR,MYALGIA,10
BR,SEIZURE,10
BR,VENOUS OCCLUSION,10
BR,ACUTE PULMONARY OEDEMA,9
BR,BEDRIDDEN,9
BR,BLOOD GLUCOSE FLUCTUATION,9
BR,BLOOD PRESSURE ABNORMAL,9
BR,DIVERTICULITIS,9
BR,DRY MOUTH,9
BR,DYSGEUSIA,9
BR,DYSSTASIA,9
BR,EPISTAXIS,9
BR,HAEMATOCHEZIA,9
BR,IMPAIRED HEALING,9
BR,INCORRECT DOSE ADMINISTERED,9
BR,INFLAMMATION,9
BR,OEDEMA,9
BR,OROPHARYNGEAL PAIN,9
BR,VITAMIN D DEFICIENCY,9
BR,AGITATION,8
BR,ARTERIAL OCCLUSIVE DISEASE,8
BR,ARTHROPATHY,8
BR,BLOOD POTASSIUM DECREASED,8
BR,BLOOD UREA INCREASED,8
BR,CELLULITIS,8
BR,CHOKING,8
BR,CONCOMITANT DISEASE AGGRAVATED,8
BR,CYANOSIS,8
BR,DEMENTIA ALZHEIMER^S TYPE,8
BR,DEPRESSED LEVEL OF CONSCIOUSNESS,8
BR,GLAUCOMA,8
BR,HAEMATEMESIS,8
BR,HAEMATOMA,8
BR,INJECTION SITE ERYTHEMA,8
BR,INJECTION SITE PRURITUS,8
BR,ISCHAEMIA,8
BR,JOINT INJURY,8
BR,LABYRINTHITIS,8
BR,MITRAL VALVE DISEASE,8
BR,MULTI-ORGAN FAILURE,8
BR,NOSOCOMIAL INFECTION,8
BR,PRODUCT QUALITY ISSUE,8
BR,PULMONARY FIBROSIS,8
BR,SKIN EXFOLIATION,8
BR,THYROID DISORDER,8
BR,UNEVALUABLE EVENT,8
BR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,8
BR,ANGINA PECTORIS,7
BR,APHASIA,7
BR,ARTERIOSCLEROSIS CORONARY ARTERY,7
BR,ARTHRITIS,7
BR,BLOOD POTASSIUM INCREASED,7
BR,BLOOD URIC ACID INCREASED,7
BR,DELIRIUM,7
BR,DIABETES MELLITUS INADEQUATE CONTROL,7
BR,DIABETIC NEUROPATHY,7
BR,DIABETIC RETINOPATHY,7
BR,DRUG HYPERSENSITIVITY,7
BR,DRUG PRESCRIBING ERROR,7
BR,FIBROMYALGIA,7
BR,GASTROINTESTINAL DISORDER,7
BR,HEPATIC ENCEPHALOPATHY,7
BR,MEDICATION ERROR,7
BR,MICTURITION DISORDER,7
BR,MOBILITY DECREASED,7
BR,PHARYNGITIS,7
BR,POLLAKIURIA,7
BR,PROTEINURIA,7
BR,PULMONARY ARTERIAL HYPERTENSION,7
BR,RENAL FAILURE CHRONIC,7
BR,RIB FRACTURE,7
BR,SHOCK,7
BR,URINARY RETENTION,7
BR,ACUTE RESPIRATORY FAILURE,6
BR,ADVERSE EVENT,6
BR,AMNESIA,6
BR,BLINDNESS UNILATERAL,6
BR,BLOOD GLUCOSE ABNORMAL,6
BR,BREAST CANCER,6
BR,COLITIS,6
BR,CORONARY ARTERY DISEASE,6
BR,CROHN^S DISEASE,6
BR,DEPRESSED MOOD,6
BR,DEVICE MALFUNCTION,6
BR,DEVICE RELATED INFECTION,6
BR,DISORIENTATION,6
BR,DYSPNOEA EXERTIONAL,6
BR,FEAR,6
BR,FEEDING DISORDER,6
BR,GASTRIC DISORDER,6
BR,GENERALISED OEDEMA,6
BR,HAEMATURIA,6
BR,HEAD DISCOMFORT,6
BR,HEART RATE IRREGULAR,6
BR,HEPATIC FAILURE,6
BR,HEPATIC NEOPLASM,6
BR,HEPATIC STEATOSIS,6
BR,INCORRECT PRODUCT STORAGE,6
BR,INJECTION SITE SWELLING,6
BR,LIGAMENT SPRAIN,6
BR,MUSCLE ATROPHY,6
BR,NEOPLASM,6
BR,NEUTROPENIA,6
BR,PALLOR,6
BR,PALPITATIONS,6
BR,PERIPHERAL COLDNESS,6
BR,PERITONITIS BACTERIAL,6
BR,PULMONARY CONGESTION,6
BR,PULMONARY HAEMORRHAGE,6
BR,SCIATICA,6
BR,SECRETION DISCHARGE,6
BR,SINUSITIS,6
BR,SKIN DISORDER,6
BR,SLEEP DISORDER,6
BR,SLUGGISHNESS,6
BR,SPINAL FRACTURE,6
BR,THROMBOCYTOPENIA,6
BR,WHITE BLOOD CELL COUNT DECREASED,6
BR,YELLOW SKIN,6
BR,ABSCESS,5
BR,AGEUSIA,5
BR,APNOEA,5
BR,BALANCE DISORDER,5
BR,BONE DISORDER,5
BR,BREATH SOUNDS ABNORMAL,5
BR,BURNING SENSATION,5
BR,COAGULOPATHY,5
BR,CONTUSION,5
BR,CRYING,5
BR,DRUG DEPENDENCE,5
BR,DRUG INTOLERANCE,5
BR,ENCEPHALOPATHY,5
BR,ENDOCARDITIS,5
BR,EYE PAIN,5
BR,FLATULENCE,5
BR,FORMICATION,5
BR,GLUCOSE TOLERANCE IMPAIRED,5
BR,H1N1 INFLUENZA,5
BR,HALLUCINATION,5
BR,HEPATIC PAIN,5
BR,HYPERAEMIA,5
BR,HYPOKALAEMIA,5
BR,HYPOKINESIA,5
BR,HYPOPHAGIA,5
BR,ILL-DEFINED DISORDER,5
BR,INCORRECT ROUTE OF DRUG ADMINISTRATION,5
BR,INCREASED BRONCHIAL SECRETION,5
BR,INFLUENZA LIKE ILLNESS,5
BR,INFUSION RELATED REACTION,5
BR,INJECTION SITE MASS,5
BR,LOCALISED INFECTION,5
BR,MOUTH HAEMORRHAGE,5
BR,MUSCULOSKELETAL DISORDER,5
BR,NECK PAIN,5
BR,NEUROPATHY PERIPHERAL,5
BR,ORAL PAIN,5
BR,PERIPHERAL VASCULAR DISORDER,5
BR,PROSTATIC DISORDER,5
BR,PRURITUS GENERALISED,5
BR,PYELONEPHRITIS,5
BR,RENAL FAILURE ACUTE,5
BR,RESPIRATORY TRACT INFECTION,5
BR,RETCHING,5
BR,SKIN BURNING SENSATION,5
BR,SKIN LESION,5
BR,STOMATITIS,5
BR,STRESS,5
BR,SUFFOCATION FEELING,5
BR,SURGERY,5
BR,SYSTEMIC LUPUS ERYTHEMATOSUS,5
BR,TOXICITY TO VARIOUS AGENTS,5
BR,URINARY INCONTINENCE,5
BR,URTICARIA,5
BR,VARICES OESOPHAGEAL,5
BR,VENTRICULAR FIBRILLATION,5
BR,VISUAL ACUITY REDUCED,5
BR,ACCIDENT,4
BR,ANGIOPATHY,4
BR,APHTHOUS ULCER,4
BR,APPARENT DEATH,4
BR,ATROPHY,4
BR,BACK DISORDER,4
BR,BLOOD PRESSURE INADEQUATELY CONTROLLED,4
BR,CARDIAC FAILURE ACUTE,4
BR,CARDIOMYOPATHY,4
BR,CAROTID ARTERY OCCLUSION,4
BR,CHOKING SENSATION,4
BR,CHOLECYSTITIS,4
BR,CHOLELITHIASIS,4
BR,DECREASED IMMUNE RESPONSIVENESS,4
BR,DENGUE FEVER,4
BR,DRUG EFFECT DECREASED,4
BR,EYE DISORDER,4
BR,EYE HAEMORRHAGE,4
BR,FEELING COLD,4
BR,FEELING OF DESPAIR,4
BR,FIBROSIS,4
BR,FOOT DEFORMITY,4
BR,GASTROINTESTINAL INFECTION,4
BR,GLYCOSYLATED HAEMOGLOBIN INCREASED,4
BR,HAEMOLYSIS,4
BR,HEPATIC CIRRHOSIS,4
BR,HERPES VIRUS INFECTION,4
BR,HERPES ZOSTER,4
BR,HIATUS HERNIA,4
BR,HYPERKALAEMIA,4
BR,HYPERKERATOSIS,4
BR,HYPERTENSIVE CRISIS,4
BR,IMMUNE SYSTEM DISORDER,4
BR,INJECTION SITE HAEMATOMA,4
BR,INTERVERTEBRAL DISC PROTRUSION,4
BR,INTESTINAL HAEMORRHAGE,4
BR,ISCHAEMIC STROKE,4
BR,JOINT EFFUSION,4
BR,LEFT VENTRICULAR DYSFUNCTION,4
BR,LEG AMPUTATION,4
BR,LOWER LIMB FRACTURE,4
BR,MALIGNANT NEOPLASM PROGRESSION,4
BR,MALNUTRITION,4
BR,MASS,4
BR,MELAENA,4
BR,METASTASES TO LUNG,4
BR,MITRAL VALVE INCOMPETENCE,4
BR,MUSCLE HAEMORRHAGE,4
BR,MUSCULOSKELETAL CHEST PAIN,4
BR,MUSCULOSKELETAL PAIN,4
BR,MYOCARDIAL ISCHAEMIA,4
BR,NASAL CONGESTION,4
BR,NEOPLASM PROGRESSION,4
BR,NEPHROLITHIASIS,4
BR,NODULE,4
BR,ORAL DISCOMFORT,4
BR,OVERDOSE,4
BR,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,4
BR,PANCREATITIS,4
BR,PANCYTOPENIA,4
BR,PARKINSON^S DISEASE,4
BR,PERITONITIS,4
BR,PHARYNGEAL OEDEMA,4
BR,POST PROCEDURAL COMPLICATION,4
BR,PROSTATOMEGALY,4
BR,RASH MACULAR,4
BR,RASH PUSTULAR,4
BR,RECTAL HAEMORRHAGE,4
BR,RETINAL HAEMORRHAGE,4
BR,RHINORRHOEA,4
BR,SENSORY LOSS,4
BR,SKIN ULCER,4
BR,SPLENOMEGALY,4
BR,SUDDEN DEATH,4
BR,TINNITUS,4
BR,TYPE 2 DIABETES MELLITUS,4
BR,ULCER,4
BR,UPPER GASTROINTESTINAL HAEMORRHAGE,4
BR,UPPER LIMB FRACTURE,4
BR,URINE OUTPUT DECREASED,4
BR,VASCULAR STENT THROMBOSIS,4
BR,VENTRICULAR TACHYCARDIA,4
BR,VERTIGO,4
BR,VIRAL INFECTION,4
BR,WOUND INFECTION,4
BR,ABNORMAL BEHAVIOUR,3
BR,ABORTION SPONTANEOUS,3
BR,AGGRESSION,3
BR,AMERICAN TRYPANOSOMIASIS,3
BR,ANGINA UNSTABLE,3
BR,ANURIA,3
BR,APHAGIA,3
BR,APHTHOUS STOMATITIS,3
BR,ATELECTASIS,3
BR,BACTERAEMIA,3
BR,BIPOLAR DISORDER,3
BR,BLOOD GROWTH HORMONE INCREASED,3
BR,BLOOD TEST ABNORMAL,3
BR,BONE LOSS,3
BR,BRONCHOPNEUMONIA,3
BR,BUNDLE BRANCH BLOCK LEFT,3
BR,C-REACTIVE PROTEIN INCREASED,3
BR,CARDIAC FAILURE CHRONIC,3
BR,CARDIAC MURMUR,3
BR,CARDIAC OPERATION,3
BR,CARDIAC VALVE DISEASE,3
BR,CARTILAGE INJURY,3
BR,CATARACT OPERATION,3
BR,CHONDROPATHY,3
BR,COGNITIVE DISORDER,3
BR,CONGESTIVE CARDIOMYOPATHY,3
BR,CORNEAL OPACITY,3
BR,DEAFNESS,3
BR,DEFORMITY,3
BR,DIABETIC FOOT,3
BR,DIABETIC NEPHROPATHY,3
BR,DIARRHOEA HAEMORRHAGIC,3
BR,DRUG DISPENSING ERROR,3
BR,DRUG-INDUCED LIVER INJURY,3
BR,DYSPEPSIA,3
BR,EXOSTOSIS,3
BR,EXPIRED PRODUCT ADMINISTERED,3
BR,EYE PRURITUS,3
BR,FAECES DISCOLOURED,3
BR,FEELING HOT,3
BR,FUNCTIONAL GASTROINTESTINAL DISORDER,3
BR,GASTRIC HAEMORRHAGE,3
BR,GASTRIC ULCER,3
BR,GASTROENTERITIS,3
BR,GASTROINTESTINAL HAEMORRHAGE,3
BR,GASTROINTESTINAL PAIN,3
BR,GOUT,3
BR,GRAFT LOSS,3
BR,GRIP STRENGTH DECREASED,3
BR,HAEMATOCRIT DECREASED,3
BR,HAEMODYNAMIC INSTABILITY,3
BR,HEMIPARESIS,3
BR,HEMIPLEGIA,3
BR,HEPATIC CANCER,3
BR,HEPATIC ENZYME INCREASED,3
BR,HEPATOTOXICITY,3
BR,HICCUPS,3
BR,HIP FRACTURE,3
BR,HYPONATRAEMIA,3
BR,HYPOTHYROIDISM,3
BR,HYPOTONIA,3
BR,INGUINAL HERNIA,3
BR,INJECTION SITE INDURATION,3
BR,INJURY,3
BR,INTENTIONAL DRUG MISUSE,3
BR,INTESTINAL PERFORATION,3
BR,INTRACRANIAL PRESSURE INCREASED,3
BR,ISCHAEMIC CARDIOMYOPATHY,3
BR,KIDNEY INFECTION,3
BR,KLEBSIELLA INFECTION,3
BR,LABORATORY TEST ABNORMAL,3
BR,LIMB DISCOMFORT,3
BR,LUNG NEOPLASM MALIGNANT,3
BR,LYMPHADENOPATHY,3
BR,MATERNAL EXPOSURE DURING PREGNANCY,3
BR,MIGRAINE,3
BR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,3
BR,MULTIPLE SCLEROSIS RELAPSE,3
BR,MUSCLE RIGIDITY,3
BR,NECROSIS,3
BR,NEOPLASM MALIGNANT,3
BR,NEPHROPATHY,3
BR,NERVOUS SYSTEM DISORDER,3
BR,NOCTURIA,3
BR,OBSTRUCTIVE AIRWAYS DISORDER,3
BR,OESOPHAGITIS,3
BR,ORAL CANDIDIASIS,3
BR,ORTHOSTATIC HYPOTENSION,3
BR,OXYGEN CONSUMPTION DECREASED,3
BR,PERICARDIAL EFFUSION,3
BR,PNEUMONIA BACTERIAL,3
BR,PNEUMONITIS,3
BR,POLYNEUROPATHY,3
BR,POOR PERIPHERAL CIRCULATION,3
BR,POSTOPERATIVE WOUND INFECTION,3
BR,PULMONARY PAIN,3
BR,PULMONARY THROMBOSIS,3
BR,RED BLOOD CELL COUNT DECREASED,3
BR,RENAL CANCER,3
BR,RENAL PAIN,3
BR,RESPIRATORY ARREST,3
BR,RESPIRATORY DISTRESS,3
BR,RHEUMATIC DISORDER,3
BR,SERUM FERRITIN INCREASED,3
BR,SJOGREN^S SYNDROME,3
BR,SKIN WOUND,3
BR,STAPHYLOCOCCAL INFECTION,3
BR,STENT PLACEMENT,3
BR,SWOLLEN TONGUE,3
BR,TACHYPNOEA,3
BR,THERAPEUTIC RESPONSE UNEXPECTED,3
BR,THIRST,3
BR,TONGUE DISORDER,3
BR,TOOTH INJURY,3
BR,TRANSIENT ISCHAEMIC ATTACK,3
BR,TYPE 1 DIABETES MELLITUS,3
BR,UNDERDOSE,3
BR,UTERINE CANCER,3
BR,VAGINAL HAEMORRHAGE,3
BR,VARICOSE VEIN,3
BR,VEIN DISORDER,3
BR,ZIKA VIRUS INFECTION,3
BR,ABDOMINAL INFECTION,2
BR,ABDOMINAL PAIN LOWER,2
BR,ACCIDENT AT WORK,2
BR,ACIDOSIS,2
BR,ACTIVITIES OF DAILY LIVING IMPAIRED,2
BR,ACUTE HEPATIC FAILURE,2
BR,ACUTE RESPIRATORY DISTRESS SYNDROME,2
BR,AMENORRHOEA,2
BR,ANKLE FRACTURE,2
BR,AORTIC ANEURYSM,2
BR,AORTIC STENOSIS,2
BR,AORTIC VALVE STENOSIS,2
BR,APATHY,2
BR,ARTERIOSCLEROSIS,2
BR,ATRIAL THROMBOSIS,2
BR,ATRIOVENTRICULAR BLOCK,2
BR,BLADDER DISORDER,2
BR,BLOOD BLISTER,2
BR,BLOOD CHOLESTEROL ABNORMAL,2
BR,BLOOD CREATINE INCREASED,2
BR,BLOOD CREATININE ABNORMAL,2
BR,BLOOD DISORDER,2
BR,BLOOD LACTATE DEHYDROGENASE INCREASED,2
BR,BLOOD POTASSIUM ABNORMAL,2
BR,BLOOD PRESSURE SYSTOLIC INCREASED,2
BR,BLOOD SODIUM DECREASED,2
BR,BLOOD TRIGLYCERIDES ABNORMAL,2
BR,BLOOD UREA ABNORMAL,2
BR,BLOOD URIC ACID,2
BR,BLOOD URINE PRESENT,2
BR,BODY HEIGHT INCREASED,2
BR,BODY MASS INDEX INCREASED,2
BR,BODY TEMPERATURE ABNORMAL,2
BR,BONE EROSION,2
BR,BONE MARROW DISORDER,2
BR,BRAIN DEATH,2
BR,BRAIN OEDEMA,2
BR,BREATH ODOUR,2
BR,BRONCHIOLITIS,2
BR,BURN ORAL CAVITY,2
BR,CALCIUM DEFICIENCY,2
BR,CANDIDA INFECTION,2
BR,CARBON MONOXIDE DIFFUSING CAPACITY DECREASED,2
BR,CARDIAC HYPERTROPHY,2
BR,CARDIOPULMONARY FAILURE,2
BR,CARPAL TUNNEL SYNDROME,2
BR,CATARACT DIABETIC,2
BR,CATARRH,2
BR,CATHETER PLACEMENT,2
BR,CENTRAL NERVOUS SYSTEM LESION,2
BR,CEREBRAL ATROPHY,2
BR,CEREBRAL ISCHAEMIA,2
BR,CHEST DISCOMFORT,2
BR,CHIKUNGUNYA VIRUS INFECTION,2
BR,CHOLECYSTITIS ACUTE,2
BR,CHROMATURIA,2
BR,CHRONIC GASTRITIS,2
BR,COCCYDYNIA,2
BR,COLD SWEAT,2
BR,CONJUNCTIVITIS,2
BR,CONTRAINDICATED PRODUCT ADMINISTERED,2
BR,CRYSTAL ARTHROPATHY,2
BR,CUSHING^S SYNDROME,2
BR,CYST,2
BR,DEAFNESS UNILATERAL,2
BR,DEEP VEIN THROMBOSIS,2
BR,DERMATITIS,2
BR,DERMATITIS ALLERGIC,2
BR,DEVELOPMENTAL DELAY,2
BR,DIABETIC COMPLICATION,2
BR,DIABETIC METABOLIC DECOMPENSATION,2
BR,DISCOMFORT,2
BR,DISEASE RECURRENCE,2
BR,DRUG ADMINISTERED AT INAPPROPRIATE SITE,2
BR,DRUG EFFECT INCOMPLETE,2
BR,DRY EYE,2
BR,DUODENAL ULCER,2
BR,DYSARTHRIA,2
BR,DYSENTERY,2
BR,EJECTION FRACTION DECREASED,2
BR,EMBOLISM,2
BR,EMOTIONAL DISORDER,2
BR,EMOTIONAL DISTRESS,2
BR,ENDOCARDITIS BACTERIAL,2
BR,ENDOTRACHEAL INTUBATION COMPLICATION,2
BR,EPILEPSY,2
BR,ESCHERICHIA INFECTION,2
BR,EXPOSURE DURING PREGNANCY,2
BR,EYE INFECTION,2
BR,FACE OEDEMA,2
BR,FEBRILE NEUTROPENIA,2
BR,FILOVIRUS INFECTION,2
BR,FINGER DEFORMITY,2
BR,FOETAL EXPOSURE DURING PREGNANCY,2
BR,FOOD INTOLERANCE,2
BR,FOOT FRACTURE,2
BR,FORCED EXPIRATORY VOLUME DECREASED,2
BR,FUNCTIONAL RESIDUAL CAPACITY DECREASED,2
BR,FURUNCLE,2
BR,GAIT INABILITY,2
BR,GASTRIC ULCER HAEMORRHAGE,2
BR,GASTRITIS EROSIVE,2
BR,GASTROINTESTINAL CARCINOMA,2
BR,GASTROINTESTINAL NEOPLASM,2
BR,GASTROINTESTINAL STROMAL TUMOUR,2
BR,GENERAL PHYSICAL CONDITION ABNORMAL,2
BR,GINGIVAL BLEEDING,2
BR,GINGIVAL PAIN,2
BR,GROIN PAIN,2
BR,HAEMODIALYSIS,2
BR,HAEMOPTYSIS,2
BR,HAEMORRHAGIC STROKE,2
BR,HAEMORRHOIDS,2
BR,HALLUCINATION_ VISUAL,2
BR,HAND DEFORMITY,2
BR,HEAD INJURY,2
BR,HEPATIC CYST,2
BR,HEPATITIS,2
BR,HEPATITIS C,2
BR,HEPATOMEGALY,2
BR,HERNIA,2
BR,HIP ARTHROPLASTY,2
BR,HYPERURICAEMIA,2
BR,HYPOTHERMIA,2
BR,IMMUNOSUPPRESSION,2
BR,INGROWN HAIR,2
BR,INJECTION SITE BRUISING,2
BR,INJECTION SITE INJURY,2
BR,INTENTIONAL PRODUCT USE ISSUE,2
BR,INTERNATIONAL NORMALISED RATIO INCREASED,2
BR,INTERSTITIAL LUNG DISEASE,2
BR,INTESTINAL ISCHAEMIA,2
BR,INTESTINAL OBSTRUCTION,2
BR,INTESTINAL PROLAPSE,2
BR,IRRITABILITY,2
BR,JOINT DISLOCATION,2
BR,KNEE ARTHROPLASTY,2
BR,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,2
BR,LACTOSE INTOLERANCE,2
BR,LEFT VENTRICULAR HYPERTROPHY,2
BR,LETHARGY,2
BR,LEUKOCYTOSIS,2
BR,LIMB DEFORMITY,2
BR,LIP DISCOLOURATION,2
BR,LIVER FUNCTION TEST ABNORMAL,2
BR,LIVER TRANSPLANT,2
BR,LOOSE TOOTH,2
BR,LOSS OF CONTROL OF LEGS,2
BR,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,2
BR,LOWER RESPIRATORY TRACT INFECTION BACTERIAL,2
BR,LUMBAR VERTEBRAL FRACTURE,2
BR,LUNG HYPERINFLATION,2
BR,MASTICATION DISORDER,2
BR,METASTASES TO LIVER,2
BR,METASTATIC RENAL CELL CARCINOMA,2
BR,MICTURITION URGENCY,2
BR,MIOSIS,2
BR,MITRAL VALVE STENOSIS,2
BR,MOTOR DYSFUNCTION,2
BR,MUSCLE ABSCESS,2
BR,MUSCLE DISORDER,2
BR,MYOCLONUS,2
BR,NAIL DISORDER,2
BR,NEEDLE ISSUE,2
BR,NEPHROTIC SYNDROME,2
BR,NEURITIS,2
BR,NIGHTMARE,2
BR,NO THERAPEUTIC RESPONSE,2
BR,OBESITY,2
BR,OCULAR HYPERAEMIA,2
BR,OESOPHAGEAL VARICEAL LIGATION,2
BR,ONYCHALGIA,2
BR,OSTEOMYELITIS,2
BR,OSTEOPENIA,2
BR,OVARIAN CANCER,2
BR,OXYGEN SATURATION ABNORMAL,2
BR,PAIN IN JAW,2
BR,PANCREATIC NEOPLASM,2
BR,PANCREATITIS ACUTE,2
BR,PANIC DISORDER,2
BR,PARAPLEGIA,2
BR,PELVIC PAIN,2
BR,PERIPHERAL EMBOLISM,2
BR,PHARYNGEAL DISORDER,2
BR,PHOTOPHOBIA,2
BR,PNEUMONIA ASPIRATION,2
BR,POLYURIA,2
BR,PROCEDURAL SITE REACTION,2
BR,PRODUCT ADHESION ISSUE,2
BR,PROSTATE CANCER,2
BR,PSEUDOMONAS INFECTION,2
BR,PSORIATIC ARTHROPATHY,2
BR,PSYCHOMOTOR HYPERACTIVITY,2
BR,PULMONARY ARTERIAL PRESSURE INCREASED,2
BR,PULMONARY MASS,2
BR,PULMONARY SEPSIS,2
BR,PULSELESS ELECTRICAL ACTIVITY,2
BR,RASH ERYTHEMATOUS,2
BR,RED BLOOD CELL SEDIMENTATION RATE ABNORMAL,2
BR,RED BLOOD CELL SEDIMENTATION RATE INCREASED,2
BR,REFLUX GASTRITIS,2
BR,RENAL CELL CARCINOMA,2
BR,RETICULOCYTE COUNT INCREASED,2
BR,RETINAL DETACHMENT,2
BR,RHEUMATOID FACTOR INCREASED,2
BR,RHINITIS,2
BR,RIGHT VENTRICULAR DYSFUNCTION,2
BR,RIGHT VENTRICULAR FAILURE,2
BR,SKIN ATROPHY,2
BR,SKIN HYPERPIGMENTATION,2
BR,SKIN IRRITATION,2
BR,SKIN MASS,2
BR,SKIN REACTION,2
BR,SNEEZING,2
BR,SOFT TISSUE INFECTION,2
BR,SPINAL COLUMN INJURY,2
BR,SPINAL CORD DISORDER,2
BR,SPINAL DEFORMITY,2
BR,SPLEEN DISORDER,2
BR,SYSTOLIC DYSFUNCTION,2
BR,TENDON DISORDER,2
BR,TENDON RUPTURE,2
BR,TENDONITIS,2
BR,TENSION,2
BR,THERAPEUTIC RESPONSE DECREASED,2
BR,THROAT TIGHTNESS,2
BR,THYROID CANCER,2
BR,THYROID MASS,2
BR,TONGUE DISCOLOURATION,2
BR,TOOTH INFECTION,2
BR,TOTAL LUNG CAPACITY DECREASED,2
BR,TRANSFUSION,2
BR,TREATMENT NONCOMPLIANCE,2
BR,TRICUSPID VALVE INCOMPETENCE,2
BR,UPPER RESPIRATORY TRACT INFECTION,2
BR,URINARY TRACT DISORDER,2
BR,VASCULAR RUPTURE,2
BR,VENTRICULAR HYPOKINESIA,2
BR,VIRAL UPPER RESPIRATORY TRACT INFECTION,2
BR,VITAMIN D DECREASED,2
BR,VITREOUS FLOATERS,2
BR,WAIST CIRCUMFERENCE INCREASED,2
BR,WHITE BLOOD CELL COUNT ABNORMAL,2
BR,WOUND COMPLICATION,2
BR,WOUND DEHISCENCE,2
BR,WOUND HAEMORRHAGE,2
BR,WRONG DRUG ADMINISTERED,2
BR,ABDOMINAL CAVITY DRAINAGE,1
BR,ABDOMINAL HERNIA,1
BR,ABDOMINAL NEOPLASM,1
BR,ABDOMINAL OPERATION,1
BR,ABNORMAL FAECES,1
BR,ABNORMAL SENSATION IN EYE,1
BR,ABNORMAL WEIGHT GAIN,1
BR,ACNE,1
BR,ACQUIRED IMMUNODEFICIENCY SYNDROME,1
BR,ACUTE MYELOID LEUKAEMIA,1
BR,AFFECT LABILITY,1
BR,ALANINE AMINOTRANSFERASE ABNORMAL,1
BR,ALANINE AMINOTRANSFERASE INCREASED,1
BR,ALLERGIC COUGH,1
BR,ALLERGY TO ARTHROPOD BITE,1
BR,ALLERGY TO CHEMICALS,1
BR,ALPHA 1 FOETOPROTEIN INCREASED,1
BR,ANAL FISSURE,1
BR,ANAL HAEMORRHAGE,1
BR,ANAL INFLAMMATION,1
BR,ANAL SPHINCTER ATONY,1
BR,ANAPHYLACTIC REACTION,1
BR,ANASTOMOTIC COMPLICATION,1
BR,ANGIOPLASTY,1
BR,ANKYLOSING SPONDYLITIS,1
BR,ANORECTAL INFECTION BACTERIAL,1
BR,ANOSMIA,1
BR,AORTIC CALCIFICATION,1
BR,AORTIC DILATATION,1
BR,AORTIC DISORDER,1
BR,AORTIC INJURY,1
BR,AORTIC OCCLUSION,1
BR,AORTIC SURGERY,1
BR,AORTIC VALVE CALCIFICATION,1
BR,AORTIC VALVE INCOMPETENCE,1
BR,APPENDICECTOMY,1
BR,APPLICATION SITE ERYTHEMA,1
BR,APPLICATION SITE OEDEMA,1
BR,APPLICATION SITE PRURITUS,1
BR,ARTERIAL INSUFFICIENCY,1
BR,ARTERIAL RUPTURE,1
BR,ARTERIAL STENOSIS,1
BR,ARTERIOGRAM RENAL ABNORMAL,1
BR,ARTERIOVENOUS FISTULA SITE COMPLICATION,1
BR,ARTHRITIS INFECTIVE,1
BR,ASPARTATE AMINOTRANSFERASE ABNORMAL,1
BR,ASPARTATE AMINOTRANSFERASE INCREASED,1
BR,ASPIRATION BRONCHIAL,1
BR,ASTHENOPIA,1
BR,ATRIAL FLUTTER,1
BR,ATYPICAL PNEUMONIA,1
BR,AUTOIMMUNE HAEMOLYTIC ANAEMIA,1
BR,AZOTAEMIA,1
BR,BACTERIAL SEPSIS,1
BR,BACTERIAL TEST POSITIVE,1
BR,BACTERIAL VAGINOSIS,1
BR,BENIGN PROSTATIC HYPERPLASIA,1
BR,BILIRUBIN CONJUGATED INCREASED,1
BR,BIOPSY LUNG ABNORMAL,1
BR,BLADDER CANCER,1
BR,BLADDER PAIN,1
BR,BLADDER PAPILLOMA,1
BR,BLINDNESS TRANSIENT,1
BR,BLISTER RUPTURE,1
BR,BLOOD 25-HYDROXYCHOLECALCIFEROL DECREASED,1
BR,BLOOD ALBUMIN DECREASED,1
BR,BLOOD ALBUMIN INCREASED,1
BR,BLOOD ALKALINE PHOSPHATASE INCREASED,1
BR,BLOOD CHOLESTEROL DECREASED,1
BR,BLOOD CREATINE PHOSPHOKINASE ABNORMAL,1
BR,BLOOD CREATININE,1
BR,BLOOD CREATININE DECREASED,1
BR,BLOOD IMMUNOGLOBULIN G INCREASED,1
BR,BLOOD INSULIN INCREASED,1
BR,BLOOD PHOSPHORUS DECREASED,1
BR,BLOOD PHOSPHORUS INCREASED,1
BR,BLOOD PRESSURE,1
BR,BLOOD PRESSURE AMBULATORY INCREASED,1
BR,BLOOD SODIUM ABNORMAL,1
BR,BLOOD TESTOSTERONE DECREASED,1
BR,BLOOD THYROID STIMULATING HORMONE ABNORMAL,1
BR,BLOOD THYROID STIMULATING HORMONE INCREASED,1
BR,BLOOD URIC ACID ABNORMAL,1
BR,BODY TEMPERATURE DECREASED,1
BR,BONE DENSITY INCREASED,1
BR,BONE FISSURE,1
BR,BONE MARROW FAILURE,1
BR,BONE NEOPLASM,1
BR,BONE OPERATION,1
BR,BONE SWELLING,1
BR,BRAIN CANCER METASTATIC,1
BR,BRAIN HERNIATION,1
BR,BRAIN HYPOXIA,1
BR,BRAIN NEOPLASM,1
BR,BREAST CANCER FEMALE,1
BR,BREAST ENGORGEMENT,1
BR,BREAST NEOPLASM,1
BR,BREAST TENDERNESS,1
BR,BRONCHIAL OBSTRUCTION,1
BR,BRONCHIECTASIS,1
BR,BURSITIS,1
BR,C3 GLOMERULOPATHY,1
BR,CALCULUS URINARY,1
BR,CANCER SURGERY,1
BR,CAPILLARY FRAGILITY,1
BR,CARCINOID TUMOUR,1
BR,CARDIAC FIBRILLATION,1
BR,CARDIAC FLUTTER,1
BR,CARDIAC INFECTION,1
BR,CARDIAC OUTPUT DECREASED,1
BR,CARDIAC SIDEROSIS,1
BR,CARDIAC VALVE REPLACEMENT COMPLICATION,1
BR,CARDIAC VENTRICULAR DISORDER,1
BR,CARDIOTHORACIC RATIO INCREASED,1
BR,CARDIOTOXICITY,1
BR,CARDIOVASCULAR FUNCTION TEST ABNORMAL,1
BR,CARDIOVERSION,1
BR,CATHETER SITE INFECTION,1
BR,CEREBRAL DISORDER,1
BR,CEREBRAL HAEMATOMA,1
BR,CEREBRAL HAEMORRHAGE,1
BR,CEREBROVASCULAR DISORDER,1
BR,CEREBROVASCULAR INSUFFICIENCY,1
BR,CERVIX DISORDER,1
BR,CHEST WALL MASS,1
BR,CHONDRITIS,1
BR,CHONDROMALACIA,1
BR,CHORDAE TENDINAE RUPTURE,1
BR,CHRONIC MYELOID LEUKAEMIA,1
BR,CHRONIC SINUSITIS,1
BR,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,1
BR,CLOSTRIDIAL INFECTION,1
BR,COAGULATION TIME SHORTENED,1
BR,COLITIS ISCHAEMIC,1
BR,COLITIS ULCERATIVE,1
BR,COLON CANCER,1
BR,COMPLEMENT FACTOR C3 DECREASED,1
BR,COMPLICATION ASSOCIATED WITH DEVICE,1
BR,COMPLICATION OF DEVICE REMOVAL,1
BR,COMPLICATIONS OF TRANSPLANTED KIDNEY,1
BR,COMPUTERISED TOMOGRAM ABNORMAL,1
BR,CONNECTIVE TISSUE DISORDER,1
BR,COORDINATION ABNORMAL,1
BR,CORNEAL TRANSPLANT,1
BR,CORONARY ARTERY INSUFFICIENCY,1
BR,CORONARY REVASCULARISATION,1
BR,CRANIOCEREBRAL INJURY,1
BR,CREATININE RENAL CLEARANCE DECREASED,1
BR,CREATININE URINE INCREASED,1
BR,CREPITATIONS,1
BR,CRYPTOCOCCOSIS,1
BR,CUSHINGOID,1
BR,CYSTIC FIBROSIS,1
BR,CYSTITIS,1
BR,CYTOKINE RELEASE SYNDROME,1
BR,DANDRUFF,1
BR,DAYDREAMING,1
BR,DECREASED ACTIVITY,1
BR,DECUBITUS ULCER,1
BR,DELUSION,1
BR,DEMENTIA OF THE ALZHEIMER^S TYPE_ UNCOMPLICATED,1
BR,DEPRESSIVE SYMPTOM,1
BR,DERMATITIS BULLOUS,1
BR,DERMATITIS CONTACT,1
BR,DIALYSIS,1
BR,DIAPHRAGMATIC DISORDER,1
BR,DIASTASIS RECTI ABDOMINIS,1
BR,DIASTOLIC DYSFUNCTION,1
BR,DIPLOPIA,1
BR,DISTRIBUTIVE SHOCK,1
BR,DISTURBANCE IN ATTENTION,1
BR,DRUG ABUSE,1
BR,DRUG DOSE TITRATION NOT PERFORMED,1
BR,DRUG EFFECT DELAYED,1
BR,DRUG ERUPTION,1
BR,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
BR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
BR,DRUG RESISTANCE,1
BR,DRUG TOLERANCE DECREASED,1
BR,DRY THROAT,1
BR,DUODENAL POLYP,1
BR,DYSKINESIA OESOPHAGEAL,1
BR,DYSLIPIDAEMIA,1
BR,EAR INFECTION,1
BR,EAR NEOPLASM,1
BR,EAR PAIN,1
BR,EAR PRURITUS,1
BR,ELECTROCARDIOGRAM ABNORMAL,1
BR,ELECTROCARDIOGRAM PR PROLONGATION,1
BR,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,1
BR,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
BR,ELECTROLYTE IMBALANCE,1
BR,EMPYEMA,1
BR,ENCEPHALOMYELITIS,1
BR,ENDOTRACHEAL INTUBATION,1
BR,ENTERITIS INFECTIOUS,1
BG,CARDIAC FAILURE,4
BG,DYSPNOEA,3
BG,ORTHOPNOEA,3
BG,PULMONARY CONGESTION,3
BG,ANGINA PECTORIS,2
BG,CARDIAC FAILURE CONGESTIVE,2
BG,CORONARY ARTERY STENOSIS,2
BG,DIASTOLIC DYSFUNCTION,2
BG,GENERAL PHYSICAL HEALTH DETERIORATION,2
BG,HAEMORRHAGIC STROKE,2
BG,HYPERTENSION,2
BG,LEFT ATRIAL DILATATION,2
BG,PERIPHERAL SWELLING,2
BG,PLEURAL EFFUSION,2
BG,RENAL FAILURE,2
BG,RESPIRATORY FAILURE,2
BG,SYNCOPE,2
BG,URINE OUTPUT DECREASED,2
BG,ACUTE CORONARY SYNDROME,1
BG,ACUTE KIDNEY INJURY,1
BG,ACUTE MYELOID LEUKAEMIA,1
BG,ACUTE MYOCARDIAL INFARCTION,1
BG,ANAEMIA,1
BG,ANGINA UNSTABLE,1
BG,ARRHYTHMIA,1
BG,ASTHENIA,1
BG,ATRIAL FLUTTER,1
BG,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
BG,BLOOD BILIRUBIN INCREASED,1
BG,BLOOD BILIRUBIN UNCONJUGATED INCREASED,1
BG,BUNDLE BRANCH BLOCK RIGHT,1
BG,CARDIOGENIC SHOCK,1
BG,CONCOMITANT DISEASE AGGRAVATED,1
BG,CREATININE RENAL CLEARANCE ABNORMAL,1
BG,CYANOSIS,1
BG,DIZZINESS,1
BG,DRUG DOSE OMISSION,1
BG,DUODENAL ULCER,1
BG,ELECTROCARDIOGRAM PR PROLONGATION,1
BG,EXTRAVASATION BLOOD,1
BG,GASTROINTESTINAL BACTERIAL INFECTION,1
BG,GASTROINTESTINAL HAEMORRHAGE,1
BG,HEART SOUNDS ABNORMAL,1
BG,HEPATOMEGALY,1
BG,HIATUS HERNIA,1
BG,HYDRONEPHROSIS,1
BG,HYPOTENSION,1
BG,INTERNATIONAL NORMALISED RATIO INCREASED,1
BG,MULTI-ORGAN FAILURE,1
BG,MYOCARDIAL ISCHAEMIA,1
BG,OEDEMA PERIPHERAL,1
BG,OESOPHAGEAL ULCER HAEMORRHAGE,1
BG,OESOPHAGITIS,1
BG,PETECHIAE,1
BG,PROTHROMBIN TIME PROLONGED,1
BG,PULMONARY OEDEMA,1
BG,RALES,1
BG,RIGHT VENTRICULAR FAILURE,1
BG,RIGHT VENTRICULAR HYPERTROPHY,1
BG,SINUS BRADYCARDIA,1
BG,TACHYCARDIA,1
BG,THROMBOSIS IN DEVICE,1
BG,VIRAL INFECTION,1
BG,VOMITING,1
CA,DYSPNOEA,466
CA,FATIGUE,335
CA,DEATH,331
CA,FALL,283
CA,PNEUMONIA,269
CA,DRUG INEFFECTIVE,265
CA,NAUSEA,262
CA,ASTHENIA,253
CA,DIARRHOEA,239
CA,PERIPHERAL SWELLING,220
CA,VOMITING,210
CA,DIZZINESS,199
CA,MALAISE,191
CA,COUGH,190
CA,ARTHRALGIA,186
CA,WEIGHT DECREASED,186
CA,PAIN,179
CA,OEDEMA PERIPHERAL,178
CA,HYPOTENSION,177
CA,HEADACHE,167
CA,HAEMOGLOBIN DECREASED,166
CA,BLOOD PRESSURE INCREASED,155
CA,CARDIAC FAILURE CONGESTIVE,155
CA,PYREXIA,154
CA,PAIN IN EXTREMITY,148
CA,ANAEMIA,130
CA,BACK PAIN,121
CA,ABDOMINAL PAIN,120
CA,DECREASED APPETITE,118
CA,WEIGHT INCREASED,115
CA,GAIT DISTURBANCE,114
CA,NASOPHARYNGITIS,114
CA,HYPERTENSION,112
CA,JOINT SWELLING,109
CA,MYOCARDIAL INFARCTION,105
CA,BLOOD CREATININE INCREASED,102
CA,ATRIAL FIBRILLATION,101
CA,RASH,100
CA,OXYGEN SATURATION DECREASED,99
CA,BRONCHITIS,97
CA,INFECTION,97
CA,SOMNOLENCE,94
CA,CHEST PAIN,93
CA,CONFUSIONAL STATE,91
CA,SYNOVITIS,90
CA,CARDIAC FAILURE,89
CA,PULMONARY OEDEMA,87
CA,CONDITION AGGRAVATED,85
CA,DRUG INTOLERANCE,84
CA,HERPES ZOSTER,82
CA,FLUID RETENTION,81
CA,HEART RATE INCREASED,79
CA,PLEURAL EFFUSION,78
CA,RENAL FAILURE,78
CA,CONSTIPATION,76
CA,DRUG HYPERSENSITIVITY,76
CA,URINARY TRACT INFECTION,76
CA,MUSCLE SPASMS,75
CA,BALANCE DISORDER,74
CA,GASTROOESOPHAGEAL REFLUX DISEASE,73
CA,PRURITUS,73
CA,RHEUMATOID ARTHRITIS,73
CA,ABDOMINAL PAIN UPPER,72
CA,ARTHRITIS,71
CA,CHEST DISCOMFORT,71
CA,CONTUSION,71
CA,RENAL IMPAIRMENT,71
CA,SEPSIS,71
CA,ACUTE KIDNEY INJURY,69
CA,BLOOD PRESSURE DECREASED,69
CA,INFLUENZA,69
CA,CHILLS,68
CA,CARDIAC DISORDER,67
CA,ABDOMINAL DISCOMFORT,66
CA,EPISTAXIS,66
CA,DEHYDRATION,65
CA,HEART RATE DECREASED,65
CA,INFUSION RELATED REACTION,65
CA,INSOMNIA,64
CA,BLOOD CHOLESTEROL INCREASED,62
CA,CELLULITIS,62
CA,PRODUCTIVE COUGH,60
CA,SWELLING,60
CA,ABDOMINAL DISTENSION,59
CA,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,58
CA,FIBROMYALGIA,58
CA,GENERAL PHYSICAL HEALTH DETERIORATION,58
CA,DIVERTICULITIS,57
CA,HYPERSENSITIVITY,57
CA,OEDEMA,57
CA,LEUKOPENIA,56
CA,LUNG INFECTION,56
CA,ASCITES,54
CA,DISEASE PROGRESSION,54
CA,LOSS OF CONSCIOUSNESS,54
CA,PRODUCT USE ISSUE,54
CA,TREMOR,54
CA,BLOOD PRESSURE SYSTOLIC INCREASED,52
CA,GLAUCOMA,52
CA,BLOOD GLUCOSE INCREASED,50
CA,GASTROINTESTINAL HAEMORRHAGE,50
CA,LIVER FUNCTION TEST ABNORMAL,50
CA,TOXICITY TO VARIOUS AGENTS,50
CA,COMA,49
CA,LOWER RESPIRATORY TRACT INFECTION,49
CA,SYNCOPE,49
CA,COLITIS MICROSCOPIC,48
CA,ERYTHEMA,48
CA,PLATELET COUNT DECREASED,48
CA,MUSCULAR WEAKNESS,47
CA,OROPHARYNGEAL PAIN,46
CA,RECTAL HAEMORRHAGE,46
CA,SINUSITIS,46
CA,BLOOD PRESSURE DIASTOLIC DECREASED,45
CA,DIABETES MELLITUS,45
CA,INTERNATIONAL NORMALISED RATIO INCREASED,45
CA,MOBILITY DECREASED,45
CA,PNEUMONIA ASPIRATION,45
CA,ASTHMA,44
CA,DELIRIUM,44
CA,DYSPNOEA EXERTIONAL,44
CA,MALIGNANT NEOPLASM PROGRESSION,43
CA,DYSPEPSIA,42
CA,HYPERHIDROSIS,42
CA,PALPITATIONS,42
CA,WHEEZING,42
CA,FEELING ABNORMAL,41
CA,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,41
CA,INTESTINAL OBSTRUCTION,41
CA,NASAL CONGESTION,41
CA,ANXIETY,40
CA,CEREBROVASCULAR ACCIDENT,40
CA,DEPRESSION,40
CA,SPUTUM DISCOLOURED,40
CA,TREATMENT FAILURE,40
CA,ARTERIOSCLEROSIS CORONARY ARTERY,39
CA,BLOOD PRESSURE FLUCTUATION,39
CA,BODY TEMPERATURE DECREASED,39
CA,MUSCULOSKELETAL PAIN,39
CA,LUNG DISORDER,38
CA,PNEUMONIA VIRAL,37
CA,SKIN ULCER,37
CA,HAEMORRHAGE,36
CA,HEPATIC ENZYME INCREASED,36
CA,HYPOAESTHESIA,36
CA,VISION BLURRED,36
CA,ARTHROPATHY,35
CA,ASPHYXIA,35
CA,DRUG DOSE OMISSION,35
CA,HEPATIC CIRRHOSIS,35
CA,PULMONARY HYPERTENSION,35
CA,COGNITIVE DISORDER,34
CA,DYSPHONIA,34
CA,FLUSHING,34
CA,MUSCULOSKELETAL STIFFNESS,34
CA,RENAL DISORDER,34
CA,CARDIAC ARREST,33
CA,MYALGIA,32
CA,ORTHOSTATIC HYPOTENSION,32
CA,PULMONARY EMBOLISM,32
CA,RENAL FAILURE ACUTE,32
CA,URINARY RETENTION,32
CA,C-REACTIVE PROTEIN INCREASED,31
CA,DEPRESSED LEVEL OF CONSCIOUSNESS,31
CA,HEART RATE IRREGULAR,31
CA,HOSPITALISATION,31
CA,JAUNDICE,31
CA,SOFT TISSUE DISORDER,31
CA,THYROID DISORDER,31
CA,WHITE BLOOD CELL COUNT INCREASED,31
CA,ACUTE MYOCARDIAL INFARCTION,30
CA,ALANINE AMINOTRANSFERASE INCREASED,30
CA,BURNING SENSATION,30
CA,LOCALISED INFECTION,30
CA,TACHYCARDIA,30
CA,THROMBOCYTOPENIA,30
CA,CYSTITIS,29
CA,LIMB INJURY,29
CA,THROMBOSIS,29
CA,GOUT,28
CA,HEPATIC FAILURE,28
CA,INJECTION SITE PAIN,28
CA,WOUND,28
CA,DEEP VEIN THROMBOSIS,27
CA,HYPOKALAEMIA,27
CA,MEMORY IMPAIRMENT,27
CA,PARAESTHESIA,27
CA,ARRHYTHMIA,26
CA,DEPRESSED MOOD,26
CA,GLOMERULAR FILTRATION RATE DECREASED,26
CA,HOT FLUSH,26
CA,INFLUENZA LIKE ILLNESS,26
CA,RIB FRACTURE,26
CA,STOMATITIS,26
CA,ASPARTATE AMINOTRANSFERASE INCREASED,25
CA,BRADYCARDIA,25
CA,DYSPHAGIA,25
CA,NECK PAIN,25
CA,RED BLOOD CELL COUNT DECREASED,25
CA,RESPIRATORY FAILURE,25
CA,VISUAL IMPAIRMENT,25
CA,BLOOD POTASSIUM INCREASED,24
CA,HAEMOPTYSIS,24
CA,HIP FRACTURE,24
CA,IMPAIRED HEALING,24
CA,PALLOR,24
CA,POLLAKIURIA,24
CA,AMNESIA,23
CA,BLOOD POTASSIUM DECREASED,23
CA,CATARACT,23
CA,DRUG EFFECT INCOMPLETE,23
CA,HYPERKALAEMIA,23
CA,HYPOPHAGIA,23
CA,INFLAMMATION,23
CA,OVERDOSE,23
CA,RHINORRHOEA,23
CA,STRESS,23
CA,URTICARIA,23
CA,ANGINA PECTORIS,22
CA,COLONIC PSEUDO-OBSTRUCTION,22
CA,CORONARY ARTERY DISEASE,22
CA,DISCOMFORT,22
CA,DRUG EFFECT DECREASED,22
CA,HAEMATOCHEZIA,22
CA,LETHARGY,22
CA,MIGRAINE,22
CA,RESPIRATORY DISTRESS,22
CA,SKIN REACTION,22
CA,SLEEP APNOEA SYNDROME,22
CA,BLOOD BILIRUBIN INCREASED,21
CA,CREATININE RENAL CLEARANCE DECREASED,21
CA,DYSURIA,21
CA,FLUID OVERLOAD,21
CA,LOCAL SWELLING,21
CA,OSTEOARTHRITIS,21
CA,PANCYTOPENIA,21
CA,SEIZURE,21
CA,BODY TEMPERATURE INCREASED,20
CA,DYSARTHRIA,20
CA,FLATULENCE,20
CA,HAEMORRHOIDS,20
CA,HYPERSOMNIA,20
CA,HYPOXIA,20
CA,PAIN IN JAW,20
CA,PULMONARY ARTERIAL HYPERTENSION,20
CA,SKIN DISCOLOURATION,20
CA,SPINAL FRACTURE,20
CA,WHITE BLOOD CELL COUNT DECREASED,20
CA,ACTIVITIES OF DAILY LIVING IMPAIRED,19
CA,BLOOD TEST ABNORMAL,19
CA,DEVICE RELATED INFECTION,19
CA,DRY MOUTH,19
CA,FEBRILE NEUTROPENIA,19
CA,GASTROINTESTINAL DISORDER,19
CA,HEPATIC ENCEPHALOPATHY,19
CA,MULTIPLE FRACTURES,19
CA,SEPTIC SHOCK,19
CA,UPPER GASTROINTESTINAL HAEMORRHAGE,19
CA,BLOOD PRESSURE ABNORMAL,18
CA,CHRONIC KIDNEY DISEASE,18
CA,CROHN^S DISEASE,18
CA,DISORIENTATION,18
CA,FEELING COLD,18
CA,HYPOKINESIA,18
CA,LACERATION,18
CA,MUSCULOSKELETAL DISCOMFORT,18
CA,PULMONARY FIBROSIS,18
CA,RASH PRURITIC,18
CA,RESPIRATORY RATE INCREASED,18
CA,SEDATION,18
CA,SKIN EXFOLIATION,18
CA,SWOLLEN TONGUE,18
CA,TENDERNESS,18
CA,ALOPECIA,17
CA,EYE SWELLING,17
CA,FAECES DISCOLOURED,17
CA,HALLUCINATION,17
CA,HYPONATRAEMIA,17
CA,LIMB DISCOMFORT,17
CA,MELAENA,17
CA,RASH ERYTHEMATOUS,17
CA,RIGHT VENTRICULAR FAILURE,17
CA,SCAR,17
CA,SKIN ABRASION,17
CA,TRANSFUSION,17
CA,ABASIA,16
CA,BLOOD IRON DECREASED,16
CA,CLOSTRIDIUM DIFFICILE INFECTION,16
CA,DYSGEUSIA,16
CA,ENCEPHALOPATHY,16
CA,GENERALISED OEDEMA,16
CA,HAEMATOMA,16
CA,NEOPLASM MALIGNANT,16
CA,ORAL PAIN,16
CA,PANCREATITIS,16
CA,RALES,16
CA,THROAT IRRITATION,16
CA,TRANSIENT ISCHAEMIC ATTACK,16
CA,TYPE 2 DIABETES MELLITUS,16
CA,UPPER RESPIRATORY TRACT INFECTION,16
CA,ATELECTASIS,15
CA,BONE PAIN,15
CA,CARDIOMEGALY,15
CA,DIABETES MELLITUS INADEQUATE CONTROL,15
CA,HAEMATEMESIS,15
CA,HYPOGLYCAEMIA,15
CA,IMMUNODEFICIENCY,15
CA,LYMPHADENOPATHY,15
CA,MASS,15
CA,MUSCULOSKELETAL CHEST PAIN,15
CA,NEOPLASM,15
CA,NEUROPATHY PERIPHERAL,15
CA,PSORIASIS,15
CA,RESPIRATORY TRACT INFECTION,15
CA,ROAD TRAFFIC ACCIDENT,15
CA,SCLERODERMA,15
CA,SKIN DISORDER,15
CA,SPLENOMEGALY,15
CA,SWELLING FACE,15
CA,THERAPEUTIC RESPONSE DECREASED,15
CA,VIRAL UPPER RESPIRATORY TRACT INFECTION,15
CA,ADVERSE EVENT,14
CA,AGITATION,14
CA,BLOOD CALCIUM DECREASED,14
CA,C-REACTIVE PROTEIN ABNORMAL,14
CA,CHROMATURIA,14
CA,DRY SKIN,14
CA,EYE HAEMORRHAGE,14
CA,GAMMA-GLUTAMYLTRANSFERASE INCREASED,14
CA,HYPERGLYCAEMIA,14
CA,MULTI-ORGAN FAILURE,14
CA,MUTISM,14
CA,MYOCARDIAL ISCHAEMIA,14
CA,OSTEOPOROSIS,14
CA,PERICARDIAL EFFUSION,14
CA,RESPIRATORY DISORDER,14
CA,SLEEP DISORDER,14
CA,STAPHYLOCOCCAL INFECTION,14
CA,UPPER LIMB FRACTURE,14
CA,URINARY INCONTINENCE,14
CA,BLOOD GLUCOSE DECREASED,13
CA,BLOOD SODIUM DECREASED,13
CA,ELECTROCARDIOGRAM QT PROLONGED,13
CA,HAEMATOCRIT DECREASED,13
CA,HAEMATURIA,13
CA,LIVER DISORDER,13
CA,MOUTH HAEMORRHAGE,13
CA,POOR QUALITY SLEEP,13
CA,POST PROCEDURAL INFECTION,13
CA,PRESYNCOPE,13
CA,PULMONARY FUNCTION TEST DECREASED,13
CA,SKIN FISSURES,13
CA,TOOTH DISORDER,13
CA,UNEVALUABLE EVENT,13
CA,VIRAL INFECTION,13
CA,WOUND INFECTION,13
CA,BLISTER,12
CA,BLOOD MAGNESIUM DECREASED,12
CA,CHOLELITHIASIS,12
CA,DERMATITIS,12
CA,DYSKINESIA,12
CA,EATING DISORDER,12
CA,ELECTROLYTE IMBALANCE,12
CA,EXERCISE TOLERANCE DECREASED,12
CA,FACE OEDEMA,12
CA,GASTRIC DISORDER,12
CA,JOINT STIFFNESS,12
CA,LUNG NEOPLASM MALIGNANT,12
CA,METASTASES TO LIVER,12
CA,PULMONARY MASS,12
CA,QUALITY OF LIFE DECREASED,12
CA,URINE ODOUR ABNORMAL,12
CA,VERTIGO,12
CA,ACUTE CORONARY SYNDROME,11
CA,BLOOD PRESSURE SYSTOLIC DECREASED,11
CA,BURSITIS,11
CA,CARDIAC OUTPUT DECREASED,11
CA,CONCOMITANT DISEASE AGGRAVATED,11
CA,ECCHYMOSIS,11
CA,FEELING HOT,11
CA,FOOT FRACTURE,11
CA,FORCED EXPIRATORY VOLUME DECREASED,11
CA,GALLBLADDER DISORDER,11
CA,HEAD DISCOMFORT,11
CA,HYPOVOLAEMIA,11
CA,KNEE ARTHROPLASTY,11
CA,LOWER GASTROINTESTINAL HAEMORRHAGE,11
CA,MIDDLE INSOMNIA,11
CA,MOVEMENT DISORDER,11
CA,NEPHROLITHIASIS,11
CA,NIGHT SWEATS,11
CA,OCULAR HYPERAEMIA,11
CA,ORAL HERPES,11
CA,ORTHOPNOEA,11
CA,PELVIC FRACTURE,11
CA,PERICARDITIS,11
CA,PROTEINURIA,11
CA,PULMONARY CONGESTION,11
CA,SKIN LESION,11
CA,SUICIDAL IDEATION,11
CA,TACHYPNOEA,11
CA,TINNITUS,11
CA,VENTRICULAR TACHYCARDIA,11
CA,ANGIOEDEMA,10
CA,BLOOD ALBUMIN DECREASED,10
CA,BLOOD PRESSURE DIASTOLIC INCREASED,10
CA,BLOOD UREA INCREASED,10
CA,BREAST CANCER,10
CA,BREATH SOUNDS ABNORMAL,10
CA,COLITIS,10
CA,DISTURBANCE IN ATTENTION,10
CA,DRUG-INDUCED LIVER INJURY,10
CA,FUNGAL INFECTION,10
CA,HAEMOGLOBIN ABNORMAL,10
CA,HERNIA,10
CA,HYPOAESTHESIA ORAL,10
CA,INCORRECT DOSE ADMINISTERED,10
CA,JOINT INJURY,10
CA,KIDNEY INFECTION,10
CA,NEUTROPENIA,10
CA,PERIPHERAL COLDNESS,10
CA,POST PROCEDURAL HAEMORRHAGE,10
CA,PRODUCT QUALITY ISSUE,10
CA,PRODUCT SUBSTITUTION ISSUE,10
CA,RASH GENERALISED,10
CA,RASH MACULO-PAPULAR,10
CA,SCIATICA,10
CA,SHOCK,10
CA,SKIN HAEMORRHAGE,10
CA,SKIN INFECTION,10
CA,TORSADE DE POINTES,10
CA,VISUAL ACUITY REDUCED,10
CA,ABNORMAL BEHAVIOUR,9
CA,ABSCESS,9
CA,ALTERED STATE OF CONSCIOUSNESS,9
CA,BACK INJURY,9
CA,BLOOD ALKALINE PHOSPHATASE INCREASED,9
CA,BLOOD CREATINE PHOSPHOKINASE INCREASED,9
CA,BLOOD URINE PRESENT,9
CA,CARDIOVASCULAR DISORDER,9
CA,CHOLECYSTITIS,9
CA,CONVULSION,9
CA,DRUG LEVEL INCREASED,9
CA,DRUG RESISTANCE,9
CA,HEART VALVE INCOMPETENCE,9
CA,HEPATIC STEATOSIS,9
CA,IMMUNE SYSTEM DISORDER,9
CA,INJECTION SITE MASS,9
CA,INTERSTITIAL LUNG DISEASE,9
CA,INTESTINAL PERFORATION,9
CA,IRRITABILITY,9
CA,ISCHAEMIC STROKE,9
CA,LIGAMENT SPRAIN,9
CA,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,9
CA,MENTAL STATUS CHANGES,9
CA,METABOLIC ACIDOSIS,9
CA,OSTEOMYELITIS,9
CA,PAIN OF SKIN,9
CA,PLASMA CELL MYELOMA,9
CA,PNEUMOTHORAX,9
CA,POLYP,9
CA,POST PROCEDURAL COMPLICATION,9
CA,PRODUCT USE IN UNAPPROVED INDICATION,9
CA,RESPIRATORY TRACT CONGESTION,9
CA,SECRETION DISCHARGE,9
CA,SINUS BRADYCARDIA,9
CA,SINUS CONGESTION,9
CA,SKIN CANCER,9
CA,SPEECH DISORDER,9
CA,SUBDURAL HAEMATOMA,9
CA,ACCIDENT,8
CA,ANAPHYLACTIC REACTION,8
CA,ANGINA UNSTABLE,8
CA,AORTIC STENOSIS,8
CA,APHASIA,8
CA,APHONIA,8
CA,ATRIAL FLUTTER,8
CA,BLOOD DISORDER,8
CA,BLOOD GLUCOSE ABNORMAL,8
CA,CARDIAC VALVE DISEASE,8
CA,DEFORMITY,8
CA,DEMENTIA,8
CA,DIPLOPIA,8
CA,DYSLIPIDAEMIA,8
CA,EAR PAIN,8
CA,ECZEMA,8
CA,ENCEPHALITIS,8
CA,ENCEPHALITIS BRAIN STEM,8
CA,ESCHERICHIA INFECTION,8
CA,EYE DISORDER,8
CA,EYE INFECTION,8
CA,EYE PAIN,8
CA,FEMUR FRACTURE,8
CA,FORCED VITAL CAPACITY DECREASED,8
CA,GASTROENTERITIS VIRAL,8
CA,HEPATIC NEOPLASM,8
CA,HYPERTONIC BLADDER,8
CA,ILL-DEFINED DISORDER,8
CA,IMMOBILE,8
CA,INJECTION SITE SWELLING,8
CA,INTENTIONAL OVERDOSE,8
CA,INTESTINAL RESECTION,8
CA,LYMPHOCYTE COUNT DECREASED,8
CA,MOUTH ULCERATION,8
CA,MULTIPLE ORGAN DYSFUNCTION SYNDROME,8
CA,MUSCLE STRAIN,8
CA,NEEDLE ISSUE,8
CA,NO THERAPEUTIC RESPONSE,8
CA,OBSTRUCTIVE AIRWAYS DISORDER,8
CA,PERITONITIS BACTERIAL,8
CA,PHARYNGEAL OEDEMA,8
CA,PSYCHIATRIC SYMPTOM,8
CA,RED CELL DISTRIBUTION WIDTH INCREASED,8
CA,SINUS DISORDER,8
CA,SKIN ATROPHY,8
CA,SQUAMOUS CELL CARCINOMA,8
CA,SUDDEN DEATH,8
CA,THERAPY NON-RESPONDER,8
CA,TOOTH ABSCESS,8
CA,TROPONIN INCREASED,8
CA,UNDERDOSE,8
CA,VASCULITIS,8
CA,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,8
CA,ABDOMINAL PAIN LOWER,7
CA,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,7
CA,ACUTE PULMONARY OEDEMA,7
CA,ACUTE RESPIRATORY DISTRESS SYNDROME,7
CA,ANTI-ERYTHROPOIETIN ANTIBODY NEGATIVE,7
CA,APLASIA PURE RED CELL,7
CA,BASAL CELL CARCINOMA,7
CA,BLINDNESS,7
CA,BLOOD LACTATE DEHYDROGENASE INCREASED,7
CA,BONE MARROW FAILURE,7
CA,CARDIOGENIC SHOCK,7
CA,COMPRESSION FRACTURE,7
CA,CONTRAINDICATED PRODUCT ADMINISTERED,7
CA,CORONARY ARTERY OCCLUSION,7
CA,DECREASED ACTIVITY,7
CA,DIABETIC KETOACIDOSIS,7
CA,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,7
CA,DYSSTASIA,7
CA,FAECES SOFT,7
CA,FULL BLOOD COUNT DECREASED,7
CA,HAEMORRHOIDAL HAEMORRHAGE,7
CA,HIATUS HERNIA,7
CA,HIP ARTHROPLASTY,7
CA,HYPOMAGNESAEMIA,7
CA,HYPOVENTILATION,7
CA,INJECTION SITE REACTION,7
CA,INTERNAL HAEMORRHAGE,7
CA,INTERVERTEBRAL DISC PROTRUSION,7
CA,LABORATORY TEST ABNORMAL,7
CA,LOCALISED OEDEMA,7
CA,MEDICATION ERROR,7
CA,METASTASES TO LUNG,7
CA,MIXED DEMENTIA,7
CA,MYOCLONUS,7
CA,NERVOUSNESS,7
CA,PERIPHERAL VENOUS DISEASE,7
CA,PETECHIAE,7
CA,PNEUMONITIS,7
CA,PROSTATE CANCER METASTATIC,7
CA,PRURITUS GENERALISED,7
CA,PULMONARY FUNCTION TEST ABNORMAL,7
CA,PULMONARY THROMBOSIS,7
CA,RESTLESS LEGS SYNDROME,7
CA,RHABDOMYOLYSIS,7
CA,STENT PLACEMENT,7
CA,SYSTEMIC LUPUS ERYTHEMATOSUS,7
CA,THROAT TIGHTNESS,7
CA,UROSEPSIS,7
CA,VAGINAL HAEMORRHAGE,7
CA,VENOUS PRESSURE JUGULAR INCREASED,7
CA,WOUND HAEMORRHAGE,7
CA,ACCIDENTAL OVERDOSE,6
CA,ADVERSE DRUG REACTION,6
CA,ASPIRATION,6
CA,ATRIOVENTRICULAR BLOCK,6
CA,BACTERIAL SEPSIS,6
CA,BILIRUBIN CONJUGATED INCREASED,6
CA,BLADDER DISORDER,6
CA,BLOOD IRON INCREASED,6
CA,BLOOD LACTIC ACID INCREASED,6
CA,BONE DISORDER,6
CA,BRAIN NATRIURETIC PEPTIDE INCREASED,6
CA,BRONCHIECTASIS,6
CA,CARDIAC FAILURE CHRONIC,6
CA,CARDIAC OPERATION,6
CA,CARDIAC PACEMAKER INSERTION,6
CA,CARDIO-RESPIRATORY ARREST,6
CA,CEREBRAL HAEMORRHAGE,6
CA,CHEST X-RAY ABNORMAL,6
CA,DEAFNESS BILATERAL,6
CA,DELUSION,6
CA,DEVICE OCCLUSION,6
CA,DRY EYE,6
CA,EAR INFECTION,6
CA,EYE DISCHARGE,6
CA,FEELING OF BODY TEMPERATURE CHANGE,6
CA,FREQUENT BOWEL MOVEMENTS,6
CA,GASTRIC HAEMORRHAGE,6
CA,GASTROENTERITIS,6
CA,GASTROINTESTINAL SOUNDS ABNORMAL,6
CA,GINGIVAL PAIN,6
CA,GROIN PAIN,6
CA,HAEMOLYTIC ANAEMIA,6
CA,HEPATOTOXICITY,6
CA,HYDRONEPHROSIS,6
CA,HYPERBILIRUBINAEMIA,6
CA,HYPERCHOLESTEROLAEMIA,6
CA,HYPERLIPIDAEMIA,6
CA,HYPOTHYROIDISM,6
CA,INJECTION SITE EXTRAVASATION,6
CA,INTERNATIONAL NORMALISED RATIO DECREASED,6
CA,INTERVERTEBRAL DISC DEGENERATION,6
CA,JOINT DESTRUCTION,6
CA,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,6
CA,LEFT VENTRICULAR DYSFUNCTION,6
CA,LYMPHOEDEMA,6
CA,MACULAR DEGENERATION,6
CA,MALLORY-WEISS SYNDROME,6
CA,MITRAL VALVE INCOMPETENCE,6
CA,MULTIPLE DRUG THERAPY,6
CA,NASAL DRYNESS,6
CA,NEOPLASM PROGRESSION,6
CA,OBESITY,6
CA,ORAL CANDIDIASIS,6
CA,ORAL DISCOMFORT,6
CA,OTOTOXICITY,6
CA,PANIC ATTACK,6
CA,POLYURIA,6
CA,POOR VENOUS ACCESS,6
CA,PROSTATE CANCER,6
CA,PSEUDOMONAS INFECTION,6
CA,RASH MACULAR,6
CA,RENAL FUNCTION TEST ABNORMAL,6
CA,SCAB,6
CA,SEROTONIN SYNDROME,6
CA,SINUS HEADACHE,6
CA,SKIN IRRITATION,6
CA,SPINAL DEFORMITY,6
CA,SURGERY,6
CA,TOOTH EXTRACTION,6
CA,UPPER-AIRWAY COUGH SYNDROME,6
CA,URINE OUTPUT DECREASED,6
CA,VARICOSE VEIN,6
CA,VEIN DISORDER,6
CA,VENTRICULAR FIBRILLATION,6
CA,WEIGHT FLUCTUATION,6
CA,ABDOMINAL HERNIA,5
CA,ACNE,5
CA,AGEUSIA,5
CA,AMMONIA INCREASED,5
CA,APNOEA,5
CA,ARTHRITIS INFECTIVE,5
CA,AUTONOMIC NERVOUS SYSTEM IMBALANCE,5
CA,BACTERIAL INFECTION,5
CA,BLEEDING VARICOSE VEIN,5
CA,CANDIDA INFECTION,5
CA,CARBON MONOXIDE DIFFUSING CAPACITY DECREASED,5
CA,CARDIAC FLUTTER,5
CA,CARDIOMYOPATHY,5
CA,CARPAL TUNNEL SYNDROME,5
CA,CATARACT OPERATION,5
CA,CATHETER SITE INFECTION,5
CA,CATHETER SITE PAIN,5
CA,CATHETERISATION CARDIAC,5
CA,CENTRAL VENOUS CATHETERISATION,5
CA,CHOKING,5
CA,CIRCULATORY COLLAPSE,5
CA,COLITIS ULCERATIVE,5
CA,CORONARY ARTERY BYPASS,5
CA,CRYING,5
CA,CYST,5
CA,DEAFNESS UNILATERAL,5
CA,DECUBITUS ULCER,5
CA,DIARRHOEA HAEMORRHAGIC,5
CA,DIZZINESS POSTURAL,5
CA,DRUG WITHDRAWAL SYNDROME,5
CA,EJECTION FRACTION DECREASED,5
CA,EMPHYSEMA,5
CA,ESCHERICHIA SEPSIS,5
CA,EXOSTOSIS,5
CA,EXTRASYSTOLES,5
CA,FISTULA,5
CA,FLAGELLATE DERMATITIS,5
CA,FURUNCLE,5
CA,GASTRIC ULCER,5
CA,HAEMOLYSIS,5
CA,HAEMORRHAGE URINARY TRACT,5
CA,HEAD INJURY,5
CA,HEPATIC CONGESTION,5
CA,HEPATIC ENZYME ABNORMAL,5
CA,HEPATITIS ACUTE,5
CA,HUNGER,5
CA,HYPERCALCAEMIA,5
CA,HYPOPNOEA,5
CA,INCORRECT ROUTE OF DRUG ADMINISTRATION,5
CA,INCREASED APPETITE,5
CA,INFECTED SKIN ULCER,5
CA,ISCHAEMIC CARDIOMYOPATHY,5
CA,JOINT EFFUSION,5
CA,JOINT RANGE OF MOTION DECREASED,5
CA,LARYNGITIS,5
CA,LIVER FUNCTION TEST INCREASED,5
CA,LIVER INJURY,5
CA,LOWER LIMB FRACTURE,5
CA,LUNG ABSCESS,5
CA,MELANOCYTIC NAEVUS,5
CA,METASTASES TO BONE,5
CA,MULTIPLE SCLEROSIS RELAPSE,5
CA,OXYGEN SUPPLEMENTATION,5
CA,PANCREATITIS ACUTE,5
CA,PLATELET COUNT INCREASED,5
CA,PROSTATOMEGALY,5
CA,PULMONARY HAEMORRHAGE,5
CA,REGURGITATION,5
CA,RESTLESSNESS,5
CA,ROTATOR CUFF SYNDROME,5
CA,SERUM FERRITIN INCREASED,5
CA,SINUS TACHYCARDIA,5
CA,SKIN BURNING SENSATION,5
CA,SMALL INTESTINAL OBSTRUCTION,5
CA,SPINAL COLUMN STENOSIS,5
CA,SPINAL COMPRESSION FRACTURE,5
CA,SPINAL PAIN,5
CA,STAPHYLOCOCCUS TEST POSITIVE,5
CA,STEVENS-JOHNSON SYNDROME,5
CA,STREPTOCOCCAL BACTERAEMIA,5
CA,SUICIDE ATTEMPT,5
CA,SUPERFICIAL INJURY OF EYE,5
CA,TERMINAL STATE,5
CA,UNRESPONSIVE TO STIMULI,5
CA,VARICES OESOPHAGEAL,5
CA,ABSCESS LIMB,4
CA,ACUTE HEPATIC FAILURE,4
CA,ACUTE MYELOID LEUKAEMIA,4
CA,AKATHISIA,4
CA,ALBUMIN URINE PRESENT,4
CA,AORTIC VALVE STENOSIS,4
CA,APHTHOUS STOMATITIS,4
CA,APHTHOUS ULCER,4
CA,APPETITE DISORDER,4
CA,APPLICATION SITE BRUISE,4
CA,ARTERIAL OCCLUSIVE DISEASE,4
CA,ARTERIOSCLEROSIS,4
CA,ARTHROPOD BITE,4
CA,ASPERGILLUS INFECTION,4
CA,AZOTAEMIA,4
CA,BACK DISORDER,4
CA,BETA HAEMOLYTIC STREPTOCOCCAL INFECTION,4
CA,BILE DUCT STONE,4
CA,BLOOD COUNT ABNORMAL,4
CA,BLOOD ELECTROLYTES DECREASED,4
CA,BLOOD PRESSURE DIASTOLIC ABNORMAL,4
CA,BONE MARROW TOXICITY,4
CA,BOWEL MOVEMENT IRREGULARITY,4
CA,BRONCHOSPASM,4
CA,CALCINOSIS,4
CA,CARDIAC MURMUR,4
CA,CARPAL TUNNEL DECOMPRESSION,4
CA,CHOKING SENSATION,4
CA,CHOLESTASIS,4
CA,COAGULOPATHY,4
CA,CORONARY ARTERY EMBOLISM,4
CA,CORONARY ARTERY STENOSIS,4
CA,CYANOSIS,4
CA,CYSTITIS KLEBSIELLA,4
CA,DEAFNESS,4
CA,DEAFNESS NEUROSENSORY,4
CA,DEMENTIA ALZHEIMER^S TYPE,4
CA,DIASTOLIC DYSFUNCTION,4
CA,DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT,4
CA,DRUG ADMINISTRATION ERROR,4
CA,DRUG DEPENDENCE,4
CA,DRUG PRESCRIBING ERROR,4
CA,DUODENITIS,4
CA,DYSPNOEA PAROXYSMAL NOCTURNAL,4
CA,EAR CONGESTION,4
CA,EAR DISCOMFORT,4
CA,ENTEROCOCCAL INFECTION,4
CA,EOSINOPHIL COUNT INCREASED,4
CA,EOSINOPHILIA,4
CA,EUPHORIC MOOD,4
CA,EYE INFLAMMATION,4
CA,EYE IRRITATION,4
CA,EYE PRURITUS,4
CA,FACIAL PAIN,4
CA,FAECES HARD,4
CA,FRACTURE,4
CA,FRUSTRATION TOLERANCE DECREASED,4
CA,GASTRIC ULCER HAEMORRHAGE,4
CA,GENERALISED TONIC-CLONIC SEIZURE,4
CA,GINGIVAL BLEEDING,4
CA,HAEMORRHAGE INTRACRANIAL,4
CA,HAND FRACTURE,4
CA,HEMIPARESIS,4
CA,HEPATIC FUNCTION ABNORMAL,4
CA,HEPATITIS C,4
CA,HEPATOCELLULAR CARCINOMA,4
CA,HICCUPS,4
CA,HUMERUS FRACTURE,4
CA,HYPERVENTILATION,4
CA,HYPOACUSIS,4
CA,HYPOVOLAEMIC SHOCK,4
CA,IMMUNOSUPPRESSION,4
CA,INCONTINENCE,4
CA,INCORRECT DRUG ADMINISTRATION DURATION,4
CA,INCREASED VISCOSITY OF BRONCHIAL SECRETION,4
CA,INFUSION SITE ERYTHEMA,4
CA,INJECTION SITE PRURITUS,4
CA,INTENTIONAL PRODUCT MISUSE,4
CA,INTESTINAL ISCHAEMIA,4
CA,IRON DEFICIENCY ANAEMIA,4
CA,LACRIMATION INCREASED,4
CA,LACTIC ACIDOSIS,4
CA,LARGE INTESTINE POLYP,4
CA,LARYNGEAL OEDEMA,4
CA,LIMB OPERATION,4
CA,LIP SWELLING,4
CA,LUNG CARCINOMA CELL TYPE UNSPECIFIED RECURRENT,4
CA,LUNG CONSOLIDATION,4
CA,LUNG INFILTRATION,4
CA,LYMPHOCELE,4
CA,LYMPHOMA,4
CA,MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED,4
CA,MEAN CELL HAEMOGLOBIN INCREASED,4
CA,MEAN CELL VOLUME INCREASED,4
CA,METAMORPHOPSIA,4
CA,MOOD ALTERED,4
CA,NASAL DISCHARGE DISCOLOURATION,4
CA,NERVE INJURY,4
CA,NERVOUS SYSTEM DISORDER,4
CA,NEURALGIA,4
CA,NEUTROPHIL COUNT DECREASED,4
CA,NOCTURIA,4
CA,NODULE,4
CA,NON-ALCOHOLIC STEATOHEPATITIS,4
CA,OESOPHAGEAL VARICES HAEMORRHAGE,4
CA,OESOPHAGITIS,4
CA,ORAL MUCOSAL BLISTERING,4
CA,ORAL PRURITUS,4
CA,ORGANISING PNEUMONIA,4
CA,PACKED RED BLOOD CELL TRANSFUSION,4
CA,PALLIATIVE CARE,4
CA,PANCREATIC CYST,4
CA,PARALYSIS,4
CA,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,4
CA,PERIPHERAL ISCHAEMIA,4
CA,PERIPHERAL SENSORY NEUROPATHY,4
CA,PERITONITIS,4
CA,PHARYNGITIS,4
CA,PHLEBITIS,4
CA,PILOERECTION,4
CA,PLEURISY,4
CA,PNEUMONIA LEGIONELLA,4
CA,PNEUMONIA STAPHYLOCOCCAL,4
CA,POSTOPERATIVE WOUND INFECTION,4
CA,PRERENAL FAILURE,4
CA,PROCEDURAL COMPLICATION,4
CA,PROTEIN TOTAL DECREASED,4
CA,RASH PAPULAR,4
CA,RECTAL ADENOCARCINOMA,4
CA,RENAL CYST,4
CA,RENAL FAILURE CHRONIC,4
CA,RENAL MASS,4
CA,RETCHING,4
CA,RHINITIS,4
CA,SCROTAL SWELLING,4
CA,SEASONAL ALLERGY,4
CA,SENSORY DISTURBANCE,4
CA,SKIN DEPIGMENTATION,4
CA,SKIN PLAQUE,4
CA,SNEEZING,4
CA,SPINAL CORD COMPRESSION,4
CA,SPINAL OSTEOARTHRITIS,4
CA,STASIS DERMATITIS,4
CA,STRESS FRACTURE,4
CA,SUPRAVENTRICULAR TACHYCARDIA,4
CA,THIRST,4
CA,THROMBOTIC MICROANGIOPATHY,4
CA,TOOTH FRACTURE,4
CA,TRANSPLANT REJECTION,4
CA,TREATMENT NONCOMPLIANCE,4
CA,TUBERCULIN TEST POSITIVE,4
CA,ULCER,4
CA,ULCER HAEMORRHAGE,4
CA,UMBILICAL HERNIA,4
CA,URETERIC STENOSIS,4
CA,URINARY TRACT INFECTION BACTERIAL,4
CA,URINARY TRACT OBSTRUCTION,4
CA,UTERINE LEIOMYOMA,4
CA,VACCINATION SITE PAIN,4
CA,VENTRICULAR EXTRASYSTOLES,4
CA,VIRAL MUTATION IDENTIFIED,4
CA,VIROLOGIC FAILURE,4
CA,WOUND COMPLICATION,4
CA,WOUND DRAINAGE,4
CA,WOUND SECRETION,4
CA,WRIST FRACTURE,4
CA,YELLOW SKIN,4
CA,ABDOMINAL ABSCESS,3
CA,ABDOMINAL TENDERNESS,3
CA,ABNORMAL LOSS OF WEIGHT,3
CA,ADENOCARCINOMA OF COLON,3
CA,ALVEOLITIS,3
CA,ANAL HAEMORRHAGE,3
CA,ANAL INCONTINENCE,3
CA,ANAPHYLACTIC SHOCK,3
CA,ANGIOPLASTY,3
CA,ANTI A ANTIBODY,3
CA,ANURIA,3
CA,AORTIC ANEURYSM,3
CA,APHAGIA,3
CA,ARTERIAL RUPTURE,3
CA,AUTOIMMUNE HAEMOLYTIC ANAEMIA,3
CA,BEDRIDDEN,3
CA,BENIGN BREAST NEOPLASM,3
CA,BENIGN PROSTATIC HYPERPLASIA,3
CA,BLOOD BILIRUBIN UNCONJUGATED INCREASED,3
CA,BLOOD CREATININE ABNORMAL,3
CA,BLOOD GLUCOSE FLUCTUATION,3
CA,BLOOD PH DECREASED,3
CA,BLOOD PHOSPHORUS INCREASED,3
CA,BLOOD PRESSURE INADEQUATELY CONTROLLED,3
CA,BONE DENSITY DECREASED,3
CA,BREAST CANCER METASTATIC,3
CA,BREAST MASS,3
CA,BUNDLE BRANCH BLOCK RIGHT,3
CA,CARCINOID HEART DISEASE,3
CA,CARDIAC ASSISTANCE DEVICE USER,3
CA,CARDIAC HYPERTROPHY,3
CA,CARDIAC INFECTION,3
CA,CARDIOVERSION,3
CA,CATHETER SITE DISCHARGE,3
CA,CATHETER SITE ERYTHEMA,3
CA,CATHETER SITE HAEMORRHAGE,3
CA,CHOLECYSTECTOMY,3
CA,COLECTOMY,3
CA,COLORECTAL ADENOCARCINOMA,3
CA,CONJUNCTIVITIS,3
CA,CORNEAL THINNING,3
CA,COSTOCHONDRITIS,3
CA,DERMATITIS CONTACT,3
CA,DERMATITIS HERPETIFORMIS,3
CA,DEVICE BREAKAGE,3
CA,DEVICE FAILURE,3
CA,DEVICE INTERACTION,3
CA,DIALYSIS,3
CA,DISSEMINATED INTRAVASCULAR COAGULATION,3
CA,DIVERTICULUM,3
CA,DIVERTICULUM INTESTINAL HAEMORRHAGIC,3
CA,DRUG CLEARANCE DECREASED,3
CA,DRUG TOLERANCE INCREASED,3
CA,DUST ALLERGY,3
CA,DYSGRAPHIA,3
CA,EJECTION FRACTION ABNORMAL,3
CA,ELECTROCARDIOGRAM ABNORMAL,3
CA,EMBOLIC STROKE,3
CA,ENDOCARDITIS,3
CA,EROSIVE DUODENITIS,3
CA,ERUCTATION,3
CA,ESCHERICHIA URINARY TRACT INFECTION,3
CA,EXPOSURE DURING PREGNANCY,3
CA,EYELID PTOSIS,3
CA,FAECAL INCONTINENCE,3
CA,FAECES PALE,3
CA,FEMALE GENITAL TRACT FISTULA,3
CA,FEMORAL NECK FRACTURE,3
CA,FINGER DEFORMITY,3
CA,FLUID INTAKE REDUCED,3
CA,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,3
CA,FOOT DEFORMITY,3
CA,GAIT INABILITY,3
CA,GASTRIC DILATATION,3
CA,GASTRITIS,3
CA,GASTROINTESTINAL CARCINOMA,3
CA,GASTROINTESTINAL INFECTION,3
CA,GLIOBLASTOMA,3
CA,GLYCOSYLATED HAEMOGLOBIN INCREASED,3
CA,GRAFT VERSUS HOST DISEASE,3
CA,GRANULOMATOSIS WITH POLYANGIITIS,3
CA,GROIN ABSCESS,3
CA,HAEMATOTOXICITY,3
CA,HAEMOGLOBINURIA,3
CA,HEPATIC PAIN,3
CA,HEPATITIS,3
CA,HIP SURGERY,3
CA,HYPERKERATOSIS,3
CA,HYPERREFLEXIA,3
CA,HYPERTHERMIA,3
CA,HYPERTRICHOSIS,3
CA,HYPOALBUMINAEMIA,3
CA,HYPOCALCAEMIA,3
CA,IDIOPATHIC PULMONARY FIBROSIS,3
CA,IMPAIRED GASTRIC EMPTYING,3
CA,IMPAIRED WORK ABILITY,3
CA,INCOHERENT,3
KY,DEATH,1
CF,DEATH NEONATAL,1
CF,MATERNAL EXPOSURE DURING PREGNANCY,1
CL,HYPERKALAEMIA,14
CL,LACTIC ACIDOSIS,13
CL,OVERDOSE,12
CL,PNEUMONIA,11
CL,CHEST PAIN,9
CL,DYSPNOEA,9
CL,NAUSEA,9
CL,ANAEMIA,8
CL,DIARRHOEA,8
CL,FATIGUE,7
CL,HYPOTENSION,7
CL,PULMONARY HYPERTENSION,7
CL,ACUTE MYOCARDIAL INFARCTION,6
CL,COUGH,6
CL,GENERAL PHYSICAL HEALTH DETERIORATION,6
CL,HEADACHE,6
CL,HYPERTENSION,6
CL,SYNCOPE,6
CL,ATRIOVENTRICULAR BLOCK,5
CL,AZOTAEMIA,5
CL,CARDIAC DISORDER,5
CL,CARDIAC FAILURE,5
CL,DIZZINESS,5
CL,HYPOGLYCAEMIA,5
CL,METABOLIC ACIDOSIS,5
CL,OEDEMA PERIPHERAL,5
CL,URINARY TRACT INFECTION,5
CL,VOMITING,5
CL,ARRHYTHMIA,4
CL,BRADYARRHYTHMIA,4
CL,DISORIENTATION,4
CL,DRUG INEFFECTIVE,4
CL,LOSS OF CONSCIOUSNESS,4
CL,PAIN IN EXTREMITY,4
CL,RENAL FAILURE,4
CL,RESPIRATORY FAILURE,4
CL,ABASIA,3
CL,ABDOMINAL DISTENSION,3
CL,ACUTE KIDNEY INJURY,3
CL,AGITATION,3
CL,ANGINA PECTORIS,3
CL,BLOOD BILIRUBIN INCREASED,3
CL,BLOOD CREATININE INCREASED,3
CL,CHOKING SENSATION,3
CL,CONDITION AGGRAVATED,3
CL,DEATH,3
CL,DECREASED APPETITE,3
CL,DEPRESSED MOOD,3
CL,MYALGIA,3
CL,NASOPHARYNGITIS,3
CL,PHARYNGITIS,3
CL,PULMONARY OEDEMA,3
CL,RENAL IMPAIRMENT,3
CL,SINUS BRADYCARDIA,3
CL,SOMNOLENCE,3
CL,ABDOMINAL PAIN,2
CL,ASCITES,2
CL,BACK PAIN,2
CL,BLOOD PRESSURE DECREASED,2
CL,BRAIN NATRIURETIC PEPTIDE INCREASED,2
CL,CARDIO-RESPIRATORY ARREST,2
CL,CARDIOMEGALY,2
CL,CEREBROVASCULAR ACCIDENT,2
CL,CHOKING,2
CL,CORONARY ARTERY DISEASE,2
CL,DEHYDRATION,2
CL,DEPRESSION,2
CL,DISEASE COMPLICATION,2
CL,DRY MOUTH,2
CL,ERYTHEMA,2
CL,FLUID RETENTION,2
CL,GAIT DISTURBANCE,2
CL,GENERALISED OEDEMA,2
CL,HEARING IMPAIRED,2
CL,HEART RATE DECREASED,2
CL,HEPATOMEGALY,2
CL,HYPERGLYCAEMIA,2
CL,HYPOKALAEMIA,2
CL,INTENTIONAL PRODUCT USE ISSUE,2
CL,LARYNGITIS,2
CL,MELAENA,2
CL,MENSTRUATION IRREGULAR,2
CL,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
CL,MUSCULAR WEAKNESS,2
CL,OROPHARYNGEAL PAIN,2
CL,PAIN,2
CL,PERIPHERAL ISCHAEMIA,2
CL,PHYSICAL DISABILITY,2
CL,PLEURAL EFFUSION,2
CL,POOR QUALITY SLEEP,2
CL,POSTOPERATIVE WOUND INFECTION,2
CL,PULMONARY ARTERIAL HYPERTENSION,2
CL,RESPIRATORY SYMPTOM,2
CL,RIGHT VENTRICULAR FAILURE,2
CL,SEPSIS,2
CL,SKIN FISSURES,2
CL,SKIN ULCER,2
CL,SWELLING,2
CL,THROAT IRRITATION,2
CL,WEIGHT DECREASED,2
CL,ABDOMINAL SEPSIS,1
CL,ACTIVITIES OF DAILY LIVING IMPAIRED,1
CL,ADENOCARCINOMA,1
CL,ALANINE AMINOTRANSFERASE INCREASED,1
CL,ALLERGIC BRONCHITIS,1
CL,AMENORRHOEA,1
CL,AMMONIA INCREASED,1
CL,AMNESIA,1
CL,ANAPHYLACTIC SHOCK,1
CL,ANURIA,1
CL,ANXIETY,1
CL,AORTIC DISORDER,1
CL,ARTERIAL INSUFFICIENCY,1
CL,ARTERIAL OCCLUSIVE DISEASE,1
CL,ARTHRALGIA,1
CL,ASPARTATE AMINOTRANSFERASE INCREASED,1
CL,ASTHENIA,1
CL,ATRIAL SEPTAL DEFECT,1
CL,ATROPHY,1
CL,BACTERAEMIA,1
CL,BALANCE DISORDER,1
CL,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
CL,BLOOD GASES ABNORMAL,1
CL,BLOOD POTASSIUM DECREASED,1
CL,BLOOD POTASSIUM INCREASED,1
CL,BLOOD UREA INCREASED,1
CL,BRADYPHRENIA,1
CL,BRAIN NATRIURETIC PEPTIDE ABNORMAL,1
CL,BRONCHIAL OBSTRUCTION,1
CL,BRONCHITIS,1
CL,CARDIAC ARREST,1
CL,CARDIAC FAILURE CONGESTIVE,1
CL,CARDIAC FLUTTER,1
CL,CARDIAC VALVE REPLACEMENT COMPLICATION,1
CL,CATARACT,1
CL,CELLULITIS,1
CL,CEREBRAL ATROPHY,1
CL,CEREBRAL VENTRICLE DILATATION,1
CL,CHOLELITHIASIS,1
CL,CHOLESTASIS,1
CL,CHROMATURIA,1
CL,CLOSTRIDIUM DIFFICILE INFECTION,1
CL,COELIAC DISEASE,1
CL,COLON ADENOMA,1
CL,CONFUSIONAL STATE,1
CL,CONSTIPATION,1
CL,CYANOSIS,1
CL,DERMATITIS ALLERGIC,1
CL,DEVICE MALFUNCTION,1
CL,DIABETIC FOOT,1
CL,DIVERTICULUM,1
CL,DRUG DOSE OMISSION,1
CL,DRUG EFFECT DECREASED,1
CL,DRUG PRESCRIBING ERROR,1
CL,DRY SKIN,1
CL,DYSARTHRIA,1
CL,DYSKINESIA,1
CL,DYSPHAGIA,1
CL,DYSPHONIA,1
CL,DYSPNOEA EXERTIONAL,1
CL,DYSPNOEA PAROXYSMAL NOCTURNAL,1
CL,DYSURIA,1
CL,ECHOCARDIOGRAM ABNORMAL,1
CL,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,1
CL,ELECTROCARDIOGRAM QT PROLONGED,1
CL,ELECTROCARDIOGRAM T WAVE PEAKED,1
CL,ENCEPHALOPATHY,1
CL,ENDOCARDITIS BACTERIAL,1
CL,ENDOMETRIAL HYPERPLASIA,1
CL,ENERGY INCREASED,1
CL,EPILEPSY,1
CL,EPISTAXIS,1
CL,EUPHORIC MOOD,1
CL,EXPIRED PRODUCT ADMINISTERED,1
CL,FAECES DISCOLOURED,1
CL,FEELING ABNORMAL,1
CL,FEELING COLD,1
CL,FLUID OVERLOAD,1
CL,GANGRENE,1
CL,GASTRIC ULCER,1
CL,GASTROENTERITIS VIRAL,1
CL,GENERAL PHYSICAL CONDITION,1
CL,GENERALISED TONIC-CLONIC SEIZURE,1
CL,GINGIVAL PAIN,1
CL,GLOMERULAR FILTRATION RATE DECREASED,1
CL,HAEMATEMESIS,1
CL,HAEMATOCRIT DECREASED,1
CL,HAEMATOLOGY TEST ABNORMAL,1
CL,HAEMATURIA,1
CL,HAEMODIALYSIS,1
CL,HAEMORRHAGE URINARY TRACT,1
CL,HEART RATE INCREASED,1
CL,HEART RATE NORMAL,1
CL,HEMIPARESIS,1
CL,HEPATIC CIRRHOSIS,1
CL,HEPATIC ENCEPHALOPATHY,1
CL,HEPATIC FAILURE,1
CL,HIP FRACTURE,1
CL,HOSPITALISATION,1
CL,HYDROCELE,1
CL,HYPERCAPNIA,1
CL,HYPERHIDROSIS,1
CL,HYPERSENSITIVITY,1
CL,HYPERSPLENISM,1
CL,HYPERTENSIVE CRISIS,1
CL,HYPERTRIGLYCERIDAEMIA,1
CL,HYPOACUSIS,1
CL,HYPOAESTHESIA,1
CL,HYPOPERFUSION,1
CL,HYPOPHAGIA,1
CL,HYPOTONIA,1
CL,IMMOBILE,1
CL,IMMUNODEFICIENCY,1
CL,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
CL,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
CL,INFARCTION,1
CL,INFECTED SKIN ULCER,1
CL,INGUINAL HERNIA,1
CL,INSOMNIA,1
CL,INTENTIONAL PRODUCT MISUSE,1
CL,ISCHAEMIC STROKE,1
CL,JAUNDICE,1
CL,JUGULAR VEIN DISTENSION,1
CL,KIDNEY INFECTION,1
CL,KLEBSIELLA SEPSIS,1
CL,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
CL,LACUNAR INFARCTION,1
CL,LIMB INJURY,1
CL,LIVER DISORDER,1
CL,LUMBAR RADICULOPATHY,1
CL,MALAISE,1
CL,MULTI-ORGAN FAILURE,1
CL,MUSCLE ATROPHY,1
CL,MUSCLE SPASMS,1
CL,MYOSITIS,1
CL,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED,1
CL,NASAL CONGESTION,1
CL,NECK PAIN,1
CL,NEPHROLITHIASIS,1
CL,NEPHROSTOMY,1
CL,NEUROPATHY PERIPHERAL,1
CL,OBSTRUCTIVE AIRWAYS DISORDER,1
CL,OEDEMA,1
CL,ORAL MUCOSAL ERYTHEMA,1
CL,OXYGEN SATURATION DECREASED,1
CL,OXYGEN SATURATION NORMAL,1
CL,PAIN OF SKIN,1
CL,PALLOR,1
CL,PALMAR ERYTHEMA,1
CL,PANCREATIC CARCINOMA,1
CL,PANCREATITIS,1
CL,PANIC ATTACK,1
CL,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
CL,PERIPHERAL SWELLING,1
CL,PLEUROPERITONEAL COMMUNICATION,1
CL,PNEUMONITIS,1
CL,PO2 DECREASED,1
CL,POLYMERASE CHAIN REACTION POSITIVE,1
CL,POLYURIA,1
CL,PORTAL HYPERTENSION,1
CL,POST PROCEDURAL HAEMORRHAGE,1
CL,PRESCRIBED OVERDOSE,1
CL,PRESYNCOPE,1
CL,PRODUCT USE ISSUE,1
CL,PROTEIN TOTAL DECREASED,1
CL,PROTEINURIA,1
CL,PULMONARY ARTERIAL PRESSURE INCREASED,1
CL,PULMONARY FIBROSIS,1
CL,PULMONARY FUNCTION TEST ABNORMAL,1
CL,PULMONARY PAIN,1
CL,PYREXIA,1
CL,RASH,1
CL,RECTAL HAEMORRHAGE,1
CL,RECTAL NEOPLASM,1
CL,RENAL FAILURE ACUTE,1
CL,RESTLESSNESS,1
CL,ROTAVIRUS INFECTION,1
CL,SALIVARY HYPERSECRETION,1
CL,SEIZURE,1
CL,SENILE DEMENTIA,1
CL,SEPTIC SHOCK,1
CL,SKIN INFECTION,1
CL,SKIN IRRITATION,1
CL,SUBARACHNOID HAEMORRHAGE,1
CL,SUDDEN DEATH,1
CL,SUPERINFECTION,1
CL,SWELLING FACE,1
CL,SYSTEMIC LUPUS ERYTHEMATOSUS,1
CL,TACHYARRHYTHMIA,1
CL,TACHYCARDIA,1
CL,TELANGIECTASIA,1
CL,THROMBOSIS,1
CL,TONGUE DISCOLOURATION,1
CL,TRACHEOBRONCHITIS,1
CL,TROPONIN INCREASED,1
CL,UPPER RESPIRATORY TRACT INFECTION,1
CL,URINE OUTPUT DECREASED,1
CL,VAGINAL HAEMORRHAGE,1
CL,VARICELLA,1
CL,VARICOSE ULCERATION,1
CL,VARICOSE VEIN,1
CL,VASCULAR CAUTERISATION,1
CL,VASCULAR RESISTANCE SYSTEMIC INCREASED,1
CL,VIRAL PHARYNGITIS,1
CL,WALKING DISTANCE TEST NORMAL,1
CL,WHITE BLOOD CELL COUNT DECREASED,1
CN,LYMPHOCYTE COUNT DECREASED,92
CN,HAEMOGLOBIN DECREASED,89
CN,BLOOD UREA INCREASED,68
CN,NEUTROPHIL COUNT INCREASED,68
CN,BLOOD GLUCOSE INCREASED,60
CN,WHITE BLOOD CELL COUNT INCREASED,59
CN,BLOOD CREATININE INCREASED,43
CN,INCISION SITE PAIN,41
CN,RED BLOOD CELLS URINE POSITIVE,41
CN,PROTEIN URINE PRESENT,39
CN,DIARRHOEA,36
CN,ALANINE AMINOTRANSFERASE INCREASED,33
CN,PYREXIA,33
CN,PLATELET COUNT DECREASED,30
CN,C-REACTIVE PROTEIN INCREASED,27
CN,CHEST DISCOMFORT,27
CN,BLOOD ALBUMIN DECREASED,25
CN,DYSPNOEA,25
CN,ANAEMIA,23
CN,LUNG INFECTION,23
CN,BLOOD TRIGLYCERIDES INCREASED,22
CN,CARDIAC FAILURE,19
CN,RENAL IMPAIRMENT,19
CN,NAUSEA,18
CN,ABDOMINAL DISTENSION,17
CN,ACUTE KIDNEY INJURY,17
CN,ASPARTATE AMINOTRANSFERASE INCREASED,17
CN,VOMITING,17
CN,WHITE BLOOD CELL COUNT DECREASED,17
CN,PNEUMONIA,16
CN,PROCEDURAL PAIN,16
CN,BLOOD CHOLESTEROL INCREASED,15
CN,URINARY TRACT INFECTION,15
CN,HYPOKALAEMIA,14
CN,OEDEMA PERIPHERAL,14
CN,OVERDOSE,14
CN,BILIRUBIN CONJUGATED INCREASED,13
CN,COUGH,13
CN,KIDNEY TRANSPLANT REJECTION,13
CN,LOW DENSITY LIPOPROTEIN INCREASED,13
CN,HEPATIC FUNCTION ABNORMAL,12
CN,RESPIRATORY FAILURE,12
CN,ABDOMINAL PAIN,11
CN,COMPLICATIONS OF TRANSPLANTED KIDNEY,11
CN,FATIGUE,11
CN,HIGH DENSITY LIPOPROTEIN DECREASED,11
CN,HYPOALBUMINAEMIA,11
CN,CONDITION AGGRAVATED,10
CN,DIABETES MELLITUS,10
CN,PALPITATIONS,10
CN,RENAL FAILURE,10
CN,THROMBOCYTOPENIA,10
CN,URINE OUTPUT DECREASED,10
CN,ASTHENIA,9
CN,ATRIAL FIBRILLATION,9
CN,CONSTIPATION,9
CN,DIZZINESS,9
CN,HYPERURICAEMIA,9
CN,LEUKOPENIA,9
CN,BLOOD BILIRUBIN INCREASED,8
CN,BLOOD URINE PRESENT,8
CN,BONE MARROW FAILURE,8
CN,DECREASED APPETITE,8
CN,HYPOTENSION,8
CN,LIVER INJURY,8
CN,LOSS OF CONSCIOUSNESS,8
CN,PAIN IN EXTREMITY,8
CN,WOUND COMPLICATION,8
CN,ACUTE MYOCARDIAL INFARCTION,7
CN,ARRHYTHMIA,7
CN,CHEST PAIN,7
CN,HAEMATURIA,7
CN,HYPERLIPIDAEMIA,7
CN,RHABDOMYOLYSIS,7
CN,UPPER RESPIRATORY TRACT INFECTION,7
CN,ASCITES,6
CN,BLOOD POTASSIUM DECREASED,6
CN,BLOOD POTASSIUM INCREASED,6
CN,BLOOD PRESSURE DECREASED,6
CN,COMA,6
CN,DRUG-INDUCED LIVER INJURY,6
CN,GLOMERULAR FILTRATION RATE DECREASED,6
CN,NEUTROPHIL COUNT DECREASED,6
CN,OEDEMA,6
CN,PRODUCTIVE COUGH,6
CN,PROTEINURIA,6
CN,PULMONARY HYPERTENSION,6
CN,TOXICITY TO VARIOUS AGENTS,6
CN,CARDIAC ARREST,5
CN,CARDIOMYOPATHY,5
CN,CEREBRAL INFARCTION,5
CN,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,5
CN,CORONARY ARTERY DISEASE,5
CN,DEATH,5
CN,HAEMOPTYSIS,5
CN,HYPERKALAEMIA,5
CN,INSOMNIA,5
CN,METABOLIC ACIDOSIS,5
CN,MULTIPLE ORGAN DYSFUNCTION SYNDROME,5
CN,NASOPHARYNGITIS,5
CN,PULMONARY ARTERIAL HYPERTENSION,5
CN,RENAL FAILURE ACUTE,5
CN,RIGHT VENTRICULAR FAILURE,5
CN,URINE ANALYSIS ABNORMAL,5
CN,VISION BLURRED,5
CN,BODY TEMPERATURE INCREASED,4
CN,CARDIOMEGALY,4
CN,CIRCULATORY COLLAPSE,4
CN,COR PULMONALE,4
CN,CYANOSIS,4
CN,CYTOMEGALOVIRUS INFECTION,4
CN,DEPRESSED LEVEL OF CONSCIOUSNESS,4
CN,DISSEMINATED CRYPTOCOCCOSIS,4
CN,EJECTION FRACTION DECREASED,4
CN,ELECTROCARDIOGRAM T WAVE INVERSION,4
CN,HAEMATOCHEZIA,4
CN,HICCUPS,4
CN,HIGH DENSITY LIPOPROTEIN INCREASED,4
CN,HYDRONEPHROSIS,4
CN,HYPERHIDROSIS,4
CN,HYPOCALCAEMIA,4
CN,HYPOPROTEINAEMIA,4
CN,INTERSTITIAL LUNG DISEASE,4
CN,LIVER DISORDER,4
CN,MUSCULAR WEAKNESS,4
CN,MUSCULOSKELETAL PAIN,4
CN,MYOSITIS,4
CN,NEPHROLITHIASIS,4
CN,PLEURAL EFFUSION,4
CN,PRURITUS,4
CN,RENAL CYST,4
CN,SLEEP DISORDER,4
CN,TOXIC EPIDERMAL NECROLYSIS,4
CN,TRICUSPID VALVE INCOMPETENCE,4
CN,URETERIC STENOSIS,4
CN,VENTRICULAR TACHYCARDIA,4
CN,WEIGHT DECREASED,4
CN,WHEEZING,4
CN,ACUTE RESPIRATORY FAILURE,3
CN,AGRANULOCYTOSIS,3
CN,ATRIOVENTRICULAR BLOCK COMPLETE,3
CN,BLOOD ALBUMIN INCREASED,3
CN,BLOOD CREATININE DECREASED,3
CN,BLOOD PRESSURE INCREASED,3
CN,CARDIAC DISORDER,3
CN,CARDIAC FAILURE CHRONIC,3
CN,CHILLS,3
CN,DYSURIA,3
CN,ELECTROCARDIOGRAM QT PROLONGED,3
CN,ERUCTATION,3
CN,FEELING ABNORMAL,3
CN,GASTROINTESTINAL HAEMORRHAGE,3
CN,GINGIVAL BLEEDING,3
CN,HEART RATE INCREASED,3
CN,HYPERCALCAEMIA,3
CN,HYPERGLYCAEMIA,3
CN,HYPERTENSION,3
CN,HYPONATRAEMIA,3
CN,HYPOREFLEXIA,3
CN,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,3
CN,MALAISE,3
CN,MITRAL VALVE INCOMPETENCE,3
CN,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED,3
CN,NEPHROPATHY TOXIC,3
CN,NEUTROPENIA,3
CN,PANCREATITIS ACUTE,3
CN,PERICARDIAL EFFUSION,3
CN,PLATELET COUNT INCREASED,3
CN,POLLAKIURIA,3
CN,PRODUCT USE ISSUE,3
CN,RENAL INJURY,3
CN,RESPIRATORY ACIDOSIS,3
CN,SEPTIC SHOCK,3
CN,UNRESPONSIVE TO STIMULI,3
CN,VENTRICULAR FIBRILLATION,3
CN,ABDOMINAL DISCOMFORT,2
CN,ABDOMINAL PAIN UPPER,2
CN,AMAUROSIS,2
CN,ANAL ABSCESS,2
CN,ANAPHYLACTIC REACTION,2
CN,ARTERIOSCLEROSIS,2
CN,ARTERIOSCLEROSIS CORONARY ARTERY,2
CN,ASPARTATE AMINOTRANSFERASE DECREASED,2
CN,ASTHMA,2
CN,AZOTAEMIA,2
CN,BACK PAIN,2
CN,BK VIRUS INFECTION,2
CN,BLOOD CHOLESTEROL DECREASED,2
CN,BLOOD CREATINE PHOSPHOKINASE INCREASED,2
CN,BLOOD GLUCOSE DECREASED,2
CN,BLOOD SODIUM INCREASED,2
CN,BLOOD URIC ACID INCREASED,2
CN,BRONCHITIS,2
CN,CARDIAC FAILURE ACUTE,2
CN,CARDIAC FAILURE CONGESTIVE,2
CN,CARDIAC VALVE DISEASE,2
CN,CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER,2
CN,CONCOMITANT DISEASE AGGRAVATED,2
CN,CONFUSIONAL STATE,2
CN,CORONARY ARTERY STENOSIS,2
CN,CYSTITIS,2
CN,DELAYED RECOVERY FROM ANAESTHESIA,2
CN,DELIRIUM,2
CN,DRUG INEFFECTIVE,2
CN,DRUG LEVEL INCREASED,2
CN,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
CN,DRUG RESISTANCE,2
CN,DYSPNOEA EXERTIONAL,2
CN,ENCEPHALOPATHY,2
CN,ERYTHEMA,2
CN,FEBRILE NEUTROPENIA,2
CN,GAIT DISTURBANCE,2
CN,GASTRITIS,2
CN,GASTROENTERITIS,2
CN,GRANULOCYTOPENIA,2
CN,HAEMATOMA,2
CN,HAEMORRHAGE INTRACRANIAL,2
CN,HEADACHE,2
CN,HEART RATE DECREASED,2
CN,HEPATIC ENZYME INCREASED,2
CN,HEPATITIS B DNA INCREASED,2
CN,HYPERBILIRUBINAEMIA,2
CN,HYPERMAGNESAEMIA,2
CN,HYPERPARATHYROIDISM SECONDARY,2
CN,HYPERTHYROIDISM,2
CN,HYPOTONIA,2
CN,HYPOXIA,2
CN,IMPAIRED HEALING,2
CN,INFECTION,2
CN,INTERNATIONAL NORMALISED RATIO INCREASED,2
CN,INTESTINAL OBSTRUCTION,2
CN,JAUNDICE,2
CN,KIDNEY INFECTION,2
CN,LATENT SYPHILIS,2
CN,LEFT VENTRICULAR ENLARGEMENT,2
CN,LOW DENSITY LIPOPROTEIN DECREASED,2
CN,LYMPHOCYTE COUNT INCREASED,2
CN,MATERNAL EXPOSURE DURING PREGNANCY,2
CN,MELAENA,2
CN,MOUTH ULCERATION,2
CN,MULTI-ORGAN FAILURE,2
CN,MUSCLE ATROPHY,2
CN,MYOCARDITIS,2
CN,NERVE INJURY,2
CN,NEUROPATHY PERIPHERAL,2
CN,OLIGURIA,2
CN,OROPHARYNGEAL PAIN,2
CN,OXYGEN SATURATION DECREASED,2
CN,PALLOR,2
CN,PARATHYROID TUMOUR BENIGN,2
CN,PARVOVIRUS INFECTION,2
CN,PERIPHERAL SWELLING,2
CN,PERITONITIS,2
CN,PLASMA CELL MYELOMA,2
CN,PNEUMOCYSTIS JIROVECII PNEUMONIA,2
CN,PNEUMONITIS,2
CN,POSTOPERATIVE WOUND COMPLICATION,2
CN,PROTHROMBIN TIME PROLONGED,2
CN,PURPURA,2
CN,RED BLOOD CELL COUNT DECREASED,2
CN,REGURGITATION,2
CN,SEIZURE,2
CN,SEPSIS,2
CN,SKIN EXFOLIATION,2
CN,SOMNOLENCE,2
CN,SUDDEN DEATH,2
CN,SUPRAVENTRICULAR TACHYCARDIA,2
CN,SYNCOPE,2
CN,TACHYCARDIA,2
CN,TRANSAMINASES INCREASED,2
CN,TUBERCULOUS PLEURISY,2
CN,UPPER GASTROINTESTINAL HAEMORRHAGE,2
CN,URETERIC OBSTRUCTION,2
CN,VENTRICULAR EXTRASYSTOLES,2
CN,VIRAL INFECTION,2
CN,ABDOMINAL PAIN LOWER,1
CN,ABORTION,1
CN,ACID BASE BALANCE ABNORMAL,1
CN,ACINETOBACTER TEST POSITIVE,1
CN,ACTIVATED PARTIAL THROMBOPLASTIN TIME ABNORMAL,1
CN,ACUTE LEFT VENTRICULAR FAILURE,1
CN,ACUTE PULMONARY OEDEMA,1
CN,ACUTE RESPIRATORY DISTRESS SYNDROME,1
CN,ALANINE AMINOTRANSFERASE DECREASED,1
CN,ALLERGY TEST POSITIVE,1
CN,ALTERED STATE OF CONSCIOUSNESS,1
CN,ANAL FISSURE,1
CN,ANAPHYLACTIC SHOCK,1
CN,ANGINA UNSTABLE,1
CN,AORTIC VALVE INCOMPETENCE,1
CN,APLASTIC ANAEMIA,1
CN,ARTHRALGIA,1
CN,ASPERGILLUS INFECTION,1
CN,ASPHYXIA,1
CN,ATELECTASIS,1
CN,ATRIAL FLUTTER,1
CN,ATRIAL SEPTAL DEFECT ACQUIRED,1
CN,BACK DISORDER,1
CN,BACTERAEMIA,1
CN,BENIGN PROSTATIC HYPERPLASIA,1
CN,BIOPSY MUSCLE ABNORMAL,1
CN,BLINDNESS,1
CN,BLISTER,1
CN,BLOOD ALKALINE PHOSPHATASE INCREASED,1
CN,BLOOD BILIRUBIN DECREASED,1
CN,BLOOD CALCIUM DECREASED,1
CN,BLOOD CORTISOL INCREASED,1
CN,BLOOD CREATINE INCREASED,1
CN,BLOOD CREATININE ABNORMAL,1
CN,BLOOD ELECTROLYTES ABNORMAL,1
CN,BLOOD PH DECREASED,1
CN,BLOOD PHOSPHORUS DECREASED,1
CN,BLOOD PRESSURE SYSTOLIC DECREASED,1
CN,BLOOD PRESSURE SYSTOLIC INCREASED,1
CN,BLOOD SODIUM DECREASED,1
CN,BLOOD TRIGLYCERIDES DECREASED,1
CN,BLOOD UREA DECREASED,1
CN,BLOODY DISCHARGE,1
CN,BODY TEMPERATURE DECREASED,1
CN,BRAIN HERNIATION,1
CN,BRAIN NATRIURETIC PEPTIDE INCREASED,1
CN,BRAIN OEDEMA,1
CN,BUNDLE BRANCH BLOCK LEFT,1
CN,C-REACTIVE PROTEIN DECREASED,1
CN,CANDIDA INFECTION,1
CN,CARDIAC ANEURYSM,1
CN,CATARACT,1
CN,CEREBRAL HAEMATOMA,1
CN,CEREBRAL HAEMORRHAGE,1
CN,CHOKING,1
CN,CHOLESTASIS,1
CN,CHRONIC GASTRITIS,1
CN,CHRONIC KIDNEY DISEASE,1
CN,COAGULATION TEST ABNORMAL,1
CN,COAGULOPATHY,1
CN,COGNITIVE DISORDER,1
CN,COLON CANCER,1
CN,COMPLICATIONS OF TRANSPLANT SURGERY,1
CN,CONCOMITANT DISEASE PROGRESSION,1
CN,CONJUNCTIVITIS,1
CN,CORONARY ARTERY OCCLUSION,1
CN,CREATININE RENAL CLEARANCE DECREASED,1
CN,CRYSTALLURIA,1
CN,DEAFNESS NEUROSENSORY,1
CN,DECREASED ACTIVITY,1
CN,DEFIANT BEHAVIOUR,1
CN,DEHYDRATION,1
CN,DELAYED GRAFT FUNCTION,1
CN,DEMENTIA,1
CN,DERMATITIS EXFOLIATIVE,1
CN,DIABETES INSIPIDUS,1
CN,DIABETIC NEPHROPATHY,1
CN,DIABETIC RETINOPATHY,1
CN,DILATATION VENTRICULAR,1
CN,DRUG EFFECT DECREASED,1
CN,DRUG ERUPTION,1
CN,DRUG HYPERSENSITIVITY,1
CN,DRUG-DISEASE INTERACTION,1
CN,DRY SKIN,1
CN,DYSARTHRIA,1
CN,DYSBACTERIOSIS,1
CN,DYSPEPSIA,1
CN,DYSPHAGIA,1
CN,DYSPHONIA,1
CN,ECZEMA,1
CN,EFFUSION,1
CN,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,1
CN,EMBOLISM VENOUS,1
CN,ENTERITIS,1
CN,EPIDIDYMAL DISORDER,1
CN,EPIDIDYMITIS,1
CN,EPISTAXIS,1
CN,ERYTHEMA MULTIFORME,1
CN,ERYTHROPENIA,1
CN,ESSENTIAL HYPERTENSION,1
CN,EXPOSURE DURING PREGNANCY,1
CN,EXTRASYSTOLES,1
CN,EYE DISORDER,1
CN,EYELID OEDEMA,1
CN,FACE OEDEMA,1
CN,FAECES DISCOLOURED,1
CN,FALL,1
CN,FISTULA,1
CN,FLANK PAIN,1
CN,FOETAL DISTRESS SYNDROME,1
CN,FOETAL EXPOSURE DURING PREGNANCY,1
CN,FUNCTIONAL GASTROINTESTINAL DISORDER,1
CN,FUNGAL INFECTION,1
CN,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
CN,GASTRIC HAEMORRHAGE,1
CN,GASTRIC ULCER HAEMORRHAGE,1
CN,GASTROINTESTINAL DISORDER,1
CN,GENERAL PHYSICAL HEALTH DETERIORATION,1
CN,GLOMERULONEPHRITIS PROLIFERATIVE,1
CN,GLUCOSE TOLERANCE IMPAIRED,1
CN,GOUTY ARTHRITIS,1
CN,GRAFT THROMBOSIS,1
CN,GRANULOCYTE COUNT INCREASED,1
CN,GUILLAIN-BARRE SYNDROME,1
CN,GYNAECOMASTIA,1
CN,HAEMATEMESIS,1
CN,HAEMATOCRIT DECREASED,1
CN,HAEMOGLOBIN INCREASED,1
CN,HAEMORRHAGE,1
CN,HAEMORRHOIDS,1
CN,HEPATIC CYST,1
CN,HEPATIC FAILURE,1
CN,HEPATIC STEATOSIS,1
CN,HEPATOMEGALY,1
CN,HERPES ZOSTER,1
CN,HYDROCELE,1
CN,HYDROCEPHALUS,1
CN,HYPERTENSIVE HEART DISEASE,1
CN,HYPOAESTHESIA,1
CN,HYPOCHLORAEMIA,1
CN,HYPOGLYCAEMIA,1
CN,HYPOPHOSPHATAEMIA,1
CN,HYPOTHYROIDISM,1
CN,HYPOVOLAEMIC SHOCK,1
CN,INCISION SITE HAEMORRHAGE,1
CN,INCORRECT DRUG ADMINISTRATION RATE,1
CN,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
CN,INFLAMMATION,1
CN,INTENTIONAL OVERDOSE,1
CN,INTENTIONAL PRODUCT MISUSE,1
CN,IRON DEFICIENCY ANAEMIA,1
CN,KIDNEY ENLARGEMENT,1
CN,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
CN,LABOUR INDUCTION,1
CN,LACTIC ACIDOSIS,1
CN,LACUNAR INFARCTION,1
CN,LARYNGEAL INFLAMMATION,1
CN,LDL/HDL RATIO INCREASED,1
CN,LEFT VENTRICULAR FAILURE,1
CN,LETHARGY,1
CN,LIP SWELLING,1
CN,LONG QT SYNDROME,1
CN,LOW BIRTH WEIGHT BABY,1
CN,LOWER GASTROINTESTINAL HAEMORRHAGE,1
CN,LOWER RESPIRATORY TRACT INFECTION,1
CN,LUNG DISORDER,1
CN,LUNG NEOPLASM MALIGNANT,1
CN,LYMPHADENOPATHY,1
CN,MALIGNANT NEOPLASM PROGRESSION,1
CN,MARROW HYPERPLASIA,1
CN,MENINGITIS VIRAL,1
CN,METABOLIC DISORDER,1
CN,METABOLIC ENCEPHALOPATHY,1
CN,METASTASES TO LUNG,1
CN,METASTASES TO URINARY TRACT,1
CN,MICROALBUMINURIA,1
CN,MICTURITION URGENCY,1
CN,MOUTH HAEMORRHAGE,1
CN,MULTI-ORGAN DISORDER,1
CN,MUSCLE RIGIDITY,1
CN,MUSCULOSKELETAL DISCOMFORT,1
CN,MYALGIA,1
CN,MYELODYSPLASTIC SYNDROME,1
CN,MYOCARDIAL INFARCTION,1
CN,MYOCARDIAL ISCHAEMIA,1
CN,MYOCARDIAL RUPTURE,1
CN,MYOGLOBIN BLOOD INCREASED,1
CN,MYOPATHY,1
CN,NEONATAL ASPHYXIA,1
CN,NEPHROGENIC ANAEMIA,1
CN,NEPHROGENIC DIABETES INSIPIDUS,1
CN,NERVOUS SYSTEM DISORDER,1
CN,NERVOUSNESS,1
CN,NIGHT SWEATS,1
CN,NIKOLSKY^S SIGN,1
CN,OBSTRUCTION GASTRIC,1
CN,OCCULT BLOOD POSITIVE,1
CN,OEDEMATOUS KIDNEY,1
CN,ORAL MUCOSAL ERUPTION,1
CN,OSTEOPOROSIS,1
CN,OTITIS EXTERNA,1
CN,OVARIAN CYST RUPTURED,1
CN,PAIN,1
CN,PANCREATIC INJURY,1
CN,PANCREATITIS,1
CN,PARAESTHESIA,1
CN,PCO2 INCREASED,1
CN,PERICARDIAL FIBROSIS,1
CN,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
CN,PERITONSILLITIS,1
CN,PHARYNGITIS,1
CN,PLEURISY,1
CN,POOR QUALITY SLEEP,1
CN,POST PROCEDURAL URINE LEAK,1
CN,POSTOPERATIVE WOUND INFECTION,1
CN,PREMATURE BABY,1
CN,PRESCRIBED OVERDOSE,1
CN,PRESYNCOPE,1
CN,PROCTALGIA,1
CN,PRODUCT QUALITY ISSUE,1
CN,PROTEIN TOTAL ABNORMAL,1
CN,PULMONARY CONGESTION,1
CN,PULMONARY HAEMORRHAGE,1
CN,PULMONARY INFARCTION,1
CN,PULMONARY MASS,1
CN,PULMONARY SEPSIS,1
CN,PYURIA,1
CN,RALES,1
CN,RASH,1
CN,RASH GENERALISED,1
CN,RASH PAPULAR,1
CN,RASH PRURITIC,1
CN,RED BLOOD CELLS URINE,1
CN,RENAL ARTERY STENOSIS,1
CN,RENAL ATROPHY,1
CN,RENAL FAILURE CHRONIC,1
CN,RENAL GRAFT INFECTION,1
CN,RENAL HAEMATOMA,1
CN,RENAL HAEMORRHAGE,1
CN,RENAL PAIN,1
CN,RENAL TUBULAR DISORDER,1
CN,RESPIRATORY DISORDER,1
CN,RESPIRATORY RATE INCREASED,1
CN,RESPIRATORY TRACT INFECTION FUNGAL,1
CN,RETICULOCYTE COUNT DECREASED,1
CN,RHINORRHOEA,1
CN,RHYTHM IDIOVENTRICULAR,1
CN,SCROTAL SWELLING,1
CN,SECONDARY HYPOTHYROIDISM,1
CN,SHOCK,1
CN,SINUS ARRHYTHMIA,1
CN,SINUS BRADYCARDIA,1
CN,SKIN DISORDER,1
CN,SKIN EROSION,1
CN,SKIN INDURATION,1
CN,SKIN LESION,1
CN,SKIN NECROSIS,1
CN,SKIN ULCER,1
CN,SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION_ INSOMNIA TYPE,1
CN,SPINAL OSTEOARTHRITIS,1
CN,SPLENOMEGALY,1
CN,SPUTUM RETENTION,1
CN,STAPHYLOCOCCAL INFECTION,1
CN,STEVENS-JOHNSON SYNDROME,1
CN,STROKE IN EVOLUTION,1
CN,SUBARACHNOID HAEMORRHAGE,1
CN,SUBDURAL HAEMATOMA,1
CN,SUFFOCATION FEELING,1
CN,SUICIDE ATTEMPT,1
CN,SUPRAVENTRICULAR EXTRASYSTOLES,1
CN,SWELLING,1
CN,SWELLING FACE,1
CN,TACHYARRHYTHMIA,1
CN,TACHYPNOEA,1
CN,TENDERNESS,1
CN,THROMBIN TIME ABNORMAL,1
CN,THROMBOCYTOSIS,1
CN,TIC,1
CN,TORSADE DE POINTES,1
CN,TUBULOINTERSTITIAL NEPHRITIS,1
CN,TUMOUR HAEMORRHAGE,1
CN,TUMOUR LYSIS SYNDROME,1
CN,TYPE 2 DIABETES MELLITUS,1
CN,URETEROLITHIASIS,1
CN,URINARY RETENTION,1
CN,URINARY TRACT PAIN,1
CN,URINE OUTPUT INCREASED,1
CN,VENOUS THROMBOSIS LIMB,1
CN,VENTRICULAR SEPTAL DEFECT REPAIR,1
CN,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
CN,VITAMIN B1 DEFICIENCY,1
CN,WEIGHT INCREASED,1
CN,WERNICKE^S ENCEPHALOPATHY,1
CN,WHITE BLOOD CELL COUNT ABNORMAL,1
CN,WOUND HEALING NORMAL,1
CN,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
CN,XANTHOPSIA,1
CO,DEATH,83
CO,ACUTE MYOCARDIAL INFARCTION,81
CO,DYSPNOEA,73
CO,CARDIAC FAILURE,69
CO,CARDIO-RESPIRATORY ARREST,60
CO,DIZZINESS,58
CO,ASTHENIA,52
CO,FATIGUE,50
CO,GENERAL PHYSICAL HEALTH DETERIORATION,50
CO,MALAISE,50
CO,VOMITING,48
CO,CHEST PAIN,44
CO,URINARY TRACT INFECTION,42
CO,PNEUMONIA,41
CO,PULMONARY OEDEMA,40
CO,ABDOMINAL PAIN,39
CO,COUGH,38
CO,HYPOTENSION,38
CO,PAIN,37
CO,PYREXIA,36
CO,HEADACHE,35
CO,DECREASED APPETITE,34
CO,FLUID RETENTION,34
CO,DIARRHOEA,33
CO,INFLAMMATION,33
CO,PERIPHERAL SWELLING,33
CO,FALL,31
CO,ABDOMINAL PAIN UPPER,29
CO,ANAEMIA,29
CO,ASPHYXIA,28
CO,FEELING ABNORMAL,27
CO,PAIN IN EXTREMITY,25
CO,BACK PAIN,24
CO,HAEMOGLOBIN DECREASED,24
CO,MYOCARDIAL INFARCTION,24
CO,CHOKING,23
CO,DEPRESSED MOOD,23
CO,NAUSEA,23
CO,WEIGHT DECREASED,23
CO,ABDOMINAL DISTENSION,21
CO,RENAL FAILURE,21
CO,SYNCOPE,21
CO,HYPERTENSION,20
CO,HYPERTENSIVE CRISIS,20
CO,CARDIAC DISORDER,19
CO,DRUG INEFFECTIVE,19
CO,INFLUENZA,19
CO,PLATELET COUNT DECREASED,19
CO,SEPSIS,19
CO,ARRHYTHMIA,18
CO,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,18
CO,OEDEMA PERIPHERAL,18
CO,RESPIRATORY FAILURE,18
CO,BLOOD CREATININE INCREASED,17
CO,BLOOD GLUCOSE INCREASED,17
CO,GAIT DISTURBANCE,17
CO,INSOMNIA,17
CO,SWELLING,17
CO,DIABETIC FOOT,16
CO,GASTROINTESTINAL HAEMORRHAGE,16
CO,ARTHRALGIA,15
CO,DEPRESSION,15
CO,GASTRITIS,15
CO,SEIZURE,15
CO,TACHYCARDIA,15
CO,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,14
CO,HYPOGLYCAEMIA,14
CO,LOSS OF CONSCIOUSNESS,14
CO,ASCITES,13
CO,BONE PAIN,13
CO,PRODUCT USE ISSUE,13
CO,RENAL DISORDER,13
CO,BLOOD PRESSURE INCREASED,12
CO,CORONARY ARTERY DISEASE,12
CO,DISORIENTATION,12
CO,EATING DISORDER,12
CO,GENERALISED OEDEMA,12
CO,HYPERGLYCAEMIA,12
CO,PULMONARY HYPERTENSION,12
CO,RESPIRATORY DISTRESS,12
CO,SKIN DISCOLOURATION,12
CO,THROMBOSIS,12
CO,DYSURIA,11
CO,CARDIAC ARREST,10
CO,CEREBROVASCULAR ACCIDENT,10
CO,HEPATIC CIRRHOSIS,10
CO,HYPERHIDROSIS,10
CO,MALIGNANT NEOPLASM PROGRESSION,10
CO,PERITONEAL DIALYSIS COMPLICATION,10
CO,PLEURAL EFFUSION,10
CO,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,10
CO,CARDIOMEGALY,9
CO,CONDITION AGGRAVATED,9
CO,DISEASE COMPLICATION,9
CO,DRUG INTOLERANCE,9
CO,ERYTHEMA,9
CO,MEMORY IMPAIRMENT,9
CO,MOUTH HAEMORRHAGE,9
CO,OEDEMA,9
CO,PRODUCTIVE COUGH,9
CO,SWELLING FACE,9
CO,AGITATION,8
CO,BLINDNESS,8
CO,BLOOD PRESSURE DECREASED,8
CO,CARDIAC FAILURE CONGESTIVE,8
CO,CHILLS,8
CO,CHOKING SENSATION,8
CO,COAGULOPATHY,8
CO,CONTRAINDICATED PRODUCT ADMINISTERED,8
CO,CONTUSION,8
CO,EPISTAXIS,8
CO,NERVOUS SYSTEM DISORDER,8
CO,OROPHARYNGEAL PAIN,8
CO,PALLOR,8
CO,PERITONITIS BACTERIAL,8
CO,SPEECH DISORDER,8
CO,UROSEPSIS,8
CO,ANXIETY,7
CO,CHEST DISCOMFORT,7
CO,COMA,7
CO,DIABETES MELLITUS,7
CO,GASTROINTESTINAL DISORDER,7
CO,HAEMATURIA,7
CO,HAEMORRHAGE,7
CO,HEPATOMEGALY,7
CO,HIP FRACTURE,7
CO,INFECTION,7
CO,LIVER DISORDER,7
CO,LUNG DISORDER,7
CO,PULMONARY ARTERIAL HYPERTENSION,7
CO,SEPTIC SHOCK,7
CO,SOMNOLENCE,7
CO,THROMBOCYTOPENIA,7
CO,ANGINA UNSTABLE,6
CO,ATRIAL FIBRILLATION,6
CO,CARDIOVASCULAR DISORDER,6
CO,CATARACT,6
CO,CHOLELITHIASIS,6
CO,CYANOSIS,6
CO,DELIRIUM,6
CO,DIABETIC COMPLICATION,6
CO,DIABETIC NEUROPATHY,6
CO,DISEASE PROGRESSION,6
CO,DRUG DOSE OMISSION,6
CO,DYSPHAGIA,6
CO,FEELING OF DESPAIR,6
CO,GAIT INABILITY,6
CO,HEPATITIS,6
CO,HYPOPHAGIA,6
CO,MOVEMENT DISORDER,6
CO,MUSCULAR WEAKNESS,6
CO,NEPHROLITHIASIS,6
CO,PERITONITIS,6
CO,PRURITUS GENERALISED,6
CO,RENAL IMPAIRMENT,6
CO,STOMATITIS,6
CO,UNDERDOSE,6
CO,UPPER GASTROINTESTINAL HAEMORRHAGE,6
CO,URINARY INCONTINENCE,6
CO,VISUAL IMPAIRMENT,6
CO,ABDOMINAL DISCOMFORT,5
CO,ALOPECIA,5
CO,AMNESIA,5
CO,BACTERAEMIA,5
CO,BLISTER,5
CO,CARDIAC VALVE DISEASE,5
CO,CELLULITIS,5
CO,CHRONIC MYELOID LEUKAEMIA,5
CO,CRANIOCEREBRAL INJURY,5
CO,DECREASED IMMUNE RESPONSIVENESS,5
CO,DECUBITUS ULCER,5
CO,DRUG PRESCRIBING ERROR,5
CO,EYE PAIN,5
CO,FEELING HOT,5
CO,HEAD INJURY,5
CO,HIATUS HERNIA,5
CO,HYPOAESTHESIA,5
CO,INFARCTION,5
CO,INTERNATIONAL NORMALISED RATIO INCREASED,5
CO,LUNG INFECTION,5
CO,MOBILITY DECREASED,5
CO,MULTI-ORGAN FAILURE,5
CO,OXYGEN SATURATION DECREASED,5
CO,PERICARDIAL EFFUSION,5
CO,PLATELET COUNT INCREASED,5
CO,POST PROCEDURAL COMPLICATION,5
CO,PSYCHIATRIC SYMPTOM,5
CO,RENAL CYST,5
CO,RESPIRATORY DISORDER,5
CO,SPLENOMEGALY,5
CO,SUDDEN DEATH,5
CO,URINE OUTPUT DECREASED,5
CO,VERTIGO,5
CO,ARTERIAL OCCLUSIVE DISEASE,4
CO,BLOOD IRON INCREASED,4
CO,BLOOD POTASSIUM INCREASED,4
CO,BRONCHITIS,4
CO,CHRONIC GASTRITIS,4
CO,CHRONIC KIDNEY DISEASE,4
CO,DEHYDRATION,4
CO,DEVICE RELATED INFECTION,4
CO,ENCEPHALOPATHY,4
CO,ENDOCARDITIS,4
CO,EXTREMITY NECROSIS,4
CO,EYELID OEDEMA,4
CO,FEELING COLD,4
CO,FUNGAL PERITONITIS,4
CO,GASTRIC DISORDER,4
CO,GASTROINTESTINAL INFECTION,4
CO,HAEMATEMESIS,4
CO,HAEMATOCHEZIA,4
CO,HAEMATOMA,4
CO,HAEMORRHOIDS,4
CO,HYPOKALAEMIA,4
CO,INGUINAL HERNIA,4
CO,INTESTINAL OBSTRUCTION,4
CO,IRON OVERLOAD,4
CO,ISCHAEMIC CARDIOMYOPATHY,4
CO,JOINT INJURY,4
CO,JOINT SWELLING,4
CO,LIMB INJURY,4
CO,LOCALISED INFECTION,4
CO,MASS,4
CO,MOOD ALTERED,4
CO,NECK PAIN,4
CO,NEURALGIA,4
CO,PNEUMONIA BACTERIAL,4
CO,PRESCRIBED UNDERDOSE,4
CO,PULMONARY EMBOLISM,4
CO,RASH GENERALISED,4
CO,RECTAL HAEMORRHAGE,4
CO,RESPIRATORY TRACT INFECTION,4
CO,SOFT TISSUE INFECTION,4
CO,TREMOR,4
CO,UMBILICAL HERNIA,4
CO,VIRAL INFECTION,4
CO,WEIGHT INCREASED,4
CO,YELLOW SKIN,4
CO,ABDOMINAL HERNIA,3
CO,ABDOMINAL SEPSIS,3
CO,ABNORMAL BEHAVIOUR,3
CO,ACUTE CORONARY SYNDROME,3
CO,ANAL HAEMORRHAGE,3
CO,ANAL INCONTINENCE,3
CO,ANGINA PECTORIS,3
CO,ANURIA,3
CO,AORTIC VALVE INCOMPETENCE,3
CO,APHASIA,3
CO,APNOEA,3
CO,BACTERIAL INFECTION,3
CO,BENIGN PROSTATIC HYPERPLASIA,3
CO,BLOOD GROWTH HORMONE INCREASED,3
CO,BLOOD POTASSIUM DECREASED,3
CO,BLOOD UREA INCREASED,3
CO,BRADYCARDIA,3
CO,BRAIN DEATH,3
CO,BREAST CANCER,3
CO,BURNING SENSATION,3
CO,CATHETER SITE INFECTION,3
CO,CEREBRAL HAEMORRHAGE,3
CO,CEREBRAL ISCHAEMIA,3
CO,CHIKUNGUNYA VIRUS INFECTION,3
CO,CHROMATURIA,3
CO,CORONARY ARTERY OCCLUSION,3
CO,DEPENDENT PERSONALITY DISORDER,3
CO,DIABETIC RETINOPATHY,3
CO,DISCOMFORT,3
CO,DIVERTICULITIS,3
CO,DRY SKIN,3
CO,DYSARTHRIA,3
CO,DYSSTASIA,3
CO,EJECTION FRACTION DECREASED,3
CO,ELECTROLYTE IMBALANCE,3
CO,EYE DISORDER,3
CO,FACE OEDEMA,3
CO,FEMUR FRACTURE,3
CO,FLATULENCE,3
CO,GASTRIC ULCER,3
CO,GASTROENTERITIS,3
CO,GROIN PAIN,3
CO,HAEMOPTYSIS,3
CO,HEPATIC ENCEPHALOPATHY,3
CO,HEPATIC FAILURE,3
CO,HEPATIC LESION,3
CO,HYPERKALAEMIA,3
CO,HYPERSENSITIVITY,3
CO,HYPERSOMNIA,3
CO,HYPOKINESIA,3
CO,HYPOTONIA,3
CO,IMMUNODEFICIENCY,3
CO,JAUNDICE,3
CO,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,3
CO,LIMB DISCOMFORT,3
CO,LIVER INJURY,3
CO,MALLORY-WEISS SYNDROME,3
CO,METASTASES TO LUNG,3
CO,METASTASES TO SPINE,3
CO,MITRAL VALVE DISEASE,3
CO,MULTI-ORGAN DISORDER,3
CO,MULTIPLE ORGAN DYSFUNCTION SYNDROME,3
CO,NASOPHARYNGITIS,3
CO,NONINFECTIVE GINGIVITIS,3
CO,OESOPHAGITIS,3
CO,ORAL DISORDER,3
CO,OSTEOPOROSIS,3
CO,OVERDOSE,3
CO,PALPITATIONS,3
CO,PARAESTHESIA,3
CO,PARALYSIS,3
CO,PARANEOPLASTIC SYNDROME,3
CO,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,3
CO,PHARYNGEAL DISORDER,3
CO,POLYNEUROPATHY,3
CO,PULMONARY CONGESTION,3
CO,PULMONARY MASS,3
CO,RASH,3
CO,RECURRENT CANCER,3
CO,RENAL PAIN,3
CO,RESPIRATORY ARREST,3
CO,ROAD TRAFFIC ACCIDENT,3
CO,SENSORY LOSS,3
CO,SKIN ULCER,3
CO,SOFT TISSUE DISORDER,3
CO,THERAPY NON-RESPONDER,3
CO,THERMAL BURN,3
CO,THYROID DISORDER,3
CO,TOXIC EPIDERMAL NECROLYSIS,3
CO,TUBERCULOSIS,3
CO,ULTRAFILTRATION FAILURE,3
CO,UNDERWEIGHT,3
CO,VISUAL ACUITY REDUCED,3
CO,WALKING DISABILITY,3
CO,WHITE BLOOD CELL COUNT INCREASED,3
CO,WOUND,3
CO,ABASIA,2
CO,AGGRESSION,2
CO,APATHY,2
CO,ARTERIOVENOUS FISTULA,2
CO,ARTHRITIS,2
CO,BACK INJURY,2
CO,BLOOD ALBUMIN DECREASED,2
CO,BLOOD CHOLESTEROL INCREASED,2
CO,BLOOD GLUCOSE ABNORMAL,2
CO,BLOOD PRESSURE FLUCTUATION,2
CO,BLOOD URIC ACID INCREASED,2
CO,BLOOD URINE PRESENT,2
CO,BONE DISORDER,2
CO,CARDIAC OUTPUT DECREASED,2
CO,CARDIAC PACEMAKER INSERTION,2
CO,CARDIAC PROCEDURE COMPLICATION,2
CO,CARDIOGENIC SHOCK,2
CO,CARDIOMYOPATHY,2
CO,CEREBRAL DISORDER,2
CO,CEREBRAL HAEMATOMA,2
CO,CEREBRAL INFARCTION,2
CO,CHOLECYSTITIS,2
CO,COLITIS,2
CO,CONCOMITANT DISEASE AGGRAVATED,2
CO,CONFUSIONAL STATE,2
CO,CONJUNCTIVAL DISORDER,2
CO,CONSTIPATION,2
CO,CRITICAL ILLNESS,2
CO,DEEP VEIN THROMBOSIS,2
CO,DEVICE MALFUNCTION,2
CO,DIABETES MELLITUS INADEQUATE CONTROL,2
CO,DIABETIC NEPHROPATHY,2
CO,DIABETIC VASCULAR DISORDER,2
CO,DISEASE RECURRENCE,2
CO,DRUG DISPENSING ERROR,2
CO,DRUG HYPERSENSITIVITY,2
CO,DYSKINESIA,2
CO,DYSPEPSIA,2
CO,DYSPHONIA,2
CO,EAR HAEMORRHAGE,2
CO,EAR PAIN,2
CO,EOSINOPHILIA,2
CO,EYE INFECTION,2
CO,EYE IRRITATION,2
CO,FAECES DISCOLOURED,2
CO,FEAR,2
CO,FEEDING DISORDER,2
CO,FOOD INTOLERANCE,2
CO,GANGRENE,2
CO,GASTRIC CANCER,2
CO,GENERAL PHYSICAL CONDITION ABNORMAL,2
CO,GENERALISED ERYTHEMA,2
CO,GINGIVAL BLEEDING,2
CO,GLAUCOMA,2
CO,GLOSSODYNIA,2
CO,HAEMORRHAGIC STROKE,2
CO,HALLUCINATION,2
CO,HAND FRACTURE,2
CO,HEART RATE DECREASED,2
CO,HEMIPARESIS,2
CO,HEMIPLEGIA,2
CO,HEPATIC STEATOSIS,2
CO,HERPES ZOSTER,2
CO,HORMONE LEVEL ABNORMAL,2
CO,HYDRONEPHROSIS,2
CO,HYPOTHYROIDISM,2
CO,HYPOVOLAEMIC SHOCK,2
CO,ILL-DEFINED DISORDER,2
CO,IMMUNOSUPPRESSION,2
CO,INCOHERENT,2
CO,INTERNATIONAL NORMALISED RATIO ABNORMAL,2
CO,INTRA-ABDOMINAL FLUID COLLECTION,2
CO,INTRACRANIAL HAEMATOMA,2
CO,ISCHAEMIA,2
CO,ISCHAEMIC STROKE,2
CO,JOINT RANGE OF MOTION DECREASED,2
CO,KIDNEY TRANSPLANT REJECTION,2
CO,KLEBSIELLA INFECTION,2
CO,LEFT VENTRICULAR HYPERTROPHY,2
CO,LEUKOPENIA,2
CO,LIVER FUNCTION TEST ABNORMAL,2
CO,LOCAL SWELLING,2
CO,LOWER GASTROINTESTINAL HAEMORRHAGE,2
CO,METASTASES TO BONE,2
CO,METASTASES TO LIVER,2
CO,METRORRHAGIA,2
CO,MUCOUS MEMBRANE DISORDER,2
CO,MUSCULOSKELETAL CHEST PAIN,2
CO,MUSCULOSKELETAL PAIN,2
CO,MYALGIA,2
CO,MYELOFIBROSIS,2
CO,MYOPATHY,2
CO,NEPHROPATHY,2
CO,NERVOUSNESS,2
CO,OCULAR ICTERUS,2
CO,OESOPHAGEAL OBSTRUCTION,2
CO,ONYCHOCLASIS,2
CO,OSTEOARTHRITIS,2
CO,OSTEOMYELITIS,2
CO,PARATHYROID DISORDER,2
CO,PERIPHERAL VASCULAR DISORDER,2
CO,PETECHIAE,2
CO,PHLEBITIS,2
CO,PHOTOPHOBIA,2
CO,POST PROCEDURAL INFECTION,2
CO,POSTOPERATIVE WOUND INFECTION,2
CO,PRIMARY MYELOFIBROSIS,2
CO,PRODUCT AVAILABILITY ISSUE,2
CO,PRODUCT USE IN UNAPPROVED INDICATION,2
CO,PROSTATIC SPECIFIC ANTIGEN INCREASED,2
CO,PRURITUS,2
CO,PULMONARY ARTERIAL PRESSURE INCREASED,2
CO,PULMONARY HAEMORRHAGE,2
CO,PULMONARY SEPSIS,2
CO,PURULENT DISCHARGE,2
CO,RENAL FAILURE CHRONIC,2
CO,RENAL INJURY,2
CO,RENAL TRANSPLANT,2
CO,RHINITIS,2
CO,RHINORRHOEA,2
CO,SENILE DEMENTIA,2
CO,SENSORY DISTURBANCE,2
CO,SKELETAL INJURY,2
CO,SLEEP APNOEA SYNDROME,2
CO,SLEEP DISORDER,2
CO,SPINAL FRACTURE,2
CO,SUBCUTANEOUS ABSCESS,2
CO,SYSTEMIC LUPUS ERYTHEMATOSUS,2
CO,TACHYPNOEA,2
CO,TERMINAL STATE,2
CO,THROMBOPHLEBITIS SEPTIC,2
CO,TINNITUS,2
CO,TRAUMATIC LUNG INJURY,2
CO,TREATMENT NONCOMPLIANCE,2
CO,TROPONIN INCREASED,2
CO,TUBERCULIN TEST POSITIVE,2
CO,UPPER LIMB FRACTURE,2
CO,URINE ODOUR ABNORMAL,2
CO,VAGINAL HAEMORRHAGE,2
CO,VARICOSE VEIN,2
CO,VENOUS VALVE RUPTURED,2
CO,VISION BLURRED,2
CO,VITAL FUNCTIONS ABNORMAL,2
CO,VITREOUS FLOATERS,2
CO,VULVOVAGINAL INFLAMMATION,2
CO,ABDOMINAL COMPARTMENT SYNDROME,1
CO,ABDOMINAL MASS,1
CO,ABDOMINAL PAIN LOWER,1
CO,ABDOMINAL WALL ABSCESS,1
CO,ACCIDENT,1
CO,ACCIDENT AT HOME,1
CO,ACCIDENTAL OVERDOSE,1
CO,ACNE,1
CO,ACUTE KIDNEY INJURY,1
CO,ACUTE LEUKAEMIA,1
CO,ACUTE LYMPHOCYTIC LEUKAEMIA,1
CO,ACUTE MYELOID LEUKAEMIA,1
CO,ACUTE PULMONARY OEDEMA,1
CO,ADENOMA BENIGN,1
CO,ADVERSE DRUG REACTION,1
CO,ADVERSE EVENT,1
CO,AIRWAY BURNS,1
CO,ALTERED STATE OF CONSCIOUSNESS,1
CO,ANEURYSM RUPTURED,1
CO,ANKLE BRACHIAL INDEX ABNORMAL,1
CO,ANKLE FRACTURE,1
CO,ANKYLOSING SPONDYLITIS,1
CO,ANOPHTHALMOS,1
CO,ANORECTAL DISCOMFORT,1
CO,AORTIC ANEURYSM,1
CO,AORTIC ARTERIOSCLEROSIS,1
CO,AORTIC CALCIFICATION,1
CO,AORTIC DILATATION,1
CO,AORTIC VALVE CALCIFICATION,1
CO,AORTIC VALVE DISEASE,1
CO,AORTIC VALVE SCLEROSIS,1
CO,APPARENT DEATH,1
CO,APPENDICITIS,1
CO,APPLICATION SITE MASS,1
CO,APPLICATION SITE PAIN,1
CO,ARTERIAL DISORDER,1
CO,ARTERIOSCLEROSIS,1
CO,ARTERIOSCLEROSIS CORONARY ARTERY,1
CO,ARTHROPATHY,1
CO,ARTHROPOD STING,1
CO,ASPIRATION,1
CO,ASPIRATION BRONCHIAL,1
CO,ASTHMA,1
CO,ASTHMATIC CRISIS,1
CO,ATRIAL FLUTTER,1
CO,ATRIOVENTRICULAR BLOCK COMPLETE,1
CO,AZOTAEMIA,1
CO,B-CELL LYMPHOMA,1
CO,BACTERIAL SEPSIS,1
CO,BACTERIAL TRANSLOCATION,1
CO,BALANCE DISORDER,1
CO,BILE DUCT OBSTRUCTION,1
CO,BIPOLAR DISORDER,1
CO,BLADDER DISORDER,1
CO,BLADDER INJURY,1
CO,BLADDER MASS,1
CO,BLISTER RUPTURE,1
CO,BLOOD BILIRUBIN INCREASED,1
CO,BLOOD BLISTER,1
CO,BLOOD CALCIUM DECREASED,1
CO,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,1
CO,BLOOD CREATININE ABNORMAL,1
CO,BLOOD DISORDER,1
CO,BLOOD ELECTROLYTES ABNORMAL,1
CO,BLOOD ERYTHROPOIETIN DECREASED,1
CO,BLOOD GLUCOSE DECREASED,1
CO,BLOOD IRON DECREASED,1
CO,BLOOD PARATHYROID HORMONE ABNORMAL,1
CO,BLOOD PRESSURE SYSTOLIC DECREASED,1
CO,BLOOD PRESSURE SYSTOLIC INCREASED,1
CO,BLOOD SODIUM ABNORMAL,1
CO,BLOOD TRIGLYCERIDES INCREASED,1
CO,BLOOD UREA ABNORMAL,1
CO,BLOODY PERITONEAL EFFLUENT,1
CO,BONE CANCER,1
CO,BONE MARROW DISORDER,1
CO,BONE MARROW FAILURE,1
CO,BRAIN COMPRESSION,1
CO,BRAIN NATRIURETIC PEPTIDE INCREASED,1
CO,BRAIN STEM THROMBOSIS,1
CO,BREAST MASS,1
CO,BREAST PAIN,1
CO,BREAST SWELLING,1
CO,BREATH ODOUR,1
CO,BRONCHIAL DISORDER,1
CO,BRONCHITIS BACTERIAL,1
CO,BRONCHOPNEUMONIA,1
CO,BUNDLE BRANCH BLOCK RIGHT,1
CO,BURN OF INTERNAL ORGANS,1
CO,CACHEXIA,1
CO,CALCULUS URINARY,1
CO,CANCER PAIN,1
CO,CARDIAC FAILURE CHRONIC,1
CO,CARDIAC MURMUR,1
CO,CARDIAC VENTRICULAR THROMBOSIS,1
CO,CARDIOPULMONARY FAILURE,1
CO,CATARACT OPERATION,1
CO,CATHETERISATION CARDIAC,1
CO,CENTRAL NERVOUS SYSTEM LESION,1
CO,CENTRAL NERVOUS SYSTEM LEUKAEMIA,1
CO,CEREBRAL ARTERY THROMBOSIS,1
CO,CEREBRAL THROMBOSIS,1
CO,CERVICAL SPINAL STENOSIS,1
CO,CHEILITIS,1
CO,CHEST INJURY,1
CO,CHONDRITIS,1
CO,CHRONIC MYELOID LEUKAEMIA RECURRENT,1
CO,CLAVICLE FRACTURE,1
CO,CLOSTRIDIUM DIFFICILE INFECTION,1
CO,COCCYDYNIA,1
CO,COMMINUTED FRACTURE,1
CO,COMPLICATION ASSOCIATED WITH DEVICE,1
CO,CONGESTIVE CARDIOMYOPATHY,1
CO,CONJUNCTIVITIS,1
CO,CONVULSION,1
CO,CORNEAL DISORDER,1
CO,CORONARY ARTERY THROMBOSIS,1
CO,CRYING,1
CO,CUSHING^S SYNDROME,1
CO,CYANOSIS CENTRAL,1
CO,CYSTITIS,1
CO,CYSTOCELE,1
CO,CYTOGENETIC ANALYSIS ABNORMAL,1
CO,DEAFNESS,1
CO,DECREASED ACTIVITY,1
CO,DELAYED RECOVERY FROM ANAESTHESIA,1
CO,DEMENTIA,1
CO,DENGUE FEVER,1
CO,DEPRESSIVE SYMPTOM,1
CO,DERMAL CYST,1
CO,DEVICE DAMAGE,1
CO,DEVICE OCCLUSION,1
CO,DIABETIC COMA,1
CO,DIABETIC FOOT INFECTION,1
CO,DIABETIC METABOLIC DECOMPENSATION,1
CO,DIAPHRAGMALGIA,1
CO,DIET REFUSAL,1
CO,DISSEMINATED TUBERCULOSIS,1
CO,DISTURBANCE IN ATTENTION,1
CO,DIZZINESS POSTURAL,1
CO,DRUG DOSE TITRATION NOT PERFORMED,1
CO,DRUG TOLERANCE,1
CO,DRUG-INDUCED LIVER INJURY,1
CO,DRY EYE,1
CO,DRY THROAT,1
CO,DYSCHEZIA,1
CO,DYSLALIA,1
CO,DYSLIPIDAEMIA,1
CO,DYSPNOEA EXERTIONAL,1
CO,ECZEMA,1
CO,ELECTROCARDIOGRAM ABNORMAL,1
CO,EMBOLISM,1
CO,EMOTIONAL DISORDER,1
CO,EMPHYSEMA,1
CO,ENCEPHALITIS AUTOIMMUNE,1
CO,ENTEROBACTER SEPSIS,1
CO,EROSIVE OESOPHAGITIS,1
CO,ERYSIPELAS,1
CO,ESCHAR,1
CO,ESCHERICHIA SEPSIS,1
CO,ESCHERICHIA URINARY TRACT INFECTION,1
CO,EXCORIATION,1
CO,EXERCISE TOLERANCE DECREASED,1
CO,EYE HAEMORRHAGE,1
CO,EYE INFLAMMATION,1
CO,EYE SWELLING,1
CO,FACIAL ASYMMETRY,1
CO,FACIAL NEURALGIA,1
CO,FEELING DRUNK,1
CO,FEMORAL ARTERY OCCLUSION,1
CO,FIBRIN D DIMER INCREASED,1
CO,FREQUENT BOWEL MOVEMENTS,1
CO,FUNGAEMIA,1
CO,FURUNCLE,1
CO,GALLBLADDER DISORDER,1
CO,GASTRIC BYPASS,1
CO,GASTRIC DILATATION,1
CO,GASTRIC HAEMORRHAGE,1
CO,GASTRIC ULCER HAEMORRHAGE,1
CO,GASTRITIS EROSIVE,1
CO,GASTROINTESTINAL AMYLOIDOSIS,1
CO,GASTROINTESTINAL INFLAMMATION,1
CO,GASTROINTESTINAL NEOPLASM,1
CO,GASTROOESOPHAGEAL REFLUX DISEASE,1
CO,GENERALISED TONIC-CLONIC SEIZURE,1
CO,GINGIVAL PAIN,1
CO,GLOMERULONEPHRITIS,1
CO,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
CO,GOUT,1
CO,HAEMARTHROSIS,1
CO,HAEMATOLOGY TEST ABNORMAL,1
CO,HAEMODIALYSIS,1
CO,HAEMODYNAMIC INSTABILITY,1
CO,HAEMOLYSIS,1
CO,HAEMORRHAGE INTRACRANIAL,1
CO,HAEMORRHAGE URINARY TRACT,1
CO,HAEMORRHAGIC DISORDER,1
CO,HAIR COLOUR CHANGES,1
CO,HALLUCINATION_ VISUAL,1
CO,HAND DEFORMITY,1
CO,HEAD DISCOMFORT,1
CO,HEART RATE INCREASED,1
CO,HEART RATE IRREGULAR,1
CO,HEART VALVE STENOSIS,1
CO,HELICOBACTER GASTRITIS,1
CO,HEPATIC CANCER,1
CO,HERNIA REPAIR,1
CO,HERNIAL EVENTRATION,1
CO,HERPES DERMATITIS,1
CO,HERPES SIMPLEX,1
CO,HERPES VIRUS INFECTION,1
CO,HICCUPS,1
CO,HYPERCALCAEMIA,1
CO,HYPERNATRAEMIA,1
CO,HYPERTENSIVE CARDIOMYOPATHY,1
CO,HYPERTENSIVE ENCEPHALOPATHY,1
CO,HYPERTENSIVE HEART DISEASE,1
CO,HYPERTENSIVE NEPHROPATHY,1
CO,HYPERTHYROIDISM,1
CO,HYPERTRIGLYCERIDAEMIA,1
CO,HYPERTROPHY,1
CO,HYPOACUSIS,1
CO,HYPOAESTHESIA ORAL,1
CO,HYPONATRAEMIA,1
CO,HYPOPERFUSION,1
CO,HYPOTHERMIA,1
CO,HYPOXIA,1
CO,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,1
CO,HYSTERECTOMY,1
CO,ILEOSTOMY,1
CO,IMMOBILE,1
CO,INCISION SITE INFECTION,1
CO,INCONTINENCE,1
CO,INCORRECT DRUG ADMINISTRATION DURATION,1
CO,INCREASED APPETITE,1
CO,INDURATION,1
CO,INFECTED SKIN ULCER,1
CO,INFECTIOUS PLEURAL EFFUSION,1
CO,INFLAMMATORY PAIN,1
CO,INFLUENZA LIKE ILLNESS,1
CO,INFUSION RELATED REACTION,1
CO,INFUSION SITE ERYTHEMA,1
CO,INJECTION SITE ERYTHEMA,1
CO,INJECTION SITE PAIN,1
CO,INJURY,1
CO,INTENTIONAL PRODUCT MISUSE,1
CO,INTENTIONAL UNDERDOSE,1
CO,INTERNAL HAEMORRHAGE,1
CO,INTERVERTEBRAL DISC COMPRESSION,1
CO,INTESTINAL DILATATION,1
CO,INTESTINAL HAEMORRHAGE,1
CO,INTESTINAL ISCHAEMIA,1
CO,INTESTINAL PERFORATION,1
CO,INTRA-ABDOMINAL HAEMATOMA,1
CO,INTRAOCULAR PRESSURE TEST ABNORMAL,1
CO,IRON DEFICIENCY,1
CO,JOINT EFFUSION,1
CO,JOINT STIFFNESS,1
CO,KIDNEY ENLARGEMENT,1
CO,KYPHOSIS,1
CO,LABORATORY TEST ABNORMAL,1
CO,LACERATION,1
CO,LACRIMATION INCREASED,1
CO,LARYNGEAL CANCER,1
CO,LEFT ATRIAL DILATATION,1
CO,LEFT VENTRICULAR DILATATION,1
CO,LETHARGY,1
CO,LEUKAEMIC INFILTRATION HEPATIC,1
CO,LEUKOENCEPHALOPATHY,1
CO,LIMB FRACTURE,1
CO,LIP DISCOLOURATION,1
CO,LOCALISED OEDEMA,1
CO,LOWER LIMB FRACTURE,1
CO,LOWER RESPIRATORY TRACT INFECTION,1
CO,LUMBAR VERTEBRAL FRACTURE,1
CO,LUNG CANCER METASTATIC,1
CO,LUNG CYST,1
CO,LYMPHADENITIS,1
CO,LYMPHOMA,1
CO,MACULAR DEGENERATION,1
CO,MAJOR DEPRESSION,1
CO,MALIGNANT MELANOMA OF SITES OTHER THAN SKIN,1
CO,MALIGNANT NEOPLASM OF LACRIMAL GLAND,1
CO,MALNUTRITION,1
CO,MEDICAL DEVICE DISCOMFORT,1
CO,MEDICAL DEVICE SITE BRUISE,1
CO,MEDICATION ERROR,1
CO,MELAENA,1
CO,MENINGITIS BACTERIAL,1
CO,MENINGOENCEPHALITIS VIRAL,1
CO,MENORRHAGIA,1
CO,METABOLIC ACIDOSIS,1
CO,METABOLIC SYNDROME,1
CO,METASTASES TO KIDNEY,1
CO,METASTATIC NEOPLASM,1
CO,MITRAL VALVE INCOMPETENCE,1
CO,MITRAL VALVE PROLAPSE,1
CO,MOUTH ULCERATION,1
CO,MUCOSAL DISCOLOURATION,1
CO,MUCOSAL INFLAMMATION,1
CO,MULTIMORBIDITY,1
CO,MULTIPLE INJURIES,1
CO,MUSCLE FATIGUE,1
CO,MUSCLE RIGIDITY,1
CO,MUSCLE SPASMS,1
CO,MUSCLE SWELLING,1
CO,MUSCLE TIGHTNESS,1
CO,MUSCULOSKELETAL DISCOMFORT,1
CO,MUSCULOSKELETAL STIFFNESS,1
CO,MYOCARDIAL ISCHAEMIA,1
CO,MYOCARDIAL OEDEMA,1
CO,MYOGLOBIN BLOOD INCREASED,1
CO,MYOSITIS,1
CO,NAIL AVULSION,1
CO,NASAL CONGESTION,1
CO,NASOPHARYNGEAL CANCER,1
CO,NECROSIS,1
CO,NEONATAL RESPIRATORY DISTRESS SYNDROME,1
CO,NEOPLASM MALIGNANT,1
CO,NEOPLASM PROGRESSION,1
CO,NEOVASCULARISATION,1
CO,NEPHROSCLEROSIS,1
CO,NEUROENDOCRINE TUMOUR,1
CO,NEUROPATHY PERIPHERAL,1
CO,NEUROTOXICITY,1
CO,NEUTROPHIL COUNT DECREASED,1
CO,NEUTROPHIL COUNT INCREASED,1
CO,NEUTROPHILIA,1
CO,NIPPLE INFLAMMATION,1
CO,NIPPLE PAIN,1
CO,NONINFECTIOUS PERITONITIS,1
CO,NOSOCOMIAL INFECTION,1
CO,OBESITY,1
CO,OBSTRUCTION GASTRIC,1
CO,OESOPHAGEAL MASS,1
CO,OESOPHAGEAL VARICES HAEMORRHAGE,1
CO,OLIGURIA,1
CO,ONCOLOGIC COMPLICATION,1
CO,OPTIC NERVE SHEATH HAEMORRHAGE,1
CO,ORAL DISCOMFORT,1
CO,ORAL HERPES,1
CO,ORAL MUCOSAL BLISTERING,1
CO,ORAL MUCOSAL EXFOLIATION,1
CO,ORAL PAIN,1
CO,ORCHITIS,1
CO,OROPHARYNGEAL PLAQUE,1
CO,OVARIAN HAEMORRHAGE,1
CO,OVARIAN RUPTURE,1
CO,OXYGEN CONSUMPTION INCREASED,1
CO,OXYGEN THERAPY,1
CO,PACKED RED BLOOD CELL TRANSFUSION,1
CO,PAIN IN JAW,1
CO,PANCREATIC DISORDER,1
CO,PANCREATIC MASS,1
CO,PANCREATIC NECROSIS,1
CO,PANCREATIC NEUROENDOCRINE TUMOUR,1
CO,PANCREATITIS,1
CO,PANCYTOPENIA,1
CO,PAPILLARY THYROID CANCER,1
CO,PAPULE,1
CO,PARACENTESIS,1
CO,PARATHYROID GLAND ENLARGEMENT,1
CO,PARATHYROIDECTOMY,1
CO,PATHOGEN RESISTANCE,1
CO,PELVIC MASS,1
CO,PENILE OEDEMA,1
CO,PEPTIC ULCER,1
CO,PERIPHERAL COLDNESS,1
CO,PERIPHERAL EMBOLISM,1
CO,PERIPHERAL VENOUS DISEASE,1
CO,PERITONEAL ABSCESS,1
CO,PERITONEAL CLOUDY EFFLUENT,1
CO,PERITONITIS VIRAL,1
CO,PHANTOM PAIN,1
CO,PHARYNGEAL NEOPLASM,1
CO,PHARYNGITIS,1
CO,PLASMA CELL MYELOMA,1
CO,PNEUMOPERITONEUM,1
CO,POISONING,1
CO,POLLAKIURIA,1
CO,POLYMERASE CHAIN REACTION POSITIVE,1
CO,POOR PERIPHERAL CIRCULATION,1
CO,POST PROCEDURAL HAEMORRHAGE,1
CO,POST PROCEDURAL OEDEMA,1
CO,POST-TRAUMATIC PAIN,1
CO,POSTOPERATIVE WOUND COMPLICATION,1
CO,PRESBYOPIA,1
CO,PRESYNCOPE,1
CO,PROCEDURAL COMPLICATION,1
CO,PROCEDURAL HAEMORRHAGE,1
CO,PROCEDURAL PAIN,1
CO,PROCTITIS,1
CO,PRODUCT CONTAINER ISSUE,1
CO,PRODUCT CONTAMINATION,1
CO,PRODUCT PHYSICAL ISSUE,1
CO,PRODUCT QUALITY ISSUE,1
CO,PRODUCT SUPPLY ISSUE,1
CO,PRODUCT TASTE ABNORMAL,1
CO,PROSOPAGNOSIA,1
CO,PROSTATIC DISORDER,1
CO,PROSTATOMEGALY,1
CO,PROTHROMBIN TIME PROLONGED,1
CO,PSEUDOMONAS INFECTION,1
CO,PSORIASIS,1
CO,PULMONARY FIBROSIS,1
CO,PULMONARY INFARCTION,1
CO,PULMONARY PAIN,1
CO,PULMONARY THROMBOSIS,1
CO,PYODERMA GANGRENOSUM,1
CO,QUALITY OF LIFE DECREASED,1
CO,RADIATION ASSOCIATED PAIN,1
CO,RADIATION SKIN INJURY,1
CO,RASH ERYTHEMATOUS,1
CO,RECTAL PROLAPSE,1
CO,RED BLOOD CELL ABNORMALITY,1
CO,RED BLOOD CELL COUNT DECREASED,1
CO,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
CO,RENAL ANEURYSM,1
CO,RENAL FAILURE ACUTE,1
CO,RENAL NEOPLASM,1
CO,RESPIRATORY DEPRESSION,1
CO,RESPIRATORY GAS EXCHANGE DISORDER,1
CO,RESPIRATORY TRACT CONGESTION,1
CO,RESPIRATORY TRACT INFECTION VIRAL,1
CO,RETINAL DETACHMENT,1
CO,RETINAL DISORDER,1
CO,RHEUMATOID ARTHRITIS,1
CO,ROTATOR CUFF SYNDROME,1
CO,SCLERODERMA,1
CO,SCROTAL OEDEMA,1
CO,SCROTAL SWELLING,1
CO,SEBORRHOEIC DERMATITIS,1
CO,SECOND PRIMARY MALIGNANCY,1
CO,SELF INJURIOUS BEHAVIOUR,1
CO,SELF-INJURIOUS IDEATION,1
CO,SEMINAL VESICULAR DISORDER,1
CO,SERUM FERRITIN INCREASED,1
CO,SHOCK,1
CO,SHOCK HYPOGLYCAEMIC,1
CO,SICKLE CELL ANAEMIA,1
CO,SINUS NODE DYSFUNCTION,1
CO,SKIN DISORDER,1
CO,SKIN EXFOLIATION,1
CO,SKIN FISSURES,1
CO,SKIN INJURY,1
CO,SKIN LESION,1
CO,SKIN WRINKLING,1
CO,SLOW SPEECH,1
CO,SNEEZING,1
CO,SPINAL COLUMN INJURY,1
CO,SPINAL PAIN,1
CO,SPONDYLITIS,1
CO,SPONDYLOLYSIS,1
CO,STAPHYLOCOCCAL BACTERAEMIA,1
CO,STAPHYLOCOCCAL SEPSIS,1
CO,STEVENS-JOHNSON SYNDROME,1
CO,STOMAL HERNIA,1
CO,STRESS,1
CO,SUPRAVENTRICULAR TACHYCARDIA,1
CO,TESTICULAR OEDEMA,1
CO,THERAPY CESSATION,1
CO,THINKING ABNORMAL,1
CO,THORACIC VERTEBRAL FRACTURE,1
CO,THROAT IRRITATION,1
CO,THROMBOCYTOSIS,1
CO,THROMBOPHLEBITIS,1
CO,THROMBOTIC STROKE,1
CO,TONGUE BLISTERING,1
CO,TONGUE HAEMORRHAGE,1
CO,TONGUE MOVEMENT DISTURBANCE,1
CO,TOOTH EXTRACTION,1
CO,TOOTH INJURY,1
CO,TOOTH LOSS,1
CO,TRANSAMINASES ABNORMAL,1
CO,TRANSAMINASES INCREASED,1
CO,TRANSFUSION RELATED COMPLICATION,1
CO,TRANSIENT ISCHAEMIC ATTACK,1
CO,TRANSPLANT,1
CO,TRAUMATIC HAEMATOMA,1
CO,TRISMUS,1
CO,TROPONIN T INCREASED,1
CO,TUBERCULOSIS GASTROINTESTINAL,1
CO,TUMOUR MARKER INCREASED,1
CO,TYPE 2 DIABETES MELLITUS,1
CO,ULCER,1
CO,UNEVALUABLE EVENT,1
CO,URAEMIC ENCEPHALOPATHY,1
CO,URETHRAL OBSTRUCTION,1
CO,URINARY RETENTION,1
CO,URINARY TRACT DISORDER,1
CO,URINARY TRACT STOMA COMPLICATION,1
CO,URINE ABNORMALITY,1
CO,URTICARIA,1
CO,UTERINE MASS,1
CO,VAGINAL ABSCESS,1
CO,VARICELLA,1
CO,VARICES OESOPHAGEAL,1
CO,VASCULAR RUPTURE,1
CO,VASCULITIS,1
CO,VEIN DISORDER,1
CO,VENOUS OCCLUSION,1
CO,VENOUS THROMBOSIS,1
CO,VENTRICULAR ARRHYTHMIA,1
CO,VENTRICULAR HYPOKINESIA,1
CO,VENTRICULAR INTERNAL DIAMETER ABNORMAL,1
CO,VITREOUS HAEMORRHAGE,1
CO,VULVOVAGINAL CANDIDIASIS,1
CO,VULVOVAGINAL PAIN,1
CO,WHEEZING,1
CO,WHITE BLOOD CELL COUNT DECREASED,1
CO,WOUND SECRETION,1
CR,DYSPNOEA,3
CR,FALL,3
CR,HYPERTENSION,3
CR,ABDOMINAL PAIN,2
CR,AORTIC ANEURYSM,2
CR,ATRIAL FIBRILLATION,2
CR,BLOOD PRESSURE INCREASED,2
CR,BLOOD THYROID STIMULATING HORMONE ABNORMAL,2
CR,BRAIN NATRIURETIC PEPTIDE ABNORMAL,2
CR,BUNDLE BRANCH BLOCK LEFT,2
CR,BUNDLE BRANCH BLOCK RIGHT,2
CR,C-REACTIVE PROTEIN ABNORMAL,2
CR,CARDIAC FAILURE CHRONIC,2
CR,CARDIOMEGALY,2
CR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
CR,CONDUCTION DISORDER,2
CR,DIARRHOEA,2
CR,DYSLIPIDAEMIA,2
CR,EJECTION FRACTION DECREASED,2
CR,ELECTROCARDIOGRAM QRS COMPLEX ABNORMAL,2
CR,FATIGUE,2
CR,FRACTURED COCCYX,2
CR,GOITRE,2
CR,LEFT VENTRICULAR DILATATION,2
CR,MALAISE,2
CR,MITRAL VALVE INCOMPETENCE,2
CR,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE ABNORMAL,2
CR,OBSTRUCTIVE AIRWAYS DISORDER,2
CR,OEDEMA PERIPHERAL,2
CR,OXYGEN SATURATION INCREASED,2
CR,PULMONARY ARTERIAL PRESSURE ABNORMAL,2
CR,THYROIDITIS,2
CR,TRICUSPID VALVE INCOMPETENCE,2
CR,TYPE 2 DIABETES MELLITUS,2
CR,VENTRICULAR HYPOKINESIA,2
CR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
CR,ABDOMINAL ABSCESS,1
CR,ABDOMINAL DISCOMFORT,1
CR,ABSCESS,1
CR,ABSCESS LIMB,1
CR,ARRHYTHMIA,1
CR,ARTHROPATHY,1
CR,BACK PAIN,1
CR,BLOOD GROWTH HORMONE INCREASED,1
CR,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
CR,CARDIAC DISORDER,1
CR,CEREBROSPINAL FLUID LEAKAGE,1
CR,CHEST DISCOMFORT,1
CR,CHOLELITHIASIS,1
CR,COUGH,1
CR,DEAFNESS,1
CR,DEATH,1
CR,DIABETES MELLITUS INADEQUATE CONTROL,1
CR,DRUG INTOLERANCE,1
CR,DRUG PRESCRIBING ERROR,1
CR,FEELING ABNORMAL,1
CR,FISTULA,1
CR,GLOSSODYNIA,1
CR,HEADACHE,1
CR,HEMIPLEGIA,1
CR,HYPERGLYCAEMIA,1
CR,HYPOACUSIS,1
CR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
CR,INTENTIONAL UNDERDOSE,1
CR,ISCHAEMIC STROKE,1
CR,LUNG NEOPLASM MALIGNANT,1
CR,MEMORY IMPAIRMENT,1
CR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
CR,NEOPLASM,1
CR,NEOPLASM MALIGNANT,1
CR,NEOPLASM PROGRESSION,1
CR,PAIN,1
CR,PRODUCT STORAGE ERROR,1
CR,PRODUCT USE ISSUE,1
CR,RHINORRHOEA,1
CR,SEPSIS,1
CR,SINUSITIS,1
CR,SKIN FISSURES,1
CR,SKIN LESION,1
CR,SYNCOPE,1
CR,THROMBOSIS MESENTERIC VESSEL,1
CR,URINARY BLADDER HAEMORRHAGE,1
CR,VAGINAL ABSCESS,1
CR,VOMITING,1
CR,WEIGHT DECREASED,1
CR,WRIST FRACTURE,1
HR,LACTIC ACIDOSIS,8
HR,DYSPNOEA,7
HR,ASTHENIA,6
HR,ATRIAL FIBRILLATION,6
HR,PNEUMONIA,6
HR,RENAL FAILURE,6
HR,HAEMATURIA,5
HR,HYPOGLYCAEMIA,5
HR,MULTI-ORGAN FAILURE,5
HR,RESPIRATORY FAILURE,5
HR,DEATH,4
HR,DIZZINESS,4
HR,HYPOTHERMIA,4
HR,BRADYCARDIA,3
HR,CARDIAC FAILURE,3
HR,CARDIO-RESPIRATORY ARREST,3
HR,CEREBRAL HAEMORRHAGE,3
HR,DIARRHOEA,3
HR,EPISTAXIS,3
HR,FATIGUE,3
HR,HYPERTENSION,3
HR,RENAL FAILURE ACUTE,3
HR,RHABDOMYOLYSIS,3
HR,ACUTE MYOCARDIAL INFARCTION,2
HR,ANAEMIA,2
HR,ANGINA PECTORIS,2
HR,ANURIA,2
HR,AZOTAEMIA,2
HR,BRAIN HERNIATION,2
HR,BRAIN OEDEMA,2
HR,CEREBRAL ISCHAEMIA,2
HR,CHEST DISCOMFORT,2
HR,CHRONIC KIDNEY DISEASE,2
HR,CONTUSION,2
HR,DIPLOPIA,2
HR,ESCHERICHIA INFECTION,2
HR,GASTROINTESTINAL HAEMORRHAGE,2
HR,HEADACHE,2
HR,HYPOTENSION,2
HR,INFLAMMATION,2
HR,INTERNATIONAL NORMALISED RATIO INCREASED,2
HR,KLEBSIELLA INFECTION,2
HR,MELAENA,2
HR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
HR,NAUSEA,2
HR,NERVOUS SYSTEM DISORDER,2
HR,OEDEMA PERIPHERAL,2
HR,PALPITATIONS,2
HR,PERIPHERAL SWELLING,2
HR,PLEURAL EFFUSION,2
HR,ABDOMINAL PAIN LOWER,1
HR,ACUTE KIDNEY INJURY,1
HR,ADENOCARCINOMA OF COLON,1
HR,AMNESTIC DISORDER,1
HR,AORTIC STENOSIS,1
HR,APATHY,1
HR,ASTHMA,1
HR,ATAXIA,1
HR,BLOOD CREATININE INCREASED,1
HR,BLOOD PRESSURE INCREASED,1
HR,BLOOD UREA INCREASED,1
HR,BRADYARRHYTHMIA,1
HR,BRAIN COMPRESSION,1
HR,BURNING SENSATION,1
HR,CARDIAC FAILURE CONGESTIVE,1
HR,CARDIOMYOPATHY,1
HR,CAROTID ARTERY STENOSIS,1
HR,CENTRAL NERVOUS SYSTEM LESION,1
HR,CEREBRAL INFARCTION,1
HR,CEREBROVASCULAR ACCIDENT,1
HR,CHEST PAIN,1
HR,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
HR,COLORECTAL CANCER METASTATIC,1
HR,CONSTIPATION,1
HR,CORONARY ARTERY OCCLUSION,1
HR,CORONARY ARTERY STENOSIS,1
HR,CYTOMEGALOVIRUS COLITIS,1
HR,CYTOMEGALOVIRUS INFECTION,1
HR,DEEP VEIN THROMBOSIS,1
HR,DISCOLOURED VOMIT,1
HR,DRY SKIN,1
HR,DYSPNOEA EXERTIONAL,1
HR,EPILEPSY,1
HR,ESCHERICHIA TEST POSITIVE,1
HR,EXERCISE TOLERANCE DECREASED,1
HR,EXTRAPYRAMIDAL DISORDER,1
HR,FAECES DISCOLOURED,1
HR,FALL,1
HR,FEBRILE NEUTROPENIA,1
HR,FLATULENCE,1
HR,GAIT DISTURBANCE,1
HR,GASTRITIS,1
HR,GASTRITIS EROSIVE,1
HR,GASTROOESOPHAGEAL REFLUX DISEASE,1
HR,HAEMATEMESIS,1
HR,HAEMATOCHEZIA,1
HR,HAEMOGLOBIN ABNORMAL,1
HR,HAEMOLYSIS,1
HR,HAEMORRHAGE URINARY TRACT,1
HR,HEAD INJURY,1
HR,HEART RATE INCREASED,1
HR,HEART RATE IRREGULAR,1
HR,HEMIPARESIS,1
HR,HEPATIC ENZYME INCREASED,1
HR,HYPERKALAEMIA,1
HR,HYPERPHOSPHATAEMIA,1
HR,HYPOKALAEMIA,1
HR,HYPONATRAEMIA,1
HR,HYPOXIA,1
HR,INCARCERATED HERNIA,1
HR,INCARCERATED HIATUS HERNIA,1
HR,INFARCTION,1
HR,INJURY,1
HR,KERATOPATHY,1
HR,KLEBSIELLA TEST POSITIVE,1
HR,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
HR,LEUKOCYTOSIS,1
HR,MALAISE,1
HR,METABOLIC ACIDOSIS,1
HR,MICROCYTIC ANAEMIA,1
HR,MICTURITION DISORDER,1
HR,MUSCULOSKELETAL DISCOMFORT,1
HR,NEUROLOGICAL DECOMPENSATION,1
HR,OLIGURIA,1
HR,ORTHOPNOEA,1
HR,PAIN,1
HR,PALLOR,1
HR,PARAESTHESIA,1
HR,PARKINSONISM,1
HR,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
HR,PERIPHERAL ARTERY ANGIOPLASTY,1
HR,PETECHIAE,1
HR,PNEUMONITIS,1
HR,POLLAKIURIA,1
HR,POLYP,1
HR,PUPILS UNEQUAL,1
HR,PYREXIA,1
HR,RASH,1
HR,RECTAL HAEMORRHAGE,1
HR,RESPIRATORY DISORDER,1
HR,RESPIRATORY TRACT INFECTION,1
HR,SKIN HYPERPIGMENTATION,1
HR,SKIN TURGOR DECREASED,1
HR,SKIN ULCER,1
HR,SOMNOLENCE,1
HR,SUBCUTANEOUS HAEMATOMA,1
HR,SUFFOCATION FEELING,1
HR,SYNCOPE,1
HR,TACHYCARDIA,1
HR,TACHYPNOEA,1
HR,THROMBOCYTOPENIA,1
HR,TREMOR,1
HR,URETHRITIS,1
HR,URINARY RETENTION,1
HR,VERTIGO,1
HR,VOMITING,1
CY,HYPERCALCAEMIA,2
CY,CARDIAC FAILURE CHRONIC,1
CY,CEREBROVASCULAR ACCIDENT,1
CY,DIZZINESS,1
CY,DRUG INEFFECTIVE,1
CY,DRUG PRESCRIBING ERROR,1
CY,DYSPNOEA,1
CY,GINGIVAL BLEEDING,1
CY,MYOCARDIAL INFARCTION,1
CY,MYOCARDIAL ISCHAEMIA,1
CY,NAUSEA,1
CY,PRODUCT USE ISSUE,1
CY,THROMBOCYTOPENIC PURPURA,1
CY,URINE OUTPUT DECREASED,1
CZ,CARDIAC FAILURE,8
CZ,VENTRICULAR FIBRILLATION,7
CZ,HYPOTENSION,5
CZ,INTERVERTEBRAL DISCITIS,5
CZ,POLYMYOSITIS,5
CZ,RENAL FAILURE,5
CZ,SALMONELLA SEPSIS,5
CZ,DIARRHOEA,4
CZ,HYPERKALAEMIA,4
CZ,PNEUMONIA,4
CZ,CALCULUS URINARY,3
CZ,CARDIAC ARREST,3
CZ,DEHYDRATION,3
CZ,DRUG LEVEL INCREASED,3
CZ,DYSPNOEA,3
CZ,HYPERCALCIURIA,3
CZ,RENAL IMPAIRMENT,3
CZ,ACUTE MYELOID LEUKAEMIA,2
CZ,ANAEMIA,2
CZ,ATRIAL FIBRILLATION,2
CZ,BLOOD PRESSURE INCREASED,2
CZ,CHEST WALL HAEMATOMA,2
CZ,CHRONIC KIDNEY DISEASE,2
CZ,CIRCULATORY COLLAPSE,2
CZ,DEATH,2
CZ,DYSPNOEA EXERTIONAL,2
CZ,FALL,2
CZ,FATIGUE,2
CZ,FEBRILE NEUTROPENIA,2
CZ,FEMUR FRACTURE,2
CZ,HEPATIC FUNCTION ABNORMAL,2
CZ,HYPONATRAEMIA,2
CZ,LIVER INJURY,2
CZ,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
CZ,MUSCULAR WEAKNESS,2
CZ,OEDEMA PERIPHERAL,2
CZ,PULMONARY OEDEMA,2
CZ,SEPSIS,2
CZ,SPINAL FRACTURE,2
CZ,SYNCOPE,2
CZ,ABASIA,1
CZ,ABSCESS,1
CZ,ACUTE KIDNEY INJURY,1
CZ,ALANINE AMINOTRANSFERASE INCREASED,1
CZ,ALTERED STATE OF CONSCIOUSNESS,1
CZ,ANGINA UNSTABLE,1
CZ,ARRHYTHMIA,1
CZ,ASPARTATE AMINOTRANSFERASE INCREASED,1
CZ,ATRIOVENTRICULAR BLOCK,1
CZ,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
CZ,BONE MARROW FAILURE,1
CZ,BRADYCARDIA,1
CZ,BRAIN NATRIURETIC PEPTIDE INCREASED,1
CZ,BRONCHITIS,1
CZ,CARDIAC DISORDER,1
CZ,CARDIAC FAILURE ACUTE,1
CZ,CARDIOGENIC SHOCK,1
CZ,CHEST PAIN,1
CZ,CHORDAE TENDINAE RUPTURE,1
CZ,COAGULATION TIME PROLONGED,1
CZ,COLITIS,1
CZ,COMPRESSION FRACTURE,1
CZ,CONTRAINDICATED PRODUCT ADMINISTERED,1
CZ,CORONARY ARTERY OCCLUSION,1
CZ,DEAFNESS,1
CZ,DEMENTIA,1
CZ,DIASTOLIC DYSFUNCTION,1
CZ,DUODENITIS,1
CZ,ELECTROCARDIOGRAM QT PROLONGED,1
CZ,EPISTAXIS,1
CZ,ERYSIPELAS,1
CZ,GASTRIC HAEMORRHAGE,1
CZ,GASTRIC ULCER,1
CZ,GASTROENTERITIS SALMONELLA,1
CZ,HAEMATURIA,1
CZ,HAEMOGLOBIN DECREASED,1
CZ,HAEMOLYSIS,1
CZ,HAEMOPTYSIS,1
CZ,HEPATIC ENZYME INCREASED,1
CZ,HEPATITIS E,1
CZ,HYPERCHLORAEMIA,1
CZ,HYPERTENSION,1
CZ,INFLUENZA,1
CZ,INTESTINAL HAEMORRHAGE,1
CZ,ISCHAEMIC STROKE,1
CZ,LEUKOPENIA,1
CZ,LIPASE INCREASED,1
CZ,LIVER DISORDER,1
CZ,LUNG INFILTRATION,1
CZ,METABOLIC ACIDOSIS,1
CZ,MUSCLE CONTRACTIONS INVOLUNTARY,1
CZ,MUSCLE NECROSIS,1
CZ,MYDRIASIS,1
CZ,MYOCARDIAL NECROSIS MARKER INCREASED,1
CZ,MYOGLOBIN BLOOD INCREASED,1
CZ,MYOPATHY,1
CZ,ORTHOPNOEA,1
CZ,OSTEOARTHRITIS,1
CZ,PAIN,1
CZ,PERIPHERAL SWELLING,1
CZ,POTENTIATING DRUG INTERACTION,1
CZ,PROCALCITONIN INCREASED,1
CZ,PRODUCT USE IN UNAPPROVED INDICATION,1
CZ,PSOAS ABSCESS,1
CZ,PYREXIA,1
CZ,QUALITY OF LIFE DECREASED,1
CZ,RECTAL HAEMORRHAGE,1
CZ,RENAL COLIC,1
CZ,RIB FRACTURE,1
CZ,SALMONELLOSIS,1
CZ,SARCOPENIA,1
CZ,SEPTIC SHOCK,1
CZ,SEXUAL DYSFUNCTION,1
CZ,SINUS BRADYCARDIA,1
CZ,SKIN DISORDER,1
CZ,SLEEP APNOEA SYNDROME,1
CZ,STOMATITIS,1
CZ,SYSTOLIC DYSFUNCTION,1
CZ,TACHYPNOEA,1
CZ,THORACIC VERTEBRAL FRACTURE,1
CZ,THROMBOCYTOPENIA,1
CZ,THROMBOTIC MICROANGIOPATHY,1
CZ,TONGUE HAEMORRHAGE,1
CZ,TRANSAMINASES INCREASED,1
CZ,TROPONIN INCREASED,1
CZ,URINARY TRACT INFECTION,1
CZ,VENTRICULAR TACHYCARDIA,1
CZ,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
DK,ANAEMIA,12
DK,PYREXIA,10
DK,HYPOKALAEMIA,8
DK,CARDIAC FAILURE,6
DK,DIARRHOEA,6
DK,DYSPNOEA,6
DK,TORSADE DE POINTES,6
DK,DIZZINESS,5
DK,ELECTROCARDIOGRAM QT PROLONGED,5
DK,OSTEONECROSIS OF JAW,5
DK,PRURITUS,5
DK,PULMONARY OEDEMA,5
DK,RENAL FAILURE,5
DK,ACUTE MYOCARDIAL INFARCTION,4
DK,AORTIC VALVE STENOSIS,4
DK,ATRIAL FIBRILLATION,4
DK,COAGULATION FACTOR INCREASED,4
DK,FATIGUE,4
DK,HYPERKALAEMIA,4
DK,HYPOTENSION,4
DK,INFECTION,4
DK,INTERNATIONAL NORMALISED RATIO INCREASED,4
DK,QUADRIPARESIS,4
DK,ABDOMINAL PAIN UPPER,3
DK,ARTERIOSCLEROSIS,3
DK,BLOOD CREATININE INCREASED,3
DK,CONDITION AGGRAVATED,3
DK,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,3
DK,HAEMATEMESIS,3
DK,HEADACHE,3
DK,JAW OPERATION,3
DK,PARALYSIS,3
DK,PNEUMONIA,3
DK,PSEUDOPORPHYRIA,3
DK,RHABDOMYOLYSIS,3
DK,SYNCOPE,3
DK,VOMITING,3
DK,ABDOMINAL PAIN,2
DK,ACUTE RESPIRATORY DISTRESS SYNDROME,2
DK,ANTICHOLINERGIC SYNDROME,2
DK,ASPIRATION,2
DK,ASTHENIA,2
DK,BLISTER,2
DK,CARDIAC ARREST,2
DK,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
DK,DEHYDRATION,2
DK,DELIRIUM,2
DK,DRUG INEFFECTIVE,2
DK,DRUG-INDUCED LIVER INJURY,2
DK,HAEMOGLOBIN DECREASED,2
DK,HYPERCALCAEMIA,2
DK,HYPOTONIA,2
DK,INFECTED SKIN ULCER,2
DK,IRRITABLE BOWEL SYNDROME,2
DK,LUNG INFECTION,2
DK,MALAISE,2
DK,METABOLIC ALKALOSIS,2
DK,PAIN,2
DK,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,2
DK,PULMONARY EMBOLISM,2
DK,RASH,2
DK,RASH MACULAR,2
DK,SKIN BURNING SENSATION,2
DK,SKIN ULCER,2
DK,SLEEP DISORDER,2
DK,SUICIDE ATTEMPT,2
DK,URINARY TRACT INFECTION,2
DK,WEIGHT INCREASED,2
DK,ACCIDENTAL OVERDOSE,1
DK,ACUTE KIDNEY INJURY,1
DK,ALANINE AMINOTRANSFERASE INCREASED,1
DK,ALKALOSIS,1
DK,ANAPHYLACTIC REACTION,1
DK,ANGIOEDEMA,1
DK,ASPHYXIA,1
DK,ATRIAL FLUTTER,1
DK,BLINDNESS,1
DK,BLOOD BILIRUBIN INCREASED,1
DK,BLOOD CREATINE INCREASED,1
DK,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
DK,BLOOD POTASSIUM INCREASED,1
DK,BLOOD PRESSURE DECREASED,1
DK,BLOOD PRESSURE INCREASED,1
DK,BRAIN HERNIATION,1
DK,BRAIN INJURY,1
DK,BRAIN MIDLINE SHIFT,1
DK,BRAIN OEDEMA,1
DK,BRAIN STEM SYNDROME,1
DK,C-REACTIVE PROTEIN INCREASED,1
DK,CARDIAC TAMPONADE,1
DK,CEREBELLAR HAEMORRHAGE,1
DK,CEREBRAL HAEMORRHAGE,1
DK,COLD SWEAT,1
DK,COMA,1
DK,CONCOMITANT DISEASE PROGRESSION,1
DK,CONFUSIONAL STATE,1
DK,CONSTIPATION,1
DK,CONTRAST MEDIA ALLERGY,1
DK,CREPITATIONS,1
DK,CYSTITIS,1
DK,CYTOKINE STORM,1
DK,DEPRESSED LEVEL OF CONSCIOUSNESS,1
DK,DERMATITIS ALLERGIC,1
DK,DEVICE DISLOCATION,1
DK,DEVICE LEAD ISSUE,1
DK,DIABETIC GASTROPATHY,1
DK,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
DK,DRUG DISPENSING ERROR,1
DK,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
DK,ENDOTRACHEAL INTUBATION,1
DK,EPISTAXIS,1
DK,ERYTHEMA,1
DK,EXPOSED BONE IN JAW,1
DK,EYE HAEMORRHAGE,1
DK,FEMORAL NECK FRACTURE,1
DK,FLUID OVERLOAD,1
DK,GAIT INABILITY,1
DK,GASTRIC ULCER,1
DK,GLOMERULAR FILTRATION RATE DECREASED,1
DK,HAEMORRHAGE INTRACRANIAL,1
DK,HEART RATE DECREASED,1
DK,HELICOBACTER INFECTION,1
DK,HEMIPARESIS,1
DK,HYDROCEPHALUS,1
DK,HYPERTENSION,1
DK,HYPOACUSIS,1
DK,ILEUS,1
DK,INCORRECT DOSE ADMINISTERED,1
DK,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,1
DK,INTERSTITIAL LUNG DISEASE,1
DK,INTRAVENTRICULAR HAEMORRHAGE,1
DK,LARGE INTESTINAL STENOSIS,1
DK,LEUKOCYTOSIS,1
DK,LUNG INFILTRATION,1
DK,LUNG NEOPLASM MALIGNANT,1
DK,LYMPHADENOPATHY,1
DK,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
DK,MYALGIA,1
DK,MYOCARDIAL INFARCTION,1
DK,NAUSEA,1
DK,NEOPLASM SKIN,1
DK,NEPHROGENIC SYSTEMIC FIBROSIS,1
DK,NYSTAGMUS,1
DK,OEDEMA,1
DK,OEDEMA PERIPHERAL,1
DK,ORTHOSTATIC HYPOTENSION,1
DK,OXYGEN SATURATION DECREASED,1
DK,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
DK,PARAESTHESIA,1
DK,PHOTOSENSITIVITY REACTION,1
DK,PORPHYRIA NON-ACUTE,1
DK,PRESYNCOPE,1
DK,PRODUCT USE ISSUE,1
DK,PUPILLARY REFLEX IMPAIRED,1
DK,RASH MACULO-PAPULAR,1
DK,RENAL FAILURE ACUTE,1
DK,RENAL IMPAIRMENT,1
DK,RESPIRATORY FAILURE,1
DK,SCAB,1
DK,SEIZURE,1
DK,SEPSIS,1
DK,SINUS BRADYCARDIA,1
DK,SINUS TACHYCARDIA,1
DK,SKIN DISORDER,1
DK,SKIN NECROSIS,1
DK,SKIN WOUND,1
DK,SQUAMOUS CELL CARCINOMA OF SKIN,1
DK,SUBCUTANEOUS ABSCESS,1
DK,SUDDEN CARDIAC DEATH,1
DK,SUPERIOR VENA CAVA SYNDROME,1
DK,TACHYCARDIA,1
DK,TOE AMPUTATION,1
DK,VENTRICULAR ARRHYTHMIA,1
DK,VENTRICULAR FIBRILLATION,1
DK,VENTRICULAR TACHYCARDIA,1
DK,WEIGHT DECREASED,1
DO,PRODUCT USE IN UNAPPROVED INDICATION,2
DO,ACUTE MYOCARDIAL INFARCTION,1
DO,ANAEMIA,1
DO,ATRIAL FIBRILLATION,1
DO,CARDIOGENIC SHOCK,1
DO,CHOLANGIOCARCINOMA,1
DO,DEHYDRATION,1
DO,DISEASE PROGRESSION,1
DO,DUODENAL ULCER,1
DO,GASTROINTESTINAL HAEMORRHAGE,1
DO,HEPATIC FAILURE,1
DO,HYPOKALAEMIA,1
DO,HYPOTENSION,1
DO,LARYNGEAL OEDEMA,1
DO,NEPHROCALCINOSIS,1
DO,PSEUDO-BARTTER SYNDROME,1
DO,SUDDEN DEATH,1
DO,TACHYCARDIA,1
DO,THROMBOSIS,1
EC,ABDOMINAL PAIN,4
EC,DYSPNOEA,4
EC,DEATH,3
EC,RENAL FAILURE,3
EC,SEPSIS,3
EC,ACUTE MYOCARDIAL INFARCTION,2
EC,BLOOD CREATININE INCREASED,2
EC,BLOOD UREA INCREASED,2
EC,COAGULATION TIME PROLONGED,2
EC,DIZZINESS,2
EC,DRUG INEFFECTIVE,2
EC,HEADACHE,2
EC,HYPOTENSION,2
EC,PULMONARY OEDEMA,2
EC,ANAEMIA,1
EC,ANGIOEDEMA,1
EC,AORTIC VALVE STENOSIS,1
EC,APHONIA,1
EC,BLOOD POTASSIUM INCREASED,1
EC,CARDIAC ARREST,1
EC,CARDIAC FAILURE,1
EC,CARDIAC FAILURE CONGESTIVE,1
EC,CARDIO-RESPIRATORY ARREST,1
EC,CHEST PAIN,1
EC,CHOLELITHIASIS,1
EC,CONTRAINDICATED PRODUCT ADMINISTERED,1
EC,DEEP VEIN THROMBOSIS,1
EC,DEMENTIA,1
EC,DIABETIC FOOT,1
EC,DISORIENTATION,1
EC,DYSPHONIA,1
EC,FACE OEDEMA,1
EC,FALL,1
EC,FATIGUE,1
EC,GASTROINTESTINAL HAEMORRHAGE,1
EC,GENERAL PHYSICAL HEALTH DETERIORATION,1
EC,GINGIVAL PAIN,1
EC,GLOMERULAR FILTRATION RATE DECREASED,1
EC,HAEMATOMA,1
EC,HEPATIC FAILURE,1
EC,HYPERCALCAEMIA,1
EC,HYPERTENSIVE CRISIS,1
EC,HYPONATRAEMIA,1
EC,LARYNGEAL CANCER,1
EC,LOSS OF CONSCIOUSNESS,1
EC,MALAISE,1
EC,MEMORY IMPAIRMENT,1
EC,METABOLIC DISORDER,1
EC,MITRAL VALVE STENOSIS,1
EC,MUSCULAR WEAKNESS,1
EC,NAUSEA,1
EC,NERVOUS SYSTEM DISORDER,1
EC,OCULAR HYPERTENSION,1
EC,PARAESTHESIA,1
EC,PERITONEAL DISORDER,1
EC,PERITONEAL EFFLUENT ABNORMAL,1
EC,PERITONITIS,1
EC,RENAL IMPAIRMENT,1
EC,RENAL TRANSPLANT,1
EC,SENSORY DISTURBANCE,1
EC,SYSTEMIC LUPUS ERYTHEMATOSUS,1
EC,TRANSPLANT,1
EC,URINARY TRACT INFECTION,1
EC,URINE SODIUM ABNORMAL,1
EC,VIRAL PHARYNGITIS,1
EC,VISION BLURRED,1
EC,VOMITING,1
EG,HYPOTENSION,3
EG,BLOOD GLUCOSE INCREASED,2
EG,CARDIAC ARREST,2
EG,DEATH,2
EG,ALTERED STATE OF CONSCIOUSNESS,1
EG,ANAEMIA,1
EG,ANAPHYLACTIC SHOCK,1
EG,BALLOON ATRIAL SEPTOSTOMY,1
EG,BIOPSY BONE MARROW,1
EG,BLOOD CREATININE INCREASED,1
EG,BLOOD GLUCOSE FLUCTUATION,1
EG,C-REACTIVE PROTEIN INCREASED,1
EG,CARDIAC FAILURE,1
EG,CARDIOGENIC SHOCK,1
EG,COMA HEPATIC,1
EG,DEVICE USE ERROR,1
EG,DIABETIC HYPERGLYCAEMIC COMA,1
EG,FEBRILE NEUTROPENIA,1
EG,GANGRENE,1
EG,GASTRIC VARICES,1
EG,HAEMATEMESIS,1
EG,HAEMORRHAGE,1
EG,HEPATIC CIRRHOSIS,1
EG,HYPERGLYCAEMIA,1
EG,HYPERTENSION,1
EG,INCORRECT DOSE ADMINISTERED BY DEVICE,1
EG,MEGAKARYOCYTE DESTRUCTION INCREASED,1
EG,MUSCLE ABSCESS,1
EG,NEUTROPENIA,1
EG,PLATELET MORPHOLOGY ABNORMAL,1
EG,POLYCYTHAEMIA,1
EG,RENAL FAILURE,1
EG,SEIZURE,1
EG,SEPSIS,1
EG,SPLENECTOMY,1
EG,THROMBOCYTOPENIA,1
EG,TREATMENT FAILURE,1
EG,VARICES OESOPHAGEAL,1
EG,VENTRICULAR FIBRILLATION,1
EG,VENTRICULAR SEPTAL DEFECT REPAIR,1
EG,VENTRICULAR TACHYCARDIA,1
SV,ALANINE AMINOTRANSFERASE INCREASED,1
SV,ASCITES,1
SV,ASPARTATE AMINOTRANSFERASE INCREASED,1
SV,BILIRUBIN CONJUGATED INCREASED,1
SV,BLOOD ALKALINE PHOSPHATASE INCREASED,1
SV,BLOOD BILIRUBIN INCREASED,1
SV,BLOOD BILIRUBIN UNCONJUGATED INCREASED,1
SV,BLOOD CREATININE ABNORMAL,1
SV,BLOOD FIBRINOGEN DECREASED,1
SV,BLOOD IRON DECREASED,1
SV,BLOOD LACTATE DEHYDROGENASE INCREASED,1
SV,BUNDLE BRANCH BLOCK LEFT,1
SV,CARDIAC FAILURE CONGESTIVE,1
SV,CARDIOMEGALY,1
SV,CARDIOMYOPATHY,1
SV,CHROMOSOME ANALYSIS ABNORMAL,1
SV,COAGULOPATHY,1
SV,DEATH,1
SV,ECCHYMOSIS,1
SV,END STAGE RENAL DISEASE,1
SV,FLUID OVERLOAD,1
SV,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
SV,HAEMATOTOXICITY,1
SV,HAEMATURIA,1
SV,HAEMOGLOBIN ABNORMAL,1
SV,HEART RATE DECREASED,1
SV,HEPATIC FAILURE,1
SV,HYPOKINESIA,1
SV,INTERNATIONAL NORMALISED RATIO DECREASED,1
SV,LYMPHOCYTE COUNT DECREASED,1
SV,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
SV,MYOCARDIAC ABSCESS,1
SV,NEUTROPHIL COUNT INCREASED,1
SV,OXYGEN SATURATION DECREASED,1
SV,PLATELET COUNT DECREASED,1
SV,PLEURAL EFFUSION,1
SV,PROTEIN TOTAL DECREASED,1
SV,PROTHROMBIN TIME PROLONGED,1
SV,RENAL DISORDER,1
SV,SKIN HAEMORRHAGE,1
SV,WHITE BLOOD CELL COUNT DECREASED,1
EE,BRADYCARDIA,3
EE,ABDOMINAL PAIN,2
EE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
EE,MALAISE,2
EE,ALANINE AMINOTRANSFERASE INCREASED,1
EE,ANXIETY,1
EE,ASPARTATE AMINOTRANSFERASE INCREASED,1
EE,ASTHENIA,1
EE,BLOOD ALKALINE PHOSPHATASE INCREASED,1
EE,BLOOD CREATININE INCREASED,1
EE,BLOOD UREA INCREASED,1
EE,BRAIN NATRIURETIC PEPTIDE INCREASED,1
EE,CANDIDA INFECTION,1
EE,CARDIAC ARREST,1
EE,CARDIAC FAILURE,1
EE,CEREBRAL HAEMORRHAGE,1
EE,CEREBROVASCULAR ACCIDENT,1
EE,CHOLESTASIS,1
EE,COMA,1
EE,CONFUSIONAL STATE,1
EE,COUGH,1
EE,DEATH,1
EE,DIARRHOEA,1
EE,DIZZINESS,1
EE,DYSPNOEA,1
EE,ELECTROCARDIOGRAM QT PROLONGED,1
EE,FLUID RETENTION,1
EE,HEAD DISCOMFORT,1
EE,HEPATIC ENZYME INCREASED,1
EE,HYPERTRANSAMINASAEMIA,1
EE,HYPOPHYSITIS,1
EE,HYPOPITUITARISM,1
EE,HYPOTENSION,1
EE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
EE,LUNG CANCER METASTATIC,1
EE,NAUSEA,1
EE,PALPITATIONS,1
EE,PERIORBITAL OEDEMA,1
EE,PNEUMONITIS,1
EE,PULMONARY OEDEMA,1
EE,PYREXIA,1
EE,RASH,1
EE,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
EE,SLEEP DISORDER,1
EE,URTICARIA,1
EE,VENTRICULAR EXTRASYSTOLES,1
SZ,MYOCARDIAL ISCHAEMIA,1
SZ,RASH MACULO-PAPULAR,1
SZ,RENAL FAILURE ACUTE,1
SZ,RESPIRATORY FAILURE,1
ET,HAEMORRHAGE,1
ET,INTERNATIONAL NORMALISED RATIO INCREASED,1
FI,HYPOGLYCAEMIA,13
FI,HYPOTHERMIA,13
FI,SEIZURE,12
FI,HYPOTENSION,8
FI,PNEUMONIA,8
FI,BRADYCARDIA,7
FI,LACTIC ACIDOSIS,6
FI,CONFUSIONAL STATE,5
FI,FALL,5
FI,HYPERKALAEMIA,5
FI,SOMNOLENCE,5
FI,BLOOD GLUCOSE INCREASED,4
FI,BLOOD PH DECREASED,4
FI,UNRESPONSIVE TO STIMULI,4
FI,URINARY TRACT INFECTION,4
FI,CARDIAC DISORDER,3
FI,ELECTROCARDIOGRAM ABNORMAL,3
FI,MUSCLE RIGIDITY,3
FI,MUSCULAR WEAKNESS,3
FI,RENAL FAILURE,3
FI,ACUTE KIDNEY INJURY,2
FI,APGAR SCORE LOW,2
FI,BLOOD CREATININE INCREASED,2
FI,BLOOD LACTIC ACID INCREASED,2
FI,CARDIAC FAILURE,2
FI,DEATH,2
FI,DEATH NEONATAL,2
FI,DYSARTHRIA,2
FI,DYSPNOEA,2
FI,EXPOSURE DURING PREGNANCY,2
FI,FOETAL EXPOSURE DURING PREGNANCY,2
FI,FOETAL GROWTH RESTRICTION,2
FI,HAEMOGLOBIN DECREASED,2
FI,HEART RATE ABNORMAL,2
FI,LOW BIRTH WEIGHT BABY,2
FI,MATERNAL EXPOSURE DURING PREGNANCY,2
FI,MUSCULOSKELETAL STIFFNESS,2
FI,PLACENTAL INSUFFICIENCY,2
FI,PREMATURE BABY,2
FI,RENAL IMPAIRMENT,2
FI,SEPSIS,2
FI,UROSEPSIS,2
FI,ABDOMINAL DISCOMFORT,1
FI,ABDOMINAL PAIN UPPER,1
FI,ABDOMINAL TENDERNESS,1
FI,ABSCESS ORAL,1
FI,ACIDOSIS,1
FI,APLASIA PURE RED CELL,1
FI,BASAL GANGLIA HAEMORRHAGE,1
FI,BASE EXCESS NEGATIVE,1
FI,BLOOD BICARBONATE DECREASED,1
FI,BLOOD POTASSIUM INCREASED,1
FI,BLOOD UREA INCREASED,1
FI,BRAIN STEM INFARCTION,1
FI,CAESAREAN SECTION,1
FI,CAPILLARY LEAK SYNDROME,1
FI,CEREBRAL INFARCTION,1
FI,CEREBROVASCULAR ACCIDENT,1
FI,CONDITION AGGRAVATED,1
FI,CUTANEOUS SYMPTOM,1
FI,DEHYDRATION,1
FI,DIALYSIS,1
FI,DIARRHOEA,1
FI,DISSEMINATED INTRAVASCULAR COAGULATION,1
FI,DRUG EFFECT DECREASED,1
FI,DRUG INEFFECTIVE,1
FI,DYSLIPIDAEMIA,1
FI,DYSSTASIA,1
FI,DYSURIA,1
FI,ELECTROCARDIOGRAM QT PROLONGED,1
FI,EXOSTOSIS OF JAW,1
FI,FATIGUE,1
FI,FEELING ABNORMAL,1
FI,HAEMATOMA,1
FI,HAEMOLYSIS,1
FI,HAEMOLYTIC URAEMIC SYNDROME,1
FI,HEART RATE IRREGULAR,1
FI,HELLP SYNDROME,1
FI,HEPATIC ENZYME INCREASED,1
FI,HEPATOTOXICITY,1
FI,HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL,1
FI,HYPERGLYCAEMIA,1
FI,HYPERTENSION,1
FI,HYPOTHYROIDISM,1
FI,HYPOXIA,1
FI,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,1
FI,INFECTION,1
FI,INFLUENZA A VIRUS TEST POSITIVE,1
FI,INTERNATIONAL NORMALISED RATIO INCREASED,1
FI,JAUNDICE,1
FI,MATERNAL DRUGS AFFECTING FOETUS,1
FI,MELAENA,1
FI,NERVOUS SYSTEM DISORDER,1
FI,OEDEMA PERIPHERAL,1
FI,OESOPHAGEAL CANDIDIASIS,1
FI,OESOPHAGEAL HAEMORRHAGE,1
FI,OXYGEN SATURATION DECREASED,1
FI,PANCREATITIS ACUTE,1
FI,PANCREATITIS CHRONIC,1
FI,PHARYNGEAL ABSCESS,1
FI,PLACENTA PRAEVIA HAEMORRHAGE,1
FI,PNEUMONIA ASPIRATION,1
FI,PRE-ECLAMPSIA,1
FI,PRESCRIBED UNDERDOSE,1
FI,PROSTATE CANCER,1
FI,PULMONARY OEDEMA,1
FI,PYREXIA,1
FI,RESPIRATORY TRACT INFECTION,1
FI,SPEECH DISORDER,1
FI,TOOTH INFECTION,1
FI,TREMOR,1
FI,URINE OUTPUT DECREASED,1
FI,VISUAL IMPAIRMENT,1
FR,ACUTE KIDNEY INJURY,482
FR,FALL,227
FR,CARDIAC FAILURE,191
FR,ANAEMIA,181
FR,HYPOTENSION,158
FR,RENAL FAILURE,156
FR,DIARRHOEA,155
FR,HYPERKALAEMIA,143
FR,DYSPNOEA,140
FR,HYPONATRAEMIA,137
FR,OVERDOSE,124
FR,INTERNATIONAL NORMALISED RATIO INCREASED,122
FR,THROMBOCYTOPENIA,122
FR,CONFUSIONAL STATE,104
FR,DEHYDRATION,100
FR,CHOLESTASIS,98
FR,BRADYCARDIA,97
FR,RENAL FAILURE ACUTE,96
FR,ASTHENIA,93
FR,GENERAL PHYSICAL HEALTH DETERIORATION,87
FR,MALAISE,81
FR,VOMITING,80
FR,HEPATOCELLULAR INJURY,77
FR,HYPOKALAEMIA,75
FR,OEDEMA PERIPHERAL,74
FR,PRURITUS,74
FR,EOSINOPHILIA,73
FR,RECTAL HAEMORRHAGE,72
FR,DEATH,71
FR,HAEMATOMA,70
FR,PANCYTOPENIA,69
FR,RASH MACULO-PAPULAR,69
FR,SOMNOLENCE,68
FR,SEPSIS,66
FR,LACTIC ACIDOSIS,61
FR,MELAENA,61
FR,PYREXIA,61
FR,NAUSEA,60
FR,ATRIAL FIBRILLATION,56
FR,NEUTROPENIA,54
FR,AGRANULOCYTOSIS,53
FR,SEPTIC SHOCK,52
FR,RHABDOMYOLYSIS,51
FR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,50
FR,INTERSTITIAL LUNG DISEASE,50
FR,CARDIAC ARREST,49
FR,LUNG DISORDER,48
FR,PLEURAL EFFUSION,48
FR,TOXIC SKIN ERUPTION,48
FR,ACUTE PULMONARY OEDEMA,46
FR,CONDITION AGGRAVATED,46
FR,DECREASED APPETITE,46
FR,CARDIO-RESPIRATORY ARREST,44
FR,DRUG INEFFECTIVE,44
FR,RASH,44
FR,ISCHAEMIC STROKE,43
FR,HYPOGLYCAEMIA,42
FR,SHOCK HAEMORRHAGIC,42
FR,SUBDURAL HAEMATOMA,42
FR,BLOOD CREATININE INCREASED,41
FR,ABDOMINAL PAIN,40
FR,ENCEPHALOPATHY,40
FR,HAEMATURIA,40
FR,RESPIRATORY DISTRESS,40
FR,DISORIENTATION,38
FR,EPISTAXIS,38
FR,WEIGHT DECREASED,38
FR,ERYTHEMA,37
FR,ANGIOEDEMA,36
FR,COMA,36
FR,TOXICITY TO VARIOUS AGENTS,36
FR,ELECTROCARDIOGRAM QT PROLONGED,35
FR,PULMONARY EMBOLISM,34
FR,CEREBRAL HAEMATOMA,33
FR,LOSS OF CONSCIOUSNESS,32
FR,PNEUMONIA,32
FR,FATIGUE,31
FR,HAEMOGLOBIN DECREASED,31
FR,RENAL IMPAIRMENT,31
FR,ACUTE PRERENAL FAILURE,30
FR,ECZEMA,30
FR,GASTROINTESTINAL HAEMORRHAGE,30
FR,HEPATITIS,30
FR,ARTHRALGIA,29
FR,HEPATIC ENCEPHALOPATHY,29
FR,HYPERTHERMIA,29
FR,CARDIOGENIC SHOCK,28
FR,CEREBRAL HAEMORRHAGE,28
FR,METABOLIC ACIDOSIS,28
FR,ORTHOSTATIC HYPOTENSION,27
FR,JAUNDICE,26
FR,MUSCLE HAEMORRHAGE,26
FR,COLITIS,25
FR,PULMONARY OEDEMA,25
FR,BONE MARROW FAILURE,24
FR,CHEST PAIN,24
FR,GENERALISED OEDEMA,24
FR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,24
FR,ALTERED STATE OF CONSCIOUSNESS,23
FR,HALLUCINATION,23
FR,OEDEMA,23
FR,RESPIRATORY FAILURE,23
FR,VERTIGO,23
FR,DERMATITIS EXFOLIATIVE,22
FR,HEAD INJURY,22
FR,HEPATIC FAILURE,22
FR,DISTURBANCE IN ATTENTION,21
FR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,21
FR,HEADACHE,21
FR,PACKED RED BLOOD CELL TRANSFUSION,21
FR,PURPURA,21
FR,TOXIC EPIDERMAL NECROLYSIS,21
FR,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,20
FR,CARDIOACTIVE DRUG LEVEL INCREASED,20
FR,CHRONIC KIDNEY DISEASE,20
FR,COUGH,20
FR,INFLAMMATION,20
FR,TACHYCARDIA,20
FR,ACUTE RESPIRATORY DISTRESS SYNDROME,19
FR,AGITATION,19
FR,ASCITES,19
FR,DERMATITIS BULLOUS,19
FR,HYPERNATRAEMIA,19
FR,HYPOTHERMIA,19
FR,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,19
FR,PAIN,19
FR,PANCREATITIS ACUTE,19
FR,RASH ERYTHEMATOUS,19
FR,RENAL TUBULAR NECROSIS,19
FR,SYNCOPE,19
FR,ARRHYTHMIA,18
FR,CELL DEATH,18
FR,CONSTIPATION,18
FR,DIZZINESS,18
FR,HAEMORRHAGE,18
FR,HYPOCALCAEMIA,18
FR,MULTI-ORGAN FAILURE,18
FR,PNEUMONIA ASPIRATION,18
FR,PULMONARY FIBROSIS,18
FR,ACUTE CORONARY SYNDROME,17
FR,GAIT DISTURBANCE,17
FR,HAEMATEMESIS,17
FR,LUNG INFECTION,17
FR,PEMPHIGOID,17
FR,RASH MACULAR,17
FR,TRANSFUSION,17
FR,VENTRICULAR TACHYCARDIA,17
FR,ACUTE RESPIRATORY FAILURE,16
FR,ALANINE AMINOTRANSFERASE INCREASED,16
FR,ANURIA,16
FR,BLOOD BILIRUBIN INCREASED,16
FR,DEEP VEIN THROMBOSIS,16
FR,HYPERGLYCAEMIA,16
FR,INFECTION,16
FR,PULMONARY ARTERIAL HYPERTENSION,16
FR,PYELONEPHRITIS,16
FR,URINARY TRACT INFECTION,16
FR,WEIGHT INCREASED,16
FR,ABDOMINAL PAIN UPPER,15
FR,ACCIDENTAL OVERDOSE,15
FR,ACUTE MOTOR-SENSORY AXONAL NEUROPATHY,15
FR,ASPARTATE AMINOTRANSFERASE INCREASED,15
FR,DIABETES MELLITUS,15
FR,DIABETES MELLITUS INADEQUATE CONTROL,15
FR,HAEMORRHAGIC ANAEMIA,15
FR,HYPOVOLAEMIC SHOCK,15
FR,MANIA,15
FR,MEDICATION ERROR,15
FR,STATUS EPILEPTICUS,15
FR,TUBULOINTERSTITIAL NEPHRITIS,15
FR,BLOOD ALKALINE PHOSPHATASE INCREASED,14
FR,GLOMERULAR FILTRATION RATE DECREASED,14
FR,HEPATIC ENZYME INCREASED,14
FR,HEPATITIS CHOLESTATIC,14
FR,HYPERAMMONAEMIA,14
FR,HYPERSENSITIVITY VASCULITIS,14
FR,HYPOXIA,14
FR,INCORRECT DOSE ADMINISTERED,14
FR,OBSESSIVE-COMPULSIVE DISORDER,14
FR,PAIN IN EXTREMITY,14
FR,PRODUCT USE IN UNAPPROVED INDICATION,14
FR,PRODUCT USE ISSUE,14
FR,SPEECH DISORDER,14
FR,TRANSAMINASES INCREASED,14
FR,URINARY RETENTION,14
FR,URTICARIA,14
FR,BALANCE DISORDER,13
FR,CEREBROVASCULAR ACCIDENT,13
FR,CHILLS,13
FR,DYSPHAGIA,13
FR,DYSPNOEA EXERTIONAL,13
FR,EOSINOPHILIC PNEUMONIA,13
FR,EXTRAPYRAMIDAL DISORDER,13
FR,FEBRILE NEUTROPENIA,13
FR,HEPATOCELLULAR CARCINOMA,13
FR,HYPERTENSION,13
FR,HYPOMAGNESAEMIA,13
FR,INSOMNIA,13
FR,MALIGNANT NEOPLASM PROGRESSION,13
FR,PALPITATIONS,13
FR,RESTLESSNESS,13
FR,SEIZURE,13
FR,TRANSIENT ISCHAEMIC ATTACK,13
FR,ALVEOLAR LUNG DISEASE,12
FR,DIFFUSE ALVEOLAR DAMAGE,12
FR,DRUG ADMINISTRATION ERROR,12
FR,DRUG LEVEL INCREASED,12
FR,DYSKINESIA,12
FR,EPILEPSY,12
FR,ERYSIPELAS,12
FR,HEPATITIS FULMINANT,12
FR,HYPERTHYROIDISM,12
FR,LEUKOPENIA,12
FR,NEPHROCALCINOSIS,12
FR,OXYGEN SATURATION DECREASED,12
FR,PLATELET COUNT DECREASED,12
FR,TREMOR,12
FR,ANAPHYLACTIC SHOCK,11
FR,ATRIOVENTRICULAR BLOCK,11
FR,C-REACTIVE PROTEIN INCREASED,11
FR,CARDIAC FAILURE CONGESTIVE,11
FR,DYSARTHRIA,11
FR,GASTROINTESTINAL DISORDER,11
FR,HAEMARTHROSIS,11
FR,MUSCLE SPASMS,11
FR,MYOCARDIAL INFARCTION,11
FR,MYOCLONUS,11
FR,PLEURISY,11
FR,PULMONARY HYPERTENSION,11
FR,PULMONARY INTERSTITIAL EMPHYSEMA SYNDROME,11
FR,RASH MORBILLIFORM,11
FR,RENAL FAILURE CHRONIC,11
FR,SHOCK,11
FR,SUDDEN DEATH,11
FR,ATRIOVENTRICULAR BLOCK FIRST DEGREE,10
FR,BACK PAIN,10
FR,BLISTER,10
FR,CONGESTIVE CARDIOMYOPATHY,10
FR,CONVULSION,10
FR,CYANOSIS,10
FR,DEPRESSED LEVEL OF CONSCIOUSNESS,10
FR,DEPRESSION,10
FR,ECCHYMOSIS,10
FR,FACE OEDEMA,10
FR,FEBRILE BONE MARROW APLASIA,10
FR,GASTRIC ULCER,10
FR,GENERAL PHYSICAL CONDITION ABNORMAL,10
FR,HAEMODYNAMIC INSTABILITY,10
FR,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,10
FR,MALNUTRITION,10
FR,NEPHROTIC SYNDROME,10
FR,PERITONITIS,10
FR,TORSADE DE POINTES,10
FR,ATRIOVENTRICULAR BLOCK COMPLETE,9
FR,BRONCHITIS,9
FR,CARDIAC FAILURE ACUTE,9
FR,CIRCULATORY COLLAPSE,9
FR,DRUG INTOLERANCE,9
FR,HAEMOPTYSIS,9
FR,HEPATITIS ACUTE,9
FR,HYPERBILIRUBINAEMIA,9
FR,HYPERCALCAEMIA,9
FR,HYPERTRIGLYCERIDAEMIA,9
FR,IRON DEFICIENCY ANAEMIA,9
FR,LIVER INJURY,9
FR,MUCOSAL INFLAMMATION,9
FR,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,9
FR,PARAESTHESIA,9
FR,PERICARDIAL EFFUSION,9
FR,PYELONEPHRITIS ACUTE,9
FR,RESPIRATORY DISORDER,9
FR,SKIN EXFOLIATION,9
FR,VISUAL ACUITY REDUCED,9
FR,ABNORMAL BEHAVIOUR,8
FR,CLOSTRIDIUM DIFFICILE COLITIS,8
FR,COGNITIVE DISORDER,8
FR,CRANIOCEREBRAL INJURY,8
FR,CREATININE RENAL CLEARANCE DECREASED,8
FR,DELIRIUM,8
FR,DRUG-INDUCED LIVER INJURY,8
FR,ELECTROCARDIOGRAM ABNORMAL,8
FR,HALLUCINATION_ VISUAL,8
FR,HEPATIC CIRRHOSIS,8
FR,HYPERSENSITIVITY,8
FR,LICHENOID KERATOSIS,8
FR,LIPASE INCREASED,8
FR,NORMOCHROMIC NORMOCYTIC ANAEMIA,8
FR,OLIGURIA,8
FR,PERICARDITIS,8
FR,PERSECUTORY DELUSION,8
FR,PSYCHOMOTOR HYPERACTIVITY,8
FR,RALES,8
FR,STOMATITIS,8
FR,VASCULAR PURPURA,8
FR,AGGRESSION,7
FR,AMNESIA,7
FR,BRONCHOSPASM,7
FR,BUNDLE BRANCH BLOCK RIGHT,7
FR,CARDIOPULMONARY FAILURE,7
FR,CELLULITIS,7
FR,DISINHIBITION,7
FR,DISORGANISED SPEECH,7
FR,ESCHERICHIA INFECTION,7
FR,HAEMOLYTIC ANAEMIA,7
FR,HAEMORRHAGE SUBCUTANEOUS,7
FR,HEMIPLEGIA,7
FR,HEPARIN-INDUCED THROMBOCYTOPENIA,7
FR,HYPERHIDROSIS,7
FR,HYPERLACTACIDAEMIA,7
FR,HYPOVOLAEMIA,7
FR,ILEUS PARALYTIC,7
FR,LOGORRHOEA,7
FR,MITRAL VALVE INCOMPETENCE,7
FR,MUSCULAR WEAKNESS,7
FR,PERIPHERAL ISCHAEMIA,7
FR,PULMONARY ALVEOLAR HAEMORRHAGE,7
FR,RASH PAPULAR,7
FR,RENAL TUBULAR DISORDER,7
FR,SKIN NECROSIS,7
FR,SUBCUTANEOUS HAEMATOMA,7
FR,TACHYPNOEA,7
FR,THROMBOTIC MICROANGIOPATHY,7
FR,TONIC CLONIC MOVEMENTS,7
FR,ABDOMINAL DISTENSION,6
FR,ALOPECIA,6
FR,ANGINA PECTORIS,6
FR,BLOOD CULTURE POSITIVE,6
FR,BLOOD PRESSURE DECREASED,6
FR,BRONCHOPNEUMOPATHY,6
FR,BUNDLE BRANCH BLOCK LEFT,6
FR,CACHEXIA,6
FR,CRYSTALLURIA,6
FR,DISSEMINATED INTRAVASCULAR COAGULATION,6
FR,DRUG PRESCRIBING ERROR,6
FR,DRY MOUTH,6
FR,EJECTION FRACTION DECREASED,6
FR,ESCHERICHIA SEPSIS,6
FR,FOETAL EXPOSURE DURING PREGNANCY,6
FR,HAEMORRHAGIC STROKE,6
FR,HYPERCALCIURIA,6
FR,HYPOALBUMINAEMIA,6
FR,HYPOTHYROIDISM,6
FR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,6
FR,LEFT VENTRICULAR FAILURE,6
FR,LIVER DISORDER,6
FR,LYMPHADENOPATHY,6
FR,MICROCYTIC ANAEMIA,6
FR,MIOSIS,6
FR,MOBILITY DECREASED,6
FR,NERVOUS SYSTEM DISORDER,6
FR,PANCREATITIS,6
FR,PETECHIAE,6
FR,PLASMA CELL MYELOMA,6
FR,PNEUMOCYSTIS JIROVECII PNEUMONIA,6
FR,PRERENAL FAILURE,6
FR,PRURITUS GENERALISED,6
FR,SEROTONIN SYNDROME,6
FR,SINUS BRADYCARDIA,6
FR,SKIN LESION,6
FR,SKIN ULCER,6
FR,SPLENOMEGALY,6
FR,SPONTANEOUS HAEMATOMA,6
FR,SUBARACHNOID HAEMORRHAGE,6
FR,TACHYPHRENIA,6
FR,TONGUE OEDEMA,6
FR,VARICES OESOPHAGEAL,6
FR,VISUAL IMPAIRMENT,6
FR,ANXIETY,5
FR,APHASIA,5
FR,APLASIA,5
FR,BACTERAEMIA,5
FR,BILIRUBIN CONJUGATED INCREASED,5
FR,BLOOD CREATINE INCREASED,5
FR,BLOOD POTASSIUM INCREASED,5
FR,CARDIAC DISORDER,5
FR,CHOLELITHIASIS,5
FR,CLOSTRIDIUM DIFFICILE INFECTION,5
FR,CONTRAINDICATED PRODUCT ADMINISTERED,5
FR,DEVICE RELATED INFECTION,5
FR,DISEASE PROGRESSION,5
FR,DRUG ABUSE,5
FR,DRUG DEPENDENCE,5
FR,DRUG ERUPTION,5
FR,DYSPHONIA,5
FR,DYSURIA,5
FR,ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY,5
FR,ELECTROLYTE IMBALANCE,5
FR,FLUID OVERLOAD,5
FR,GASTRITIS,5
FR,GASTROINTESTINAL STOMA COMPLICATION,5
FR,GENERALISED ERYTHEMA,5
FR,HAEMOTHORAX,5
FR,HYPOGLYCAEMIC COMA,5
FR,INCORRECT ROUTE OF DRUG ADMINISTRATION,5
FR,INTRA-ABDOMINAL HAEMATOMA,5
FR,KLEBSIELLA INFECTION,5
FR,LEUKOCYTOSIS,5
FR,LOCALISED OEDEMA,5
FR,MORGANELLA INFECTION,5
FR,MOUTH HAEMORRHAGE,5
FR,NEPHROPATHY,5
FR,NEUROLEPTIC MALIGNANT SYNDROME,5
FR,OSTEONECROSIS OF JAW,5
FR,PALLOR,5
FR,PERICARDIAL HAEMORRHAGE,5
FR,PERIORBITAL HAEMATOMA,5
FR,PERITONEAL HAEMORRHAGE,5
FR,POLYURIA,5
FR,PREMATURE BABY,5
FR,PROTEINURIA,5
FR,PSYCHOMOTOR SKILLS IMPAIRED,5
FR,RASH GENERALISED,5
FR,SPINAL PAIN,5
FR,TUMOUR LYSIS SYNDROME,5
FR,UPPER GASTROINTESTINAL HAEMORRHAGE,5
FR,WOUND,5
FR,WRONG STRENGTH,5
FR,ABDOMINAL WALL HAEMATOMA,4
FR,ANGIODYSPLASIA,4
FR,ASPERGILLUS INFECTION,4
FR,ATRIAL THROMBOSIS,4
FR,BACTERIAL SEPSIS,4
FR,BLOOD CREATINE PHOSPHOKINASE INCREASED,4
FR,BLOOD GLUCOSE INCREASED,4
FR,BLOOD LACTATE DEHYDROGENASE INCREASED,4
FR,BLOOD LACTIC ACID INCREASED,4
FR,BLOOD THYROID STIMULATING HORMONE INCREASED,4
FR,BLOOD UREA INCREASED,4
FR,BRONCHIAL OBSTRUCTION,4
FR,BURNING SENSATION,4
FR,CEREBRAL ARTERY THROMBOSIS,4
FR,CHRONIC RESPIRATORY FAILURE,4
FR,CLONUS,4
FR,COLITIS MICROSCOPIC,4
FR,CONJUNCTIVAL HAEMORRHAGE,4
FR,CONJUNCTIVITIS,4
FR,CYTOMEGALOVIRUS INFECTION,4
FR,DERMATITIS,4
FR,DERMATITIS EXFOLIATIVE GENERALISED,4
FR,DIALYSIS,4
FR,DIVERTICULUM,4
FR,DIVERTICULUM INTESTINAL,4
FR,DRUG DISPENSING ERROR,4
FR,DRUG LEVEL ABOVE THERAPEUTIC,4
FR,DRUG WITHDRAWAL SYNDROME,4
FR,DUODENITIS,4
FR,DYSSTASIA,4
FR,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,4
FR,ENDOCARDITIS,4
FR,ENDOCARDITIS STAPHYLOCOCCAL,4
FR,ENTEROBACTER INFECTION,4
FR,EOSINOPHIL COUNT INCREASED,4
FR,FAECES DISCOLOURED,4
FR,FEMUR FRACTURE,4
FR,FIXED ERUPTION,4
FR,FOLATE DEFICIENCY,4
FR,FRACTURE,4
FR,GASTRIC HAEMORRHAGE,4
FR,GASTROINTESTINAL NECROSIS,4
FR,GLYCOSYLATED HAEMOGLOBIN INCREASED,4
FR,GOUT,4
FR,HAEMOLYSIS,4
FR,HALLUCINATION_ AUDITORY,4
FR,HEPATIC FUNCTION ABNORMAL,4
FR,HERPES ZOSTER,4
FR,HIP FRACTURE,4
FR,HYPOCHROMIC ANAEMIA,4
FR,HYPOPROTHROMBINAEMIA,4
FR,IMMUNE THROMBOCYTOPENIC PURPURA,4
FR,INCOHERENT,4
FR,INTENTIONAL PRODUCT MISUSE,4
FR,INTERNATIONAL NORMALISED RATIO DECREASED,4
FR,JOINT DISLOCATION,4
FR,LINEAR IGA DISEASE,4
FR,LYMPHOCYTE COUNT DECREASED,4
FR,LYMPHOPENIA,4
FR,MATERNAL EXPOSURE DURING PREGNANCY,4
FR,METABOLIC ENCEPHALOPATHY,4
FR,MIXED LIVER INJURY,4
FR,MYDRIASIS,4
FR,MYOCARDIAL ISCHAEMIA,4
FR,NECROSIS,4
FR,NEPHROPATHY TOXIC,4
FR,OCULAR ICTERUS,4
FR,PHLEBITIS DEEP,4
FR,POST PROCEDURAL HAEMORRHAGE,4
FR,PRODUCT QUALITY ISSUE,4
FR,PRODUCT SUBSTITUTION ISSUE,4
FR,PROTHROMBIN TIME RATIO DECREASED,4
FR,PRURIGO,4
FR,PSEUDOMONAS INFECTION,4
FR,RASH PRURITIC,4
FR,RED BLOOD CELL COUNT DECREASED,4
FR,ROTATOR CUFF SYNDROME,4
FR,SINUSITIS,4
FR,STAPHYLOCOCCAL SEPSIS,4
FR,SUICIDAL IDEATION,4
FR,THERAPEUTIC RESPONSE DECREASED,4
FR,THERAPY CESSATION,4
FR,TREATMENT FAILURE,4
FR,TROPONIN INCREASED,4
FR,VENOOCCLUSIVE LIVER DISEASE,4
FR,WHITE BLOOD CELL COUNT INCREASED,4
FR,WOUND HAEMORRHAGE,4
FR,ABASIA,3
FR,ABDOMINAL CAVITY DRAINAGE,3
FR,ABNORMAL FAECES,3
FR,ACIDOSIS,3
FR,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,3
FR,ADENOCARCINOMA OF COLON,3
FR,ADRENAL INSUFFICIENCY,3
FR,ADVERSE EVENT,3
FR,ANAEMIA MACROCYTIC,3
FR,ANAPHYLACTOID SHOCK,3
FR,ANTIBIOTIC LEVEL ABOVE THERAPEUTIC,3
FR,APATHY,3
FR,ARTERIAL DISORDER,3
FR,ATRIAL FLUTTER,3
FR,ATRIAL TACHYCARDIA,3
FR,BACTERIAL PYELONEPHRITIS,3
FR,BASAL CELL CARCINOMA,3
FR,BLAST CELL COUNT INCREASED,3
FR,BLOOD LACTIC ACID,3
FR,BRAIN INJURY,3
FR,BRONCHOPULMONARY ASPERGILLOSIS,3
FR,BUNDLE BRANCH BLOCK,3
FR,CALCULUS URINARY,3
FR,CARDIAC FAILURE CHRONIC,3
FR,CARDIAC TAMPONADE,3
FR,CARDIOMYOPATHY,3
FR,CEREBRAL INFARCTION,3
FR,CHEST DISCOMFORT,3
FR,COAGULOPATHY,3
FR,COLITIS ISCHAEMIC,3
FR,COLORECTAL ADENOCARCINOMA,3
FR,COMMUNICATION DISORDER,3
FR,CONCOMITANT DISEASE AGGRAVATED,3
FR,CREPITATIONS,3
FR,CUTANEOUS LUPUS ERYTHEMATOSUS,3
FR,CUTANEOUS VASCULITIS,3
FR,DERMO-HYPODERMITIS,3
FR,DIPLOPIA,3
FR,DRUG DIVERSION,3
FR,DRUG HYPERSENSITIVITY,3
FR,DUODENAL ULCER,3
FR,DYSGEUSIA,3
FR,DYSPNOEA AT REST,3
FR,ELECTROENCEPHALOGRAM ABNORMAL,3
FR,EMPHYSEMA,3
FR,ENTEROCOCCAL INFECTION,3
FR,EXTRA DOSE ADMINISTERED,3
FR,EXTRADURAL HAEMATOMA,3
FR,EYE PAIN,3
FR,EYELID MYOCLONUS,3
FR,FAECALOMA,3
FR,FASCIITIS,3
FR,FEMORAL NECK FRACTURE,3
FR,FLUID RETENTION,3
FR,FUNGAL INFECTION,3
FR,GASTRIC POLYPS,3
FR,GASTROINTESTINAL ANGIODYSPLASIA,3
FR,GASTROINTESTINAL MOTILITY DISORDER,3
FR,HAEMATOCHEZIA,3
FR,HAEMORRHAGIC DISORDER,3
FR,HALLUCINATIONS_ MIXED,3
FR,HEMIPARESIS,3
FR,HEPATIC HAEMATOMA,3
FR,HEPATIC HAEMORRHAGE,3
FR,HEPATIC STEATOSIS,3
FR,HEPATOMEGALY,3
FR,HISTIOCYTOSIS HAEMATOPHAGIC,3
FR,HOT FLUSH,3
FR,HUMERUS FRACTURE,3
FR,HYPERCAPNIA,3
FR,HYPOGAMMAGLOBULINAEMIA,3
FR,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,3
FR,INFLUENZA,3
FR,INFUSION RELATED REACTION,3
FR,INJURY,3
FR,INTERNATIONAL NORMALISED RATIO FLUCTUATION,3
FR,INTESTINAL HAEMORRHAGE,3
FR,INTESTINAL ISCHAEMIA,3
FR,JAUNDICE CHOLESTATIC,3
FR,JOINT INJURY,3
FR,LARGE INTESTINE PERFORATION,3
FR,LIP OEDEMA,3
FR,LYMPHANGITIS,3
FR,LYMPHOCYTE COUNT INCREASED,3
FR,LYMPHOCYTOSIS,3
FR,MELANODERMA,3
FR,MEMORY IMPAIRMENT,3
FR,MOUTH ULCERATION,3
FR,MYALGIA,3
FR,MYELODYSPLASTIC SYNDROME,3
FR,MYOCARDITIS,3
FR,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED,3
FR,NEPHROLITHIASIS,3
FR,NEUROLOGICAL DECOMPENSATION,3
FR,NEUROPATHY PERIPHERAL,3
FR,NIGHTMARE,3
FR,ORGANISING PNEUMONIA,3
FR,ORTHOPNOEA,3
FR,PAIN IN JAW,3
FR,PANCREATITIS NECROTISING,3
FR,PERIPHERAL VENOUS DISEASE,3
FR,PHOTOSENSITIVITY REACTION,3
FR,PNEUMONITIS,3
FR,PREMATURE LABOUR,3
FR,PRESCRIBED UNDERDOSE,3
FR,PROSTATITIS,3
FR,PROTHROMBIN TIME SHORTENED,3
FR,PSORIASIS,3
FR,PULMONARY MASS,3
FR,RASH SCARLATINIFORM,3
FR,RECTOSIGMOID CANCER,3
FR,RENAL HAEMATOMA,3
FR,RESPIRATORY ARREST,3
FR,RETROPERITONEAL HAEMATOMA,3
FR,RHINITIS,3
FR,RIB FRACTURE,3
FR,RIGHT VENTRICULAR FAILURE,3
FR,SCAB,3
FR,SCIATICA,3
FR,SENSE OF OPPRESSION,3
FR,SINUS NODE DYSFUNCTION,3
FR,SJOGREN^S SYNDROME,3
FR,SKIN INFECTION,3
FR,SKIN TOXICITY,3
FR,SKULL FRACTURE,3
FR,SLEEP DISORDER,3
FR,SPLENIC HAEMATOMA,3
FR,STAPHYLOCOCCAL INFECTION,3
FR,STREPTOCOCCAL INFECTION,3
FR,STRESS CARDIOMYOPATHY,3
FR,SUBILEUS,3
FR,SURGERY,3
FR,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,3
FR,THROMBOPHLEBITIS SUPERFICIAL,3
FR,THROMBOSIS,3
FR,TINNITUS,3
FR,TRANSPLANT REJECTION,3
FR,ULCER,3
FR,ULCER HAEMORRHAGE,3
FR,VENOUS THROMBOSIS,3
FR,VENOUS THROMBOSIS LIMB,3
FR,VENTRICULAR ARRHYTHMIA,3
FR,VENTRICULAR EXTRASYSTOLES,3
FR,VISION BLURRED,3
FR,VITAMIN B12 DEFICIENCY,3
FR,WRONG DRUG ADMINISTERED,3
FR,ABSCESS,2
FR,ACCIDENTAL POISONING,2
FR,ACNE,2
FR,ACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,2
FR,ACUTE MYELOID LEUKAEMIA,2
FR,ACUTE MYOCARDIAL INFARCTION,2
FR,ADENOCARCINOMA PANCREAS,2
FR,AFFECTIVE DISORDER,2
FR,ALVEOLITIS,2
FR,AMMONIA INCREASED,2
FR,ANAL FISSURE,2
FR,ANGINA UNSTABLE,2
FR,ANTIDIURETIC HORMONE ABNORMALITY,2
FR,ANTIPSYCHOTIC DRUG LEVEL INCREASED,2
FR,AORTIC DILATATION,2
FR,AORTIC VALVE INCOMPETENCE,2
FR,AORTIC VALVE STENOSIS,2
FR,AREFLEXIA,2
FR,ARTERITIS,2
FR,ARTHRITIS,2
FR,ARTHRITIS BACTERIAL,2
FR,ASTHMA,2
FR,ATRIOVENTRICULAR BLOCK SECOND DEGREE,2
FR,AUTOIMMUNE HEPATITIS,2
FR,BACTERIAL PROSTATITIS,2
FR,BICYTOPENIA,2
FR,BIOPSY SKIN ABNORMAL,2
FR,BLADDER DILATATION,2
FR,BLINDNESS UNILATERAL,2
FR,BLOOD BICARBONATE DECREASED,2
FR,BLOOD CORTISOL DECREASED,2
FR,BLOOD IMMUNOGLOBULIN G DECREASED,2
FR,BLOOD IMMUNOGLOBULIN M DECREASED,2
FR,BLOOD PARATHYROID HORMONE INCREASED,2
FR,BLOOD PRESSURE INCREASED,2
FR,BLOOD SODIUM DECREASED,2
FR,BLOOD THYROID STIMULATING HORMONE DECREASED,2
FR,BLOOD URIC ACID INCREASED,2
FR,BONE MARROW DISORDER,2
FR,BRADYARRHYTHMIA,2
FR,BRAIN ABSCESS,2
FR,BRAIN CONTUSION,2
FR,BRAIN DEATH,2
FR,BRAIN STEM STROKE,2
FR,BRONCHIAL DISORDER,2
FR,BURSITIS,2
FR,CANDIDA INFECTION,2
FR,CANDIDA SEPSIS,2
FR,CARDIAC ABLATION,2
FR,CARDIAC MURMUR,2
FR,CARDIOMEGALY,2
FR,CARDIORENAL SYNDROME,2
FR,CEREBELLAR HAEMATOMA,2
FR,CEREBELLAR SYNDROME,2
FR,CEREBRAL ISCHAEMIA,2
FR,CERVICAL VERTEBRAL FRACTURE,2
FR,CHOLANGITIS,2
FR,CHOLECYSTECTOMY,2
FR,CHOLECYSTITIS,2
FR,CHRONIC LYMPHOCYTIC LEUKAEMIA,2
FR,CLOSTRIDIUM COLITIS,2
FR,COAGULATION FACTOR V LEVEL DECREASED,2
FR,COAGULATION TIME SHORTENED,2
FR,COLON NEOPLASM,2
FR,CONTUSION,2
FR,COOMBS TEST POSITIVE,2
FR,COR PULMONALE ACUTE,2
FR,CORONARY ARTERY OCCLUSION,2
FR,CORONARY ARTERY STENOSIS,2
FR,CRYSTAL ARTHROPATHY,2
FR,DEAFNESS,2
FR,DECUBITUS ULCER,2
FR,DELUSION OF GRANDEUR,2
FR,DIABETIC METABOLIC DECOMPENSATION,2
FR,DIARRHOEA INFECTIOUS,2
FR,DIFFUSE LARGE B-CELL LYMPHOMA,2
FR,DILATATION ATRIAL,2
FR,DIVERTICULITIS,2
FR,DRUG ADMINISTERED AT INAPPROPRIATE SITE,2
FR,DRUG EFFECT DELAYED,2
FR,DRY SKIN,2
FR,DYSPEPSIA,2
FR,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,2
FR,ELECTROCARDIOGRAM ST SEGMENT ABNORMAL,2
FR,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,2
FR,EMBOLIC STROKE,2
FR,EMBOLISM ARTERIAL,2
FR,ENTEROCUTANEOUS FISTULA,2
FR,EPIDERMAL NECROSIS,2
FR,ESCHERICHIA PYELONEPHRITIS,2
FR,ESCHERICHIA TEST POSITIVE,2
FR,ESCHERICHIA URINARY TRACT INFECTION,2
FR,EXTREMITY NECROSIS,2
FR,EYE PRURITUS,2
FR,FACIAL BONES FRACTURE,2
FR,FACIAL PARALYSIS,2
FR,FACTOR V INHIBITION,2
FR,FAILURE TO THRIVE,2
FR,FEELING ABNORMAL,2
FR,FEELING HOT,2
FR,FLATULENCE,2
FR,FOOD INTOLERANCE,2
FR,FURUNCLE,2
FR,GASTRIC ULCER HAEMORRHAGE,2
FR,GASTRODUODENITIS HAEMORRHAGIC,2
FR,GENERALISED TONIC-CLONIC SEIZURE,2
FR,GINGIVAL BLEEDING,2
FR,GINGIVITIS,2
FR,GRAFT VERSUS HOST DISEASE,2
FR,HAEMODIALYSIS,2
FR,HAEMOPHILUS INFECTION,2
FR,HEART RATE DECREASED,2
FR,HEPATECTOMY,2
FR,HEPATIC LESION,2
FR,HERPES VIRUS INFECTION,2
FR,HIATUS HERNIA,2
FR,HISTOLOGY ABNORMAL,2
FR,HOSPITALISATION,2
FR,HYPERCREATININAEMIA,2
FR,HYPERLIPASAEMIA,2
FR,HYPERTENSIVE CRISIS,2
FR,HYPOTONIA,2
FR,HYPOVENTILATION,2
FR,IDIOPATHIC PULMONARY FIBROSIS,2
FR,INCORRECT DRUG ADMINISTRATION DURATION,2
FR,INFECTION IN AN IMMUNOCOMPROMISED HOST,2
FR,INGUINAL HERNIA,2
FR,INJECTION SITE PAIN,2
FR,INTENTIONAL PRODUCT USE ISSUE,2
FR,INTERNATIONAL NORMALISED RATIO ABNORMAL,2
FR,INTESTINAL OBSTRUCTION,2
FR,INTESTINAL POLYP,2
FR,INTRADUCTAL PROLIFERATIVE BREAST LESION,2
FR,ISCHAEMIC CARDIOMYOPATHY,2
FR,JOINT EFFUSION,2
FR,JOINT MICROHAEMORRHAGE,2
FR,JUGULAR VEIN THROMBOSIS,2
FR,KLEBSIELLA SEPSIS,2
FR,LACRIMATION INCREASED,2
FR,LEFT VENTRICULAR DYSFUNCTION,2
FR,LEUKOENCEPHALOPATHY,2
FR,LIMB DISCOMFORT,2
FR,LIP SWELLING,2
FR,LIVER FUNCTION TEST ABNORMAL,2
FR,LIVER FUNCTION TEST INCREASED,2
FR,LIVER TRANSPLANT,2
FR,LOCAL SWELLING,2
FR,LUNG CONSOLIDATION,2
FR,LYMPHOCELE,2
FR,LYMPHOEDEMA,2
FR,LYMPHOMA,2
FR,MACULAR OEDEMA,2
FR,MAJOR DEPRESSION,2
FR,MALABSORPTION,2
FR,MENINGORRHAGIA,2
FR,MENTAL IMPAIRMENT,2
FR,MESENTERIC ARTERY THROMBOSIS,2
FR,METABOLIC ALKALOSIS,2
FR,MICROANGIOPATHY,2
FR,MITRAL VALVE DISEASE,2
FR,MONOCYTE COUNT DECREASED,2
FR,MOTOR DYSFUNCTION,2
FR,MOVEMENT DISORDER,2
FR,MUCOUS MEMBRANE DISORDER,2
FR,MUSCULOSKELETAL PAIN,2
FR,MYOPATHY,2
FR,NASOPHARYNGITIS,2
FR,NECK PAIN,2
FR,NEOPLASM PROGRESSION,2
FR,NEPHRITIS ALLERGIC,2
FR,NEPHROANGIOSCLEROSIS,2
FR,NEURALGIA,2
FR,NEUTROPHIL COUNT DECREASED,2
FR,NORMOCYTIC ANAEMIA,2
FR,OEDEMA MOUTH,2
FR,OESOPHAGEAL VARICEAL LIGATION,2
FR,OESOPHAGITIS,2
FR,OPTIC ISCHAEMIC NEUROPATHY,2
FR,ORAL DISCOMFORT,2
FR,ORAL HERPES,2
FR,OROPHARYNGEAL PAIN,2
FR,OSTEOARTHRITIS,2
FR,OSTEOLYSIS,2
FR,PANNICULITIS,2
FR,PARALYSIS,2
FR,PARANEOPLASTIC SYNDROME,2
FR,PARKINSONISM,2
FR,PATHOLOGICAL FRACTURE,2
FR,PELVIC FRACTURE,2
FR,PERIPHERAL ARTERY STENOSIS,2
FR,PERIPHERAL MOTOR NEUROPATHY,2
FR,PHLEBITIS,2
FR,PLEURAL DISORDER,2
FR,PNEUMONIA BACTERIAL,2
FR,PNEUMONIA KLEBSIELLA,2
FR,PNEUMONIA LEGIONELLA,2
FR,PNEUMOPERITONEUM,2
FR,POLYARTHRITIS,2
FR,POLYCYTHAEMIA,2
FR,PORTOPULMONARY HYPERTENSION,2
FR,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,2
FR,POSTICTAL STATE,2
FR,PREGNANCY,2
FR,PRESYNCOPE,2
FR,PROCTITIS,2
FR,PRODUCT PHYSICAL ISSUE,2
FR,PROSTATITIS ESCHERICHIA COLI,2
FR,PROTHROMBIN LEVEL ABNORMAL,2
FR,PROTHROMBIN LEVEL DECREASED,2
FR,PSEUDOMONAL SEPSIS,2
FR,PSYCHOMOTOR RETARDATION,2
FR,PULSELESS ELECTRICAL ACTIVITY,2
FR,PYELOCALIECTASIS,2
FR,RASH PUSTULAR,2
FR,RED BLOOD CELL SCHISTOCYTES PRESENT,2
FR,RESPIRATORY ALKALOSIS,2
FR,RETINAL ARTERY OCCLUSION,2
FR,RETINAL EXUDATES,2
FR,RETINOPATHY,2
FR,RETROGRADE AMNESIA,2
FR,RHEUMATOID ARTHRITIS,2
FR,SALIVARY HYPERSECRETION,2
FR,SCLERODERMA,2
FR,SEPTIC ARTHRITIS STAPHYLOCOCCAL,2
FR,SEPTIC EMBOLUS,2
FR,SERUM FERRITIN INCREASED,2
FR,SINOATRIAL BLOCK,2
FR,SINUSITIS ASPERGILLUS,2
FR,SKIN DISCOLOURATION,2
FR,SKIN DISORDER,2
FR,SKIN PLAQUE,2
FR,SKIN REACTION,2
FR,SKIN SWELLING,2
FR,SLEEP APNOEA SYNDROME,2
FR,SMALL INTESTINAL HAEMORRHAGE,2
FR,SMALL INTESTINAL OBSTRUCTION,2
FR,SODIUM RETENTION,2
FR,SPLENIC INFARCTION,2
FR,SPLENIC RUPTURE,2
FR,SUBDURAL HAEMORRHAGE,2
FR,SUPERINFECTION,2
FR,SWELLING FACE,2
FR,SYSTEMIC SCLEROSIS,2
FR,T-CELL LYMPHOMA,2
FR,TACHYARRHYTHMIA,2
FR,TELANGIECTASIA,2
FR,TENDONITIS,2
FR,TENOSYNOVITIS,2
FR,TETANY,2
FR,THERAPEUTIC EMBOLISATION,2
FR,THERMAL BURN,2
FR,THROMBOCYTOPENIC PURPURA,2
FR,TONGUE DRY,2
FR,TOOTH FRACTURE,2
FR,TOXIC ENCEPHALOPATHY,2
FR,TOXOPLASMOSIS,2
FR,TRANSITIONAL CELL CARCINOMA,2
FR,TRICUSPID VALVE INCOMPETENCE,2
FR,TUBERCULOSIS,2
FR,TYPE 2 DIABETES MELLITUS,2
FR,URETHRAL STENOSIS,2
FR,URINARY TRACT INFECTION BACTERIAL,2
FR,UVEITIS,2
FR,VASCULITIS NECROTISING,2
FR,VENTRICULAR FIBRILLATION,2
FR,VENTRICULAR HYPOKINESIA,2
FR,VESSEL PUNCTURE SITE HAEMATOMA,2
FR,VIRAL INFECTION,2
FR,WHITE BLOOD CELL COUNT DECREASED,2
FR,WOUND EVISCERATION,2
FR,WRIST FRACTURE,2
FR,WRONG PATIENT RECEIVED MEDICATION,2
FR,ABDOMINAL HERNIA,1
FR,ABDOMINAL SEPSIS,1
FR,ABNORMAL DREAMS,1
FR,ABSCESS LIMB,1
FR,ACINETOBACTER INFECTION,1
FR,ACINETOBACTER TEST POSITIVE,1
FR,ACQUIRED GENE MUTATION,1
FR,ACTINIC KERATOSIS,1
FR,ACTIVATED PARTIAL THROMBOPLASTIN TIME,1
FR,ACUTE HEPATIC FAILURE,1
FR,ACUTE LEUKAEMIA,1
FR,ADDISON^S DISEASE,1
FR,ADENOCARCINOMA GASTRIC,1
FR,ADRENAL CORTEX NECROSIS,1
FR,ADRENAL HAEMORRHAGE,1
FR,ADRENOCORTICOTROPIC HORMONE DEFICIENCY,1
FR,AGEUSIA,1
FR,AIR EMBOLISM,1
FR,AKATHISIA,1
FR,ALCOHOLISM,1
FR,ALVEOLITIS ALLERGIC,1
FR,AMYOTROPHY,1
FR,ANAEMIA FOLATE DEFICIENCY,1
FR,ANAEMIA MEGALOBLASTIC,1
FR,ANAEMIA POSTOPERATIVE,1
FR,ANAEMIA VITAMIN B12 DEFICIENCY,1
FR,ANAL FISTULA,1
FR,ANAL ULCER,1
FR,ANALGESIC DRUG LEVEL INCREASED,1
FR,ANAPHYLACTIC REACTION,1
FR,ANAPHYLACTOID REACTION,1
FR,ANEURYSM,1
FR,ANGIOTENSIN CONVERTING ENZYME INCREASED,1
FR,ANISOCYTOSIS,1
FR,ANKLE FRACTURE,1
FR,ANTI FACTOR V ANTIBODY,1
FR,ANTIBODY TEST ABNORMAL,1
FR,ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC,1
FR,ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC,1
FR,ANTICOAGULATION DRUG LEVEL DECREASED,1
FR,ANTICOAGULATION DRUG LEVEL INCREASED,1
FR,ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC,1
FR,ANTINEUTROPHIL CYTOPLASMIC ANTIBODY,1
FR,AORTIC ANEURYSM RUPTURE,1
FR,AORTIC ARTERIOSCLEROSIS,1
FR,AORTIC EMBOLUS,1
FR,AORTIC STENOSIS,1
FR,AORTIC THROMBOSIS,1
FR,AORTIC VALVE DISEASE,1
FR,AORTIC VALVE REPLACEMENT,1
FR,APHAGIA,1
FR,APHTHOUS ULCER,1
FR,APLASIA PURE RED CELL,1
FR,APLASTIC ANAEMIA,1
FR,APNOEA,1
FR,APNOEIC ATTACK,1
FR,APPLICATION SITE INFLAMMATION,1
FR,APPLICATION SITE NECROSIS,1
FR,APTYALISM,1
FR,ARTERIAL THROMBOSIS,1
FR,ARTERIOSCLEROSIS,1
FR,ARTHROPATHY,1
FR,ASYMPTOMATIC BACTERIURIA,1
FR,ATAXIA,1
FR,AUTOIMMUNE COLITIS,1
FR,B-CELL LYMPHOMA,1
FR,BACTERASCITES,1
FR,BACTERIAL TEST POSITIVE,1
FR,BACTERIAL TRANSLOCATION,1
FR,BASELINE FOETAL HEART RATE VARIABILITY DISORDER,1
FR,BEDRIDDEN,1
FR,BETA 2 MICROGLOBULIN INCREASED,1
FR,BEZOAR,1
FR,BIOPSY LIVER,1
FR,BK VIRUS INFECTION,1
FR,BLADDER CANCER,1
GE,CARDIAC FAILURE,1
GE,GENERALISED OEDEMA,1
GE,HYPOALBUMINAEMIA,1
GE,HYPOPROTEINAEMIA,1
GE,NEPHROTIC SYNDROME,1
DE,DYSPNOEA,71
DE,GENERAL PHYSICAL HEALTH DETERIORATION,69
DE,PNEUMONIA,64
DE,CARDIAC FAILURE,57
DE,RENAL FAILURE,54
DE,DEATH,48
DE,FALL,40
DE,DIARRHOEA,38
DE,FATIGUE,35
DE,SEPSIS,35
DE,ATRIAL FIBRILLATION,31
DE,NAUSEA,31
DE,ACUTE KIDNEY INJURY,30
DE,OEDEMA PERIPHERAL,30
DE,ASTHENIA,29
DE,ANAEMIA,28
DE,HAEMOGLOBIN DECREASED,26
DE,DEHYDRATION,25
DE,PLEURAL EFFUSION,25
DE,RESPIRATORY FAILURE,25
DE,RHABDOMYOLYSIS,25
DE,THROMBOCYTOPENIA,25
DE,VOMITING,24
DE,BLOOD CREATININE INCREASED,23
DE,HYPOKALAEMIA,23
DE,HYPOTENSION,23
DE,PYREXIA,22
DE,DECREASED APPETITE,21
DE,RENAL FAILURE ACUTE,20
DE,WEIGHT DECREASED,19
DE,PULMONARY EMBOLISM,18
DE,DRUG INEFFECTIVE,17
DE,HEPATIC FAILURE,17
DE,INFECTION,17
DE,PAIN IN EXTREMITY,17
DE,TORSADE DE POINTES,17
DE,MALIGNANT NEOPLASM PROGRESSION,16
DE,OEDEMA,16
DE,DIZZINESS,15
DE,FEBRILE NEUTROPENIA,15
DE,ARTHRALGIA,14
DE,C-REACTIVE PROTEIN INCREASED,14
DE,GASTROINTESTINAL HAEMORRHAGE,14
DE,MYOCARDIAL INFARCTION,14
DE,ASCITES,13
DE,BASAL CELL CARCINOMA,13
DE,BRONCHITIS,13
DE,CEREBROVASCULAR ACCIDENT,13
DE,CONFUSIONAL STATE,13
DE,COUGH,13
DE,HYPONATRAEMIA,13
DE,MULTI-ORGAN FAILURE,13
DE,CEREBRAL HAEMORRHAGE,12
DE,CIRCULATORY COLLAPSE,12
DE,LEUKOPENIA,12
DE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,12
DE,NEUTROPENIA,12
DE,PRURITUS,12
DE,CONSTIPATION,11
DE,HYPERTENSION,11
DE,HYPERTENSIVE CRISIS,11
DE,INSOMNIA,11
DE,PAIN,11
DE,PULMONARY OEDEMA,11
DE,RENAL IMPAIRMENT,11
DE,SEPTIC SHOCK,11
DE,SYNCOPE,11
DE,TOXIC EPIDERMAL NECROLYSIS,11
DE,ABDOMINAL PAIN,10
DE,ANGINA PECTORIS,10
DE,CEREBRAL INFARCTION,10
DE,DEPRESSION,10
DE,FOETAL EXPOSURE DURING PREGNANCY,10
DE,MUSCLE SPASMS,10
DE,MUSCULAR WEAKNESS,10
DE,PANCYTOPENIA,10
DE,SKIN ULCER,10
DE,URINARY TRACT INFECTION,10
DE,WEIGHT INCREASED,10
DE,ACUTE MYOCARDIAL INFARCTION,9
DE,ARRHYTHMIA,9
DE,BLOOD BILIRUBIN INCREASED,9
DE,CHEST PAIN,9
DE,CONTUSION,9
DE,DIABETES MELLITUS,9
DE,DYSPNOEA EXERTIONAL,9
DE,EPISTAXIS,9
DE,GAIT DISTURBANCE,9
DE,HAEMORRHAGE,9
DE,PERIPHERAL SWELLING,9
DE,PREMATURE BABY,9
DE,RESTLESSNESS,9
DE,SOMNOLENCE,9
DE,TACHYARRHYTHMIA,9
DE,ABDOMINAL PAIN UPPER,8
DE,BRONCHOPNEUMONIA,8
DE,CARDIOVASCULAR DISORDER,8
DE,CEREBRAL ISCHAEMIA,8
DE,DISTURBANCE IN ATTENTION,8
DE,HEADACHE,8
DE,OVERDOSE,8
DE,SLEEP DISORDER,8
DE,STEVENS-JOHNSON SYNDROME,8
DE,ACTINIC KERATOSIS,7
DE,ACUTE HEPATIC FAILURE,7
DE,ALANINE AMINOTRANSFERASE INCREASED,7
DE,BACK PAIN,7
DE,BLOOD GLUCOSE INCREASED,7
DE,CARDIAC ARREST,7
DE,CARDIOMEGALY,7
DE,CONDITION AGGRAVATED,7
DE,CORONARY ARTERY DISEASE,7
DE,DISEASE PROGRESSION,7
DE,DYSPHAGIA,7
DE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,7
DE,HAEMATOMA,7
DE,HEMIPARESIS,7
DE,HYPERKALAEMIA,7
DE,LACTIC ACIDOSIS,7
DE,MALAISE,7
DE,RASH,7
DE,SQUAMOUS CELL CARCINOMA,7
DE,VERTIGO,7
DE,AFFECTIVE DISORDER,6
DE,ANGIOTENSIN CONVERTING ENZYME INHIBITOR FOETOPATHY,6
DE,ATRIAL SEPTAL DEFECT,6
DE,BLOOD CREATINE PHOSPHOKINASE INCREASED,6
DE,BOWEN^S DISEASE,6
DE,BRONCHOPULMONARY DYSPLASIA,6
DE,CHILLS,6
DE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,6
DE,CYANOSIS,6
DE,DRUG-INDUCED LIVER INJURY,6
DE,ELECTROCARDIOGRAM QT PROLONGED,6
DE,ENCEPHALITIS,6
DE,HEPATIC CIRRHOSIS,6
DE,HEPATIC ENZYME INCREASED,6
DE,HYPOMAGNESAEMIA,6
DE,IMPAIRED HEALING,6
DE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,6
DE,INTRAVENTRICULAR HAEMORRHAGE,6
DE,MELAENA,6
DE,OXYGEN SATURATION DECREASED,6
DE,PATENT DUCTUS ARTERIOSUS,6
DE,PERICARDIAL EFFUSION,6
DE,PERSISTENT FOETAL CIRCULATION,6
DE,PNEUMONIA ASPIRATION,6
DE,PRECANCEROUS SKIN LESION,6
DE,PRODUCT USE ISSUE,6
DE,PULMONARY HYPOPLASIA,6
DE,RETINAL DETACHMENT,6
DE,STAPHYLOCOCCAL SEPSIS,6
DE,TACHYCARDIA,6
DE,TRANSAMINASES INCREASED,6
DE,URINARY INCONTINENCE,6
DE,URINARY RETENTION,6
DE,ACUTE CORONARY SYNDROME,5
DE,BLISTER,5
DE,BLOOD LACTATE DEHYDROGENASE INCREASED,5
DE,CARDIAC FAILURE CHRONIC,5
DE,CARDIOMYOPATHY,5
DE,CHOLECYSTITIS,5
DE,CONGESTIVE CARDIOMYOPATHY,5
DE,CONVULSION,5
DE,DEEP VEIN THROMBOSIS,5
DE,DRUG LEVEL INCREASED,5
DE,EPILEPSY,5
DE,ERYTHEMA,5
DE,FEMUR FRACTURE,5
DE,HEPATOCELLULAR INJURY,5
DE,HEPATOTOXICITY,5
DE,HYPERSENSITIVITY,5
DE,HYPOAESTHESIA,5
DE,HYPOGLYCAEMIA,5
DE,INFLAMMATION,5
DE,LOWER GASTROINTESTINAL HAEMORRHAGE,5
DE,MOBILITY DECREASED,5
DE,MUCOSAL INFLAMMATION,5
DE,MYALGIA,5
DE,OBSTRUCTIVE AIRWAYS DISORDER,5
DE,OLIGOHYDRAMNIOS,5
DE,OSTEOARTHRITIS,5
DE,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,5
DE,RESPIRATORY SYNCYTIAL VIRUS INFECTION,5
DE,RIGHT VENTRICULAR FAILURE,5
DE,SEIZURE,5
DE,SKIN CANCER,5
DE,STAPHYLOCOCCAL INFECTION,5
DE,UPPER GASTROINTESTINAL HAEMORRHAGE,5
DE,UROSEPSIS,5
DE,URTICARIA,5
DE,WHITE BLOOD CELL COUNT DECREASED,5
DE,ANGINA UNSTABLE,4
DE,ANGIOEDEMA,4
DE,ANXIETY,4
DE,ASPARTATE AMINOTRANSFERASE INCREASED,4
DE,BLOOD CALCIUM DECREASED,4
DE,BLOOD POTASSIUM INCREASED,4
DE,CEREBRAL ARTERY OCCLUSION,4
DE,CHEST DISCOMFORT,4
DE,COAGULOPATHY,4
DE,COGNITIVE DISORDER,4
DE,DEPRESSED LEVEL OF CONSCIOUSNESS,4
DE,DERMATITIS ALLERGIC,4
DE,DISORIENTATION,4
DE,DRUG ABUSE,4
DE,DRUG CLEARANCE DECREASED,4
DE,DRUG DEPENDENCE,4
DE,DRUG WITHDRAWAL SYNDROME,4
DE,DRY SKIN,4
DE,DYSMORPHISM,4
DE,ESCHERICHIA URINARY TRACT INFECTION,4
DE,FEBRILE INFECTION,4
DE,FEMORAL NECK FRACTURE,4
DE,FLUID RETENTION,4
DE,GASTRITIS,4
DE,GASTROINTESTINAL INFECTION,4
DE,GOUT,4
DE,HEART RATE INCREASED,4
DE,HERPES ZOSTER,4
DE,HUMERUS FRACTURE,4
DE,HYPERSENSITIVITY VASCULITIS,4
DE,HYPOCALCAEMIA,4
DE,HYPOCHROMIC ANAEMIA,4
DE,INCORRECT DOSE ADMINISTERED,4
DE,INFLAMMATORY MARKER INCREASED,4
DE,INGUINAL HERNIA,4
DE,INTRACRANIAL PRESSURE INCREASED,4
DE,JAUNDICE,4
DE,LARGE INTESTINE POLYP,4
DE,LONG QT SYNDROME,4
DE,LUNG INFILTRATION,4
DE,MUSCLE HAEMORRHAGE,4
DE,MUSCLE INJURY,4
DE,NECROSIS,4
DE,NEPHROCALCINOSIS,4
DE,PANCREATITIS,4
DE,PETECHIAE,4
DE,PNEUMOTHORAX,4
DE,POLYNEUROPATHY,4
DE,PROCEDURAL HAEMORRHAGE,4
DE,PSORIASIS,4
DE,PSYCHOTIC DISORDER,4
DE,RASH GENERALISED,4
DE,SEROMA,4
DE,SHUNT OCCLUSION,4
DE,SKIN HAEMORRHAGE,4
DE,SQUAMOUS CELL CARCINOMA OF SKIN,4
DE,STATUS EPILEPTICUS,4
DE,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,4
DE,TRANSIENT ISCHAEMIC ATTACK,4
DE,TUBULOINTERSTITIAL NEPHRITIS,4
DE,UMBILICAL HERNIA,4
DE,UPPER LIMB FRACTURE,4
DE,VENTRICULAR TACHYCARDIA,4
DE,ABDOMINAL HERNIA,3
DE,ABSCESS,3
DE,ACCIDENT,3
DE,ACUTE ABDOMEN,3
DE,AGRANULOCYTOSIS,3
DE,AORTIC STENOSIS,3
DE,APATHY,3
DE,ATRIAL FLUTTER,3
DE,BLOOD ALBUMIN DECREASED,3
DE,BLOOD ALKALINE PHOSPHATASE INCREASED,3
DE,BLOOD PRESSURE DECREASED,3
DE,BLOOD PRESSURE SYSTOLIC INCREASED,3
DE,BLOOD SODIUM DECREASED,3
DE,BLOOD UREA INCREASED,3
DE,BONE MARROW FAILURE,3
DE,BRADYCARDIA,3
DE,BRAIN OEDEMA,3
DE,BRONCHOPULMONARY ASPERGILLOSIS,3
DE,BURSITIS,3
DE,CARDIAC DISORDER,3
DE,CELLULITIS,3
DE,CHOLANGITIS,3
DE,CHRONIC GASTRITIS,3
DE,CLEFT PALATE,3
DE,CYSTITIS,3
DE,CYTOMEGALOVIRUS INFECTION,3
DE,DIVERTICULITIS,3
DE,DRUG INTOLERANCE,3
DE,DRUG TOLERANCE,3
DE,DYSARTHRIA,3
DE,ECZEMA,3
DE,EJECTION FRACTION DECREASED,3
DE,ERYSIPELAS,3
DE,ERYTHEMA MULTIFORME,3
DE,EXPOSURE DURING PREGNANCY,3
DE,FLUID OVERLOAD,3
DE,FLUSHING,3
DE,FUNGAL INFECTION,3
DE,GASTRIC ULCER,3
DE,GASTROENTERITIS,3
DE,GASTROENTERITIS NOROVIRUS,3
DE,GENERALISED OEDEMA,3
DE,GLOMERULAR FILTRATION RATE DECREASED,3
DE,HAEMANGIOMA,3
DE,HAEMATOCHEZIA,3
DE,HAEMATURIA,3
DE,HAEMORRHOIDAL HAEMORRHAGE,3
DE,HALLUCINATION,3
DE,HEPATIC FUNCTION ABNORMAL,3
DE,HYPERBILIRUBINAEMIA,3
DE,HYPERHIDROSIS,3
DE,HYPERTHYROIDISM,3
DE,HYPOXIA,3
DE,IMMUNOSUPPRESSANT DRUG LEVEL DECREASED,3
DE,IMPAIRED SELF-CARE,3
DE,INTERNATIONAL NORMALISED RATIO INCREASED,3
DE,INTERVERTEBRAL DISC PROTRUSION,3
DE,ISCHAEMIC STROKE,3
DE,LIMB REDUCTION DEFECT,3
DE,LIPASE INCREASED,3
DE,LOSS OF CONSCIOUSNESS,3
DE,LYMPHOCELE,3
DE,LYMPHOEDEMA,3
DE,MEDICATION ERROR,3
DE,MENTAL DISORDER,3
DE,METABOLIC ACIDOSIS,3
DE,METASTASES TO CENTRAL NERVOUS SYSTEM,3
DE,METASTASES TO LUNG,3
DE,METASTASES TO MENINGES,3
DE,MITRAL VALVE INCOMPETENCE,3
DE,MULTIPLE DRUG THERAPY,3
DE,NASOPHARYNGITIS,3
DE,NEPHRITIS ALLERGIC,3
DE,ORAL CANDIDIASIS,3
DE,PALLOR,3
DE,PALPITATIONS,3
DE,PLASMA CELL MYELOMA,3
DE,POST PROCEDURAL HAEMORRHAGE,3
DE,PREMATURE RUPTURE OF MEMBRANES,3
DE,PRESCRIBED UNDERDOSE,3
DE,PRURITUS GENERALISED,3
DE,PSEUDOMONAS INFECTION,3
DE,PULMONARY HAEMORRHAGE,3
DE,PURULENT DISCHARGE,3
DE,RASH MACULO-PAPULAR,3
DE,RECTAL HAEMORRHAGE,3
DE,RENAL CELL CARCINOMA,3
DE,SALIVARY HYPERSECRETION,3
DE,SHOCK HAEMORRHAGIC,3
DE,SPINAL FRACTURE,3
DE,SPLENOMEGALY,3
DE,STASIS DERMATITIS,3
DE,STOMATITIS,3
DE,SUBDURAL HAEMATOMA,3
DE,SUDDEN CARDIAC DEATH,3
DE,SUDDEN DEATH,3
DE,SUPRAVENTRICULAR TACHYCARDIA,3
DE,SWELLING,3
DE,TALIPES,3
DE,TOXICITY TO VARIOUS AGENTS,3
DE,TUMOUR LYSIS SYNDROME,3
DE,UPPER RESPIRATORY TRACT INFECTION,3
DE,URETERIC STENOSIS,3
DE,VASCULITIS,3
DE,VENTRICULAR FIBRILLATION,3
DE,VISUAL IMPAIRMENT,3
DE,VITAMIN D DEFICIENCY,3
DE,WOUND,3
DE,ABASIA,2
DE,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,2
DE,ADMINISTRATION SITE REACTION,2
DE,AKINESIA,2
DE,AMNESIA,2
DE,ANAL HAEMORRHAGE,2
DE,ANASTOMOTIC LEAK,2
DE,APHASIA,2
DE,ARTERIOSCLEROSIS,2
DE,ASPERGILLUS INFECTION,2
DE,ASPIRATION,2
DE,ASTHMA,2
DE,ATRIOVENTRICULAR BLOCK COMPLETE,2
DE,BLOOD DISORDER,2
DE,BLOOD IRON DECREASED,2
DE,BLOOD POTASSIUM DECREASED,2
DE,BLOOD PRESSURE FLUCTUATION,2
DE,BODY TEMPERATURE INCREASED,2
DE,BONE PAIN,2
DE,BRADYARRHYTHMIA,2
DE,BREAST CANCER,2
DE,BREATH SOUNDS ABNORMAL,2
DE,BRONCHITIS BACTERIAL,2
DE,CARCINOMA IN SITU OF SKIN,2
DE,CARDIAC DEATH,2
DE,CARDIOGENIC SHOCK,2
DE,CARDIOPULMONARY FAILURE,2
DE,CARDIOVERSION,2
DE,CATARACT,2
DE,CEREBRAL VENTRICULAR RUPTURE,2
DE,CHOLELITHIASIS,2
DE,CHOLESTASIS,2
DE,CHROMATURIA,2
DE,CHRONIC HEPATITIS,2
DE,COLITIS,2
DE,COLITIS ULCERATIVE,2
DE,COLON ADENOMA,2
DE,COMA,2
DE,COMA HEPATIC,2
DE,COMPARTMENT SYNDROME,2
DE,CONCOMITANT DISEASE AGGRAVATED,2
DE,CONCUSSION,2
DE,CONJUNCTIVITIS,2
DE,CONJUNCTIVITIS INFECTIVE,2
DE,CORONARY ARTERY STENOSIS,2
DE,CYTOPENIA,2
DE,DELIRIUM,2
DE,DEPRESSED MOOD,2
DE,DERMATITIS EXFOLIATIVE,2
DE,DEVICE RELATED INFECTION,2
DE,DIABETIC FOOT,2
DE,DIABETIC HYPEROSMOLAR COMA,2
DE,DRUG ADMINISTRATION ERROR,2
DE,DRUG EFFECT DECREASED,2
DE,DRUG ERUPTION,2
DE,DRUG HYPERSENSITIVITY,2
DE,DUODENAL ULCER,2
DE,DYSGEUSIA,2
DE,DYSPNOEA AT REST,2
DE,DYSSTASIA,2
DE,ENDOCARDITIS,2
DE,EYE SWELLING,2
DE,FAMILIAL MEDITERRANEAN FEVER,2
DE,FISTULA,2
DE,FLANK PAIN,2
DE,GANGRENE,2
DE,GASTRIC HAEMORRHAGE,2
DE,GASTRITIS EROSIVE,2
DE,GASTROOESOPHAGEAL REFLUX DISEASE,2
DE,GOITRE,2
DE,GRAND MAL CONVULSION,2
DE,HAEMARTHROSIS,2
DE,HAEMATEMESIS,2
DE,HAEMATOCRIT DECREASED,2
DE,HAEMATOTOXICITY,2
DE,HAEMOLYSIS,2
DE,HAEMOLYTIC URAEMIC SYNDROME,2
DE,HAEMOPTYSIS,2
DE,HAEMORRHAGE INTRACRANIAL,2
DE,HAEMOTHORAX,2
DE,HALLUCINATION_ VISUAL,2
DE,HEPATIC FIBROSIS,2
DE,HEPATIC NECROSIS,2
DE,HEPATORENAL SYNDROME,2
DE,HERNIA OBSTRUCTIVE,2
DE,HYDRONEPHROSIS,2
DE,HYPERCALCAEMIA,2
DE,HYPERCAPNIA,2
DE,HYPERGLYCAEMIA,2
DE,HYPERKINESIA,2
DE,HYPERNATRAEMIA,2
DE,HYPOACUSIS,2
DE,HYPOTHERMIA,2
DE,HYPOVOLAEMIC SHOCK,2
DE,IDIOPATHIC INTRACRANIAL HYPERTENSION,2
DE,INCORRECT ROUTE OF DRUG ADMINISTRATION,2
DE,INFECTED DERMAL CYST,2
DE,INFECTIOUS PLEURAL EFFUSION,2
DE,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,2
DE,INTENTIONAL OVERDOSE,2
DE,INTESTINAL HAEMORRHAGE,2
DE,INTESTINAL PROLAPSE,2
DE,IRON DEFICIENCY ANAEMIA,2
DE,IRON OVERLOAD,2
DE,ISCHAEMIC CARDIOMYOPATHY,2
DE,KIDNEY TRANSPLANT REJECTION,2
DE,LARGE INTESTINE PERFORATION,2
DE,LARYNGEAL OEDEMA,2
DE,LEFT VENTRICULAR DYSFUNCTION,2
DE,LEFT VENTRICULAR FAILURE,2
DE,LICHENIFICATION,2
DE,LIP EROSION,2
DE,LIVER ABSCESS,2
DE,LIVER FUNCTION TEST INCREASED,2
DE,LOW BIRTH WEIGHT BABY,2
DE,LUNG INFECTION,2
DE,LYMPHADENOPATHY,2
DE,LYMPHATIC DISORDER,2
DE,LYMPHOPROLIFERATIVE DISORDER,2
DE,MALIGNANT PERITONEAL NEOPLASM,2
DE,MANIA,2
DE,MASTOIDITIS,2
DE,MATERNAL EXPOSURE DURING PREGNANCY,2
DE,MENISCUS INJURY,2
DE,METASTATIC RENAL CELL CARCINOMA,2
DE,MUSCLE SWELLING,2
DE,MYELODYSPLASTIC SYNDROME,2
DE,MYOGLOBIN BLOOD INCREASED,2
DE,MYOPATHY,2
DE,NECK PAIN,2
DE,NECROTISING FASCIITIS,2
DE,NEOPLASM PROGRESSION,2
DE,NEPHROGENIC ANAEMIA,2
DE,NERVOUS SYSTEM DISORDER,2
DE,NEUROTOXICITY,2
DE,NIKOLSKY^S SIGN,2
DE,OEDEMA NEONATAL,2
DE,OESOPHAGEAL CANDIDIASIS,2
DE,ORAL DISORDER,2
DE,ORTHOSTATIC HYPOTENSION,2
DE,ORTHOSTATIC INTOLERANCE,2
DE,OSTEITIS,2
DE,OSTEOMYELITIS,2
DE,PANIC ATTACK,2
DE,PERITONEAL HERNIA,2
DE,PLATELET COUNT DECREASED,2
DE,PNEUMONIA KLEBSIELLA,2
DE,PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL,2
DE,PNEUMONITIS,2
DE,PREMATURE DELIVERY,2
DE,PRERENAL FAILURE,2
DE,PULMONARY FIBROSIS,2
DE,PULMONARY HYPERTENSION,2
DE,PUPILLARY REFLEX IMPAIRED,2
DE,PUPILS UNEQUAL,2
DE,RASH MACULAR,2
DE,RASH PUSTULAR,2
DE,RED BLOOD CELL COUNT DECREASED,2
DE,RENAL ARTERY STENOSIS,2
DE,RENAL CYST,2
DE,RENAL DISORDER,2
DE,RENAL FAILURE CHRONIC,2
DE,RENAL FUNCTION TEST ABNORMAL,2
DE,RENAL INJURY,2
DE,RENAL TRANSPLANT FAILURE,2
DE,RESPIRATORY ACIDOSIS,2
DE,RESPIRATORY DISORDER,2
DE,RESPIRATORY DISORDER NEONATAL,2
DE,RESPIRATORY SYNCYTIAL VIRUS BRONCHIOLITIS,2
DE,RESPIRATORY TRACT INFECTION,2
DE,RETINAL HAEMORRHAGE,2
DE,RHEUMATOID ARTHRITIS,2
DE,ROAD TRAFFIC ACCIDENT,2
DE,SELECTIVE EATING DISORDER,2
DE,SHOCK,2
DE,SKIN DISCOLOURATION,2
DE,SKIN NECROSIS,2
DE,SPUTUM DISCOLOURED,2
DE,STOMA SITE INFLAMMATION,2
DE,SUBARACHNOID HAEMORRHAGE,2
DE,SUBILEUS,2
DE,SUICIDE ATTEMPT,2
DE,SUPERINFECTION BACTERIAL,2
DE,SURGERY,2
DE,SWELLING FACE,2
DE,SWOLLEN TONGUE,2
DE,THROMBOSIS,2
DE,THROMBOSIS IN DEVICE,2
DE,THROMBOTIC THROMBOCYTOPENIC PURPURA,2
DE,TOOTH EXTRACTION,2
DE,TRANSPLANT REJECTION,2
DE,TRAUMATIC HAEMORRHAGE,2
DE,TREMOR,2
DE,TRICUSPID VALVE INCOMPETENCE,2
DE,WOUND DEHISCENCE,2
DE,WOUND INFECTION,2
DE,WRONG DRUG ADMINISTERED,2
DE,WRONG TECHNIQUE IN DRUG USAGE PROCESS,2
DE,ABDOMINAL CAVITY DRAINAGE,1
DE,ABDOMINAL DISCOMFORT,1
DE,ABDOMINAL DISTENSION,1
DE,ABDOMINAL MASS,1
DE,ABDOMINAL PAIN LOWER,1
DE,ABDOMINAL WALL INFECTION,1
DE,ABNORMAL WEIGHT GAIN,1
DE,ACCIDENTAL EXPOSURE TO PRODUCT,1
DE,ACCIDENTAL OVERDOSE,1
DE,ACINETOBACTER INFECTION,1
DE,ACQUIRED PHIMOSIS,1
DE,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,1
DE,ACUTE MYELOID LEUKAEMIA,1
DE,ACUTE MYELOMONOCYTIC LEUKAEMIA,1
DE,ACUTE RESPIRATORY FAILURE,1
DE,ACUTE RIGHT VENTRICULAR FAILURE,1
DE,ADENOCARCINOMA,1
DE,ADENOVIRUS INFECTION,1
DE,ADHESION,1
DE,ADRENAL INSUFFICIENCY,1
DE,ADVERSE EVENT,1
DE,AGEUSIA,1
DE,AGITATION,1
DE,ALOPECIA,1
DE,ALTERED STATE OF CONSCIOUSNESS,1
DE,AMYLASE INCREASED,1
DE,ANAPHYLACTIC REACTION,1
DE,ANASTOMOTIC COMPLICATION,1
DE,ANGIOPLASTY,1
DE,ANOSMIA,1
DE,ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC,1
DE,AORTIC ANEURYSM,1
DE,AORTIC ANEURYSM RUPTURE,1
DE,AORTIC DISORDER,1
DE,AORTIC VALVE DISEASE,1
DE,AORTIC VALVE SCLEROSIS,1
DE,AORTIC VALVE STENOSIS,1
DE,APNOEA,1
DE,APPLICATION SITE ACNE,1
DE,APPLICATION SITE ERYTHEMA,1
DE,APPLICATION SITE PRURITUS,1
DE,ARRHYTHMIA SUPRAVENTRICULAR,1
DE,ARTERIAL OCCLUSIVE DISEASE,1
DE,ARTERIAL REPAIR,1
DE,ARTERIOSCLEROSIS CORONARY ARTERY,1
DE,ARTHROPATHY,1
DE,ASPHYXIA,1
DE,ATAXIA,1
DE,ATELECTASIS,1
DE,ATRIOVENTRICULAR BLOCK,1
DE,ATRIOVENTRICULAR SEPTAL DEFECT,1
DE,ATYPICAL PNEUMONIA,1
DE,AUTONOMIC NEUROPATHY,1
DE,AUTOSOMAL CHROMOSOME ANOMALY,1
DE,AZOTAEMIA,1
DE,B-CELL LYMPHOMA,1
DE,BACK DISORDER,1
DE,BACTERAEMIA,1
DE,BEDRIDDEN,1
DE,BENIGN PROSTATIC HYPERPLASIA,1
DE,BICYTOPENIA,1
DE,BIFASCICULAR BLOCK,1
DE,BILE DUCT STONE,1
DE,BILIARY DILATATION,1
DE,BK VIRUS INFECTION,1
DE,BLINDNESS,1
DE,BLOOD BICARBONATE INCREASED,1
DE,BLOOD BLISTER,1
DE,BLOOD CALCITONIN DECREASED,1
DE,BLOOD COUNT ABNORMAL,1
DE,BLOOD GLUCOSE ABNORMAL,1
DE,BLOOD GLUCOSE FLUCTUATION,1
DE,BLOOD INSULIN DECREASED,1
DE,BLOOD IRON INCREASED,1
DE,BLOOD MAGNESIUM DECREASED,1
DE,BLOOD PHOSPHORUS INCREASED,1
DE,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
DE,BLOOD PRESSURE INCREASED,1
DE,BLOOD PRODUCT TRANSFUSION DEPENDENT,1
DE,BLOOD TEST ABNORMAL,1
DE,BLOOD URIC ACID INCREASED,1
DE,BRAIN ABSCESS,1
DE,BRAIN DEATH,1
DE,BRAIN INJURY,1
DE,BRAIN MIDLINE SHIFT,1
DE,BRAIN NEOPLASM,1
DE,BREAST NECROSIS,1
DE,BREECH DELIVERY,1
DE,BREECH PRESENTATION,1
DE,BRONCHIAL CARCINOMA,1
DE,BRONCHIAL OBSTRUCTION,1
DE,BUNDLE BRANCH BLOCK RIGHT,1
DE,CAESAREAN SECTION,1
DE,CAMPYLOBACTER GASTROENTERITIS,1
DE,CANDIDA SEPSIS,1
DE,CAPILLARY LEAK SYNDROME,1
DE,CARCINOMA IN SITU,1
DE,CARDIAC FAILURE ACUTE,1
DE,CARDIAC OUTPUT DECREASED,1
DE,CARDIAC VALVE DISEASE,1
DE,CARDIAC VENTRICULAR THROMBOSIS,1
DE,CARDIO-RESPIRATORY ARREST,1
DE,CARDIOVASCULAR INSUFFICIENCY,1
DE,CAROTID ARTERY STENOSIS,1
DE,CATHETERISATION CARDIAC,1
DE,CENTRAL NERVOUS SYSTEM LYMPHOMA,1
DE,CEPHALHAEMATOMA,1
DE,CEREBELLAR ATROPHY,1
DE,CEREBRAL ARTERIOSCLEROSIS,1
DE,CEREBRAL ARTERY EMBOLISM,1
DE,CEREBROVASCULAR ACCIDENT PROPHYLAXIS,1
DE,CHANGE OF BOWEL HABIT,1
DE,CHEMOTHERAPY,1
DE,CHEST TUBE INSERTION,1
DE,CHOLANGITIS SCLEROSING,1
DE,CHONDROMALACIA,1
DE,CHRONIC ALLOGRAFT NEPHROPATHY,1
DE,CHRONIC KIDNEY DISEASE,1
DE,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
DE,CLOSTRIDIAL INFECTION,1
DE,CLOSTRIDIUM DIFFICILE COLITIS,1
DE,CLOSTRIDIUM TEST POSITIVE,1
DE,COAGULATION TEST,1
DE,COLITIS ISCHAEMIC,1
DE,COMPLETED SUICIDE,1
DE,COMPLEX PARTIAL SEIZURES,1
DE,COMPLICATIONS OF TRANSPLANTED KIDNEY,1
DE,COMPUTERISED TOMOGRAM THORAX ABNORMAL,1
DE,CONGENITAL MUSCULOSKELETAL ANOMALY,1
DE,CONTRAST MEDIA ALLERGY,1
DE,CREATININE RENAL CLEARANCE DECREASED,1
DE,CUSHING^S SYNDROME,1
DE,CYANOSIS CENTRAL,1
DE,CYTOKINE RELEASE SYNDROME,1
DE,CYTOTOXIC CARDIOMYOPATHY,1
DE,DECREASED ACTIVITY,1
DE,DELIRIUM TREMENS,1
DE,DEMENTIA,1
DE,DEMENTIA ALZHEIMER^S TYPE,1
DE,DERMATITIS,1
DE,DERMATITIS BULLOUS,1
DE,DERMATOMYOSITIS,1
DE,DEVICE DISLOCATION,1
DE,DEVICE OCCLUSION,1
DE,DEVICE RELATED SEPSIS,1
DE,DEVICE USE ISSUE,1
DE,DIABETES INSIPIDUS,1
DE,DIABETES MELLITUS INADEQUATE CONTROL,1
DE,DIABETIC GASTROPATHY,1
DE,DIABETIC KETOACIDOSIS,1
DE,DIABETIC NEPHROPATHY,1
DE,DIABETIC RETINOPATHY,1
DE,DIARRHOEA HAEMORRHAGIC,1
DE,DIPLOPIA,1
DE,DISABILITY,1
DE,DISCOMFORT,1
DE,DISEASE RECURRENCE,1
DE,DISSEMINATED INTRAVASCULAR COAGULATION,1
DE,DIVERTICULUM INTESTINAL HAEMORRHAGIC,1
DE,DIZZINESS POSTURAL,1
DE,DRUG ABUSER,1
DE,DRUG EFFECT INCOMPLETE,1
DE,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
DE,DRUG LEVEL FLUCTUATING,1
DE,DRUG PRESCRIBING ERROR,1
DE,DRUG USE DISORDER,1
DE,DRY EYE,1
DE,DRY MOUTH,1
DE,DYSLIPIDAEMIA,1
DE,DYSPEPSIA,1
DE,DYSPHONIA,1
DE,ECCHYMOSIS,1
DE,ELECTROCARDIOGRAM ABNORMAL,1
DE,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,1
DE,ELECTROLYTE IMBALANCE,1
DE,ELECTROPHORESIS PROTEIN ABNORMAL,1
DE,EMBOLIC CEREBRAL INFARCTION,1
DE,EMOTIONAL DISORDER,1
DE,ENCEPHALOPATHY,1
DE,ENTERITIS,1
DE,ENTEROCOCCAL SEPSIS,1
DE,ENTEROCOLITIS,1
DE,EOSINOPHILIA,1
DE,EPIDERMOLYSIS,1
DE,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,1
DE,EPSTEIN-BARR VIRUS INFECTION,1
DE,EPSTEIN-BARR VIRUS TEST POSITIVE,1
DE,ESCHERICHIA INFECTION,1
DE,ESCHERICHIA SEPSIS,1
DE,EXERCISE TOLERANCE DECREASED,1
DE,EXTRAPYRAMIDAL DISORDER,1
DE,EXTRAVASATION,1
DE,EXTREMITY NECROSIS,1
DE,EYE DISORDER,1
DE,EYELID DISORDER,1
DE,FACE OEDEMA,1
DE,FACIAL PARESIS,1
DE,FAECES DISCOLOURED,1
DE,FEAR,1
DE,FEELING ABNORMAL,1
DE,FEELING COLD,1
DE,FEELING HOT,1
DE,FIBRIN D DIMER INCREASED,1
DE,FINGER AMPUTATION,1
DE,FLATULENCE,1
DE,FLUID INTAKE REDUCED,1
DE,FOOD ALLERGY,1
DE,FORCED EXPIRATORY VOLUME DECREASED,1
DE,FORCED VITAL CAPACITY DECREASED,1
DE,FREQUENT BOWEL MOVEMENTS,1
DE,FUNGAL SEPSIS,1
DE,GASTRIC DISORDER,1
DE,GASTROINTESTINAL ANGIODYSPLASIA,1
DE,GASTROINTESTINAL DISORDER,1
DE,GASTROINTESTINAL INFLAMMATION,1
DE,GENERAL PHYSICAL CONDITION ABNORMAL,1
DE,GENERALISED TONIC-CLONIC SEIZURE,1
DE,GENITAL ABSCESS,1
DE,GENITOURINARY TRACT NEOPLASM,1
DE,GINGIVAL BLEEDING,1
DE,GLAUCOMA,1
DE,GLOMERULAR FILTRATION RATE INCREASED,1
DE,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
DE,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,1
DE,GRANULOCYTOPENIA,1
DE,GRANULOMATOSIS WITH POLYANGIITIS,1
DE,H1N1 INFLUENZA,1
DE,HAEMODIALYSIS,1
DE,HAEMODYNAMIC TEST ABNORMAL,1
DE,HAEMOLYTIC ANAEMIA,1
DE,HAEMORRHAGIC ANAEMIA,1
DE,HAEMORRHAGIC STROKE,1
DE,HAEMORRHOIDS,1
DE,HAEMOSTASIS,1
DE,HAIR DISORDER,1
DE,HEART VALVE INCOMPETENCE,1
DE,HEMIANAESTHESIA,1
DE,HEPATIC CONGESTION,1
DE,HEPATIC ENCEPHALOPATHY,1
DE,HEPATIC STEATOSIS,1
DE,HEPATIC VEIN OCCLUSION,1
DE,HEPATITIS B,1
DE,HEPATITIS C,1
DE,HEPATITIS C RNA INCREASED,1
DE,HEPATOMEGALY,1
DE,HERPES SIMPLEX PNEUMONIA,1
DE,HERPES VIRUS INFECTION,1
DE,HIATUS HERNIA,1
DE,HIDRADENITIS,1
DE,HISTOLOGY ABNORMAL,1
DE,HOSPITALISATION,1
DE,HOT FLUSH,1
DE,HYDROCHOLECYSTIS,1
DE,HYPERCHOLESTEROLAEMIA,1
DE,HYPERTROPHY,1
DE,HYPERURICAEMIA,1
DE,HYPERVOLAEMIA,1
DE,HYPOALBUMINAEMIA,1
DE,HYPOPARATHYROIDISM,1
DE,HYPOPHAGIA,1
DE,HYPOPHOSPHATAEMIA,1
DE,HYPOPHYSITIS,1
DE,HYPOPNOEA,1
DE,HYPOVENTILATION,1
DE,ILEUS,1
DE,IMMOBILE,1
DE,IMMUNODEFICIENCY,1
DE,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,1
DE,INCORRECT DOSAGE ADMINISTERED,1
DE,INCORRECT DRUG ADMINISTRATION RATE,1
DE,INCREASED TENDENCY TO BRUISE,1
DE,INFECTION IN AN IMMUNOCOMPROMISED HOST,1
DE,INFERIOR VENA CAVA DILATATION,1
DE,INFLUENZA LIKE ILLNESS,1
DE,INFUSION SITE EXTRAVASATION,1
DE,INHIBITORY DRUG INTERACTION,1
DE,INTENTIONAL PRODUCT MISUSE,1
DE,INTERVERTEBRAL DISC OPERATION,1
DE,INTESTINAL ISCHAEMIA,1
DE,INTRA-ABDOMINAL HAEMATOMA,1
DE,INTRA-ABDOMINAL HAEMORRHAGE,1
DE,IRON DEFICIENCY,1
DE,ISCHAEMIA,1
DE,JAW FRACTURE,1
DE,JOINT CREPITATION,1
DE,JOINT DESTRUCTION,1
DE,JOINT DISLOCATION,1
DE,JOINT SWELLING,1
DE,JUGULAR VEIN DISTENSION,1
DE,KIDNEY ENLARGEMENT,1
DE,KLEBSIELLA SEPSIS,1
DE,LABORATORY TEST ABNORMAL,1
DE,LABORATORY TEST INTERFERENCE,1
DE,LACERATION,1
DE,LARGE INTESTINAL HAEMORRHAGE,1
DE,LARYNGITIS BACTERIAL,1
DE,LARYNGITIS FUNGAL,1
DE,LEG AMPUTATION,1
DE,LETHARGY,1
DE,LEUKOCYTOSIS,1
DE,LIMB DISCOMFORT,1
DE,LIP AND/OR ORAL CAVITY CANCER,1
DE,LIP SWELLING,1
DE,LIPIDS INCREASED,1
DE,LISTLESS,1
DE,LIVE BIRTH,1
DE,LIVER FUNCTION TEST ABNORMAL,1
DE,LIVER INJURY,1
DE,LOCAL SWELLING,1
DE,LOCALISED INFECTION,1
DE,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
DE,LUMBAR VERTEBRAL FRACTURE,1
DE,LUNG DISORDER,1
DE,LUPUS VASCULITIS,1
DE,LYMPHANGIECTASIA,1
DE,LYMPHANGIOSIS CARCINOMATOSA,1
DE,LYMPHOCYTE COUNT INCREASED,1
DE,LYMPHOMA,1
DE,MACULAR DEGENERATION,1
DE,MALIGNANT HYPERTENSION,1
DE,MALNUTRITION,1
DE,MEAN CELL VOLUME INCREASED,1
DE,MEDICAL DEVICE COMPLICATION,1
DE,MEMORY IMPAIRMENT,1
DE,MENORRHAGIA,1
DE,METASTASES TO KIDNEY,1
DE,METASTASES TO LIVER,1
DE,METASTASES TO LYMPH NODES,1
DE,METASTASES TO SPINE,1
DE,METASTASES TO THE MEDIASTINUM,1
DE,METASTATIC MALIGNANT MELANOMA,1
DE,MICTURITION URGENCY,1
DE,MITRAL VALVE DISEASE,1
DE,MONOPARESIS,1
DE,MORPHOEA,1
DE,MOVEMENT DISORDER,1
DE,MUCOSAL EROSION,1
DE,MUCOSAL HAEMORRHAGE,1
DE,MUCOSAL INFECTION,1
DE,MUSCLE ENZYME INCREASED,1
DE,MUSCULAR DYSTROPHY,1
DE,MUSCULOSKELETAL CHEST PAIN,1
DE,MUSCULOSKELETAL PAIN,1
DE,NAIL DISORDER,1
DE,NASAL DRYNESS,1
DE,NEOPLASM,1
DE,NEOPLASM SKIN,1
DE,NEPHROPATHY,1
DE,NEPHROPATHY TOXIC,1
DE,NEPHROTIC SYNDROME,1
DE,NEUROENDOCRINE CARCINOMA OF THE SKIN,1
DE,NEUROLEPTIC MALIGNANT SYNDROME,1
DE,NEUROLOGICAL DECOMPENSATION,1
DE,NEUROPATHY PERIPHERAL,1
DE,NEUTROPHIL COUNT DECREASED,1
DE,NIGHT SWEATS,1
DE,NOCTURIA,1
DE,NODAL ARRHYTHMIA,1
DE,NON-SMALL CELL LUNG CANCER STAGE II,1
DE,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
DE,OBSTRUCTIVE UROPATHY,1
DE,OCULAR HYPERAEMIA,1
DE,ODYNOPHAGIA,1
DE,OEDEMA DUE TO CARDIAC DISEASE,1
DE,OEDEMATOUS PANCREATITIS,1
DE,OESOPHAGEAL CARCINOMA,1
DE,OESOPHAGEAL PAIN,1
DE,OESOPHAGEAL POLYP,1
DE,OESOPHAGEAL STENOSIS,1
DE,OESOPHAGEAL ULCER,1
DE,OESOPHAGITIS,1
DE,OESOPHAGITIS ULCERATIVE,1
DE,ONYCHOLYSIS,1
DE,OPHTHALMIC HERPES ZOSTER,1
DE,OPPORTUNISTIC INFECTION,1
DE,OPTIC ATROPHY,1
DE,ORGANISING PNEUMONIA,1
DE,OROPHARYNGEAL PAIN,1
DE,ORTHOPNOEA,1
DE,OSTEOCHONDROSIS,1
DE,OSTEONECROSIS,1
DE,OSTEOPOROSIS,1
DE,OSTEOPOROTIC FRACTURE,1
DE,OVARIAN ADENOMA,1
DE,OVERWEIGHT,1
DE,PACKED RED BLOOD CELL TRANSFUSION,1
DE,PAIN IN JAW,1
DE,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
DE,PANCREATIC CARCINOMA,1
DE,PANCREATIC CARCINOMA METASTATIC,1
DE,PANCREATIC DISORDER,1
DE,PANCREATIC PSEUDOCYST,1
DE,PANCREATITIS NECROTISING,1
DE,PANCREATITIS RELAPSING,1
DE,PANNICULITIS,1
DE,PARAESTHESIA,1
DE,PARKINSON^S DISEASE,1
DE,PARTIAL SEIZURES,1
DE,PATHOLOGICAL FRACTURE,1
DE,PCO2 INCREASED,1
DE,PELVIC VENOUS THROMBOSIS,1
DE,PENILE OEDEMA,1
DE,PERICARDIAL DRAINAGE,1
DE,PERICARDIAL HAEMORRHAGE,1
DE,PERICARDITIS,1
DE,PERIODONTITIS,1
DE,PERIPHERAL ARTERY STENOSIS,1
DE,PERIPHERAL ARTERY THROMBOSIS,1
DE,PERIPHERAL ISCHAEMIA,1
DE,PERIPHERAL MOTOR NEUROPATHY,1
DE,PERIPHERAL VASCULAR DISORDER,1
DE,PERIRENAL HAEMATOMA,1
DE,PERITONITIS,1
DE,PERITONITIS BACTERIAL,1
DE,PERONEAL NERVE PALSY,1
DE,PH BODY FLUID DECREASED,1
DE,PHARYNGEAL HAEMORRHAGE,1
DE,PHOTOPSIA,1
DE,PLATELET COUNT INCREASED,1
DE,PLATELET DISTRIBUTION WIDTH DECREASED,1
DE,PLEUROTHOTONUS,1
DE,PNEUMATOSIS INTESTINALIS,1
DE,PNEUMONIA CYTOMEGALOVIRAL,1
DE,PNEUMONIA ESCHERICHIA,1
DE,PNEUMONIA VIRAL,1
DE,POLYMYOSITIS,1
DE,POLYP,1
DE,POST PROCEDURAL COMPLICATION,1
DE,POST PROCEDURAL HAEMATOMA,1
DE,POST PROCEDURAL MYOCARDIAL INFARCTION,1
DE,POSTOPERATIVE WOUND INFECTION,1
DE,PRESYNCOPE,1
DE,PRODUCT USE IN UNAPPROVED INDICATION,1
DE,PRODUCTIVE COUGH,1
DE,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
DE,PROSTATOMEGALY,1
DE,PROTEIN DEFICIENCY,1
GH,ANXIETY,1
GH,BLOOD PRESSURE DECREASED,1
GH,CHEST PAIN,1
GH,CONSTIPATION,1
GH,DEHYDRATION,1
GH,DYSPHAGIA,1
GH,FLUID OVERLOAD,1
GH,HYPERTENSION,1
GH,ILL-DEFINED DISORDER,1
GH,LUNG DISORDER,1
GH,PAIN,1
GH,PLEURAL EFFUSION,1
GH,POST PROCEDURAL DISCHARGE,1
GH,SCREAMING,1
GH,WEIGHT DECREASED,1
GH,WEIGHT INCREASED,1
GR,DYSPNOEA,32
GR,DRUG INEFFECTIVE,28
GR,OEDEMA PERIPHERAL,19
GR,RENAL IMPAIRMENT,19
GR,ACUTE KIDNEY INJURY,17
GR,CARDIAC FAILURE,17
GR,FATIGUE,16
GR,BLOOD CREATININE INCREASED,15
GR,DEATH,15
GR,DIARRHOEA,14
GR,HYPOTENSION,14
GR,PYREXIA,14
GR,RENAL FAILURE,13
GR,CONDITION AGGRAVATED,12
GR,HYPERKALAEMIA,12
GR,ATRIAL FIBRILLATION,11
GR,CARDIAC ARREST,11
GR,BLOOD UREA INCREASED,9
GR,HYPONATRAEMIA,9
GR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,9
GR,ASTHENIA,8
GR,PULMONARY OEDEMA,8
GR,ANAEMIA,7
GR,EJECTION FRACTION DECREASED,7
GR,HYPOKALAEMIA,7
GR,PNEUMONIA,7
GR,RESPIRATORY TRACT INFECTION,7
GR,URINE OUTPUT DECREASED,7
GR,BLOOD SODIUM DECREASED,6
GR,C-REACTIVE PROTEIN INCREASED,6
GR,CARDIAC FAILURE ACUTE,6
GR,DEHYDRATION,6
GR,FALL,6
GR,HAEMATOCRIT DECREASED,6
GR,SYNCOPE,6
GR,WEIGHT INCREASED,6
GR,ACUTE HEPATIC FAILURE,5
GR,ARRHYTHMIA,5
GR,CARDIO-RESPIRATORY ARREST,5
GR,DIZZINESS,5
GR,DRUG RESISTANCE,5
GR,DYSPNOEA AT REST,5
GR,GASTROINTESTINAL HAEMORRHAGE,5
GR,MENTAL IMPAIRMENT,5
GR,MITRAL VALVE INCOMPETENCE,5
GR,MYOCARDIAL INFARCTION,5
GR,PLEURAL EFFUSION,5
GR,SEPTIC SHOCK,5
GR,TOXICITY TO VARIOUS AGENTS,5
GR,VOMITING,5
GR,ABDOMINAL ADHESIONS,4
GR,ALANINE AMINOTRANSFERASE INCREASED,4
GR,ASPARTATE AMINOTRANSFERASE INCREASED,4
GR,BLOOD GLUCOSE INCREASED,4
GR,BLOOD POTASSIUM INCREASED,4
GR,BRAIN NATRIURETIC PEPTIDE INCREASED,4
GR,DISEASE PROGRESSION,4
GR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,4
GR,ELECTROLYTE IMBALANCE,4
GR,GAIT DISTURBANCE,4
GR,GRANULOMA,4
GR,HYPOXIA,4
GR,INFECTION,4
GR,JUGULAR VEIN DISTENSION,4
GR,OEDEMA,4
GR,PALPITATIONS,4
GR,PULMONARY ARTERIAL PRESSURE INCREASED,4
GR,PULMONARY HYPERTENSION,4
GR,RIGHT VENTRICULAR FAILURE,4
GR,ACUTE RESPIRATORY FAILURE,3
GR,ANGINA PECTORIS,3
GR,BLOOD ALKALINE PHOSPHATASE INCREASED,3
GR,BLOOD URIC ACID INCREASED,3
GR,CARDIAC DYSFUNCTION,3
GR,CARDIAC FAILURE CONGESTIVE,3
GR,CARDIAC MURMUR,3
GR,CEREBROVASCULAR ACCIDENT,3
GR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
GR,CONSTIPATION,3
GR,DERMATITIS EXFOLIATIVE,3
GR,DRUG CROSS-REACTIVITY,3
GR,DYSPNOEA EXERTIONAL,3
GR,ELECTROCARDIOGRAM QT PROLONGED,3
GR,FEBRILE NEUTROPENIA,3
GR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,3
GR,GENERAL PHYSICAL HEALTH DETERIORATION,3
GR,GENERALISED ERYTHEMA,3
GR,GLOMERULAR FILTRATION RATE DECREASED,3
GR,HAEMOGLOBIN DECREASED,3
GR,HAEMOPTYSIS,3
GR,HEPATIC FAILURE,3
GR,HYPERNATRAEMIA,3
GR,HYPERTENSION,3
GR,LACTIC ACIDOSIS,3
GR,LIMB INJURY,3
GR,METABOLIC ACIDOSIS,3
GR,MYDRIASIS,3
GR,ORTHOPNOEA,3
GR,PLASMA CELL MYELOMA,3
GR,RENAL FAILURE ACUTE,3
GR,RESPIRATORY FAILURE,3
GR,SEPSIS,3
GR,SOMNOLENCE,3
GR,THERAPY NON-RESPONDER,3
GR,THROMBOCYTOPENIA,3
GR,TRICUSPID VALVE INCOMPETENCE,3
GR,TROPONIN INCREASED,3
GR,URINARY TRACT INFECTION,3
GR,WEIGHT DECREASED,3
GR,ACUTE PULMONARY OEDEMA,2
GR,ALVEOLAR OXYGEN PARTIAL PRESSURE DECREASED,2
GR,ANION GAP INCREASED,2
GR,ASCITES,2
GR,ASTHMA,2
GR,ATRIOVENTRICULAR BLOCK,2
GR,BACTERAEMIA,2
GR,BLOOD BILIRUBIN INCREASED,2
GR,BLOOD CHLORIDE INCREASED,2
GR,BLOOD CREATININE ABNORMAL,2
GR,BUNDLE BRANCH BLOCK LEFT,2
GR,CHEST PAIN,2
GR,CHRONIC KIDNEY DISEASE,2
GR,COMA,2
GR,DEMENTIA,2
GR,DYSGEUSIA,2
GR,EAR INFECTION,2
GR,EXERCISE TOLERANCE DECREASED,2
GR,FAECES DISCOLOURED,2
GR,GENERALISED OEDEMA,2
GR,HAEMODYNAMIC INSTABILITY,2
GR,HAEMORRHAGE INTRACRANIAL,2
GR,HEPATIC ENZYME INCREASED,2
GR,HYPEROSMOLAR STATE,2
GR,HYPERSENSITIVITY,2
GR,HYPOALBUMINAEMIA,2
GR,HYPOGLYCAEMIA,2
GR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
GR,INSOMNIA,2
GR,INTERNATIONAL NORMALISED RATIO INCREASED,2
GR,ISCHAEMIC STROKE,2
GR,LIVER DISORDER,2
GR,LIVER FUNCTION TEST ABNORMAL,2
GR,LIVER INJURY,2
GR,LOWER RESPIRATORY TRACT INFECTION,2
GR,LUNG INFECTION,2
GR,LUNG NEOPLASM MALIGNANT,2
GR,MALIGNANT NEOPLASM PROGRESSION,2
GR,MUCOSAL DRYNESS,2
GR,MULTI-ORGAN FAILURE,2
GR,MYALGIA,2
GR,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED,2
GR,NEPHROPATHY,2
GR,NEUTROPENIA,2
GR,NORMOCHROMIC ANAEMIA,2
GR,NORMOCHROMIC NORMOCYTIC ANAEMIA,2
GR,OLIGURIA,2
GR,OSTEONECROSIS OF JAW,2
GR,OSTEOPOROSIS,2
GR,PAIN,2
GR,PEMPHIGOID,2
GR,PERICARDIAL EFFUSION,2
GR,PLEURISY,2
GR,PNEUMONITIS,2
GR,PRURITUS,2
GR,PULMONARY ARTERIAL HYPERTENSION,2
GR,PULMONARY CONGESTION,2
GR,RASH,2
GR,RED BLOOD CELL SEDIMENTATION RATE INCREASED,2
GR,RENAL DISORDER,2
GR,SHORT-BOWEL SYNDROME,2
GR,SKIN TURGOR DECREASED,2
GR,SLUGGISHNESS,2
GR,SUDDEN DEATH,2
GR,THROMBOSIS,2
GR,TREMOR,2
GR,WHITE BLOOD CELL COUNT INCREASED,2
GR,ABDOMINAL DISCOMFORT,1
GR,ABDOMINAL PAIN,1
GR,ABDOMINAL PAIN UPPER,1
GR,ABDOMINAL RIGIDITY,1
GR,ABORTION INDUCED,1
GR,ACNE,1
GR,ACUTE MYOCARDIAL INFARCTION,1
GR,ADVERSE EVENT,1
GR,AFFECTIVE DISORDER,1
GR,AGITATION,1
GR,AGRANULOCYTOSIS,1
GR,ALTERED STATE OF CONSCIOUSNESS,1
GR,AMMONIA INCREASED,1
GR,ANAL INCONTINENCE,1
GR,ANAPHYLACTIC SHOCK,1
GR,ANGINA UNSTABLE,1
GR,ANXIETY,1
GR,AORTIC ANEURYSM RUPTURE,1
GR,AORTIC DISSECTION,1
GR,AORTIC THROMBOSIS,1
GR,ARTERIOSCLEROSIS,1
GR,ARTHRALGIA,1
GR,ATRIAL THROMBOSIS,1
GR,ATRIOVENTRICULAR BLOCK COMPLETE,1
GR,BACK PAIN,1
GR,BALANCE DISORDER,1
GR,BASAL GANGLIA HAEMORRHAGE,1
GR,BILIARY COLIC,1
GR,BIOPSY LUNG ABNORMAL,1
GR,BLINDNESS,1
GR,BLOOD ALBUMIN INCREASED,1
GR,BLOOD BILIRUBIN ABNORMAL,1
GR,BLOOD CHLORIDE DECREASED,1
GR,BLOOD CHOLESTEROL ABNORMAL,1
GR,BLOOD CHOLESTEROL INCREASED,1
GR,BLOOD GLUCOSE DECREASED,1
GR,BLOOD POTASSIUM ABNORMAL,1
GR,BLOOD SODIUM ABNORMAL,1
GR,BRADYCARDIA,1
GR,BRAIN OEDEMA,1
GR,BRONCHITIS,1
GR,CARDIAC DISORDER,1
GR,CARDIAC FAILURE CHRONIC,1
GR,CARDIAC TAMPONADE,1
GR,CARDIAC VALVE DISEASE,1
GR,CARDIORENAL SYNDROME,1
GR,CARDIOVASCULAR DISORDER,1
GR,CATARACT,1
GR,CATHETER SITE INFECTION,1
GR,CEREBRAL ATROPHY,1
GR,CEREBRAL HAEMORRHAGE,1
GR,CHEST DISCOMFORT,1
GR,CHILLS,1
GR,CHOLECYSTITIS ACUTE,1
GR,CHROMATURIA,1
GR,COMPLICATION ASSOCIATED WITH DEVICE,1
GR,COMPUTERISED TOMOGRAM THORAX ABNORMAL,1
GR,CONFUSIONAL STATE,1
GR,CONTRAINDICATED PRODUCT ADMINISTERED,1
GR,CONTUSION,1
GR,CORONA VIRUS INFECTION,1
GR,CORONARY ARTERY THROMBOSIS,1
GR,CUSHING^S SYNDROME,1
GR,CYANOSIS,1
GR,CYSTITIS,1
GR,DEAFNESS,1
GR,DEAFNESS TRANSITORY,1
GR,DECREASED APPETITE,1
GR,DECUBITUS ULCER,1
GR,DELUSION,1
GR,DEPRESSED LEVEL OF CONSCIOUSNESS,1
GR,DERMATITIS,1
GR,DERMATITIS ALLERGIC,1
GR,DEVICE INTERACTION,1
GR,DEVICE OCCLUSION,1
GR,DEVICE RELATED INFECTION,1
GR,DIPLEGIA,1
GR,DISORIENTATION,1
GR,DIVERTICULITIS,1
GR,DIVERTICULUM,1
GR,DRUG INTOLERANCE,1
GR,DYSKINESIA,1
GR,DYSPEPSIA,1
GR,DYSPHAGIA,1
GR,DYSSTASIA,1
GR,ELECTROCARDIOGRAM ST SEGMENT ABNORMAL,1
GR,ELECTROCARDIOGRAM T WAVE INVERSION,1
GR,EMBOLIC STROKE,1
GR,END STAGE RENAL DISEASE,1
GR,ENTERITIS,1
GR,EOSINOPHILIA,1
GR,EPISTAXIS,1
GR,ERYTHEMA,1
GR,ESCHERICHIA URINARY TRACT INFECTION,1
GR,EXOSTOSIS OF JAW,1
GR,EXPIRED PRODUCT ADMINISTERED,1
GR,EXPOSED BONE IN JAW,1
GR,EXPOSURE DURING PREGNANCY,1
GR,EYE MOVEMENT DISORDER,1
GR,EYELID OEDEMA,1
GR,FACE OEDEMA,1
GR,FISTULA,1
GR,FLUID OVERLOAD,1
GR,FUNCTIONAL RESIDUAL CAPACITY,1
GR,FUNGAL OESOPHAGITIS,1
GR,GAIT INABILITY,1
GR,GASTRIC HAEMORRHAGE,1
GR,GASTROENTERITIS,1
GR,GASTROINTESTINAL INFLAMMATION,1
GR,GENERALISED TONIC-CLONIC SEIZURE,1
GR,HAEMATOCHEZIA,1
GR,HAEMATOCRIT ABNORMAL,1
GR,HAEMATURIA,1
GR,HAEMODIALYSIS,1
GR,HAEMOLYSIS,1
GR,HAEMOLYTIC URAEMIC SYNDROME,1
GR,HAEMORRHOIDAL HAEMORRHAGE,1
GR,HEAD INJURY,1
GR,HEPATIC ENCEPHALOPATHY,1
GR,HEPATITIS CHOLESTATIC,1
GR,HEPATOCELLULAR CARCINOMA,1
GR,HIP FRACTURE,1
GR,HOSPITALISATION,1
GR,HYDROCEPHALUS,1
GR,HYPERAEMIA,1
GR,HYPERCALCAEMIA,1
GR,HYPERGLYCAEMIA,1
GR,HYPERKINESIA,1
GR,HYPERVOLAEMIA,1
GR,HYPOAESTHESIA,1
GR,HYPOCHLORAEMIA,1
GR,HYPOPHAGIA,1
GR,HYPOPHOSPHATAEMIA,1
GR,ILEUS PARALYTIC,1
GR,INCORRECT DOSE ADMINISTERED,1
GR,INCREASED APPETITE,1
GR,INJURY,1
GR,INTENTIONAL PRODUCT MISUSE,1
GR,INTERSTITIAL LUNG DISEASE,1
GR,INTERVERTEBRAL DISC PROTRUSION,1
GR,INTESTINAL PERFORATION,1
GR,INTESTINAL POLYP,1
GR,INTRAOCULAR PRESSURE INCREASED,1
GR,JAUNDICE,1
GR,JAUNDICE CHOLESTATIC,1
GR,JOINT SWELLING,1
GR,KLEBSIELLA INFECTION,1
GR,LACERATION,1
GR,LEFT VENTRICULAR DYSFUNCTION,1
GR,LIP OEDEMA,1
GR,LIVER PALPABLE,1
GR,LOSS OF CONSCIOUSNESS,1
GR,LUNG INFILTRATION,1
GR,MALAISE,1
GR,MEDICATION ERROR,1
GR,MELAENA,1
GR,METABOLIC ALKALOSIS,1
GR,METASTATIC GASTRIC CANCER,1
GR,MOBILITY DECREASED,1
GR,MOOD SWINGS,1
GR,MUCOSAL INFLAMMATION,1
GR,MUSCULAR WEAKNESS,1
GR,MUSCULOSKELETAL CHEST PAIN,1
GR,MYOCARDIAL ISCHAEMIA,1
GR,MYOPATHY,1
GR,NASOPHARYNGITIS,1
GR,NAUSEA,1
GR,NEPHROPATHY TOXIC,1
GR,NEUTROPHIL COUNT INCREASED,1
GR,NO THERAPEUTIC RESPONSE,1
GR,NOSOCOMIAL INFECTION,1
GR,OSTEOLYSIS,1
GR,OXYGEN SATURATION DECREASED,1
GR,PAIN IN EXTREMITY,1
GR,PAIN IN JAW,1
GR,PALLOR,1
GR,PARAESTHESIA,1
GR,PARALYSIS,1
GR,PARKINSON^S DISEASE,1
GR,PERICARDITIS,1
GR,PERICARDITIS CONSTRICTIVE,1
GR,PERIPHERAL VASCULAR DISORDER,1
GR,PHARYNGITIS,1
GR,PHOTOSENSITIVITY REACTION,1
GR,PNEUMONIA ASPIRATION,1
GR,PNEUMOTHORAX,1
GR,POLYCYTHAEMIA,1
GR,PORTAL VEIN THROMBOSIS,1
GR,POST PROCEDURAL HAEMORRHAGE,1
GR,PRESYNCOPE,1
GR,PRODUCT PACKAGING ISSUE,1
GR,PRODUCT PHYSICAL ISSUE,1
GR,PRODUCT TASTE ABNORMAL,1
GR,PRODUCT USE ISSUE,1
GR,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
GR,PROTEIN TOTAL DECREASED,1
GR,PROTHROMBIN TIME PROLONGED,1
GR,PULMONARY EMBOLISM,1
GR,PULMONARY FIBROSIS,1
GR,PULMONARY HAEMORRHAGE,1
GR,PURULENT DISCHARGE,1
GR,RALES,1
GR,RED BLOOD CELL COUNT DECREASED,1
GR,RENAL ARTERY STENOSIS,1
GR,RESPIRATORY DISTRESS,1
GR,RETCHING,1
GR,RETINAL ARTERY OCCLUSION,1
GR,RHABDOMYOLYSIS,1
GR,SEDATION,1
GR,SEIZURE,1
GR,SENSORY DISTURBANCE,1
GR,SHOCK,1
GR,SKIN DISCOLOURATION,1
GR,SKIN INFECTION,1
GR,SPINAL PAIN,1
GR,SQUAMOUS CELL CARCINOMA,1
GR,STATUS EPILEPTICUS,1
GR,STOMA SITE ERYTHEMA,1
GR,SUBDURAL HAEMATOMA,1
GR,SUDDEN CARDIAC DEATH,1
GR,SWELLING,1
GR,TACHYARRHYTHMIA,1
GR,TACHYCARDIA,1
GR,TACHYPNOEA,1
GR,TERMINAL STATE,1
GR,THERAPY CHANGE,1
GR,THROAT IRRITATION,1
GR,TONGUE OEDEMA,1
GR,TOXIC EPIDERMAL NECROLYSIS,1
GR,TRAUMATIC HAEMORRHAGE,1
GR,TREATMENT FAILURE,1
GR,TROPONIN I INCREASED,1
GR,ULTRAFILTRATION FAILURE,1
GR,URINARY INCONTINENCE,1
GR,URINE OSMOLARITY INCREASED,1
GR,URINE PHOSPHORUS INCREASED,1
GR,URINE POTASSIUM INCREASED,1
GR,URTICARIA,1
GR,VENTRICULAR ARRHYTHMIA,1
GR,VENTRICULAR HYPOKINESIA,1
GR,VENTRICULAR TACHYCARDIA,1
GR,VIRAL INFECTION,1
GR,VISION BLURRED,1
GR,WHEEZING,1
GR,WITHDRAWAL SYNDROME,1
GT,ACUTE RESPIRATORY FAILURE,1
GT,ANAPHYLACTIC REACTION,1
GT,ATRIAL FIBRILLATION,1
GT,CARDIAC FAILURE CONGESTIVE,1
GT,CEREBRAL ATROPHY,1
GT,CEREBRAL INFARCTION,1
GT,DISEASE PROGRESSION,1
GT,DYSPHAGIA,1
GT,GAIT INABILITY,1
GT,HYPOPHAGIA,1
GT,MALAISE,1
GT,MESENTERIC VEIN THROMBOSIS,1
GT,OROPHARYNGEAL CANDIDIASIS,1
GT,PNEUMONIA,1
GT,PRESCRIBED UNDERDOSE,1
GT,PRODUCT USE COMPLAINT,1
GT,PULMONARY EMBOLISM,1
GT,RESPIRATORY DISORDER,1
GT,SEPTIC SHOCK,1
GT,SOMNOLENCE,1
GT,STRIDOR,1
GT,THROAT IRRITATION,1
GT,TOXICITY TO VARIOUS AGENTS,1
GT,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
HT,ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC,1
HT,DECREASED APPETITE,1
HT,DRUG DOSE OMISSION,1
HT,HERBAL INTERACTION,1
HT,INTERNATIONAL NORMALISED RATIO INCREASED,1
HN,DEATH,2
HN,CARDIAC DISORDER,1
HN,CARDIAC FAILURE,1
HN,CARDIAC FAILURE CONGESTIVE,1
HN,CONGESTIVE CARDIOMYOPATHY,1
HN,DYSPNOEA,1
HN,FLUID RETENTION,1
HN,HAEMOGLOBIN DECREASED,1
HN,OEDEMA,1
HN,PLATELET COUNT DECREASED,1
HN,WHITE BLOOD CELL COUNT DECREASED,1
HK,ANAEMIA,4
HK,DELIRIUM,3
HK,DIARRHOEA,3
HK,ABDOMINAL DISTENSION,2
HK,ACUTE KIDNEY INJURY,2
HK,APLASIA PURE RED CELL,2
HK,CARDIAC FAILURE,2
HK,COAGULOPATHY,2
HK,DEHYDRATION,2
HK,GENERAL PHYSICAL HEALTH DETERIORATION,2
HK,HAEMOGLOBIN DECREASED,2
HK,MALAISE,2
HK,METABOLIC ACIDOSIS,2
HK,MULTI-ORGAN FAILURE,2
HK,MUSCLE HAEMORRHAGE,2
HK,NEUROPATHY PERIPHERAL,2
HK,NEUROTOXICITY,2
HK,OEDEMA PERIPHERAL,2
HK,RENAL IMPAIRMENT,2
HK,RETROPERITONEAL HAEMATOMA,2
HK,SHOCK,2
HK,TOXICITY TO VARIOUS AGENTS,2
HK,ABDOMINAL PAIN,1
HK,ACOUSTIC NEUROMA,1
HK,ACUTE HEPATIC FAILURE,1
HK,ADENOCARCINOMA GASTRIC,1
HK,ANGIOEDEMA,1
HK,ANURIA,1
HK,BLOOD CREATININE INCREASED,1
HK,BLOOD SODIUM INCREASED,1
HK,BLOOD UREA INCREASED,1
HK,CARDIAC ARREST,1
HK,CARDIAC NEOPLASM UNSPECIFIED,1
HK,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
HK,CIRCULATORY COLLAPSE,1
HK,COMA SCALE ABNORMAL,1
HK,CONFUSIONAL STATE,1
HK,DEATH,1
HK,DECREASED APPETITE,1
HK,DIZZINESS,1
HK,DYSARTHRIA,1
HK,DYSPNOEA,1
HK,FLUID RETENTION,1
HK,HYPERGLYCAEMIA,1
HK,HYPOCHROMIC ANAEMIA,1
HK,HYPOTENSION,1
HK,IMPAIRED HEALING,1
HK,INTERNATIONAL NORMALISED RATIO DECREASED,1
HK,INTERNATIONAL NORMALISED RATIO INCREASED,1
HK,INTESTINAL ISCHAEMIA,1
HK,JAUNDICE,1
HK,LACTIC ACIDOSIS,1
HK,LEFT VENTRICULAR FAILURE,1
HK,MALIGNANT NEOPLASM PROGRESSION,1
HK,MASS,1
HK,METABOLIC ENCEPHALOPATHY,1
HK,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
HK,NAUSEA,1
HK,NEPHROGENIC DIABETES INSIPIDUS,1
HK,OLIGURIA,1
HK,ORTHOPNOEA,1
HK,OVARIAN NEOPLASM,1
HK,PAIN IN EXTREMITY,1
HK,PALLOR,1
HK,PANCYTOPENIA,1
HK,PARONYCHIA,1
HK,PLATELET COUNT DECREASED,1
HK,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
HK,PNEUMONIA,1
HK,RASH,1
HK,RESPIRATORY DISTRESS,1
HK,RESPIRATORY FAILURE,1
HK,SUPERINFECTION,1
HK,TACHYARRHYTHMIA,1
HK,THROMBOCYTOPENIA,1
HK,TOXIC EPIDERMAL NECROLYSIS,1
HK,UPPER GASTROINTESTINAL HAEMORRHAGE,1
HK,VISION BLURRED,1
HK,VOMITING,1
HK,WOUND INFECTION FUNGAL,1
HK,ZYGOMYCOSIS,1
HU,RIGHT VENTRICULAR FAILURE,10
HU,DYSPNOEA,9
HU,PNEUMONIA,8
HU,DEATH,7
HU,CARDIAC FAILURE,6
HU,DIARRHOEA,6
HU,ANAEMIA,5
HU,ASTHENIA,5
HU,COUGH,5
HU,DEHYDRATION,5
HU,RESPIRATORY FAILURE,5
HU,ATRIAL FIBRILLATION,4
HU,BLOOD PRESSURE INCREASED,4
HU,CARDIOPULMONARY FAILURE,4
HU,CHEST PAIN,4
HU,CIRCULATORY COLLAPSE,4
HU,DISEASE PROGRESSION,4
HU,HEPATIC FAILURE,4
HU,OEDEMA PERIPHERAL,4
HU,PYREXIA,4
HU,VOMITING,4
HU,ACUTE MYOCARDIAL INFARCTION,3
HU,BLOOD CREATINE PHOSPHOKINASE INCREASED,3
HU,CARDIAC ARREST,3
HU,CONDITION AGGRAVATED,3
HU,HYPERHIDROSIS,3
HU,HYPOKALAEMIA,3
HU,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,3
HU,PERIPHERAL ISCHAEMIA,3
HU,PERIPHERAL SWELLING,3
HU,PULMONARY ARTERIAL HYPERTENSION,3
HU,SEPTIC SHOCK,3
HU,VENTRICULAR FIBRILLATION,3
HU,ALANINE AMINOTRANSFERASE INCREASED,2
HU,ASPARTATE AMINOTRANSFERASE INCREASED,2
HU,ATRIAL THROMBOSIS,2
HU,ATRIOVENTRICULAR BLOCK,2
HU,AUTOIMMUNE HAEMOLYTIC ANAEMIA,2
HU,BLOOD ALKALINE PHOSPHATASE INCREASED,2
HU,BLOOD CREATININE INCREASED,2
HU,BLOOD GLUCOSE INCREASED,2
HU,BLOOD UREA INCREASED,2
HU,CARDIAC FAILURE CONGESTIVE,2
HU,CEREBROVASCULAR ACCIDENT,2
HU,CLOSTRIDIUM DIFFICILE COLITIS,2
HU,CONCOMITANT DISEASE PROGRESSION,2
HU,DEEP VEIN THROMBOSIS,2
HU,DIZZINESS,2
HU,DRUG HYPERSENSITIVITY,2
HU,DRUG PRESCRIBING ERROR,2
HU,EPISTAXIS,2
HU,FATIGUE,2
HU,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
HU,GASTROINTESTINAL HAEMORRHAGE,2
HU,HAEMATOCRIT DECREASED,2
HU,HEPATIC ENZYME INCREASED,2
HU,HYPONATRAEMIA,2
HU,INFECTIOUS PLEURAL EFFUSION,2
HU,ISCHAEMIC STROKE,2
HU,LOCAL SWELLING,2
HU,MELAENA,2
HU,NAUSEA,2
HU,PEMPHIGOID,2
HU,PRURITUS,2
HU,PULMONARY FIBROSIS,2
HU,PULMONARY HYPERTENSION,2
HU,RENAL FAILURE,2
HU,RENAL IMPAIRMENT,2
HU,RIGHT VENTRICULAR SYSTOLIC PRESSURE INCREASED,2
HU,SEPSIS,2
HU,THROMBOCYTOPENIA,2
HU,TOXIC SKIN ERUPTION,2
HU,ACUTE KIDNEY INJURY,1
HU,ACUTE MYELOID LEUKAEMIA,1
HU,AGITATION,1
HU,AORTIC STENOSIS,1
HU,ARTHRALGIA,1
HU,ASCITES,1
HU,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
HU,ATYPICAL TERATOID/RHABDOID TUMOUR OF CNS,1
HU,AUTOIMMUNE DISORDER,1
HU,AZOTAEMIA,1
HU,BLOOD BILIRUBIN INCREASED,1
HU,BLOOD LACTATE DEHYDROGENASE INCREASED,1
HU,BLOOD PRESSURE DECREASED,1
HU,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
HU,BRAIN CONTUSION,1
HU,BREAST CANCER,1
HU,BRONCHITIS,1
HU,C-REACTIVE PROTEIN INCREASED,1
HU,CACHEXIA,1
HU,CLOSTRIDIUM DIFFICILE SEPSIS,1
HU,CONTRAINDICATED PRODUCT ADMINISTERED,1
HU,DECREASED APPETITE,1
HU,DERMATITIS,1
HU,DERMATITIS BULLOUS,1
HU,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
HU,DRUG INEFFECTIVE,1
HU,DYSGEUSIA,1
HU,ELECTROCARDIOGRAM PQ INTERVAL PROLONGED,1
HU,ELECTROCARDIOGRAM QT PROLONGED,1
HU,EPILEPSY,1
HU,ERYTHEMA,1
HU,FACE OEDEMA,1
HU,FAECES DISCOLOURED,1
HU,FEBRILE NEUTROPENIA,1
HU,FLUID RETENTION,1
HU,GANGRENE,1
HU,GASTRIC HAEMORRHAGE,1
HU,GASTROINTESTINAL INFECTION,1
HU,GASTROINTESTINAL MOTILITY DISORDER,1
HU,GASTROINTESTINAL MUCOSAL EXFOLIATION,1
HU,GENERALISED OEDEMA,1
HU,GLOMERULAR FILTRATION RATE DECREASED,1
HU,HAEMATEMESIS,1
HU,HAEMATOCHEZIA,1
HU,HAEMORRHAGIC TRANSFORMATION STROKE,1
HU,HEPATITIS FULMINANT,1
HU,HEPATOMEGALY,1
HU,HEPATORENAL SYNDROME,1
HU,HYDROTHORAX,1
HU,HYPERBILIRUBINAEMIA,1
HU,HYPERSENSITIVITY,1
HU,HYPERTENSION,1
HU,HYPERTENSIVE CRISIS,1
HU,HYPOALBUMINAEMIA,1
HU,HYPOKINESIA,1
HU,HYPOTONIA,1
HU,ILEUS PARALYTIC,1
HU,ILIAC ARTERY OCCLUSION,1
HU,IMMUNOSUPPRESSION,1
HU,INFLAMMATION,1
HU,JAUNDICE,1
HU,KLEBSIELLA TEST POSITIVE,1
HU,LARYNGEAL CANCER,1
HU,LEFT VENTRICULAR FAILURE,1
HU,LIP INJURY,1
HU,LIVER DISORDER,1
HU,LUNG TRANSPLANT,1
HU,MACULE,1
HU,MALIGNANT NEOPLASM PROGRESSION,1
HU,MEGACOLON,1
HU,METASTASES TO BONE,1
HU,METASTASES TO BONE MARROW,1
HU,MUSCLE HAEMORRHAGE,1
HU,MYOCARDIAL ISCHAEMIA,1
HU,NASAL INJURY,1
HU,NEPHROCALCINOSIS,1
HU,NEUROTOXICITY,1
HU,NEUTROPHIL COUNT INCREASED,1
HU,OEDEMA,1
HU,OESOPHAGEAL ULCER,1
HU,OESOPHAGEAL ULCER HAEMORRHAGE,1
HU,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
HU,PERITONITIS BACTERIAL,1
HU,PLATELET COUNT DECREASED,1
HU,PNEUMOTHORAX,1
HU,PRODUCT CONTAINER ISSUE,1
HU,PRODUCT USE ISSUE,1
HU,PULMONARY CONGESTION,1
HU,PULMONARY EMBOLISM,1
HU,RASH,1
HU,RECTAL ADENOCARCINOMA,1
HU,RED BLOOD CELL COUNT DECREASED,1
HU,REFUSAL OF EXAMINATION,1
HU,RESPIRATORY ARREST,1
HU,ROAD TRAFFIC ACCIDENT,1
HU,SHUNT OCCLUSION,1
HU,SKIN ULCER,1
HU,SPLENOMEGALY,1
HU,STAPHYLOCOCCAL INFECTION,1
HU,STOMATITIS,1
HU,SUDDEN DEATH,1
HU,SWELLING FACE,1
HU,SYNCOPE,1
HU,TINNITUS,1
HU,TOXICITY TO VARIOUS AGENTS,1
HU,TRANSAMINASES INCREASED,1
HU,TUBULOINTERSTITIAL NEPHRITIS,1
HU,UNDERDOSE,1
HU,UPPER RESPIRATORY TRACT INFECTION,1
HU,VASCULITIS,1
HU,VIRAL INFECTION,1
HU,VISUAL IMPAIRMENT,1
HU,WHITE BLOOD CELL COUNT DECREASED,1
HU,WHITE BLOOD CELL COUNT INCREASED,1
IS,ABDOMINAL DISCOMFORT,1
IS,ABDOMINAL DISTENSION,1
IS,ARRHYTHMIA,1
IS,BRADYCARDIA,1
IS,DRUG INTOLERANCE,1
IS,DRUG-INDUCED LIVER INJURY,1
IS,LIVER FUNCTION TEST INCREASED,1
IS,LUNG ADENOCARCINOMA,1
IS,NON-CARDIAC CHEST PAIN,1
IS,PLEURAL EFFUSION,1
IN,DYSPNOEA,9
IN,PULMONARY OEDEMA,8
IN,CONFUSIONAL STATE,7
IN,DECREASED APPETITE,7
IN,DIZZINESS,7
IN,ANAL INCONTINENCE,6
IN,ASTHENIA,6
IN,BLOOD CREATININE INCREASED,6
IN,HEADACHE,6
IN,HYPOKALAEMIA,6
IN,SEROTONIN SYNDROME,6
IN,TORSADE DE POINTES,6
IN,URINARY INCONTINENCE,6
IN,ACUTE KIDNEY INJURY,5
IN,DRUG LEVEL INCREASED,5
IN,HICCUPS,5
IN,MENTAL STATUS CHANGES,5
IN,ABDOMINAL DISTENSION,4
IN,CARDIAC FAILURE,4
IN,DISEASE PROGRESSION,4
IN,DRUG INEFFECTIVE,4
IN,FOETAL EXPOSURE DURING PREGNANCY,4
IN,RENAL FAILURE,4
IN,RENAL FAILURE ACUTE,4
IN,RHABDOMYOLYSIS,4
IN,ALTERED STATE OF CONSCIOUSNESS,3
IN,ANAEMIA,3
IN,DISORIENTATION,3
IN,ELECTROCARDIOGRAM QT PROLONGED,3
IN,EXPOSURE DURING PREGNANCY,3
IN,GINGIVAL HYPERTROPHY,3
IN,HYPERKALAEMIA,3
IN,HYPERTENSION,3
IN,HYPOTENSION,3
IN,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,3
IN,LOW BIRTH WEIGHT BABY,3
IN,LOWER RESPIRATORY TRACT INFECTION,3
IN,MATERNAL EXPOSURE DURING PREGNANCY,3
IN,MEAN ARTERIAL PRESSURE DECREASED,3
IN,PREMATURE BABY,3
IN,RENAL FAILURE CHRONIC,3
IN,SUDDEN DEATH,3
IN,UNDERDOSE,3
IN,ASCITES,2
IN,CARDIO-RESPIRATORY ARREST,2
IN,CARDIOMEGALY,2
IN,CHEST PAIN,2
IN,CONCOMITANT DISEASE PROGRESSION,2
IN,CORONARY ARTERY DISEASE,2
IN,DIARRHOEA,2
IN,DRUG ABUSE,2
IN,GAIT DISTURBANCE,2
IN,HAEMATOCRIT DECREASED,2
IN,HEPATIC ENCEPHALOPATHY,2
IN,HYPERCALCAEMIA,2
IN,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,2
IN,KIDNEY TRANSPLANT REJECTION,2
IN,LYMPHOCYTE PERCENTAGE DECREASED,2
IN,MUSCLE SPASMS,2
IN,NEPHROPATHY,2
IN,NODAL ARRHYTHMIA,2
IN,OEDEMA,2
IN,OLIGOHYDRAMNIOS,2
IN,PANCREATITIS ACUTE,2
IN,PERIPHERAL SWELLING,2
IN,PRODUCT USE ISSUE,2
IN,RENAL IMPAIRMENT,2
IN,STROKE VOLUME DECREASED,2
IN,TOXICITY TO VARIOUS AGENTS,2
IN,TREATMENT FAILURE,2
IN,VASCULAR RESISTANCE SYSTEMIC DECREASED,2
IN,VENTRICULAR TACHYCARDIA,2
IN,VOMITING,2
IN,WHITE BLOOD CELL COUNT INCREASED,2
IN,ACIDOSIS HYPERCHLORAEMIC,1
IN,ACUTE CORONARY SYNDROME,1
IN,ACUTE MYOCARDIAL INFARCTION,1
IN,ANISOCYTOSIS,1
IN,ATRIAL FLUTTER,1
IN,ATRIOVENTRICULAR DISSOCIATION,1
IN,BACK INJURY,1
IN,BACTERIAL INFECTION,1
IN,BLOOD ALKALINE PHOSPHATASE DECREASED,1
IN,BLOOD BICARBONATE DECREASED,1
IN,BLOOD POTASSIUM DECREASED,1
IN,BLOOD PRESSURE INCREASED,1
IN,BLOOD SODIUM DECREASED,1
IN,BLOOD UREA INCREASED,1
IN,BRADYCARDIA FOETAL,1
IN,BUNDLE BRANCH BLOCK LEFT,1
IN,CAPILLARITIS,1
IN,CARDIAC ARREST,1
IN,CARDIAC DISORDER,1
IN,CARDIAC FAILURE CONGESTIVE,1
IN,CARDIAC TAMPONADE,1
IN,CAROTID ARTERY STENOSIS,1
IN,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
IN,COAGULOPATHY,1
IN,COMPLICATIONS OF TRANSPLANTED KIDNEY,1
IN,CONCOMITANT DISEASE AGGRAVATED,1
IN,CONDITION AGGRAVATED,1
IN,COUNTERFEIT DRUG ADMINISTERED,1
IN,CREPITATIONS,1
IN,CRYING,1
IN,CYANOSIS,1
IN,DELUSIONAL PERCEPTION,1
IN,DEPRESSION,1
IN,DEVICE MALFUNCTION,1
IN,DIABETES MELLITUS,1
IN,DIABETES MELLITUS INADEQUATE CONTROL,1
IN,DIABETIC NEPHROPATHY,1
IN,DIABETIC RETINOPATHY,1
IN,DIARRHOEA HAEMORRHAGIC,1
IN,DISCOMFORT,1
IN,DRUG PRESCRIBING ERROR,1
IN,DRUG USE DISORDER,1
IN,DRY MOUTH,1
IN,DYSENTERY,1
IN,DYSLIPIDAEMIA,1
IN,DYSPNOEA EXERTIONAL,1
IN,EJECTION FRACTION DECREASED,1
IN,ELECTROCARDIOGRAM ABNORMAL,1
IN,ELECTROCARDIOGRAM PR SHORTENED,1
IN,ELECTROCARDIOGRAM R ON T PHENOMENON,1
IN,ELECTROLYTE IMBALANCE,1
IN,EMBOLIC STROKE,1
IN,ERYTHEMA,1
IN,EXTRASYSTOLES,1
IN,FALL,1
IN,FLUID OVERLOAD,1
IN,FOETAL DISTRESS SYNDROME,1
IN,FRACTURE,1
IN,GAIT INABILITY,1
IN,GASTROINTESTINAL HAEMORRHAGE,1
IN,GENERALISED OEDEMA,1
IN,GLOMERULONEPHRITIS,1
IN,GRANULOMATOSIS WITH POLYANGIITIS,1
IN,GRUNTING,1
IN,HAEMANGIOMA,1
IN,HAEMATURIA,1
IN,HAEMODIALYSIS,1
IN,HAEMOGLOBIN DECREASED,1
IN,HAEMOPTYSIS,1
IN,HAEMORRHAGIC STROKE,1
IN,HEAD INJURY,1
IN,HEART RATE DECREASED,1
IN,HEPATIC FUNCTION ABNORMAL,1
IN,HEPATIC STEATOSIS,1
IN,HYPERCHLORHYDRIA,1
IN,HYPERGLYCAEMIA,1
IN,HYPERNATRAEMIA,1
IN,HYPOAESTHESIA,1
IN,HYPOGLYCAEMIA,1
IN,HYPONATRAEMIA,1
IN,INFECTION,1
IN,INFLAMMATION,1
IN,INSOMNIA,1
IN,INTENTIONAL OVERDOSE,1
IN,INTRACARDIAC THROMBUS,1
IN,ISCHAEMIC CEREBRAL INFARCTION,1
IN,JOINT STIFFNESS,1
IN,KIDNEY FIBROSIS,1
IN,LACUNAR INFARCTION,1
IN,LIP OEDEMA,1
IN,LUNG INFILTRATION,1
IN,MACROCYTOSIS,1
IN,METABOLIC ACIDOSIS,1
IN,MUCORMYCOSIS,1
IN,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
IN,MUSCLE TIGHTNESS,1
IN,MUSCULOSKELETAL PAIN,1
IN,MYALGIA,1
IN,NEPHROPATHY TOXIC,1
IN,NEUTROPHIL PERCENTAGE INCREASED,1
IN,NODAL RHYTHM,1
IN,NODULE,1
IN,OEDEMA PERIPHERAL,1
IN,ORTHOSTATIC HYPOTENSION,1
IN,PACKED RED BLOOD CELL TRANSFUSION,1
IN,PAIN,1
IN,PANCREATITIS,1
IN,PANCREATITIS RELAPSING,1
IN,PERIODONTITIS,1
IN,PERIORBITAL OEDEMA,1
IN,PLATELET COUNT DECREASED,1
IN,PLEURAL EFFUSION,1
IN,PNEUMOTHORAX,1
IN,POLYNEUROPATHY,1
IN,PREMATURE DELIVERY,1
IN,PRODUCT USE IN UNAPPROVED INDICATION,1
IN,PROSTATOMEGALY,1
IN,PROTEIN TOTAL DECREASED,1
IN,PROTHROMBIN CONSUMPTION TIME SHORTENED,1
IN,PSEUDOMONAS INFECTION,1
IN,PULMONARY ALVEOLAR HAEMORRHAGE,1
IN,PYODERMA GANGRENOSUM,1
IN,PYREXIA,1
IN,QUADRIPLEGIA,1
IN,RENAL CORTICAL NECROSIS,1
IN,RENAL CYST,1
IN,RENAL TUBULAR NECROSIS,1
IN,RESPIRATORY DISTRESS,1
IN,SEBACEOUS CARCINOMA,1
IN,SEIZURE,1
IN,SHOCK,1
IN,SINUS BRADYCARDIA,1
IN,SINUS NODE DYSFUNCTION,1
IN,SKIN PLAQUE,1
IN,SPINAL COMPRESSION FRACTURE,1
IN,SPINAL FRACTURE,1
IN,SUBARACHNOID HAEMORRHAGE,1
IN,SUDDEN CARDIAC DEATH,1
IN,SUICIDAL IDEATION,1
IN,SWELLING,1
IN,SWELLING FACE,1
IN,THROMBOPHLEBITIS,1
IN,TUBULOINTERSTITIAL NEPHRITIS,1
IN,ULCER,1
IN,URINARY TRACT INFECTION,1
IN,URINE FLOW DECREASED,1
IN,URINE OUTPUT DECREASED,1
IN,VASCULAR ENCEPHALOPATHY,1
IN,WHITE BLOOD CELL COUNT DECREASED,1
IN,WOUND DEHISCENCE,1
IN,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
ID,DEATH,4
ID,DYSPNOEA,4
ID,BLOOD CREATININE INCREASED,2
ID,CEREBROVASCULAR ACCIDENT,2
ID,ACUTE KIDNEY INJURY,1
ID,ACUTE MYOCARDIAL INFARCTION,1
ID,ASTHENIA,1
ID,BLISTER,1
ID,BLOOD PRESSURE DECREASED,1
ID,CARDIAC FAILURE CONGESTIVE,1
ID,CARDIOVASCULAR DISORDER,1
ID,CEREBROVASCULAR DISORDER,1
ID,CORONARY ARTERY RESTENOSIS,1
ID,CREATININE RENAL CLEARANCE DECREASED,1
ID,CREATININE RENAL CLEARANCE INCREASED,1
ID,DIABETES MELLITUS,1
ID,DRUG INEFFECTIVE,1
ID,DRUG RESISTANCE,1
ID,DYSPEPSIA,1
ID,EJECTION FRACTION DECREASED,1
ID,FURUNCLE,1
ID,GENERALISED OEDEMA,1
ID,HAEMATEMESIS,1
ID,HAEMATURIA,1
ID,HAEMOGLOBIN DECREASED,1
ID,HEADACHE,1
ID,INFARCTION,1
ID,INFECTION,1
ID,ISCHAEMIC STROKE,1
ID,LIMB INJURY,1
ID,LOSS OF CONSCIOUSNESS,1
ID,NAUSEA,1
ID,PERIPHERAL COLDNESS,1
ID,PULMONARY HYPERTENSION,1
ID,SEPTIC SHOCK,1
ID,VOMITING,1
IR,CONDITION AGGRAVATED,2
IR,HYPOTENSION,2
IR,PULMONARY OEDEMA,2
IR,SIALOADENITIS,2
IR,ABDOMINAL DISCOMFORT,1
IR,ANURIA,1
IR,ASCITES,1
IR,BLISTER,1
IR,BLOOD CREATININE INCREASED,1
IR,BLOOD UREA INCREASED,1
IR,CARDIAC ARREST,1
IR,CARDIO-RESPIRATORY ARREST,1
IR,CARDIOMEGALY,1
IR,DEATH,1
IR,DERMATITIS,1
IR,DYSPNOEA,1
IR,HEPATIC FAILURE,1
IR,INTENTIONAL OVERDOSE,1
IR,METABOLIC ACIDOSIS,1
IR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
IR,NAUSEA,1
IR,OEDEMA,1
IR,OEDEMA PERIPHERAL,1
IR,OXYGEN SATURATION DECREASED,1
IR,PAROTITIS,1
IR,PRODUCT USE ISSUE,1
IR,PYREXIA,1
IR,RESPIRATORY DISTRESS,1
IR,RHABDOMYOLYSIS,1
IR,SHOCK,1
IR,SUBCUTANEOUS HAEMATOMA,1
IR,TACHYCARDIA,1
IR,TOXICITY TO VARIOUS AGENTS,1
IQ,STEVENS-JOHNSON SYNDROME,3
IE,DEATH,25
IE,LOWER RESPIRATORY TRACT INFECTION,17
IE,FALL,16
IE,COUGH,13
IE,PNEUMONIA,13
IE,VOMITING,13
IE,DYSPNOEA,12
IE,DIARRHOEA,11
IE,MALAISE,11
IE,ACUTE HEPATIC FAILURE,9
IE,ASTHENIA,9
IE,CARDIAC FAILURE,8
IE,HAEMOGLOBIN DECREASED,8
IE,PYREXIA,8
IE,DIZZINESS,7
IE,HAEMOGLOBIN ABNORMAL,7
IE,HEADACHE,7
IE,SOMNOLENCE,7
IE,ANAEMIA,6
IE,FATIGUE,6
IE,FLUID RETENTION,6
IE,NAUSEA,6
IE,RENAL FAILURE,6
IE,RENAL IMPAIRMENT,6
IE,SEPSIS,6
IE,ACUTE KIDNEY INJURY,5
IE,ATRIAL FIBRILLATION,5
IE,CARDIAC ARREST,5
IE,ENCEPHALOPATHY,5
IE,HYPERKALAEMIA,5
IE,HYPONATRAEMIA,5
IE,LETHARGY,5
IE,PRODUCT USE ISSUE,5
IE,RESPIRATORY TRACT INFECTION,5
IE,TOXICITY TO VARIOUS AGENTS,5
IE,ABDOMINAL PAIN,4
IE,ARTHRALGIA,4
IE,ASCITES,4
IE,ASTERIXIS,4
IE,BLOOD PRESSURE DECREASED,4
IE,CARDIAC FAILURE CONGESTIVE,4
IE,CEREBRAL HAEMORRHAGE,4
IE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,4
IE,COMPLICATIONS OF TRANSPLANTED LIVER,4
IE,CONFUSIONAL STATE,4
IE,CONTUSION,4
IE,DECREASED APPETITE,4
IE,DEHYDRATION,4
IE,HEPATIC FAILURE,4
IE,HOSPITALISATION,4
IE,NEUROMYOPATHY,4
IE,OEDEMA PERIPHERAL,4
IE,PAIN,4
IE,PERIPHERAL SWELLING,4
IE,PNEUMONIA KLEBSIELLA,4
IE,PRURITUS,4
IE,RESPIRATORY RATE INCREASED,4
IE,SEPTIC SHOCK,4
IE,VENTRICULAR TACHYCARDIA,4
IE,ACUTE MYOCARDIAL INFARCTION,3
IE,BACK PAIN,3
IE,BLOOD PHOSPHORUS DECREASED,3
IE,BLOOD POTASSIUM DECREASED,3
IE,BRONCHIOLITIS,3
IE,CHEST PAIN,3
IE,DIALYSIS,3
IE,HIP FRACTURE,3
IE,HYPERTENSION,3
IE,INFECTION,3
IE,MYOCARDIAL INFARCTION,3
IE,PRODUCTIVE COUGH,3
IE,RHABDOMYOLYSIS,3
IE,URINARY TRACT INFECTION,3
IE,WHEEZING,3
IE,ABDOMINAL DISCOMFORT,2
IE,ANGINA PECTORIS,2
IE,ANXIETY,2
IE,BLISTER,2
IE,BLOOD PRESSURE INCREASED,2
IE,BRAIN OEDEMA,2
IE,BRONCHOSPASM,2
IE,C-REACTIVE PROTEIN INCREASED,2
IE,CEREBRAL INFARCTION,2
IE,CONCOMITANT DISEASE PROGRESSION,2
IE,CRANIOCEREBRAL INJURY,2
IE,CRYING,2
IE,CYSTITIS,2
IE,DELIRIUM,2
IE,DERMATITIS,2
IE,GAIT DISTURBANCE,2
IE,GASTROINTESTINAL PAIN,2
IE,HAEMATOMA,2
IE,HAEMORRHAGE,2
IE,HEART RATE INCREASED,2
IE,HEART RATE IRREGULAR,2
IE,HYPOTENSION,2
IE,INCORRECT DOSE ADMINISTERED,2
IE,INFLUENZA,2
IE,INFLUENZA LIKE ILLNESS,2
IE,IRRITABILITY,2
IE,LIVER DISORDER,2
IE,LIVER FUNCTION TEST ABNORMAL,2
IE,LOCALISED INFECTION,2
IE,MEDICAL DEVICE COMPLICATION,2
IE,MUSCLE SPASMS,2
IE,MYALGIA,2
IE,NEUTROPENIA,2
IE,OCULAR ICTERUS,2
IE,OTITIS EXTERNA,2
IE,PAIN IN EXTREMITY,2
IE,PLATELET COUNT DECREASED,2
IE,PRODUCT USE IN UNAPPROVED INDICATION,2
IE,PULMONARY OEDEMA,2
IE,PULMONARY SEPSIS,2
IE,RASH,2
IE,RASH PRURITIC,2
IE,RECTAL HAEMORRHAGE,2
IE,RESPIRATORY DISTRESS,2
IE,RESPIRATORY TRACT CONGESTION,2
IE,RHEUMATOID ARTHRITIS,2
IE,RHINORRHOEA,2
IE,SKIN EXFOLIATION,2
IE,SPUTUM DISCOLOURED,2
IE,STAPHYLOCOCCUS TEST POSITIVE,2
IE,SUBARACHNOID HAEMORRHAGE,2
IE,TACHYPNOEA,2
IE,TUBULOINTERSTITIAL NEPHRITIS,2
IE,UNRESPONSIVE TO STIMULI,2
IE,UPPER GASTROINTESTINAL HAEMORRHAGE,2
IE,UPPER LIMB FRACTURE,2
IE,URTICARIA,2
IE,VENTRICULAR FIBRILLATION,2
IE,WEIGHT DECREASED,2
IE,ABDOMINAL ADHESIONS,1
IE,ABDOMINAL DISTENSION,1
IE,ABDOMINAL PAIN UPPER,1
IE,ABNORMAL FAECES,1
IE,ACIDOSIS,1
IE,ACTIVITIES OF DAILY LIVING IMPAIRED,1
IE,ADENOVIRUS INFECTION,1
IE,AGORAPHOBIA,1
IE,ALANINE AMINOTRANSFERASE INCREASED,1
IE,ALOPECIA,1
IE,AMNESIA,1
IE,ANAPHYLACTIC REACTION,1
IE,ANTIPSYCHOTIC DRUG LEVEL INCREASED,1
IE,AORTIC ANEURYSM,1
IE,AORTIC STENOSIS,1
IE,ARTHROPATHY,1
IE,ASPIRATION,1
IE,BED REST,1
IE,BLEPHARITIS,1
IE,BLOOD BILIRUBIN INCREASED,1
IE,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
IE,BLOOD CREATININE INCREASED,1
IE,BLOOD LACTATE DEHYDROGENASE INCREASED,1
IE,BLOOD PRESSURE ABNORMAL,1
IE,BLOOD TEST ABNORMAL,1
IE,BLOOD UREA INCREASED,1
IE,BLOOD URINE PRESENT,1
IE,BODY TEMPERATURE INCREASED,1
IE,BRAIN MIDLINE SHIFT,1
IE,BRONCHOPNEUMONIA,1
IE,CARDIAC FLUTTER,1
IE,CARDIAC OPERATION,1
IE,CARDIOGENIC SHOCK,1
IE,CARPAL TUNNEL SYNDROME,1
IE,CATARACT OPERATION,1
IE,CELLULITIS,1
IE,CEREBELLAR INFARCTION,1
IE,CHEST DISCOMFORT,1
IE,CHILLS,1
IE,CHOLELITHIASIS,1
IE,CLOSTRIDIUM DIFFICILE INFECTION,1
IE,COAGULATION TEST ABNORMAL,1
IE,CONJUNCTIVAL HYPERAEMIA,1
IE,CONSTIPATION,1
IE,CORONARY ARTERY DISEASE,1
IE,CORONARY ARTERY OCCLUSION,1
IE,CREPITATIONS,1
IE,CYANOSIS CENTRAL,1
IE,CYST,1
IE,DEPRESSED LEVEL OF CONSCIOUSNESS,1
IE,DERMATITIS INFECTED,1
IE,DEVICE MALFUNCTION,1
IE,DEVICE OCCLUSION,1
IE,DIABETES MELLITUS,1
IE,DISEASE PROGRESSION,1
IE,DIVERTICULITIS,1
IE,DIVERTICULUM INTESTINAL,1
IE,DRUG DOSE OMISSION,1
IE,DRUG HYPERSENSITIVITY,1
IE,DRUG INEFFECTIVE,1
IE,DRUG LEVEL INCREASED,1
IE,DRUG-INDUCED LIVER INJURY,1
IE,DYSGEUSIA,1
IE,DYSPEPSIA,1
IE,EAR CONGESTION,1
IE,EAR INFECTION,1
IE,EAR SWELLING,1
IE,ELECTROCARDIOGRAM QT PROLONGED,1
IE,ELECTROCARDIOGRAM ST SEGMENT ABNORMAL,1
IE,EMOTIONAL DISTRESS,1
IE,EOSINOPHIL COUNT INCREASED,1
IE,ESCHERICHIA INFECTION,1
IE,EYE PAIN,1
IE,FACIAL PAIN,1
IE,FEAR,1
IE,FEEDING DISORDER,1
IE,FLUID OVERLOAD,1
IE,FLUSHING,1
IE,FOOT DEFORMITY,1
IE,FORMICATION,1
IE,GASTRIC DISORDER,1
IE,GASTRIC HAEMORRHAGE,1
IE,GASTRIC ULCER HAEMORRHAGE,1
IE,GASTROENTERITIS NOROVIRUS,1
IE,GENERAL PHYSICAL HEALTH DETERIORATION,1
IE,GLASSY EYES,1
IE,GLUCOSE TOLERANCE IMPAIRED,1
IE,GOUT,1
IE,GROIN PAIN,1
IE,HAEMATEMESIS,1
IE,HAEMATOCHEZIA,1
IE,HAEMATURIA,1
IE,HAEMOLYTIC ANAEMIA,1
IE,HAEMORRHAGE INTRACRANIAL,1
IE,HAEMORRHAGIC TRANSFORMATION STROKE,1
IE,HAEMORRHOIDS,1
IE,HALLUCINATION,1
IE,HALLUCINATION_ AUDITORY,1
IE,HEART RATE DECREASED,1
IE,HEPATITIS,1
IE,HEPATOTOXICITY,1
IE,HERNIA,1
IE,HYDROCEPHALUS,1
IE,HYPERCALCAEMIA,1
IE,HYPOAESTHESIA,1
IE,HYPOALBUMINAEMIA,1
IE,HYPOPHAGIA,1
IE,HYPOTHALAMO-PITUITARY DISORDER,1
IE,ILL-DEFINED DISORDER,1
IE,IMPAIRED GASTRIC EMPTYING,1
IE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
IE,INFECTED SKIN ULCER,1
IE,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,1
IE,INJECTION SITE ERYTHEMA,1
IE,INJECTION SITE PAPULE,1
IE,INSOMNIA,1
IE,INTERNATIONAL NORMALISED RATIO DECREASED,1
IE,INTERNATIONAL NORMALISED RATIO INCREASED,1
IE,INTESTINAL OBSTRUCTION,1
IE,INTESTINAL PERFORATION,1
IE,INVESTIGATION,1
IE,JAUNDICE,1
IE,JOINT INJURY,1
IE,KIDNEY INFECTION,1
IE,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
IE,LACERATION,1
IE,LINEAR IGA DISEASE,1
IE,LIVER INJURY,1
IE,LUNG CONSOLIDATION,1
IE,LUNG DISORDER,1
IE,LUNG INFECTION,1
IE,LUNG NEOPLASM MALIGNANT,1
IE,LUNG SQUAMOUS CELL CARCINOMA STAGE III,1
IE,LYMPHOMA,1
IE,MALIGNANT ASCITES,1
IE,MEDICATION ERROR,1
IE,MELAENA,1
IE,METABOLIC ACIDOSIS,1
IE,METAPNEUMOVIRUS INFECTION,1
IE,MITRAL VALVE INCOMPETENCE,1
IE,MUSCULOSKELETAL CHEST PAIN,1
IE,MUSCULOSKELETAL PAIN,1
IE,MYOCARDITIS,1
IE,MYOSITIS,1
IE,NASOPHARYNGITIS,1
IE,NECK PAIN,1
IE,NEPHROLITHIASIS,1
IE,NERVOUSNESS,1
IE,NEUTROPHIL COUNT DECREASED,1
IE,NEUTROPHIL COUNT INCREASED,1
IE,OESOPHAGEAL VARICES HAEMORRHAGE,1
IE,ORAL DISORDER,1
IE,OROPHARYNGEAL PAIN,1
IE,OXYGEN SATURATION DECREASED,1
IE,OXYGEN SATURATION INCREASED,1
IE,PALLOR,1
IE,PALPITATIONS,1
IE,PANIC ATTACK,1
IE,PANIC DISORDER,1
IE,PELVIC MASS,1
IE,PERIPHERAL ARTERY THROMBOSIS,1
IE,PERIPHERAL COLDNESS,1
IE,PHARYNGEAL ERYTHEMA,1
IE,PHARYNGITIS,1
IE,PHOTOSENSITIVITY REACTION,1
IE,PLASMA CELL MYELOMA,1
IE,PLEURAL EFFUSION,1
IE,PLEURITIC PAIN,1
IE,PNEUMOCOCCAL SEPSIS,1
IE,PNEUMONIA VIRAL,1
IE,POLYMYALGIA RHEUMATICA,1
IE,POSTOPERATIVE WOUND INFECTION,1
IE,PRODUCT SUBSTITUTION ISSUE,1
IE,PULMONARY CONGESTION,1
IE,PULMONARY EMBOLISM,1
IE,PULMONARY FIBROSIS,1
IE,PULMONARY HAEMORRHAGE,1
IE,PULMONARY HYPERTENSION,1
IE,PULMONARY VEIN STENOSIS,1
IE,PULSELESS ELECTRICAL ACTIVITY,1
IE,PURPURA,1
IE,RASH ERYTHEMATOUS,1
IE,RASH GENERALISED,1
IE,RASH MACULAR,1
IE,RECTAL POLYP,1
IE,RED BLOOD CELL COUNT DECREASED,1
IE,RENAL FAILURE ACUTE,1
IE,RENAL PAIN,1
IE,RESPIRATORY DISORDER,1
IE,RESPIRATORY FAILURE,1
IE,RESPIRATORY SYNCYTIAL VIRUS BRONCHIOLITIS,1
IE,RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE,1
IE,RETINAL DISORDER,1
IE,RIB FRACTURE,1
IE,SEIZURE,1
IE,SEROTONIN SYNDROME,1
IE,SKIN DISCOLOURATION,1
IE,SKIN EROSION,1
IE,SKIN FISSURES,1
IE,SKIN INFECTION,1
IE,SKULL FRACTURE,1
IE,SNEEZING,1
IE,SOMNAMBULISM,1
IE,SPEECH DISORDER,1
IE,SPUTUM ABNORMAL,1
IE,SQUAMOUS CELL CARCINOMA,1
IE,SUBDURAL HAEMORRHAGE,1
IE,SYSTEMIC LUPUS ERYTHEMATOSUS RASH,1
IE,TACHYARRHYTHMIA,1
IE,TACHYCARDIA,1
IE,THROMBOSIS IN DEVICE,1
IE,TOXIC EPIDERMAL NECROLYSIS,1
IE,TRACHEOSTOMY,1
IE,TRANSFUSION,1
IE,TRANSIENT ISCHAEMIC ATTACK,1
IE,TRICUSPID VALVE INCOMPETENCE,1
IE,TYPE 2 DIABETES MELLITUS,1
IE,UPPER RESPIRATORY TRACT INFECTION,1
IE,URINARY HESITATION,1
IE,URINARY INCONTINENCE,1
IE,VISUAL IMPAIRMENT,1
IE,VULVOVAGINAL BURNING SENSATION,1
IE,WEIGHT GAIN POOR,1
IE,WEIGHT INCREASED,1
IE,WHITE BLOOD CELL COUNT INCREASED,1
IL,HYPONATRAEMIA,9
IL,TOXICITY TO VARIOUS AGENTS,9
IL,MUCOSAL INFLAMMATION,6
IL,PANCYTOPENIA,6
IL,PNEUMONITIS,5
IL,CONFUSIONAL STATE,4
IL,DYSPNOEA,4
IL,FALL,4
IL,HIP FRACTURE,4
IL,PYREXIA,4
IL,RENAL IMPAIRMENT,4
IL,ASTHENIA,3
IL,CARDIAC FAILURE CONGESTIVE,3
IL,CHEST PAIN,3
IL,HAEMOGLOBIN DECREASED,3
IL,HYPERTENSION,3
IL,MATERNAL EXPOSURE DURING PREGNANCY,3
IL,PULMONARY OEDEMA,3
IL,SEIZURE,3
IL,URINARY TRACT INFECTION,3
IL,BLOOD LACTATE DEHYDROGENASE INCREASED,2
IL,EPISTAXIS,2
IL,FATIGUE,2
IL,GAIT DISTURBANCE,2
IL,HAEMATURIA,2
IL,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,2
IL,MULTI-ORGAN FAILURE,2
IL,OLIGURIA,2
IL,PNEUMONIA,2
IL,RENAL FAILURE,2
IL,RETROPERITONEAL HAEMATOMA,2
IL,SEPTIC SHOCK,2
IL,ABASIA,1
IL,ABDOMINAL PAIN,1
IL,ACTIVITIES OF DAILY LIVING IMPAIRED,1
IL,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
IL,ADDISON^S DISEASE,1
IL,ALANINE AMINOTRANSFERASE INCREASED,1
IL,ANGIOEDEMA,1
IL,AORTIC STENOSIS,1
IL,ARTHRALGIA,1
IL,ARTHRITIS,1
IL,ASPARTATE AMINOTRANSFERASE INCREASED,1
IL,ATRIAL FIBRILLATION,1
IL,ATRIAL SEPTAL DEFECT,1
IL,BACTERIAL INFECTION,1
IL,BICUSPID AORTIC VALVE,1
IL,BLOOD BILIRUBIN INCREASED,1
IL,BLOOD CREATINE INCREASED,1
IL,BLOOD CREATININE INCREASED,1
IL,BLOOD PRESSURE ABNORMAL,1
IL,BLOOD UREA INCREASED,1
IL,BREAST CANCER,1
IL,BRONCHITIS,1
IL,CARDIAC FAILURE,1
IL,CELLULITIS,1
IL,CEREBRAL INFARCTION,1
IL,CEREBROVASCULAR ACCIDENT,1
IL,CHILLS,1
IL,CHRONIC KIDNEY DISEASE,1
IL,COAGULOPATHY,1
IL,CONTUSION,1
IL,COUGH,1
IL,CREATININE RENAL CLEARANCE ABNORMAL,1
IL,CRYOGLOBULINAEMIA,1
IL,CYSTITIS KLEBSIELLA,1
IL,DEEP VEIN THROMBOSIS,1
IL,DERMATITIS PSORIASIFORM,1
IL,DIALYSIS,1
IL,DRUG EFFECT INCOMPLETE,1
IL,DRUG HYPERSENSITIVITY,1
IL,DRUG-DISEASE INTERACTION,1
IL,ENDOMETRIAL CANCER METASTATIC,1
IL,EPIDIDYMITIS,1
IL,FEBRILE NEUTROPENIA,1
IL,FEELING HOT,1
IL,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,1
IL,FOREIGN BODY ASPIRATION,1
IL,GASTROENTERITIS,1
IL,GASTROINTESTINAL HAEMORRHAGE,1
IL,GASTROINTESTINAL ULCER HAEMORRHAGE,1
IL,GENERALISED OEDEMA,1
IL,GINGIVAL BLEEDING,1
IL,HAEMATOMA,1
IL,HAEMORRHAGE,1
IL,HAEMORRHAGE INTRACRANIAL,1
IL,HEADACHE,1
IL,HEPATIC ENCEPHALOPATHY,1
IL,HEPATIC FAILURE,1
IL,HEPATOTOXICITY,1
IL,HYDRONEPHROSIS,1
IL,HYPERGLYCAEMIA,1
IL,HYPERKALAEMIA,1
IL,HYPERSENSITIVITY VASCULITIS,1
IL,HYPOGLYCAEMIA,1
IL,HYPOTENSION,1
IL,HYPOTHYROIDISM,1
IL,IIIRD NERVE PARALYSIS,1
IL,INFECTION,1
IL,INFUSION RELATED REACTION,1
IL,INJECTION SITE HAEMORRHAGE,1
IL,ISCHAEMIC STROKE,1
IL,JOINT SWELLING,1
IL,KAPOSI^S SARCOMA,1
IL,LARYNGEAL OEDEMA,1
IL,LIMB DISCOMFORT,1
IL,METABOLIC ACIDOSIS,1
IL,MOBILITY DECREASED,1
IL,MONOPLEGIA,1
IL,MOUTH HAEMORRHAGE,1
IL,MUSCLE HAEMORRHAGE,1
IL,NEONATAL RESPIRATORY DISTRESS SYNDROME,1
IL,NORMAL NEWBORN,1
IL,PAIN,1
IL,PALPITATIONS,1
IL,PATENT DUCTUS ARTERIOSUS,1
IL,PERICARDIAL EFFUSION,1
IL,PERIPHERAL SWELLING,1
IL,PNEUMONIA PNEUMOCOCCAL,1
IL,POST PROCEDURAL HAEMORRHAGE,1
IL,PROTHROMBIN TIME PROLONGED,1
IL,PSORIASIS,1
IL,PULMONARY CONGESTION,1
IL,PULMONARY HYPERTENSION,1
IL,RASH,1
IL,RASH PRURITIC,1
IL,RENAL DYSPLASIA,1
IL,RENAL FAILURE ACUTE,1
IL,SEIZURE LIKE PHENOMENA,1
IL,SINUS BRADYCARDIA,1
IL,SKELETAL INJURY,1
IL,SPINAL OSTEOARTHRITIS,1
IL,SUBARACHNOID HAEMORRHAGE,1
IL,SUBCUTANEOUS HAEMATOMA,1
IL,SUDDEN HEARING LOSS,1
IL,SURGERY,1
IL,THORACIC VERTEBRAL FRACTURE,1
IL,THROMBOCYTOPENIA,1
IL,THROMBOSIS,1
IL,TRAUMATIC INTRACRANIAL HAEMORRHAGE,1
IL,UPPER RESPIRATORY TRACT INFECTION,1
IL,URETERIC STENOSIS,1
IL,URINARY TRACT DISCOMFORT,1
IL,VAGINAL HAEMORRHAGE,1
IL,VAGINAL POLYP,1
IL,VASCULAR SKIN DISORDER,1
IL,VERTIGO,1
IL,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
IL,VITREOUS HAEMORRHAGE,1
IL,VOMITING,1
IL,WITHDRAWAL SYNDROME,1
IT,ANAEMIA,471
IT,ASTHENIA,469
IT,SYNCOPE,452
IT,HYPOTENSION,407
IT,HYPOGLYCAEMIA,396
IT,DYSPNOEA,335
IT,SOPOR,330
IT,HYPONATRAEMIA,278
IT,ACUTE KIDNEY INJURY,271
IT,HYPOKALAEMIA,271
IT,INTERNATIONAL NORMALISED RATIO INCREASED,255
IT,CONFUSIONAL STATE,247
IT,VOMITING,235
IT,PRESYNCOPE,206
IT,HYPERKALAEMIA,200
IT,DEHYDRATION,196
IT,LOSS OF CONSCIOUSNESS,189
IT,OVERDOSE,185
IT,FALL,184
IT,MELAENA,184
IT,BRADYCARDIA,183
IT,RENAL FAILURE ACUTE,183
IT,MALAISE,174
IT,DIARRHOEA,172
IT,CARDIAC FAILURE,168
IT,NAUSEA,151
IT,DRUG ABUSE,137
IT,PYREXIA,133
IT,TOXICITY TO VARIOUS AGENTS,132
IT,RECTAL HAEMORRHAGE,129
IT,ELECTROCARDIOGRAM QT PROLONGED,128
IT,ABDOMINAL PAIN,118
IT,ATRIAL FIBRILLATION,118
IT,LACTIC ACIDOSIS,113
IT,HEAD INJURY,109
IT,METABOLIC ACIDOSIS,108
IT,RENAL FAILURE,101
IT,EPISTAXIS,98
IT,ERYTHEMA,98
IT,PNEUMONIA,96
IT,OEDEMA PERIPHERAL,95
IT,ORTHOSTATIC HYPOTENSION,95
IT,PRURITUS,95
IT,MEDICATION ERROR,94
IT,DECREASED APPETITE,93
IT,HEADACHE,89
IT,ABDOMINAL PAIN UPPER,88
IT,BLOOD CREATININE INCREASED,87
IT,THROMBOCYTOPENIA,87
IT,CEREBRAL HAEMORRHAGE,85
IT,HAEMATURIA,85
IT,HYPERHIDROSIS,85
IT,RHABDOMYOLYSIS,84
IT,DRUG INEFFECTIVE,82
IT,DISORIENTATION,78
IT,COMA,76
IT,RESPIRATORY FAILURE,76
IT,DYSARTHRIA,75
IT,HAEMATOMA,74
IT,HAEMATEMESIS,73
IT,GASTROINTESTINAL HAEMORRHAGE,71
IT,BRADYPHRENIA,70
IT,HYPOCALCAEMIA,69
IT,VERTIGO,69
IT,PLEURAL EFFUSION,66
IT,RENAL IMPAIRMENT,66
IT,HYPOCOAGULABLE STATE,64
IT,NEUTROPENIA,63
IT,HYPOGLYCAEMIC COMA,62
IT,APHASIA,60
IT,SUBDURAL HAEMATOMA,60
IT,SOMNOLENCE,58
IT,HYPERTENSION,57
IT,HYPOMAGNESAEMIA,56
IT,RASH,55
IT,ASCITES,54
IT,CARDIAC ARREST,54
IT,SINUS BRADYCARDIA,49
IT,SEPSIS,48
IT,BRADYKINESIA,47
IT,DIZZINESS,47
IT,FATIGUE,46
IT,HYPERGLYCAEMIA,46
IT,AGITATION,44
IT,ARRHYTHMIA,43
IT,CONDITION AGGRAVATED,43
IT,HEPATIC FAILURE,43
IT,TREMOR,43
IT,INJURY,42
IT,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,42
IT,LEUKOPENIA,42
IT,TONGUE OEDEMA,42
IT,PULMONARY OEDEMA,41
IT,URTICARIA,41
IT,EPILEPSY,40
IT,GAIT DISTURBANCE,40
IT,CHEST PAIN,39
IT,INTENTIONAL SELF-INJURY,39
IT,COUGH,38
IT,HAEMORRHAGE,38
IT,JAUNDICE,38
IT,PSYCHOMOTOR HYPERACTIVITY,38
IT,TRANSAMINASES INCREASED,38
IT,HYPERTENSIVE CRISIS,37
IT,PALLOR,37
IT,PALPITATIONS,37
IT,DEATH,36
IT,ANGIOEDEMA,35
IT,HAEMOPTYSIS,35
IT,OLIGURIA,35
IT,PANCYTOPENIA,35
IT,TRANSFUSION,35
IT,GRAVITATIONAL OEDEMA,34
IT,HAEMOGLOBIN DECREASED,34
IT,OEDEMA,34
IT,PULMONARY EMBOLISM,34
IT,COGNITIVE DISORDER,33
IT,ELECTROLYTE IMBALANCE,33
IT,FEBRILE NEUTROPENIA,33
IT,HEPATITIS ACUTE,33
IT,IRON DEFICIENCY ANAEMIA,33
IT,SEPTIC SHOCK,33
IT,ARTHRALGIA,32
IT,DYSPHAGIA,32
IT,SUBARACHNOID HAEMORRHAGE,32
IT,ACUTE MYOCARDIAL INFARCTION,31
IT,ANURIA,31
IT,ISCHAEMIC STROKE,31
IT,TACHYCARDIA,31
IT,WEIGHT DECREASED,31
IT,BALANCE DISORDER,30
IT,PAIN IN EXTREMITY,30
IT,ATRIAL FLUTTER,29
IT,HYPERBILIRUBINAEMIA,29
IT,MULTI-ORGAN FAILURE,29
IT,BLOOD PRESSURE INCREASED,28
IT,GASTRIC HAEMORRHAGE,28
IT,MYOCARDIAL INFARCTION,28
IT,CONSTIPATION,27
IT,METABOLIC ALKALOSIS,27
IT,MICROCYTIC ANAEMIA,27
IT,RASH MACULO-PAPULAR,27
IT,ACCIDENTAL OVERDOSE,26
IT,HYPERSENSITIVITY,26
IT,MUSCLE SPASMS,26
IT,MYALGIA,26
IT,VENTRICULAR EXTRASYSTOLES,26
IT,CARDIOACTIVE DRUG LEVEL INCREASED,25
IT,EJECTION FRACTION DECREASED,25
IT,HALLUCINATION_ VISUAL,25
IT,HYPOVOLAEMIC SHOCK,25
IT,PRURITUS GENERALISED,25
IT,SHOCK,25
IT,COLD SWEAT,24
IT,DRUG HYPERSENSITIVITY,24
IT,MUCOSAL INFLAMMATION,24
IT,PARAESTHESIA,24
IT,PNEUMONITIS,24
IT,SPEECH DISORDER,24
IT,BLOOD SODIUM DECREASED,23
IT,CARDIO-RESPIRATORY ARREST,23
IT,CHRONIC KIDNEY DISEASE,23
IT,GENERAL PHYSICAL HEALTH DETERIORATION,23
IT,GENERALISED OEDEMA,23
IT,HEMIPLEGIA,23
IT,INCORRECT DOSE ADMINISTERED,23
IT,INTERSTITIAL LUNG DISEASE,23
IT,LIP OEDEMA,23
IT,NODAL ARRHYTHMIA,23
IT,ACUTE PULMONARY OEDEMA,22
IT,BLOOD UREA INCREASED,22
IT,HALLUCINATION,22
IT,HYPONATRAEMIC SYNDROME,22
IT,PAIN,22
IT,ALANINE AMINOTRANSFERASE INCREASED,21
IT,CARDIAC FAILURE ACUTE,21
IT,ECCHYMOSIS,21
IT,FACE OEDEMA,21
IT,HEPATIC ENCEPHALOPATHY,21
IT,SHOCK HAEMORRHAGIC,21
IT,ACUTE RESPIRATORY FAILURE,20
IT,BRONCHOSPASM,20
IT,CEREBROVASCULAR ACCIDENT,20
IT,DEEP VEIN THROMBOSIS,20
IT,DIABETIC METABOLIC DECOMPENSATION,20
IT,DUODENAL ULCER,20
IT,DYSPNOEA EXERTIONAL,20
IT,URINARY TRACT INFECTION,20
IT,BRADYARRHYTHMIA,19
IT,CONTUSION,19
IT,DROP ATTACKS,19
IT,GASTRITIS EROSIVE,19
IT,INTERNATIONAL NORMALISED RATIO ABNORMAL,19
IT,MITRAL VALVE INCOMPETENCE,19
IT,PULMONARY HYPERTENSION,19
IT,BLOOD GLUCOSE INCREASED,18
IT,DERMATITIS BULLOUS,18
IT,EXTRASYSTOLES,18
IT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,18
IT,GINGIVAL BLEEDING,18
IT,HYPERTRANSAMINASAEMIA,18
IT,INSOMNIA,18
IT,PETECHIAE,18
IT,RENAL FAILURE CHRONIC,18
IT,SEROTONIN SYNDROME,18
IT,TOXIC EPIDERMAL NECROLYSIS,18
IT,ABDOMINAL WALL HAEMATOMA,17
IT,BLOOD CREATINE PHOSPHOKINASE INCREASED,17
IT,CARDIAC FAILURE CONGESTIVE,17
IT,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,17
IT,DRUG-INDUCED LIVER INJURY,17
IT,HAEMATOCHEZIA,17
IT,HAEMORRHAGIC ANAEMIA,17
IT,HYPERPYREXIA,17
IT,INTENTIONAL OVERDOSE,17
IT,OXYGEN SATURATION DECREASED,17
IT,PSYCHOMOTOR RETARDATION,17
IT,SWELLING,17
IT,TORSADE DE POINTES,17
IT,TOXIC SKIN ERUPTION,17
IT,AMNESIA,16
IT,ASPARTATE AMINOTRANSFERASE INCREASED,16
IT,CEREBRAL ISCHAEMIA,16
IT,DYSPHONIA,16
IT,DYSURIA,16
IT,MUSCULAR WEAKNESS,16
IT,OSTEONECROSIS OF JAW,16
IT,TRANSIENT ISCHAEMIC ATTACK,16
IT,ABDOMINAL DISTENSION,15
IT,BACK PAIN,15
IT,BLOOD POTASSIUM DECREASED,15
IT,CARDIOGENIC SHOCK,15
IT,FAECES DISCOLOURED,15
IT,HEMIPARESIS,15
IT,INTESTINAL HAEMORRHAGE,15
IT,LIVER DISORDER,15
IT,MUSCLE HAEMORRHAGE,15
IT,NORMOCHROMIC NORMOCYTIC ANAEMIA,15
IT,RESPIRATORY ACIDOSIS,15
IT,SKIN EXFOLIATION,15
IT,SPONTANEOUS HAEMATOMA,15
IT,SUDDEN DEATH,15
IT,ALTERED STATE OF CONSCIOUSNESS,14
IT,ATRIOVENTRICULAR BLOCK FIRST DEGREE,14
IT,BLOOD POTASSIUM INCREASED,14
IT,BRONCHITIS,14
IT,BUNDLE BRANCH BLOCK,14
IT,LETHARGY,14
IT,MALIGNANT NEOPLASM PROGRESSION,14
IT,PACKED RED BLOOD CELL TRANSFUSION,14
IT,POLYURIA,14
IT,PRODUCT USE ISSUE,14
IT,STEVENS-JOHNSON SYNDROME,14
IT,SUPRAVENTRICULAR EXTRASYSTOLES,14
IT,C-REACTIVE PROTEIN INCREASED,13
IT,CHOLELITHIASIS,13
IT,DELIRIUM,13
IT,DISEASE PROGRESSION,13
IT,FAECALOMA,13
IT,GASTROENTERITIS,13
IT,PRODUCT USE IN UNAPPROVED INDICATION,13
IT,RASH GENERALISED,13
IT,STOMATITIS,13
IT,TACHYARRHYTHMIA,13
IT,TETANY,13
IT,VASCULITIS,13
IT,ANXIETY,12
IT,ATRIOVENTRICULAR BLOCK SECOND DEGREE,12
IT,BUNDLE BRANCH BLOCK RIGHT,12
IT,DERMATITIS,12
IT,FACIAL BONES FRACTURE,12
IT,HYPOCHLORAEMIA,12
IT,HYPOGLYCAEMIC UNCONSCIOUSNESS,12
IT,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,12
IT,LEUKOCYTOSIS,12
IT,MULTIPLE ORGAN DYSFUNCTION SYNDROME,12
IT,PANCREATITIS ACUTE,12
IT,RASH ERYTHEMATOUS,12
IT,SUBCUTANEOUS HAEMATOMA,12
IT,URINARY RETENTION,12
IT,AGGRESSION,11
IT,AGRANULOCYTOSIS,11
IT,APRAXIA,11
IT,ATRIAL THROMBOSIS,11
IT,BUNDLE BRANCH BLOCK LEFT,11
IT,CEREBRAL ARTERY OCCLUSION,11
IT,DRUG ADMINISTRATION ERROR,11
IT,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,11
IT,DYSKINESIA,11
IT,DYSPEPSIA,11
IT,ERYTHEMA MULTIFORME,11
IT,GASTRIC ULCER,11
IT,GASTRIC ULCER HAEMORRHAGE,11
IT,HEPATIC CIRRHOSIS,11
IT,HEPATOCELLULAR CARCINOMA,11
IT,HYPERCREATININAEMIA,11
IT,HYPERPARATHYROIDISM,11
IT,HYPOCHROMIC ANAEMIA,11
IT,INTENTIONAL PRODUCT MISUSE,11
IT,LEFT VENTRICULAR HYPERTROPHY,11
IT,MATERNAL EXPOSURE DURING PREGNANCY,11
IT,PERIORBITAL OEDEMA,11
IT,SKIN LESION,11
IT,URINARY INCONTINENCE,11
IT,VISION BLURRED,11
IT,ANGINA PECTORIS,10
IT,ATAXIA,10
IT,AZOTAEMIA,10
IT,BLOOD MAGNESIUM DECREASED,10
IT,BLOOD OSMOLARITY DECREASED,10
IT,BLOOD PRESSURE DECREASED,10
IT,BRONCHOPNEUMONIA,10
IT,CARDIAC ABLATION,10
IT,CARDIAC DISORDER,10
IT,CHOLESTASIS,10
IT,CONGESTIVE CARDIOMYOPATHY,10
IT,CONJUNCTIVAL HAEMORRHAGE,10
IT,CONJUNCTIVITIS,10
IT,CRANIOCEREBRAL INJURY,10
IT,DERMATITIS EXFOLIATIVE,10
IT,DRUG PRESCRIBING ERROR,10
IT,DYSSTASIA,10
IT,ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY,10
IT,EXTRAPYRAMIDAL DISORDER,10
IT,HYPERLACTACIDAEMIA,10
IT,INTRA-ABDOMINAL HAEMATOMA,10
IT,METABOLIC DISORDER,10
IT,MIOSIS,10
IT,MUSCULOSKELETAL STIFFNESS,10
IT,MYOCARDIAL ISCHAEMIA,10
IT,PERICARDIAL EFFUSION,10
IT,PRESCRIBED OVERDOSE,10
IT,RED BLOOD CELL COUNT DECREASED,10
IT,SUICIDE ATTEMPT,10
IT,VASOPLEGIA SYNDROME,10
IT,ATRIOVENTRICULAR BLOCK,9
IT,BRONCHOSTENOSIS,9
IT,CAROTID ARTERIOSCLEROSIS,9
IT,CEREBRAL HAEMATOMA,9
IT,DISSEMINATED INTRAVASCULAR COAGULATION,9
IT,DYSPNOEA AT REST,9
IT,ELECTROCARDIOGRAM QT SHORTENED,9
IT,FLUSHING,9
IT,HAEMATOCRIT DECREASED,9
IT,HIRSUTISM,9
IT,HYPERNATRAEMIA,9
IT,JOINT INJURY,9
IT,MACROGLOSSIA,9
IT,MOVEMENT DISORDER,9
IT,NEPHROCALCINOSIS,9
IT,NIH STROKE SCALE SCORE INCREASED,9
IT,NO THERAPEUTIC RESPONSE,9
IT,ORAL MUCOSA EROSION,9
IT,PALATAL OEDEMA,9
IT,PELVIC FRACTURE,9
IT,PURPURA,9
IT,RASH PRURITIC,9
IT,RESPIRATORY ARREST,9
IT,RETCHING,9
IT,STRANGURY,9
IT,THROMBOSIS,9
IT,URINE OUTPUT DECREASED,9
IT,VENTRICULAR FIBRILLATION,9
IT,VENTRICULAR FLUTTER,9
IT,VENTRICULAR TACHYCARDIA,9
IT,VISUAL IMPAIRMENT,9
IT,VITAMIN D DEFICIENCY,9
IT,WEIGHT INCREASED,9
IT,AMYLASE INCREASED,8
IT,BREATH SOUNDS ABNORMAL,8
IT,CHILLS,8
IT,CONDUCTION DISORDER,8
IT,CYANOSIS,8
IT,DEPRESSED LEVEL OF CONSCIOUSNESS,8
IT,DIVERTICULITIS,8
IT,DUODENAL ULCER HAEMORRHAGE,8
IT,DYSENTERY,8
IT,ESCHERICHIA URINARY TRACT INFECTION,8
IT,GENERALISED TONIC-CLONIC SEIZURE,8
IT,HEPATOCELLULAR INJURY,8
IT,HEPATORENAL SYNDROME,8
IT,INFECTION,8
IT,IRON DEFICIENCY,8
IT,ISCHAEMIC CARDIOMYOPATHY,8
IT,LANGUAGE DISORDER,8
IT,LEUKOENCEPHALOPATHY,8
IT,MYOCARDIAL NECROSIS MARKER INCREASED,8
IT,MYOCLONUS,8
IT,OESOPHAGEAL VARICES HAEMORRHAGE,8
IT,OESOPHAGITIS,8
IT,OSTEONECROSIS,8
IT,PETIT MAL EPILEPSY,8
IT,PLATELET COUNT DECREASED,8
IT,PROTHROMBIN TIME PROLONGED,8
IT,PSYCHOMOTOR SKILLS IMPAIRED,8
IT,RESPIRATORY DEPRESSION,8
IT,SINUS TACHYCARDIA,8
IT,THROAT TIGHTNESS,8
IT,TONGUE BITING,8
IT,TRICUSPID VALVE INCOMPETENCE,8
IT,ACUTE CORONARY SYNDROME,7
IT,AORTIC ANEURYSM,7
IT,BLOOD ALKALINE PHOSPHATASE INCREASED,7
IT,BLOOD CREATINE INCREASED,7
IT,BRAIN OEDEMA,7
IT,CEREBROVASCULAR DISORDER,7
IT,CORROSIVE OROPHARYNGEAL INJURY,7
IT,DEPRESSION,7
IT,DIABETES MELLITUS,7
IT,DIPLOPIA,7
IT,DRUG USE DISORDER,7
IT,ELECTROCARDIOGRAM ABNORMAL,7
IT,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,7
IT,EPIGASTRIC DISCOMFORT,7
IT,ERYSIPELAS,7
IT,FLATULENCE,7
IT,GASTRITIS,7
IT,HAEMORRHAGE INTRACRANIAL,7
IT,HEPATIC FUNCTION ABNORMAL,7
IT,HYPERCAPNIA,7
IT,HYPOKINESIA,7
IT,HYPOTHERMIA,7
IT,HYPOTHYROIDISM,7
IT,LIVER INJURY,7
IT,LUNG DISORDER,7
IT,MOTOR DYSFUNCTION,7
IT,MUSCULOSKELETAL PAIN,7
IT,NEPHROTIC SYNDROME,7
IT,PLASMA CELL MYELOMA,7
IT,RIB FRACTURE,7
IT,SEIZURE,7
IT,SUBDURAL HAEMORRHAGE,7
IT,TACHYPNOEA,7
IT,VITAMIN B12 DEFICIENCY,7
IT,ACIDOSIS,6
IT,AORTIC ARTERIOSCLEROSIS,6
IT,ATRIOVENTRICULAR BLOCK COMPLETE,6
IT,BLOOD BILIRUBIN INCREASED,6
IT,BLOOD SODIUM INCREASED,6
IT,CACHEXIA,6
IT,CHOLECYSTITIS ACUTE,6
IT,CIRCADIAN RHYTHM SLEEP DISORDER,6
IT,CLOSTRIDIUM DIFFICILE COLITIS,6
IT,COAGULATION TIME PROLONGED,6
IT,COAGULOPATHY,6
IT,DRUG INTOLERANCE,6
IT,DRUG LEVEL INCREASED,6
IT,DYSPHEMIA,6
IT,ENCEPHALOPATHY,6
IT,EYELID OEDEMA,6
IT,GASTROINTESTINAL DISORDER,6
IT,GAZE PALSY,6
IT,HAEMORRHAGIC STROKE,6
IT,HEART RATE INCREASED,6
IT,HEPATIC LESION,6
IT,HEPATOTOXICITY,6
IT,HYPERAMMONAEMIA,6
IT,HYPERCOAGULATION,6
IT,HYPERINSULINAEMIC HYPOGLYCAEMIA,6
IT,HYPERURICAEMIA,6
IT,HYPOKALAEMIC SYNDROME,6
IT,HYPOPARATHYROIDISM,6
IT,HYPOVOLAEMIA,6
IT,HYPOXIA,6
IT,INFUSION RELATED REACTION,6
IT,INTESTINAL OBSTRUCTION,6
IT,LIPASE INCREASED,6
IT,LONG QT SYNDROME,6
IT,LUNG NEOPLASM MALIGNANT,6
IT,LYMPHANGITIS,6
IT,NON-24-HOUR SLEEP-WAKE DISORDER,6
IT,NYSTAGMUS,6
IT,ON AND OFF PHENOMENON,6
IT,PERIPHERAL ISCHAEMIA,6
IT,PERIPHERAL SWELLING,6
IT,PERITONITIS,6
IT,PREMATURE BABY,6
IT,PRODUCT SUBSTITUTION ISSUE,6
IT,PROTEINURIA,6
IT,PULMONARY FIBROSIS,6
IT,RESPIRATORY DISORDER,6
IT,RESPIRATORY DISTRESS,6
IT,SENSORY DISTURBANCE,6
IT,STAPHYLOCOCCAL INFECTION,6
IT,TENDONITIS,6
IT,TOXIC ENCEPHALOPATHY,6
IT,VENTRICULAR HYPOKINESIA,6
IT,WALKING DISABILITY,6
IT,WHEEZING,6
IT,WHITE BLOOD CELL COUNT INCREASED,6
IT,WOUND HAEMORRHAGE,6
IT,ACCIDENTAL EXPOSURE TO PRODUCT,5
IT,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,5
IT,ACUTE HEPATIC FAILURE,5
IT,ACUTE MYELOID LEUKAEMIA,5
IT,ACUTE RESPIRATORY DISTRESS SYNDROME,5
IT,ADRENAL INSUFFICIENCY,5
IT,ADVERSE DRUG REACTION,5
IT,ANAPHYLACTIC SHOCK,5
IT,AORTIC VALVE INCOMPETENCE,5
IT,ARTERIAL THROMBOSIS,5
IT,AUTOIMMUNE HAEMOLYTIC ANAEMIA,5
IT,BLOOD LACTATE DEHYDROGENASE INCREASED,5
IT,BODY TEMPERATURE INCREASED,5
IT,BONE MARROW FAILURE,5
IT,CARDIAC FAILURE CHRONIC,5
IT,CELLULITIS,5
IT,CEREBELLAR HAEMORRHAGE,5
IT,CEREBELLAR SYNDROME,5
IT,CHEST DISCOMFORT,5
IT,CLOSTRIDIUM DIFFICILE INFECTION,5
IT,CONCOMITANT DISEASE PROGRESSION,5
IT,CONTRAINDICATED PRODUCT ADMINISTERED,5
IT,CONVULSION,5
IT,CULTURE STOOL POSITIVE,5
IT,CYSTITIS HAEMORRHAGIC,5
IT,CYTOMEGALOVIRUS INFECTION,5
IT,DIABETES MELLITUS INADEQUATE CONTROL,5
IT,DIARRHOEA HAEMORRHAGIC,5
IT,DIVERTICULUM INTESTINAL HAEMORRHAGIC,5
IT,DRY SKIN,5
IT,DYSGEUSIA,5
IT,ECZEMA,5
IT,ELECTROCARDIOGRAM T WAVE INVERSION,5
IT,EYE MOVEMENT DISORDER,5
IT,FACE INJURY,5
IT,FAECES SOFT,5
IT,FEELING COLD,5
IT,FLUID RETENTION,5
IT,GASTROENTERITIS CLOSTRIDIAL,5
IT,GENERALISED ERYTHEMA,5
IT,HAEMODYNAMIC INSTABILITY,5
IT,HAEMOTHORAX,5
IT,HEPATITIS A,5
IT,HYPERAEMIA,5
IT,HYPERCALCAEMIA,5
IT,HYPERCHOLESTEROLAEMIA,5
IT,HYPOAESTHESIA,5
IT,INFLAMMATORY MARKER INCREASED,5
IT,INTESTINAL PERFORATION,5
IT,LARYNGEAL OEDEMA,5
IT,LARYNGOSPASM,5
IT,LEFT VENTRICULAR FAILURE,5
IT,LOCALISED OEDEMA,5
IT,LOW BIRTH WEIGHT BABY,5
IT,MILK-ALKALI SYNDROME,5
IT,MUSCLE RIGIDITY,5
IT,NEUROPATHY PERIPHERAL,5
IT,NEUTROPHILIA,5
IT,NORMOCYTIC ANAEMIA,5
IT,OBSTRUCTIVE AIRWAYS DISORDER,5
IT,OROPHARYNGEAL PAIN,5
IT,ORTHOPNOEA,5
IT,OSMOTIC DEMYELINATION SYNDROME,5
IT,PARALYSIS,5
IT,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,5
IT,PNEUMONIA ASPIRATION,5
IT,POLYARTHRITIS,5
IT,POLYNEUROPATHY,5
IT,PORTAL VEIN THROMBOSIS,5
IT,PREMATURE DELIVERY,5
IT,PRERENAL FAILURE,5
IT,PRODUCTIVE COUGH,5
IT,RESPIRATORY TRACT INFECTION,5
IT,RESTLESSNESS,5
IT,RETROPERITONEAL HAEMATOMA,5
IT,SEDATION,5
IT,SINOATRIAL BLOCK,5
IT,SKIN ULCER HAEMORRHAGE,5
IT,SPLENOMEGALY,5
IT,TINNITUS,5
IT,TREATMENT NONCOMPLIANCE,5
IT,TROPONIN INCREASED,5
IT,TUBULOINTERSTITIAL NEPHRITIS,5
IT,ULCER HAEMORRHAGE,5
IT,VASCULAR ENCEPHALOPATHY,5
IT,VISUAL ACUITY REDUCED,5
IT,VULVOVAGINAL CANDIDIASIS,5
IT,VULVOVAGINAL PRURITUS,5
IT,WHITE BLOOD CELL COUNT DECREASED,5
IT,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,4
IT,ACUTE PRERENAL FAILURE,4
IT,ALOPECIA,4
IT,AMYLOIDOSIS,4
IT,ANAPHYLACTIC REACTION,4
IT,ARTERIAL HAEMORRHAGE,4
IT,BLOOD FIBRINOGEN INCREASED,4
IT,BLOOD LACTIC ACID INCREASED,4
IT,BLOOD URIC ACID INCREASED,4
IT,BONE MARROW TOXICITY,4
IT,BONE PAIN,4
IT,BURNING SENSATION,4
IT,CANDIDA INFECTION,4
IT,CARDIAC FIBRILLATION,4
IT,CARDIAC MURMUR,4
IT,CARDIOMEGALY,4
IT,CARDIOMYOPATHY,4
IT,CATARRH,4
IT,CHROMATURIA,4
IT,DEVELOPMENTAL DELAY,4
IT,DIALYSIS,4
IT,DISORGANISED SPEECH,4
IT,DIVERTICULUM INTESTINAL,4
IT,DYSTONIA,4
IT,ENTERITIS,4
IT,EROSIVE OESOPHAGITIS,4
IT,ERYTHEMA MIGRANS,4
IT,EXTRA DOSE ADMINISTERED,4
IT,EYE DISORDER,4
IT,FEEDING DISORDER,4
IT,FEELING ABNORMAL,4
IT,GANGRENE,4
IT,GASTROINTESTINAL TOXICITY,4
IT,GOITRE,4
IT,HAEMARTHROSIS,4
IT,HAEMOCONCENTRATION,4
IT,HAEMORRHAGIC EROSIVE GASTRITIS,4
IT,HAEMORRHOIDS,4
IT,HEART RATE DECREASED,4
IT,HEPATITIS,4
IT,HEPATITIS CHOLESTATIC,4
IT,HETEROPLASIA,4
IT,HOT FLUSH,4
IT,HYPERCREATINAEMIA,4
IT,HYPERKERATOSIS,4
IT,HYPERTENSIVE HEART DISEASE,4
IT,HYPONATRAEMIC ENCEPHALOPATHY,4
IT,ILEUS PARALYTIC,4
IT,INCORRECT DOSAGE ADMINISTERED,4
IT,INFLAMMATION,4
IT,INFLUENZA,4
IT,INFUSION SITE ERYTHEMA,4
IT,INTENTIONAL DRUG MISUSE,4
IT,IRRITABILITY,4
IT,JAUNDICE CHOLESTATIC,4
IT,LIMB INJURY,4
IT,LIP INJURY,4
IT,LIP SWELLING,4
IT,LYMPHOPENIA,4
IT,MOBILITY DECREASED,4
IT,MYOGLOBIN BLOOD INCREASED,4
IT,MYOPATHY,4
IT,NERVOUS SYSTEM DISORDER,4
IT,NODAL RHYTHM,4
IT,OCCULT BLOOD,4
IT,OPTIC ISCHAEMIC NEUROPATHY,4
IT,PALMAR ERYTHEMA,4
IT,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,4
IT,PERFORMANCE STATUS DECREASED,4
IT,PHOTOPSIA,4
IT,PSEUDOMONAL SEPSIS,4
IT,PULMONARY TOXICITY,4
IT,RHYTHM IDIOVENTRICULAR,4
IT,SENSE OF OPPRESSION,4
IT,SKIN REACTION,4
IT,SKIN ULCER,4
IT,SLUGGISHNESS,4
IT,STAPHYLOCOCCAL SEPSIS,4
IT,SWELLING FACE,4
IT,TONIC CLONIC MOVEMENTS,4
IT,TONSILLAR HAEMORRHAGE,4
IT,TRAUMATIC INTRACRANIAL HAEMORRHAGE,4
IT,TYPE 2 DIABETES MELLITUS,4
IT,UNDERDOSE,4
IT,UNEVALUABLE EVENT,4
IT,VASCULAR PARKINSONISM,4
IT,ABASIA,3
IT,ABDOMINAL DISCOMFORT,3
IT,ABSCESS,3
IT,AKATHISIA,3
IT,AORTIC ANEURYSM RUPTURE,3
IT,AORTIC STENOSIS,3
IT,APNOEA,3
IT,ARTERIOSCLEROSIS CORONARY ARTERY,3
IT,ASTRINGENT THERAPY,3
IT,ATRIAL TACHYCARDIA,3
IT,BENIGN PROSTATIC HYPERPLASIA,3
IT,BLINDNESS,3
IT,BLOOD BICARBONATE INCREASED,3
IT,BLOOD GLUCOSE DECREASED,3
IT,C-REACTIVE PROTEIN ABNORMAL,3
IT,CARDIAC VENTRICULAR THROMBOSIS,3
IT,CARDIOPULMONARY FAILURE,3
IT,CARDIOVASCULAR DISORDER,3
IT,CHRONIC ALLOGRAFT NEPHROPATHY,3
IT,CHRONIC RESPIRATORY FAILURE,3
IT,CLAVICLE FRACTURE,3
IT,CLONUS,3
IT,COMPENSATORY SWEATING,3
IT,CREATININE RENAL CLEARANCE DECREASED,3
IT,DELUSION,3
IT,DIABETIC HYPEROSMOLAR COMA,3
IT,DIVERTICULAR PERFORATION,3
IT,DIVERTICULUM,3
IT,DRUG CLEARANCE DECREASED,3
IT,DRY MOUTH,3
IT,ECHOCARDIOGRAM ABNORMAL,3
IT,EMBOLISM,3
IT,EOSINOPHILIA,3
IT,EROSIVE DUODENITIS,3
IT,ERUCTATION,3
IT,ERYTHRODERMIC PSORIASIS,3
IT,EXPOSED BONE IN JAW,3
IT,EXPOSURE DURING PREGNANCY,3
IT,FAMILIAL PERIODIC PARALYSIS,3
IT,FEELING HOT,3
IT,FEMUR FRACTURE,3
IT,FISTULA,3
IT,FRACTURE,3
IT,FRACTURED COCCYX,3
IT,GASTRIC CANCER,3
IT,GASTRODUODENAL ULCER,3
IT,GASTROINTESTINAL ANGIODYSPLASIA,3
IT,GASTROINTESTINAL HYPOMOTILITY,3
IT,GLOMERULAR FILTRATION RATE DECREASED,3
IT,GLOSSITIS,3
IT,GRANULOMA ANNULARE,3
IT,HAEMATOMA EVACUATION,3
IT,HAEMOLYTIC URAEMIC SYNDROME,3
IT,HEART SOUNDS ABNORMAL,3
IT,HEPATIC CYST,3
IT,HEPATIC ENZYME INCREASED,3
IT,HEPATITIS C,3
IT,HEPATOMEGALY,3
IT,HEPATOPULMONARY SYNDROME,3
IT,HYPERREFLEXIA,3
IT,HYPERSENSITIVITY VASCULITIS,3
IT,HYPERTHERMIA,3
IT,HYPERTHYROIDISM,3
IT,HYPOALBUMINAEMIA,3
IT,HYPORESPONSIVE TO STIMULI,3
IT,IMMUNOSUPPRESSANT DRUG LEVEL DECREASED,3
IT,IMPLANT SITE HAEMATOMA,3
IT,INCONTINENCE,3
IT,INCORRECT DRUG ADMINISTRATION DURATION,3
IT,INCORRECT ROUTE OF DRUG ADMINISTRATION,3
IT,ISCHAEMIA,3
IT,JOINT SWELLING,3
IT,LABORATORY TEST ABNORMAL,3
IT,LACERATION,3
IT,LEFT VENTRICULAR DYSFUNCTION,3
IT,LUNG CONSOLIDATION,3
IT,LYMPHADENOPATHY,3
IT,MEDIASTINAL DISORDER,3
IT,MENINGITIS,3
IT,METRORRHAGIA,3
IT,MITRAL VALVE DISEASE,3
IT,MONOCYTE COUNT INCREASED,3
IT,MOUTH HAEMORRHAGE,3
IT,MUCOUS MEMBRANE DISORDER,3
IT,MYELODYSPLASTIC SYNDROME,3
IT,MYOCARDIAL NECROSIS,3
IT,MYOCARDITIS,3
IT,NAIL DISCOLOURATION,3
IT,NERVOUSNESS,3
IT,NEUROLOGICAL DECOMPENSATION,3
IT,NEUTROPHIL COUNT INCREASED,3
IT,OESOPHAGEAL ULCER,3
IT,OPTIC NEURITIS,3
IT,ORAL CANDIDIASIS,3
IT,OXYGEN SATURATION INCREASED,3
IT,PANIC ATTACK,3
IT,PARAPARESIS,3
IT,PLATELET TRANSFUSION,3
IT,PNEUMONIA PNEUMOCOCCAL,3
IT,POST PROCEDURAL HAEMORRHAGE,3
IT,POTENTIATING DRUG INTERACTION,3
IT,PSYCHOTIC DISORDER,3
IT,PULMONARY ARTERIAL HYPERTENSION,3
IT,PULMONARY ARTERIAL PRESSURE ABNORMAL,3
IT,PULMONARY ARTERIAL PRESSURE INCREASED,3
IT,PULMONARY VALVE INCOMPETENCE,3
IT,PYELOCALIECTASIS,3
IT,RALES,3
IT,RASH PAPULAR,3
IT,RASH VESICULAR,3
IT,RENAL HAEMATOMA,3
IT,RESTING TREMOR,3
IT,RETROPERITONEAL HAEMORRHAGE,3
IT,RIGHT VENTRICULAR DYSFUNCTION,3
IT,SELF INJURIOUS BEHAVIOUR,3
IT,SKIN DISCOLOURATION,3
IT,SPINAL FRACTURE,3
IT,SQUAMOUS CELL CARCINOMA OF SKIN,3
IT,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,3
IT,SUBENDOCARDIAL ISCHAEMIA,3
IT,SUFFOCATION FEELING,3
IT,SWOLLEN TONGUE,3
IT,THROMBOPHLEBITIS,3
IT,TIME PERCEPTION ALTERED,3
IT,TRAUMATIC HAEMATOMA,3
IT,UROSEPSIS,3
IT,VASOCONSTRICTION,3
IT,VENOUS THROMBOSIS LIMB,3
IT,VISUAL FIELD DEFECT,3
IT,WOUND,3
IT,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,3
IT,ACTIVITIES OF DAILY LIVING IMPAIRED,2
IT,ADENOCARCINOMA,2
IT,ADENOCARCINOMA GASTRIC,2
IT,ADENOCARCINOMA PANCREAS,2
IT,AGEUSIA,2
IT,ANAEMIA MACROCYTIC,2
IT,ANAEMIA VITAMIN B12 DEFICIENCY,2
IT,ANAL STENOSIS,2
IT,ANGINA UNSTABLE,2
IT,AORTIC CALCIFICATION,2
IT,APHTHOUS ULCER,2
IT,AREFLEXIA,2
IT,ARTERIOSCLEROSIS,2
IT,ASTERIXIS,2
IT,ASTHMA,2
IT,ATELECTASIS,2
IT,ATRIOVENTRICULAR DISSOCIATION,2
IT,AURICULAR HAEMATOMA,2
IT,AUTOIMMUNE HEPATITIS,2
IT,BACTERIAL INFECTION,2
IT,BASAL CELL CARCINOMA,2
IT,BASE EXCESS INCREASED,2
IT,BILE DUCT STONE,2
IT,BILIARY COLIC,2
IT,BILIARY DILATATION,2
IT,BLADDER CANCER,2
IT,BLEEDING VARICOSE VEIN,2
IT,BLISTER RUPTURE,2
IT,BLOOD CALCIUM DECREASED,2
IT,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,2
IT,BLOOD CREATININE ABNORMAL,2
IT,BLOOD GLUCOSE ABNORMAL,2
IT,BLOOD GLUCOSE FLUCTUATION,2
IT,BLOOD IRON DECREASED,2
IT,BLOOD PH INCREASED,2
IT,BLOOD PHOSPHORUS DECREASED,2
IT,BLOOD PRESSURE INADEQUATELY CONTROLLED,2
IT,BLOOD TEST ABNORMAL,2
IT,BLOOD THYROID STIMULATING HORMONE ABNORMAL,2
IT,BLOOD TRIGLYCERIDES INCREASED,2
IT,BONE CYST,2
IT,BRAIN NATRIURETIC PEPTIDE ABNORMAL,2
IT,BRAIN NATRIURETIC PEPTIDE INCREASED,2
IT,BREATH ODOUR,2
IT,BRONCHIECTASIS,2
IT,CAESAREAN SECTION,2
IT,CANDIDA TEST POSITIVE,2
IT,CAPILLARY LEAK SYNDROME,2
IT,CARBON DIOXIDE INCREASED,2
IT,CARDIAC OUTPUT DECREASED,2
IT,CARDIAC TAMPONADE,2
IT,CARDIO-RESPIRATORY DISTRESS,2
IT,CARDIOTOXICITY,2
IT,CEREBELLAR STROKE,2
IT,CEREBRAL INFARCTION,2
IT,CEREBRAL THROMBOSIS,2
IT,CERVICOBRACHIAL SYNDROME,2
IT,CHEST INJURY,2
IT,CHEST X-RAY ABNORMAL,2
IT,CHEYNE-STOKES RESPIRATION,2
IT,CHRONIC GASTRITIS,2
IT,CIRCULATORY COLLAPSE,2
IT,CLOSTRIDIUM TEST POSITIVE,2
IT,CLUBBING,2
IT,COLITIS ISCHAEMIC,2
IT,COMPLETED SUICIDE,2
IT,COPROLALIA,2
IT,CORONARY ARTERY DISEASE,2
IT,CORONARY ARTERY OCCLUSION,2
IT,CORONARY ARTERY STENOSIS,2
IT,DEAFNESS,2
IT,DECUBITUS ULCER,2
IT,DEPENDENCE ON OXYGEN THERAPY,2
IT,DEPRESSED MOOD,2
IT,DIABETIC COMA,2
IT,DILATATION VENTRICULAR,2
IT,DISCOMFORT,2
IT,DRUG ABUSER,2
IT,DRUG ERUPTION,2
IT,DRY EYE,2
IT,DYSLIPIDAEMIA,2
IT,DYSPHORIA,2
IT,EFFUSION,2
IT,ELECTROCARDIOGRAM QRS COMPLEX ABNORMAL,2
IT,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,2
IT,ELEPHANTIASIS,2
IT,EMBOLIC STROKE,2
IT,EMPHYSEMA,2
IT,ENDOCARDITIS BACTERIAL,2
IT,ENTEROCOLITIS,2
IT,EPIDERMOLYSIS BULLOSA,2
IT,ERYTHROPOIESIS ABNORMAL,2
IT,EXOPHTHALMOS,2
IT,EXTRADURAL HAEMATOMA,2
IT,EYE PAIN,2
IT,EYE SWELLING,2
IT,EYELID PTOSIS,2
IT,FAECAL INCONTINENCE,2
IT,FASTING,2
IT,FEBRILE BONE MARROW APLASIA,2
IT,FIBRIN D DIMER INCREASED,2
IT,FLANK PAIN,2
IT,FLUID INTAKE REDUCED,2
IT,FLUID OVERLOAD,2
IT,FOETAL EXPOSURE DURING PREGNANCY,2
IT,FORMICATION,2
IT,FULL BLOOD COUNT DECREASED,2
IT,FUNGAL INFECTION,2
IT,GASTRIC DISORDER,2
IT,GASTRIC MUCOSAL LESION,2
IT,GASTROINTESTINAL MOTILITY DISORDER,2
IT,GASTROOESOPHAGEAL REFLUX DISEASE,2
IT,GINGIVITIS,2
IT,GLOSSODYNIA,2
IT,GROIN PAIN,2
IT,HAEMANGIOMA OF LIVER,2
IT,HAEMATIDROSIS,2
IT,HAEMOGLOBINAEMIA,2
IT,HAEMOLYTIC ANAEMIA,2
IT,HAEMORRHAGIC DISORDER,2
IT,HAEMORRHOIDAL HAEMORRHAGE,2
IT,HALLUCINATIONS_ MIXED,2
IT,HEART RATE IRREGULAR,2
IT,HEPATIC ENZYME ABNORMAL,2
IT,HEPATIC STEATOSIS,2
IT,HEPATITIS C RNA,2
IT,HERNIA,2
IT,HERPES ZOSTER,2
IT,HIATUS HERNIA,2
IT,HYPERCHLORHYDRIA,2
IT,HYPERTRIGLYCERIDAEMIA,2
IT,HYPERVENTILATION,2
IT,HYPOCHROMASIA,2
IT,HYPOGAMMAGLOBULINAEMIA,2
IT,HYPOGLYCAEMIC SEIZURE,2
IT,HYPONATRAEMIC SEIZURE,2
IT,HYPOPERFUSION,2
IT,HYPOPHAGIA,2
IT,HYPOTONIA,2
IT,IMPETIGO,2
IT,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,2
IT,INTERNATIONAL NORMALISED RATIO FLUCTUATION,2
IT,INTESTINAL ISCHAEMIA,2
IT,INTESTINAL POLYP,2
IT,INTRA-ABDOMINAL HAEMORRHAGE,2
IT,KIDNEY INFECTION,2
IT,KLEBSIELLA INFECTION,2
IT,KLEBSIELLA SEPSIS,2
IT,LACRIMATION INCREASED,2
IT,LEFT ATRIAL ENLARGEMENT,2
IT,LEFT VENTRICULAR DILATATION,2
IT,LOCALISED INFECTION,2
IT,LUMBAR VERTEBRAL FRACTURE,2
IT,LUNG ADENOCARCINOMA,2
IT,LYMPHOCYTE COUNT DECREASED,2
IT,LYMPHOCYTE PERCENTAGE DECREASED,2
IT,MALNUTRITION,2
IT,MATERNAL EXPOSURE BEFORE PREGNANCY,2
IT,MEMORY IMPAIRMENT,2
IT,MESENTERITIS,2
IT,METASTASES TO BONE,2
IT,METASTASES TO CENTRAL NERVOUS SYSTEM,2
IT,METASTASES TO LIVER,2
IT,METASTASES TO LUNG,2
IT,MICROLITHIASIS,2
IT,MIGRAINE,2
IT,MONOPARESIS,2
IT,MOOD ALTERED,2
IT,MUCOSAL DISCOLOURATION,2
IT,MUSCLE ATROPHY,2
IT,MYASTHENIC SYNDROME,2
IT,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE ABNORMAL,2
IT,NASAL CAVITY CANCER,2
IT,NASOPHARYNGITIS,2
IT,NECK PAIN,2
IT,NEOPLASM PROGRESSION,2
IT,NEPHROLITHIASIS,2
IT,NEPHROPATHY TOXIC,2
IT,NEURODEVELOPMENTAL DISORDER,2
IT,NEUROGLYCOPENIA,2
IT,NEUROTOXICITY,2
IT,NON-HODGKIN^S LYMPHOMA,2
IT,OBESITY,2
IT,OCCULT BLOOD POSITIVE,2
IT,OROPHARYNGEAL SWELLING,2
IT,PANCREATITIS,2
IT,PAPILLARY THYROID CANCER,2
IT,PAPULE,2
IT,PARKINSONISM,2
IT,PAROSMIA,2
IT,PATHOLOGICAL FRACTURE,2
IT,PELVIC HAEMATOMA,2
IT,PERIPHERAL ARTERY ANEURYSM,2
IT,PERIPHERAL ARTERY OCCLUSION,2
IT,PERIPHERAL EMBOLISM,2
IT,PERITONEAL HAEMORRHAGE,2
IT,PERITONITIS BACTERIAL,2
IT,PHARYNGEAL INFLAMMATION,2
IT,PHOTOSENSITIVITY REACTION,2
IT,PLEUROPERICARDITIS,2
IT,PNEUMONIA BACTERIAL,2
JM,DEATH,2
JM,CARDIAC FAILURE,1
JM,CEREBRAL ISCHAEMIA,1
JM,CEREBROVASCULAR ACCIDENT,1
JM,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
JM,DRUG INEFFECTIVE,1
JM,DRUG RESISTANCE,1
JM,GASTRITIS,1
JM,HYPERTENSIVE HEART DISEASE,1
JM,HYPOACUSIS,1
JM,PROSTATOMEGALY,1
JM,PULMONARY OEDEMA,1
JM,RENAL FAILURE,1
JM,WHITE BLOOD CELL COUNT INCREASED,1
JP,CARDIAC FAILURE,542
JP,ANAEMIA,489
JP,PNEUMONIA,447
JP,RENAL IMPAIRMENT,415
JP,PLATELET COUNT DECREASED,388
JP,PYREXIA,370
JP,HEPATIC FUNCTION ABNORMAL,321
JP,DECREASED APPETITE,302
JP,DIARRHOEA,284
JP,INTERSTITIAL LUNG DISEASE,284
JP,NAUSEA,227
JP,DEHYDRATION,217
JP,BLOOD CREATININE INCREASED,213
JP,SEPSIS,210
JP,BLOOD UREA INCREASED,207
JP,MALAISE,193
JP,PLEURAL EFFUSION,192
JP,WHITE BLOOD CELL COUNT DECREASED,192
JP,CEREBRAL INFARCTION,178
JP,HAEMOGLOBIN DECREASED,174
JP,OEDEMA PERIPHERAL,173
JP,VOMITING,170
JP,HYPOKALAEMIA,165
JP,HYPERKALAEMIA,163
JP,OEDEMA,161
JP,NEUTROPHIL COUNT DECREASED,156
JP,DYSPNOEA,155
JP,ACUTE KIDNEY INJURY,152
JP,BLOOD PRESSURE DECREASED,151
JP,RENAL FAILURE,145
JP,ASPARTATE AMINOTRANSFERASE INCREASED,139
JP,DEATH,139
JP,FALL,138
JP,CONSTIPATION,137
JP,ALTERED STATE OF CONSCIOUSNESS,133
JP,CONDITION AGGRAVATED,133
JP,LIVER DISORDER,133
JP,DISSEMINATED INTRAVASCULAR COAGULATION,132
JP,CARDIAC FAILURE CONGESTIVE,131
JP,RASH,131
JP,FEBRILE NEUTROPENIA,129
JP,ALANINE AMINOTRANSFERASE INCREASED,128
JP,ASCITES,125
JP,HYPERTENSION,124
JP,PANCYTOPENIA,117
JP,MALIGNANT NEOPLASM PROGRESSION,112
JP,GASTROINTESTINAL HAEMORRHAGE,110
JP,HYPONATRAEMIA,109
JP,RESPIRATORY FAILURE,105
JP,HYPERNATRAEMIA,104
JP,ATRIAL FIBRILLATION,100
JP,DIZZINESS,98
JP,DRUG INEFFECTIVE,97
JP,LOSS OF CONSCIOUSNESS,97
JP,PNEUMONIA ASPIRATION,97
JP,HEADACHE,92
JP,C-REACTIVE PROTEIN INCREASED,89
JP,DEPRESSED LEVEL OF CONSCIOUSNESS,89
JP,NEUTROPENIA,88
JP,URINARY TRACT INFECTION,88
JP,BLOOD ALKALINE PHOSPHATASE INCREASED,85
JP,SOMNOLENCE,84
JP,GAMMA-GLUTAMYLTRANSFERASE INCREASED,83
JP,CELLULITIS,81
JP,HYPOGLYCAEMIA,80
JP,THROMBOCYTOPENIA,80
JP,DISEASE PROGRESSION,79
JP,CARDIAC FAILURE CHRONIC,77
JP,HEPATIC ENCEPHALOPATHY,77
JP,HEPATIC FAILURE,76
JP,HYPERURICAEMIA,76
JP,HYPOTENSION,76
JP,ABDOMINAL PAIN,73
JP,RENAL DISORDER,73
JP,WEIGHT INCREASED,72
JP,WHITE BLOOD CELL COUNT INCREASED,72
JP,CEREBRAL HAEMORRHAGE,70
JP,BRADYCARDIA,69
JP,DIABETES MELLITUS,69
JP,DRUG ERUPTION,69
JP,INSOMNIA,69
JP,BLOOD BILIRUBIN INCREASED,68
JP,BLOOD LACTATE DEHYDROGENASE INCREASED,68
JP,ERYTHEMA,68
JP,SEPTIC SHOCK,68
JP,BRONCHITIS,67
JP,DELIRIUM,67
JP,PRURITUS,66
JP,STOMATITIS,65
JP,ELECTROCARDIOGRAM QT PROLONGED,64
JP,PULMONARY OEDEMA,63
JP,BLOOD GLUCOSE INCREASED,62
JP,BACK PAIN,61
JP,CARDIAC FAILURE ACUTE,61
JP,CARDIO-RESPIRATORY ARREST,61
JP,GENERALISED OEDEMA,61
JP,HYPERGLYCAEMIA,61
JP,HYPOXIA,60
JP,THIRST,60
JP,RENAL FAILURE ACUTE,59
JP,HAEMOPTYSIS,57
JP,RHABDOMYOLYSIS,57
JP,SUBDURAL HAEMATOMA,57
JP,COUGH,56
JP,MELAENA,56
JP,SEIZURE,56
JP,HYPOALBUMINAEMIA,55
JP,MULTI-ORGAN FAILURE,55
JP,NASOPHARYNGITIS,54
JP,RED BLOOD CELL COUNT DECREASED,54
JP,SHOCK,54
JP,BONE MARROW FAILURE,53
JP,DRUG-INDUCED LIVER INJURY,53
JP,HYPOCALCAEMIA,53
JP,INFECTION,53
JP,RIGHT VENTRICULAR FAILURE,53
JP,GAIT DISTURBANCE,52
JP,BLOOD CREATINE PHOSPHOKINASE INCREASED,51
JP,DEVICE RELATED INFECTION,51
JP,VENTRICULAR TACHYCARDIA,51
JP,BLOOD POTASSIUM INCREASED,49
JP,ASTHENIA,48
JP,COLON CANCER,48
JP,EPISTAXIS,48
JP,HERPES ZOSTER,48
JP,LYMPHOCYTE COUNT DECREASED,48
JP,PULMONARY ARTERIAL HYPERTENSION,48
JP,HAEMATURIA,47
JP,HYPOAESTHESIA,47
JP,CARDIAC ARREST,46
JP,PERITONITIS,46
JP,OSTEONECROSIS OF JAW,45
JP,ARTHRALGIA,44
JP,PULMONARY ALVEOLAR HAEMORRHAGE,44
JP,TOXIC EPIDERMAL NECROLYSIS,44
JP,URINE OUTPUT DECREASED,44
JP,BLOOD URIC ACID INCREASED,43
JP,OVERDOSE,43
JP,ASTHMA,42
JP,HAEMORRHAGE SUBCUTANEOUS,42
JP,HEPATIC CIRRHOSIS,42
JP,PNEUMONIA BACTERIAL,42
JP,MUSCULAR WEAKNESS,41
JP,ANGINA PECTORIS,40
JP,EOSINOPHIL COUNT INCREASED,40
JP,GASTRIC ULCER,40
JP,HEPATOCELLULAR CARCINOMA,40
JP,PULMONARY HYPERTENSION,40
JP,MYELODYSPLASTIC SYNDROME,39
JP,MYOCARDIAL INFARCTION,39
JP,PULMONARY CONGESTION,39
JP,ACUTE MYOCARDIAL INFARCTION,38
JP,CHRONIC KIDNEY DISEASE,38
JP,CONCOMITANT DISEASE AGGRAVATED,38
JP,FATIGUE,38
JP,INTERNATIONAL NORMALISED RATIO INCREASED,38
JP,PAIN,38
JP,VENTRICULAR FIBRILLATION,38
JP,BLOOD POTASSIUM DECREASED,37
JP,EMBOLIC STROKE,37
JP,ENTEROCOLITIS,37
JP,SUDDEN DEATH,37
JP,UPPER RESPIRATORY TRACT INFLAMMATION,37
JP,HAEMATOCRIT DECREASED,36
JP,ILEUS,36
JP,IRON DEFICIENCY ANAEMIA,36
JP,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,36
JP,ARRHYTHMIA,35
JP,GASTROENTERITIS,35
JP,HYPOTHYROIDISM,35
JP,JAUNDICE,35
JP,MULTIPLE ORGAN DYSFUNCTION SYNDROME,35
JP,OXYGEN SATURATION DECREASED,35
JP,PNEUMOTHORAX,35
JP,FLUID RETENTION,34
JP,SHOCK HAEMORRHAGIC,34
JP,STEVENS-JOHNSON SYNDROME,34
JP,BRAIN NATRIURETIC PEPTIDE INCREASED,33
JP,GENERAL PHYSICAL HEALTH DETERIORATION,33
JP,HYPERCALCAEMIA,33
JP,ABDOMINAL DISTENSION,32
JP,GASTRIC ULCER HAEMORRHAGE,32
JP,LEUKOPENIA,32
JP,PROTEINURIA,32
JP,BLOOD ALBUMIN DECREASED,31
JP,BLOOD PRESSURE INCREASED,31
JP,DRUG EFFECT INCOMPLETE,31
JP,DYSPHAGIA,31
JP,FEMUR FRACTURE,31
JP,HYPOPHAGIA,31
JP,METABOLIC ACIDOSIS,31
JP,PAIN IN EXTREMITY,31
JP,TRANSFUSION,31
JP,HAEMORRHAGE,30
JP,HYPERAMMONAEMIA,30
JP,PLASMA CELL MYELOMA,30
JP,PNEUMOCYSTIS JIROVECII PNEUMONIA,30
JP,TACHYCARDIA,30
JP,WEIGHT DECREASED,30
JP,HAEMATEMESIS,29
JP,MYALGIA,29
JP,SPINAL COMPRESSION FRACTURE,29
JP,SYNCOPE,29
JP,TUMOUR LYSIS SYNDROME,29
JP,CYTOMEGALOVIRUS INFECTION,28
JP,GASTRIC CANCER,28
JP,INFLUENZA,28
JP,URTICARIA,28
JP,AGRANULOCYTOSIS,27
JP,CHEST PAIN,27
JP,LUNG DISORDER,27
JP,PALPITATIONS,27
JP,RESPIRATORY DISORDER,27
JP,TREMOR,27
JP,FACE OEDEMA,26
JP,PANCREATITIS ACUTE,26
JP,PERICARDIAL EFFUSION,26
JP,ABDOMINAL PAIN UPPER,25
JP,ANURIA,25
JP,CARDIOMEGALY,25
JP,DEEP VEIN THROMBOSIS,25
JP,NEPHROTIC SYNDROME,25
JP,PULMONARY EMBOLISM,25
JP,AZOTAEMIA,24
JP,BLOOD SODIUM DECREASED,24
JP,CHEST DISCOMFORT,24
JP,CIRCULATORY COLLAPSE,24
JP,HYPERBILIRUBINAEMIA,24
JP,NEUROPATHY PERIPHERAL,24
JP,PANCREATIC CARCINOMA,24
JP,RESTLESSNESS,24
JP,SKIN ULCER,24
JP,UPPER GASTROINTESTINAL HAEMORRHAGE,24
JP,VENTRICULAR EXTRASYSTOLES,24
JP,ACUTE RESPIRATORY DISTRESS SYNDROME,23
JP,CARDIAC TAMPONADE,23
JP,DYSARTHRIA,23
JP,GLYCOSYLATED HAEMOGLOBIN INCREASED,23
JP,HEPATIC ENZYME INCREASED,23
JP,INFLAMMATION,23
JP,PRODUCT USE ISSUE,23
JP,RENAL FAILURE CHRONIC,23
JP,SUBARACHNOID HAEMORRHAGE,23
JP,ACUTE RESPIRATORY FAILURE,22
JP,CHOLECYSTITIS,22
JP,FEELING ABNORMAL,22
JP,LUNG NEOPLASM MALIGNANT,22
JP,NEPHROGENIC ANAEMIA,22
JP,OSTEOMYELITIS,22
JP,PROSTATE CANCER,22
JP,PSEUDOMEMBRANOUS COLITIS,22
JP,THROMBOTIC MICROANGIOPATHY,22
JP,TOXICITY TO VARIOUS AGENTS,22
JP,ANAPHYLACTIC SHOCK,21
JP,CHOLELITHIASIS,21
JP,ECZEMA,21
JP,EXPOSURE DURING PREGNANCY,21
JP,HAEMATOCHEZIA,21
JP,RESPIRATORY ARREST,21
JP,URINARY RETENTION,21
JP,CYTOMEGALOVIRUS VIRAEMIA,20
JP,DEMENTIA,20
JP,DRUG LEVEL INCREASED,20
JP,HYPERTHYROIDISM,20
JP,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,20
JP,LYMPHOMA,20
JP,MALNUTRITION,20
JP,PEMPHIGOID,20
JP,PULMONARY HAEMORRHAGE,20
JP,ABDOMINAL DISCOMFORT,19
JP,AMYLASE INCREASED,19
JP,BACTERAEMIA,19
JP,CYSTITIS,19
JP,GASTROOESOPHAGEAL REFLUX DISEASE,19
JP,ILEUS PARALYTIC,19
JP,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,19
JP,PRESCRIBED UNDERDOSE,19
JP,STAPHYLOCOCCAL INFECTION,19
JP,TORSADE DE POINTES,19
JP,CATARACT,18
JP,CHOLANGITIS,18
JP,DECUBITUS ULCER,18
JP,DYSURIA,18
JP,ERYTHEMA MULTIFORME,18
JP,HAEMODIALYSIS,18
JP,INTESTINAL OBSTRUCTION,18
JP,ORTHOSTATIC HYPOTENSION,18
JP,PYELONEPHRITIS,18
JP,TOXIC ENCEPHALOPATHY,18
JP,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,17
JP,ATRIOVENTRICULAR BLOCK COMPLETE,17
JP,DEPRESSION,17
JP,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,17
JP,DUODENAL ULCER HAEMORRHAGE,17
JP,EOSINOPHILIA,17
JP,EPILEPSY,17
JP,FEMORAL NECK FRACTURE,17
JP,LARGE INTESTINE PERFORATION,17
JP,LARGE INTESTINE POLYP,17
JP,OESOPHAGEAL VARICES HAEMORRHAGE,17
JP,SKIN EROSION,17
JP,THERAPEUTIC RESPONSE DECREASED,17
JP,ANGINA UNSTABLE,16
JP,APLASIA PURE RED CELL,16
JP,BREAST CANCER,16
JP,COLITIS ISCHAEMIC,16
JP,CONTUSION,16
JP,DYSGEUSIA,16
JP,DYSPNOEA EXERTIONAL,16
JP,EYELID OEDEMA,16
JP,GASTRITIS,16
JP,HALLUCINATION,16
JP,HEPATORENAL SYNDROME,16
JP,HYPOMAGNESAEMIA,16
JP,LACTIC ACIDOSIS,16
JP,LIVER FUNCTION TEST ABNORMAL,16
JP,LOWER GASTROINTESTINAL HAEMORRHAGE,16
JP,ORGANISING PNEUMONIA,16
JP,SERUM FERRITIN INCREASED,16
JP,SKIN DISORDER,16
JP,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,15
JP,CONVULSION,15
JP,DISORIENTATION,15
JP,FAECES DISCOLOURED,15
JP,HEPATITIS FULMINANT,15
JP,HYPERCAPNIA,15
JP,HYPERHIDROSIS,15
JP,HYPOPHOSPHATAEMIA,15
JP,INTENTIONAL PRODUCT MISUSE,15
JP,NON-SMALL CELL LUNG CANCER,15
JP,OROPHARYNGEAL PAIN,15
JP,PLATELET COUNT INCREASED,15
JP,PRERENAL FAILURE,15
JP,STAPHYLOCOCCAL SEPSIS,15
JP,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,15
JP,ACUTE MYELOID LEUKAEMIA,14
JP,BLOOD CALCIUM DECREASED,14
JP,CANCER PAIN,14
JP,CHOLECYSTITIS ACUTE,14
JP,COAGULOPATHY,14
JP,CYSTITIS HAEMORRHAGIC,14
JP,DERMATITIS ACNEIFORM,14
JP,DRY SKIN,14
JP,ELECTROLYTE IMBALANCE,14
JP,ENDOCARDITIS,14
JP,FEEDING DISORDER,14
JP,GASTROINTESTINAL PERFORATION,14
JP,HAEMORRHAGIC DIATHESIS,14
JP,HISTIOCYTOSIS HAEMATOPHAGIC,14
JP,HYPOPROTEINAEMIA,14
JP,LYMPHADENOPATHY,14
JP,METASTATIC RENAL CELL CARCINOMA,14
JP,NEOPLASM PROGRESSION,14
JP,PNEUMONITIS,14
JP,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,14
JP,PROTHROMBIN TIME PROLONGED,14
JP,RASH GENERALISED,14
JP,TOXIC SKIN ERUPTION,14
JP,TUBULOINTERSTITIAL NEPHRITIS,14
JP,BACTERIAL INFECTION,13
JP,BLISTER,13
JP,CEREBRAL ARTERY EMBOLISM,13
JP,CHILLS,13
JP,CONTRAINDICATED PRODUCT ADMINISTERED,13
JP,CYTOMEGALOVIRUS TEST POSITIVE,13
JP,DEVICE OCCLUSION,13
JP,HEART RATE DECREASED,13
JP,HEMIPLEGIA,13
JP,HUMERUS FRACTURE,13
JP,INFUSION SITE PAIN,13
JP,INTESTINAL ISCHAEMIA,13
JP,MYOCARDIAL ISCHAEMIA,13
JP,NEUTROPHIL COUNT INCREASED,13
JP,OSTEOPOROSIS,13
JP,PIGMENTATION DISORDER,13
JP,PROTEIN URINE PRESENT,13
JP,PSEUDO-BARTTER SYNDROME,13
JP,RHINITIS ALLERGIC,13
JP,SWELLING,13
JP,THALAMUS HAEMORRHAGE,13
JP,WHEEZING,13
JP,APPENDICITIS,12
JP,BLOOD SODIUM INCREASED,12
JP,BRAIN OEDEMA,12
JP,CARDIAC DISORDER,12
JP,CATHETER SITE INFECTION,12
JP,COMA,12
JP,DRUG ABUSE,12
JP,FOETAL EXPOSURE DURING PREGNANCY,12
JP,GASTROINTESTINAL NECROSIS,12
JP,HAEMOLYTIC ANAEMIA,12
JP,HYDRONEPHROSIS,12
JP,HYPERLIPIDAEMIA,12
JP,HYPERPHOSPHATAEMIA,12
JP,HYPERSENSITIVITY,12
JP,MATERNAL EXPOSURE DURING PREGNANCY,12
JP,MOUTH HAEMORRHAGE,12
JP,MUSCULOSKELETAL PAIN,12
JP,PALLOR,12
JP,PERIPHERAL SWELLING,12
JP,PHARYNGITIS,12
JP,RECTAL CANCER,12
JP,SPEECH DISORDER,12
JP,TRANSIENT ISCHAEMIC ATTACK,12
JP,ABNORMAL BEHAVIOUR,11
JP,ANAPHYLACTIC REACTION,11
JP,ASPIRATION,11
JP,DERMATITIS,11
JP,DIABETIC NEPHROPATHY,11
JP,DRUG RESISTANCE,11
JP,DUODENAL ULCER,11
JP,ENCEPHALOPATHY,11
JP,FRACTURE,11
JP,GRAFT VERSUS HOST DISEASE,11
JP,HAEMORRHAGIC INFARCTION,11
JP,HYPERTHERMIA,11
JP,IMMUNE THROMBOCYTOPENIC PURPURA,11
JP,JAUNDICE CHOLESTATIC,11
JP,MARASMUS,11
JP,OCCULT BLOOD POSITIVE,11
JP,OLIGURIA,11
JP,PRODUCT USE IN UNAPPROVED INDICATION,11
JP,PROTEIN TOTAL DECREASED,11
JP,PYELONEPHRITIS ACUTE,11
JP,RENAL ATROPHY,11
JP,RESPIRATORY DISTRESS,11
JP,SMALL INTESTINAL HAEMORRHAGE,11
JP,SUPRAVENTRICULAR TACHYCARDIA,11
JP,UPPER RESPIRATORY TRACT INFECTION,11
JP,WERNICKE^S ENCEPHALOPATHY,11
JP,ABDOMINAL PAIN LOWER,10
JP,ALOPECIA,10
JP,BENIGN PROSTATIC HYPERPLASIA,10
JP,BILE DUCT STONE,10
JP,BLOOD CHLORIDE DECREASED,10
JP,BONE PAIN,10
JP,BRAIN STEM HAEMORRHAGE,10
JP,COLITIS,10
JP,CONFUSIONAL STATE,10
JP,DIABETES MELLITUS INADEQUATE CONTROL,10
JP,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,10
JP,DYSKINESIA,10
JP,DYSSTASIA,10
JP,EJECTION FRACTION DECREASED,10
JP,ENTERITIS INFECTIOUS,10
JP,EOSINOPHILIC PNEUMONIA,10
JP,FIBRIN D DIMER INCREASED,10
JP,FLUSHING,10
JP,FOETAL GROWTH RESTRICTION,10
JP,GASTRIC HAEMORRHAGE,10
JP,GASTRIC MUCOSAL LESION,10
JP,GENERALISED ERYTHEMA,10
JP,GYNAECOMASTIA,10
JP,HAEMORRHAGIC ANAEMIA,10
JP,HAEMORRHOIDS,10
JP,MOVEMENT DISORDER,10
JP,MUSCLE SPASMS,10
JP,PLEURISY,10
JP,POLLAKIURIA,10
JP,PRODUCTIVE COUGH,10
JP,PURPURA,10
JP,RENAL ISCHAEMIA,10
JP,SINUSITIS,10
JP,SKIN EXFOLIATION,10
JP,SUPRAVENTRICULAR EXTRASYSTOLES,10
JP,SYSTEMIC LUPUS ERYTHEMATOSUS,10
JP,THROMBOSIS,10
JP,VITREOUS HAEMORRHAGE,10
JP,ACIDOSIS,9
JP,AORTIC DISSECTION,9
JP,ARTHRITIS,9
JP,ATRIAL FLUTTER,9
JP,BLAST CELL COUNT INCREASED,9
JP,BLOOD PHOSPHORUS DECREASED,9
JP,BLOOD TRIGLYCERIDES INCREASED,9
JP,BRONCHOPNEUMONIA,9
JP,BUNDLE BRANCH BLOCK RIGHT,9
JP,CEREBELLAR HAEMORRHAGE,9
JP,COMPRESSION FRACTURE,9
JP,CREATININE RENAL CLEARANCE DECREASED,9
JP,CYTOMEGALOVIRUS ENTEROCOLITIS,9
JP,DISUSE SYNDROME,9
JP,DRUG INTOLERANCE,9
JP,DYSLALIA,9
JP,DYSPHONIA,9
JP,EATING DISORDER,9
JP,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,9
JP,FUNGAL INFECTION,9
JP,HAEMORRHAGE INTRACRANIAL,9
JP,HAEMORRHOIDAL HAEMORRHAGE,9
JP,HEART RATE INCREASED,9
JP,HEPATITIS ACUTE,9
JP,HOT FLUSH,9
JP,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,9
JP,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,9
JP,LIPASE INCREASED,9
JP,LOW CARDIAC OUTPUT SYNDROME,9
JP,LUNG INFECTION,9
JP,LUNG INFILTRATION,9
JP,MALLORY-WEISS SYNDROME,9
JP,METABOLIC ALKALOSIS,9
JP,METASTASES TO BONE,9
JP,MITRAL VALVE INCOMPETENCE,9
JP,MYOCLONUS,9
JP,NASAL CONGESTION,9
JP,ORAL CANDIDIASIS,9
JP,OSTEONECROSIS,9
JP,PARONYCHIA,9
JP,PERITONITIS BACTERIAL,9
JP,PNEUMONIA STAPHYLOCOCCAL,9
JP,POST PROCEDURAL HAEMORRHAGE,9
JP,PRESCRIBED OVERDOSE,9
JP,PRURITUS GENERALISED,9
JP,RHEUMATOID ARTHRITIS,9
JP,ROAD TRAFFIC ACCIDENT,9
JP,SINUS NODE DYSFUNCTION,9
JP,SURGERY,9
JP,VENTRICULAR ARRHYTHMIA,9
JP,VITAMIN B1 DEFICIENCY,9
JP,ACUTE HEPATIC FAILURE,8
JP,AORTIC ANEURYSM,8
JP,BLADDER CANCER,8
JP,BLOOD PRESSURE SYSTOLIC INCREASED,8
JP,CARDIOGENIC SHOCK,8
JP,CATHETER REMOVAL,8
JP,CELL MARKER INCREASED,8
JP,CHRONIC GRAFT VERSUS HOST DISEASE,8
JP,CLOSTRIDIUM DIFFICILE COLITIS,8
JP,COLD SWEAT,8
JP,DIVERTICULITIS,8
JP,GLAUCOMA,8
JP,GOUT,8
JP,HAEMORRHAGIC CEREBRAL INFARCTION,8
JP,HEPATIC CANCER,8
JP,HEPATIC CONGESTION,8
JP,HEPATIC STEATOSIS,8
JP,HICCUPS,8
JP,HYPOTHERMIA,8
JP,INFUSION RELATED REACTION,8
JP,INTENTIONAL UNDERDOSE,8
JP,LONG QT SYNDROME,8
JP,MALIGNANT PLEURAL EFFUSION,8
JP,MEDICATION RESIDUE PRESENT,8
JP,METASTASES TO LUNG,8
JP,MYELOFIBROSIS,8
JP,NECROSIS,8
JP,NEPHROLITHIASIS,8
JP,OCCULT BLOOD,8
JP,OTITIS MEDIA,8
JP,PAIN IN JAW,8
JP,PELVIC FRACTURE,8
JP,PERIPHERAL SENSORY NEUROPATHY,8
JP,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,8
JP,POTENTIATING DRUG INTERACTION,8
JP,RASH MACULO-PAPULAR,8
JP,RECTAL ULCER,8
JP,RENAL TUBULAR DISORDER,8
JP,RENAL TUBULAR NECROSIS,8
JP,RESPIRATORY TRACT INFECTION,8
JP,VENOUS THROMBOSIS LIMB,8
JP,VERTIGO,8
JP,ACTIVITIES OF DAILY LIVING IMPAIRED,7
JP,ACUTE GRAFT VERSUS HOST DISEASE,7
JP,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,7
JP,AGGRESSION,7
JP,AMMONIA INCREASED,7
JP,ANAPHYLACTOID REACTION,7
JP,ANXIETY,7
JP,ASPERGILLUS INFECTION,7
JP,ASPHYXIA,7
JP,ATELECTASIS,7
JP,BILE DUCT CANCER,7
JP,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,7
JP,BLOOD GLUCOSE DECREASED,7
JP,CALCULUS URINARY,7
JP,CARDIAC OUTPUT DECREASED,7
JP,CHEST X-RAY ABNORMAL,7
JP,CHOLESTASIS,7
JP,CHRONIC MYELOID LEUKAEMIA,7
JP,COLITIS MICROSCOPIC,7
JP,CONJUNCTIVITIS,7
JP,DERMATITIS CONTACT,7
JP,DILATATION VENTRICULAR,7
JP,DRUG ADMINISTRATION ERROR,7
JP,DYSLIPIDAEMIA,7
JP,DYSPEPSIA,7
JP,ELECTROCARDIOGRAM T WAVE ABNORMAL,7
JP,GANGRENE,7
JP,GASTRIC ANTRAL VASCULAR ECTASIA,7
JP,GENITAL HAEMORRHAGE,7
JP,GLOMERULAR FILTRATION RATE DECREASED,7
JP,GRANULOCYTOPENIA,7
JP,HAEMATOMA,7
JP,HEPATITIS C,7
JP,HYPERAMYLASAEMIA,7
JP,HYPOGLYCAEMIC COMA,7
JP,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,7
JP,INCORRECT DOSE ADMINISTERED,7
JP,INFUSION SITE ERYTHEMA,7
JP,INJURY,7
JP,ISCHAEMIC HEPATITIS,7
JP,LEFT VENTRICULAR DYSFUNCTION,7
JP,METASTASES TO LIVER,7
JP,METASTASES TO LYMPH NODES,7
JP,MIOSIS,7
JP,MUSCULOSKELETAL STIFFNESS,7
JP,NYSTAGMUS,7
JP,OESOPHAGEAL ULCER,7
JP,PERIODONTITIS,7
JP,PLATELET TRANSFUSION,7
JP,PNEUMOMEDIASTINUM,7
JP,PORTAL VEIN THROMBOSIS,7
JP,PSYCHIATRIC SYMPTOM,7
JP,PUTAMEN HAEMORRHAGE,7
JP,RENAL CELL CARCINOMA,7
JP,SICK SINUS SYNDROME,7
JP,STATUS EPILEPTICUS,7
JP,SUBCUTANEOUS HAEMATOMA,7
JP,SUDDEN CARDIAC DEATH,7
JP,VASCULAR PSEUDOANEURYSM,7
JP,ACUTE PULMONARY OEDEMA,6
JP,AGITATION,6
JP,ANAEMIA MACROCYTIC,6
JP,APLASTIC ANAEMIA,6
JP,ATRIAL TACHYCARDIA,6
JP,ATRIOVENTRICULAR BLOCK,6
JP,AUTOIMMUNE HEPATITIS,6
JP,BLOOD BETA-D-GLUCAN INCREASED,6
JP,BRAIN CONTUSION,6
JP,BRAIN HERNIATION,6
JP,BRONCHOPULMONARY ASPERGILLOSIS,6
JP,CALCIPHYLAXIS,6
JP,CARDIOMYOPATHY,6
JP,CEREBELLAR INFARCTION,6
JP,CHOLANGITIS ACUTE,6
JP,COGNITIVE DISORDER,6
JP,COLORECTAL CANCER,6
JP,COMA SCALE ABNORMAL,6
JP,COMPUTERISED TOMOGRAM ABNORMAL,6
JP,CONGESTIVE CARDIOMYOPATHY,6
JP,CORONARY ARTERY STENOSIS,6
JP,CYANOSIS,6
JP,DEAFNESS NEUROSENSORY,6
JP,DECREASED ACTIVITY,6
JP,DRUG DOSE OMISSION,6
JP,ELECTROCARDIOGRAM ABNORMAL,6
JP,END STAGE RENAL DISEASE,6
JP,EPSTEIN-BARR VIRUS INFECTION,6
JP,EXTRASYSTOLES,6
JP,EYE MOVEMENT DISORDER,6
JP,FAECES SOFT,6
JP,GASTRITIS EROSIVE,6
JP,GASTROINTESTINAL DISORDER,6
JP,GINGIVAL BLEEDING,6
JP,GLUCOSE URINE PRESENT,6
JP,GRAFT VERSUS HOST DISEASE IN SKIN,6
JP,HALLUCINATION_ AUDITORY,6
JP,HALLUCINATION_ VISUAL,6
JP,HEART TRANSPLANT REJECTION,6
JP,HEMIPARESIS,6
JP,HOSPITALISATION,6
JP,HYPERTENSIVE ENCEPHALOPATHY,6
JP,HYPOCHLORAEMIA,6
JP,HYPOGLYCAEMIC ENCEPHALOPATHY,6
JP,INCORRECT ROUTE OF DRUG ADMINISTRATION,6
JP,INFECTIOUS PLEURAL EFFUSION,6
JP,INJECTION SITE ERYTHEMA,6
JP,INJECTION SITE PAIN,6
JP,INTENTIONAL DRUG MISUSE,6
JP,IRON OVERLOAD,6
JP,LIVER FUNCTION TEST INCREASED,6
JP,LUMBAR VERTEBRAL FRACTURE,6
JP,MENORRHAGIA,6
JP,MUSCLE HAEMORRHAGE,6
JP,NEOPLASM MALIGNANT,6
JP,NEPHROCALCINOSIS,6
JP,NO ADVERSE EVENT,6
JP,NORMOCHROMIC NORMOCYTIC ANAEMIA,6
JP,OCULAR HYPERAEMIA,6
JP,OESOPHAGEAL CANDIDIASIS,6
JP,OESOPHAGEAL CARCINOMA,6
JP,ORAL HERPES,6
JP,OSTEOMALACIA,6
JP,PARALYSIS,6
JP,PERICARDITIS,6
JP,PNEUMATOSIS INTESTINALIS,6
JP,PNEUMONIA INFLUENZAL,6
JP,PNEUMONIA MYCOPLASMAL,6
JP,POLYURIA,6
JP,PROTEIN-LOSING GASTROENTEROPATHY,6
JP,PRURIGO,6
JP,PULMONARY VENO-OCCLUSIVE DISEASE,6
JP,RASH ERYTHEMATOUS,6
JP,RASH PAPULAR,6
JP,RECTAL HAEMORRHAGE,6
JP,RHINORRHOEA,6
JP,SEROTONIN SYNDROME,6
JP,SHUNT OCCLUSION,6
JP,SINUS BRADYCARDIA,6
JP,SINUS TACHYCARDIA,6
JP,SKIN DISCOLOURATION,6
JP,SMALL INTESTINAL PERFORATION,6
JP,SPINAL COLUMN STENOSIS,6
JP,STRESS CARDIOMYOPATHY,6
JP,SUBCUTANEOUS ABSCESS,6
JP,SUICIDE ATTEMPT,6
JP,TACHYPNOEA,6
JP,TENDERNESS,6
JP,THYROIDITIS,6
JP,TREATMENT NONCOMPLIANCE,6
JP,URETERIC RUPTURE,6
JP,VENOOCCLUSIVE LIVER DISEASE,6
JP,VISUAL ACUITY REDUCED,6
JP,VITAMIN B1 DECREASED,6
JP,WRONG TECHNIQUE IN DRUG USAGE PROCESS,6
JP,ABDOMINAL TENDERNESS,5
JP,ACUTE PRERENAL FAILURE,5
JP,ADENOCARCINOMA GASTRIC,5
JP,ADENOVIRUS INFECTION,5
JP,ADRENAL INSUFFICIENCY,5
JP,AORTIC VALVE INCOMPETENCE,5
JP,ATAXIA,5
JP,ATRIOVENTRICULAR BLOCK SECOND DEGREE,5
JP,BASEDOW^S DISEASE,5
JP,BLOOD PRESSURE DIASTOLIC DECREASED,5
JP,BLOOD PRESSURE SYSTOLIC DECREASED,5
JP,BLOOD URINE PRESENT,5
JP,BRAIN STEM INFARCTION,5
JP,BREATH SOUNDS ABNORMAL,5
JP,CAESAREAN SECTION,5
JP,CAROTID ARTERY OCCLUSION,5
JP,CATHETER MANAGEMENT,5
JP,CHYLOTHORAX,5
JP,CONCOMITANT DISEASE PROGRESSION,5
JP,CONJUNCTIVAL HAEMORRHAGE,5
JP,DELUSION,5
JP,DERMATITIS EXFOLIATIVE,5
JP,DERMATOMYOSITIS,5
JP,DIABETIC GANGRENE,5
JP,DIABETIC HYPERGLYCAEMIC COMA,5
JP,DIPLOPIA,5
JP,DIZZINESS POSTURAL,5
JP,DRY MOUTH,5
JP,ECZEMA ASTEATOTIC,5
JP,EMBOLIC CEREBRAL INFARCTION,5
JP,EPIGASTRIC DISCOMFORT,5
JP,FACTOR V INHIBITION,5
JP,FEELING COLD,5
JP,FEELING HOT,5
JP,GASTRIC PERFORATION,5
JP,GASTROINTESTINAL STROMAL TUMOUR,5
JP,GASTROINTESTINAL ULCER,5
JP,GLOMERULONEPHRITIS,5
JP,GLUCOSE TOLERANCE IMPAIRED,5
JP,HEAD INJURY,5
JP,HEPATITIS,5
JP,HEPATOTOXICITY,5
JP,HIATUS HERNIA,5
JP,HYPERCHOLESTEROLAEMIA,5
JP,HYPOACUSIS,5
JP,HYPOGAMMAGLOBULINAEMIA,5
JP,HYPOVOLAEMIA,5
JP,HYPOVOLAEMIC SHOCK,5
JP,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,5
JP,IMPAIRED HEALING,5
JP,INTENTIONAL PRODUCT USE ISSUE,5
JP,INTRA-ABDOMINAL HAEMORRHAGE,5
JP,ISCHAEMIC STROKE,5
JP,JOINT SWELLING,5
JP,JUGULAR VEIN DISTENSION,5
JP,KIDNEY TRANSPLANT REJECTION,5
JP,LACUNAR INFARCTION,5
JP,LARGE INTESTINAL HAEMORRHAGE,5
JP,LEUKOENCEPHALOPATHY,5
JP,MENTAL DISORDER,5
JP,MONOCYTE COUNT INCREASED,5
JP,MUCOUS MEMBRANE DISORDER,5
JP,MUSCLE RIGIDITY,5
JP,MYOGLOBIN BLOOD INCREASED,5
JP,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED,5
JP,NECROTISING FASCIITIS,5
JP,NOCTURIA,5
JP,OCULOMUCOCUTANEOUS SYNDROME,5
JP,OESOPHAGITIS,5
JP,ORAL INFECTION,5
JP,ORAL PAIN,5
JP,ORTHOSTATIC INTOLERANCE,5
JP,OSTEOARTHRITIS,5
JP,PACKED RED BLOOD CELL TRANSFUSION,5
JP,PANCREATIC CARCINOMA METASTATIC,5
JP,PARKINSON^S DISEASE,5
JP,PEPTIC ULCER,5
JP,PERICARDIAL HAEMORRHAGE,5
JP,PNEUMONIA CYTOMEGALOVIRAL,5
JP,PO2 DECREASED,5
JP,PRESYNCOPE,5
JP,PRINZMETAL ANGINA,5
JP,PROTEIN URINE,5
JP,PSEUDOMONAS INFECTION,5
JP,RESPIRATORY RATE DECREASED,5
JP,RIB FRACTURE,5
JP,SCHIZOPHRENIA,5
JP,SCROTAL OEDEMA,5
JP,SECOND PRIMARY MALIGNANCY,5
JP,SHOSHIN BERIBERI,5
JP,SINUS ARREST,5
JP,SKIN ABRASION,5
JP,SKIN INFECTION,5
JP,SMALL INTESTINE CARCINOMA,5
JP,SPLENOMEGALY,5
JP,SPUTUM RETENTION,5
JP,SYSTEMIC MYCOSIS,5
JP,TONSILLITIS,5
JP,TUBERCULOSIS,5
JP,TYPE 2 DIABETES MELLITUS,5
JP,UNEVALUABLE EVENT,5
JP,VISUAL IMPAIRMENT,5
JP,ABASIA,4
JP,ACUTE CORONARY SYNDROME,4
JP,ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE,4
JP,ACUTE GRAFT VERSUS HOST DISEASE IN LIVER,4
JP,AKATHISIA,4
JP,ANAL FISSURE,4
JP,ANGIOEDEMA,4
JP,ANKLE FRACTURE,4
JP,ANXIETY DISORDER,4
JP,AORTIC ANEURYSM RUPTURE,4
JP,AORTIC VALVE STENOSIS,4
JP,APHAGIA,4
JP,APHASIA,4
JP,ARTERIAL OCCLUSIVE DISEASE,4
JP,ARTERIOVENOUS SHUNT OPERATION,4
JP,ASTERIXIS,4
JP,ATRIAL THROMBOSIS,4
JP,BALANCE DISORDER,4
JP,BILIRUBIN CONJUGATED INCREASED,4
JP,BLADDER NEOPLASM,4
JP,BLOOD BICARBONATE DECREASED,4
JP,BLOOD BICARBONATE INCREASED,4
JP,BLOOD CHLORIDE INCREASED,4
JP,BLOOD CHOLESTEROL INCREASED,4
JP,BLOOD CHOLINESTERASE DECREASED,4
JP,BLOOD CREATININE ABNORMAL,4
JP,BLOOD PARATHYROID HORMONE INCREASED,4
JP,BONE DENSITY DECREASED,4
JP,BRADYKINESIA,4
JP,BRAIN NEOPLASM,4
JP,BURSITIS,4
JP,CALCULUS URETERIC,4
JP,CARDIAC ABLATION,4
JP,CARDIAC AMYLOIDOSIS,4
JP,CARDIAC HYPERTROPHY,4
JP,CATARACT OPERATION,4
JP,CEREBRAL ISCHAEMIA,4
JP,CEREBRAL VENOUS THROMBOSIS,4
JP,CEREBRAL VENTRICULAR RUPTURE,4
JP,CERVIX CARCINOMA,4
JP,CHOLINERGIC SYNDROME,4
JP,CHONDROCALCINOSIS PYROPHOSPHATE,4
JP,CHRONIC GASTRITIS,4
JP,CLAVICLE FRACTURE,4
JP,CLONIC CONVULSION,4
JP,COLON ADENOMA,4
JP,COMA HEPATIC,4
JP,COMPUTERISED TOMOGRAM THORAX ABNORMAL,4
JP,CONJUNCTIVITIS ALLERGIC,4
JP,CORONARY ARTERY DISEASE,4
JP,CYSTITIS VIRAL,4
JP,CYTOMEGALOVIRUS CHORIORETINITIS,4
JP,CYTOPENIA,4
JP,DEMENTIA ALZHEIMER^S TYPE,4
JP,DENTAL FISTULA,4
JP,DEVICE BREAKAGE,4
JP,DIABETIC KETOACIDOSIS,4
JP,DIALYSIS,4
JP,DISCOMFORT,4
JP,DISEASE RECURRENCE,4
JP,DIVERTICULAR PERFORATION,4
JP,DIVERTICULUM INTESTINAL HAEMORRHAGIC,4
JP,DRUG HYPERSENSITIVITY,4
JP,DRUG LEVEL DECREASED,4
JP,DRUG PRESCRIBING ERROR,4
JP,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,4
JP,ENTEROCOLITIS HAEMORRHAGIC,4
JP,ESCHERICHIA INFECTION,4
JP,FANCONI SYNDROME ACQUIRED,4
JP,FIBRIN DEGRADATION PRODUCTS INCREASED,4
JP,FLUID OVERLOAD,4
JP,FREQUENT BOWEL MOVEMENTS,4
JP,GALLBLADDER PERFORATION,4
JP,GASTROINTESTINAL MUCOSAL DISORDER,4
JP,GLOSSITIS,4
JP,GOUTY ARTHRITIS,4
JP,GRAND MAL CONVULSION,4
JP,HAEMOTHORAX,4
JP,HEAT ILLNESS,4
JP,HYPERMAGNESAEMIA,4
JP,HYPERPARATHYROIDISM SECONDARY,4
JP,HYPERTRIGLYCERIDAEMIA,4
JP,HYPOAESTHESIA ORAL,4
JP,HYPOREFLEXIA,4
JP,IDIOPATHIC PULMONARY FIBROSIS,4
JP,INCONTINENCE,4
JP,INFECTED DERMAL CYST,4
JP,INFECTIVE SPONDYLITIS,4
JP,INFLUENZA LIKE ILLNESS,4
JP,INFUSION SITE EXTRAVASATION,4
JP,INFUSION SITE SWELLING,4
JP,INTENTIONAL OVERDOSE,4
JP,INTERMITTENT CLAUDICATION,4
JP,INTESTINAL PERFORATION,4
JP,IRRITABILITY,4
JP,LIP SWELLING,4
JP,LIVER ABSCESS,4
JP,LOCAL SWELLING,4
JP,LUMBAR SPINAL STENOSIS,4
JP,LYMPHOCYTE COUNT INCREASED,4
JP,LYMPHOCYTE STIMULATION TEST POSITIVE,4
JP,MALABSORPTION,4
JP,MEDICATION ERROR,4
JP,MENTAL STATUS CHANGES,4
JP,METASTASES TO PERITONEUM,4
JP,MITRAL VALVE DISEASE,4
JP,MOUTH ULCERATION,4
JP,MUSCULOSKELETAL DISCOMFORT,4
JP,MYOCARDITIS,4
JP,MYOPATHY,4
JP,MYOSITIS,4
JP,N-TELOPEPTIDE URINE INCREASED,4
JP,NEPHROPATHY,4
JP,NEPHROSCLEROSIS,4
JP,ORTHOPNOEA,4
JP,PANCREATITIS,4
JP,PERIPHERAL COLDNESS,4
JP,PHARYNGEAL OEDEMA,4
JP,PHOTOSENSITIVITY REACTION,4
JP,POST PROCEDURAL HAEMATOMA,4
JP,PREMATURE BABY,4
JP,PROTHROMBIN TIME RATIO INCREASED,4
JP,PSEUDOMONAL SEPSIS,4
JP,PULMONARY ARTERY THROMBOSIS,4
JP,PULMONARY HYPERTENSIVE CRISIS,4
JP,PULMONARY INFARCTION,4
JP,PULMONARY TUBERCULOSIS,4
JP,RADIUS FRACTURE,4
JP,RECTAL ULCER HAEMORRHAGE,4
JP,RENAL ARTERY STENOSIS,4
JP,RENAL TUBULAR ACIDOSIS,4
JP,RESPIRATORY DEPRESSION,4
JP,RESPIRATORY SYNCYTIAL VIRUS INFECTION,4
JP,RESTLESS LEGS SYNDROME,4
JP,RETINAL HAEMORRHAGE,4
JP,RHINITIS,4
JP,SCIATICA,4
JP,SMALL INTESTINE ULCER,4
JP,SPLENIC INFARCTION,4
JP,STREPTOCOCCAL INFECTION,4
JP,SUBDURAL HAEMORRHAGE,4
JP,SUDDEN HEARING LOSS,4
JP,SWELLING FACE,4
JP,SYSTEMIC CANDIDA,4
JP,TACHYARRHYTHMIA,4
JP,TACHYCARDIA PAROXYSMAL,4
JP,THROMBOPHLEBITIS,4
JP,THROMBOTIC CEREBRAL INFARCTION,4
JP,TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED,4
JP,TOOTH DISORDER,4
JP,TRANSAMINASES INCREASED,4
JP,TRICUSPID VALVE INCOMPETENCE,4
JP,TUMOUR HAEMORRHAGE,4
JP,UNDERDOSE,4
JP,URINARY BLADDER HAEMORRHAGE,4
JP,URINE OUTPUT INCREASED,4
JP,VIRAL HAEMORRHAGIC CYSTITIS,4
JP,VIRAL INFECTION,4
JP,VISCERAL CONGESTION,4
JP,VITAMIN D DECREASED,4
JP,ABORTION INDUCED,3
JP,ABSCESS,3
JP,ABSCESS JAW,3
JP,ACCIDENTAL OVERDOSE,3
JP,ACIDOSIS HYPERCHLORAEMIC,3
JP,ACNE,3
JP,ACQUIRED HAEMOPHILIA,3
JP,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,3
JP,ACUTE LUNG INJURY,3
JP,AMYLOIDOSIS,3
JP,ANAL FISTULA,3
JP,ANGER,3
JP,ANION GAP INCREASED,3
JP,ANTI-INSULIN ANTIBODY POSITIVE,3
JP,ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS,3
JP,APATHY,3
JP,ARTERIOSCLEROSIS,3
JP,ASPARTATE AMINOTRANSFERASE DECREASED,3
JP,ATRIOVENTRICULAR BLOCK FIRST DEGREE,3
JP,ATYPICAL MYCOBACTERIAL INFECTION,3
JP,BACTERIAL SEPSIS,3
JO,DEATH,2
JO,CIRCULATORY COLLAPSE,1
JO,ECZEMA,1
JO,FATIGUE,1
JO,HELICOBACTER GASTRITIS,1
JO,INTRACARDIAC MASS,1
JO,PARALYSIS,1
JO,RASH GENERALISED,1
JO,RENAL FAILURE,1
KZ,ASTHMA,1
KZ,HAEMATOCHEZIA,1
KZ,HYPOVOLAEMIC SHOCK,1
KZ,INFLUENZA LIKE ILLNESS,1
KZ,LEUKOPENIA,1
KZ,NEUTROPENIA,1
KZ,PULMONARY TUBERCULOSIS,1
KZ,PUS IN STOOL,1
KZ,THROMBOCYTOPENIA,1
KE,CARDIAC FAILURE CONGESTIVE,1
KE,CEREBRAL ARTERY EMBOLISM,1
KE,DEATH,1
KE,DECUBITUS ULCER,1
KE,DISEASE PROGRESSION,1
KE,ECCHYMOSIS,1
KE,INFECTION,1
KE,INTERNATIONAL NORMALISED RATIO DECREASED,1
KE,LUNG DISORDER,1
KE,METASTASES TO SPINE,1
KE,OVERDOSE,1
KE,PARALYSIS,1
KE,PURPURA,1
KP,DYSPNOEA,1
KP,ENTEROCOLITIS,1
KP,HEPATOPULMONARY SYNDROME,1
KR,NAUSEA,62
KR,PYREXIA,51
KR,PNEUMONIA,44
KR,NEUTROPENIA,39
KR,CONSTIPATION,35
KR,DIARRHOEA,32
KR,DYSPNOEA,32
KR,FEBRILE NEUTROPENIA,30
KR,DECREASED APPETITE,27
KR,COUGH,26
KR,VOMITING,22
KR,ASTHENIA,21
KR,ACUTE KIDNEY INJURY,17
KR,DYSPEPSIA,17
KR,ANAEMIA,16
KR,DIZZINESS,16
KR,DRUG INEFFECTIVE,16
KR,PRODUCTIVE COUGH,16
KR,ABDOMINAL PAIN,14
KR,CARDIAC FAILURE,14
KR,ALANINE AMINOTRANSFERASE INCREASED,13
KR,HEADACHE,13
KR,INSOMNIA,13
KR,URINARY TRACT INFECTION,13
KR,BLOOD CREATININE INCREASED,12
KR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,12
KR,SEPSIS,12
KR,ASPARTATE AMINOTRANSFERASE INCREASED,11
KR,ATRIAL FIBRILLATION,11
KR,HICCUPS,11
KR,HYPERKALAEMIA,11
KR,HYPOPHAGIA,11
KR,NEUTROPHIL COUNT DECREASED,11
KR,OEDEMA,11
KR,PAIN,11
KR,DELIRIUM,10
KR,STOMATITIS,10
KR,FALL,9
KR,HYPOKALAEMIA,9
KR,PLATELET COUNT DECREASED,9
KR,PLEURAL EFFUSION,9
KR,THROMBOCYTOPENIA,9
KR,ARTHRALGIA,8
KR,CARDIAC ARREST,8
KR,HYPONATRAEMIA,8
KR,LACTIC ACIDOSIS,8
KR,TUMOUR LYSIS SYNDROME,8
KR,ASCITES,7
KR,MYALGIA,7
KR,PARAESTHESIA,7
KR,PULMONARY OEDEMA,7
KR,BLOOD BILIRUBIN INCREASED,6
KR,DEATH,6
KR,DIABETES MELLITUS,6
KR,FATIGUE,6
KR,GASTROINTESTINAL HAEMORRHAGE,6
KR,GENERALISED OEDEMA,6
KR,HYPOALBUMINAEMIA,6
KR,JAUNDICE,6
KR,MELAENA,6
KR,NASOPHARYNGITIS,6
KR,ORAL CANDIDIASIS,6
KR,PALPITATIONS,6
KR,RASH,6
KR,SEPTIC SHOCK,6
KR,UPPER RESPIRATORY TRACT INFECTION,6
KR,ABDOMINAL DISTENSION,5
KR,BACK PAIN,5
KR,CHEST PAIN,5
KR,DEEP VEIN THROMBOSIS,5
KR,DISEASE PROGRESSION,5
KR,GASTROOESOPHAGEAL REFLUX DISEASE,5
KR,HAEMOGLOBIN DECREASED,5
KR,HAEMOPTYSIS,5
KR,HERPES ZOSTER,5
KR,HYPERBILIRUBINAEMIA,5
KR,HYPOGLYCAEMIA,5
KR,HYPOTENSION,5
KR,ILEUS,5
KR,LEUKOCYTOSIS,5
KR,OEDEMA PERIPHERAL,5
KR,PAIN IN EXTREMITY,5
KR,PERICARDIAL EFFUSION,5
KR,PULMONARY EMBOLISM,5
KR,RHINORRHOEA,5
KR,WEIGHT INCREASED,5
KR,ARRHYTHMIA,4
KR,CEREBRAL INFARCTION,4
KR,COLITIS,4
KR,COLONIC HAEMATOMA,4
KR,ELECTROLYTE IMBALANCE,4
KR,FEMUR FRACTURE,4
KR,HEPATIC ENCEPHALOPATHY,4
KR,HYPERGLYCAEMIA,4
KR,HYPERTENSION,4
KR,LEUKOPENIA,4
KR,LIVER FUNCTION TEST INCREASED,4
KR,METABOLIC ACIDOSIS,4
KR,OSTEOPOROSIS,4
KR,PANCYTOPENIA,4
KR,SHOCK,4
KR,SURGERY,4
KR,ABDOMINAL DISCOMFORT,3
KR,ACUTE MYOCARDIAL INFARCTION,3
KR,ALOPECIA,3
KR,AZOTAEMIA,3
KR,CELLULITIS,3
KR,CHOLECYSTITIS ACUTE,3
KR,CLOSTRIDIUM DIFFICILE COLITIS,3
KR,DYSPHAGIA,3
KR,ENCEPHALOPATHY,3
KR,EPISTAXIS,3
KR,ERYTHEMA,3
KR,HEPATIC FAILURE,3
KR,MULTI-ORGAN FAILURE,3
KR,NEUROPATHY PERIPHERAL,3
KR,ORAL PAIN,3
KR,PNEUMONITIS,3
KR,PRESCRIBED UNDERDOSE,3
KR,PRURITUS,3
KR,RADIATION OESOPHAGITIS,3
KR,SEIZURE,3
KR,SPINAL COMPRESSION FRACTURE,3
KR,VENTRICULAR TACHYCARDIA,3
KR,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,2
KR,AIDS DEMENTIA COMPLEX,2
KR,ANXIETY,2
KR,APPENDICITIS,2
KR,ATRIOVENTRICULAR BLOCK COMPLETE,2
KR,BLOOD UREA INCREASED,2
KR,BRONCHITIS,2
KR,CARDIAC FAILURE CONGESTIVE,2
KR,CARDIOGENIC SHOCK,2
KR,CATHETER SITE PAIN,2
KR,CEREBROVASCULAR ACCIDENT,2
KR,CHEST DISCOMFORT,2
KR,COLITIS ULCERATIVE,2
KR,COMA,2
KR,COMPRESSION FRACTURE,2
KR,CONGESTIVE CARDIOMYOPATHY,2
KR,CYTOMEGALOVIRUS COLITIS,2
KR,DEPRESSED MOOD,2
KR,DEPRESSION,2
KR,DEVICE RELATED INFECTION,2
KR,DEVICE RELATED SEPSIS,2
KR,DRY MOUTH,2
KR,DYSPNOEA EXERTIONAL,2
KR,DYSURIA,2
KR,EPIGASTRIC DISCOMFORT,2
KR,FIBROMYALGIA,2
KR,GASTRIC PERFORATION,2
KR,GASTRIC ULCER HAEMORRHAGE,2
KR,GASTRITIS,2
KR,GASTROENTERITIS,2
KR,GENERAL PHYSICAL HEALTH DETERIORATION,2
KR,GOUT,2
KR,HAEMATOCHEZIA,2
KR,HAEMATURIA,2
KR,HAEMORRHAGE,2
KR,HEPATITIS,2
KR,HEPATOTOXICITY,2
KR,HERPES VIRUS INFECTION,2
KR,HYDRONEPHROSIS,2
KR,HYPERCALCAEMIA,2
KR,HYPERHIDROSIS,2
KR,HYPERTHERMIA,2
KR,HYPOAESTHESIA,2
KR,HYPOCALCAEMIA,2
KR,HYPOPHOSPHATAEMIA,2
KR,ILEAL PERFORATION,2
KR,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,2
KR,INFECTION,2
KR,INTERSTITIAL LUNG DISEASE,2
KR,ISCHAEMIC STROKE,2
KR,LARYNGITIS,2
KR,LIVER FUNCTION TEST ABNORMAL,2
KR,LOSS OF CONSCIOUSNESS,2
KR,MALIGNANT NEOPLASM PROGRESSION,2
KR,MITRAL VALVE INCOMPETENCE,2
KR,MUSCULOSKELETAL PAIN,2
KR,MYOSITIS,2
KR,NECK PAIN,2
KR,OESOPHAGEAL CANDIDIASIS,2
KR,OESOPHAGITIS,2
KR,OXYGEN SATURATION DECREASED,2
KR,PERITONEAL HAEMORRHAGE,2
KR,PHARYNGITIS,2
KR,PLASMA CELL MYELOMA,2
KR,PNEUMONIA FUNGAL,2
KR,PNEUMOTHORAX,2
KR,POLYNEUROPATHY,2
KR,POST PROCEDURAL HAEMORRHAGE,2
KR,POST PROCEDURAL INFECTION,2
KR,PROCTALGIA,2
KR,PROTHROMBIN TIME PROLONGED,2
KR,PULMONARY CONGESTION,2
KR,RENAL IMPAIRMENT,2
KR,RESPIRATORY FAILURE,2
KR,STAPHYLOCOCCAL INFECTION,2
KR,TORSADE DE POINTES,2
KR,TOXIC ENCEPHALOPATHY,2
KR,TREMOR,2
KR,URINARY RETENTION,2
KR,VENTRICULAR FIBRILLATION,2
KR,VERTEBROPLASTY,2
KR,VOCAL CORD PARALYSIS,2
KR,WHITE BLOOD CELL COUNT DECREASED,2
KR,ABDOMINAL PAIN UPPER,1
KR,ACUTE MYELOID LEUKAEMIA,1
KR,ACUTE PROMYELOCYTIC LEUKAEMIA DIFFERENTIATION SYNDROME,1
KR,ACUTE PULMONARY OEDEMA,1
KR,ACUTE RESPIRATORY FAILURE,1
KR,ADRENAL INSUFFICIENCY,1
KR,ALCOHOLIC LIVER DISEASE,1
KR,AMYLASE INCREASED,1
KR,ANAL FISSURE,1
KR,ANAL HAEMORRHAGE,1
KR,ANAPHYLACTIC SHOCK,1
KR,ANGINA PECTORIS,1
KR,ANION GAP INCREASED,1
KR,ANKLE FRACTURE,1
KR,ANTIBODY TEST ABNORMAL,1
KR,AORTIC VALVE INCOMPETENCE,1
KR,APGAR SCORE ABNORMAL,1
KR,APHASIA,1
KR,ARTHRITIS BACTERIAL,1
KR,ASPIRATION,1
KR,ASTHMA,1
KR,ATRIAL FLUTTER,1
KR,ATYPICAL PNEUMONIA,1
KR,BACTERIAL INFECTION,1
KR,BACTERIAL TEST POSITIVE,1
KR,BALLISMUS,1
KR,BENIGN PROSTATIC HYPERPLASIA,1
KR,BILE DUCT STONE,1
KR,BILIRUBIN CONJUGATED INCREASED,1
KR,BK VIRUS INFECTION,1
KR,BLADDER DYSFUNCTION,1
KR,BLINDNESS,1
KR,BLOOD ALKALINE PHOSPHATASE INCREASED,1
KR,BLOOD BICARBONATE DECREASED,1
KR,BLOOD CALCIUM DECREASED,1
KR,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
KR,BLOOD GLUCOSE INCREASED,1
KR,BLOOD LACTATE DEHYDROGENASE INCREASED,1
KR,BLOOD PH DECREASED,1
KR,BLOOD PRESSURE DECREASED,1
KR,BLOOD SODIUM ABNORMAL,1
KR,BLOOD UREA NITROGEN/CREATININE RATIO INCREASED,1
KR,BLOOD URIC ACID INCREASED,1
KR,BODY TEMPERATURE DECREASED,1
KR,BRADYCARDIA,1
KR,BRAIN CANCER METASTATIC,1
KR,BRAIN NATRIURETIC PEPTIDE INCREASED,1
KR,BRAIN STEM INFARCTION,1
KR,BRONCHIECTASIS,1
KR,BRONCHIOLITIS,1
KR,BURSITIS,1
KR,C-REACTIVE PROTEIN INCREASED,1
KR,CAESAREAN SECTION,1
KR,CALCULUS URETERIC,1
KR,CANCER PAIN,1
KR,CANDIDA INFECTION,1
KR,CARDIAC ABLATION,1
KR,CARDIAC FAILURE ACUTE,1
KR,CARDIAC SEPTAL DEFECT REPAIR,1
KR,CARDIOMEGALY,1
KR,CARDIOMYOPATHY,1
KR,CATHETER SITE HAEMORRHAGE,1
KR,CENTRAL NERVOUS SYSTEM LESION,1
KR,CEREBELLAR INFARCTION,1
KR,CEREBRAL ARTERY OCCLUSION,1
KR,CEREBRAL VENTRICLE DILATATION,1
KR,CEREBROSPINAL FLUID LEAKAGE,1
KR,CHEST INJURY,1
KR,CHILLS,1
KR,CHOLANGITIS,1
KR,CHOLECYSTITIS CHRONIC,1
KR,CHROMATURIA,1
KR,CHRONIC GASTRITIS,1
KR,CHRONIC KIDNEY DISEASE,1
KR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
KR,CLONIC CONVULSION,1
KR,CLOSTRIDIUM DIFFICILE INFECTION,1
KR,COLD SWEAT,1
KR,COLITIS ISCHAEMIC,1
KR,CONDITION AGGRAVATED,1
KR,CONJUNCTIVAL HAEMORRHAGE,1
KR,CONJUNCTIVAL HYPERAEMIA,1
KR,CORONARY ARTERY DISSECTION,1
KR,CREATININE RENAL CLEARANCE DECREASED,1
KR,CUSHINGOID,1
KR,CYANOSIS,1
KR,CYST RUPTURE,1
KR,CYSTITIS,1
KR,CYTOMEGALOVIRUS GASTRITIS,1
KR,DEAFNESS NEUROSENSORY,1
KR,DECUBITUS ULCER,1
KR,DEHYDRATION,1
KR,DENTAL CARIES,1
KR,DISSEMINATED INTRAVASCULAR COAGULATION,1
KR,DRUG ABUSE,1
KR,DRUG DEPENDENCE,1
KR,DRUG EFFECT INCOMPLETE,1
KR,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
KR,DUODENAL POLYP,1
KR,DUODENITIS,1
KR,DURAL ARTERIOVENOUS FISTULA,1
KR,DYSARTHRIA,1
KR,DYSFUNCTIONAL UTERINE BLEEDING,1
KR,DYSPHONIA,1
KR,EAR PAIN,1
KR,EJECTION FRACTION DECREASED,1
KR,ELECTROCARDIOGRAM QT PROLONGED,1
KR,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
KR,ELECTROCARDIOGRAM ST-T SEGMENT DEPRESSION,1
KR,EMPHYSEMA,1
KR,ENDOTRACHEAL INTUBATION,1
KR,ENTEROCOCCAL INFECTION,1
KR,EYE HAEMORRHAGE,1
KR,EYE MOVEMENT DISORDER,1
KR,EYE SWELLING,1
KR,FACE OEDEMA,1
KR,FEELING HOT,1
KR,FEMORAL NECK FRACTURE,1
KR,FLANK PAIN,1
KR,FLUID RETENTION,1
KR,FOETAL DISTRESS SYNDROME,1
KR,FOETAL EXPOSURE DURING PREGNANCY,1
KR,FOETAL HEART RATE INCREASED,1
KR,FOOD CRAVING,1
KR,FRACTURED SACRUM,1
KR,FUNGAL TEST POSITIVE,1
KR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
KR,GASTRIC CANCER,1
KR,GASTRIC POLYPS,1
KR,GASTROINTESTINAL ULCER,1
KR,GENETIC POLYMORPHISM,1
KR,GLOMERULAR FILTRATION RATE DECREASED,1
KR,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
KR,HAEMARTHROSIS,1
KR,HAEMATEMESIS,1
KR,HAEMATOMA,1
KR,HAEMATOMA EVACUATION,1
KR,HAEMODIALYSIS,1
KR,HAEMORRHOIDS,1
KR,HAEMOSIDEROSIS,1
KR,HEMIPARESIS,1
KR,HEPATIC CIRRHOSIS,1
KR,HEPATIC ENZYME INCREASED,1
KR,HEPATITIS B,1
KR,HEPATITIS TOXIC,1
KR,HEPATOCELLULAR CARCINOMA,1
KR,HERPES SIMPLEX,1
KR,HIV ANTIBODY POSITIVE,1
KR,HYDROCEPHALUS,1
KR,HYPERNATRAEMIA,1
KR,HYPERPLASTIC CHOLECYSTOPATHY,1
KR,HYPERTHERMIA MALIGNANT,1
KR,HYPERTONIC BLADDER,1
KR,HYPERTROPHIC CARDIOMYOPATHY,1
KR,HYPOPHOSPHATASIA,1
KR,HYPOPROTEINAEMIA,1
KR,ILIAC ARTERY OCCLUSION,1
KR,IMPLANTABLE DEFIBRILLATOR INSERTION,1
KR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
KR,INFECTIOUS COLITIS,1
KR,INFERIOR VENA CAVA SYNDROME,1
KR,INFLUENZA,1
KR,INFLUENZA LIKE ILLNESS,1
KR,INGUINAL HERNIA,1
KR,INTELLECTUAL DISABILITY,1
KR,INTERNATIONAL NORMALISED RATIO INCREASED,1
KR,INTERVERTEBRAL DISC PROTRUSION,1
KR,INTRACRANIAL ANEURYSM,1
KR,IRRITABILITY,1
KR,ISCHAEMIA,1
KR,JUGULAR VEIN THROMBOSIS,1
KR,KLEBSIELLA INFECTION,1
KR,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
KR,LARGE INTESTINAL OBSTRUCTION,1
KR,LARGE INTESTINE BENIGN NEOPLASM,1
KR,LEFT VENTRICULAR DYSFUNCTION,1
KR,LETHARGY,1
KR,LIPASE INCREASED,1
KR,LIVER ABSCESS,1
KR,LIVER DISORDER,1
KR,LIVER TRANSPLANT,1
KR,LOCAL SWELLING,1
KR,LUMBAR RADICULOPATHY,1
KR,LUMBAR SPINAL STENOSIS,1
KR,LUNG CANCER METASTATIC,1
KR,LUNG LOBECTOMY,1
KR,LUNG NEOPLASM MALIGNANT,1
KR,LUPUS PNEUMONITIS,1
KR,LYMPHOEDEMA,1
KR,MALIGNANT PLEURAL EFFUSION,1
KR,MATERNAL DRUGS AFFECTING FOETUS,1
KR,MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED,1
KR,MEAN CELL VOLUME DECREASED,1
KR,MEDICAL DEVICE SITE DISCHARGE,1
KR,MENINGITIS,1
KR,MENINGITIS VIRAL,1
KR,MENTAL IMPAIRMENT,1
KR,MESOTHELIOMA MALIGNANT,1
KR,METABOLIC ENCEPHALOPATHY,1
KR,METASTASES TO LIVER,1
KR,METASTASES TO LUNG,1
KR,METASTATIC GASTRIC CANCER,1
KR,METHAEMOGLOBINAEMIA,1
KR,MICTURITION DISORDER,1
KR,MICTURITION URGENCY,1
KR,MUCOSAL INFLAMMATION,1
KR,MUSCLE SPASTICITY,1
KR,MUSCLE STRAIN,1
KR,MUSCLE TIGHTNESS,1
KR,MUSCULAR WEAKNESS,1
KR,MUSCULOSKELETAL DISCOMFORT,1
KR,MYCOBACTERIUM CHELONAE INFECTION,1
KR,MYCOPLASMA INFECTION,1
KR,MYELODYSPLASTIC SYNDROME,1
KR,NECROSIS,1
KR,NEOPLASM PROGRESSION,1
KR,NEPHROPATHY TOXIC,1
KR,NEPHROSTOMY,1
KR,NEURALGIA,1
KR,NEUROLOGICAL SYMPTOM,1
KR,NEUTROPENIC INFECTION,1
KR,NEUTROPHIL COUNT INCREASED,1
KR,NO ADVERSE EVENT,1
KR,OBSTRUCTION GASTRIC,1
KR,OCULAR ICTERUS,1
KR,OESOPHAGEAL HAEMORRHAGE,1
KR,OLIGURIA,1
KR,OROPHARYNGEAL PAIN,1
KR,ORTHOPNOEA,1
KR,ORTHOSTATIC HYPOTENSION,1
KR,OSTEOSCLEROSIS,1
KR,OTITIS MEDIA,1
KR,OXYGEN SATURATION ABNORMAL,1
KR,PALLOR,1
KR,PANCREATITIS,1
KR,PARAINFLUENZAE VIRUS INFECTION,1
KR,PCO2 DECREASED,1
KR,PELVIC PAIN,1
KR,PERCUTANEOUS CORONARY INTERVENTION,1
KR,PERICARDITIS,1
KR,PERINEAL ERYTHEMA,1
KR,PERIODONTITIS,1
KR,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
KR,PERIPHERAL SENSORY NEUROPATHY,1
KR,PERIPHERAL SWELLING,1
KR,PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED,1
KR,PERITONITIS,1
KR,PETECHIAE,1
KR,PETIT MAL EPILEPSY,1
KR,PHLEBITIS,1
KR,PLEURODESIS,1
KR,PNEUMONIA MYCOPLASMAL,1
KR,PNEUMONIA STREPTOCOCCAL,1
KR,PNEUMOPERITONEUM,1
KR,POLYP,1
KR,POLYPECTOMY,1
KR,POSTOPERATIVE ILEUS,1
KR,POSTOPERATIVE WOUND INFECTION,1
KR,PROCALCITONIN INCREASED,1
KR,PRURITUS GENITAL,1
KR,PSEUDOMEMBRANOUS COLITIS,1
KR,PULMONARY ARTERIAL HYPERTENSION,1
KR,PULMONARY ARTERY BANDING,1
KR,PULMONARY ARTERY DILATATION,1
KR,PULMONARY FIBROSIS,1
KR,PULMONARY HAEMORRHAGE,1
KR,PULMONARY HYPERTENSION,1
KR,PULMONARY HYPOPLASIA,1
KR,PULMONARY INFARCTION,1
KR,PULMONARY TUBERCULOSIS,1
KR,PUNCTURE SITE PAIN,1
KR,PURPURA,1
KR,PYURIA,1
KR,RADIATION ASSOCIATED PAIN,1
KR,RADIATION MUCOSITIS,1
KR,RADIATION PNEUMONITIS,1
KR,RASH MACULO-PAPULAR,1
KR,RASH PAPULAR,1
KR,RASH PRURITIC,1
KR,RECTAL CANCER,1
KR,RECTAL HAEMORRHAGE,1
KR,RED BLOOD CELL COUNT DECREASED,1
KR,RENAL FAILURE,1
KR,RENAL FAILURE ACUTE,1
KR,RESPIRATION ABNORMAL,1
KR,RETINOPATHY OF PREMATURITY,1
KR,RHABDOMYOLYSIS,1
KR,RHINITIS,1
KR,RIGHT VENTRICULAR HYPERTROPHY,1
KR,SEIZURE LIKE PHENOMENA,1
KR,SINUS ARREST,1
KR,SINUSITIS,1
KR,SKIN EXFOLIATION,1
KR,SLEEP DISORDER,1
KR,SMALL INTESTINAL OBSTRUCTION,1
KR,SOMNOLENCE,1
KR,SPASTIC PARALYSIS,1
KR,SPINAL PAIN,1
KR,SPONDYLOLISTHESIS,1
KR,STEVENS-JOHNSON SYNDROME,1
KR,SUBDURAL HAEMORRHAGE,1
KR,SUDDEN DEATH,1
KR,SUPRAVENTRICULAR TACHYCARDIA,1
KR,SWELLING,1
KR,SYNCOPE,1
KR,SYSTEMIC LUPUS ERYTHEMATOSUS,1
KR,TACHYPNOEA,1
KR,TEMPOROMANDIBULAR JOINT SYNDROME,1
KR,TENDERNESS,1
KR,THORACIC VERTEBRAL FRACTURE,1
KR,THORACOSTOMY,1
KR,THROMBIN TIME PROLONGED,1
KR,THROMBOPHLEBITIS,1
KR,THROMBOSIS,1
KR,THROMBOSIS IN DEVICE,1
KR,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
KR,TONSILLITIS,1
KR,TOOTH ABSCESS,1
KR,TRAUMATIC HAEMOTHORAX,1
KR,TUBERCULOSIS,1
KR,TUMOUR HAEMORRHAGE,1
KR,UNEVALUABLE EVENT,1
KR,URETERIC CANCER,1
KR,URINARY INCONTINENCE,1
KR,URINE OUTPUT DECREASED,1
KR,URTICARIA,1
KR,UTERINE HAEMORRHAGE,1
KR,VAGINAL HAEMORRHAGE,1
KR,VARICES OESOPHAGEAL,1
KR,VASCULAR DEMENTIA,1
KR,VENA CAVA THROMBOSIS,1
KR,VENOOCCLUSIVE DISEASE,1
KR,VENOUS THROMBOSIS,1
KR,VULVOVAGINAL PAIN,1
KR,WEIGHT DECREASED,1
KR,WHITE BLOOD CELL COUNT ABNORMAL,1
KR,ZYGOMYCOSIS,1
KW,ASTHENIA,1
KG,TREATMENT NONCOMPLIANCE,1
KG,TUBERCULOSIS,1
LA,DYSPNOEA,4
LA,HYPOKALAEMIA,4
LV,ANAEMIA,1
LV,FAILURE TO THRIVE,1
LV,FEBRILE NEUTROPENIA,1
LV,NEUTROPENIA,1
LV,PNEUMONIA ASPIRATION,1
LV,PULMONARY OEDEMA,1
LV,PYREXIA,1
LV,RESPIRATORY FAILURE,1
LV,THROMBOCYTOPENIA,1
LV,WEIGHT DECREASED,1
LB,BLOOD CREATININE INCREASED,17
LB,DYSPNOEA,13
LB,FATIGUE,9
LB,OEDEMA,9
LB,BLOOD UREA INCREASED,8
LB,DIARRHOEA,8
LB,PULMONARY OEDEMA,8
LB,ANAEMIA,7
LB,DEATH,7
LB,HYPERGLYCAEMIA,7
LB,RENAL FAILURE,7
LB,CHEST PAIN,6
LB,GENERAL PHYSICAL HEALTH DETERIORATION,6
LB,INFLUENZA,6
LB,OEDEMA PERIPHERAL,6
LB,PNEUMONIA,6
LB,ACUTE PULMONARY OEDEMA,5
LB,CARDIAC ARREST,5
LB,COUGH,5
LB,HYPOTENSION,5
LB,INFECTION,5
LB,MYOCARDIAL INFARCTION,5
LB,RASH,5
LB,SWELLING,5
LB,TACHYCARDIA,5
LB,URINARY TRACT INFECTION,5
LB,URINE OUTPUT DECREASED,5
LB,ASTHENIA,4
LB,BRONCHITIS,4
LB,CARDIAC DISORDER,4
LB,CARDIAC FAILURE,4
LB,DEHYDRATION,4
LB,HAEMOGLOBIN DECREASED,4
LB,HEPATIC FAILURE,4
LB,HYPERTENSION,4
LB,HYPOGLYCAEMIA,4
LB,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,4
LB,PYREXIA,4
LB,VOMITING,4
LB,WEIGHT INCREASED,4
LB,ABDOMINAL PAIN UPPER,3
LB,ASCITES,3
LB,CEREBROVASCULAR ACCIDENT,3
LB,CONFUSIONAL STATE,3
LB,DIZZINESS,3
LB,EJECTION FRACTION DECREASED,3
LB,FALL,3
LB,GAIT DISTURBANCE,3
LB,HAEMATOCRIT DECREASED,3
LB,HEADACHE,3
LB,HYPOAESTHESIA,3
LB,ISCHAEMIC STROKE,3
LB,MUSCLE SPASMS,3
LB,NEUROPATHY PERIPHERAL,3
LB,PAIN IN EXTREMITY,3
LB,VISION BLURRED,3
LB,WEIGHT DECREASED,3
LB,ABDOMINAL DISTENSION,2
LB,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,2
LB,ARTHRALGIA,2
LB,BLOOD POTASSIUM ABNORMAL,2
LB,BLOOD PRESSURE FLUCTUATION,2
LB,CATARACT,2
LB,CONJUNCTIVAL HAEMORRHAGE,2
LB,DECREASED APPETITE,2
LB,DRUG PRESCRIBING ERROR,2
LB,EAR DISORDER,2
LB,FLUID RETENTION,2
LB,GASTROENTERITIS,2
LB,GENERALISED OEDEMA,2
LB,HAEMATOCHEZIA,2
LB,HAEMORRHAGE,2
LB,HEPATIC CIRRHOSIS,2
LB,HYPERKALAEMIA,2
LB,HYPOACUSIS,2
LB,HYPOKINESIA,2
LB,LOSS OF CONSCIOUSNESS,2
LB,LUNG INFECTION,2
LB,MOTOR DYSFUNCTION,2
LB,MULTI-ORGAN FAILURE,2
LB,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
LB,MUSCULOSKELETAL PAIN,2
LB,NEUTROPENIA,2
LB,PAIN,2
LB,PALPITATIONS,2
LB,PCO2 DECREASED,2
LB,PERIPHERAL SWELLING,2
LB,PLEURAL EFFUSION,2
LB,PRESCRIBED UNDERDOSE,2
LB,PROTEINURIA,2
LB,RENAL DISORDER,2
LB,RENAL IMPAIRMENT,2
LB,SEPTIC SHOCK,2
LB,SKIN IRRITATION,2
LB,SPEECH DISORDER,2
LB,THROMBOCYTOPENIA,2
LB,THYROID DISORDER,2
LB,UNDERDOSE,2
LB,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
LB,ABASIA,1
LB,ABDOMINAL WALL HAEMORRHAGE,1
LB,ACUTE KIDNEY INJURY,1
LB,ADENOIDAL HYPERTROPHY,1
LB,ANAL ABSCESS,1
LB,ANGINA PECTORIS,1
LB,ANGIOPLASTY,1
LB,ANURIA,1
LB,ANXIETY,1
LB,AORTIC CALCIFICATION,1
LB,AORTIC VALVE STENOSIS,1
LB,APHASIA,1
LB,APHONIA,1
LB,ASPARTATE AMINOTRANSFERASE INCREASED,1
LB,ATRIOVENTRICULAR BLOCK,1
LB,BALANCE DISORDER,1
LB,BILE DUCT STONE,1
LB,BLADDER CANCER,1
LB,BLINDNESS,1
LB,BLINDNESS UNILATERAL,1
LB,BLISTER,1
LB,BLOOD ALKALINE PHOSPHATASE INCREASED,1
LB,BLOOD CREATINE INCREASED,1
LB,BLOOD POTASSIUM INCREASED,1
LB,BLOOD PRESSURE DECREASED,1
LB,BLOOD URIC ACID ABNORMAL,1
LB,BLOOD URINE PRESENT,1
LB,BRADYCARDIA,1
LB,BRAIN INJURY,1
LB,BREAST PAIN,1
LB,C-REACTIVE PROTEIN INCREASED,1
LB,CARBON DIOXIDE INCREASED,1
LB,CARDIAC FAILURE CONGESTIVE,1
LB,CARDIAC OPERATION,1
LB,CARDIO-RESPIRATORY ARREST,1
LB,CARDIOVASCULAR INSUFFICIENCY,1
LB,CHEST DISCOMFORT,1
LB,CHILLS,1
LB,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
LB,COLECTOMY,1
LB,CONDITION AGGRAVATED,1
LB,CORONARY ARTERY DISEASE,1
LB,DEEP VEIN THROMBOSIS,1
LB,DEMENTIA ALZHEIMER^S TYPE,1
LB,DISCOMFORT,1
LB,DISEASE PROGRESSION,1
LB,DRUG INEFFECTIVE,1
LB,DRUG INTOLERANCE,1
LB,DRY MOUTH,1
LB,DRY SKIN,1
LB,DYSLIPIDAEMIA,1
LB,DYSPEPSIA,1
LB,DYSPHAGIA,1
LB,DYSPHONIA,1
LB,EAR PAIN,1
LB,EATING DISORDER,1
LB,EMBOLISM,1
LB,EPILEPSY,1
LB,EPISTAXIS,1
LB,ERYTHEMA,1
LB,FEBRILE NEUTROPENIA,1
LB,FRACTURE,1
LB,FUNGAL INFECTION,1
LB,FURUNCLE,1
LB,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
LB,GASTRIC DISORDER,1
LB,GASTROINTESTINAL HAEMORRHAGE,1
LB,GINGIVAL BLEEDING,1
LB,GINGIVITIS,1
LB,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
LB,GOUT,1
LB,HAEMATEMESIS,1
LB,HAEMODIALYSIS,1
LB,HAEMODYNAMIC INSTABILITY,1
LB,HAEMOPTYSIS,1
LB,HAEMORRHAGE INTRACRANIAL,1
LB,HEART RATE DECREASED,1
LB,HEPATIC ENCEPHALOPATHY,1
LB,HEPATIC INFECTION,1
LB,HEPATIC VEIN THROMBOSIS,1
LB,HIP FRACTURE,1
LB,HOT FLUSH,1
LB,HYPERCHOLESTEROLAEMIA,1
LB,HYPERURICAEMIA,1
LB,HYPOXIA,1
LB,INFLUENZA LIKE ILLNESS,1
LB,INGUINAL HERNIA,1
LB,INSOMNIA,1
LB,INTENTIONAL PRODUCT MISUSE,1
LB,INTERNATIONAL NORMALISED RATIO INCREASED,1
LB,IRON DEFICIENCY ANAEMIA,1
LB,JOINT DISLOCATION,1
LB,LETHARGY,1
LB,LEUKOCYTOSIS,1
LB,LIVER DISORDER,1
LB,LOW DENSITY LIPOPROTEIN INCREASED,1
LB,LOWER LIMB FRACTURE,1
LB,LUNG NEOPLASM MALIGNANT,1
LB,LYMPHOPENIA,1
LB,MUSCULOSKELETAL DISORDER,1
LB,MYALGIA,1
LB,MYELOFIBROSIS,1
LB,OVARIAN CYST,1
LB,OXYGEN SATURATION DECREASED,1
LB,PANCREATIC DISORDER,1
LB,PANCYTOPENIA,1
LB,PARAESTHESIA,1
LB,PEMPHIGOID,1
LB,PERITONITIS BACTERIAL,1
LB,PLASMA CELL LEUKAEMIA,1
LB,PLASMACYTOMA,1
LB,PLATELET COUNT INCREASED,1
LB,PROSTATE CANCER METASTATIC,1
LB,PULMONARY EMBOLISM,1
LB,PULMONARY HAEMORRHAGE,1
LB,PULSE ABNORMAL,1
LB,RED BLOOD CELL COUNT DECREASED,1
LB,SEIZURE,1
LB,SENSORY DISTURBANCE,1
LB,SENSORY LOSS,1
LB,SEPSIS,1
LB,SINUSITIS,1
LB,SKIN DISCOLOURATION,1
LB,SKIN DISORDER,1
LB,SKIN EXFOLIATION,1
LB,SKIN INFECTION,1
LB,SKIN INJURY,1
LB,SLEEP DISORDER,1
LB,SOMNOLENCE,1
LB,STENOSIS,1
LB,SYNCOPE,1
LB,SYSTOLIC HYPERTENSION,1
LB,TERMINAL STATE,1
LB,THROMBOCYTOSIS,1
LB,THROMBOPHLEBITIS,1
LB,THROMBOSIS IN DEVICE,1
LB,TOOTHACHE,1
LB,TREATMENT NONCOMPLIANCE,1
LB,TREMOR,1
LB,TROPONIN I INCREASED,1
LB,ULCER,1
LB,UPPER LIMB FRACTURE,1
LB,URTICARIA,1
LB,VARICOSE VEIN,1
LB,VENOUS STENOSIS,1
LB,VERTIGO,1
LB,VIRAL INFECTION,1
LB,VISUAL IMPAIRMENT,1
LB,WRONG DRUG ADMINISTERED,1
LS,DEATH,1
LS,RESPIRATORY FAILURE,1
LT,FOETAL EXPOSURE DURING PREGNANCY,2
LT,PREMATURE BABY,2
LT,ANEURYSM,1
LT,ARTERIAL INJURY,1
LT,CARDIOMYOPATHY,1
LT,CEREBROVASCULAR ACCIDENT,1
LT,CONDITION AGGRAVATED,1
LT,CORONARY ARTERY ANEURYSM,1
LT,CORONARY ARTERY THROMBOSIS,1
LT,DEATH,1
LT,DRUG EFFECT INCOMPLETE,1
LT,DRUG INEFFECTIVE,1
LT,DRUG RESISTANCE,1
LT,EXPOSURE DURING PREGNANCY,1
LT,MATERNAL EXPOSURE DURING PREGNANCY,1
LT,MYOCARDITIS,1
LT,NO THERAPEUTIC RESPONSE,1
LT,PREMATURE DELIVERY,1
LT,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,1
LU,DEHYDRATION,3
LU,RENAL IMPAIRMENT,3
LU,RENAL TRANSPLANT FAILURE,3
LU,ACUTE KIDNEY INJURY,2
LU,ASTHENIA,2
LU,ERYTHEMA,2
LU,HYPOXIA,2
LU,VERTIGO,2
LU,ANAEMIA,1
LU,ATRIAL FIBRILLATION,1
LU,BLOOD CREATININE INCREASED,1
LU,CEREBROVASCULAR ACCIDENT,1
LU,CHOLECYSTITIS,1
LU,DEATH,1
LU,DIARRHOEA,1
LU,DYSPNOEA,1
LU,FALL,1
LU,FATIGUE,1
LU,FEAR,1
LU,GASTRIC HAEMORRHAGE,1
LU,GENERAL PHYSICAL HEALTH DETERIORATION,1
LU,HAEMOGLOBIN DECREASED,1
LU,HEART RATE INCREASED,1
LU,HEPATOCELLULAR INJURY,1
LU,HYPONATRAEMIA,1
LU,HYPOTENSION,1
LU,IMMOBILE,1
LU,INJECTION SITE NODULE,1
LU,INTERSTITIAL LUNG DISEASE,1
LU,LARGE INTESTINAL HAEMORRHAGE,1
LU,LOWER LIMB FRACTURE,1
LU,MOBILITY DECREASED,1
LU,NAUSEA,1
LU,PAIN IN EXTREMITY,1
LU,PRESCRIBED UNDERDOSE,1
LU,PRODUCT USE ISSUE,1
LU,PYREXIA,1
LU,RENAL FAILURE,1
LU,RENAL FAILURE ACUTE,1
LU,RHABDOMYOLYSIS,1
LU,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,1
LU,THROMBOCYTOPENIA,1
LU,VISION BLURRED,1
MO,HAEMORRHAGIC ASCITES,1
MK,DYSPNOEA,2
MK,FATIGUE,2
MK,HEPATITIS TOXIC,2
MK,ABDOMINAL PAIN UPPER,1
MK,ANAEMIA,1
MK,AORTIC VALVE INCOMPETENCE,1
MK,ARRHYTHMIA,1
MK,ARTERIOSCLEROSIS,1
MK,ATRIAL FIBRILLATION,1
MK,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
MK,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
MK,BLOOD PRESSURE DIASTOLIC INCREASED,1
MK,BLOOD PRESSURE INCREASED,1
MK,BREATH SOUNDS ABNORMAL,1
MK,CARDIAC FAILURE CHRONIC,1
MK,CARDIAC MURMUR,1
MK,CARDIOMYOPATHY,1
MK,CYANOSIS,1
MK,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,1
MK,FALL,1
MK,HEART RATE IRREGULAR,1
MK,HEART VALVE CALCIFICATION,1
MK,HYPERTENSION,1
MK,HYPOTENSION,1
MK,INFERIOR VENA CAVA DILATATION,1
MK,JOINT SWELLING,1
MK,MALAISE,1
MK,MITRAL VALVE DISEASE,1
MK,MITRAL VALVE INCOMPETENCE,1
MK,NAUSEA,1
MK,OEDEMA PERIPHERAL,1
MK,OVERDOSE,1
MK,PAIN,1
MK,PAIN IN EXTREMITY,1
MK,PAIN IN JAW,1
MK,PARAESTHESIA,1
MK,PECTUS CARINATUM,1
MK,PERIPHERAL SWELLING,1
MK,PLEURAL EFFUSION,1
MK,POLYARTHRITIS,1
MK,PULMONARY HYPERTENSION,1
MK,RENAL IMPAIRMENT,1
MK,SUBDURAL HAEMATOMA,1
MK,SUICIDE ATTEMPT,1
MK,TACHYARRHYTHMIA,1
MK,TACHYCARDIA,1
MK,TACHYPNOEA,1
MK,TRICUSPID VALVE INCOMPETENCE,1
MK,VASODILATATION,1
MW,ANAEMIA,1
MW,BACTERIAL SEPSIS,1
MW,KAPOSI^S SARCOMA,1
MY,DYSPNOEA,4
MY,CARDIAC FAILURE,3
MY,CARDIAC FAILURE CONGESTIVE,3
MY,HYPOGLYCAEMIA,3
MY,PYREXIA,3
MY,ANAEMIA,2
MY,ATRIAL FIBRILLATION,2
MY,DIARRHOEA,2
MY,HYPOTENSION,2
MY,JAUNDICE,2
MY,LETHARGY,2
MY,RENAL FAILURE,2
MY,RESPIRATORY DISTRESS,2
MY,RESPIRATORY TRACT INFECTION,2
MY,SEPSIS,2
MY,SEPTIC SHOCK,2
MY,ABDOMINAL DISTENSION,1
MY,ABDOMINAL PAIN UPPER,1
MY,ABSCESS,1
MY,ACUTE ABDOMEN,1
MY,ACUTE KIDNEY INJURY,1
MY,ACUTE RESPIRATORY DISTRESS SYNDROME,1
MY,AFFECT LABILITY,1
MY,ALANINE AMINOTRANSFERASE INCREASED,1
MY,ANAPHYLACTIC SHOCK,1
MY,ANEURYSM,1
MY,AORTIC ANEURYSM,1
MY,AORTIC ARTERIOSCLEROSIS,1
MY,ASPARTATE AMINOTRANSFERASE INCREASED,1
MY,ASTHMA,1
MY,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,1
MY,BLOOD ALKALINE PHOSPHATASE INCREASED,1
MY,BLOOD CREATININE INCREASED,1
MY,BLOOD PRODUCT TRANSFUSION,1
MY,CARDIAC ARREST,1
MY,CARDIAC FAILURE CHRONIC,1
MY,CARDIAC MURMUR,1
MY,CARDIO-RESPIRATORY ARREST,1
MY,CELLULITIS,1
MY,CHEST DISCOMFORT,1
MY,CONDITION AGGRAVATED,1
MY,CONFUSIONAL STATE,1
MY,CORONARY ARTERY DISEASE,1
MY,COUGH,1
MY,CREPITATIONS,1
MY,DECREASED APPETITE,1
MY,DIABETES MELLITUS,1
MY,DIABETES MELLITUS INADEQUATE CONTROL,1
MY,DISEASE PROGRESSION,1
MY,DRUG INEFFECTIVE,1
MY,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
MY,ELECTROCARDIOGRAM QT PROLONGED,1
MY,EPISTAXIS,1
MY,ERYTHEMA,1
MY,FATIGUE,1
MY,FLUID RETENTION,1
MY,GASTROENTERITIS,1
MY,HAEMOPTYSIS,1
MY,HEPATOMEGALY,1
MY,HYPERLIPIDAEMIA,1
MY,HYPONATRAEMIA,1
MY,HYPOXIA,1
MY,INTESTINAL ISCHAEMIA,1
MY,LEFT VENTRICULAR FAILURE,1
MY,LOWER RESPIRATORY TRACT INFECTION,1
MY,LUNG CONSOLIDATION,1
MY,MULTI-ORGAN FAILURE,1
MY,MYOCARDIAL ISCHAEMIA,1
MY,OEDEMA,1
MY,OEDEMA PERIPHERAL,1
MY,PACKED RED BLOOD CELL TRANSFUSION,1
MY,PALPITATIONS,1
MY,PERIORBITAL OEDEMA,1
MY,PERIPHERAL VASCULAR DISORDER,1
MY,PLEURAL EFFUSION,1
MY,PNEUMONIA,1
MY,PNEUMONITIS,1
MY,PRURITUS,1
MY,PULMONARY ARTERIAL HYPERTENSION,1
MY,PULMONARY HAEMORRHAGE,1
MY,RALES,1
MY,RENAL FAILURE ACUTE,1
MY,RENAL IMPAIRMENT,1
MY,RESPIRATORY ACIDOSIS,1
MY,RESPIRATORY FAILURE,1
MY,RIGHT VENTRICULAR FAILURE,1
MY,SUPRAVENTRICULAR TACHYCARDIA,1
MY,TACHYPNOEA,1
MY,THERAPEUTIC RESPONSE DECREASED,1
MY,TRAUMATIC LUNG INJURY,1
MY,UPPER GASTROINTESTINAL HAEMORRHAGE,1
MY,URINE OUTPUT DECREASED,1
MY,VENOUS PRESSURE JUGULAR INCREASED,1
MY,WEIGHT GAIN POOR,1
MY,WEIGHT INCREASED,1
MY,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
MT,FLUID RETENTION,3
MT,BLISTER,1
MT,DERMATITIS BULLOUS,1
MX,DYSPNOEA,18
MX,CARDIAC FAILURE,12
MX,DIARRHOEA,12
MX,PNEUMONIA,12
MX,ANAEMIA,11
MX,BLOOD GLUCOSE INCREASED,11
MX,RENAL FAILURE,11
MX,ASTHENIA,10
MX,DRUG PRESCRIBING ERROR,10
MX,HYPOTENSION,10
MX,VOMITING,10
MX,CARDIO-RESPIRATORY ARREST,9
MX,FATIGUE,9
MX,HAEMOGLOBIN DECREASED,9
MX,PAIN IN EXTREMITY,9
MX,WEIGHT DECREASED,9
MX,BLOOD PRESSURE DECREASED,8
MX,BLOOD PRESSURE INCREASED,8
MX,DECREASED APPETITE,8
MX,DIZZINESS,8
MX,GENERAL PHYSICAL HEALTH DETERIORATION,8
MX,HEADACHE,8
MX,OEDEMA PERIPHERAL,8
MX,PRODUCT USE IN UNAPPROVED INDICATION,8
MX,RIGHT VENTRICULAR FAILURE,8
MX,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,8
MX,ARTHRALGIA,7
MX,CARDIAC DISORDER,7
MX,CONSTIPATION,7
MX,COUGH,7
MX,FLUID RETENTION,7
MX,MYOCARDIAL INFARCTION,7
MX,PRODUCT USE ISSUE,7
MX,PYREXIA,7
MX,ARRHYTHMIA,6
MX,CONDITION AGGRAVATED,6
MX,DEPRESSION,6
MX,FALL,6
MX,HYPERTENSION,6
MX,MALAISE,6
MX,NAUSEA,6
MX,CHEST PAIN,5
MX,CONCOMITANT DISEASE AGGRAVATED,5
MX,DEHYDRATION,5
MX,DRUG INEFFECTIVE,5
MX,FEELING ABNORMAL,5
MX,GAIT DISTURBANCE,5
MX,GASTRITIS,5
MX,INFLUENZA,5
MX,PAIN,5
MX,PULMONARY ARTERIAL HYPERTENSION,5
MX,SYNCOPE,5
MX,TACHYCARDIA,5
MX,ABDOMINAL DISTENSION,4
MX,ACUTE KIDNEY INJURY,4
MX,ASCITES,4
MX,ASPHYXIA,4
MX,BACK PAIN,4
MX,BONE PAIN,4
MX,CARDIAC ARREST,4
MX,COLITIS,4
MX,DEATH,4
MX,DEPRESSED MOOD,4
MX,EMBOLISM,4
MX,GASTROINTESTINAL HAEMORRHAGE,4
MX,HEPATIC PAIN,4
MX,MEMORY IMPAIRMENT,4
MX,PALPITATIONS,4
MX,PERIPHERAL SWELLING,4
MX,PLATELET COUNT DECREASED,4
MX,PRODUCTIVE COUGH,4
MX,PULMONARY OEDEMA,4
MX,RESPIRATORY ARREST,4
MX,SEPTIC SHOCK,4
MX,TRANSFUSION,4
MX,WRONG TECHNIQUE IN DRUG USAGE PROCESS,4
MX,ABDOMINAL DISCOMFORT,3
MX,ABDOMINAL PAIN,3
MX,ABDOMINAL PAIN UPPER,3
MX,ANXIETY,3
MX,ARTERIAL OCCLUSIVE DISEASE,3
MX,BLOOD PRESSURE FLUCTUATION,3
MX,BLOOD PRESSURE INADEQUATELY CONTROLLED,3
MX,CARDIOGENIC SHOCK,3
MX,CARDIOMEGALY,3
MX,CHRONIC KIDNEY DISEASE,3
MX,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
MX,CONTUSION,3
MX,CRYING,3
MX,DEAFNESS,3
MX,ENCEPHALOPATHY,3
MX,EYE SWELLING,3
MX,FACE OEDEMA,3
MX,FEELING OF DESPAIR,3
MX,GASTRIC ULCER,3
MX,HEPATIC CIRRHOSIS,3
MX,HEPATOMEGALY,3
MX,HYPERTENSIVE CRISIS,3
MX,HYPOGLYCAEMIA,3
MX,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,3
MX,INCORRECT DOSE ADMINISTERED,3
MX,INFARCTION,3
MX,INSOMNIA,3
MX,JOINT SWELLING,3
MX,LIMB DISCOMFORT,3
MX,LOSS OF CONSCIOUSNESS,3
MX,MOBILITY DECREASED,3
MX,MONOPLEGIA,3
MX,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED,3
MX,OEDEMA,3
MX,PLEURAL EFFUSION,3
MX,RECTAL HAEMORRHAGE,3
MX,SKIN EXFOLIATION,3
MX,TREMOR,3
MX,URINARY TRACT INFECTION,3
MX,ACCIDENT,2
MX,AGITATION,2
MX,ANGINA PECTORIS,2
MX,ASPARTATE AMINOTRANSFERASE INCREASED,2
MX,BLEPHAROSPASM,2
MX,BLINDNESS,2
MX,BLOOD CHOLESTEROL INCREASED,2
MX,BLOOD CREATININE INCREASED,2
MX,BLOOD GLUCOSE DECREASED,2
MX,BLOOD TRIGLYCERIDES INCREASED,2
MX,BLOOD URIC ACID INCREASED,2
MX,BRONCHITIS,2
MX,BURNING SENSATION,2
MX,CARDIAC FAILURE CONGESTIVE,2
MX,CEREBROVASCULAR ACCIDENT,2
MX,CHILLS,2
MX,CONVULSION,2
MX,CYANOSIS,2
MX,DECREASED IMMUNE RESPONSIVENESS,2
MX,DISCOMFORT,2
MX,DIVERTICULUM,2
MX,DRY MOUTH,2
MX,DYSPHONIA,2
MX,DYSPNOEA EXERTIONAL,2
MX,EJECTION FRACTION DECREASED,2
MX,ELECTROLYTE IMBALANCE,2
MX,EPISTAXIS,2
MX,EYELID OEDEMA,2
MX,FAECES DISCOLOURED,2
MX,FEMUR FRACTURE,2
MX,GASTROENTERITIS,2
MX,GROIN PAIN,2
MX,HAEMOPTYSIS,2
MX,HEART RATE INCREASED,2
MX,HEPATIC CANCER,2
MX,HERPES VIRUS INFECTION,2
MX,HIP FRACTURE,2
MX,HYPERBILIRUBINAEMIA,2
MX,HYPERKALAEMIA,2
MX,HYPOAESTHESIA,2
MX,HYPOPHAGIA,2
MX,INFLAMMATION,2
MX,LOCAL SWELLING,2
MX,LUNG DISORDER,2
MX,METABOLIC ACIDOSIS,2
MX,MOOD ALTERED,2
MX,MULTI-ORGAN FAILURE,2
MX,MUSCLE SPASMS,2
MX,MUSCULOSKELETAL PAIN,2
MX,MUSCULOSKELETAL STIFFNESS,2
MX,NASOPHARYNGITIS,2
MX,NEPHROPATHY,2
MX,NERVOUS SYSTEM DISORDER,2
MX,NERVOUSNESS,2
MX,OLIGURIA,2
MX,OROPHARYNGEAL DISCOMFORT,2
MX,OROPHARYNGEAL PAIN,2
MX,OXYGEN CONSUMPTION INCREASED,2
MX,OXYGEN SATURATION DECREASED,2
MX,PERFORMANCE STATUS DECREASED,2
MX,PERIPHERAL VASCULAR DISORDER,2
MX,POLLAKIURIA,2
MX,PROCEDURAL PAIN,2
MX,PROSTATIC DISORDER,2
MX,PULMONARY HYPERTENSION,2
MX,RALES,2
MX,RASH,2
MX,RENAL FAILURE CHRONIC,2
MX,RENAL IMPAIRMENT,2
MX,RESPIRATORY DISORDER,2
MX,SCAB,2
MX,SEPSIS,2
MX,SKIN DISCOLOURATION,2
MX,STRESS,2
MX,SWELLING,2
MX,SWELLING FACE,2
MX,SYSTEMIC LUPUS ERYTHEMATOSUS,2
MX,TACHYPNOEA,2
MX,THROMBOCYTOPENIA,2
MX,THROMBOSIS,2
MX,TINNITUS,2
MX,TYPE 2 DIABETES MELLITUS,2
MX,UNEVALUABLE EVENT,2
MX,URINARY TRACT DISORDER,2
MX,VEIN DISORDER,2
MX,VENOUS OCCLUSION,2
MX,ABASIA,1
MX,ABDOMINAL ADHESIONS,1
MX,ABDOMINAL RIGIDITY,1
MX,ABNORMAL FAECES,1
MX,ACNE,1
MX,ACTIVITIES OF DAILY LIVING IMPAIRED,1
MX,ACUTE ABDOMEN,1
MX,ACUTE HEPATIC FAILURE,1
MX,ACUTE MYOCARDIAL INFARCTION,1
MX,ACUTE PULMONARY OEDEMA,1
MX,ACUTE RESPIRATORY FAILURE,1
MX,ADENOCARCINOMA PANCREAS,1
MX,ADVERSE EVENT,1
MX,ALANINE AMINOTRANSFERASE INCREASED,1
MX,ALOPECIA,1
MX,AMNESIA,1
MX,ANAL HAEMORRHAGE,1
MX,ANGINA UNSTABLE,1
MX,ANGIOPATHY,1
MX,ANTICOAGULATION DRUG LEVEL INCREASED,1
MX,ANURIA,1
MX,APATHY,1
MX,APHTHOUS ULCER,1
MX,APOPTOSIS,1
MX,APPARENT DEATH,1
MX,ARTERIAL THROMBOSIS,1
MX,ASPIRATION BRONCHIAL,1
MX,ATRIAL FIBRILLATION,1
MX,ATRIAL FLUTTER,1
MX,ATRIAL PRESSURE INCREASED,1
MX,ATRIAL SEPTAL DEFECT,1
MX,BACK DISORDER,1
MX,BLADDER INJURY,1
MX,BLADDER NEOPLASM,1
MX,BLINDNESS UNILATERAL,1
MX,BLISTER,1
MX,BLOOD BILIRUBIN INCREASED,1
MX,BLOOD CULTURE POSITIVE,1
MX,BLOOD DISORDER,1
MX,BLOOD GLUCOSE ABNORMAL,1
MX,BLOOD LACTATE DEHYDROGENASE INCREASED,1
MX,BLOOD POTASSIUM INCREASED,1
MX,BLOOD PRESSURE SYSTOLIC INCREASED,1
MX,BLOOD TEST ABNORMAL,1
MX,BLOOD UREA INCREASED,1
MX,BRADYCARDIA,1
MX,BRAIN NEOPLASM,1
MX,C-REACTIVE PROTEIN INCREASED,1
MX,CARDIAC FAILURE ACUTE,1
MX,CARDIAC FAILURE CHRONIC,1
MX,CARDIAC HYPERTROPHY,1
MX,CARDIAC MURMUR,1
MX,CARDIAC PACEMAKER INSERTION,1
MX,CARDIOMYOPATHY,1
MX,CARDIOVASCULAR DISORDER,1
MX,CATARRH,1
MX,CEREBRAL ARTERY EMBOLISM,1
MX,CEREBRAL HAEMORRHAGE,1
MX,CEREBRAL INFARCTION,1
MX,CEREBRAL ISCHAEMIA,1
MX,CHEST DISCOMFORT,1
MX,CHEST WALL TUMOUR,1
MX,CHOKING,1
MX,CHOLELITHIASIS,1
MX,CHRONIC RIGHT VENTRICULAR FAILURE,1
MX,COAGULOPATHY,1
MX,COLD SWEAT,1
MX,COLON CANCER,1
MX,COLON CANCER METASTATIC,1
MX,COMA,1
MX,CONFUSIONAL STATE,1
MX,CONGESTIVE CARDIOMYOPATHY,1
MX,CONTRAINDICATED PRODUCT ADMINISTERED,1
MX,CORNEAL DISORDER,1
MX,COW^S MILK INTOLERANCE,1
MX,CYST,1
MX,CYTOMEGALOVIRUS INFECTION,1
MX,DELIRIUM,1
MX,DEPRESSED LEVEL OF CONSCIOUSNESS,1
MX,DERMATITIS ALLERGIC,1
MX,DEVICE BREAKAGE,1
MX,DEVICE RELATED INFECTION,1
MX,DIABETES MELLITUS,1
MX,DIABETIC FOOT,1
MX,DIPLOPIA,1
MX,DISEASE COMPLICATION,1
MX,DISEASE PROGRESSION,1
MX,DISORIENTATION,1
MX,DISSEMINATED INTRAVASCULAR COAGULATION,1
MX,DIVERTICULITIS,1
MX,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
MX,DRUG ADMINISTRATION ERROR,1
MX,DRUG DOSE OMISSION,1
MX,DRUG HYPERSENSITIVITY,1
MX,DRUG INTOLERANCE,1
MX,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
MX,DRY SKIN,1
MX,DRY THROAT,1
MX,DYSGEUSIA,1
MX,DYSPEPSIA,1
MX,DYSSTASIA,1
MX,DYSURIA,1
MX,EARLY SATIETY,1
MX,EATING DISORDER,1
MX,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,1
MX,ENTEROCOLITIS INFECTIOUS,1
MX,ENTEROCUTANEOUS FISTULA,1
MX,EPIDERMAL NECROSIS,1
MX,EPILEPSY,1
MX,ERYSIPELAS,1
MX,ERYTHEMA OF EYELID,1
MX,ESCHERICHIA TEST POSITIVE,1
MX,EXCORIATION,1
MX,EXPIRED PRODUCT ADMINISTERED,1
MX,EXTRASYSTOLES,1
MX,EYE HAEMORRHAGE,1
MX,EYE INJURY,1
MX,EYE IRRITATION,1
MX,FAECALOMA,1
MX,FEELING COLD,1
MX,FEELING HOT,1
MX,GAIT INABILITY,1
MX,GASTRIC INFECTION,1
MX,GASTRIC ULCER PERFORATION,1
MX,GASTROENTERITIS ESCHERICHIA COLI,1
MX,GASTROINTESTINAL INFECTION,1
MX,GASTROINTESTINAL PAIN,1
MX,GASTROINTESTINAL ULCER,1
MX,GENERALISED ERYTHEMA,1
MX,GINGIVAL PAIN,1
MX,GLAUCOMA,1
MX,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
MX,HAEMATOCRIT DECREASED,1
MX,HAEMOGLOBIN INCREASED,1
MX,HAEMOLYTIC ANAEMIA,1
MX,HAEMORRHAGE,1
MX,HAEMORRHOIDAL HAEMORRHAGE,1
MX,HAEMORRHOIDS,1
MX,HAEMOTHORAX,1
MX,HEAD INJURY,1
MX,HEART RATE DECREASED,1
MX,HEART RATE IRREGULAR,1
MX,HEMIPLEGIA,1
MX,HEPATIC CONGESTION,1
MX,HEPATIC ENCEPHALOPATHY,1
MX,HEPATIC FAILURE,1
MX,HEPATIC STEATOSIS,1
MX,HEPATITIS,1
MX,HEPATITIS C,1
MX,HEPATOJUGULAR REFLUX,1
MX,HEPATORENAL SYNDROME,1
MX,HERPES ZOSTER,1
MX,HIATUS HERNIA,1
MX,HOT FLUSH,1
MX,HUNGER,1
MX,HYPERHIDROSIS,1
MX,HYPEROSMOLAR STATE,1
MX,HYPERTHYROIDISM,1
MX,HYPERVOLAEMIA,1
MX,HYPOACUSIS,1
MX,HYPOAESTHESIA ORAL,1
MX,HYPOCHONDRIASIS,1
MX,HYPOKINESIA,1
MX,HYPONATRAEMIA,1
MX,HYPOTHERMIA,1
MX,HYPOVOLAEMIC SHOCK,1
MX,HYPOXIA,1
MX,ILEUS PARALYTIC,1
MX,IMMUNE SYSTEM DISORDER,1
MX,INCOHERENT,1
MX,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
MX,INCREASED UPPER AIRWAY SECRETION,1
MX,INGUINAL HERNIA,1
MX,INJURY,1
MX,INTERNAL HAEMORRHAGE,1
MX,INTESTINAL OBSTRUCTION,1
MX,INTRA-ABDOMINAL FLUID COLLECTION,1
MX,INTRAOCULAR PRESSURE DECREASED,1
MX,INTRAOCULAR PRESSURE INCREASED,1
MX,IRON DEFICIENCY ANAEMIA,1
MX,IRREGULAR BREATHING,1
MX,IRRITABILITY,1
MX,ISCHAEMIC STROKE,1
MX,JUGULAR VEIN DISTENSION,1
MX,KIDNEY INFECTION,1
MX,LEUKOCYTOSIS,1
MX,LICHENOID KERATOSIS,1
MX,LIMB DEFORMITY,1
MX,LIP DRY,1
MX,LIVER DISORDER,1
MX,LOWER GASTROINTESTINAL HAEMORRHAGE,1
MX,LOWER LIMB FRACTURE,1
MX,LUMBAR VERTEBRAL FRACTURE,1
MX,LUNG INFECTION,1
MX,LUNG INFILTRATION,1
MX,LUNG NEOPLASM,1
MX,MALNUTRITION,1
MX,MEDICATION ERROR,1
MX,MELAENA,1
MX,MIDDLE INSOMNIA,1
MX,MOVEMENT DISORDER,1
MX,MUSCLE TIGHTNESS,1
MX,MUSCULAR WEAKNESS,1
MX,MUSCULOSKELETAL DISCOMFORT,1
MX,MYALGIA,1
MX,MYOCARDIAL ISCHAEMIA,1
MX,NASAL NEOPLASM,1
MX,NECK PAIN,1
MX,NEOPLASM MALIGNANT,1
MX,NEUROTOXICITY,1
MX,OBESITY,1
MX,OCULAR ICTERUS,1
MX,ODYNOPHAGIA,1
MX,ONCOLOGIC COMPLICATION,1
MX,OPTIC NERVE INFARCTION,1
MX,ORAL DISCOMFORT,1
MX,ORAL DISORDER,1
MX,OVERDOSE,1
MX,PACKED RED BLOOD CELL TRANSFUSION,1
MX,PAIN OF SKIN,1
MX,PALLOR,1
MX,PANCREATITIS,1
MX,PARACENTESIS,1
MX,PERICARDIAL EFFUSION,1
MX,PETECHIAE,1
MX,PHARYNGEAL OEDEMA,1
MX,PHARYNGITIS,1
MX,PHLEBITIS,1
MX,PLATELET COUNT ABNORMAL,1
MX,PNEUMONIA BACTERIAL,1
MX,PNEUMOTHORAX,1
MX,POLYMYOSITIS,1
MX,POST PROCEDURAL CELLULITIS,1
MX,PRESCRIBED UNDERDOSE,1
MX,PROCEDURAL HEADACHE,1
MX,PRURITUS,1
MX,PRURITUS GENERALISED,1
MX,PULMONARY HYPERTENSIVE CRISIS,1
MX,PULMONARY PAIN,1
MX,RASH MACULAR,1
MX,RENAL DISORDER,1
MX,RENAL IMPAIRMENT NEONATAL,1
MX,RENAL INJURY,1
MX,RENAL NEOPLASM,1
MX,RENAL PAIN,1
MX,RESPIRATORY DISTRESS,1
MX,RESPIRATORY FAILURE,1
MX,RESPIRATORY RATE DECREASED,1
MX,RHABDOMYOLYSIS,1
MX,RHINORRHOEA,1
MX,RHODOCOCCUS INFECTION,1
MX,RIB FRACTURE,1
MX,RIGHT VENTRICULAR HYPERTROPHY,1
MX,ROAD TRAFFIC ACCIDENT,1
MX,SILENT MYOCARDIAL INFARCTION,1
MX,SINGLE FUNCTIONAL KIDNEY,1
MX,SINUSITIS,1
MX,SKIN BURNING SENSATION,1
MX,SKIN FISSURES,1
MX,SKIN HAEMORRHAGE,1
MX,SKIN HYPERTROPHY,1
MX,SKIN LESION,1
MX,SKIN SWELLING,1
MX,SOFT TISSUE INFECTION,1
MX,SOMNOLENCE,1
MX,SPEECH DISORDER,1
MX,SPINAL DISORDER,1
MX,SPINAL FRACTURE,1
MX,SQUAMOUS CELL CARCINOMA,1
MX,STAPHYLOCOCCUS TEST POSITIVE,1
MX,STOMATITIS,1
MX,TEARFULNESS,1
MX,TENSION,1
MX,THERAPEUTIC EMBOLISATION,1
MX,THERAPEUTIC PRODUCT INEFFECTIVE,1
MX,THROAT IRRITATION,1
MX,THROAT TIGHTNESS,1
MX,THYROID DISORDER,1
MX,TONGUE OEDEMA,1
MX,TOOTH EXTRACTION,1
MX,TOOTH INJURY,1
MX,TOXIC EPIDERMAL NECROLYSIS,1
MX,TOXICITY TO VARIOUS AGENTS,1
MX,TRICUSPID VALVE INCOMPETENCE,1
MX,UNDERWEIGHT,1
MX,UPPER LIMB FRACTURE,1
MX,URETHRAL OBSTRUCTION,1
MX,URINARY INCONTINENCE,1
MX,URINARY RETENTION,1
MX,URINE ABNORMALITY,1
MX,URINE OUTPUT DECREASED,1
MX,UTERINE NEOPLASM,1
MX,VARICELLA ZOSTER VIRUS INFECTION,1
MX,VASCULAR RUPTURE,1
MX,VENTRICULAR EXTRASYSTOLES,1
MX,VENTRICULAR SEPTAL DEFECT,1
MX,VISION BLURRED,1
MX,VISUAL IMPAIRMENT,1
MX,WALKING DISTANCE TEST ABNORMAL,1
MX,WEIGHT INCREASED,1
MX,WOUND,1
MX,WOUND DEHISCENCE,1
ME,COMPLICATION OF DEVICE INSERTION,1
ME,DEATH,1
ME,DISEASE PROGRESSION,1
ME,HYPOKALAEMIA,1
ME,SELF-MEDICATION,1
ME,SUDDEN DEATH,1
MA,ACUTE KIDNEY INJURY,6
MA,RHABDOMYOLYSIS,6
MA,HYPOKALAEMIA,5
MA,HYPONATRAEMIA,5
MA,METABOLIC ALKALOSIS,5
MA,BLOOD CREATINE PHOSPHOKINASE INCREASED,2
MA,DIARRHOEA,1
MA,DRUG ABUSE,1
MA,GENERALISED OEDEMA,1
MA,MUSCULAR WEAKNESS,1
MA,MYALGIA,1
MA,NEPHROTIC SYNDROME,1
MA,OEDEMA PERIPHERAL,1
MA,OVERDOSE,1
MA,SWELLING FACE,1
MA,VOMITING,1
MZ,ACUTE KIDNEY INJURY,1
MZ,NEUROPATHY PERIPHERAL,1
MZ,TRANSAMINASES INCREASED,1
MZ,URINARY TRACT INFECTION,1
MM,CHEST DISCOMFORT,1
MM,DYSPNOEA,1
MM,ELECTROCARDIOGRAM QT PROLONGED,1
MM,ENLARGED UVULA,1
MM,PRURITUS GENERALISED,1
NL,DEATH,58
NL,CARDIAC FAILURE,50
NL,DYSPNOEA,43
NL,PNEUMONIA,39
NL,RENAL IMPAIRMENT,33
NL,PYREXIA,32
NL,FATIGUE,31
NL,MALAISE,30
NL,DEHYDRATION,25
NL,DIARRHOEA,25
NL,FALL,21
NL,ANAEMIA,20
NL,HYPOTENSION,20
NL,RESPIRATORY FAILURE,19
NL,RENAL FAILURE,18
NL,GENERAL PHYSICAL HEALTH DETERIORATION,17
NL,NAUSEA,16
NL,OEDEMA,16
NL,CARDIAC ARREST,14
NL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,14
NL,HYPOKALAEMIA,13
NL,PLEURAL EFFUSION,13
NL,SYNCOPE,13
NL,VENTRICULAR TACHYCARDIA,13
NL,WEIGHT DECREASED,13
NL,WEIGHT INCREASED,13
NL,ASTHENIA,12
NL,ATRIAL FIBRILLATION,12
NL,DIZZINESS,12
NL,FLUID RETENTION,12
NL,HYPONATRAEMIA,12
NL,OEDEMA PERIPHERAL,12
NL,URINARY TRACT INFECTION,12
NL,HOT FLUSH,11
NL,HYPERTENSION,11
NL,INTERNATIONAL NORMALISED RATIO INCREASED,11
NL,PAIN,11
NL,TERMINAL STATE,11
NL,ABDOMINAL PAIN,10
NL,ARRHYTHMIA,10
NL,ARTHRALGIA,10
NL,HYPOMAGNESAEMIA,10
NL,PULMONARY ARTERIAL HYPERTENSION,10
NL,ACUTE KIDNEY INJURY,9
NL,ANGIOEDEMA,9
NL,CHEST PAIN,9
NL,DECREASED APPETITE,9
NL,DELIRIUM,9
NL,EPISTAXIS,9
NL,HEADACHE,9
NL,PAIN IN EXTREMITY,9
NL,PROSTATE CANCER METASTATIC,9
NL,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,8
NL,ASCITES,8
NL,HYPERHIDROSIS,8
NL,HYPERKALAEMIA,8
NL,MYALGIA,8
NL,MYOCARDIAL INFARCTION,8
NL,PRURITUS,8
NL,VOMITING,8
NL,ANGINA PECTORIS,7
NL,BACK PAIN,7
NL,BLOOD CREATININE INCREASED,7
NL,BRADYCARDIA,7
NL,CEREBROVASCULAR ACCIDENT,7
NL,EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS,7
NL,GOUT,7
NL,HAEMODYNAMIC INSTABILITY,7
NL,HALLUCINATION,7
NL,MALIGNANT NEOPLASM PROGRESSION,7
NL,SEPSIS,7
NL,ABDOMINAL DISTENSION,6
NL,ABDOMINAL PAIN UPPER,6
NL,ASPARTATE AMINOTRANSFERASE INCREASED,6
NL,ATRIAL FLUTTER,6
NL,CONFUSIONAL STATE,6
NL,FEELING COLD,6
NL,HYPOCALCAEMIA,6
NL,HYPOPHAGIA,6
NL,LACTIC ACIDOSIS,6
NL,METABOLIC ALKALOSIS,6
NL,MULTI-ORGAN FAILURE,6
NL,MUSCLE SPASMS,6
NL,PRODUCT USE ISSUE,6
NL,PROSTATE CANCER,6
NL,PROSTATIC SPECIFIC ANTIGEN INCREASED,6
NL,PULMONARY EMBOLISM,6
NL,PULMONARY HYPERTENSION,6
NL,RECTAL HAEMORRHAGE,6
NL,TACHYCARDIA,6
NL,ALANINE AMINOTRANSFERASE INCREASED,5
NL,ALOPECIA,5
NL,C-REACTIVE PROTEIN INCREASED,5
NL,CARDIOMYOPATHY,5
NL,CHEST DISCOMFORT,5
NL,CHILLS,5
NL,CONDITION AGGRAVATED,5
NL,COUGH,5
NL,DEPRESSED MOOD,5
NL,DIABETES MELLITUS INADEQUATE CONTROL,5
NL,FEBRILE NEUTROPENIA,5
NL,GAIT DISTURBANCE,5
NL,GASTROINTESTINAL HAEMORRHAGE,5
NL,HEART RATE DECREASED,5
NL,INFECTION,5
NL,INTERSTITIAL LUNG DISEASE,5
NL,MEMORY IMPAIRMENT,5
NL,MOOD SWINGS,5
NL,PROTEINURIA,5
NL,PULMONARY OEDEMA,5
NL,SENSE OF OPPRESSION,5
NL,SOMNOLENCE,5
NL,THROMBOCYTOPENIA,5
NL,AGGRESSION,4
NL,BACTERIAL INFECTION,4
NL,BLOOD BILIRUBIN INCREASED,4
NL,BLOOD GLUCOSE INCREASED,4
NL,BLOOD POTASSIUM INCREASED,4
NL,BLOOD UREA INCREASED,4
NL,CIRCULATORY COLLAPSE,4
NL,CONSTIPATION,4
NL,DECUBITUS ULCER,4
NL,DEPRESSION,4
NL,DIABETES MELLITUS,4
NL,DISEASE PROGRESSION,4
NL,ERYTHEMA,4
NL,EYELID OEDEMA,4
NL,GLOMERULAR FILTRATION RATE DECREASED,4
NL,HAEMOGLOBIN DECREASED,4
NL,HOSPITALISATION,4
NL,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,4
NL,LOSS OF CONSCIOUSNESS,4
NL,LUNG INFECTION,4
NL,LUNG NEOPLASM MALIGNANT,4
NL,MELAENA,4
NL,NASOPHARYNGITIS,4
NL,PERITONITIS,4
NL,POOR QUALITY SLEEP,4
NL,RENAL DISORDER,4
NL,RENAL FAILURE ACUTE,4
NL,RESPIRATORY TRACT INFECTION,4
NL,RHINOVIRUS INFECTION,4
NL,SWOLLEN TONGUE,4
NL,TOXIC SKIN ERUPTION,4
NL,TOXICITY TO VARIOUS AGENTS,4
NL,TRANSIENT ISCHAEMIC ATTACK,4
NL,VISUAL IMPAIRMENT,4
NL,ABASIA,3
NL,ANGER,3
NL,ARTHROPATHY,3
NL,BLOOD ALBUMIN DECREASED,3
NL,BLOOD ALKALINE PHOSPHATASE INCREASED,3
NL,BURSITIS,3
NL,CARDIAC DISORDER,3
NL,CARDIAC OPERATION,3
NL,CATARACT,3
NL,CELLULITIS,3
NL,COGNITIVE DISORDER,3
NL,CONCOMITANT DISEASE PROGRESSION,3
NL,CYSTITIS,3
NL,DRUG ABUSE,3
NL,DRUG INEFFECTIVE,3
NL,DRUG LEVEL BELOW THERAPEUTIC,3
NL,DYSPNOEA EXERTIONAL,3
NL,ELECTROCARDIOGRAM QT PROLONGED,3
NL,ELECTROLYTE IMBALANCE,3
NL,ERYSIPELAS,3
NL,EXERCISE TOLERANCE DECREASED,3
NL,FEMUR FRACTURE,3
NL,GAMMA-GLUTAMYLTRANSFERASE INCREASED,3
NL,GASTROENTERITIS,3
NL,GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE,3
NL,HAEMORRHAGE,3
NL,HAEMORRHOIDS,3
NL,HEPATIC ENZYME INCREASED,3
NL,HIP FRACTURE,3
NL,HYPERCALCAEMIA,3
NL,HYPERGLYCAEMIA,3
NL,HYPOACUSIS,3
NL,HYPOAESTHESIA,3
NL,HYPOGLYCAEMIA,3
NL,INCORRECT ROUTE OF DRUG ADMINISTRATION,3
NL,INJECTION SITE PAIN,3
NL,INTESTINAL ISCHAEMIA,3
NL,ISCHAEMIC STROKE,3
NL,LICHENIFICATION,3
NL,LINEAR IGA DISEASE,3
NL,LIVER DISORDER,3
NL,LIVER FUNCTION TEST ABNORMAL,3
NL,LUNG DISORDER,3
NL,LUNG TRANSPLANT,3
NL,MITRAL VALVE INCOMPETENCE,3
NL,MUSCULOSKELETAL STIFFNESS,3
NL,NECK PAIN,3
NL,NEPHROTIC SYNDROME,3
NL,NIGHT SWEATS,3
NL,OXYGEN SATURATION DECREASED,3
NL,PAIN IN JAW,3
NL,PANCYTOPENIA,3
NL,PARKINSONISM,3
NL,PHARYNGEAL OEDEMA,3
NL,PLASMA CELL MYELOMA,3
NL,POST PROCEDURAL COMPLICATION,3
NL,PRODUCT USE IN UNAPPROVED INDICATION,3
NL,PRURITUS GENERALISED,3
NL,PULMONARY FIBROSIS,3
NL,RASH PAPULAR,3
NL,RENAL TRANSPLANT,3
NL,RESPIRATORY RATE INCREASED,3
NL,RHABDOMYOLYSIS,3
NL,RIGHT VENTRICULAR FAILURE,3
NL,SECRETION DISCHARGE,3
NL,SEIZURE,3
NL,SLEEP DISORDER,3
NL,SUPRAVENTRICULAR TACHYCARDIA,3
NL,TUBULOINTERSTITIAL NEPHRITIS,3
NL,URINARY RETENTION,3
NL,VISION BLURRED,3
NL,WRONG TECHNIQUE IN DRUG USAGE PROCESS,3
NL,ABDOMINAL ABSCESS,2
NL,ABDOMINAL DISCOMFORT,2
NL,ACUTE CORONARY SYNDROME,2
NL,ACUTE MYOCARDIAL INFARCTION,2
NL,ANAL ABSCESS,2
NL,AORTIC ANEURYSM,2
NL,AORTIC ANEURYSM RUPTURE,2
NL,AORTIC VALVE INCOMPETENCE,2
NL,APATHY,2
NL,ATRIOVENTRICULAR BLOCK COMPLETE,2
NL,BACTERAEMIA,2
NL,BALANCE DISORDER,2
NL,BLOOD PRESSURE INCREASED,2
NL,BLOOD SODIUM DECREASED,2
NL,BLOOD TEST ABNORMAL,2
NL,BLOOD URINE PRESENT,2
NL,BONE DISORDER,2
NL,BRONCHITIS,2
NL,BRONCHOSPASM,2
NL,CARDIAC ASTHMA,2
NL,CEREBRAL INFARCTION,2
NL,CHOLESTASIS,2
NL,COMA,2
NL,COMPLICATIONS OF TRANSPLANTED KIDNEY,2
NL,CYSTITIS NONINFECTIVE,2
NL,DEAFNESS,2
NL,DELUSION,2
NL,DEPRESSED LEVEL OF CONSCIOUSNESS,2
NL,DEVICE RELATED INFECTION,2
NL,DISCOMFORT,2
NL,DRUG LEVEL DECREASED,2
NL,DRY SKIN,2
NL,DYSGEUSIA,2
NL,DYSKINESIA,2
NL,EMPHYSEMA,2
NL,ENCEPHALOPATHY,2
NL,ESCHERICHIA URINARY TRACT INFECTION,2
NL,EXPOSURE DURING PREGNANCY,2
NL,FAECES DISCOLOURED,2
NL,FEAR,2
NL,FEELING ABNORMAL,2
NL,FLUID INTAKE REDUCED,2
NL,FLUSHING,2
NL,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,2
NL,FOETAL GROWTH RESTRICTION,2
NL,GASTRIC ULCER HAEMORRHAGE,2
NL,GASTROINTESTINAL DISORDER,2
NL,GENERALISED OEDEMA,2
NL,HAEMATOCHEZIA,2
NL,HAEMATURIA,2
NL,HEART RATE INCREASED,2
NL,HEPATIC FAILURE,2
NL,HEPATOMEGALY,2
NL,HERPES ZOSTER,2
NL,HYPERAMMONAEMIA,2
NL,HYPERBILIRUBINAEMIA,2
NL,HYPERCAPNIA,2
NL,HYPOCHLORAEMIA,2
NL,HYPOPHOSPHATAEMIA,2
NL,ILEUS,2
NL,IMMUNOSUPPRESSION,2
NL,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,2
NL,INFLUENZA,2
NL,INJECTION SITE REACTION,2
NL,INTENTIONAL PRODUCT MISUSE,2
NL,INTERNAL HAEMORRHAGE,2
NL,INTERNATIONAL NORMALISED RATIO DECREASED,2
NL,JAUNDICE,2
NL,LIVER ABSCESS,2
NL,LOCALISED OEDEMA,2
NL,MALNUTRITION,2
NL,MEDICAL DEVICE COMPLICATION,2
NL,MENTAL IMPAIRMENT,2
NL,METABOLIC ACIDOSIS,2
NL,MUCOSAL INFLAMMATION,2
NL,MUSCLE RUPTURE,2
NL,MUSCULAR WEAKNESS,2
NL,MUSCULOSKELETAL PAIN,2
NL,NEUROLOGICAL SYMPTOM,2
NL,NEUROPATHY PERIPHERAL,2
NL,NO THERAPEUTIC RESPONSE,2
NL,OCULAR HYPERAEMIA,2
NL,ORAL CANDIDIASIS,2
NL,OSTEITIS,2
NL,OSTEOARTHRITIS,2
NL,OSTEOPOROSIS,2
NL,PALLOR,2
NL,PALPITATIONS,2
NL,PELVIC FRACTURE,2
NL,PERIPHERAL VASCULAR DISORDER,2
NL,POLLAKIURIA,2
NL,PSEUDOMONAL SEPSIS,2
NL,PULMONARY CONGESTION,2
NL,PULMONARY MASS,2
NL,PULMONARY SEPSIS,2
NL,PYODERMA GANGRENOSUM,2
NL,RASH,2
NL,REBOUND EFFECT,2
NL,RESPIRATORY RATE DECREASED,2
NL,RESTLESSNESS,2
NL,RETINAL DETACHMENT,2
NL,RETINAL INFARCTION,2
NL,RIB FRACTURE,2
NL,SENSATION OF HEAVINESS,2
NL,SEPTIC SHOCK,2
NL,SHOCK,2
NL,SKIN EXFOLIATION,2
NL,SPEECH DISORDER,2
NL,SPINAL COMPRESSION FRACTURE,2
NL,SUICIDAL IDEATION,2
NL,SWELLING FACE,2
NL,TACHYPNOEA,2
NL,THERAPEUTIC RESPONSE DECREASED,2
NL,TRACHEITIS,2
NL,TRANSFUSION-RELATED ACUTE LUNG INJURY,2
NL,TUMOUR EXCISION,2
NL,URINARY BLADDER HAEMORRHAGE,2
NL,VENOOCCLUSIVE DISEASE,2
NL,VERTIGO,2
NL,VIRAL INFECTION,2
NL,VISUAL ACUITY REDUCED,2
NL,WITHDRAWAL SYNDROME,2
NL,WOUND,2
NL,ABDOMINAL RIGIDITY,1
NL,ABDOMINAL WALL ABSCESS,1
NL,ABDOMINAL WALL HAEMATOMA,1
NL,ABNORMAL BEHAVIOUR,1
NL,ABSCESS,1
NL,ACIDOSIS,1
NL,ACINETOBACTER INFECTION,1
NL,ACUTE HEPATIC FAILURE,1
NL,ACUTE RESPIRATORY DISTRESS SYNDROME,1
NL,ADDISON^S DISEASE,1
NL,ADRENAL INSUFFICIENCY,1
NL,ADRENOCORTICAL INSUFFICIENCY ACUTE,1
NL,ADVERSE DRUG REACTION,1
NL,ADVERSE EVENT,1
NL,AFFECT LABILITY,1
NL,AGE-RELATED MACULAR DEGENERATION,1
NL,ALKALOSIS,1
NL,ALKALOSIS HYPOCHLORAEMIC,1
NL,AMYLASE INCREASED,1
NL,AMYOTROPHIC LATERAL SCLEROSIS,1
NL,ANAL INFLAMMATION,1
NL,ANAPHYLACTIC SHOCK,1
NL,ANGIODYSPLASIA,1
NL,ANKLE FRACTURE,1
NL,ANKYLOSING SPONDYLITIS,1
NL,ANORECTAL DISCOMFORT,1
NL,ANTERIOR CHAMBER DISORDER,1
NL,ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC,1
NL,AORTIC SURGERY,1
NL,APHONIA,1
NL,APLASIA PURE RED CELL,1
NL,APNOEA,1
NL,APTYALISM,1
NL,AQUEOUS HUMOUR LEAKAGE,1
NL,ARTERECTOMY,1
NL,ARTERIAL HAEMORRHAGE,1
NL,ARTERIOSCLEROSIS,1
NL,ARTERIOSCLEROSIS CORONARY ARTERY,1
NL,ARTERIOVENOUS FISTULA OPERATION,1
NL,ASPERGILLUS INFECTION,1
NL,ASTHMA,1
NL,ATELECTASIS,1
NL,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
NL,BACTERIAL SEPSIS,1
NL,BACTERIAL TEST POSITIVE,1
NL,BASAL CELL CARCINOMA,1
NL,BEDRIDDEN,1
NL,BENIGN OVARIAN TUMOUR,1
NL,BILIRUBIN CONJUGATED INCREASED,1
NL,BIOPSY KIDNEY,1
NL,BLADDER CANCER,1
NL,BLINDNESS,1
NL,BLOOD BICARBONATE INCREASED,1
NL,BLOOD CHLORIDE DECREASED,1
NL,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
NL,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,1
NL,BLOOD GLUCOSE DECREASED,1
NL,BLOOD LACTATE DEHYDROGENASE DECREASED,1
NL,BLOOD MAGNESIUM DECREASED,1
NL,BLOOD POTASSIUM DECREASED,1
NL,BLOOD PRESSURE ABNORMAL,1
NL,BLOOD PRESSURE DECREASED,1
NL,BLOOD PRESSURE FLUCTUATION,1
NL,BODY TEMPERATURE INCREASED,1
NL,BONE DENSITY DECREASED,1
NL,BONE PAIN,1
NL,BRAIN HERNIATION,1
NL,BRAIN INJURY,1
NL,BRAIN STEM HAEMORRHAGE,1
NL,BREAST CANCER,1
NL,BREAST CANCER METASTATIC,1
NL,BREAST CANCER RECURRENT,1
NL,BRONCHIECTASIS,1
NL,BRONCHOPULMONARY ASPERGILLOSIS,1
NL,BURNING SENSATION,1
NL,CALCULUS URETERIC,1
NL,CANDIDA INFECTION,1
NL,CARDIAC FAILURE CHRONIC,1
NL,CARDIAC FAILURE CONGESTIVE,1
NL,CARDIAC OUTPUT DECREASED,1
NL,CARDIAC PACEMAKER INSERTION,1
NL,CARDIAC TAMPONADE,1
NL,CARDIAC VALVE DISEASE,1
NL,CARDIOMEGALY,1
NL,CARDIOVASCULAR DISORDER,1
NL,CARDIOVERSION,1
NL,CAROTID ARTERY STENOSIS,1
NL,CATARACT OPERATION,1
NL,CERVICAL SPINAL STENOSIS,1
NL,CERVICAL VERTEBRAL FRACTURE,1
NL,CERVICOBRACHIAL SYNDROME,1
NL,CHOKING,1
NL,CHOLANGITIS,1
NL,CHOLELITHIASIS,1
NL,CHOROIDAL NEOVASCULARISATION,1
NL,CHROMATURIA,1
NL,CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY,1
NL,CLAVICLE FRACTURE,1
NL,CLOSTRIDIUM DIFFICILE INFECTION,1
NL,COAGULATION TEST ABNORMAL,1
NL,COLD SWEAT,1
NL,COLITIS MICROSCOPIC,1
NL,COLON CANCER,1
NL,COLON NEOPLASM,1
NL,COLORECTAL ADENOCARCINOMA,1
NL,COMPUTERISED TOMOGRAM ABNORMAL,1
NL,CONTUSION,1
NL,CORNEAL EPITHELIUM DEFECT,1
NL,CORNEAL INFILTRATES,1
NL,CORNEAL OEDEMA,1
NL,CORNEAL PERFORATION,1
NL,CORNEAL SCAR,1
NL,CORNEAL THINNING,1
NL,CORONA VIRUS INFECTION,1
NL,CORONARY ARTERY DISEASE,1
NL,CORONARY ARTERY OCCLUSION,1
NL,CRITICAL ILLNESS,1
NL,CUSHINGOID,1
NL,CYSTITIS HAEMORRHAGIC,1
NL,CYTOMEGALOVIRUS INFECTION,1
NL,DEEP VEIN THROMBOSIS,1
NL,DEMENTIA,1
NL,DERMATITIS ALLERGIC,1
NL,DEVICE DISLOCATION,1
NL,DEVICE MALFUNCTION,1
NL,DEVICE OCCLUSION,1
NL,DEVICE RELATED SEPSIS,1
NL,DIALYSIS,1
NL,DIET REFUSAL,1
NL,DIFFUSE LARGE B-CELL LYMPHOMA,1
NL,DISINHIBITION,1
NL,DISORIENTATION,1
NL,DISSOCIATION,1
NL,DISTURBANCE IN ATTENTION,1
NL,DIVERTICULITIS,1
NL,DIVERTICULUM,1
NL,DIVERTICULUM INTESTINAL,1
NL,DOLICHOCOLON,1
NL,DRUG ADMINISTRATION ERROR,1
NL,DRUG DISPENSING ERROR,1
NL,DRUG EFFECT INCOMPLETE,1
NL,DRUG HYPERSENSITIVITY,1
NL,DRUG LEVEL,1
NL,DRUG LEVEL INCREASED,1
NL,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
NL,DRUG-DISEASE INTERACTION,1
NL,DRUG-INDUCED LIVER INJURY,1
NL,DRY MOUTH,1
NL,DUODENAL ULCER,1
NL,DUPUYTREN^S CONTRACTURE,1
NL,DYSARTHRIA,1
NL,DYSPHAGIA,1
NL,DYSPHONIA,1
NL,EAR INFECTION,1
NL,EAR NEOPLASM,1
NL,EFFUSION,1
NL,ELECTROCARDIOGRAM CHANGE,1
NL,ELECTROENCEPHALOGRAM ABNORMAL,1
NL,ELECTROLYTE DEPLETION,1
NL,EMBOLISM,1
NL,EMOTIONAL DISORDER,1
NL,ENTEROCOLITIS,1
NL,ENTEROSTOMY,1
NL,EPILEPSY,1
NL,ERYTHEMA MULTIFORME,1
NL,ESCHERICHIA INFECTION,1
NL,ESCHERICHIA TEST POSITIVE,1
NL,EXTRASYSTOLES,1
NL,EXTREMITY NECROSIS,1
NL,EYE DISCHARGE,1
NL,EYE HAEMORRHAGE,1
NL,EYE PAIN,1
NL,FACE OEDEMA,1
NL,FACIAL BONES FRACTURE,1
NL,FACIAL PAIN,1
NL,FALLOT^S TETRALOGY,1
NL,FAT NECROSIS,1
NL,FEELING OF BODY TEMPERATURE CHANGE,1
NL,FIBROMA,1
NL,FLANK PAIN,1
NL,FLAT ANTERIOR CHAMBER OF EYE,1
NL,FOETAL DEATH,1
NL,FOETAL EXPOSURE DURING PREGNANCY,1
NL,FOOT FRACTURE,1
NL,FOREIGN BODY SENSATION IN EYES,1
NL,FRACTURE,1
NL,FRACTURE DELAYED UNION,1
NL,FUNCTIONAL GASTROINTESTINAL DISORDER,1
NL,GAIT INABILITY,1
NL,GASTRIC CANCER,1
NL,GASTRIC HAEMORRHAGE,1
NL,GASTRIC ULCER,1
NL,GASTROENTERITIS VIRAL,1
NL,GASTROINTESTINAL ANGIODYSPLASIA,1
NL,GASTROINTESTINAL CARCINOMA,1
NL,GASTROINTESTINAL HYPOMOTILITY,1
NL,GASTROINTESTINAL INFLAMMATION,1
NL,GASTROINTESTINAL NECROSIS,1
NL,GASTROINTESTINAL PAIN,1
NL,GENERAL PHYSICAL CONDITION ABNORMAL,1
NL,GENITAL BLISTER,1
NL,GLOMERULONEPHRITIS,1
NL,GLOMERULONEPHRITIS MEMBRANOUS,1
NL,GLOMERULONEPHROPATHY,1
NL,GLOSSODYNIA,1
NL,GRAFT VERSUS HOST DISEASE,1
NL,GRIMACING,1
NL,GROIN PAIN,1
NL,GYNAECOMASTIA,1
NL,HAEMATOCRIT DECREASED,1
NL,HAEMATOCRIT INCREASED,1
NL,HAEMATOMA,1
NL,HAEMORRHAGE INTRACRANIAL,1
NL,HAEMORRHAGIC DIATHESIS,1
NL,HAEMOTHORAX,1
NL,HAIR COLOUR CHANGES,1
NL,HAIR GROWTH ABNORMAL,1
NL,HALLUCINATION_ AUDITORY,1
NL,HEART RATE IRREGULAR,1
NL,HEART VALVE INCOMPETENCE,1
NL,HEMIPLEGIA,1
NL,HEPATIC CIRRHOSIS,1
NL,HEPATIC ENCEPHALOPATHY,1
NL,HEPATIC NEOPLASM,1
NL,HEPATOTOXICITY,1
NL,HERNIA,1
NL,HIP ARTHROPLASTY,1
NL,HISTIOCYTOSIS HAEMATOPHAGIC,1
NL,HUMAN POLYOMAVIRUS INFECTION,1
NL,HYDRONEPHROSIS,1
NL,HYPERALDOSTERONISM,1
NL,HYPERKINESIA,1
NL,HYPERNATRAEMIA,1
NL,HYPERPHOSPHATURIA,1
NL,HYPERSENSITIVITY,1
NL,HYPERSENSITIVITY VASCULITIS,1
NL,HYPERSEXUALITY,1
NL,HYPERTHYROIDISM,1
NL,HYPOKINESIA,1
NL,HYPOPARATHYROIDISM,1
NL,HYPOTHERMIA,1
NL,HYPOVOLAEMIC SHOCK,1
NL,HYPOXIA,1
NL,IMMUNE THROMBOCYTOPENIC PURPURA,1
NL,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,1
NL,IMPLANTABLE DEFIBRILLATOR INSERTION,1
NL,INCORRECT DOSE ADMINISTERED,1
NL,INCORRECT PRODUCT STORAGE,1
NL,INCREASED APPETITE,1
NL,INFLAMMATION,1
NL,INFLAMMATORY MARKER INCREASED,1
NL,INFLUENZA LIKE ILLNESS,1
NL,INFUSION RELATED REACTION,1
NL,INGUINAL HERNIA,1
NL,INHIBITORY DRUG INTERACTION,1
NL,INJECTION SITE ERYTHEMA,1
NL,INJECTION SITE SWELLING,1
NL,INJECTION SITE WARMTH,1
NL,INNER EAR DISORDER,1
NL,INSOMNIA,1
NL,INTERVERTEBRAL DISC PROTRUSION,1
NL,INTERVERTEBRAL DISCITIS,1
NL,INTESTINAL HAEMORRHAGE,1
NL,INTRA-ABDOMINAL FLUID COLLECTION,1
NL,INTRAOCULAR LENS IMPLANT,1
NL,IRON DEFICIENCY ANAEMIA,1
NL,IRRITABLE BOWEL SYNDROME,1
NL,ISCHAEMIA,1
NL,JAW CYST,1
NL,JAW OPERATION,1
NL,JOINT EFFUSION,1
NL,KNEE ARTHROPLASTY,1
NL,LABORATORY TEST ABNORMAL,1
NL,LARGE INTESTINE PERFORATION,1
NL,LARGE INTESTINE POLYP,1
NL,LARYNGOSPASM,1
NL,LEFT VENTRICULAR DILATATION,1
NL,LEFT VENTRICULAR DYSFUNCTION,1
NL,LEFT VENTRICULAR FAILURE,1
NL,LEUKOCYTOCLASTIC VASCULITIS,1
NL,LEUKOPENIA,1
NL,LIBIDO DECREASED,1
NL,LIMB DISCOMFORT,1
NL,LIMB INJURY,1
NL,LIP SWELLING,1
NL,LISTLESS,1
NL,LOSS OF LIBIDO,1
NL,LOWER LIMB FRACTURE,1
NL,LUNG INFILTRATION,1
NL,LYMPHADENOPATHY,1
NL,MALIGNANT PLEURAL EFFUSION,1
NL,MASS,1
NL,MATERNAL EXPOSURE DURING PREGNANCY,1
NL,MEDIASTINAL SHIFT,1
NL,METABOLIC DISORDER,1
NL,METASTASES TO BONE,1
NL,METASTASES TO BONE MARROW,1
NL,METASTASES TO LUNG,1
NL,METASTASES TO PELVIS,1
NL,METASTASIS,1
NL,MICTURITION FREQUENCY DECREASED,1
NL,MOBILITY DECREASED,1
NL,MOVEMENT DISORDER,1
NL,MULTIPLE FRACTURES,1
NL,MUSCLE ATROPHY,1
NL,MUSCLE NECROSIS,1
NL,MUSCLE RIGIDITY,1
NL,MUSCULOSKELETAL CHEST PAIN,1
NL,MYASTHENIA GRAVIS,1
NL,MYOCARDIAL ISCHAEMIA,1
NL,MYOCARDIAL NECROSIS MARKER INCREASED,1
NL,MYOPATHY,1
NL,NEOPLASM MALIGNANT,1
NL,NEPHROPATHY TOXIC,1
NL,NEPHROSTOMY,1
NL,NERVE COMPRESSION,1
NL,NERVE INJURY,1
NL,NEURALGIA,1
NL,NEURODEGENERATIVE DISORDER,1
NL,NEUROLEPTIC MALIGNANT SYNDROME,1
NL,NEUTROPENIA,1
NL,NEUTROPHIL COUNT ABNORMAL,1
NL,NIGHTMARE,1
NL,NITRITE URINE PRESENT,1
NL,NOCTURIA,1
NL,NODAL RHYTHM,1
NL,NON-SMALL CELL LUNG CANCER,1
NL,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
NL,NORMOCYTIC ANAEMIA,1
NL,OBSESSIVE-COMPULSIVE DISORDER,1
NL,OESOPHAGEAL CANDIDIASIS,1
NL,OESOPHAGEAL DISORDER,1
NL,ON AND OFF PHENOMENON,1
NL,ORAL DISCOMFORT,1
NL,ORAL PAIN,1
NL,ORTHOPNOEA,1
NL,ORTHOSTATIC HYPOTENSION,1
NL,OSTEONECROSIS OF JAW,1
NL,OSTEOPOROTIC FRACTURE,1
NL,OVARIAN ENLARGEMENT,1
NL,OVARIAN EPITHELIAL CANCER,1
NL,OVERDOSE,1
NL,PALLIATIVE CARE,1
NL,PANCREATIC CARCINOMA,1
NL,PANCREATIC MASS,1
NL,PANCREATIC NEOPLASM,1
NL,PANCREATITIS NECROTISING,1
NL,PARAPLEGIA,1
NL,PARKINSON^S DISEASE,1
NL,PATELLA FRACTURE,1
NL,PELVIC PAIN,1
NL,PENILE OEDEMA,1
NL,PERFORMANCE STATUS DECREASED,1
NL,PERICARDIAL EFFUSION,1
NL,PERICARDITIS,1
NL,PERIORBITAL OEDEMA,1
NL,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
NL,PERIPHERAL COLDNESS,1
NL,PERIPHERAL SWELLING,1
NL,PERSONALITY CHANGE,1
NL,PHARYNGEAL INFLAMMATION,1
NL,PHLEBITIS,1
NL,PLEURAL DISORDER,1
NL,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
NL,PNEUMONIA ASPIRATION,1
NL,PNEUMONIA FUNGAL,1
NL,PNEUMONIA PNEUMOCOCCAL,1
NL,PNEUMONITIS,1
NL,PNEUMOTHORAX,1
NL,POLYDIPSIA,1
NL,POLYNEUROPATHY,1
NL,PORTAL HYPERTENSION,1
NL,POST PROCEDURAL HAEMORRHAGE,1
NL,PRESBYACUSIS,1
NL,PRESYNCOPE,1
NL,PRIAPISM,1
NL,PROCTALGIA,1
NL,PROSTATIC SPECIFIC ANTIGEN DECREASED,1
NL,PROTEIN TOTAL INCREASED,1
NL,PSEUDOMONAS INFECTION,1
NL,PSOAS ABSCESS,1
NL,PURPURA,1
NL,PYELONEPHRITIS,1
NL,RADIATION PROCTITIS,1
NL,RASH ERYTHEMATOUS,1
NL,REHABILITATION THERAPY,1
NL,RENAL FUNCTION TEST ABNORMAL,1
NL,RENAL HAEMORRHAGE,1
NL,RENAL NEOPLASM,1
NL,RENAL TRANSPLANT FAILURE,1
NL,RENIN INCREASED,1
NL,RESPIRATORY ACIDOSIS,1
NL,RESPIRATORY ARREST,1
NL,RESPIRATORY DEPTH DECREASED,1
NL,RESPIRATORY TRACT CONGESTION,1
NL,RESTLESS LEGS SYNDROME,1
NL,RETICULOCYTE COUNT ABNORMAL,1
NL,RIGHT VENTRICULAR DYSFUNCTION,1
NL,RIGHT VENTRICULAR HYPERTROPHY,1
NL,ROTATOR CUFF SYNDROME,1
NL,SARCOIDOSIS,1
NL,SCAR,1
NL,SCLERODERMA,1
NL,SCROTAL OEDEMA,1
NL,SECOND PRIMARY MALIGNANCY,1
NL,SEROTONIN SYNDROME,1
NL,SINUS BRADYCARDIA,1
NL,SKIN CANCER,1
NL,SKIN DISORDER,1
NL,SKIN NECROSIS,1
NL,SKIN PLAQUE,1
NL,SKIN REACTION,1
NL,SKIN TOXICITY,1
NL,SKIN WOUND,1
NL,SLEEP ATTACKS,1
NL,SLOW SPEECH,1
NL,SPASMODIC DYSPHONIA,1
NL,SPINAL FRACTURE,1
NL,SPINAL PAIN,1
NL,SPLENIC HAEMORRHAGE,1
NL,SPLENOMEGALY,1
NL,SPUTUM PURULENT,1
NL,SPUTUM RETENTION,1
NL,SQUAMOUS CELL CARCINOMA,1
NL,STENT PLACEMENT,1
NL,STOMA SITE DISCHARGE,1
NL,STOMA SITE DISCOMFORT,1
NL,STOMA SITE ERYTHEMA,1
NL,STOMA SITE PAIN,1
NL,SUBCUTANEOUS ABSCESS,1
NL,SUBDURAL HAEMATOMA,1
NL,SURGERY,1
NL,SUSPICIOUSNESS,1
NL,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,1
NL,SYSTEMIC SCLEROSIS,1
NL,THROMBOSIS,1
NL,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
NL,THYROID DISORDER,1
NL,THYROID NEOPLASM,1
NL,TIBIA FRACTURE,1
NL,TINNITUS,1
NL,TOBACCO INTERACTION,1
NL,TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED,1
NL,TONGUE OEDEMA,1
NL,TONGUE PIGMENTATION,1
NL,TOOTH FRACTURE,1
NL,TOXIC EPIDERMAL NECROLYSIS,1
NL,TRANSAMINASES INCREASED,1
NL,TRANSFUSION,1
NL,TREATMENT FAILURE,1
NL,TROPONIN INCREASED,1
NL,TROPONIN T INCREASED,1
NL,TUMOUR COMPRESSION,1
NL,ULCERATIVE KERATITIS,1
NL,UPPER GASTROINTESTINAL HAEMORRHAGE,1
NL,URETERIC STENOSIS,1
NL,URETHRAL DISORDER,1
NL,URETHRAL STENOSIS,1
NL,VARICOSE VEIN,1
NL,VASCULAR OCCLUSION,1
NL,VASCULITIS,1
NL,VENTILATION PERFUSION MISMATCH,1
NL,VENTRICULAR FIBRILLATION,1
NL,VENTRICULAR TACHYARRHYTHMIA,1
NL,VITAMIN D DEFICIENCY,1
NL,VOCAL CORD DISORDER,1
NL,WAIST CIRCUMFERENCE INCREASED,1
NL,WHITE BLOOD CELL COUNT DECREASED,1
NL,WHITE BLOOD CELL COUNT INCREASED,1
NL,WHITE BLOOD CELL DISORDER,1
NL,WOUND INFECTION,1
NL,WRIST FRACTURE,1
NL,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
NZ,DYSPNOEA,11
NZ,ACUTE KIDNEY INJURY,8
NZ,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,5
NZ,MALAISE,5
NZ,HYPERTHYROIDISM,4
NZ,HYPONATRAEMIA,4
NZ,VASCULITIS CEREBRAL,4
NZ,ANAEMIA,3
NZ,CARDIAC FAILURE,3
NZ,DEATH,3
NZ,DIARRHOEA,3
NZ,DYSPHAGIA,3
NZ,FALL,3
NZ,FATIGUE,3
NZ,HYPOKALAEMIA,3
NZ,HYPOTENSION,3
NZ,PNEUMONIA,3
NZ,PRURITUS,3
NZ,RENAL FAILURE,3
NZ,RENAL IMPAIRMENT,3
NZ,ANGIOEDEMA,2
NZ,ARTHROPATHY,2
NZ,ATRIAL FIBRILLATION,2
NZ,CARDIAC ARREST,2
NZ,CIRCULATORY COLLAPSE,2
NZ,COUGH,2
NZ,DEHYDRATION,2
NZ,DIABETES MELLITUS,2
NZ,DIZZINESS,2
NZ,GLOMERULAR FILTRATION RATE DECREASED,2
NZ,HYPOGLYCAEMIA,2
NZ,IMPAIRED HEALING,2
NZ,INSOMNIA,2
NZ,LACTIC ACIDOSIS,2
NZ,LIVER FUNCTION TEST ABNORMAL,2
NZ,MUSCULAR WEAKNESS,2
NZ,MUSCULOSKELETAL PAIN,2
NZ,NAUSEA,2
NZ,OEDEMA PERIPHERAL,2
NZ,ORTHOSTATIC HYPOTENSION,2
NZ,OSTEONECROSIS,2
NZ,PULMONARY EMBOLISM,2
NZ,RASH,2
NZ,RASH ERYTHEMATOUS,2
NZ,RHABDOMYOLYSIS,2
NZ,SOMNOLENCE,2
NZ,TORSADE DE POINTES,2
NZ,TOXICITY TO VARIOUS AGENTS,2
NZ,VOMITING,2
NZ,ABDOMINAL PAIN UPPER,1
NZ,ABNORMAL LOSS OF WEIGHT,1
NZ,ACUTE ABDOMEN,1
NZ,AFFECT LABILITY,1
NZ,ALOPECIA,1
NZ,ALTERED STATE OF CONSCIOUSNESS,1
NZ,ANXIETY,1
NZ,AORTIC DISSECTION,1
NZ,ARRHYTHMIA,1
NZ,ASTHENIA,1
NZ,ATYPICAL FEMUR FRACTURE,1
NZ,BASAL CELL CARCINOMA,1
NZ,BLOOD ALKALINE PHOSPHATASE INCREASED,1
NZ,BLOOD BILIRUBIN INCREASED,1
NZ,BLOOD GLUCOSE INCREASED,1
NZ,BLOOD PARATHYROID HORMONE DECREASED,1
NZ,BLOOD PRESSURE INCREASED,1
NZ,BRADYCARDIA,1
NZ,BRONCHOSPASM,1
NZ,CARDIAC ANEURYSM,1
NZ,CARDIAC DISORDER,1
NZ,CARDIAC FAILURE CONGESTIVE,1
NZ,CARDIAC FAILURE HIGH OUTPUT,1
NZ,CELLULITIS,1
NZ,CEREBRAL INFARCTION,1
NZ,CHEST DISCOMFORT,1
NZ,CHOLANGITIS,1
NZ,CHOLESTASIS,1
NZ,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
NZ,COMPLICATIONS OF TRANSPLANTED KIDNEY,1
NZ,CONFUSIONAL STATE,1
NZ,CONVULSION,1
NZ,CORONARY ARTERY STENOSIS,1
NZ,CORONARY ARTERY THROMBOSIS,1
NZ,CRANIOCEREBRAL INJURY,1
NZ,DECREASED APPETITE,1
NZ,DENTAL CARIES,1
NZ,DEPRESSED LEVEL OF CONSCIOUSNESS,1
NZ,DIABETIC FOOT INFECTION,1
NZ,DIABETIC NEPHROPATHY,1
NZ,DIVERTICULITIS,1
NZ,DRUG EFFECT INCOMPLETE,1
NZ,DRUG ERUPTION,1
NZ,DRUG LEVEL INCREASED,1
NZ,DRUG-INDUCED LIVER INJURY,1
NZ,DRY SKIN,1
NZ,DYSPEPSIA,1
NZ,DYSPHONIA,1
NZ,DYSURIA,1
NZ,ECZEMA,1
NZ,ELECTROCARDIOGRAM ABNORMAL,1
NZ,ELECTROCARDIOGRAM QT PROLONGED,1
NZ,ELECTROCARDIOGRAM T WAVE INVERSION,1
NZ,EOSINOPHILIA,1
NZ,EPISTAXIS,1
NZ,FOAMING AT MOUTH,1
NZ,GAIT DISTURBANCE,1
NZ,GASTROINTESTINAL ANGIODYSPLASIA,1
NZ,GASTROINTESTINAL HAEMORRHAGE,1
NZ,GLIOSIS,1
NZ,GLOMERULONEPHRITIS MEMBRANOUS,1
NZ,HAEMORRHAGE,1
NZ,HEART RATE INCREASED,1
NZ,HEMIANOPIA,1
NZ,HEPATIC ENZYME INCREASED,1
NZ,HEPATIC FAILURE,1
NZ,HYPERBILIRUBINAEMIA,1
NZ,HYPERGLYCAEMIA,1
NZ,HYPERHIDROSIS,1
NZ,HYPERSENSITIVITY VASCULITIS,1
NZ,HYPERTENSION,1
NZ,HYPOCALCAEMIA,1
NZ,HYPOMAGNESAEMIA,1
NZ,HYPOTONIA,1
NZ,INTERNAL FIXATION OF FRACTURE,1
NZ,INTERSTITIAL LUNG DISEASE,1
NZ,IRRITABILITY,1
NZ,JOINT SWELLING,1
NZ,KIDNEY TRANSPLANT REJECTION,1
NZ,LEFT VENTRICULAR DYSFUNCTION,1
NZ,LETHARGY,1
NZ,LIP SWELLING,1
NZ,LOCALISED INFECTION,1
NZ,LOWER RESPIRATORY TRACT INFECTION,1
NZ,LUNG NEOPLASM MALIGNANT,1
NZ,LYMPHADENOPATHY,1
NZ,LYMPHOPENIA,1
NZ,MELAENA,1
NZ,MENORRHAGIA,1
NZ,METASTATIC NEOPLASM,1
NZ,MOANING,1
NZ,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
NZ,MUSCLE TWITCHING,1
NZ,MYOCARDIAL INFARCTION,1
NZ,MYOCARDITIS,1
NZ,MYOSITIS,1
NZ,NEPHROTIC SYNDROME,1
NZ,NERVOUS SYSTEM DISORDER,1
NZ,NEUTROPENIA,1
NZ,OEDEMA,1
NZ,OVERDOSE,1
NZ,PAIN,1
NZ,PALPITATIONS,1
NZ,PARANOIA,1
NZ,PATHOLOGICAL FRACTURE,1
NZ,PERIORBITAL OEDEMA,1
NZ,PERIPHERAL CIRCULATORY FAILURE,1
NZ,PHARYNGEAL OEDEMA,1
NZ,PLASMA CELL MYELOMA,1
NZ,POLYDIPSIA,1
NZ,PRODUCT ADHESION ISSUE,1
NZ,PRODUCT QUALITY ISSUE,1
NZ,PRODUCT SUBSTITUTION ISSUE,1
NZ,PRODUCT USE ISSUE,1
NZ,PRODUCTIVE COUGH,1
NZ,PROTEINURIA,1
NZ,PULMONARY ARTERIAL PRESSURE DECREASED,1
NZ,PULMONARY OEDEMA,1
NZ,PYREXIA,1
NZ,RASH GENERALISED,1
NZ,RASH MACULO-PAPULAR,1
NZ,RASH PRURITIC,1
NZ,RENAL FAILURE ACUTE,1
NZ,RESPIRATORY ARREST,1
NZ,RESPIRATORY FAILURE,1
NZ,RESTLESSNESS,1
NZ,RETROPERITONEAL HAEMATOMA,1
NZ,REVERSIBLE ISCHAEMIC NEUROLOGICAL DEFICIT,1
NZ,SEDATION,1
NZ,SEIZURE,1
NZ,SEPSIS,1
NZ,SINUS BRADYCARDIA,1
NZ,SINUS TACHYCARDIA,1
NZ,SKIN BURNING SENSATION,1
NZ,SKIN GRAFT FAILURE,1
NZ,SMALL BOWEL ANGIOEDEMA,1
NZ,STOMATITIS,1
NZ,STRIDOR,1
NZ,SYNCOPE,1
NZ,THIRST,1
NZ,THROAT TIGHTNESS,1
NZ,THYROID DISORDER,1
NZ,TOTAL LUNG CAPACITY DECREASED,1
NZ,TUMOUR LYSIS SYNDROME,1
NZ,VENTRICULAR FIBRILLATION,1
NZ,VENTRICULAR TACHYCARDIA,1
NZ,VIITH NERVE PARALYSIS,1
NZ,WOUND,1
NZ,WOUND INFECTION BACTERIAL,1
NZ,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
NG,LOWER GASTROINTESTINAL HAEMORRHAGE,1
NG,PETECHIAE,1
NO,BLOOD CREATININE INCREASED,6
NO,TRANSAMINASES INCREASED,5
NO,ENDOCARDITIS,4
NO,ESCHERICHIA SEPSIS,4
NO,ESCHERICHIA URINARY TRACT INFECTION,4
NO,EXPOSURE DURING PREGNANCY,4
NO,FATIGUE,4
NO,HYPEREMESIS GRAVIDARUM,4
NO,OESOPHAGITIS,4
NO,PANCYTOPENIA,4
NO,ANAEMIA,3
NO,CONFUSIONAL STATE,3
NO,DIABETIC KETOACIDOSIS,3
NO,SOMNOLENCE,3
NO,THROMBOCYTOPENIA,3
NO,TREMOR,3
NO,ABDOMINAL PAIN UPPER,2
NO,ABNORMAL BEHAVIOUR,2
NO,AGRANULOCYTOSIS,2
NO,BLOOD PRESSURE INCREASED,2
NO,DEPRESSED LEVEL OF CONSCIOUSNESS,2
NO,DROOLING,2
NO,DRUG INEFFECTIVE,2
NO,DYSKINESIA,2
NO,DYSPNOEA,2
NO,DYSSTASIA,2
NO,FACE OEDEMA,2
NO,FALL,2
NO,HEART RATE INCREASED,2
NO,HEART RATE IRREGULAR,2
NO,HEPATIC FAILURE,2
NO,INFECTION,2
NO,INSOMNIA,2
NO,MACULE,2
NO,MASTICATION DISORDER,2
NO,OEDEMA PERIPHERAL,2
NO,PULSE ABNORMAL,2
NO,RENAL FAILURE,2
NO,RESTLESSNESS,2
NO,SPEECH DISORDER,2
NO,ACUTE KIDNEY INJURY,1
NO,ACUTE RESPIRATORY FAILURE,1
NO,ALANINE AMINOTRANSFERASE INCREASED,1
NO,AMNESIA,1
NO,AORTIC ANEURYSM,1
NO,ARTERIOSCLEROSIS,1
NO,ASCITES,1
NO,BLOOD PRESSURE DECREASED,1
NO,CARDIAC FAILURE,1
NO,CHEST PAIN,1
NO,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
NO,CONDITION AGGRAVATED,1
NO,DEATH,1
NO,DEHYDRATION,1
NO,DIARRHOEA,1
NO,EMBOLISM ARTERIAL,1
NO,FEBRILE NEUTROPENIA,1
NO,GAIT DISTURBANCE,1
NO,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
NO,GENERAL PHYSICAL HEALTH DETERIORATION,1
NO,HAEMATURIA,1
NO,HAEMOGLOBIN DECREASED,1
NO,HEPATOCELLULAR INJURY,1
NO,HYPOKINESIA,1
NO,IMPAIRED WORK ABILITY,1
NO,INCREASED INSULIN REQUIREMENT,1
NO,INFLAMMATORY PSEUDOTUMOUR,1
NO,ISCHAEMIC CARDIOMYOPATHY,1
NO,ISCHAEMIC STROKE,1
NO,LACTIC ACIDOSIS,1
NO,LISTLESS,1
NO,LOSS OF CONSCIOUSNESS,1
NO,MALIGNANT NEOPLASM PROGRESSION,1
NO,MALNUTRITION,1
NO,MEDICATION ERROR,1
NO,METABOLIC ACIDOSIS,1
NO,METASTASES TO LIVER,1
NO,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
NO,MUSCLE ATROPHY,1
NO,MYOCLONUS,1
NO,MYOGLOBIN BLOOD INCREASED,1
NO,MYOPATHY,1
NO,NEUROPATHY PERIPHERAL,1
NO,NEUTROPENIA,1
NO,ORAL INFECTION,1
NO,OSTEITIS,1
NO,OSTEONECROSIS OF JAW,1
NO,PANCREATIC CARCINOMA,1
NO,PERIPHERAL ARTERY THROMBOSIS,1
NO,PERIPHERAL ISCHAEMIA,1
NO,PLATELET COUNT INCREASED,1
NO,PNEUMONIA,1
NO,PNEUMONITIS,1
NO,PRESCRIBED OVERDOSE,1
NO,PRODUCT USE ISSUE,1
NO,RENAL FAILURE ACUTE,1
NO,RHABDOMYOLYSIS,1
NO,SKIN ABRASION,1
NO,THROMBOPHLEBITIS,1
NO,TREATMENT FAILURE,1
OM,GENERALISED OEDEMA,4
OM,ATRIAL TACHYCARDIA,3
OM,HYPOMAGNESAEMIA,3
OM,SUPRAVENTRICULAR TACHYCARDIA,3
OM,TOXICITY TO VARIOUS AGENTS,3
OM,RENAL IMPAIRMENT,2
OM,ABDOMINAL DISCOMFORT,1
OM,ARRHYTHMIA,1
OM,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
OM,NAUSEA,1
OM,PALPITATIONS,1
OM,POLYURIA,1
OM,VOMITING,1
OM,WEIGHT INCREASED,1
PK,APHASIA,1
PK,BALANCE DISORDER,1
PK,CEREBROVASCULAR ACCIDENT,1
PK,CONSTIPATION,1
PK,DISORIENTATION,1
PK,DIZZINESS,1
PK,DYSARTHRIA,1
PK,FALL,1
PK,GAIT DISTURBANCE,1
PK,HEADACHE,1
PK,HEPATIC FAILURE,1
PK,MOTOR DYSFUNCTION,1
PK,RESPIRATORY FAILURE,1
PK,SENSORY LOSS,1
PK,SWELLING FACE,1
PS,ABDOMINAL PAIN UPPER,1
PS,BLOOD PARATHYROID HORMONE INCREASED,1
PS,DRUG INEFFECTIVE,1
PS,ELECTROLYTE IMBALANCE,1
PS,FEEDING DISORDER,1
PS,HYPOTONIA,1
PS,NAUSEA,1
PS,PNEUMONIA,1
PS,RESPIRATORY FAILURE,1
PS,TREMOR,1
PS,VOMITING,1
PA,CHEST PAIN,2
PA,PAIN IN EXTREMITY,2
PA,SICKLE CELL ANAEMIA WITH CRISIS,2
PA,ABASIA,1
PA,ABDOMINAL PAIN UPPER,1
PA,ARTHRALGIA,1
PA,BLOOD IRON INCREASED,1
PA,BRONCHITIS,1
PA,CARDIOGENIC SHOCK,1
PA,CARDIOMEGALY,1
PA,CATARACT,1
PA,CEREBROVASCULAR ACCIDENT,1
PA,DISCOMFORT,1
PA,DYSPNOEA,1
PA,DYSURIA,1
PA,EYE PAIN,1
PA,FATIGUE,1
PA,FLUID RETENTION,1
PA,HAEMOGLOBIN DECREASED,1
PA,HEMIPARESIS,1
PA,HEPATIC SIDEROSIS,1
PA,HYPERGLYCAEMIA,1
PA,MALAISE,1
PA,MENINGITIS CRYPTOCOCCAL,1
PA,MYOCARDIAL INFARCTION,1
PA,OCULAR HYPERAEMIA,1
PA,PANCREATITIS,1
PA,PTERYGIUM,1
PA,PYREXIA,1
PA,RENAL CANCER,1
PA,RENAL FAILURE,1
PA,RENAL IMPAIRMENT,1
PA,RETINAL INJURY,1
PA,SKIN ULCER,1
PA,SPLEEN DISORDER,1
PA,SPLENOMEGALY,1
PA,SWELLING,1
PA,SYNCOPE,1
PA,VARICOPHLEBITIS,1
PA,VARICOSE VEIN,1
PY,ANURIA,1
PY,ASCITES,1
PY,ATRIOVENTRICULAR BLOCK COMPLETE,1
PY,CARDIAC FAILURE,1
PY,DRUG INEFFECTIVE,1
PY,ELECTROCARDIOGRAM QT PROLONGED,1
PY,ELECTROLYTE IMBALANCE,1
PY,PERFORATION,1
PY,PRODUCT USE ISSUE,1
PY,SEPSIS,1
PY,TORSADE DE POINTES,1
PE,DEATH,4
PE,BRONCHOPULMONARY ASPERGILLOSIS,3
PE,CARDIAC FAILURE CONGESTIVE,3
PE,FEBRILE NEUTROPENIA,3
PE,MULTI-ORGAN FAILURE,3
PE,CARDIOMEGALY,2
PE,DYSPHAGIA,2
PE,DYSPNOEA,2
PE,HAEMOPTYSIS,2
PE,OEDEMA PERIPHERAL,2
PE,ORAL CANDIDIASIS,2
PE,PULMONARY CONGESTION,2
PE,ABDOMINAL DISCOMFORT,1
PE,ANAEMIA,1
PE,ASTHMA,1
PE,ATRIAL FIBRILLATION,1
PE,CHEST DISCOMFORT,1
PE,COELIAC DISEASE,1
PE,COUGH,1
PE,DIZZINESS,1
PE,ENCEPHALITIS,1
PE,EROSIVE DUODENITIS,1
PE,EROSIVE OESOPHAGITIS,1
PE,GASTRITIS,1
PE,GENERAL PHYSICAL HEALTH DETERIORATION,1
PE,HAEMATOCRIT DECREASED,1
PE,HAEMORRHAGE,1
PE,HYPERKALAEMIA,1
PE,IMMUNODEFICIENCY,1
PE,INFECTED SKIN ULCER,1
PE,JOINT DISLOCATION,1
PE,LOWER GASTROINTESTINAL HAEMORRHAGE,1
PE,MALAISE,1
PE,MYOSITIS,1
PE,NAUSEA,1
PE,NEPHROTIC SYNDROME,1
PE,NEUTROPENIA,1
PE,OESOPHAGITIS HAEMORRHAGIC,1
PE,OROPHARYNGEAL PAIN,1
PE,PALPITATIONS,1
PE,PLEURAL EFFUSION,1
PE,PYREXIA,1
PE,RESPIRATORY TRACT INFECTION,1
PE,SEPSIS,1
PE,SEPTIC SHOCK,1
PE,SINUS TACHYCARDIA,1
PE,STAPHYLOCOCCAL INFECTION,1
PE,TREMOR,1
PE,UPPER GASTROINTESTINAL HAEMORRHAGE,1
PE,VOMITING,1
PE,WHITE BLOOD CELL COUNT DECREASED,1
PH,DEATH,3
PH,DYSPNOEA,3
PH,WRONG TECHNIQUE IN DRUG USAGE PROCESS,3
PH,ASCITES,2
PH,CARDIAC ARREST,2
PH,CARDIAC FAILURE,2
PH,CARDIO-RESPIRATORY ARREST,2
PH,CHILLS,2
PH,HYPOTENSION,2
PH,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
PH,MYOCARDIAL ISCHAEMIA,2
PH,PNEUMONIA,2
PH,PULMONARY OEDEMA,2
PH,PYREXIA,2
PH,RENAL DISORDER,2
PH,UPPER GASTROINTESTINAL HAEMORRHAGE,2
PH,ABDOMINAL DISTENSION,1
PH,ABDOMINAL MASS,1
PH,ACUTE CORONARY SYNDROME,1
PH,ACUTE HEPATIC FAILURE,1
PH,ANAEMIA,1
PH,ANAPHYLACTOID REACTION,1
PH,ANGINA UNSTABLE,1
PH,AORTIC ARTERIOSCLEROSIS,1
PH,ARRHYTHMIA,1
PH,BLOOD PRESSURE FLUCTUATION,1
PH,BRONCHIAL NEOPLASM,1
PH,CARDIAC FAILURE CHRONIC,1
PH,CARDIAC FAILURE CONGESTIVE,1
PH,CARDIOGENIC SHOCK,1
PH,CEREBRAL INFARCTION,1
PH,CHEST PAIN,1
PH,CONCOMITANT DISEASE PROGRESSION,1
PH,CORONARY ARTERY DISEASE,1
PH,COUGH,1
PH,DECREASED APPETITE,1
PH,DIAPHRAGMATIC DISORDER,1
PH,DISEASE PROGRESSION,1
PH,DIZZINESS,1
PH,DRUG PRESCRIBING ERROR,1
PH,ERYTHEMA,1
PH,FAECES DISCOLOURED,1
PH,FATIGUE,1
PH,FOETAL EXPOSURE DURING PREGNANCY,1
PH,GASTROENTERITIS,1
PH,GASTROINTESTINAL DISORDER,1
PH,GASTROINTESTINAL STROMAL TUMOUR,1
PH,GAZE PALSY,1
PH,HEADACHE,1
PH,HEPATIC CIRRHOSIS,1
PH,HEPATIC ENCEPHALOPATHY,1
PH,HEPATIC MASS,1
PH,HEPATOMEGALY,1
PH,HYPERKALAEMIA,1
PH,HYPERTENSION,1
PH,HYPOGLYCAEMIA,1
PH,HYPOVOLAEMIC SHOCK,1
PH,ISCHAEMIC CARDIOMYOPATHY,1
PH,LOSS OF CONSCIOUSNESS,1
PH,MASTOIDITIS,1
PH,MELAENA,1
PH,METASTATIC NEOPLASM,1
PH,MYOCARDIAL INFARCTION,1
PH,NEPHROPATHY,1
PH,NON-ALCOHOLIC STEATOHEPATITIS,1
PH,OEDEMA,1
PH,OEDEMA PERIPHERAL,1
PH,OESOPHAGEAL VARICES HAEMORRHAGE,1
PH,OVERDOSE,1
PH,PARTIAL SEIZURES,1
PH,PERICARDIAL EFFUSION MALIGNANT,1
PH,PERIORBITAL OEDEMA,1
PH,POLYURIA,1
PH,PREMATURE BABY,1
PH,PROTEIN TOTAL DECREASED,1
PH,RECURRENT CANCER,1
PH,RENAL FAILURE,1
PH,RENAL FAILURE CHRONIC,1
PH,RETROPERITONEAL LYMPHADENOPATHY,1
PH,SKIN DISCOLOURATION,1
PH,SUDDEN DEATH,1
PH,SWELLING,1
PH,TACHYCARDIA,1
PH,TACHYPNOEA,1
PH,TRANSIENT ISCHAEMIC ATTACK,1
PH,UNEVALUABLE EVENT,1
PH,VENTRICULAR EXTRASYSTOLES,1
PH,VOMITING,1
PH,WEIGHT DECREASED,1
PH,WHEEZING,1
PH,WOUND,1
PL,DYSPNOEA,31
PL,DRUG INEFFECTIVE,28
PL,PNEUMONIA,26
PL,ANAEMIA,23
PL,OEDEMA PERIPHERAL,22
PL,DIARRHOEA,19
PL,FATIGUE,18
PL,CARDIAC ARREST,17
PL,ATRIAL FIBRILLATION,16
PL,EXERCISE TOLERANCE DECREASED,16
PL,ASTHENIA,15
PL,BRADYCARDIA,15
PL,COUGH,14
PL,PULMONARY OEDEMA,14
PL,CARDIAC FAILURE,13
PL,GENERAL PHYSICAL HEALTH DETERIORATION,13
PL,PALPITATIONS,13
PL,DIZZINESS,12
PL,OLIGURIA,12
PL,PYREXIA,12
PL,PULMONARY TOXICITY,11
PL,VENTRICULAR ARRHYTHMIA,11
PL,CHRONIC KIDNEY DISEASE,9
PL,HEPATIC FAILURE,9
PL,LEFT VENTRICULAR HYPERTROPHY,9
PL,ACUTE RESPIRATORY FAILURE,8
PL,GASTROINTESTINAL HAEMORRHAGE,8
PL,PLASMA CELL MYELOMA,8
PL,RENAL FAILURE,8
PL,TOXICITY TO VARIOUS AGENTS,8
PL,BLOOD PRESSURE INCREASED,7
PL,CARDIAC FAILURE CHRONIC,7
PL,CHEST PAIN,7
PL,CIRCULATORY COLLAPSE,7
PL,DEATH,7
PL,ERYTHEMA,7
PL,HYPONATRAEMIA,7
PL,NAUSEA,7
PL,RESPIRATORY FAILURE,7
PL,SEPTIC SHOCK,7
PL,BLOOD PRESSURE DECREASED,6
PL,BRONCHITIS,6
PL,CARDIOPULMONARY FAILURE,6
PL,FOETAL EXPOSURE DURING PREGNANCY,6
PL,LOW BIRTH WEIGHT BABY,6
PL,MYOCARDIAL INFARCTION,6
PL,PLEURAL EFFUSION,6
PL,TOXIC EPIDERMAL NECROLYSIS,6
PL,ANURIA,5
PL,BLOOD CREATININE INCREASED,5
PL,CACHEXIA,5
PL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,5
PL,CORONARY ARTERY DISEASE,5
PL,DECREASED APPETITE,5
PL,DISEASE PROGRESSION,5
PL,DRUG LEVEL INCREASED,5
PL,ISCHAEMIC STROKE,5
PL,MALIGNANT NEOPLASM PROGRESSION,5
PL,PREMATURE BABY,5
PL,RASH,5
PL,SOMNOLENCE,5
PL,TACHYCARDIA,5
PL,UPPER RESPIRATORY TRACT INFECTION,5
PL,VOMITING,5
PL,CONDITION AGGRAVATED,4
PL,DEHYDRATION,4
PL,HEPATIC ENCEPHALOPATHY,4
PL,HYPERHIDROSIS,4
PL,INTERNATIONAL NORMALISED RATIO INCREASED,4
PL,LUNG CANCER METASTATIC,4
PL,MOUTH HAEMORRHAGE,4
PL,MULTIPLE ORGAN DYSFUNCTION SYNDROME,4
PL,NEUTROPENIA,4
PL,OEDEMA,4
PL,PANCYTOPENIA,4
PL,PNEUMONITIS,4
PL,RENAL FAILURE ACUTE,4
PL,STAPHYLOCOCCAL SEPSIS,4
PL,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,3
PL,ACUTE MYELOID LEUKAEMIA,3
PL,ACUTE MYOCARDIAL INFARCTION,3
PL,ALOPECIA,3
PL,ARTHRALGIA,3
PL,ASCITES,3
PL,BRONCHOPNEUMONIA,3
PL,COMPLICATIONS OF TRANSPLANTED KIDNEY,3
PL,DECUBITUS ULCER,3
PL,DEEP VEIN THROMBOSIS,3
PL,ELECTROCARDIOGRAM QT PROLONGED,3
PL,EXPOSURE DURING PREGNANCY,3
PL,GLOMERULAR FILTRATION RATE DECREASED,3
PL,HEART RATE INCREASED,3
PL,HEPATOCELLULAR CARCINOMA,3
PL,HEPATOMEGALY,3
PL,HERPES ZOSTER,3
PL,HYPERTHYROIDISM,3
PL,HYPOKINESIA,3
PL,HYPOTENSION,3
PL,INTRA-ABDOMINAL HAEMORRHAGE,3
PL,LOSS OF CONSCIOUSNESS,3
PL,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED,3
PL,PREMATURE DELIVERY,3
PL,PRODUCTIVE COUGH,3
PL,PULMONARY ARTERIAL HYPERTENSION,3
PL,STAPHYLOCOCCAL INFECTION,3
PL,SUPRAVENTRICULAR TACHYCARDIA,3
PL,SYNCOPE,3
PL,TORSADE DE POINTES,3
PL,URINARY TRACT INFECTION,3
PL,VENTRICULAR FIBRILLATION,3
PL,VENTRICULAR TACHYCARDIA,3
PL,WEIGHT INCREASED,3
PL,ABDOMINAL PAIN,2
PL,ABDOMINAL PAIN UPPER,2
PL,ACUTE HEPATIC FAILURE,2
PL,ACUTE KIDNEY INJURY,2
PL,AGRANULOCYTOSIS,2
PL,ALTERED STATE OF CONSCIOUSNESS,2
PL,AMMONIA INCREASED,2
PL,ANGINA PECTORIS,2
PL,ARRHYTHMIA,2
PL,BALANCE DISORDER,2
PL,BLISTER,2
PL,BLOOD THYROID STIMULATING HORMONE DECREASED,2
PL,BRAIN DEATH,2
PL,CEREBROVASCULAR ACCIDENT,2
PL,CONJUNCTIVITIS,2
PL,DISSEMINATED INTRAVASCULAR COAGULATION,2
PL,DRUG EFFECT INCOMPLETE,2
PL,DRUG-INDUCED LIVER INJURY,2
PL,DYSARTHRIA,2
PL,DYSKINESIA,2
PL,DYSPHAGIA,2
PL,DYSPNOEA EXERTIONAL,2
PL,FOETAL DEATH,2
PL,FOETAL GROWTH RESTRICTION,2
PL,GASTRIC ULCER,2
PL,GASTRITIS,2
PL,GENERALISED TONIC-CLONIC SEIZURE,2
PL,HAEMOGLOBIN DECREASED,2
PL,HAEMORRHAGE,2
PL,HEPATIC CIRRHOSIS,2
PL,HEPATIC ENZYME INCREASED,2
PL,HEPATITIS C,2
PL,HYPERBILIRUBINAEMIA,2
PL,HYPERCALCAEMIA,2
PL,HYPERSENSITIVITY,2
PL,HYPOALBUMINAEMIA,2
PL,HYPOKALAEMIA,2
PL,HYPOMAGNESAEMIA,2
PL,IMPAIRED HEALING,2
PL,LEUKOCYTOSIS,2
PL,LUNG NEOPLASM MALIGNANT,2
PL,MALAISE,2
PL,MATERNAL EXPOSURE DURING PREGNANCY,2
PL,MESENTERIC VEIN THROMBOSIS,2
PL,MOVEMENT DISORDER,2
PL,MULTI-ORGAN FAILURE,2
PL,MYDRIASIS,2
PL,NEUTROPHIL COUNT INCREASED,2
PL,OVERDOSE,2
PL,OXYGEN SATURATION DECREASED,2
PL,PAIN IN EXTREMITY,2
PL,PELVIC ABSCESS,2
PL,PERICARDIAL EFFUSION,2
PL,PETECHIAE,2
PL,PORTAL VEIN THROMBOSIS,2
PL,PRODUCT USE ISSUE,2
PL,PRURITUS,2
PL,QUADRIPLEGIA,2
PL,REBOUND TACHYCARDIA,2
PL,RECTAL ADENOCARCINOMA,2
PL,RENAL IMPAIRMENT,2
PL,RESPIRATORY ARREST,2
PL,RETCHING,2
PL,RHABDOMYOLYSIS,2
PL,SCAB,2
PL,SEIZURE,2
PL,SKIN HAEMORRHAGE,2
PL,SKIN LESION,2
PL,SLEEP DISORDER,2
PL,SPLENIC VEIN THROMBOSIS,2
PL,STOMATITIS,2
PL,SUDDEN DEATH,2
PL,THERAPEUTIC RESPONSE DECREASED,2
PL,THROMBOCYTOPENIA,2
PL,UROSEPSIS,2
PL,VISUAL ACUITY REDUCED,2
PL,WEIGHT DECREASED,2
PL,ACROMEGALY,1
PL,ACTIVATED PARTIAL THROMBOPLASTIN TIME,1
PL,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
PL,ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED,1
PL,ACUTE CORONARY SYNDROME,1
PL,ACUTE PRERENAL FAILURE,1
PL,ADAMS-STOKES SYNDROME,1
PL,ADENOCARCINOMA OF COLON,1
PL,ADRENAL ADENOMA,1
PL,ALANINE AMINOTRANSFERASE INCREASED,1
PL,AMYLASE INCREASED,1
PL,ANAEMIA MACROCYTIC,1
PL,ANAEMIA VITAMIN B12 DEFICIENCY,1
PL,ANGIOPATHY,1
PL,ANHEDONIA,1
PL,ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE,1
PL,ANXIETY,1
PL,AORTIC ANASTOMOSIS,1
PL,AORTIC VALVE CALCIFICATION,1
PL,APLASIA,1
PL,APLASIA PURE RED CELL,1
PL,AREFLEXIA,1
PL,ARTHROPATHY,1
PL,ARTHROPOD BITE,1
PL,ASPARTATE AMINOTRANSFERASE INCREASED,1
PL,ASPERGILLUS INFECTION,1
PL,ASTHMA,1
PL,ATELECTASIS,1
PL,ATRIAL FLUTTER,1
PL,ATYPICAL PNEUMONIA,1
PL,BACK PAIN,1
PL,BASAL CELL CARCINOMA,1
PL,BASEDOW^S DISEASE,1
PL,BLOOD ALBUMIN DECREASED,1
PL,BLOOD BILIRUBIN INCREASED,1
PL,BLOOD BLISTER,1
PL,BLOOD CALCIUM ABNORMAL,1
PL,BLOOD CALCIUM DECREASED,1
PL,BLOOD CORTICOTROPHIN DECREASED,1
PL,BLOOD CORTISOL DECREASED,1
PL,BLOOD DISORDER,1
PL,BLOOD FOLLICLE STIMULATING HORMONE DECREASED,1
PL,BLOOD GLUCOSE FLUCTUATION,1
PL,BLOOD GROWTH HORMONE ABNORMAL,1
PL,BLOOD GROWTH HORMONE INCREASED,1
PL,BLOOD PRESSURE ABNORMAL,1
PL,BLOOD PROLACTIN DECREASED,1
PL,BLOOD SODIUM DECREASED,1
PL,BLOOD UREA INCREASED,1
PL,BLOOD URINE PRESENT,1
PL,BONE MARROW FAILURE,1
PL,BRADYPHRENIA,1
PL,BRAIN CONTUSION,1
PL,BRAIN OEDEMA,1
PL,C-REACTIVE PROTEIN INCREASED,1
PL,CANDIDA INFECTION,1
PL,CANDIDIASIS,1
PL,CARDIAC FAILURE ACUTE,1
PL,CARDIOVASCULAR INSUFFICIENCY,1
PL,CAROTID SINUS SYNDROME,1
PL,CELLULITIS,1
PL,CHEST DISCOMFORT,1
PL,CHILD-PUGH-TURCOTTE SCORE INCREASED,1
PL,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
PL,CHRONIC MYELOID LEUKAEMIA,1
PL,CLOSTRIDIUM DIFFICILE COLITIS,1
PL,COAGULATION TEST ABNORMAL,1
PL,COAGULOPATHY,1
PL,COLITIS ULCERATIVE,1
PL,COLON CANCER METASTATIC,1
PL,COMA,1
PL,COMMUNICATION DISORDER,1
PL,CONJUNCTIVAL EROSION,1
PL,CONJUNCTIVAL HYPERAEMIA,1
PL,CONSTIPATION,1
PL,CONTRAINDICATED DRUG ADMINISTERED,1
PL,CONTUSION,1
PL,CORONARY ARTERY STENOSIS,1
PL,CUSHING^S SYNDROME,1
PL,CYANOSIS,1
PL,CYTOMEGALOVIRUS INFECTION,1
PL,DEAFNESS UNILATERAL,1
PL,DECREASED IMMUNE RESPONSIVENESS,1
PL,DERMATITIS,1
PL,DERMATITIS ALLERGIC,1
PL,DIABETIC FOOT,1
PL,DISEASE SUSCEPTIBILITY,1
PL,DISTURBANCE IN ATTENTION,1
PL,DIVERTICULUM INTESTINAL,1
PL,DRUG INTOLERANCE,1
PL,DRUG LEVEL DECREASED,1
PL,DRUG PRESCRIBING ERROR,1
PL,DRUG RESISTANCE,1
PL,DRY SKIN,1
PL,DYSMENORRHOEA,1
PL,DYSPEPSIA,1
PL,DYSPHONIA,1
PL,DYSPNOEA AT REST,1
PL,DYSTONIA,1
PL,DYSURIA,1
PL,EJECTION FRACTION DECREASED,1
PL,ELECTROLYTE IMBALANCE,1
PL,ENCEPHALITIS,1
PL,ENTERITIS,1
PL,ENTEROCOLITIS HAEMORRHAGIC,1
PL,EPIDIDYMITIS,1
PL,EPIGASTRIC DISCOMFORT,1
PL,EPISTAXIS,1
PL,ESCHERICHIA SEPSIS,1
PL,ESCHERICHIA TEST POSITIVE,1
PL,ESCHERICHIA URINARY TRACT INFECTION,1
PL,EXTRAPYRAMIDAL DISORDER,1
PL,EXTRAVASATION,1
PL,FALL,1
PL,FEAR,1
PL,FEBRILE INFECTION,1
PL,FEBRILE NEUTROPENIA,1
PL,FEMORAL ARTERY OCCLUSION,1
PL,FEMORAL NECK FRACTURE,1
PL,FULL BLOOD COUNT DECREASED,1
PL,FUNGAL PERITONITIS,1
PL,GAIT DISTURBANCE,1
PL,GASTRIC DISORDER,1
PL,GASTRIC MUCOSA ERYTHEMA,1
PL,GASTRIC MUCOSAL HYPERTROPHY,1
PL,GASTRIC ULCER HAEMORRHAGE,1
PL,GASTRITIS EROSIVE,1
PL,GASTRITIS HAEMORRHAGIC,1
PL,GASTROENTERITIS,1
PL,GASTROINTESTINAL FUNGAL INFECTION,1
PL,GASTROINTESTINAL INFECTION,1
PL,GASTROINTESTINAL MUCOSAL DISORDER,1
PL,GASTROINTESTINAL OEDEMA,1
PL,GASTROOESOPHAGEAL REFLUX DISEASE,1
PL,GESTATIONAL DIABETES,1
PL,GLIOMA,1
PL,GLOMERULAR FILTRATION RATE ABNORMAL,1
PL,GLOTTIS CARCINOMA,1
PL,HAEMATOMA,1
PL,HAEMORRHOIDS,1
PL,HEAD BANGING,1
PL,HEAD INJURY,1
PL,HELICOBACTER INFECTION,1
PL,HEPATIC FUNCTION ABNORMAL,1
PL,HEPATIC STEATOSIS,1
PL,HERPES VIRUS INFECTION,1
PL,HOT FLUSH,1
PL,HUNGRY BONE SYNDROME,1
PL,HYPERAEMIA,1
PL,HYPERCALCAEMIA OF MALIGNANCY,1
PL,HYPERCHOLESTEROLAEMIA,1
PL,HYPERGLYCAEMIA,1
PL,HYPERPARATHYROIDISM PRIMARY,1
PL,HYPERTENSION,1
PL,HYPERTENSIVE CRISIS,1
PL,HYPERTRANSAMINASAEMIA,1
PL,HYPOAESTHESIA,1
PL,HYPOCALCAEMIA,1
PL,HYPOGLYCAEMIA,1
PL,HYPOGLYCAEMIA NEONATAL,1
PL,HYPOGONADISM,1
PL,HYPOPERFUSION,1
PL,HYPOPITUITARISM,1
PL,HYPOTHERMIA,1
PL,HYPOTHYROIDISM,1
PL,HYPOTONIA,1
PL,HYPOVOLAEMIC SHOCK,1
PL,IDIOPATHIC PULMONARY FIBROSIS,1
PL,ILL-DEFINED DISORDER,1
PL,ILLOGICAL THINKING,1
PL,IMMUNE SYSTEM DISORDER,1
PL,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
PL,INCOHERENT,1
PL,INCORRECT DOSE ADMINISTERED,1
PL,INCORRECT DRUG ADMINISTRATION DURATION,1
PL,INFECTED SKIN ULCER,1
PL,INSOMNIA,1
PL,INSULIN-LIKE GROWTH FACTOR INCREASED,1
PL,INTERSTITIAL LUNG DISEASE,1
PL,INTRACRANIAL PRESSURE INCREASED,1
PL,INTRAVENTRICULAR HAEMORRHAGE,1
PL,IRRITABILITY,1
PL,IRRITABLE BOWEL SYNDROME,1
PL,JAUNDICE,1
PL,JOINT DISLOCATION,1
PL,JOINT EFFUSION,1
PL,JOINT SWELLING,1
PL,KIDNEY TRANSPLANT REJECTION,1
PL,KLEBSIELLA INFECTION,1
PL,KLEBSIELLA SEPSIS,1
PL,KLEBSIELLA TEST POSITIVE,1
PL,KUSSMAUL RESPIRATION,1
PL,LACTIC ACIDOSIS,1
PL,LEFT VENTRICULAR DYSFUNCTION,1
PL,LEFT VENTRICULAR FAILURE,1
PL,LETHARGY,1
PL,LEUKOPENIA,1
PL,LIPASE INCREASED,1
PL,LIVER INJURY,1
PL,LIVIDITY,1
PL,LOW CARDIAC OUTPUT SYNDROME,1
PL,LOWER GASTROINTESTINAL HAEMORRHAGE,1
PL,LUNG DISORDER,1
PL,LUNG INFECTION,1
PL,LYMPHATIC DISORDER,1
PL,LYMPHORRHOEA,1
PL,MACULAR OEDEMA,1
PL,MALNUTRITION,1
PL,MEMORY IMPAIRMENT,1
PL,METABOLIC ALKALOSIS,1
PL,METASTASES TO SKIN,1
PL,MITRAL VALVE CALCIFICATION,1
PL,MITRAL VALVE DISEASE,1
PL,MITRAL VALVE INCOMPETENCE,1
PL,MITRAL VALVE STENOSIS,1
PL,MOOD ALTERED,1
PL,MOOD SWINGS,1
PL,MUCOSAL EROSION,1
PL,MUCOSAL HAEMORRHAGE,1
PL,MUCOSAL ULCERATION,1
PL,MULTIPLE SCLEROSIS RELAPSE,1
PL,MYALGIA,1
PL,MYOCARDIAL ISCHAEMIA,1
PL,MYOPATHY,1
PL,NASAL CONGESTION,1
PL,NECROBIOSIS LIPOIDICA DIABETICORUM,1
PL,NEOPLASM,1
PL,NEOPLASM PROGRESSION,1
PL,NEPHROPATHY TOXIC,1
PL,NERVOUS SYSTEM DISORDER,1
PL,NEUROLOGICAL DECOMPENSATION,1
PL,NEUROLOGICAL SYMPTOM,1
PL,NEUTROPHILIA,1
PL,NIKOLSKY^S SIGN,1
PL,NO THERAPEUTIC RESPONSE,1
PL,NON-CARDIOGENIC PULMONARY OEDEMA,1
PL,OCULAR HYPERAEMIA,1
PL,OESTRADIOL DECREASED,1
PL,ORAL DISORDER,1
PL,ORAL FUNGAL INFECTION,1
PL,OROPHARYNGEAL PAIN,1
PL,ORTHOSTATIC HYPOTENSION,1
PL,OSTEOARTHRITIS,1
PL,OSTEONECROSIS OF JAW,1
PL,OSTEOPOROSIS,1
PL,OVARIAN NEOPLASM,1
PL,PAIN,1
PL,PALLOR,1
PL,PANCREATIC NECROSIS,1
PL,PANCREATITIS,1
PL,PANCREATITIS ACUTE,1
PL,PARAPARESIS,1
PL,PERICARDIAL HAEMORRHAGE,1
PL,PERICARDITIS,1
PL,PERIPHERAL ARTERY OCCLUSION,1
PL,PERIPHERAL ARTERY STENOSIS,1
PL,PERIPHERAL COLDNESS,1
PL,PERIPHERAL ISCHAEMIA,1
PL,PERIPHERAL SWELLING,1
PL,PERITONEAL DIALYSIS COMPLICATION,1
PL,PERITONEAL DISORDER,1
PL,PERITONEAL HAEMORRHAGE,1
PL,PERITONITIS BACTERIAL,1
PL,PLACENTAL DISORDER,1
PL,PLATELET COUNT DECREASED,1
PL,PNEUMONIA FUNGAL,1
PL,PNEUMOTHORAX,1
PL,POLLAKIURIA,1
PL,POLYP,1
PL,POST PROCEDURAL HAEMORRHAGE,1
PL,POST PROCEDURAL INFECTION,1
PL,POSTPERICARDIOTOMY SYNDROME,1
PL,PREMATURE RUPTURE OF MEMBRANES,1
PL,PROTEIN URINE PRESENT,1
PL,PSEUDOMONAS INFECTION,1
PL,PSYCHOMOTOR HYPERACTIVITY,1
PL,PULMONARY EMBOLISM,1
PL,PULMONARY HAEMORRHAGE,1
PL,PULMONARY HYPERTENSION,1
PL,PULMONARY VASCULAR DISORDER,1
PL,PULMONARY VASCULAR RESISTANCE ABNORMALITY,1
PL,PUPILLARY REFLEX IMPAIRED,1
PL,QRS AXIS ABNORMAL,1
PL,RASH ERYTHEMATOUS,1
PL,RECTAL HAEMORRHAGE,1
PL,REFUSAL OF TREATMENT BY PATIENT,1
PL,REGURGITATION,1
PL,RENAL INJURY,1
PL,RESPIRATORY DISORDER,1
PL,RESPIRATORY TRACT INFECTION,1
PL,RESTLESSNESS,1
PL,RETINAL VEIN THROMBOSIS,1
PL,RHEUMATIC DISORDER,1
PL,RIGHT VENTRICULAR DYSFUNCTION,1
PL,SARCOIDOSIS,1
PL,SECOND PRIMARY MALIGNANCY,1
PL,SERUM FERRITIN INCREASED,1
PL,SINUS BRADYCARDIA,1
PL,SINUS DISORDER,1
PL,SINUS NODE DYSFUNCTION,1
PL,SKIN CANCER,1
PL,SMALL CELL LUNG CANCER,1
PL,SMALL CELL LUNG CANCER METASTATIC,1
PL,SMALL INTESTINE CARCINOMA,1
PL,SOCIAL PROBLEM,1
PL,SPEECH DISORDER,1
PL,SPINAL OSTEOARTHRITIS,1
PL,STEVENS-JOHNSON SYNDROME,1
PL,STRAWBERRY TONGUE,1
PL,STREPTOCOCCAL INFECTION,1
PL,SUBACUTE ENDOCARDITIS,1
PL,SUBARACHNOID HAEMORRHAGE,1
PL,SWELLING,1
PL,SYSTEMIC LUPUS ERYTHEMATOSUS,1
PL,TACHYPNOEA,1
PL,TENDON RUPTURE,1
PL,THERAPEUTIC PRODUCT INEFFECTIVE,1
PL,THROMBOCYTOSIS,1
PL,THROMBOSIS,1
PL,THYROTOXIC CRISIS,1
PL,TRANSAMINASES INCREASED,1
PL,TRANSPLANT DYSFUNCTION,1
PL,TRANSPLANT FAILURE,1
PL,TREATMENT NONCOMPLIANCE,1
PL,TREMOR,1
PL,TRICUSPID VALVE INCOMPETENCE,1
PL,TROPONIN I INCREASED,1
PL,TUMOUR COMPRESSION,1
PL,TUMOUR LYSIS SYNDROME,1
PL,UMBILICAL CORD ABNORMALITY,1
PL,UPPER GASTROINTESTINAL HAEMORRHAGE,1
PL,URINARY TRACT INFLAMMATION,1
PL,UROBILINOGEN URINE INCREASED,1
PL,VASCULAR STENT THROMBOSIS,1
PL,VENOOCCLUSIVE LIVER DISEASE,1
PL,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
PL,VITAMIN D DEFICIENCY,1
PL,WHITE BLOOD CELL COUNT INCREASED,1
PT,ACUTE KIDNEY INJURY,29
PT,LACTIC ACIDOSIS,23
PT,FATIGUE,21
PT,DECREASED APPETITE,16
PT,OEDEMA PERIPHERAL,16
PT,THROMBOCYTOPENIA,16
PT,CARDIAC FAILURE,15
PT,ASTHENIA,12
PT,CHRONIC KIDNEY DISEASE,12
PT,CONDITION AGGRAVATED,12
PT,PNEUMONIA,12
PT,SHOCK,12
PT,ARTHRALGIA,11
PT,DEATH,11
PT,HYPOTENSION,10
PT,RENAL IMPAIRMENT,10
PT,ANAEMIA,9
PT,MULTIPLE ORGAN DYSFUNCTION SYNDROME,9
PT,PLEURAL EFFUSION,9
PT,PYREXIA,9
PT,DIARRHOEA,8
PT,NAUSEA,8
PT,NEUTROPENIA,8
PT,TOXICITY TO VARIOUS AGENTS,8
PT,ATRIAL FIBRILLATION,7
PT,DIABETES MELLITUS,7
PT,HAEMATURIA,7
PT,HAEMOGLOBIN DECREASED,7
PT,LUPUS-LIKE SYNDROME,7
PT,PERITONITIS BACTERIAL,7
PT,RESPIRATORY TRACT INFECTION,7
PT,SEPSIS,7
PT,SEPTIC SHOCK,7
PT,ABDOMINAL PAIN,6
PT,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,6
PT,BLOOD CREATININE INCREASED,6
PT,BLOOD UREA INCREASED,6
PT,BRADYCARDIA,6
PT,DIZZINESS,6
PT,FALL,6
PT,GENERALISED OEDEMA,6
PT,MALAISE,6
PT,PRODUCT USE ISSUE,6
PT,VOMITING,6
PT,ASCITES,5
PT,CARDIAC FAILURE ACUTE,5
PT,CARDIO-RESPIRATORY ARREST,5
PT,CONJUNCTIVITIS,5
PT,DRUG INEFFECTIVE,5
PT,DYSPNOEA,5
PT,GINGIVAL BLEEDING,5
PT,HEADACHE,5
PT,HYPOKALAEMIA,5
PT,INCORRECT DRUG ADMINISTRATION RATE,5
PT,ISCHAEMIC STROKE,5
PT,NEUROPATHY PERIPHERAL,5
PT,PANCYTOPENIA,5
PT,PERITONITIS,5
PT,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,5
PT,RENAL FAILURE,5
PT,RESPIRATORY FAILURE,5
PT,SOMNOLENCE,5
PT,TOXIC SKIN ERUPTION,5
PT,WEIGHT DECREASED,5
PT,ALOPECIA,4
PT,ALTERED STATE OF CONSCIOUSNESS,4
PT,BONE PAIN,4
PT,CATHETER SITE INFECTION,4
PT,CHEST PAIN,4
PT,CHORIORETINITIS,4
PT,COGNITIVE DISORDER,4
PT,EJECTION FRACTION DECREASED,4
PT,EPISTAXIS,4
PT,FEBRILE NEUTROPENIA,4
PT,GAIT DISTURBANCE,4
PT,GASTROINTESTINAL HAEMORRHAGE,4
PT,GENERAL PHYSICAL HEALTH DETERIORATION,4
PT,HAEMORRHAGE,4
PT,HYPERHIDROSIS,4
PT,HYPERKALAEMIA,4
PT,HYPOCALCAEMIA,4
PT,HYPONATRAEMIA,4
PT,HYPOVOLAEMIC SHOCK,4
PT,HYPOXIA,4
PT,INTERCEPTED MEDICATION ERROR,4
PT,LINEAR IGA DISEASE,4
PT,MYALGIA,4
PT,NEPHROPATHY,4
PT,ONYCHOLYSIS,4
PT,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,4
PT,PNEUMOCYSTIS JIROVECII PNEUMONIA,4
PT,PROTEINURIA,4
PT,RASH PRURITIC,4
PT,RAYNAUD^S PHENOMENON,4
PT,RENAL INJURY,4
PT,RHINORRHOEA,4
PT,SEIZURE,4
PT,URINARY TRACT INFECTION,4
PT,URINE OUTPUT DECREASED,4
PT,VISUAL ACUITY REDUCED,4
PT,ACUTE MYOCARDIAL INFARCTION,3
PT,ACUTE PULMONARY OEDEMA,3
PT,APATHY,3
PT,BLOOD BILIRUBIN INCREASED,3
PT,BLOOD PRESSURE INCREASED,3
PT,BONE MARROW TOXICITY,3
PT,BRONCHOPULMONARY ASPERGILLOSIS,3
PT,C-REACTIVE PROTEIN INCREASED,3
PT,CONFUSIONAL STATE,3
PT,DEHYDRATION,3
PT,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,3
PT,DRUG RESISTANCE,3
PT,DYSARTHRIA,3
PT,EMBOLIC STROKE,3
PT,HAEMATOCHEZIA,3
PT,HYPERTHYROIDISM,3
PT,HYPOGLYCAEMIA,3
PT,INFECTION,3
PT,INTERNATIONAL NORMALISED RATIO INCREASED,3
PT,LEUKOPENIA,3
PT,LUNG INFECTION,3
PT,MELAENA,3
PT,MULTI-ORGAN FAILURE,3
PT,MUMPS,3
PT,PAIN IN EXTREMITY,3
PT,PERITONEAL DIALYSIS COMPLICATION,3
PT,PLATELET COUNT DECREASED,3
PT,PRODUCTIVE COUGH,3
PT,RHABDOMYOLYSIS,3
PT,RHYTHM IDIOVENTRICULAR,3
PT,STAPHYLOCOCCAL INFECTION,3
PT,THROMBOSIS,3
PT,UNRESPONSIVE TO STIMULI,3
PT,ADVERSE REACTION,2
PT,ALANINE AMINOTRANSFERASE INCREASED,2
PT,ANAPHYLACTIC REACTION,2
PT,ASPARTATE AMINOTRANSFERASE INCREASED,2
PT,BILIRUBIN CONJUGATED INCREASED,2
PT,BLOOD ALKALINE PHOSPHATASE INCREASED,2
PT,BLOOD LACTATE DEHYDROGENASE INCREASED,2
PT,BONE MARROW FAILURE,2
PT,BRAIN DEATH,2
PT,BREAST PAIN,2
PT,CANDIDURIA,2
PT,CARDIAC ARREST,2
PT,CEREBROVASCULAR ACCIDENT,2
PT,CHONDROSARCOMA,2
PT,COAGULOPATHY,2
PT,COLITIS MICROSCOPIC,2
PT,CONCOMITANT DISEASE AGGRAVATED,2
PT,COUGH,2
PT,CRYSTALLURIA,2
PT,DEPRESSION,2
PT,DIABETES MELLITUS INADEQUATE CONTROL,2
PT,DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV,2
PT,DISEASE PROGRESSION,2
PT,DYSPEPSIA,2
PT,ELECTROLYTE IMBALANCE,2
PT,ERYSIPELAS,2
PT,FRACTURE,2
PT,FUNGAL PERITONITIS,2
PT,HAEMATOMA,2
PT,HAEMOPTYSIS,2
PT,HEMIPARESIS,2
PT,HIATUS HERNIA,2
PT,HYPERSENSITIVITY,2
PT,HYPERTENSION,2
PT,HYPERVOLAEMIA,2
PT,INFLUENZA LIKE ILLNESS,2
PT,INTENTIONAL PRODUCT MISUSE,2
PT,INTESTINAL ISCHAEMIA,2
PT,LEUKOCYTOSIS,2
PT,LOSS OF CONSCIOUSNESS,2
PT,MECHANICAL VENTILATION,2
PT,MENTAL STATUS CHANGES,2
PT,NEUROMYOPATHY,2
PT,OESOPHAGEAL HAEMORRHAGE,2
PT,ORAL CANDIDIASIS,2
PT,OVERDOSE,2
PT,OXYGEN SATURATION DECREASED,2
PT,PERIPHERAL ISCHAEMIA,2
PT,PLATELET COUNT INCREASED,2
PT,POLYARTHRITIS,2
PT,POLYNEUROPATHY,2
PT,PRODUCT QUALITY ISSUE,2
PT,PRODUCT USE IN UNAPPROVED INDICATION,2
PT,PRURITUS,2
PT,PULMONARY EMBOLISM,2
PT,PYELONEPHRITIS,2
PT,RASH MACULO-PAPULAR,2
PT,RECTAL HAEMORRHAGE,2
PT,RENAL CELL CARCINOMA,2
PT,RENAL FAILURE ACUTE,2
PT,RENAL TUBULAR NECROSIS,2
PT,RESPIRATORY ARREST,2
PT,RETROPERITONEAL HAEMATOMA,2
PT,SHOCK HAEMORRHAGIC,2
PT,SKIN EXFOLIATION,2
PT,STRESS,2
PT,SUDDEN DEATH,2
PT,SYNCOPE,2
PT,SYSTEMIC LUPUS ERYTHEMATOSUS,2
PT,TACHYCARDIA,2
PT,TRACHEOBRONCHITIS,2
PT,TRANSFUSION,2
PT,TREMOR,2
PT,WHITE BLOOD CELL COUNT INCREASED,2
PT,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
PT,ABDOMINAL DISTENSION,1
PT,ABDOMINAL PAIN LOWER,1
PT,ABDOMINAL WALL HAEMATOMA,1
PT,ACCIDENTAL OVERDOSE,1
PT,ACIDOSIS,1
PT,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
PT,ACUTE ON CHRONIC LIVER FAILURE,1
PT,ACUTE PSYCHOSIS,1
PT,AGE-RELATED MACULAR DEGENERATION,1
PT,ALANINE AMINOTRANSFERASE,1
PT,ALCOHOL INTERACTION,1
PT,ANAL INCONTINENCE,1
PT,ANAPHYLACTIC SHOCK,1
PT,ANGIOEDEMA,1
PT,ANOSOGNOSIA,1
PT,APHASIA,1
PT,APHTHOUS ULCER,1
PT,ARRHYTHMIA,1
PT,ASPARTATE AMINOTRANSFERASE,1
PT,ASPERGILLUS INFECTION,1
PT,ASPIRATION,1
PT,ASYMPTOMATIC BACTERIURIA,1
PT,ATRIOVENTRICULAR BLOCK COMPLETE,1
PT,ATRIOVENTRICULAR DISSOCIATION,1
PT,AZOTAEMIA,1
PT,BACTERIAL SEPSIS,1
PT,BALANCE DISORDER,1
PT,BETA GLOBULIN INCREASED,1
PT,BICYTOPENIA,1
PT,BIOPSY LIVER,1
PT,BLOOD ALBUMIN DECREASED,1
PT,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
PT,BLOOD PRESSURE ABNORMAL,1
PT,BLOOD PRESSURE IMMEASURABLE,1
PT,BLOOD PRESSURE SYSTOLIC INCREASED,1
PT,BONE FORMATION INCREASED,1
PT,BRADYPHRENIA,1
PT,BRADYPNOEA,1
PT,BREAST HAEMATOMA,1
PT,BREAST INFLAMMATION,1
PT,BRONCHOSPASM,1
PT,CACHEXIA,1
PT,CARDIAC DISORDER,1
PT,CARDIAC FUNCTION DISTURBANCE POSTOPERATIVE,1
PT,CARDIOVASCULAR DISORDER,1
PT,CELLULITIS,1
PT,CHEST DISCOMFORT,1
PT,CHEST WALL HAEMATOMA,1
PT,CHILLS,1
PT,CHOLESTASIS,1
PT,CHONDROSARCOMA METASTATIC,1
PT,CHROMATURIA,1
PT,CHRONIC RESPIRATORY FAILURE,1
PT,CIRCULATORY COLLAPSE,1
PT,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,1
PT,CLEAR CELL RENAL CELL CARCINOMA,1
PT,CLOSTRIDIUM DIFFICILE INFECTION,1
PT,COLD SWEAT,1
PT,COLLATERAL CIRCULATION,1
PT,COLONOSCOPY,1
PT,COMA,1
PT,CONGESTIVE CARDIOMYOPATHY,1
PT,CONTRAINDICATION TO MEDICAL TREATMENT,1
PT,CONTUSION,1
PT,CONVULSION,1
PT,CORNEAL DEGENERATION,1
PT,CORONARY ARTERY OCCLUSION,1
PT,CUTANEOUS VASCULITIS,1
PT,CYANOSIS CENTRAL,1
PT,CYSTITIS ESCHERICHIA,1
PT,DEEP VEIN THROMBOSIS,1
PT,DEMYELINATING POLYNEUROPATHY,1
PT,DEPRESSED LEVEL OF CONSCIOUSNESS,1
PT,DERMATOSIS,1
PT,DEVICE RELATED INFECTION,1
PT,DIABETIC KETOACIDOSIS,1
PT,DIALYSIS,1
PT,DISCOMFORT,1
PT,DISORIENTATION,1
PT,DRUG ADMINISTRATION ERROR,1
PT,DRUG HYPERSENSITIVITY,1
PT,DRUG LEVEL INCREASED,1
PT,DRUG USE DISORDER,1
PT,DYSGEUSIA,1
PT,DYSLIPIDAEMIA,1
PT,DYSPNOEA AT REST,1
PT,DYSTONIA,1
PT,EAR INJURY,1
PT,ECCHYMOSIS,1
PT,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
PT,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,1
PT,EMOTIONAL DISTRESS,1
PT,ENDOCRINE DISORDER,1
PT,ENTEROCOCCUS TEST POSITIVE,1
PT,EPILEPSY,1
PT,ERYTHEMA,1
PT,ERYTHEMA ANNULARE,1
PT,ERYTHEMA NODOSUM,1
PT,ESCHERICHIA SEPSIS,1
PT,EYE PAIN,1
PT,EYE SWELLING,1
PT,EYELID OEDEMA,1
PT,FACE OEDEMA,1
PT,FAECAL VOLUME INCREASED,1
PT,FANCONI SYNDROME ACQUIRED,1
PT,FEELING HOT,1
PT,FLUID OVERLOAD,1
PT,FLUSHING,1
PT,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,1
PT,FOETAL EXPOSURE DURING PREGNANCY,1
PT,FULL BLOOD COUNT DECREASED,1
PT,FUNGAL OESOPHAGITIS,1
PT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
PT,GASTROINTESTINAL OEDEMA,1
PT,GASTROOESOPHAGEAL REFLUX DISEASE,1
PT,GENERALISED ERYTHEMA,1
PT,GENERALISED TONIC-CLONIC SEIZURE,1
PT,GINGIVITIS,1
PT,GLAUCOMA,1
PT,GLAUCOMATOUS OPTIC DISC ATROPHY,1
PT,GOUT,1
PT,GYNAECOMASTIA,1
PT,H1N1 INFLUENZA,1
PT,HAEMOCHROMATOSIS,1
PT,HAEMODIALYSIS,1
PT,HAEMODYNAMIC INSTABILITY,1
PT,HAEMORRHAGE INTRACRANIAL,1
PT,HAEMORRHAGIC DISORDER,1
PT,HAEMORRHAGIC STROKE,1
PT,HAEMOTHORAX,1
PT,HALLUCINATION,1
PT,HALLUCINATION_ AUDITORY,1
PT,HALLUCINATION_ VISUAL,1
PT,HAPTOGLOBIN DECREASED,1
PT,HEAD INJURY,1
PT,HEART RATE INCREASED,1
PT,HEMIANOPIA HOMONYMOUS,1
PT,HEPATIC CONGESTION,1
PT,HEPATIC CYST INFECTION,1
PT,HEPATIC ENCEPHALOPATHY,1
PT,HEPATIC ENZYME INCREASED,1
PT,HEPATIC FAILURE,1
PT,HEPATIC FUNCTION ABNORMAL,1
PT,HEPATITIS,1
PT,HEPATITIS TOXIC,1
PT,HEPATORENAL SYNDROME,1
PT,HYDROCEPHALUS,1
PT,HYPERGLYCAEMIA,1
PT,HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME,1
PT,HYPERLIPASAEMIA,1
PT,HYPERURICAEMIA,1
PT,HYPOAESTHESIA,1
PT,HYPOALBUMINAEMIA,1
PT,HYPOCAPNIA,1
PT,HYPOFIBRINOGENAEMIA,1
PT,HYPOPERFUSION,1
PT,HYPOTHYROIDISM,1
PT,ILEUS PARALYTIC,1
PT,IMMUNOGLOBULINS INCREASED,1
PT,INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT,1
PT,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,1
PT,INFLAMMATORY MARKER INCREASED,1
PT,INFLUENZA,1
PT,INGROWING NAIL,1
PT,INJECTION SITE INDURATION,1
PT,INJECTION SITE PAIN,1
PT,INJECTION SITE RASH,1
PT,INSOMNIA,1
PT,INTENTIONAL PRODUCT USE ISSUE,1
PT,INTESTINAL DILATATION,1
PT,JAUNDICE,1
PT,JAUNDICE CHOLESTATIC,1
PT,JC VIRUS INFECTION,1
PT,JEJUNAL ULCER PERFORATION,1
PT,JOINT SWELLING,1
PT,KIDNEY FIBROSIS,1
PT,KIDNEY SMALL,1
PT,KLEBSIELLA TEST POSITIVE,1
PT,LARGE INTESTINE POLYP,1
PT,LARYNGEAL OEDEMA,1
PT,LEGIONELLA INFECTION,1
PT,LIMB INJURY,1
PT,LIP DISORDER,1
PT,LIP OEDEMA,1
PT,LIVE BIRTH,1
PT,LIVER DISORDER,1
PT,LIVER FUNCTION TEST ABNORMAL,1
PT,LOWER RESPIRATORY TRACT INFECTION,1
PT,LUNG NEOPLASM MALIGNANT,1
PT,LYMPHOCYTOSIS,1
PT,LYMPHOPENIA,1
PT,LYSOSOMAL ACID LIPASE DEFICIENCY,1
PT,MEAN CELL HAEMOGLOBIN INCREASED,1
PT,MEDIASTINAL DISORDER,1
PT,MEDICATION ERROR,1
PT,METABOLIC ACIDOSIS,1
PT,METASTASES TO LUNG,1
PT,MICROANGIOPATHIC HAEMOLYTIC ANAEMIA,1
PT,MOBILITY DECREASED,1
PT,MONOCYTE COUNT INCREASED,1
PT,MOTOR DYSFUNCTION,1
PT,MOUTH ULCERATION,1
PT,MUCOSAL INFLAMMATION,1
PT,MULTIMORBIDITY,1
PT,MUSCLE ATROPHY,1
PT,MUSCLE DISORDER,1
PT,MUSCLE RUPTURE,1
PT,MUSCLE SPASMS,1
PT,MUSCULAR WEAKNESS,1
PT,MUSCULOSKELETAL PAIN,1
PT,MUSCULOSKELETAL STIFFNESS,1
PT,MYOGLOBIN BLOOD INCREASED,1
PT,NASAL OBSTRUCTION,1
PT,NASAL ULCER,1
PT,NASOPHARYNGITIS,1
PT,NECK PAIN,1
PT,NEPHROANGIOSCLEROSIS,1
PT,NEPHROSCLEROSIS,1
PT,NERVOUS SYSTEM DISORDER,1
PT,NEUROLEPTIC MALIGNANT SYNDROME,1
PT,NEUTROPHILIA,1
PT,NIGHT SWEATS,1
PT,NORMOCHROMIC ANAEMIA,1
PT,NORMOCYTIC ANAEMIA,1
PT,OEDEMA,1
PT,OLIGURIA,1
PT,OPPORTUNISTIC INFECTION,1
PT,OPTIC DISC HAEMORRHAGE,1
PT,OPTIC DISC VASCULAR DISORDER,1
PT,ORAL MUCOSA EROSION,1
PT,OROPHARYNGEAL CANDIDIASIS,1
PT,OROPHARYNGEAL PAIN,1
PT,ORTHOSTATIC HYPOTENSION,1
PT,PAIN,1
PT,PANCREATIC NEOPLASM,1
PT,PATHOLOGICAL FRACTURE,1
PT,PENILE OEDEMA,1
PT,PEPTIC ULCER,1
PT,PERICARDIAL EFFUSION,1
PT,PERIORBITAL OEDEMA,1
PT,PERIPHERAL EMBOLISM,1
PT,PERIPHERAL MOTOR NEUROPATHY,1
PT,PERIPHERAL SENSORIMOTOR NEUROPATHY,1
PT,PERIPHERAL SWELLING,1
PT,PERITONEAL CLOUDY EFFLUENT,1
PT,PHARYNGEAL ERYTHEMA,1
PT,PLATELET TRANSFUSION,1
PT,PNEUMONIA BACTERIAL,1
PT,PRESCRIBED UNDERDOSE,1
PT,PROCTALGIA,1
PT,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
PT,PROTEIN-LOSING GASTROENTEROPATHY,1
PT,PSEUDOMONAL BACTERAEMIA,1
PT,PSEUDOMONAS INFECTION,1
PT,PULMONARY ALVEOLAR HAEMORRHAGE,1
PT,PULMONARY HYPERTENSION,1
PT,PULMONARY MASS,1
PT,PULMONARY OEDEMA,1
PT,PULMONARY SARCOIDOSIS,1
PT,PULMONARY VASCULITIS,1
PT,QUADRANTANOPIA,1
PT,RASH ERYTHEMATOUS,1
PT,RASH GENERALISED,1
PT,RASH MACULAR,1
PT,REFUSAL OF TREATMENT BY PATIENT,1
PT,RENAL DISORDER,1
PT,RENAL HAEMORRHAGE,1
PT,RENAL PAIN,1
PT,RENAL TUBULAR ATROPHY,1
PT,RENAL VASCULITIS,1
PT,RESPIRATORY RATE DECREASED,1
PT,RESPIRATORY RATE INCREASED,1
PT,RESTING TREMOR,1
PT,RETINAL HAEMORRHAGE,1
PT,ROAD TRAFFIC ACCIDENT,1
PT,SALIVARY HYPERSECRETION,1
PT,SARCOIDOSIS,1
PT,SARCOPENIA,1
PT,SCLERAL HAEMORRHAGE,1
PT,SCOTOMA,1
PT,SENSORY LOSS,1
PT,SINUS NODE DYSFUNCTION,1
PT,SINUS TACHYCARDIA,1
PT,SKIN LESION,1
PT,SKIN OEDEMA,1
PT,SKIN TOXICITY,1
PT,SLEEP DISORDER,1
PT,SMALL INTESTINAL HAEMORRHAGE,1
PT,SMALL INTESTINE CARCINOMA,1
PT,SPONTANEOUS HAEMATOMA,1
PT,SQUAMOUS CELL CARCINOMA,1
PT,SQUAMOUS CELL CARCINOMA OF LUNG,1
PT,STREPTOCOCCUS TEST POSITIVE,1
PT,SUBDURAL HAEMORRHAGE,1
PT,SWELLING,1
PT,THERAPEUTIC RESPONSE DECREASED,1
PT,THROMBOPHLEBITIS SUPERFICIAL,1
PT,TORTICOLLIS,1
PT,TRANSAMINASES INCREASED,1
PT,TREATMENT NONCOMPLIANCE,1
PT,TUBULOINTERSTITIAL NEPHRITIS,1
PT,TUMOUR HAEMORRHAGE,1
PT,TUNNEL VISION,1
PT,TYPE 1 DIABETES MELLITUS,1
PT,TYPE 2 DIABETES MELLITUS,1
PT,ULTRAFILTRATION FAILURE,1
PT,UPPER GASTROINTESTINAL HAEMORRHAGE,1
PT,URINARY INCONTINENCE,1
PT,URINARY RETENTION,1
PT,URINE ODOUR ABNORMAL,1
PT,VASCULAR WALL HYPERTROPHY,1
PT,VASCULITIS CEREBRAL,1
PT,VENOUS THROMBOSIS LIMB,1
PT,VENTRICULAR FIBRILLATION,1
PT,VERTIGO,1
PT,VIITH NERVE PARALYSIS,1
PT,VISION BLURRED,1
PT,VISUAL IMPAIRMENT,1
PT,VULVOVAGINAL PRURITUS,1
PT,WHEEZING,1
PT,WRIST FRACTURE,1
PR,FATIGUE,15
PR,DRUG INEFFECTIVE,10
PR,PAIN,10
PR,ASTHENIA,9
PR,NASOPHARYNGITIS,9
PR,ARTHRALGIA,8
PR,DIZZINESS,7
PR,INJECTION SITE PAIN,7
PR,PAIN IN EXTREMITY,6
PR,PNEUMONIA,6
PR,FALL,5
PR,FLUID RETENTION,5
PR,MALAISE,5
PR,VOMITING,5
PR,ASTHMA,4
PR,BLOOD GLUCOSE INCREASED,4
PR,DECREASED APPETITE,4
PR,DYSPNOEA,4
PR,HYPERTENSION,4
PR,NAUSEA,4
PR,ANAEMIA,3
PR,BACK PAIN,3
PR,CATARACT,3
PR,CHEST PAIN,3
PR,HAEMOGLOBIN DECREASED,3
PR,HEADACHE,3
PR,JOINT SWELLING,3
PR,LOSS OF CONSCIOUSNESS,3
PR,MOBILITY DECREASED,3
PR,OEDEMA PERIPHERAL,3
PR,PULMONARY OEDEMA,3
PR,SOMNOLENCE,3
PR,WEIGHT DECREASED,3
PR,ABASIA,2
PR,ABSCESS,2
PR,ALOPECIA,2
PR,ASPHYXIA,2
PR,BLOOD GLUCOSE DECREASED,2
PR,BLOOD POTASSIUM DECREASED,2
PR,BRONCHITIS,2
PR,CARDIAC FAILURE CONGESTIVE,2
PR,DIARRHOEA,2
PR,DISCOMFORT,2
PR,DRUG DOSE OMISSION,2
PR,DRUG HYPERSENSITIVITY,2
PR,EPISTAXIS,2
PR,GAIT DISTURBANCE,2
PR,HEART RATE DECREASED,2
PR,HYPERHIDROSIS,2
PR,HYPOTHYROIDISM,2
PR,INSOMNIA,2
PR,MUSCULAR WEAKNESS,2
PR,OSTEOARTHRITIS,2
PR,PERIPHERAL SWELLING,2
PR,PLATELET COUNT DECREASED,2
PR,PRURITUS,2
PR,PSORIASIS,2
PR,PYREXIA,2
PR,SKIN ULCER,2
PR,STOMATITIS,2
PR,URINARY TRACT INFECTION,2
PR,WEIGHT INCREASED,2
PR,ABDOMINAL DISCOMFORT,1
PR,ABDOMINAL DISTENSION,1
PR,ABDOMINAL PAIN,1
PR,ABDOMINAL PAIN UPPER,1
PR,ABSCESS NECK,1
PR,ACQUIRED CARDIAC SEPTAL DEFECT,1
PR,AMNESIA,1
PR,AUDITORY DISORDER,1
PR,BACTERIAL INFECTION,1
PR,BALANCE DISORDER,1
PR,BLOOD CHOLESTEROL INCREASED,1
PR,BLOOD GLUCOSE ABNORMAL,1
PR,BLOOD GLUCOSE FLUCTUATION,1
PR,BLOOD POTASSIUM INCREASED,1
PR,BLOOD PRESSURE DECREASED,1
PR,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
PR,BONE PAIN,1
PR,BRAIN NEOPLASM MALIGNANT,1
PR,BREAST CANCER FEMALE,1
PR,CARDIAC ANEURYSM,1
PR,CARDIAC ARREST,1
PR,CARDIAC DISORDER,1
PR,CARDIAC ENZYMES INCREASED,1
PR,CARDIAC FAILURE,1
PR,CARDIAC MURMUR,1
PR,CARDIO-RESPIRATORY ARREST,1
PR,CELLULITIS,1
PR,CHEILITIS,1
PR,CHIKUNGUNYA VIRUS INFECTION,1
PR,CHOLELITHIASIS,1
PR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
PR,COLITIS ULCERATIVE,1
PR,CORONARY ARTERY OCCLUSION,1
PR,CYST,1
PR,DEATH,1
PR,DECREASED IMMUNE RESPONSIVENESS,1
PR,DEHYDRATION,1
PR,DIABETES MELLITUS,1
PR,DIABETES MELLITUS INADEQUATE CONTROL,1
PR,DRUG EFFECT DECREASED,1
PR,DRUG INTOLERANCE,1
PR,DRUG PRESCRIBING ERROR,1
PR,DYSGEUSIA,1
PR,DYSMENORRHOEA,1
PR,DYSPHONIA,1
PR,DYSURIA,1
PR,EMERGENCY CARE,1
PR,ENDOMETRIAL CANCER,1
PR,ENDOMETRIAL THICKENING,1
PR,ENDOMETRIOSIS,1
PR,ERYTHEMA,1
PR,EYE SWELLING,1
PR,FACIAL PARESIS,1
PR,FEELING ABNORMAL,1
PR,FEELING HOT,1
PR,FUNGAL SKIN INFECTION,1
PR,GASTRIC DISORDER,1
PR,GASTROINTESTINAL BACTERIAL INFECTION,1
PR,GASTROINTESTINAL INFLAMMATION,1
PR,GASTROOESOPHAGEAL REFLUX DISEASE,1
PR,GENITAL SWELLING,1
PR,GLOSSODYNIA,1
PR,HAEMOPTYSIS,1
PR,HAEMORRHAGE,1
PR,HAND DEFORMITY,1
PR,HEAD INJURY,1
PR,HEART RATE IRREGULAR,1
PR,HEPATIC ENZYME INCREASED,1
PR,HEPATIC STEATOSIS,1
PR,HERNIA,1
PR,HERPES ZOSTER,1
PR,HIP FRACTURE,1
PR,HOSPITALISATION,1
PR,HYPERCHOLESTEROLAEMIA,1
PR,HYPERSENSITIVITY,1
PR,HYPERTENSIVE CRISIS,1
PR,HYPERTHYROIDISM,1
PR,HYPOAESTHESIA,1
PR,HYSTERECTOMY,1
PR,IMMUNODEFICIENCY,1
PR,IMPAIRED HEALING,1
PR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
PR,INCISION SITE INFECTION,1
PR,INFARCTION,1
PR,INFECTION,1
PR,INFLAMMATION,1
PR,INJECTION SITE DISCOMFORT,1
PR,INJECTION SITE ERYTHEMA,1
PR,INJECTION SITE REACTION,1
PR,INTERNATIONAL NORMALISED RATIO DECREASED,1
PR,ISCHAEMIC CARDIOMYOPATHY,1
PR,ISCHAEMIC STROKE,1
PR,LIMB DISCOMFORT,1
PR,LIVER DISORDER,1
PR,LOCAL SWELLING,1
PR,LUMBAR SPINAL STENOSIS,1
PR,LUNG DISORDER,1
PR,LUNG NEOPLASM MALIGNANT,1
PR,MEDICAL DEVICE SITE PUSTULE,1
PR,MEMORY IMPAIRMENT,1
PR,MENORRHAGIA,1
PR,MENTAL STATUS CHANGES,1
PR,MOUTH ULCERATION,1
PR,MUSCLE ATROPHY,1
PR,MUSCLE SPASMS,1
PR,MUSCULOSKELETAL PAIN,1
PR,MYALGIA,1
PR,MYOCARDIAL INFARCTION,1
PR,NERVOUSNESS,1
PR,OEDEMA,1
PR,OESOPHAGEAL VARICES HAEMORRHAGE,1
PR,ORAL FUNGAL INFECTION,1
PR,ORAL HERPES,1
PR,ORAL INFECTION,1
PR,ORAL PAIN,1
PR,OROPHARYNGEAL PAIN,1
PR,OROPHARYNGEAL PLAQUE,1
PR,OSTEOPOROSIS,1
PR,OVERDOSE,1
PR,OXYGEN SATURATION ABNORMAL,1
PR,PALPITATIONS,1
PR,PARAESTHESIA,1
PR,PHLEBITIS,1
PR,PLASMA CELL MYELOMA,1
PR,PLEURITIC PAIN,1
PR,POST PROCEDURAL CELLULITIS,1
PR,POST PROCEDURAL STROKE,1
PR,POSTOPERATIVE WOUND INFECTION,1
PR,PSORIATIC ARTHROPATHY,1
PR,RASH MACULAR,1
PR,RECTAL HAEMORRHAGE,1
PR,RENAL FAILURE CHRONIC,1
PR,RESPIRATORY ARREST,1
PR,RESPIRATORY DEPRESSION,1
PR,RESPIRATORY FAILURE,1
PR,SECRETION DISCHARGE,1
PR,SKIN EXFOLIATION,1
PR,SKIN FISSURES,1
PR,SPEECH DISORDER,1
PR,SPINAL COMPRESSION FRACTURE,1
PR,STRESS,1
PR,SWELLING,1
PR,SYNCOPE,1
PR,TACHYCARDIA,1
PR,TENDON RUPTURE,1
PR,THROMBOCYTOPENIA,1
PR,TRANSFUSION RELATED COMPLICATION,1
PR,URINARY TRACT INFECTION BACTERIAL,1
PR,UTERINE ENLARGEMENT,1
PR,UTERINE LEIOMYOMA,1
PR,VAGINAL DISCHARGE,1
PR,VAGINAL HAEMORRHAGE,1
PR,VARICOSE VEIN,1
PR,VASCULAR INSUFFICIENCY,1
PR,VENOUS OCCLUSION,1
PR,VISUAL IMPAIRMENT,1
PR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
QA,HYPOPHOSPHATAEMIA,7
QA,LEUKOPENIA,6
QA,NEUTROPENIA,5
QA,HYPOKALAEMIA,3
QA,BLOOD POTASSIUM DECREASED,1
QA,HYPERTHERMIA,1
QA,WHITE BLOOD CELL COUNT DECREASED,1
QA,WHITE BLOOD CELL COUNT INCREASED,1
RO,ABDOMINAL PAIN,6
RO,DEATH,6
RO,ANAEMIA,5
RO,PYREXIA,5
RO,VOMITING,5
RO,ASTHENIA,4
RO,CARDIO-RESPIRATORY ARREST,4
RO,DIABETES MELLITUS,4
RO,HEPATIC FAILURE,4
RO,ACUTE KIDNEY INJURY,3
RO,ACUTE MYOCARDIAL INFARCTION,3
RO,ALKALOSIS,3
RO,CARDIAC ARREST,3
RO,EPISTAXIS,3
RO,GASTROINTESTINAL HAEMORRHAGE,3
RO,HYPOKALAEMIA,3
RO,MULTIPLE ORGAN DYSFUNCTION SYNDROME,3
RO,NAUSEA,3
RO,PRURITUS,3
RO,SEIZURE,3
RO,SHOCK HAEMORRHAGIC,3
RO,STRONGYLOIDIASIS,3
RO,ABDOMINAL DISTENSION,2
RO,ACUTE TONSILLITIS,2
RO,AMNESIA,2
RO,ANURIA,2
RO,AORTIC VALVE INCOMPETENCE,2
RO,BLOOD PRESSURE INCREASED,2
RO,CONDITION AGGRAVATED,2
RO,DECREASED APPETITE,2
RO,DEHYDRATION,2
RO,DIARRHOEA,2
RO,DIZZINESS,2
RO,DRUG ABUSE,2
RO,FATIGUE,2
RO,GENERALISED OEDEMA,2
RO,HAEMATURIA,2
RO,HEADACHE,2
RO,HYPERURICAEMIA,2
RO,HYPOGLYCAEMIA,2
RO,HYPOPROTEINAEMIA,2
RO,OEDEMA PERIPHERAL,2
RO,OLIGURIA,2
RO,PLEURAL EFFUSION,2
RO,PLEURISY,2
RO,PNEUMONIA,2
RO,SEPSIS,2
RO,STUPOR,2
RO,THERAPEUTIC RESPONSE UNEXPECTED,2
RO,ACUTE RESPIRATORY DISTRESS SYNDROME,1
RO,ACUTE RESPIRATORY FAILURE,1
RO,ALTERED STATE OF CONSCIOUSNESS,1
RO,ASCITES,1
RO,ASPIRATION PLEURAL CAVITY,1
RO,ATRIAL FIBRILLATION,1
RO,BONE MARROW FAILURE,1
RO,BONE PAIN,1
RO,BRADYPHRENIA,1
RO,BRONCHOSPASM,1
RO,BURN OESOPHAGEAL,1
RO,CALCIUM DEFICIENCY,1
RO,CARDIAC FAILURE,1
RO,CARDIAC FAILURE CHRONIC,1
RO,CARDIAC FAILURE CONGESTIVE,1
RO,CARDIAC VALVE VEGETATION,1
RO,CARDIOGENIC SHOCK,1
RO,CELL DEATH,1
RO,CHRONIC KIDNEY DISEASE,1
RO,CLOSTRIDIUM DIFFICILE COLITIS,1
RO,COLOSTOMY,1
RO,COMA,1
RO,CONSTIPATION,1
RO,CORONARY ARTERY THROMBOSIS,1
RO,DEGENERATIVE AORTIC VALVE DISEASE,1
RO,DELIRIUM,1
RO,DISSEMINATED INTRAVASCULAR COAGULATION,1
RO,DRUG ADMINISTRATION ERROR,1
RO,DRUG INEFFECTIVE,1
RO,DYSARTHRIA,1
RO,DYSPHAGIA,1
RO,EMOTIONAL DISORDER,1
RO,ENDOCARDITIS BACTERIAL,1
RO,EOSINOPHILIA,1
RO,ESCHERICHIA URINARY TRACT INFECTION,1
RO,FEBRILE BONE MARROW APLASIA,1
RO,FLUID RETENTION,1
RO,GASTRITIS EROSIVE,1
RO,GENERAL PHYSICAL HEALTH DETERIORATION,1
RO,GINGIVAL BLEEDING,1
RO,HAEMATEMESIS,1
RO,HAEMATOMA,1
RO,HAEMODIALYSIS,1
RO,HAEMOGLOBIN DECREASED,1
RO,HAEMORRHAGE,1
RO,HAEMORRHAGIC STROKE,1
RO,HAEMORRHOIDS,1
RO,HYPERCHOLESTEROLAEMIA,1
RO,HYPERHIDROSIS,1
RO,HYPERKALAEMIA,1
RO,HYPERPARATHYROIDISM,1
RO,HYPERPARATHYROIDISM SECONDARY,1
RO,HYPERTENSIVE CRISIS,1
RO,HYPOAESTHESIA,1
RO,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
RO,INTENTIONAL PRODUCT USE ISSUE,1
RO,INTERSTITIAL LUNG DISEASE,1
RO,IRON DEFICIENCY,1
RO,IRON DEFICIENCY ANAEMIA,1
RO,ISCHAEMIC CARDIOMYOPATHY,1
RO,KLEBSIELLA INFECTION,1
RO,LABILE HYPERTENSION,1
RO,LARYNGOSPASM,1
RO,LEFT VENTRICULAR DYSFUNCTION,1
RO,LEFT VENTRICULAR HYPERTROPHY,1
RO,LEUKOCYTOSIS,1
RO,LEUKOPENIA,1
RO,LICHEN SCLEROSUS,1
RO,LOCALISED INFECTION,1
RO,LOSS OF CONSCIOUSNESS,1
RO,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
RO,LUNG ABSCESS,1
RO,METABOLIC ACIDOSIS,1
RO,MITRAL VALVE INCOMPETENCE,1
RO,MYOCARDIAL ISCHAEMIA,1
RO,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED,1
RO,NASAL INJURY,1
RO,NEPHROCALCINOSIS,1
RO,NEPHROTIC SYNDROME,1
RO,ODYNOPHAGIA,1
RO,OEDEMA,1
RO,ORAL CANDIDIASIS,1
RO,ORAL HERPES,1
RO,OSTEOMALACIA,1
RO,OSTEOPENIA,1
RO,PANCYTOPENIA,1
RO,PARAESTHESIA,1
RO,PARAESTHESIA ORAL,1
RO,PNEUMOTHORAX,1
RO,PRE-EXISTING CONDITION IMPROVED,1
RO,PRODUCT USE IN UNAPPROVED INDICATION,1
RO,PROTEINURIA,1
RO,PULMONARY MICROEMBOLI,1
RO,RASH,1
RO,RENAL FAILURE CHRONIC,1
RO,RENAL IMPAIRMENT,1
RO,RESPIRATORY DISTRESS,1
RO,RESPIRATORY FAILURE,1
RO,RESTRICTIVE CARDIOMYOPATHY,1
RO,SECONDARY HYPERTENSION,1
RO,SEPSIS SYNDROME,1
RO,SUBCUTANEOUS HAEMATOMA,1
RO,SWELLING,1
RO,SYNCOPE,1
RO,TACHYCARDIA,1
RO,THIRST,1
RO,TOXICITY TO VARIOUS AGENTS,1
RO,TREATMENT FAILURE,1
RO,TREMOR,1
RO,TUBERCULOSIS,1
RO,URINARY TRACT INFECTION BACTERIAL,1
RO,URINE CALCIUM DECREASED,1
RO,URINE OUTPUT DECREASED,1
RO,URINE PHOSPHORUS DECREASED,1
RO,VARICOSE VEIN,1
RO,VERTIGO,1
RO,WEIGHT INCREASED,1
RO,WHEEZING,1
RU,DYSPNOEA,11
RU,CARDIOGENIC SHOCK,9
RU,CARDIAC FAILURE ACUTE,8
RU,TUBULOINTERSTITIAL NEPHRITIS,7
RU,ASTHENIA,6
RU,CARDIAC FAILURE,6
RU,CONDITION AGGRAVATED,6
RU,PNEUMONIA,6
RU,PULMONARY OEDEMA,6
RU,ACUTE KIDNEY INJURY,5
RU,ACUTE MYOCARDIAL INFARCTION,5
RU,GASTROENTERITIS,5
RU,HAEMORRHAGE,5
RU,MYOCARDIAL INFARCTION,5
RU,BLOOD CREATININE INCREASED,4
RU,CEREBROVASCULAR ACCIDENT,4
RU,DEHYDRATION,4
RU,DIZZINESS,4
RU,DRUG ABUSE,4
RU,GASTRODUODENITIS,4
RU,ISCHAEMIC STROKE,4
RU,MULTI-ORGAN FAILURE,4
RU,PULMONARY EMBOLISM,4
RU,PYREXIA,4
RU,ALANINE AMINOTRANSFERASE INCREASED,3
RU,ASPARTATE AMINOTRANSFERASE INCREASED,3
RU,ATRIAL FIBRILLATION,3
RU,BLOOD BILIRUBIN INCREASED,3
RU,BLOOD PRESSURE DECREASED,3
RU,BODY TEMPERATURE INCREASED,3
RU,CHRONIC KIDNEY DISEASE,3
RU,HYPERTENSION,3
RU,HYPOTENSION,3
RU,PULMONARY ARTERIAL HYPERTENSION,3
RU,RENAL FAILURE,3
RU,THROMBOSIS IN DEVICE,3
RU,VASCULAR STENT THROMBOSIS,3
RU,ANAEMIA,2
RU,ANURIA,2
RU,ASCITES,2
RU,AUTOIMMUNE THYROIDITIS,2
RU,BLOOD PRESSURE INCREASED,2
RU,BLOOD UREA INCREASED,2
RU,BRAIN OEDEMA,2
RU,CARDIAC FAILURE CHRONIC,2
RU,CARDIOPULMONARY FAILURE,2
RU,CHEST PAIN,2
RU,COMA,2
RU,CONTUSION,2
RU,DIARRHOEA,2
RU,DISEASE PROGRESSION,2
RU,DRUG INEFFECTIVE,2
RU,ELECTROLYTE IMBALANCE,2
RU,EPISTAXIS,2
RU,ERYTHEMA,2
RU,GASTRIC POLYPS,2
RU,HAEMOGLOBIN DECREASED,2
RU,HEPATIC FAILURE,2
RU,HYPONATRAEMIA,2
RU,INTENTIONAL PRODUCT MISUSE,2
RU,IRON DEFICIENCY ANAEMIA,2
RU,LEUKOCYTOSIS,2
RU,LOSS OF CONSCIOUSNESS,2
RU,LUNG NEOPLASM MALIGNANT,2
RU,MYOCARDIAL RUPTURE,2
RU,OEDEMA,2
RU,OEDEMA PERIPHERAL,2
RU,PERIPHERAL SWELLING,2
RU,PRODUCTIVE COUGH,2
RU,SEIZURE,2
RU,VOMITING,2
RU,ACUTE PRERENAL FAILURE,1
RU,ACUTE PSYCHOSIS,1
RU,ACUTE RESPIRATORY FAILURE,1
RU,ADRENAL DISORDER,1
RU,ADRENOCORTICAL INSUFFICIENCY ACUTE,1
RU,AMENORRHOEA,1
RU,AMYLOIDOSIS,1
RU,ANAEMIA VITAMIN B12 DEFICIENCY,1
RU,ANGINA PECTORIS,1
RU,ANGINA UNSTABLE,1
RU,ANGIOEDEMA,1
RU,AORTIC THROMBOSIS,1
RU,APNOEA,1
RU,ARRHYTHMIA,1
RU,ARTERIAL PERFORATION,1
RU,ASPHYXIA,1
RU,ATRIAL FLUTTER,1
RU,ATRIAL THROMBOSIS,1
RU,BACK PAIN,1
RU,BLOOD GLUCOSE INCREASED,1
RU,BLOOD POTASSIUM INCREASED,1
RU,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
RU,BONE PAIN,1
RU,BRADYCARDIA,1
RU,BREAST HAEMATOMA,1
RU,BRONCHITIS,1
RU,CARDIAC CIRRHOSIS,1
RU,CARDIAC FAILURE CONGESTIVE,1
RU,CARDIAC TAMPONADE,1
RU,CARDIAC VALVE SCLEROSIS,1
RU,CARDIO-RESPIRATORY ARREST,1
RU,CARDIOVASCULAR INSUFFICIENCY,1
RU,CAROTID ARTERY STENOSIS,1
RU,CENTRAL NERVOUS SYSTEM LESION,1
RU,CEREBRAL INFARCTION,1
RU,CHILLS,1
RU,CHOLECYSTITIS,1
RU,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
RU,CONCOMITANT DISEASE AGGRAVATED,1
RU,CONCOMITANT DISEASE PROGRESSION,1
RU,CONVULSION,1
RU,CORONARY ARTERY DISEASE,1
RU,COUGH,1
RU,CYANOSIS,1
RU,DEATH,1
RU,DEEP VEIN THROMBOSIS,1
RU,DRUG DOSE OMISSION,1
RU,DYSPNOEA EXERTIONAL,1
RU,EAR HAEMORRHAGE,1
RU,ENDOCARDITIS,1
RU,EXTRAVASATION BLOOD,1
RU,FATIGUE,1
RU,FLUID RETENTION,1
RU,GASTRITIS EROSIVE,1
RU,GASTROINTESTINAL INFECTION,1
RU,GASTROOESOPHAGEAL REFLUX DISEASE,1
RU,GASTROOESOPHAGEAL SPHINCTER INSUFFICIENCY,1
RU,GENERAL PHYSICAL HEALTH DETERIORATION,1
RU,GINGIVAL BLEEDING,1
RU,GOUT,1
RU,HAEMODYNAMIC INSTABILITY,1
RU,HAEMOPTYSIS,1
RU,HAEMORRHAGIC DISORDER,1
RU,HEART RATE INCREASED,1
RU,HEART RATE IRREGULAR,1
RU,HEPATITIS ACUTE,1
RU,HEPATOMEGALY,1
RU,HERNIA,1
RU,HYDROTHORAX,1
RU,HYPERHIDROSIS,1
RU,HYPERPARATHYROIDISM,1
RU,HYPERTENSIVE NEPHROPATHY,1
RU,HYPERTHERMIA,1
RU,HYPOGLYCAEMIA,1
RU,HYPOKALAEMIA,1
RU,HYPOTHYROIDISM,1
RU,INSOMNIA,1
RU,INTERNATIONAL NORMALISED RATIO INCREASED,1
RU,ISCHAEMIC CARDIOMYOPATHY,1
RU,JAUNDICE,1
RU,LIQUID PRODUCT PHYSICAL ISSUE,1
RU,LOCALISED OEDEMA,1
RU,LUNG INFILTRATION,1
RU,LYMPHOCYTE COUNT INCREASED,1
RU,MESENTERIC ARTERY THROMBOSIS,1
RU,METABOLIC ACIDOSIS,1
RU,METASTASES TO LIVER,1
RU,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
RU,MUSCLE SPASTICITY,1
RU,MYOCARDIAL ISCHAEMIA,1
RU,NAUSEA,1
RU,NEUROTOXICITY,1
RU,NEUTROPENIA,1
RU,OBESITY,1
RU,OSTEOARTHRITIS,1
RU,OSTEOPOROSIS,1
RU,PALPITATIONS,1
RU,PANCREATITIS,1
RU,PARAESTHESIA,1
RU,PERIODONTITIS,1
RU,PLASMA CELL MYELOMA,1
RU,PLEURISY,1
RU,PNEUMONIA ASPIRATION,1
RU,POLYURIA,1
RU,PORTAL VEIN THROMBOSIS,1
RU,POST PROCEDURAL HAEMATOMA,1
RU,PROCALCITONIN INCREASED,1
RU,PRODUCT USE ISSUE,1
RU,PULMONARY ARTERIAL PRESSURE INCREASED,1
RU,PULMONARY HYPERTENSION,1
RU,PYLORIC SPHINCTER INSUFFICIENCY,1
RU,RECTAL HAEMORRHAGE,1
RU,RENAL CYST,1
RU,RENAL DISORDER,1
RU,RENAL IMPAIRMENT,1
RU,RESPIRATORY FAILURE,1
RU,RESPIRATORY TRACT INFECTION,1
RU,REYE^S SYNDROME,1
RU,RHABDOMYOLYSIS,1
RU,RIGHT VENTRICULAR FAILURE,1
RU,SCROTAL SWELLING,1
RU,SELF-MEDICATION,1
RU,SEPSIS,1
RU,SEPTIC SHOCK,1
RU,SHOCK,1
RU,SOMNOLENCE,1
RU,SPLENOMEGALY,1
RU,SUDDEN DEATH,1
RU,SWELLING FACE,1
RU,SWOLLEN TONGUE,1
RU,SYNCOPE,1
RU,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,1
RU,SYSTEMIC SCLEROSIS,1
RU,TACHYCARDIA,1
RU,THROMBOANGIITIS OBLITERANS,1
RU,THROMBOCYTOPENIA,1
RU,THROMBOCYTOSIS,1
RU,THYROIDITIS,1
RU,TONGUE DRY,1
RU,TOOTH FRACTURE,1
RU,TRANSAMINASES INCREASED,1
RU,TRANSIENT ISCHAEMIC ATTACK,1
RU,URINARY TRACT INFECTION,1
RU,URINE OUTPUT DECREASED,1
RU,URTICARIA,1
RU,VARICELLA,1
RU,VASCULAR STENT OCCLUSION,1
RU,VENTRICULAR EXTRASYSTOLES,1
RU,VENTRICULAR FIBRILLATION,1
RU,VERTIGO,1
RW,GOUTY ARTHRITIS,6
RW,ACUTE KIDNEY INJURY,5
RW,HYPERKALAEMIA,5
RW,HYPERURICAEMIA,2
RW,ACUTE HEPATIC FAILURE,1
RW,BRONCHOSPASM,1
RW,HYPOKALAEMIA,1
RW,HYPOMAGNESAEMIA,1
RW,HYPOTENSION,1
RW,LOWER GASTROINTESTINAL HAEMORRHAGE,1
RW,RENAL FAILURE,1
RW,RENAL INJURY,1
RW,TRANSAMINASES INCREASED,1
RW,VOMITING,1
WS,ASTHENIA,1
WS,GASTROINTESTINAL HAEMORRHAGE,1
SA,BACTERIAL INFECTION,4
SA,FLUID OVERLOAD,3
SA,HYPERKALAEMIA,3
SA,OEDEMA,3
SA,OLIGURIA,3
SA,RENAL FAILURE CHRONIC,3
SA,RENAL IMPAIRMENT,3
SA,DRUG INEFFECTIVE,2
SA,GENERALISED TONIC-CLONIC SEIZURE,2
SA,HYPERGLYCAEMIA,2
SA,ABDOMINAL PAIN UPPER,1
SA,AGITATION,1
SA,ALBUMINURIA,1
SA,ASTERIXIS,1
SA,ATRIAL FIBRILLATION,1
SA,ATRIOVENTRICULAR BLOCK COMPLETE,1
SA,BILE DUCT STENOSIS,1
SA,BILIARY TRACT INFECTION,1
SA,BLOOD CREATININE INCREASED,1
SA,BLOOD POTASSIUM INCREASED,1
SA,CARDIAC ARREST,1
SA,CARDIAC FAILURE,1
SA,CARDIAC FAILURE CONGESTIVE,1
SA,CEREBROVASCULAR ACCIDENT,1
SA,CHEST PAIN,1
SA,CHRONIC KIDNEY DISEASE,1
SA,COMA,1
SA,CONSCIOUSNESS FLUCTUATING,1
SA,CONVULSION,1
SA,COUGH,1
SA,DELIRIUM,1
SA,DIARRHOEA,1
SA,DIZZINESS,1
SA,DRUG RESISTANCE,1
SA,DYSPNOEA,1
SA,DYSPNOEA EXERTIONAL,1
SA,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,1
SA,HAEMOGLOBIN DECREASED,1
SA,HAEMOPTYSIS,1
SA,HERPES SIMPLEX PHARYNGITIS,1
SA,HYPERREFLEXIA,1
SA,HYPOCALCAEMIA,1
SA,HYPOMAGNESAEMIA,1
SA,HYPOTENSION,1
SA,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
SA,LACTIC ACIDOSIS,1
SA,METABOLIC ACIDOSIS,1
SA,METABOLIC ENCEPHALOPATHY,1
SA,MYOCARDIAL INFARCTION,1
SA,MYOCLONUS,1
SA,NEPHROTIC SYNDROME,1
SA,NYSTAGMUS,1
SA,OVERDOSE,1
SA,POST PROCEDURAL BILE LEAK,1
SA,PRODUCT USE ISSUE,1
SA,PRURITUS GENERALISED,1
SA,PULMONARY HAEMORRHAGE,1
SA,RENAL FAILURE ACUTE,1
SA,RHEUMATOID ARTHRITIS,1
SA,SOMNOLENCE,1
SA,SUDDEN CARDIAC DEATH,1
SA,TACHYPNOEA,1
SA,VENTRICULAR ASYSTOLE,1
RS,CARDIAC ARREST,4
RS,CARDIAC FAILURE,4
RS,HYPOTENSION,4
RS,ANAPHYLACTIC REACTION,3
RS,CIRCULATORY COLLAPSE,3
RS,GASTROINTESTINAL HAEMORRHAGE,3
RS,HYPOKALAEMIA,3
RS,SEPSIS,3
RS,THROMBOCYTOPENIA,3
RS,URTICARIA,3
RS,ACIDOSIS,2
RS,ARRHYTHMIA,2
RS,BRADYCARDIA,2
RS,BRONCHOPULMONARY ASPERGILLOSIS,2
RS,CHILLS,2
RS,DRUG ADMINISTRATION ERROR,2
RS,DRUG INEFFECTIVE,2
RS,PNEUMOPERITONEUM,2
RS,SELF INJURIOUS BEHAVIOUR,2
RS,SKIN EXFOLIATION,2
RS,SKIN NECROSIS,2
RS,SUBILEUS,2
RS,TOXIC EPIDERMAL NECROLYSIS,2
RS,ACNE,1
RS,ACUTE MYOCARDIAL INFARCTION,1
RS,AMENORRHOEA,1
RS,ANAEMIA,1
RS,ARTHRALGIA,1
RS,ASCITES,1
RS,ASTROCYTOMA_ LOW GRADE,1
RS,BLOOD CREATININE INCREASED,1
RS,BLOOD GLUCOSE INCREASED,1
RS,BLOOD POTASSIUM INCREASED,1
RS,BLOOD UREA INCREASED,1
RS,C-REACTIVE PROTEIN INCREASED,1
RS,CARDIAC FAILURE ACUTE,1
RS,CARDIOVASCULAR INSUFFICIENCY,1
RS,CEREBRAL INFARCTION,1
RS,COAGULOPATHY,1
RS,CONDITION AGGRAVATED,1
RS,CUTANEOUS VASCULITIS,1
RS,DEATH,1
RS,DIARRHOEA,1
RS,DIARRHOEA INFECTIOUS,1
RS,DISSEMINATED INTRAVASCULAR COAGULATION,1
RS,DRUG ABUSE,1
RS,ERYTHEMA,1
RS,FREQUENT BOWEL MOVEMENTS,1
RS,GASTRIC CANCER,1
RS,GASTRIC ULCER HAEMORRHAGE,1
RS,HAEMATOMA,1
RS,HAEMORRHAGE,1
RS,HALLUCINATION,1
RS,HEPATITIS B,1
RS,HYPERSENSITIVITY,1
RS,HYPERSENSITIVITY VASCULITIS,1
RS,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,1
RS,JOINT SWELLING,1
RS,LEUKOPENIA,1
RS,LIP SWELLING,1
RS,MALAISE,1
RS,MALIGNANT NEOPLASM PROGRESSION,1
RS,METABOLIC SYNDROME,1
RS,PAIN IN EXTREMITY,1
RS,PERIPHERAL SWELLING,1
RS,PNEUMONIA,1
RS,PORTAL HYPERTENSION,1
RS,POST PROCEDURAL COMPLICATION,1
RS,PROLAPSE,1
RS,PROTEINURIA,1
RS,PRURITUS,1
RS,PULMONARY HYPERTENSION,1
RS,RASH,1
RS,RASH GENERALISED,1
RS,SELF-MEDICATION,1
RS,SHOCK HAEMORRHAGIC,1
RS,SKIN PAPILLOMA,1
RS,STAPHYLOCOCCAL SEPSIS,1
RS,SUDDEN DEATH,1
RS,SWELLING FACE,1
RS,SWOLLEN TONGUE,1
RS,SYSTEMIC-PULMONARY ARTERY SHUNT,1
RS,TACHYCARDIA,1
RS,TRANSAMINASES INCREASED,1
RS,TREMOR,1
RS,URINARY TRACT INFECTION,1
RS,UROSEPSIS,1
RS,VARICES OESOPHAGEAL,1
RS,VASCULAR RUPTURE,1
RS,VENTRICULAR TACHYCARDIA,1
RS,WEIGHT DECREASED,1
RS,WEIGHT INCREASED,1
RS,WHITE BLOOD CELL COUNT DECREASED,1
RS,WOUND INFECTION,1
SG,NEPHROPATHY,4
SG,ANAEMIA,3
SG,CARDIAC FAILURE CONGESTIVE,3
SG,HYPOKALAEMIA,3
SG,RASH,3
SG,SEPSIS,3
SG,ACUTE KIDNEY INJURY,2
SG,ANGIOEDEMA,2
SG,ATRIAL FIBRILLATION,2
SG,CARDIAC FAILURE,2
SG,DIZZINESS,2
SG,HYPOTENSION,2
SG,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
SG,PNEUMONIA,2
SG,ACUTE PULMONARY OEDEMA,1
SG,ACUTE STRESS DISORDER,1
SG,ANTICOAGULATION DRUG LEVEL INCREASED,1
SG,APLASIA PURE RED CELL,1
SG,BONE MARROW FAILURE,1
SG,BRAIN CONTUSION,1
SG,BRONCHITIS,1
SG,CAMPYLOBACTER GASTROENTERITIS,1
SG,CELLULITIS,1
SG,CEREBRAL INFARCTION,1
SG,CHOLECYSTITIS ACUTE,1
SG,CHRONIC GASTRITIS,1
SG,COLITIS,1
SG,CONSTIPATION,1
SG,CORONARY ARTERY RESTENOSIS,1
SG,DEATH,1
SG,DERMATITIS EXFOLIATIVE,1
SG,DRUG ADMINISTRATION ERROR,1
SG,DRUG INEFFECTIVE,1
SG,ECZEMA ASTEATOTIC,1
SG,EMBOLIC STROKE,1
SG,ERYTHEMA,1
SG,EYE SWELLING,1
SG,FEMUR FRACTURE,1
SG,FLUID OVERLOAD,1
SG,GASTRITIS,1
SG,GASTROENTERITIS,1
SG,GASTROINTESTINAL HAEMORRHAGE,1
SG,HAEMATOMA,1
SG,HAEMOGLOBIN INCREASED,1
SG,HAEMOPTYSIS,1
SG,HEPATOMEGALY,1
SG,HEPATOTOXICITY,1
SG,IGA NEPHROPATHY,1
SG,INTERNATIONAL NORMALISED RATIO INCREASED,1
SG,INTRADUCTAL PAPILLARY-MUCINOUS CARCINOMA OF PANCREAS,1
SG,ISCHAEMIC STROKE,1
SG,LACERATION,1
SG,LEUKOPENIA,1
SG,METABOLIC ACIDOSIS,1
SG,MYOCARDIAL ISCHAEMIA,1
SG,NON-SMALL CELL LUNG CANCER,1
SG,OEDEMA,1
SG,OESOPHAGEAL VARICES HAEMORRHAGE,1
SG,ORTHOSTATIC HYPOTENSION,1
SG,OSTEOARTHRITIS,1
SG,PANCREATITIS,1
SG,PERICARDIAL EFFUSION,1
SG,PERIPHERAL VASCULAR DISORDER,1
SG,PNEUMONIA INFLUENZAL,1
SG,PROTHROMBIN LEVEL INCREASED,1
SG,PULMONARY HYPERTENSION,1
SG,RASH MACULO-PAPULAR,1
SG,RENAL FAILURE,1
SG,RENAL FAILURE ACUTE,1
SG,RESPIRATORY ACIDOSIS,1
SG,RESPIRATORY DEPRESSION,1
SG,RESPIRATORY TRACT INFECTION,1
SG,SKIN EXFOLIATION,1
SG,SKULL FRACTURED BASE,1
SG,SYNCOPE,1
SG,THROMBOCYTOPENIA,1
SG,THROMBOPHLEBITIS,1
SG,TOXICITY TO VARIOUS AGENTS,1
SG,TREATMENT NONCOMPLIANCE,1
SG,UNEVALUABLE EVENT,1
SG,UPPER RESPIRATORY TRACT INFECTION,1
SG,VASCULAR STENT THROMBOSIS,1
SG,VENTRICULAR FIBRILLATION,1
SG,VENTRICULAR TACHYCARDIA,1
SG,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
SG,WHEEZING,1
SG,WHITE BLOOD CELL COUNT INCREASED,1
SK,CARDIOPULMONARY FAILURE,4
SK,ANAEMIA,3
SK,HYPERKALAEMIA,3
SK,ASTHENIA,2
SK,CHEST PAIN,2
SK,CIRCULATORY COLLAPSE,2
SK,DEATH,2
SK,DEHYDRATION,2
SK,DYSPNOEA,2
SK,EXPOSURE DURING PREGNANCY,2
SK,ACUTE KIDNEY INJURY,1
SK,ACUTE MYOCARDIAL INFARCTION,1
SK,ANXIETY,1
SK,ATRIAL FIBRILLATION,1
SK,ATRIAL FLUTTER,1
SK,ATRIAL THROMBOSIS,1
SK,BACTERIURIA,1
SK,BLOOD CREATININE INCREASED,1
SK,BLOOD PRESSURE FLUCTUATION,1
SK,BRONCHOPNEUMONIA,1
SK,CARDIAC FAILURE CHRONIC,1
SK,CARDIAC FAILURE CONGESTIVE,1
SK,CATABOLIC STATE,1
SK,CEREBRAL HAEMORRHAGE,1
SK,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
SK,COMA,1
SK,COMPLETED SUICIDE,1
SK,CONCOMITANT DISEASE PROGRESSION,1
SK,CONDITION AGGRAVATED,1
SK,CORONARY ARTERY DISEASE,1
SK,DIARRHOEA,1
SK,DRUG EFFECT INCOMPLETE,1
SK,EMPYEMA,1
SK,FALL,1
SK,FEBRILE NEUTROPENIA,1
SK,GASTROINTESTINAL HAEMORRHAGE,1
SK,HAEMOPTYSIS,1
SK,HAEMORRHAGE INTRACRANIAL,1
SK,HAEMORRHOIDS,1
SK,HYPOALBUMINAEMIA,1
SK,HYPOKALAEMIA,1
SK,HYPONATRAEMIA,1
SK,HYPOPROTEINAEMIA,1
SK,HYPOTENSION,1
SK,IIIRD NERVE DISORDER,1
SK,INTESTINAL POLYP,1
SK,ISCHAEMIC STROKE,1
SK,LEFT VENTRICULAR FAILURE,1
SK,LEUKOCYTURIA,1
SK,LIVER DISORDER,1
SK,LOSS OF CONSCIOUSNESS,1
SK,LOWER RESPIRATORY TRACT INFECTION,1
SK,MALIGNANT NEOPLASM PROGRESSION,1
SK,METABOLIC ACIDOSIS,1
SK,METRORRHAGIA,1
SK,MITRAL VALVE INCOMPETENCE,1
SK,MYOCARDIAL INFARCTION,1
SK,NODAL RHYTHM,1
SK,PAIN,1
SK,PALPITATIONS,1
SK,PLEURAL EFFUSION,1
SK,PREMATURE SEPARATION OF PLACENTA,1
SK,PULMONARY EMBOLISM,1
SK,PULMONARY OEDEMA,1
SK,RENAL FAILURE CHRONIC,1
SK,SOMNOLENCE,1
SK,TACHYCARDIA,1
SK,THROMBOCYTOPENIA,1
SK,TREATMENT FAILURE,1
SK,UTERINE LEIOMYOMA,1
SK,VASCULAR STENT THROMBOSIS,1
SI,DYSPNOEA,21
SI,CHOKING,14
SI,DIZZINESS,13
SI,GAIT DISTURBANCE,10
SI,FALL,9
SI,HYPOTENSION,9
SI,CHEST PAIN,8
SI,GENERAL PHYSICAL HEALTH DETERIORATION,8
SI,OEDEMA PERIPHERAL,8
SI,CARDIAC FAILURE,7
SI,COUGH,6
SI,FATIGUE,6
SI,DEPRESSION,5
SI,SYNCOPE,5
SI,CARDIOMYOPATHY,4
SI,HYPONATRAEMIA,4
SI,ASTHENIA,3
SI,BLOOD PRESSURE INCREASED,3
SI,BRADYCARDIA,3
SI,CEREBRAL HAEMATOMA,3
SI,CHRONIC KIDNEY DISEASE,3
SI,CONDITION AGGRAVATED,3
SI,DRUG ADMINISTRATION ERROR,3
SI,EJECTION FRACTION DECREASED,3
SI,FOOD REFUSAL,3
SI,HAEMATURIA,3
SI,HYPOGLYCAEMIA,3
SI,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,3
SI,MEDICAL DEVICE SITE HAEMORRHAGE,3
SI,SLEEP DISORDER,3
SI,VENTRICULAR ASYSTOLE,3
SI,ACUTE MYOCARDIAL INFARCTION,2
SI,BLOOD PRESSURE ABNORMAL,2
SI,BUNDLE BRANCH BLOCK LEFT,2
SI,CARDIAC FAILURE CHRONIC,2
SI,CEREBRAL HAEMORRHAGE,2
SI,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
SI,DIARRHOEA,2
SI,GLAUCOMA,2
SI,GLOMERULAR FILTRATION RATE DECREASED,2
SI,HAEMOGLOBIN DECREASED,2
SI,HEADACHE,2
SI,HYPERTENSION,2
SI,INFUSION RELATED REACTION,2
SI,INSOMNIA,2
SI,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED,2
SI,PAIN,2
SI,PERIPHERAL SWELLING,2
SI,PRODUCT USE ISSUE,2
SI,PRURITUS,2
SI,RALES,2
SI,SEPSIS,2
SI,TACHYCARDIA,2
SI,ABDOMINAL PAIN,1
SI,ABDOMINAL PAIN UPPER,1
SI,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
SI,ACUTE KIDNEY INJURY,1
SI,APHASIA,1
SI,ARTHRALGIA,1
SI,BACK PAIN,1
SI,BILE DUCT STONE,1
SI,BLOOD BILIRUBIN INCREASED,1
SI,BLOOD CREATININE INCREASED,1
SI,BLOOD GASES ABNORMAL,1
SI,BLOOD IRON DECREASED,1
SI,BLOOD LACTATE DEHYDROGENASE INCREASED,1
SI,BLOOD LACTIC ACID INCREASED,1
SI,BLOOD PARATHYROID HORMONE ABNORMAL,1
SI,BLOOD PH INCREASED,1
SI,BLOOD PRESSURE DECREASED,1
SI,BLOOD UREA INCREASED,1
SI,BRAIN NATRIURETIC PEPTIDE INCREASED,1
SI,BRONCHOPULMONARY ASPERGILLOSIS,1
SI,C-REACTIVE PROTEIN INCREASED,1
SI,CARDIAC FAILURE CONGESTIVE,1
SI,CARDIAC VENTRICULAR DISORDER,1
SI,CEREBROVASCULAR ACCIDENT,1
SI,COMA,1
SI,COMPLETED SUICIDE,1
SI,CONCOMITANT DISEASE AGGRAVATED,1
SI,CONGESTIVE CARDIOMYOPATHY,1
SI,CONSTIPATION,1
SI,CONTRAINDICATED PRODUCT ADMINISTERED,1
SI,CONVULSION,1
SI,CORNEAL DEPOSITS,1
SI,CORONARY ARTERY STENOSIS,1
SI,CYSTATIN C INCREASED,1
SI,DEATH,1
SI,DEPRESSION SUICIDAL,1
SI,DISORIENTATION,1
SI,DISTURBANCE IN ATTENTION,1
SI,DYSPEPSIA,1
SI,DYSPNOEA EXERTIONAL,1
SI,EMBOLISM,1
SI,EPILEPSY,1
SI,FEBRILE NEUTROPENIA,1
SI,FEELING COLD,1
SI,FOETAL EXPOSURE DURING PREGNANCY,1
SI,GASTROINTESTINAL HAEMORRHAGE,1
SI,GENERAL PHYSICAL CONDITION ABNORMAL,1
SI,GINGIVAL BLEEDING,1
SI,GRAND MAL CONVULSION,1
SI,HAEMATOCHEZIA,1
SI,HAEMATOCRIT DECREASED,1
SI,HAEMOGLOBIN INCREASED,1
SI,HALLUCINATION_ VISUAL,1
SI,HEART DISEASE CONGENITAL,1
SI,HEART RATE INCREASED,1
SI,HEART RATE IRREGULAR,1
SI,HEPATIC CONGESTION,1
SI,HEPATIC ENZYME ABNORMAL,1
SI,HEPATIC FAILURE,1
SI,HYPERHIDROSIS,1
SI,HYPERSENSITIVITY,1
SI,HYPERVENTILATION,1
SI,HYPERVOLAEMIA,1
SI,HYPOAESTHESIA,1
SI,HYPOTONIA,1
SI,HYPOVOLAEMIA,1
SI,HYPOXIA,1
SI,INFLAMMATORY MARKER INCREASED,1
SI,INJECTION SITE HAEMATOMA,1
SI,INTENTIONAL OVERDOSE,1
SI,ISCHAEMIC STROKE,1
SI,LEFT ATRIAL ENLARGEMENT,1
SI,LEFT VENTRICULAR ENLARGEMENT,1
SI,LIMB DISCOMFORT,1
SI,LIVER DISORDER,1
SI,LOW BIRTH WEIGHT BABY,1
SI,LUNG TRANSPLANT,1
SI,LYMPHOCYTE COUNT DECREASED,1
SI,MACROCYTOSIS,1
SI,MEAN CELL HAEMOGLOBIN INCREASED,1
SI,MUSCULOSKELETAL PAIN,1
SI,NIGHT SWEATS,1
SI,NORMOCYTIC ANAEMIA,1
SI,OCCULT BLOOD POSITIVE,1
SI,OXYGEN SATURATION DECREASED,1
SI,PACEMAKER GENERATED ARRHYTHMIA,1
SI,PAIN IN EXTREMITY,1
SI,PANCREATITIS,1
SI,PARANOIA,1
SI,PERICARDIAL EFFUSION,1
SI,PERIPHERAL ARTERY OCCLUSION,1
SI,PERIPHERAL COLDNESS,1
SI,PERIPHERAL ISCHAEMIA,1
SI,PNEUMONIA,1
SI,POLYURIA,1
SI,POOR QUALITY SLEEP,1
SI,PREMATURE BABY,1
SI,PULMONARY HYPERTENSION,1
SI,RED BLOOD CELL COUNT DECREASED,1
SI,RED CELL DISTRIBUTION WIDTH INCREASED,1
SI,RENAL FAILURE,1
SI,RESPIRATORY RATE DECREASED,1
SI,SERUM FERRITIN DECREASED,1
SI,SINUS TACHYCARDIA,1
SI,SPINAL PAIN,1
SI,STENOSIS,1
SI,SUBARACHNOID HAEMORRHAGE,1
SI,SUBDURAL HAEMATOMA,1
SI,SUDDEN CARDIAC DEATH,1
SI,SUICIDE ATTEMPT,1
SI,TACHYPNOEA,1
SI,THROMBOCYTOPENIA,1
SI,TINNITUS,1
SI,URINARY INCONTINENCE,1
SI,VISION BLURRED,1
SI,VISUAL IMPAIRMENT,1
ZA,DEATH,25
ZA,CARDIAC FAILURE,20
ZA,RENAL FAILURE,20
ZA,HYPOKALAEMIA,9
ZA,DYSPNOEA,6
ZA,ACUTE KIDNEY INJURY,5
ZA,CARDIAC DISORDER,5
ZA,CEREBROVASCULAR ACCIDENT,5
ZA,CHEST PAIN,5
ZA,GASTROINTESTINAL HAEMORRHAGE,5
ZA,HYPOTENSION,5
ZA,PERIPHERAL SWELLING,5
ZA,PNEUMONIA,5
ZA,RENAL IMPAIRMENT,5
ZA,ATRIAL FIBRILLATION,4
ZA,CARDIAC FAILURE CONGESTIVE,4
ZA,FLUID RETENTION,4
ZA,HAEMOGLOBIN DECREASED,4
ZA,MALAISE,4
ZA,PAIN IN EXTREMITY,4
ZA,VOMITING,4
ZA,ANTICHOLINERGIC SYNDROME,3
ZA,FLUID OVERLOAD,3
ZA,GAIT DISTURBANCE,3
ZA,HEPATIC FAILURE,3
ZA,INFECTION,3
ZA,LUNG INFECTION,3
ZA,MYOCARDIAL ISCHAEMIA,3
ZA,PAIN,3
ZA,PLEURAL EFFUSION,3
ZA,PULMONARY EMBOLISM,3
ZA,PULMONARY OEDEMA,3
ZA,SEPSIS,3
ZA,ACUTE MYOCARDIAL INFARCTION,2
ZA,ANAEMIA,2
ZA,AORTIC STENOSIS,2
ZA,ASTHENIA,2
ZA,ASTHMA,2
ZA,BACK PAIN,2
ZA,BLOOD GLUCOSE DECREASED,2
ZA,BRADYCARDIA,2
ZA,BRAIN NEOPLASM,2
ZA,BRONCHITIS,2
ZA,CARDIOVASCULAR DISORDER,2
ZA,COMA,2
ZA,CORONARY ARTERY DISEASE,2
ZA,DIARRHOEA,2
ZA,EATING DISORDER,2
ZA,ERYTHEMA,2
ZA,EXPOSURE DURING PREGNANCY,2
ZA,FALL,2
ZA,GASTROOESOPHAGEAL REFLUX DISEASE,2
ZA,HOSPITALISATION,2
ZA,HYPERHIDROSIS,2
ZA,HYPERNATRAEMIA,2
ZA,HYPERTENSION,2
ZA,INFLAMMATION,2
ZA,JAUNDICE,2
ZA,LUNG DISORDER,2
ZA,NAUSEA,2
ZA,NON-CARDIAC CHEST PAIN,2
ZA,OEDEMA PERIPHERAL,2
ZA,PERICARDIAL EFFUSION,2
ZA,PERIPHERAL VASCULAR DISORDER,2
ZA,RASH,2
ZA,RESPIRATORY DISTRESS,2
ZA,THROMBOSIS,2
ZA,VENTRICULAR TACHYCARDIA,2
ZA,WHITE BLOOD CELL COUNT INCREASED,2
ZA,ABASIA,1
ZA,ABDOMINAL DISCOMFORT,1
ZA,ABDOMINAL HERNIA,1
ZA,ABDOMINAL NEOPLASM,1
ZA,ABDOMINAL STRANGULATED HERNIA,1
ZA,ABNORMAL DREAMS,1
ZA,ABORTION SPONTANEOUS,1
ZA,ABSCESS OF EYELID,1
ZA,ACUTE PULMONARY OEDEMA,1
ZA,ADVERSE DRUG REACTION,1
ZA,AMPUTATION,1
ZA,ANGINA PECTORIS,1
ZA,ANGIOEDEMA,1
ZA,ANXIETY,1
ZA,ARRHYTHMIA,1
ZA,ARTHRITIS,1
ZA,ASPERGILLUS INFECTION,1
ZA,ATRIOVENTRICULAR BLOCK COMPLETE,1
ZA,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
ZA,BLOOD ALBUMIN DECREASED,1
ZA,BLOOD CREATININE INCREASED,1
ZA,BLOOD DISORDER,1
ZA,BLOOD IRON ABNORMAL,1
ZA,BLOOD IRON DECREASED,1
ZA,BLOOD PHOSPHORUS ABNORMAL,1
ZA,BLOOD POTASSIUM DECREASED,1
ZA,BLOOD POTASSIUM INCREASED,1
ZA,BLOOD PRESSURE DECREASED,1
ZA,BLOOD SODIUM DECREASED,1
ZA,BLOOD THYROID STIMULATING HORMONE DECREASED,1
ZA,BLOOD UREA INCREASED,1
ZA,BODY TEMPERATURE INCREASED,1
ZA,BRONCHOPNEUMONIA,1
ZA,BURNING SENSATION,1
ZA,C-REACTIVE PROTEIN INCREASED,1
ZA,CARDIAC ARREST,1
ZA,CARDIOGENIC SHOCK,1
ZA,CELLULITIS,1
ZA,CHEST DISCOMFORT,1
ZA,CHRONIC KIDNEY DISEASE,1
ZA,CHRONIC MYELOID LEUKAEMIA,1
ZA,COELIAC DISEASE,1
ZA,CONFUSIONAL STATE,1
ZA,CONSTIPATION,1
ZA,CONTUSION,1
ZA,COUGH,1
ZA,CRYING,1
ZA,CYSTITIS,1
ZA,DECREASED ACTIVITY,1
ZA,DEEP VEIN THROMBOSIS,1
ZA,DERMATITIS ALLERGIC,1
ZA,DIABETES MELLITUS,1
ZA,DIABETIC KETOACIDOSIS,1
ZA,DIABETIC ULCER,1
ZA,DIASTOLIC DYSFUNCTION,1
ZA,DISEASE PROGRESSION,1
ZA,DISEASE RECURRENCE,1
ZA,DISSEMINATED TUBERCULOSIS,1
ZA,DRUG DISPENSING ERROR,1
ZA,DRUG HYPERSENSITIVITY,1
ZA,DRUG LEVEL DECREASED,1
ZA,DRUG-INDUCED LIVER INJURY,1
ZA,DRY MOUTH,1
ZA,DYSPEPSIA,1
ZA,DYSPHAGIA,1
ZA,DYSPNOEA PAROXYSMAL NOCTURNAL,1
ZA,ELECTROCARDIOGRAM Q WAVES,1
ZA,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,1
ZA,ELECTROCARDIOGRAM T WAVE INVERSION,1
ZA,EPISTAXIS,1
ZA,EYE PRURITUS,1
ZA,FACIAL PARALYSIS,1
ZA,FEBRILE NEUTROPENIA,1
ZA,FISTULA,1
ZA,FLUID IMBALANCE,1
ZA,FLUID INTAKE REDUCED,1
ZA,FOETAL DEATH,1
ZA,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
ZA,GASTRIC DILATATION,1
ZA,GASTRIC ULCER PERFORATION,1
ZA,GASTROINTESTINAL NECROSIS,1
ZA,GENERALISED OEDEMA,1
ZA,GLOMERULAR FILTRATION RATE DECREASED,1
ZA,HAEMATOCRIT DECREASED,1
ZA,HAEMOGLOBIN ABNORMAL,1
ZA,HAEMORRHAGE,1
ZA,HALLUCINATION,1
ZA,HEART RATE IRREGULAR,1
ZA,HEART VALVE REPLACEMENT,1
ZA,HEMIPARESIS,1
ZA,HEPATITIS,1
ZA,HEPATOMEGALY,1
ZA,HEPATOTOXICITY,1
ZA,HERNIA,1
ZA,HERPES ZOSTER DISSEMINATED,1
ZA,HYPERGLYCAEMIA,1
ZA,HYPOAESTHESIA,1
ZA,HYPOGLYCAEMIC COMA,1
ZA,HYPOPHAGIA,1
ZA,HYPOXIA,1
ZA,ILL-DEFINED DISORDER,1
ZA,IMMUNE THROMBOCYTOPENIC PURPURA,1
ZA,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
ZA,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
ZA,INITIAL INSOMNIA,1
ZA,INTRACARDIAC THROMBUS,1
ZA,INVASIVE DUCTAL BREAST CARCINOMA,1
ZA,ISCHAEMIC HEPATITIS,1
ZA,JAUNDICE HEPATOCELLULAR,1
ZA,JOINT INJURY,1
ZA,JOINT SWELLING,1
ZA,LARGE INTESTINE PERFORATION,1
ZA,LARGE INTESTINE POLYP,1
ZA,LEFT VENTRICULAR FAILURE,1
ZA,LEUKAEMIA,1
ZA,LIGAMENT RUPTURE,1
ZA,LIMB DISCOMFORT,1
ZA,LIVER DISORDER,1
ZA,LIVER INJURY,1
ZA,LOSS OF CONSCIOUSNESS,1
ZA,LYMPHOCYTE COUNT INCREASED,1
ZA,MALIGNANT MELANOMA,1
ZA,MALIGNANT NEOPLASM PROGRESSION,1
ZA,MECHANICAL URTICARIA,1
ZA,MEDICATION ERROR,1
ZA,MELAENA,1
ZA,MITRAL VALVE INCOMPETENCE,1
ZA,MONOCYTE COUNT INCREASED,1
ZA,MULTI-ORGAN FAILURE,1
ZA,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
ZA,MUSCULOSKELETAL CHEST PAIN,1
ZA,MUSCULOSKELETAL PAIN,1
ZA,MUSCULOSKELETAL STIFFNESS,1
ZA,MYOCARDIAL INFARCTION,1
ZA,MYOSITIS,1
ZA,NEPHROLITHIASIS,1
ZA,NEUTROPENIA,1
ZA,NEUTROPENIC SEPSIS,1
ZA,NEUTROPHIL COUNT INCREASED,1
ZA,OBSTRUCTION,1
ZA,ORTHOPNOEA,1
ZA,OSTEOPOROSIS,1
ZA,PANIC REACTION,1
ZA,PATELLA FRACTURE,1
ZA,PERIPHERAL EMBOLISM,1
ZA,PERITONITIS,1
ZA,PHOTOPHOBIA,1
ZA,PLASMA CELL MYELOMA,1
ZA,PLATELET COUNT INCREASED,1
ZA,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
ZA,PNEUMONIA CYTOMEGALOVIRAL,1
ZA,PNEUMONIA HAEMOPHILUS,1
ZA,PNEUMONITIS,1
ZA,POST PROCEDURAL DISCHARGE,1
ZA,PRESCRIBED OVERDOSE,1
ZA,PROCALCITONIN INCREASED,1
ZA,PROCEDURAL INTESTINAL PERFORATION,1
ZA,PROSTATOMEGALY,1
ZA,PSEUDOMEMBRANOUS COLITIS,1
ZA,PSYCHIATRIC SYMPTOM,1
ZA,RASH ERYTHEMATOUS,1
ZA,RED BLOOD CELL COUNT DECREASED,1
ZA,RESPIRATORY FAILURE,1
ZA,RETCHING,1
ZA,RHABDOMYOLYSIS,1
ZA,ROAD TRAFFIC ACCIDENT,1
ZA,SCREAMING,1
ZA,SEPTIC SHOCK,1
ZA,SERUM FERRITIN INCREASED,1
ZA,SHOCK,1
ZA,SHOULDER OPERATION,1
ZA,SINUS ARREST,1
ZA,SINUS DISORDER,1
ZA,SKIN CANCER,1
ZA,SKIN LESION,1
ZA,SKIN SENSITISATION,1
ZA,SOMNOLENCE,1
ZA,SWELLING,1
ZA,SYNCOPE,1
ZA,SYSTEMIC CANDIDA,1
ZA,TACHYCARDIA,1
ZA,TOXICITY TO VARIOUS AGENTS,1
ZA,TYPE 1 DIABETES MELLITUS,1
ZA,TYPE 2 DIABETES MELLITUS,1
ZA,UMBILICAL HERNIA,1
ZA,UPPER GASTROINTESTINAL HAEMORRHAGE,1
ZA,URINARY INCONTINENCE,1
ZA,URINARY RETENTION POSTOPERATIVE,1
ZA,URINARY TRACT INFECTION,1
ZA,URTICARIA,1
ZA,VAGINAL HAEMORRHAGE,1
ZA,VERTIGO,1
ZA,WRONG DRUG ADMINISTERED,1
ES,ACUTE KIDNEY INJURY,129
ES,HYPERKALAEMIA,72
ES,CARDIAC FAILURE,49
ES,CONDITION AGGRAVATED,49
ES,HYPONATRAEMIA,49
ES,ANAEMIA,44
ES,TOXICITY TO VARIOUS AGENTS,40
ES,RENAL FAILURE ACUTE,37
ES,HYPOTENSION,36
ES,DYSPNOEA,34
ES,SOMNOLENCE,34
ES,RENAL FAILURE,33
ES,PNEUMONIA,32
ES,DIARRHOEA,30
ES,RENAL IMPAIRMENT,30
ES,HYPOKALAEMIA,29
ES,PYREXIA,29
ES,ASTHENIA,28
ES,ATRIAL FIBRILLATION,27
ES,DISORIENTATION,26
ES,STUPOR,26
ES,TRANSAMINASES INCREASED,26
ES,HEPATIC ENCEPHALOPATHY,25
ES,HYPOMAGNESAEMIA,24
ES,RESPIRATORY TRACT INFECTION,24
ES,RESPIRATORY FAILURE,22
ES,BRADYCARDIA,21
ES,DEATH,21
ES,ELECTROCARDIOGRAM QT PROLONGED,21
ES,OEDEMA PERIPHERAL,21
ES,SEPSIS,21
ES,VOMITING,21
ES,CHRONIC KIDNEY DISEASE,20
ES,DECREASED APPETITE,20
ES,ERYTHRODERMIC PSORIASIS,20
ES,EUPHORIC MOOD,20
ES,TORSADE DE POINTES,19
ES,TOXIC EPIDERMAL NECROLYSIS,19
ES,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,18
ES,LACTIC ACIDOSIS,18
ES,THROMBOCYTOPENIA,18
ES,ERYTHEMA,17
ES,FEBRILE NEUTROPENIA,17
ES,GASTROINTESTINAL HAEMORRHAGE,17
ES,CARDIO-RESPIRATORY ARREST,16
ES,FALL,16
ES,PLEURAL EFFUSION,16
ES,MYOCLONUS,15
ES,CARDIAC FAILURE CONGESTIVE,14
ES,FATIGUE,14
ES,HYPERTENSION,14
ES,METABOLIC ACIDOSIS,14
ES,NAUSEA,14
ES,NEUTROPENIA,14
ES,RHABDOMYOLYSIS,14
ES,BLOOD CREATININE INCREASED,13
ES,HEPATITIS CHOLESTATIC,13
ES,SEPTIC SHOCK,13
ES,SHOCK,13
ES,URINARY TRACT INFECTION,13
ES,CARDIAC ARREST,12
ES,GENERAL PHYSICAL HEALTH DETERIORATION,12
ES,SYNCOPE,12
ES,UPPER GASTROINTESTINAL HAEMORRHAGE,12
ES,ACUTE PULMONARY OEDEMA,11
ES,ATRIOVENTRICULAR BLOCK COMPLETE,11
ES,OVERDOSE,11
ES,VENTRICULAR TACHYCARDIA,11
ES,DRUG INEFFECTIVE,10
ES,HAEMATURIA,10
ES,HEPATITIS,10
ES,HYPERSENSITIVITY VASCULITIS,10
ES,LUNG INFILTRATION,10
ES,NEUROTOXICITY,10
ES,PANCYTOPENIA,10
ES,PEMPHIGOID,10
ES,SKIN ULCER,10
ES,ATRIOVENTRICULAR BLOCK,9
ES,CONSTIPATION,9
ES,DEPRESSED LEVEL OF CONSCIOUSNESS,9
ES,DIZZINESS,9
ES,HEPATIC FAILURE,9
ES,HYPOGLYCAEMIA,9
ES,INTERNATIONAL NORMALISED RATIO INCREASED,9
ES,LOSS OF CONSCIOUSNESS,9
ES,MALAISE,9
ES,MULTI-ORGAN FAILURE,9
ES,MULTIPLE ORGAN DYSFUNCTION SYNDROME,9
ES,OEDEMA,9
ES,STEVENS-JOHNSON SYNDROME,9
ES,ABDOMINAL PAIN,8
ES,ASCITES,8
ES,CARDIOGENIC SHOCK,8
ES,COUGH,8
ES,DIABETES MELLITUS INADEQUATE CONTROL,8
ES,DYSPHAGIA,8
ES,HYPOCALCAEMIA,8
ES,HYPOCOAGULABLE STATE,8
ES,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,8
ES,INTERSTITIAL LUNG DISEASE,8
ES,LOWER GASTROINTESTINAL HAEMORRHAGE,8
ES,MUCOSAL INFLAMMATION,8
ES,NODAL RHYTHM,8
ES,RENAL FAILURE CHRONIC,8
ES,TACHYCARDIA,8
ES,URINARY TRACT DISCOMFORT,8
ES,ACUTE HEPATIC FAILURE,7
ES,ASPHYXIA,7
ES,CONFUSIONAL STATE,7
ES,GAIT DISTURBANCE,7
ES,HAEMODYNAMIC INSTABILITY,7
ES,HEPATIC NECROSIS,7
ES,HEPATOTOXICITY,7
ES,HYPERBILIRUBINAEMIA,7
ES,LIVIDITY,7
ES,MUSCULAR WEAKNESS,7
ES,PAIN,7
ES,PLATELET COUNT DECREASED,7
ES,PULMONARY EMBOLISM,7
ES,RASH,7
ES,SUBDURAL HAEMATOMA,7
ES,TREATMENT NONCOMPLIANCE,7
ES,VENTRICULAR EXTRASYSTOLES,7
ES,WRONG PATIENT RECEIVED MEDICATION,7
ES,ABDOMINAL DISTENSION,6
ES,ACUTE MYOCARDIAL INFARCTION,6
ES,ANURIA,6
ES,BACK PAIN,6
ES,BLOOD BILIRUBIN INCREASED,6
ES,CHEST PAIN,6
ES,FLUID RETENTION,6
ES,HYPERGLYCAEMIA,6
ES,HYPERTRANSAMINASAEMIA,6
ES,PANCREATITIS ACUTE,6
ES,PERICARDIAL EFFUSION,6
ES,PRURITUS,6
ES,RIGHT VENTRICULAR FAILURE,6
ES,TOXIC SKIN ERUPTION,6
ES,TREMOR,6
ES,ABDOMINAL PAIN UPPER,5
ES,ABDOMINAL WALL HAEMATOMA,5
ES,ACUTE CORONARY SYNDROME,5
ES,ASPARTATE AMINOTRANSFERASE INCREASED,5
ES,BLOOD GLUCOSE INCREASED,5
ES,BRADYPHRENIA,5
ES,CHOLELITHIASIS,5
ES,DEHYDRATION,5
ES,DEPRESSION,5
ES,DYSARTHRIA,5
ES,GASTROENTERITIS,5
ES,HEADACHE,5
ES,ISCHAEMIC STROKE,5
ES,JAUNDICE,5
ES,METABOLIC ALKALOSIS,5
ES,PNEUMONITIS,5
ES,PRESYNCOPE,5
ES,PURPURA,5
ES,RECTAL HAEMORRHAGE,5
ES,URINARY RETENTION,5
ES,ACUTE MYELOID LEUKAEMIA,4
ES,ALANINE AMINOTRANSFERASE INCREASED,4
ES,ANGINA PECTORIS,4
ES,BILE DUCT OBSTRUCTION,4
ES,BLOOD PRESSURE INCREASED,4
ES,COAGULOPATHY,4
ES,CONCOMITANT DISEASE PROGRESSION,4
ES,DISCOMFORT,4
ES,DISEASE PROGRESSION,4
ES,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,4
ES,DRUG-INDUCED LIVER INJURY,4
ES,FEELING ABNORMAL,4
ES,HAEMATOMA,4
ES,HAEMOGLOBIN DECREASED,4
ES,HALLUCINATION_ VISUAL,4
ES,HEPATITIS TOXIC,4
ES,HEPATOCELLULAR CARCINOMA,4
ES,HERPES ZOSTER,4
ES,HYPERHIDROSIS,4
ES,ISCHAEMIC HEPATITIS,4
ES,LIVER DISORDER,4
ES,MEDICATION ERROR,4
ES,MITRAL VALVE INCOMPETENCE,4
ES,MYOCARDIAL ISCHAEMIA,4
ES,OVERLAP SYNDROME,4
ES,PAIN IN EXTREMITY,4
ES,PLASMA CELL MYELOMA,4
ES,PULMONARY ARTERIAL HYPERTENSION,4
ES,SPONTANEOUS HAEMATOMA,4
ES,URTICARIA,4
ES,VENTRICULAR FIBRILLATION,4
ES,ACUTE PRERENAL FAILURE,3
ES,BALANCE DISORDER,3
ES,BLISTER,3
ES,BLOOD GLUCOSE ABNORMAL,3
ES,BRONCHOSPASM,3
ES,BUNDLE BRANCH BLOCK LEFT,3
ES,BUNDLE BRANCH BLOCK RIGHT,3
ES,CARDIAC FAILURE CHRONIC,3
ES,CARDIOMEGALY,3
ES,CEREBROVASCULAR ACCIDENT,3
ES,COLITIS,3
ES,CONGESTIVE CARDIOMYOPATHY,3
ES,CRANIOCEREBRAL INJURY,3
ES,CYTOMEGALOVIRUS INFECTION,3
ES,DERMATITIS BULLOUS,3
ES,DERMATITIS EXFOLIATIVE GENERALISED,3
ES,DRUG LEVEL INCREASED,3
ES,ENCEPHALOPATHY,3
ES,GAMMA-GLUTAMYLTRANSFERASE INCREASED,3
ES,GASTRIC ULCER,3
ES,GENERALISED OEDEMA,3
ES,HAEMATOCHEZIA,3
ES,HAEMOLYTIC URAEMIC SYNDROME,3
ES,HAEMOPTYSIS,3
ES,HAEMORRHAGE INTRACRANIAL,3
ES,HYPERSENSITIVITY,3
ES,HYPERTENSIVE CRISIS,3
ES,HYPOVOLAEMIC SHOCK,3
ES,ILEUS PARALYTIC,3
ES,INFLUENZA,3
ES,INSOMNIA,3
ES,INTERCEPTED DRUG ADMINISTRATION ERROR,3
ES,LEUKOPENIA,3
ES,LINEAR IGA DISEASE,3
ES,MALIGNANT NEOPLASM PROGRESSION,3
ES,MYOCARDIAL INFARCTION,3
ES,NEUROPATHY PERIPHERAL,3
ES,NIKOLSKY^S SIGN,3
ES,OCULAR ICTERUS,3
ES,OLIGURIA,3
ES,OSTEONECROSIS OF JAW,3
ES,PERITONITIS,3
ES,PNEUMONIA ASPIRATION,3
ES,PRODUCT USE ISSUE,3
ES,PRURITUS GENERALISED,3
ES,PUBIS FRACTURE,3
ES,PULMONARY HAEMORRHAGE,3
ES,PULMONARY OEDEMA,3
ES,PULSELESS ELECTRICAL ACTIVITY,3
ES,RALES,3
ES,RENAL TUBULAR NECROSIS,3
ES,SEROTONIN SYNDROME,3
ES,SKIN LESION,3
ES,SKIN PLAQUE,3
ES,SKIN TOXICITY,3
ES,TACHYPNOEA,3
ES,URINARY INCONTINENCE,3
ES,WEIGHT INCREASED,3
ES,WRONG TECHNIQUE IN DRUG USAGE PROCESS,3
ES,ABASIA,2
ES,ACQUIRED TRACHEO-OESOPHAGEAL FISTULA,2
ES,ACUTE LYMPHOCYTIC LEUKAEMIA,2
ES,ACUTE RESPIRATORY FAILURE,2
ES,ADRENAL INSUFFICIENCY,2
ES,AGITATION,2
ES,ANGIOPATHY,2
ES,ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC,2
ES,APHASIA,2
ES,ARTHRALGIA,2
ES,ARTHROPATHY,2
ES,ATAXIA,2
ES,ATELECTASIS,2
ES,BLOOD ALKALINE PHOSPHATASE INCREASED,2
ES,BLOOD CREATINE PHOSPHOKINASE INCREASED,2
ES,BLOOD UREA INCREASED,2
ES,BODY TEMPERATURE INCREASED,2
ES,BREAST CANCER,2
ES,BRONCHITIS,2
ES,BRONCHOPULMONARY ASPERGILLOSIS,2
ES,C-REACTIVE PROTEIN INCREASED,2
ES,CARDIAC FAILURE ACUTE,2
ES,CARDIAC TAMPONADE,2
ES,CARDIOTOXICITY,2
ES,CAROTID ARTERY STENOSIS,2
ES,CELLULITIS,2
ES,CHILLS,2
ES,CHOLECYSTITIS,2
ES,CHOLECYSTITIS ACUTE,2
ES,CHOLESTASIS,2
ES,COAGULATION TEST ABNORMAL,2
ES,COGNITIVE DISORDER,2
ES,COMA,2
ES,COMPARTMENT SYNDROME,2
ES,CONCOMITANT DISEASE AGGRAVATED,2
ES,CONTRAINDICATED PRODUCT ADMINISTERED,2
ES,CORONARY ARTERY DISEASE,2
ES,CUSHING^S SYNDROME,2
ES,DECREASED IMMUNE RESPONSIVENESS,2
ES,DECUBITUS ULCER,2
ES,DEEP VEIN THROMBOSIS,2
ES,DELIRIUM,2
ES,DEVICE RELATED INFECTION,2
ES,DRUG LEVEL ABOVE THERAPEUTIC,2
ES,DRUG PRESCRIBING ERROR,2
ES,DYSKINESIA,2
ES,DYSPEPSIA,2
ES,DYSPNOEA AT REST,2
ES,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,2
ES,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,2
ES,ENDOCARDITIS,2
ES,EOSINOPHILIA,2
ES,EXTRAVASATION,2
ES,FOETAL EXPOSURE DURING PREGNANCY,2
ES,FOOD INTOLERANCE,2
ES,GASTROENTERITIS SALMONELLA,2
ES,GASTROINTESTINAL TOXICITY,2
ES,GENERALISED TONIC-CLONIC SEIZURE,2
ES,GLOMERULAR FILTRATION RATE DECREASED,2
ES,GLOSSOPHARYNGEAL NERVE PARALYSIS,2
ES,GOUTY TOPHUS,2
ES,HAEMORRHAGE,2
ES,HAEMORRHOIDS,2
ES,HEART RATE INCREASED,2
ES,HEPATITIS ACUTE,2
ES,HEPATOCELLULAR INJURY,2
ES,HERPES OPHTHALMIC,2
ES,HYPERCALCAEMIA,2
ES,HYPERTRIGLYCERIDAEMIA,2
ES,HYPOAESTHESIA,2
ES,HYPOGLYCAEMIC COMA,2
ES,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,2
ES,INFECTION,2
ES,INFLAMMATORY MARKER INCREASED,2
ES,INTESTINAL HAEMORRHAGE,2
ES,INTESTINAL ISCHAEMIA,2
ES,INTESTINAL PERFORATION,2
ES,INTRA-ABDOMINAL HAEMATOMA,2
ES,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,2
ES,LEUKOCYTOSIS,2
ES,LOWER RESPIRATORY TRACT INFECTION,2
ES,LUNG DISORDER,2
ES,LYMPHADENOPATHY,2
ES,MELAENA,2
ES,MICROANGIOPATHY,2
ES,MUSCLE HAEMORRHAGE,2
ES,MYELODYSPLASTIC SYNDROME,2
ES,MYOCARDITIS,2
ES,NASOPHARYNGITIS,2
ES,NERVOUS SYSTEM DISORDER,2
ES,NERVOUSNESS,2
ES,NEUTROPHILIA,2
ES,ODYNOPHAGIA,2
ES,OROPHARYNGEAL CANDIDIASIS,2
ES,OSTEOPOROSIS,2
ES,PALLOR,2
ES,PALPITATIONS,2
ES,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,2
ES,PERIPHERAL ISCHAEMIA,2
ES,PERITONEAL HAEMORRHAGE,2
ES,PETECHIAE,2
ES,PNEUMONIA BACTERIAL,2
ES,PORTAL VEIN THROMBOSIS,2
ES,POST PROCEDURAL HAEMORRHAGE,2
ES,POSTOPERATIVE WOUND INFECTION,2
ES,PRESCRIBED OVERDOSE,2
ES,PULMONARY HYPERTENSION,2
ES,RASH ERYTHEMATOUS,2
ES,RENAL CANCER METASTATIC,2
ES,RESPIRATORY DISORDER,2
ES,SEIZURE,2
ES,SHOCK HAEMORRHAGIC,2
ES,SIGHT DISABILITY,2
ES,SINUS BRADYCARDIA,2
ES,SINUS NODE DYSFUNCTION,2
ES,SLEEP APNOEA SYNDROME,2
ES,SLEEP DISORDER,2
ES,SPLENOMEGALY,2
ES,STOMATITIS,2
ES,SUDDEN DEATH,2
ES,SWELLING,2
ES,TOE AMPUTATION,2
ES,TUBULOINTERSTITIAL NEPHRITIS,2
ES,UMBILICAL HERNIA,2
ES,VAGUS NERVE PARALYSIS,2
ES,VENOOCCLUSIVE LIVER DISEASE,2
ES,VISUAL IMPAIRMENT,2
ES,ABDOMINAL DISCOMFORT,1
ES,ABDOMINAL INFECTION,1
ES,ABDOMINAL SYMPTOM,1
ES,ACCIDENTAL OVERDOSE,1
ES,ACQUIRED DIAPHRAGMATIC EVENTRATION,1
ES,ADENOCARCINOMA GASTRIC,1
ES,ADENOCARCINOMA OF COLON,1
ES,ADMINISTRATION SITE PAIN,1
ES,AGGRESSION,1
ES,ALOPECIA,1
ES,ALTERED STATE OF CONSCIOUSNESS,1
ES,AMAUROSIS,1
ES,ANAEMIA MACROCYTIC,1
ES,ANAL SPHINCTER ATONY,1
ES,ANAL ULCER,1
ES,ANGINA UNSTABLE,1
ES,ANGIOEDEMA,1
ES,ANXIETY,1
ES,AORTIC STENOSIS,1
ES,AORTIC THROMBOSIS,1
ES,AORTIC VALVE INCOMPETENCE,1
ES,APHAGIA,1
ES,APHTHOUS STOMATITIS,1
ES,APLASIA,1
ES,APRAXIA,1
ES,ARRHYTHMIA,1
ES,ARTERIAL DISORDER,1
ES,ARTERIAL HAEMORRHAGE,1
ES,ARTERIOSCLEROSIS CORONARY ARTERY,1
ES,ASPERGILLUS INFECTION,1
ES,ASTHMA,1
ES,AUTOIMMUNE HAEMOLYTIC ANAEMIA,1
ES,AUTONOMIC NERVOUS SYSTEM IMBALANCE,1
ES,B-CELL LYMPHOMA,1
ES,BACTERAEMIA,1
ES,BASAL GANGLIA HAEMATOMA,1
ES,BASAL GANGLIA HAEMORRHAGE,1
ES,BASE EXCESS DECREASED,1
ES,BENIGN PROSTATIC HYPERPLASIA,1
ES,BILIARY DILATATION,1
ES,BILIRUBIN CONJUGATED INCREASED,1
ES,BIOPSY LIVER ABNORMAL,1
ES,BLADDER DYSFUNCTION,1
ES,BLINDNESS,1
ES,BLOOD ALBUMIN DECREASED,1
ES,BLOOD ALKALINE PHOSPHATASE,1
ES,BLOOD BICARBONATE DECREASED,1
ES,BLOOD CREATINE INCREASED,1
ES,BLOOD GLUCOSE DECREASED,1
ES,BLOOD GLUCOSE FLUCTUATION,1
ES,BLOOD GROWTH HORMONE INCREASED,1
ES,BLOOD LACTATE DEHYDROGENASE ABNORMAL,1
ES,BLOOD LACTATE DEHYDROGENASE INCREASED,1
ES,BLOOD PH DECREASED,1
ES,BLOOD PRESSURE DECREASED,1
ES,BODY TEMPERATURE DECREASED,1
ES,BONE DISORDER,1
ES,BONE MARROW FAILURE,1
ES,BONE MARROW INFILTRATION,1
ES,BRADYARRHYTHMIA,1
ES,BRADYKINESIA,1
ES,BRAIN HERNIATION,1
ES,BRAIN MASS,1
ES,BRAIN OEDEMA,1
ES,BREAKTHROUGH PAIN,1
ES,BREAST CANCER RECURRENT,1
ES,BREATH SOUNDS ABNORMAL,1
ES,BRONCHIECTASIS,1
ES,BRONCHOALVEOLAR LAVAGE ABNORMAL,1
ES,CAESAREAN SECTION,1
ES,CALCIPHYLAXIS,1
ES,CANDIDA INFECTION,1
ES,CAPILLARITIS,1
ES,CARDIAC AMYLOIDOSIS,1
ES,CARDIAC DISCOMFORT,1
ES,CARDIAC DISORDER,1
ES,CARDIAC MURMUR,1
ES,CARDIOVASCULAR DISORDER,1
ES,CAUDA EQUINA SYNDROME,1
ES,CENTRAL VENOUS PRESSURE INCREASED,1
ES,CEREBRAL HAEMATOMA,1
ES,CEREBRAL HAEMORRHAGE,1
ES,CHEST DISCOMFORT,1
ES,CHEST INJURY,1
ES,CHOKING SENSATION,1
ES,CHRONIC HEPATITIS,1
ES,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
ES,CHRONIC RESPIRATORY FAILURE,1
ES,COLD SWEAT,1
ES,COLITIS ISCHAEMIC,1
ES,COLON CANCER,1
ES,CONDUCT DISORDER,1
ES,CONDUCTION DISORDER,1
ES,CONTRAINDICATED DRUG ADMINISTERED,1
ES,CONTUSION,1
ES,CONVULSION,1
ES,CORONARY ARTERY BYPASS,1
ES,CORONARY ARTERY THROMBOSIS,1
ES,CREPITATIONS,1
ES,CUTANEOUS AMYLOIDOSIS,1
ES,CYANOSIS,1
ES,CYSTATIN C INCREASED,1
ES,CYTOMEGALOVIRUS GASTRITIS,1
ES,DEPRESSED MOOD,1
ES,DIABETIC HYPEROSMOLAR COMA,1
ES,DIABETIC KETOACIDOSIS,1
ES,DIABETIC RETINOPATHY,1
ES,DIALYSIS,1
ES,DIAPHRAGMATIC PARALYSIS,1
ES,DIARRHOEA INFECTIOUS,1
ES,DIASTOLIC DYSFUNCTION,1
ES,DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION,1
ES,DIVERTICULITIS INTESTINAL HAEMORRHAGIC,1
ES,DIVERTICULUM INTESTINAL,1
ES,DRUG DOSE OMISSION,1
ES,DRUG INTOLERANCE,1
ES,DRUG RESISTANCE,1
ES,DUODENAL ULCER,1
ES,DUODENAL ULCER PERFORATION,1
ES,DYSPHONIA,1
ES,DYSPNOEA EXERTIONAL,1
ES,DYSTONIA,1
ES,DYSURIA,1
ES,EATING DISORDER,1
ES,ECZEMA,1
ES,ELECTROCARDIOGRAM QRS COMPLEX SHORTENED,1
ES,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,1
ES,ELECTROCARDIOGRAM T WAVE ABNORMAL,1
ES,ELECTROCARDIOGRAM T WAVE INVERSION,1
ES,ELECTROLYTE IMBALANCE,1
ES,EMBOLIC STROKE,1
ES,EMPYEMA,1
ES,ENCEPHALITIS,1
ES,ENTEROCOLITIS INFECTIOUS,1
ES,ERECTILE DYSFUNCTION,1
ES,ERYTHEMA MULTIFORME,1
ES,ESCHERICHIA SEPSIS,1
ES,EXTENSOR PLANTAR RESPONSE,1
ES,EYE DISORDER,1
ES,EYE HAEMORRHAGE,1
ES,EYE PAIN,1
ES,FACIAL PARALYSIS,1
ES,FAECES DISCOLOURED,1
ES,FEMUR FRACTURE,1
ES,FISTULA,1
ES,FIXED DRUG ERUPTION,1
ES,FLUID INTAKE REDUCED,1
ES,FOETAL GROWTH RESTRICTION,1
ES,FOLLICULITIS,1
ES,FUNCTIONAL RESIDUAL CAPACITY DECREASED,1
ES,GALLBLADDER DISORDER,1
ES,GASTRIC HAEMORRHAGE,1
ES,GASTRIC VARICES,1
ES,GASTRITIS,1
ES,GASTROINTESTINAL ANGIODYSPLASIA,1
ES,GASTROINTESTINAL ANGIODYSPLASIA HAEMORRHAGIC,1
ES,GASTROINTESTINAL DISORDER,1
ES,GASTROINTESTINAL FUNGAL INFECTION,1
ES,GASTROINTESTINAL NECROSIS,1
ES,GASTROINTESTINAL STROMAL TUMOUR,1
ES,GASTROINTESTINAL TRACT ADENOMA,1
ES,GASTROOESOPHAGEAL REFLUX DISEASE,1
ES,GASTROOESOPHAGEAL SPHINCTER INSUFFICIENCY,1
ES,GAZE PALSY,1
ES,GENERAL PHYSICAL CONDITION ABNORMAL,1
ES,GENITAL INFECTION FUNGAL,1
ES,GLIOBLASTOMA,1
ES,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
ES,GOITRE,1
ES,GRAND MAL CONVULSION,1
ES,GUILLAIN-BARRE SYNDROME,1
ES,HAEMANGIOMA,1
ES,HAEMATEMESIS,1
ES,HAEMATOCRIT DECREASED,1
ES,HAEMOLYTIC ANAEMIA,1
ES,HAEMORRHAGIC ANAEMIA,1
ES,HAEMORRHAGIC STROKE,1
ES,HAEMORRHOIDAL HAEMORRHAGE,1
ES,HEART RATE DECREASED,1
ES,HEART TRANSPLANT REJECTION,1
ES,HEMIPARESIS,1
ES,HEPARIN-INDUCED THROMBOCYTOPENIA,1
ES,HEPATIC CYST,1
ES,HEPATIC ENZYME INCREASED,1
ES,HEPATIC FUNCTION ABNORMAL,1
ES,HEPATIC INFECTION FUNGAL,1
ES,HEPATIC STEATOSIS,1
ES,HEPATOMEGALY,1
ES,HEPATORENAL SYNDROME,1
ES,HERPES SIMPLEX,1
ES,HIATUS HERNIA,1
ES,HYDROCEPHALUS,1
ES,HYDRONEPHROSIS,1
ES,HYPERCREATININAEMIA,1
ES,HYPERLACTACIDAEMIA,1
ES,HYPERNATRAEMIA,1
ES,HYPEROSMOLAR STATE,1
ES,HYPERREFLEXIA,1
ES,HYPERTROPHIC CARDIOMYOPATHY,1
ES,HYPERURICAEMIA,1
ES,HYPOACUSIS,1
ES,HYPOAESTHESIA ORAL,1
ES,HYPOCHLORAEMIA,1
ES,HYPOKINESIA,1
ES,HYPOOSMOLAR STATE,1
ES,HYPOPHAGIA,1
ES,HYPOPNOEA,1
ES,HYPOTHYROIDISM,1
ES,HYPOVOLAEMIA,1
ES,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,1
ES,ILEUS,1
ES,IMMUNOSUPPRESSANT DRUG LEVEL DECREASED,1
ES,IMPAIRED WORK ABILITY,1
ES,IMPULSE-CONTROL DISORDER,1
ES,INCARCERATED HERNIA,1
ES,INCORRECT DRUG ADMINISTRATION RATE,1
ES,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
ES,INFECTED SKIN ULCER,1
ES,INFLAMMATION,1
ES,INFREQUENT BOWEL MOVEMENTS,1
ES,INJECTION SITE ERYTHEMA,1
ES,INJECTION SITE GRANULOMA,1
ES,INJECTION SITE HAEMATOMA,1
ES,INJECTION SITE PAIN,1
ES,INJECTION SITE PRURITUS,1
ES,INJECTION SITE RASH,1
ES,INJECTION SITE URTICARIA,1
ES,INSULIN-LIKE GROWTH FACTOR INCREASED,1
ES,INTENTIONAL PRODUCT MISUSE,1
ES,INTERNATIONAL NORMALISED RATIO ABNORMAL,1
ES,INTERNATIONAL NORMALISED RATIO FLUCTUATION,1
ES,INTESTINAL OBSTRUCTION,1
ES,INTESTINAL POLYP,1
ES,INTESTINAL SEPSIS,1
ES,INTRA-ABDOMINAL HAEMORRHAGE,1
ES,INTRACRANIAL PRESSURE INCREASED,1
ES,INVASIVE DUCTAL BREAST CARCINOMA,1
ES,IRON DEFICIENCY ANAEMIA,1
ES,IRRITABILITY,1
ES,JOINT SWELLING,1
ES,KLEBSIELLA TEST POSITIVE,1
ES,LACUNAR STROKE,1
ES,LANGUAGE DISORDER,1
ES,LARGE INTESTINE PERFORATION,1
ES,LEFT VENTRICULAR DYSFUNCTION,1
ES,LEG AMPUTATION,1
ES,LEUKOCYTURIA,1
ES,LICHEN PLANUS,1
ES,LIMB DISCOMFORT,1
ES,LIP EROSION,1
ES,LOBAR PNEUMONIA,1
ES,LOCAL SWELLING,1
ES,LOW BIRTH WEIGHT BABY,1
ES,LUNG ADENOCARCINOMA,1
ES,LUNG CANCER METASTATIC,1
ES,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV,1
ES,LUNG TRANSPLANT REJECTION,1
ES,MALNUTRITION,1
ES,MATERNAL DRUGS AFFECTING FOETUS,1
ES,MECHANICAL URTICARIA,1
ES,MEMORY IMPAIRMENT,1
ES,MESENTERIC ARTERY EMBOLISM,1
ES,METABOLIC DISORDER,1
ES,METABOLIC ENCEPHALOPATHY,1
ES,METHAEMOGLOBINAEMIA,1
ES,MICTURITION DISORDER,1
ES,MIXED LIVER INJURY,1
ES,MOTOR DYSFUNCTION,1
ES,MUCOSAL DRYNESS,1
ES,MULTIMORBIDITY,1
ES,MULTIPLE DRUG THERAPY,1
ES,MUMPS,1
ES,MUSCLE SPASMS,1
ES,MUSCULOSKELETAL STIFFNESS,1
ES,MYASTHENIA GRAVIS,1
ES,MYOSITIS,1
ES,NECK PAIN,1
ES,NECROTISING FASCIITIS,1
ES,NEGATIVE CARDIAC INOTROPIC EFFECT,1
ES,NEONATAL CHOLESTASIS,1
ES,NEONATAL HYPOCALCAEMIA,1
ES,NEPHRITIC SYNDROME,1
ES,NEPHROANGIOSCLEROSIS,1
ES,NEPHROGENIC SYSTEMIC FIBROSIS,1
ES,NEPHROLITHIASIS,1
ES,NEPHROPATHY TOXIC,1
ES,NEURALGIA,1
ES,NEUROLOGICAL DECOMPENSATION,1
ES,NEUROLOGICAL EXAMINATION ABNORMAL,1
ES,NEUROLOGICAL SYMPTOM,1
ES,NEUROMUSCULAR BLOCK PROLONGED,1
ES,NEUROMYELITIS OPTICA SPECTRUM DISORDER,1
ES,NO ADVERSE EVENT,1
ES,NODULAR REGENERATIVE HYPERPLASIA,1
ES,OESOPHAGEAL CANDIDIASIS,1
ES,OESOPHAGEAL VARICES HAEMORRHAGE,1
ES,OESOPHAGITIS,1
ES,OPTIC ISCHAEMIC NEUROPATHY,1
ES,ORAL HERPES,1
ES,ORAL PAIN,1
ES,ORGANISING PNEUMONIA,1
ES,ORTHOPNOEA,1
ES,ORTHOSTATIC HYPOTENSION,1
ES,OXYGEN SATURATION DECREASED,1
ES,PANCREATIC CARCINOMA,1
ES,PANCREATITIS,1
ES,PAPULE,1
ES,PARAPARESIS,1
ES,PARATRACHEAL LYMPHADENOPATHY,1
ES,PARKINSON^S DISEASE,1
ES,PCO2 DECREASED,1
ES,PEMPHIGUS,1
ES,PERICARDITIS,1
ES,PERICARDITIS CONSTRICTIVE,1
ES,PERIPHERAL SENSORIMOTOR NEUROPATHY,1
ES,PERIRECTAL ABSCESS,1
ES,PERITONEAL DIALYSIS,1
ES,PERITONITIS BACTERIAL,1
ES,PHLEBITIS DEEP,1
ES,PHOTOSENSITIVITY REACTION,1
ES,PITUITARY TUMOUR BENIGN,1
ES,PLASMABLASTIC LYMPHOMA,1
ES,PLATELET COUNT ABNORMAL,1
ES,PNEUMOCOCCAL INFECTION,1
ES,PNEUMONIA INFLUENZAL,1
ES,PNEUMONIA STREPTOCOCCAL,1
ES,POLYCYTHAEMIA,1
ES,POLYP,1
ES,POLYURIA,1
ES,PORPHYRIA,1
ES,POST PROCEDURAL COMPLICATION,1
ES,PREMATURE BABY,1
ES,PRIMARY HYPERALDOSTERONISM,1
ES,PRIMARY HYPOTHYROIDISM,1
ES,PROCTITIS,1
ES,PRODUCT USE IN UNAPPROVED INDICATION,1
ES,PRODUCTIVE COUGH,1
ES,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
ES,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
ES,PROTEINURIA,1
ES,PROTEUS INFECTION,1
ES,PROTEUS TEST POSITIVE,1
ES,PRURITUS GENITAL,1
ES,PSEUDOMEMBRANOUS COLITIS,1
ES,PSORIASIS,1
ES,PULMONARY CALCIFICATION,1
ES,PULMONARY FIBROSIS,1
ES,PULMONARY GRANULOMA,1
ES,PULMONARY MASS,1
ES,PULMONARY SEPSIS,1
ES,PUPILLARY REFLEX IMPAIRED,1
ES,RADIAL NERVE PALSY,1
ES,RAPID CORRECTION OF HYPONATRAEMIA,1
ES,RECTAL CANCER STAGE 0,1
ES,RENAL CELL CARCINOMA,1
ES,RENAL CYST,1
ES,RENAL HAEMATOMA,1
ES,RENAL HAEMORRHAGE,1
ES,RENAL PAIN,1
ES,RESPIRATORY DEPRESSION,1
ES,RESPIRATORY DISTRESS,1
ES,RESPIRATORY RATE INCREASED,1
ES,RESPIRATORY SYNCYTIAL VIRUS BRONCHIOLITIS,1
ES,RESTLESSNESS,1
ES,RHEUMATOID ARTHRITIS,1
ES,RHYTHM IDIOVENTRICULAR,1
ES,RIGHT VENTRICULAR DILATATION,1
ES,ROAD TRAFFIC ACCIDENT,1
ES,SCAR,1
ES,SINOATRIAL BLOCK,1
ES,SINUS RHYTHM,1
ES,SINUSITIS,1
ES,SKIN DISORDER,1
ES,SKIN EROSION,1
ES,SKIN INJURY,1
ES,SNORING,1
ES,SOMATIC SYMPTOM DISORDER,1
ES,SPINAL COMPRESSION FRACTURE,1
ES,SPINAL PAIN,1
ES,SPLENIC NECROSIS,1
ES,SPONDYLOLISTHESIS,1
ES,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,1
ES,SQUAMOUS CELL CARCINOMA OF LUNG,1
ES,STAPHYLOCOCCAL INFECTION,1
ES,STAPHYLOCOCCAL SEPSIS,1
ES,STATUS EPILEPTICUS,1
ES,STEATOHEPATITIS,1
ES,STEATORRHOEA,1
ES,STOMATOCOCCAL INFECTION,1
ES,SUBILEUS,1
ES,SUFFOCATION FEELING,1
ES,SUICIDE ATTEMPT,1
ES,SUPRAVENTRICULAR TACHYCARDIA,1
ES,SUTURE RUPTURE,1
ES,SYNOVITIS,1
ES,SYSTEMIC CANDIDA,1
ES,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,1
ES,SYSTOLIC DYSFUNCTION,1
ES,SYSTOLIC HYPERTENSION,1
ES,THERAPY NON-RESPONDER,1
ES,THERMOHYPOAESTHESIA,1
ES,THROMBOCYTOPENIC PURPURA,1
ES,THROMBOSIS IN DEVICE,1
ES,THROMBOTIC MICROANGIOPATHY,1
ES,TOOTHACHE,1
ES,TOXIC ENCEPHALOPATHY,1
ES,TRACHEOBRONCHITIS,1
ES,TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA,1
ES,TRANSFUSION-RELATED ACUTE LUNG INJURY,1
ES,TRANSITIONAL CELL CARCINOMA,1
ES,TROPONIN T INCREASED,1
ES,TUBERCULOSIS,1
ES,TUMOUR LYSIS SYNDROME,1
ES,TUMOUR PAIN,1
ES,ULCERATIVE KERATITIS,1
ES,UNRESPONSIVE TO STIMULI,1
ES,URAEMIC ENCEPHALOPATHY,1
ES,URINARY BLADDER ATROPHY,1
ES,URINARY TRACT INFECTION ENTEROCOCCAL,1
ES,URINE OUTPUT DECREASED,1
ES,USE OF ACCESSORY RESPIRATORY MUSCLES,1
ES,VARICES OESOPHAGEAL,1
ES,VARICOSE VEIN,1
ES,VASCULAR GRAFT THROMBOSIS,1
ES,VASCULITIC ULCER,1
ES,VASCULITIS,1
ES,VENOUS PRESSURE JUGULAR INCREASED,1
ES,VENTRICULAR DYSFUNCTION,1
ES,WEANING FAILURE,1
ES,WEIGHT DECREASED,1
ES,WHEEZING,1
ES,WHITE BLOOD CELL COUNT DECREASED,1
ES,WOUND,1
LK,MYOPATHY,5
LK,ABDOMINAL PAIN,1
LK,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
LK,ECHOCARDIOGRAM ABNORMAL,1
LK,EJECTION FRACTION DECREASED,1
LK,HYPOREFLEXIA,1
LK,HYPOTENSION,1
LK,OEDEMA PERIPHERAL,1
LK,PALLOR,1
SD,BLOOD CREATININE INCREASED,2
SD,BLOOD UREA INCREASED,1
SD,DIZZINESS,1
SD,HYPOTENSION,1
SD,RENAL ISCHAEMIA,1
SE,ACUTE KIDNEY INJURY,17
SE,HEADACHE,15
SE,HYPONATRAEMIA,14
SE,NAUSEA,13
SE,CARDIAC FAILURE,12
SE,HYPOTENSION,12
SE,TOXICITY TO VARIOUS AGENTS,12
SE,VOMITING,11
SE,ALOPECIA,9
SE,DEHYDRATION,9
SE,DYSPNOEA,9
SE,WEIGHT DECREASED,9
SE,APHASIA,8
SE,DIARRHOEA,8
SE,DRUG INEFFECTIVE,8
SE,HYPOMAGNESAEMIA,8
SE,NEUROLEPTIC MALIGNANT SYNDROME,8
SE,RHABDOMYOLYSIS,8
SE,DIZZINESS,7
SE,DRY MOUTH,7
SE,FALL,7
SE,FLUSHING,7
SE,ABNORMAL FAECES,6
SE,ATRIAL FIBRILLATION,6
SE,BLOOD CREATININE INCREASED,6
SE,CHROMATURIA,6
SE,EAR INFECTION,6
SE,FATIGUE,6
SE,GASTROINTESTINAL MOTILITY DISORDER,6
SE,HEART RATE INCREASED,6
SE,LIP SWELLING,6
SE,MUSCULOSKELETAL DISCOMFORT,6
SE,MUSCULOSKELETAL STIFFNESS,6
SE,ORAL DISCOMFORT,6
SE,RED BLOOD CELL COUNT DECREASED,6
SE,SOMATIC DELUSION,6
SE,SWOLLEN TONGUE,6
SE,URINE ODOUR ABNORMAL,6
SE,WHITE BLOOD CELL COUNT DECREASED,6
SE,BRADYCARDIA,5
SE,CEREBROVASCULAR ACCIDENT,5
SE,DYSSTASIA,5
SE,MUSCULAR WEAKNESS,5
SE,RENAL IMPAIRMENT,5
SE,SOMNOLENCE,5
SE,TREATMENT NONCOMPLIANCE,5
SE,ANAEMIA,4
SE,ANXIETY,4
SE,CONFUSIONAL STATE,4
SE,DECREASED APPETITE,4
SE,DEPRESSED LEVEL OF CONSCIOUSNESS,4
SE,FEBRILE NEUTROPENIA,4
SE,PNEUMONIA,4
SE,SEPSIS,4
SE,ABDOMINAL PAIN,3
SE,CALCIUM METABOLISM DISORDER,3
SE,CEREBRAL HAEMORRHAGE,3
SE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
SE,DEATH,3
SE,DEPRESSION,3
SE,DRUG ERUPTION,3
SE,HAEMATURIA,3
SE,HYPERTENSION,3
SE,LEUKOPENIA,3
SE,MAGNESIUM METABOLISM DISORDER,3
SE,MUSCLE SPASMS,3
SE,MYALGIA,3
SE,NEUROPSYCHIATRIC SYNDROME,3
SE,NEUTROPENIC SEPSIS,3
SE,OEDEMA PERIPHERAL,3
SE,OSTEONECROSIS OF JAW,3
SE,PRERENAL FAILURE,3
SE,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,3
SE,PULMONARY EMBOLISM,3
SE,RENAL FAILURE,3
SE,RESPIRATORY TRACT INFECTION,3
SE,SPEECH DISORDER,3
SE,SYNCOPE,3
SE,THROMBOCYTOPENIA,3
SE,URINARY TRACT INFECTION,3
SE,ANGIOEDEMA,2
SE,ANTIVIRAL DRUG LEVEL ABOVE THERAPEUTIC,2
SE,AUTOIMMUNE HAEMOLYTIC ANAEMIA,2
SE,BACK PAIN,2
SE,BLADDER DYSFUNCTION,2
SE,CARDIAC ARREST,2
SE,CHOLECYSTITIS,2
SE,CIRCULATORY COLLAPSE,2
SE,CONSTIPATION,2
SE,DISEASE PROGRESSION,2
SE,DYSGEUSIA,2
SE,GASTROENTERITIS,2
SE,GENERAL PHYSICAL HEALTH DETERIORATION,2
SE,HERPES ZOSTER,2
SE,HUNGER,2
SE,HYPERHIDROSIS,2
SE,HYPOKALAEMIA,2
SE,INGUINAL HERNIA,2
SE,LOSS OF CONSCIOUSNESS,2
SE,MUSCLE RUPTURE,2
SE,NEUROLOGICAL SYMPTOM,2
SE,NIGHTMARE,2
SE,OEDEMA,2
SE,OXYGEN SATURATION DECREASED,2
SE,PAIN,2
SE,PANIC ATTACK,2
SE,PHOTOSENSITIVITY REACTION,2
SE,PLASMA CELL MYELOMA,2
SE,POLYNEUROPATHY,2
SE,PROCEDURAL HAEMORRHAGE,2
SE,PRODUCT SUBSTITUTION ISSUE,2
SE,RASH,2
SE,RIGHT VENTRICULAR FAILURE,2
SE,SUICIDAL IDEATION,2
SE,URINARY RETENTION,2
SE,URTICARIA,2
SE,VASCULITIS,2
SE,VERTIGO,2
SE,VITAMIN D DEFICIENCY,2
SE,ABDOMINAL PAIN UPPER,1
SE,ACCIDENTAL UNDERDOSE,1
SE,ACTIVITIES OF DAILY LIVING IMPAIRED,1
SE,ACUTE MYELOID LEUKAEMIA,1
SE,ACUTE RESPIRATORY DISTRESS SYNDROME,1
SE,ALANINE AMINOTRANSFERASE INCREASED,1
SE,ANAL ULCER,1
SE,ANEURYSM,1
SE,ANKLE FRACTURE,1
SE,AORTIC VALVE INCOMPETENCE,1
SE,ARRHYTHMIA,1
SE,ARTHROPATHY,1
SE,ASCITES,1
SE,ASPARTATE AMINOTRANSFERASE INCREASED,1
SE,ATRIAL FLUTTER,1
SE,BACTERIAL INFECTION,1
SE,BENIGN PROSTATIC HYPERPLASIA,1
SE,BLINDNESS,1
SE,BLOOD CREATININE ABNORMAL,1
SE,BLOOD PRESSURE DECREASED,1
SE,BONE DECALCIFICATION,1
SE,BRONCHOPULMONARY ASPERGILLOSIS,1
SE,CALCIUM DEFICIENCY,1
SE,CARDIAC FAILURE ACUTE,1
SE,CARDIAC FIBRILLATION,1
SE,CARDIOMEGALY,1
SE,CHILLS,1
SE,CHOLELITHIASIS,1
SE,COGNITIVE DISORDER,1
SE,COLITIS MICROSCOPIC,1
SE,COLON CANCER,1
SE,CONTRAST ENCEPHALOPATHY,1
SE,CORONARY ARTERY DISEASE,1
SE,CRUSH INJURY,1
SE,DEMENTIA,1
SE,DERMATITIS,1
SE,DIABETES MELLITUS,1
SE,DIABETIC KETOACIDOSIS,1
SE,DISSOCIATION,1
SE,DRUG DEPENDENCE,1
SE,DRUG DISPENSING ERROR,1
SE,DRY GANGRENE,1
SE,DRY SKIN,1
SE,DYSPEPSIA,1
SE,DYSPHAGIA,1
SE,EAR CANAL ABRASION,1
SE,EJECTION FRACTION DECREASED,1
SE,ELECTROLYTE IMBALANCE,1
SE,EMOTIONAL DISTRESS,1
SE,EPILEPSY,1
SE,ERYTHEMA,1
SE,FACE INJURY,1
SE,FASCIOTOMY,1
SE,FEELING ABNORMAL,1
SE,FEELING HOT,1
SE,FEMORAL NECK FRACTURE,1
SE,FEMUR FRACTURE,1
SE,FIBULA FRACTURE,1
SE,FLANK PAIN,1
SE,FLUID RETENTION,1
SE,FOETAL EXPOSURE DURING PREGNANCY,1
SE,GAIT INABILITY,1
SE,GASTROINTESTINAL MUCOSAL DISORDER,1
SE,GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE,1
SE,GROWTH RETARDATION,1
SE,HAEMATEMESIS,1
SE,HAEMOPTYSIS,1
SE,HALLUCINATION,1
SE,HALLUCINATION_ VISUAL,1
SE,HEAD INJURY,1
SE,HEARING IMPAIRED,1
SE,HEART RATE DECREASED,1
SE,HEPATIC CIRRHOSIS,1
SE,HEPATIC ENCEPHALOPATHY,1
SE,HEPATIC ENZYME INCREASED,1
SE,HERPES SIMPLEX,1
SE,HYPERCALCAEMIA,1
SE,HYPERKERATOSIS,1
SE,HYPOAESTHESIA,1
SE,HYPOPNOEA,1
SE,HYPOXIA,1
SE,ILEUS PARALYTIC,1
SE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
SE,INFECTION,1
SE,INSOMNIA,1
SE,INTERSTITIAL LUNG DISEASE,1
SE,INTERVERTEBRAL DISC COMPRESSION,1
SE,INTESTINAL HAEMORRHAGE,1
SE,IRIDOCYCLITIS,1
SE,IRRITABILITY,1
SE,ISCHAEMIC STROKE,1
SE,JOINT DISLOCATION,1
SE,LABORATORY TEST ABNORMAL,1
SE,LARGE INTESTINE PERFORATION,1
SE,LEFT VENTRICULAR DYSFUNCTION,1
SE,LEG AMPUTATION,1
SE,LIP SQUAMOUS CELL CARCINOMA,1
SE,LIVER FUNCTION TEST ABNORMAL,1
SE,LOW BIRTH WEIGHT BABY,1
SE,LOWER LIMB FRACTURE,1
SE,LYMPHOCELE,1
SE,LYMPHOMA,1
SE,MALAISE,1
SE,MALIGNANT HYPERTENSION,1
SE,MALIGNANT MELANOMA IN SITU,1
SE,MELAENA,1
SE,MEMORY IMPAIRMENT,1
SE,METABOLIC DISORDER,1
SE,METASTASES TO BONE,1
SE,METASTASES TO THORAX,1
SE,MITRAL VALVE INCOMPETENCE,1
SE,MITRAL VALVE STENOSIS,1
SE,MUCOSAL ULCERATION,1
SE,MUSCLE HAEMORRHAGE,1
SE,MYELODYSPLASTIC SYNDROME,1
SE,MYOCARDIAL INFARCTION,1
SE,MYOSITIS,1
SE,NEPHROTIC SYNDROME,1
SE,NEUROGENIC BLADDER,1
SE,NIGHT SWEATS,1
SE,NITRITE URINE PRESENT,1
SE,NON-CARDIAC CHEST PAIN,1
SE,ORGAN FAILURE,1
SE,ORTHOSTATIC HYPOTENSION,1
SE,OSTEOMYELITIS,1
SE,OSTEONECROSIS,1
SE,OTITIS MEDIA,1
SE,PAIN IN EXTREMITY,1
SE,PANCREATIC CARCINOMA,1
SE,PARALYSIS,1
SE,PELVIC PAIN,1
SE,PEMPHIGOID,1
SE,PERIPHERAL COLDNESS,1
SE,PERIPHERAL SWELLING,1
SE,PERSONALITY CHANGE,1
SE,PLATELET COUNT DECREASED,1
SE,PNEUMONITIS,1
SE,POLYMYALGIA RHEUMATICA,1
SE,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,1
SE,PORTAL HYPERTENSION,1
SE,PORTAL VEIN THROMBOSIS,1
SE,PREMATURE BABY,1
SE,PRODUCT USE IN UNAPPROVED INDICATION,1
SE,PRODUCT USE ISSUE,1
SE,PROSTATIC DISORDER,1
SE,PRURITUS,1
SE,PULMONARY HAEMORRHAGE,1
SE,PULMONARY INFARCTION,1
SE,PYELONEPHRITIS,1
SE,PYREXIA,1
SE,QUALITY OF LIFE DECREASED,1
SE,RALES,1
SE,RED CELL DISTRIBUTION WIDTH ABNORMAL,1
SE,RESPIRATORY DEPRESSION,1
SE,RESPIRATORY DISORDER,1
SE,RESPIRATORY DISTRESS,1
SE,RESPIRATORY FAILURE,1
SE,RETCHING,1
SE,RHINITIS,1
SE,RIB FRACTURE,1
SE,SEDATION,1
SE,SENSORY LOSS,1
SE,SKIN ATROPHY,1
SE,SKIN CANCER,1
SE,SKIN INFECTION,1
SE,SKIN NECROSIS,1
SE,SMALL FOR DATES BABY,1
SE,SOLAR DERMATITIS,1
SE,SOMNAMBULISM,1
SE,SPINAL COMPRESSION FRACTURE,1
SE,SQUAMOUS CELL CARCINOMA OF SKIN,1
SE,STENOTROPHOMONAS INFECTION,1
SE,STOMATITIS,1
SE,STREPTOCOCCAL INFECTION,1
SE,SUDDEN CARDIAC DEATH,1
SE,SUPRAVENTRICULAR TACHYCARDIA,1
SE,TEMPERATURE INTOLERANCE,1
SE,TEMPERATURE REGULATION DISORDER,1
SE,THROMBOSIS,1
SE,THROMBOTIC MICROANGIOPATHY,1
SE,TIBIA FRACTURE,1
SE,TIC,1
SE,TINNITUS,1
SE,TREMOR,1
SE,UPPER RESPIRATORY TRACT INFECTION,1
SE,URETERIC OBSTRUCTION,1
SE,URETHRITIS,1
SE,VASCULAR GRAFT,1
SE,VISUAL IMPAIRMENT,1
SE,WRONG DEVICE USED,1
CH,ACUTE KIDNEY INJURY,42
CH,HYPOKALAEMIA,22
CH,THROMBOCYTOPENIA,22
CH,CARDIAC FAILURE,21
CH,AGRANULOCYTOSIS,20
CH,BRADYCARDIA,18
CH,HYPOTENSION,18
CH,DYSPNOEA,17
CH,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,16
CH,HEPATIC ENZYME INCREASED,16
CH,FALL,15
CH,HAEMOLYSIS,13
CH,JAUNDICE,13
CH,PYREXIA,13
CH,RENAL FAILURE ACUTE,13
CH,ANAEMIA,12
CH,CONFUSIONAL STATE,12
CH,CHOLESTATIC LIVER INJURY,11
CH,LEUKOPENIA,11
CH,OEDEMA PERIPHERAL,11
CH,PANCYTOPENIA,11
CH,CARDIAC ARREST,10
CH,ELECTROCARDIOGRAM QT PROLONGED,10
CH,HAEMATURIA,10
CH,TOXICITY TO VARIOUS AGENTS,10
CH,UPPER GASTROINTESTINAL HAEMORRHAGE,10
CH,VOMITING,10
CH,ANURIA,9
CH,ENCEPHALOPATHY,9
CH,HYPONATRAEMIA,9
CH,RASH MACULO-PAPULAR,9
CH,RESPIRATORY FAILURE,9
CH,DRUG ABUSE,8
CH,HYPOMAGNESAEMIA,8
CH,MELAENA,8
CH,NAUSEA,8
CH,TUBULOINTERSTITIAL NEPHRITIS,8
CH,BLOOD BILIRUBIN INCREASED,7
CH,BONE MARROW FAILURE,7
CH,CARDIOGENIC SHOCK,7
CH,DEHYDRATION,7
CH,DELIRIUM,7
CH,DRUG-INDUCED LIVER INJURY,7
CH,EXPOSURE DURING PREGNANCY,7
CH,HAEMATOCHEZIA,7
CH,HAEMOGLOBIN DECREASED,7
CH,RENAL IMPAIRMENT,7
CH,SEPSIS,7
CH,BLOOD CREATININE INCREASED,6
CH,CLOSTRIDIUM DIFFICILE COLITIS,6
CH,CONDITION AGGRAVATED,6
CH,DEPRESSED LEVEL OF CONSCIOUSNESS,6
CH,DIARRHOEA,6
CH,EPILEPSY,6
CH,HAEMATOMA,6
CH,HYPERKALAEMIA,6
CH,LONG QT SYNDROME,6
CH,METABOLIC ALKALOSIS,6
CH,PREMATURE BABY,6
CH,PURPURA,6
CH,SEIZURE,6
CH,TACHYCARDIA,6
CH,THERAPEUTIC RESPONSE INCREASED,6
CH,APLASTIC ANAEMIA,5
CH,ARRHYTHMIA,5
CH,ASPARTATE AMINOTRANSFERASE INCREASED,5
CH,CATHETER SITE HAEMORRHAGE,5
CH,CHEMOTHERAPEUTIC DRUG LEVEL INCREASED,5
CH,CHEST PAIN,5
CH,COGNITIVE DISORDER,5
CH,FEBRILE NEUTROPENIA,5
CH,GAIT DISTURBANCE,5
CH,HYPERBILIRUBINAEMIA,5
CH,INFECTION,5
CH,MALAISE,5
CH,MUSCLE HAEMORRHAGE,5
CH,NEUTROPENIC SEPSIS,5
CH,PNEUMONIA,5
CH,RENAL FAILURE CHRONIC,5
CH,THROMBOCYTOPENIC PURPURA,5
CH,TREMOR,5
CH,TYPE I HYPERSENSITIVITY,5
CH,ABDOMINAL PAIN,4
CH,ACCIDENTAL OVERDOSE,4
CH,ALANINE AMINOTRANSFERASE INCREASED,4
CH,ARTHRALGIA,4
CH,ATRIOVENTRICULAR BLOCK COMPLETE,4
CH,BACK PAIN,4
CH,BLOOD CREATINE PHOSPHOKINASE INCREASED,4
CH,CARDIAC DISORDER,4
CH,COMA,4
CH,DRUG INEFFECTIVE,4
CH,DRUG PRESCRIBING ERROR,4
CH,ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY,4
CH,ERYTHEMA,4
CH,FATIGUE,4
CH,GINGIVAL BLEEDING,4
CH,HAEMORRHAGIC ANAEMIA,4
CH,HAEMORRHAGIC DIATHESIS,4
CH,HYPERSENSITIVITY VASCULITIS,4
CH,HYPERTENSION,4
CH,HYPOCALCAEMIA,4
CH,HYPOCHLORAEMIA,4
CH,MONOCYTOPENIA,4
CH,MULTIPLE ORGAN DYSFUNCTION SYNDROME,4
CH,NEPHROCALCINOSIS,4
CH,PAIN,4
CH,PRURITUS,4
CH,SEPTIC SHOCK,4
CH,SHOCK,4
CH,SINUS BRADYCARDIA,4
CH,SOMNOLENCE,4
CH,STEVENS-JOHNSON SYNDROME,4
CH,TORSADE DE POINTES,4
CH,TOXIC EPIDERMAL NECROLYSIS,4
CH,VENTRICULAR TACHYCARDIA,4
CH,VERTIGO,4
CH,ACUTE HEPATIC FAILURE,3
CH,ACUTE MYOCARDIAL INFARCTION,3
CH,AGGRESSION,3
CH,ALLERGIC HEPATITIS,3
CH,ALVEOLITIS,3
CH,ATRIAL FIBRILLATION,3
CH,BONE MARROW EOSINOPHILIC LEUKOCYTE COUNT INCREASED,3
CH,BRAIN OEDEMA,3
CH,CAPILLARY LEAK SYNDROME,3
CH,CEREBRAL INFARCTION,3
CH,CHILLS,3
CH,CHOLESTASIS,3
CH,CHROMATOPSIA,3
CH,CLONUS,3
CH,DISORIENTATION,3
CH,DRUG ADMINISTRATION ERROR,3
CH,DRUG LEVEL INCREASED,3
CH,EOSINOPHILIA,3
CH,EOSINOPHILIC MYOCARDITIS,3
CH,EOSINOPHILIC PNEUMONIA,3
CH,FOETAL EXPOSURE DURING PREGNANCY,3
CH,GASTROINTESTINAL HAEMORRHAGE,3
CH,HEPARIN-INDUCED THROMBOCYTOPENIA,3
CH,HEPATOCELLULAR INJURY,3
CH,HYPERNATRAEMIA,3
CH,HYPOVOLAEMIA,3
CH,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,3
CH,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,3
CH,LIVER INJURY,3
CH,LOSS OF CONSCIOUSNESS,3
CH,LOW BIRTH WEIGHT BABY,3
CH,MUSCLE RIGIDITY,3
CH,NEUTROPENIA,3
CH,OVERDOSE,3
CH,PLEURAL EFFUSION,3
CH,POST PROCEDURAL HAEMORRHAGE,3
CH,RASH,3
CH,RENAL FAILURE,3
CH,RESPIRATORY DISTRESS,3
CH,SHOCK HAEMORRHAGIC,3
CH,SQUAMOUS CELL CARCINOMA,3
CH,SYNCOPE,3
CH,URINARY TRACT INFECTION,3
CH,VENOOCCLUSIVE DISEASE,3
CH,WEIGHT DECREASED,3
CH,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,2
CH,ACUTE RESPIRATORY DISTRESS SYNDROME,2
CH,AGITATION,2
CH,AGITATION POSTOPERATIVE,2
CH,ALTERED STATE OF CONSCIOUSNESS,2
CH,ANAESTHETIC COMPLICATION NEUROLOGICAL,2
CH,ASCITES,2
CH,ATELECTASIS,2
CH,ATRIOVENTRICULAR BLOCK FIRST DEGREE,2
CH,ATRIOVENTRICULAR BLOCK SECOND DEGREE,2
CH,BLOOD ALKALINE PHOSPHATASE INCREASED,2
CH,CARDIOVASCULAR DISORDER,2
CH,CEREBRAL HYPOPERFUSION,2
CH,CHRONIC KIDNEY DISEASE,2
CH,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
CH,COMA SCALE ABNORMAL,2
CH,CONTRAINDICATED PRODUCT ADMINISTERED,2
CH,CORONA VIRUS INFECTION,2
CH,DERMATITIS EXFOLIATIVE,2
CH,ELECTROLYTE IMBALANCE,2
CH,ENGRAFTMENT SYNDROME,2
CH,EOSINOPHIL COUNT INCREASED,2
CH,EPISTAXIS,2
CH,ERYSIPELAS,2
CH,FEBRILE BONE MARROW APLASIA,2
CH,FLUID OVERLOAD,2
CH,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
CH,GENERAL PHYSICAL HEALTH DETERIORATION,2
CH,GLOMERULONEPHRITIS ACUTE,2
CH,HAEMOGLOBIN URINE PRESENT,2
CH,HAEMOLYTIC ANAEMIA,2
CH,HAEMORRHAGE INTRACRANIAL,2
CH,HEPATITIS,2
CH,HEPATITIS CHOLESTATIC,2
CH,HEPATITIS FULMINANT,2
CH,HEPATOSPLENOMEGALY,2
CH,HYPERAMMONAEMIC ENCEPHALOPATHY,2
CH,HYPOXIA,2
CH,INFUSION RELATED REACTION,2
CH,INSOMNIA,2
CH,INTERNATIONAL NORMALISED RATIO INCREASED,2
CH,LACTIC ACIDOSIS,2
CH,LEFT VENTRICULAR DYSFUNCTION,2
CH,LIP SWELLING,2
CH,LYMPHADENOPATHY,2
CH,MALIGNANT NEOPLASM PROGRESSION,2
CH,MEDICATION ERROR,2
CH,METAPNEUMOVIRUS INFECTION,2
CH,MULTI-ORGAN FAILURE,2
CH,MUSCLE CONTRACTIONS INVOLUNTARY,2
CH,MUSCULAR WEAKNESS,2
CH,MYELOFIBROSIS,2
CH,NEONATAL TACHYPNOEA,2
CH,OLIGOHYDRAMNIOS,2
CH,PAIN IN EXTREMITY,2
CH,PERSECUTORY DELUSION,2
CH,PLACENTAL INSUFFICIENCY,2
CH,PLATELET COUNT DECREASED,2
CH,PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL,2
CH,PRESCRIBED OVERDOSE,2
CH,PROTEINURIA,2
CH,PSYCHOMOTOR RETARDATION,2
CH,PULMONARY EMBOLISM,2
CH,PULMONARY OEDEMA,2
CH,RASH MACULAR,2
CH,RED MAN SYNDROME,2
CH,RENAL TUBULAR DISORDER,2
CH,RENAL TUBULAR NECROSIS,2
CH,RHABDOMYOLYSIS,2
CH,SCRATCH,2
CH,SKIN TEST POSITIVE,2
CH,SUPRAVENTRICULAR EXTRASYSTOLES,2
CH,SUPRAVENTRICULAR TACHYARRHYTHMIA,2
CH,SWOLLEN TONGUE,2
CH,TACHYPNOEA,2
CH,THROAT TIGHTNESS,2
CH,TOXIC SKIN ERUPTION,2
CH,TRANSAMINASES INCREASED,2
CH,TRAUMATIC HAEMATOMA,2
CH,VENOOCCLUSIVE LIVER DISEASE,2
CH,VENTRICULAR FIBRILLATION,2
CH,WEIGHT INCREASED,2
CH,WHITE BLOOD CELL COUNT DECREASED,2
CH,WRONG DRUG ADMINISTERED,2
CH,ACIDOSIS,1
CH,ACQUIRED HAEMOPHILIA,1
CH,ACUTE CORONARY SYNDROME,1
CH,ACUTE PULMONARY OEDEMA,1
CH,AMMONIA INCREASED,1
CH,AMYLASE INCREASED,1
CH,AMYLOIDOSIS,1
CH,ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES,1
CH,ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC,1
CH,ANXIETY,1
CH,APHTHOUS STOMATITIS,1
CH,ARRHYTHMIA NEONATAL,1
CH,ASTHENIA,1
CH,ATRIOVENTRICULAR BLOCK,1
CH,BACILLUS INFECTION,1
CH,BACTERIAL SEPSIS,1
CH,BALANCE DISORDER,1
CH,BLOOD PRESSURE DECREASED,1
CH,BLOOD PRESSURE INCREASED,1
CH,BLOOD UREA INCREASED,1
CH,BLOOD URIC ACID INCREASED,1
CH,BONE MARROW OEDEMA,1
CH,BONE MARROW TOXICITY,1
CH,BREAST CANCER,1
CH,BRONCHOPULMONARY ASPERGILLOSIS,1
CH,BUNDLE BRANCH BLOCK LEFT,1
CH,BUNDLE BRANCH BLOCK RIGHT,1
CH,C-REACTIVE PROTEIN INCREASED,1
CH,CAESAREAN SECTION,1
CH,CARBAMOYL PHOSPHATE SYNTHETASE DEFICIENCY,1
CH,CARDIAC FAILURE ACUTE,1
CH,CARDIAC FLUTTER,1
CH,CARDIO-RESPIRATORY ARREST,1
CH,CARDIOPULMONARY FAILURE,1
CH,CARDIOVASCULAR INSUFFICIENCY,1
CH,CAROTID ARTERY STENOSIS,1
CH,CENTRAL NERVOUS SYSTEM LESION,1
CH,CEREBRAL HAEMORRHAGE,1
CH,CEREBROVASCULAR ACCIDENT,1
CH,CHEYNE-STOKES RESPIRATION,1
CH,CHOKING,1
CH,CHOLECYSTITIS,1
CH,CIRCULATORY COLLAPSE,1
CH,CLOSTRIDIUM DIFFICILE INFECTION,1
CH,COAGULOPATHY,1
CH,CONJUNCTIVAL HAEMORRHAGE,1
CH,CORONARY ARTERY DISEASE,1
CH,COUGH,1
CH,CREATININE RENAL CLEARANCE DECREASED,1
CH,CYSTITIS,1
CH,DECREASED APPETITE,1
CH,DIABETES INSIPIDUS,1
CH,DISEASE PROGRESSION,1
CH,DISSEMINATED INTRAVASCULAR COAGULATION,1
CH,DISTURBANCE IN ATTENTION,1
CH,DIZZINESS,1
CH,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
CH,DRY EYE,1
CH,DYSARTHRIA,1
CH,DYSKINESIA,1
CH,DYSPEPSIA,1
CH,DYSPHAGIA,1
CH,DYSPNOEA PAROXYSMAL NOCTURNAL,1
CH,ECCHYMOSIS,1
CH,ELECTROCARDIOGRAM ABNORMAL,1
CH,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,1
CH,ELECTROCARDIOGRAM QT INTERVAL ABNORMAL,1
CH,ELECTROENCEPHALOGRAM ABNORMAL,1
CH,EMBRYONAL RHABDOMYOSARCOMA,1
CH,ENCEPHALITIS,1
CH,EOSINOPHILIC PNEUMONIA ACUTE,1
CH,ESCHERICHIA SEPSIS,1
CH,EXTRACORPOREAL MEMBRANE OXYGENATION,1
CH,EXTRAPYRAMIDAL DISORDER,1
CH,EXTRAVASATION,1
CH,FEAR OF FALLING,1
CH,FOOD ALLERGY,1
CH,FRACTURED SACRUM,1
CH,FUNGAL SEPSIS,1
CH,GASTRIC ULCER,1
CH,GASTROENTERITIS,1
CH,GASTROINTESTINAL DISORDER,1
CH,GASTROINTESTINAL STROMAL TUMOUR,1
CH,GENERALISED TONIC-CLONIC SEIZURE,1
CH,GLOMERULAR FILTRATION RATE DECREASED,1
CH,GOUT,1
CH,GRAFT VERSUS HOST DISEASE IN SKIN,1
CH,GYNAECOMASTIA,1
CH,HAEMARTHROSIS,1
CH,HALLUCINATION_ VISUAL,1
CH,HEMIPLEGIA,1
CH,HEPATIC CIRRHOSIS,1
CH,HEPATIC FAILURE,1
CH,HEPATORENAL SYNDROME,1
CH,HIATUS HERNIA,1
CH,HYPERAMMONAEMIA,1
CH,HYPERHIDROSIS,1
CH,HYPERSENSITIVITY,1
CH,HYPERTHERMIA,1
CH,HYPERTONIA,1
CH,HYPOALDOSTERONISM,1
CH,HYPOGLYCAEMIA NEONATAL,1
CH,HYPOTHERMIA,1
CH,HYPOTHYROIDISM,1
CH,IMMOBILE,1
CH,INFUSION SITE ERYTHEMA,1
CH,INFUSION SITE HAEMATOMA,1
CH,INFUSION SITE OEDEMA,1
CH,INFUSION SITE PAIN,1
CH,INFUSION SITE RASH,1
CH,INHIBITORY DRUG INTERACTION,1
CH,JAUNDICE NEONATAL,1
CH,JUGULAR VEIN DISTENSION,1
CH,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
CH,LACRIMATION INCREASED,1
CH,LIMB INJURY,1
CH,LINEAR IGA DISEASE,1
CH,LIPASE INCREASED,1
CH,LIVEDO RETICULARIS,1
CH,LIVER DISORDER,1
CH,LOBAR PNEUMONIA,1
CH,LOCALISED OEDEMA,1
CH,LUMBAR SPINAL STENOSIS,1
CH,LUNG INFILTRATION,1
CH,LYMPHOPENIA,1
CH,MATERNAL EXPOSURE DURING PREGNANCY,1
CH,METABOLIC ACIDOSIS,1
CH,METABOLIC ENCEPHALOPATHY,1
CH,METHAEMOGLOBINAEMIA,1
CH,MILK ALLERGY,1
CH,MULTIPLE SCLEROSIS RELAPSE,1
CH,MYALGIA,1
CH,MYOCARDIAL INFARCTION,1
CH,MYOCARDIAL ISCHAEMIA,1
CH,MYOCARDIAL NECROSIS MARKER INCREASED,1
CH,MYOCARDITIS,1
CH,MYOCLONUS,1
CH,MYOPATHY,1
CH,NARCOLEPSY,1
CH,NASAL CAVITY CANCER,1
CH,NEONATAL INFECTION,1
CH,NEONATAL RESPIRATORY DISTRESS SYNDROME,1
CH,NEUROLOGICAL DECOMPENSATION,1
CH,NEUTROPENIC COLITIS,1
CH,NEUTROPHIL COUNT DECREASED,1
CH,NOCTURIA,1
CH,OESOPHAGEAL CANDIDIASIS,1
CH,OESOPHAGEAL MOTILITY DISORDER,1
CH,OESOPHAGITIS,1
CH,OLIGURIA,1
CH,ORAL INFECTION,1
CH,ORCHITIS,1
CH,ORTHOPNOEA,1
CH,OXYGEN SATURATION ABNORMAL,1
CH,OXYGEN SATURATION DECREASED,1
CH,PALPABLE PURPURA,1
CH,PANCREATITIS,1
CH,PELVIC FRACTURE,1
CH,PERIPHERAL SWELLING,1
CH,PERIPROSTHETIC FRACTURE,1
CH,PNEUMONIA CYTOMEGALOVIRAL,1
CH,PNEUMONIA FUNGAL,1
CH,PNEUMONIA INFLUENZAL,1
CH,PNEUMONITIS,1
CH,POLYMYOSITIS,1
CH,POLYURIA,1
CH,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
CH,POTENTIATING DRUG INTERACTION,1
CH,PREMATURE DELIVERY,1
CH,PRERENAL FAILURE,1
CH,PRESYNCOPE,1
CH,PRIMARY MYELOFIBROSIS,1
CH,PRODUCT USE ISSUE,1
CH,PROSTATITIS,1
CH,PSYCHOMOTOR HYPERACTIVITY,1
CH,PULMONARY ARTERIAL HYPERTENSION,1
CH,RALES,1
CH,RASH GENERALISED,1
CH,RASH PAPULAR,1
CH,RASH PUSTULAR,1
CH,RAYNAUD^S PHENOMENON,1
CH,RESPIRATORY DEPRESSION,1
CH,RESPIRATORY SYNCYTIAL VIRUS INFECTION,1
CH,RESTLESS LEGS SYNDROME,1
CH,RIGHT VENTRICULAR FAILURE,1
CH,RIGHT VENTRICULAR HYPERTROPHY,1
CH,ROSEOLOVIRUS TEST POSITIVE,1
CH,SCLERODACTYLIA,1
CH,SECOND PRIMARY MALIGNANCY,1
CH,SECRETION DISCHARGE,1
CH,SEROTONIN SYNDROME,1
CH,SINUS TACHYCARDIA,1
CH,SKIN DISCOLOURATION,1
CH,SKIN NECROSIS,1
CH,SPEECH DISORDER,1
CH,STAPHYLOCOCCAL BACTERAEMIA,1
CH,STAPHYLOCOCCAL SEPSIS,1
CH,STAPHYLOCOCCUS TEST POSITIVE,1
CH,SUBDURAL HAEMATOMA,1
CH,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,1
CH,SYSTEMIC SCLEROSIS,1
CH,TRACHEOBRONCHITIS,1
CH,TROPONIN INCREASED,1
CH,UROGENITAL HAEMORRHAGE,1
CH,VISION BLURRED,1
CH,VISUAL FIELD DEFECT,1
CH,VON WILLEBRAND^S FACTOR ACTIVITY DECREASED,1
SY,THROMBOSIS IN DEVICE,1
TW,DYSPNOEA,24
TW,PNEUMONIA,21
TW,PYREXIA,16
TW,ANAEMIA,15
TW,CARDIAC FAILURE CONGESTIVE,14
TW,CELLULITIS,13
TW,COUGH,13
TW,OEDEMA PERIPHERAL,12
TW,PLATELET COUNT DECREASED,12
TW,PLEURAL EFFUSION,11
TW,SEPTIC SHOCK,11
TW,PULMONARY OEDEMA,10
TW,ACUTE KIDNEY INJURY,9
TW,DECREASED APPETITE,9
TW,SEPSIS,9
TW,ABDOMINAL PAIN,8
TW,ATRIAL FIBRILLATION,8
TW,DEATH,8
TW,DIZZINESS,8
TW,HYPOTENSION,8
TW,CONSTIPATION,7
TW,DIARRHOEA,7
TW,HYPERURICAEMIA,7
TW,RESPIRATORY FAILURE,7
TW,ACUTE RESPIRATORY FAILURE,6
TW,BLOOD CREATININE INCREASED,6
TW,BRADYCARDIA,6
TW,CARDIAC FAILURE,6
TW,CHEST DISCOMFORT,6
TW,DISEASE PROGRESSION,6
TW,ERYTHEMA,6
TW,GASTROINTESTINAL HAEMORRHAGE,6
TW,HAEMORRHAGE,6
TW,HYPOKALAEMIA,6
TW,INFLUENZA,6
TW,MALAISE,6
TW,PULMONARY EMBOLISM,6
TW,RENAL IMPAIRMENT,6
TW,SYNCOPE,6
TW,UPPER RESPIRATORY TRACT INFECTION,6
TW,URINARY TRACT INFECTION,6
TW,VOMITING,6
TW,ABDOMINAL DISTENSION,5
TW,ACUTE PRERENAL FAILURE,5
TW,ACUTE PULMONARY OEDEMA,5
TW,ALANINE AMINOTRANSFERASE INCREASED,5
TW,ALTERED STATE OF CONSCIOUSNESS,5
TW,BLAST CELL COUNT INCREASED,5
TW,C-REACTIVE PROTEIN INCREASED,5
TW,DRUG DEPENDENCE,5
TW,FALL,5
TW,HYPERTENSION,5
TW,HYPONATRAEMIA,5
TW,INFECTION,5
TW,LEUKOCYTOSIS,5
TW,LUNG INFILTRATION,5
TW,NAUSEA,5
TW,OEDEMA,5
TW,PAIN,5
TW,SEIZURE,5
TW,TUBULOINTERSTITIAL NEPHRITIS,5
TW,UPPER GASTROINTESTINAL HAEMORRHAGE,5
TW,WEIGHT INCREASED,5
TW,ASPARTATE AMINOTRANSFERASE INCREASED,4
TW,ASTHENIA,4
TW,BLOOD ALKALINE PHOSPHATASE INCREASED,4
TW,BLOOD GLUCOSE INCREASED,4
TW,CARDIOMEGALY,4
TW,CONCOMITANT DISEASE PROGRESSION,4
TW,DERMATITIS BULLOUS,4
TW,DYSPNOEA EXERTIONAL,4
TW,FEBRILE NEUTROPENIA,4
TW,GASTROENTERITIS,4
TW,GOUTY ARTHRITIS,4
TW,HAEMOGLOBIN DECREASED,4
TW,HYPERKALAEMIA,4
TW,PALPITATIONS,4
TW,PANCYTOPENIA,4
TW,PULMONARY CONGESTION,4
TW,RENAL FAILURE CHRONIC,4
TW,RHINORRHOEA,4
TW,SWELLING,4
TW,TACHYPNOEA,4
TW,WHEEZING,4
TW,ABDOMINAL PAIN UPPER,3
TW,ANURIA,3
TW,ARRHYTHMIA,3
TW,ATRIAL FLUTTER,3
TW,BLOOD BILIRUBIN INCREASED,3
TW,BLOOD PRESSURE DECREASED,3
TW,BLOOD UREA INCREASED,3
TW,CARDIAC ARREST,3
TW,CARDIAC FAILURE CHRONIC,3
TW,CHOLELITHIASIS,3
TW,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
TW,COLITIS,3
TW,EPISTAXIS,3
TW,FATIGUE,3
TW,FOETAL EXPOSURE DURING PREGNANCY,3
TW,FUNGAEMIA,3
TW,GASTRITIS,3
TW,GENERAL PHYSICAL HEALTH DETERIORATION,3
TW,GLOMERULONEPHRITIS CHRONIC,3
TW,HAEMATOCHEZIA,3
TW,HAEMATOCRIT DECREASED,3
TW,HEADACHE,3
TW,HEPATITIS ACUTE,3
TW,HYPERGLYCAEMIA,3
TW,HYPERNATRAEMIA,3
TW,HYPOVOLAEMIA,3
TW,INTERNATIONAL NORMALISED RATIO INCREASED,3
TW,MULTI-ORGAN FAILURE,3
TW,NECROTISING FASCIITIS,3
TW,NEPHROLITHIASIS,3
TW,PAIN IN EXTREMITY,3
TW,PERITONEAL HAEMORRHAGE,3
TW,PREMATURE BABY,3
TW,PYELONEPHRITIS ACUTE,3
TW,RENAL FAILURE ACUTE,3
TW,THROMBOCYTOPENIA,3
TW,TOXIC EPIDERMAL NECROLYSIS,3
TW,VASCULAR DEMENTIA,3
TW,WHITE BLOOD CELL COUNT DECREASED,3
TW,WOUND COMPLICATION,3
TW,ABDOMINAL WALL HAEMATOMA,2
TW,ACUTE MYELOID LEUKAEMIA,2
TW,ADRENAL DISORDER,2
TW,AMYLASE INCREASED,2
TW,AMYLOIDOSIS,2
TW,ANXIETY,2
TW,AUTONOMIC NERVOUS SYSTEM IMBALANCE,2
TW,BACK PAIN,2
TW,BLOOD ALBUMIN DECREASED,2
TW,BLOOD LACTATE DEHYDROGENASE INCREASED,2
TW,BLOOD PRESSURE ABNORMAL,2
TW,BLOOD PRESSURE INADEQUATELY CONTROLLED,2
TW,BLOOD PRESSURE INCREASED,2
TW,BODY TINEA,2
TW,BONE PAIN,2
TW,CARBON DIOXIDE DECREASED,2
TW,CARDIAC FAILURE ACUTE,2
TW,CARDIAC VALVE DISEASE,2
TW,CARDIOGENIC SHOCK,2
TW,CEREBROVASCULAR ACCIDENT,2
TW,CHEST PAIN,2
TW,CHILLS,2
TW,CLOSTRIDIUM DIFFICILE INFECTION,2
TW,COMA,2
TW,CONDITION AGGRAVATED,2
TW,CONJUNCTIVITIS,2
TW,CORONARY ARTERY DISEASE,2
TW,DELIRIUM,2
TW,DRUG ABUSE,2
TW,DUODENAL ULCER,2
TW,EYE MOVEMENT DISORDER,2
TW,FEELING COLD,2
TW,FEMORAL NECK FRACTURE,2
TW,GASTROOESOPHAGEAL REFLUX DISEASE,2
TW,GENERALISED OEDEMA,2
TW,HAEMATEMESIS,2
TW,HAEMATOMA,2
TW,HAEMATURIA,2
TW,HAEMOLYTIC URAEMIC SYNDROME,2
TW,HAEMOPTYSIS,2
TW,HEPATIC FUNCTION ABNORMAL,2
TW,HYPOGLYCAEMIA,2
TW,HYPOTHYROIDISM,2
TW,HYPOTONIA,2
TW,HYPOVENTILATION,2
TW,INGUINAL HERNIA,2
TW,INTENTIONAL PRODUCT MISUSE,2
TW,LIVER DISORDER,2
TW,LOSS OF CONSCIOUSNESS,2
TW,LOW BIRTH WEIGHT BABY,2
TW,LYMPHOCYTE COUNT DECREASED,2
TW,LYMPHOCYTE PERCENTAGE DECREASED,2
TW,MALIGNANT NEOPLASM PROGRESSION,2
TW,METAMYELOCYTE PERCENTAGE INCREASED,2
TW,MONOCYTE PERCENTAGE INCREASED,2
TW,MUSCLE SPASMS,2
TW,MUSCULAR WEAKNESS,2
TW,MYELOCYTE PERCENTAGE INCREASED,2
TW,NEOPLASM PROGRESSION,2
TW,NEUROTOXICITY,2
TW,NIKOLSKY^S SIGN,2
TW,PALLOR,2
TW,PANCREATITIS ACUTE,2
TW,PERITONITIS,2
TW,PLASMA CELL MYELOMA,2
TW,PNEUMONIA ASPIRATION,2
TW,PNEUMOTHORAX,2
TW,PRODUCTIVE COUGH,2
TW,PROMYELOCYTE COUNT INCREASED,2
TW,PROTEINURIA,2
TW,PROTHROMBIN TIME PROLONGED,2
TW,PSEUDOMONAS INFECTION,2
TW,RALES,2
TW,RASH,2
TW,RED BLOOD CELL COUNT DECREASED,2
TW,RENAL FAILURE,2
TW,SHOCK,2
TW,SPUTUM DISCOLOURED,2
TW,STENOTROPHOMONAS INFECTION,2
TW,STOMATITIS,2
TW,TACHYCARDIA,2
TW,TOXIC ENCEPHALOPATHY,2
TW,URINE OUTPUT DECREASED,2
TW,ABDOMINAL INFECTION,1
TW,ABDOMINAL PAIN LOWER,1
TW,ABDOMINAL TENDERNESS,1
TW,ABDOMINAL WALL CYST,1
TW,ACINETOBACTER INFECTION,1
TW,ACUTE HEPATIC FAILURE,1
TW,ACUTE MYOCARDIAL INFARCTION,1
TW,ACUTE RESPIRATORY DISTRESS SYNDROME,1
TW,ADENOCARCINOMA OF COLON,1
TW,ADRENAL INSUFFICIENCY,1
TW,ALBUMINURIA,1
TW,ANAEMIA MACROCYTIC,1
TW,ANAL ABSCESS,1
TW,ANAL EROSION,1
TW,ANAL POLYP,1
TW,ANAPHYLACTIC SHOCK,1
TW,ANGINA PECTORIS,1
TW,ANGIOPATHY,1
TW,AORTIC ARTERIOSCLEROSIS,1
TW,AORTIC CALCIFICATION,1
TW,AORTIC STENOSIS,1
TW,APHTHOUS STOMATITIS,1
TW,ARTERIAL OCCLUSIVE DISEASE,1
TW,ARTERIOSCLEROSIS,1
TW,ARTHRALGIA,1
TW,ASCITES,1
TW,ASPIRATION JOINT,1
TW,ATRIOVENTRICULAR BLOCK,1
TW,ATYPICAL PNEUMONIA,1
TW,AZOTAEMIA,1
TW,BACTERAEMIA,1
TW,BAKER^S CYST EXCISION,1
TW,BASOPHIL COUNT INCREASED,1
TW,BASOPHIL PERCENTAGE INCREASED,1
TW,BENIGN PROSTATIC HYPERPLASIA,1
TW,BIOPSY LYMPH GLAND ABNORMAL,1
TW,BLADDER CANCER RECURRENT,1
TW,BLADDER TRANSITIONAL CELL CARCINOMA RECURRENT,1
TW,BLISTER,1
TW,BLOOD CALCIUM INCREASED,1
TW,BLOOD CHLORIDE INCREASED,1
TW,BLOOD GLUCOSE ABNORMAL,1
TW,BLOOD POTASSIUM DECREASED,1
TW,BLOOD PRESSURE DIASTOLIC DECREASED,1
TW,BLOOD PRESSURE SYSTOLIC INCREASED,1
TW,BLOOD URIC ACID INCREASED,1
TW,BODY TEMPERATURE INCREASED,1
TW,BREAST NEOPLASM,1
TW,BRONCHITIS,1
TW,BRONCHOSPASM,1
TW,BUNDLE BRANCH BLOCK LEFT,1
TW,CANDIDA INFECTION,1
TW,CARBUNCLE,1
TW,CARDIAC DISORDER,1
TW,CARDIAC HYPERTROPHY,1
TW,CARDIO-RESPIRATORY ARREST,1
TW,CARDIOMYOPATHY,1
TW,CARDIOPULMONARY FAILURE,1
TW,CASTLEMAN^S DISEASE,1
TW,CATARACT,1
TW,CEREBRAL HAEMORRHAGE,1
TW,CEREBRAL INFARCTION,1
TW,CHOLECYSTITIS,1
TW,CHOLECYSTITIS ACUTE,1
TW,CHRONIC KIDNEY DISEASE,1
TW,CLOSTRIDIUM DIFFICILE COLITIS,1
TW,COMPARTMENT SYNDROME,1
TW,CYSTITIS,1
TW,CYTOMEGALOVIRUS INFECTION,1
TW,DEEP VEIN THROMBOSIS,1
TW,DEHYDRATION,1
TW,DERMATITIS,1
TW,DERMATITIS ALLERGIC,1
TW,DERMATITIS DIAPER,1
TW,DEVICE DISLOCATION,1
TW,DEVICE RELATED INFECTION,1
TW,DIABETES MELLITUS,1
TW,DIABETES MELLITUS INADEQUATE CONTROL,1
TW,DIABETIC COMA,1
TW,DIABETIC NEPHROPATHY,1
TW,DIABETIC RETINOPATHY,1
TW,DIASTOLIC DYSFUNCTION,1
TW,DISEASE RECURRENCE,1
TW,DRUG DOSE OMISSION,1
TW,DRUG LEVEL INCREASED,1
TW,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
TW,DRUG WITHDRAWAL SYNDROME,1
TW,DUODENAL ULCER HAEMORRHAGE,1
TW,DUODENAL ULCER PERFORATION,1
TW,DYSPEPSIA,1
TW,ECCHYMOSIS,1
TW,EFFUSION,1
TW,ELECTROCARDIOGRAM QT PROLONGED,1
TW,ENCEPHALOMALACIA,1
TW,ENCEPHALOPATHY,1
TW,END STAGE RENAL DISEASE,1
TW,ENDOTHELIOMATOSIS,1
TW,EOSINOPHIL COUNT INCREASED,1
TW,ESCHERICHIA TEST POSITIVE,1
TW,ESCHERICHIA URINARY TRACT INFECTION,1
TW,FEELING HOT,1
TW,FIBRIN D DIMER INCREASED,1
TW,FLANK PAIN,1
TW,FLATULENCE,1
TW,FLUID IMBALANCE,1
TW,FLUID OVERLOAD,1
TW,FLUID RETENTION,1
TW,FOETAL HYPOKINESIA,1
TW,FOOT FRACTURE,1
TW,FRACTURE TREATMENT,1
TW,FURUNCLE,1
TW,GAIT DISTURBANCE,1
TW,GASTRIC CANCER,1
TW,GASTRITIS EROSIVE,1
TW,GASTRITIS HAEMORRHAGIC,1
TW,GASTROENTERITIS RADIATION,1
TW,GLOMERULAR FILTRATION RATE DECREASED,1
TW,GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE,1
TW,HAEMANGIOMA,1
TW,HAEMODYNAMIC INSTABILITY,1
TW,HAEMOGLOBINURIA,1
TW,HEAD INJURY,1
TW,HEART RATE INCREASED,1
TW,HEPATIC CIRRHOSIS,1
TW,HEPATIC CONGESTION,1
TW,HEPATIC CYST,1
TW,HEPATIC ENCEPHALOPATHY,1
TW,HEPATIC NEOPLASM,1
TW,HEPATITIS B,1
TW,HEPATOCELLULAR CARCINOMA,1
TW,HOSPITALISATION,1
TW,HYDROCEPHALUS,1
TW,HYPERBILIRUBINAEMIA,1
TW,HYPERCAPNIA,1
TW,HYPERCHOLESTEROLAEMIA,1
TW,HYPERLIPIDAEMIA,1
TW,HYPERSENSITIVITY VASCULITIS,1
TW,HYPOALBUMINAEMIA,1
TW,HYPOCALCAEMIA,1
TW,HYPOGLYCAEMIC COMA,1
TW,HYPOPHAGIA,1
TW,HYPOPITUITARISM,1
TW,HYPOREFLEXIA,1
TW,HYPOVOLAEMIC SHOCK,1
TW,HYPOXIA,1
TW,ILEUS,1
TW,IMMUNODEFICIENCY COMMON VARIABLE,1
TW,IMPAIRED QUALITY OF LIFE,1
TW,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
TW,INCONTINENCE,1
TW,INFECTIOUS COLITIS,1
TW,INGUINAL HERNIA_ OBSTRUCTIVE,1
TW,INJECTION SITE ERYTHEMA,1
TW,INJECTION SITE PAIN,1
TW,INJECTION SITE PHLEBITIS,1
TW,INJECTION SITE SWELLING,1
TW,INJURY,1
TW,INSOMNIA,1
TW,INTERSTITIAL LUNG DISEASE,1
TW,INTERVERTEBRAL DISC DEGENERATION,1
TW,ISCHAEMIA,1
TW,ISCHAEMIC STROKE,1
TW,JAUNDICE,1
TW,JAUNDICE CHOLESTATIC,1
TW,JOINT EFFUSION,1
TW,JOINT SWELLING,1
TW,KIDNEY FIBROSIS,1
TW,LEFT VENTRICULAR DYSFUNCTION,1
TW,LEFT VENTRICULAR HYPERTROPHY,1
TW,LETHARGY,1
TW,LEUKAEMIA,1
TW,LIVER FUNCTION TEST ABNORMAL,1
TW,LOCALISED OEDEMA,1
TW,LUNG CANCER METASTATIC,1
TW,LUPUS NEPHRITIS,1
TW,LYMPHADENOPATHY,1
TW,MALIGNANT HYPERTENSION,1
TW,MATERNAL EXPOSURE DURING PREGNANCY,1
TW,MELAENA,1
TW,MENSTRUAL DISORDER,1
TW,MENTAL STATUS CHANGES,1
TW,MICTURITION FREQUENCY DECREASED,1
TW,MITRAL VALVE CALCIFICATION,1
TW,MONOCYTE COUNT INCREASED,1
TW,MOUTH HAEMORRHAGE,1
TW,MUCOSAL INFLAMMATION,1
TW,MUSCULOSKELETAL STIFFNESS,1
TW,MYALGIA,1
TW,MYCOPLASMA INFECTION,1
TW,MYDRIASIS,1
TW,MYELOFIBROSIS,1
TW,MYELOPATHY,1
TW,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED,1
TW,NASOPHARYNGITIS,1
TW,NEPHROCALCINOSIS,1
TW,NEPHROPATHY TOXIC,1
TW,NEPHROTIC SYNDROME,1
TW,NEUTROPENIA,1
TW,NEUTROPENIC COLITIS,1
TW,NEUTROPHIL COUNT DECREASED,1
TW,NEUTROPHIL COUNT INCREASED,1
TW,NODAL ARRHYTHMIA,1
TW,OCCULT BLOOD POSITIVE,1
TW,OESOPHAGEAL ULCER,1
TW,OLIGURIA,1
TW,ORAL PAIN,1
TW,ORTHOPNOEA,1
TW,OSTEOPOROSIS,1
TW,OTITIS MEDIA,1
TW,OTITIS MEDIA ACUTE,1
TW,PACKED RED BLOOD CELL TRANSFUSION,1
TW,PAIN OF SKIN,1
TW,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
TW,PATHOLOGICAL FRACTURE,1
TW,PEPTIC ULCER,1
TW,PERIODONTITIS,1
TW,PERIORBITAL OEDEMA,1
TW,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
TW,PERIPHERAL SWELLING,1
TW,PETECHIAE,1
TW,PHARYNGITIS,1
TW,PNEUMOBILIA,1
TW,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
TW,PNEUMOMEDIASTINUM,1
TW,PNEUMONIA BACTERIAL,1
TW,PNEUMONIA STREPTOCOCCAL,1
TW,PNEUMONITIS,1
TW,POLYURIA,1
TW,POOR QUALITY SLEEP,1
TW,PORTAL HYPERTENSION,1
TW,PREMATURE DELIVERY,1
TW,PROCALCITONIN INCREASED,1
TW,PROCEDURAL COMPLICATION,1
TW,PROSTATE CANCER,1
TW,PRURITUS,1
TW,PSORIASIS,1
TW,PULMONARY ARTERY OCCLUSION,1
TW,PULMONARY ARTERY THROMBOSIS,1
TW,PULMONARY FIBROSIS,1
TW,PULMONARY MASS,1
TW,PULMONARY THROMBOSIS,1
TW,PULMONARY TUBERCULOSIS,1
TW,PUPILLARY REFLEX IMPAIRED,1
TW,PURPURA,1
TW,PURULENT DISCHARGE,1
TW,RANULA,1
TW,RASH PAPULAR,1
TW,RED CELL DISTRIBUTION WIDTH INCREASED,1
TW,RENAL CELL CARCINOMA,1
TW,RENAL INJURY,1
TW,RENAL TUBULAR ATROPHY,1
TW,RENAL TUBULAR NECROSIS,1
TW,RESPIRATORY ACIDOSIS,1
TW,RESPIRATORY DISTRESS,1
TW,RETROPERITONEAL ABSCESS,1
TW,RHABDOMYOLYSIS,1
TW,RIGHT VENTRICULAR FAILURE,1
TW,ROAD TRAFFIC ACCIDENT,1
TW,SALMONELLA BACTERAEMIA,1
TW,SERRATIA BACTERAEMIA,1
TW,SICK SINUS SYNDROME,1
TW,SINUS BRADYCARDIA,1
TW,SKIN BURNING SENSATION,1
TW,SKIN DISCOLOURATION,1
TW,SKIN PAPILLOMA,1
TW,SKIN TURGOR DECREASED,1
TW,SKIN ULCER,1
TW,SKIN WARM,1
TW,SODIUM RETENTION,1
TW,SOFT TISSUE INFECTION,1
TW,SPINAL COMPRESSION FRACTURE,1
TW,SPINAL OSTEOARTHRITIS,1
TW,SPLENIC ABSCESS,1
TW,SPLENOMEGALY,1
TW,STENT PLACEMENT,1
TW,STEVENS-JOHNSON SYNDROME,1
TW,STRESS ULCER,1
TW,STRIDOR,1
TW,SUBDURAL HAEMATOMA,1
TW,SUDDEN DEATH,1
TW,SUSPECTED PRODUCT CONTAMINATION,1
TW,SWELLING FACE,1
TW,SYSTEMIC LUPUS ERYTHEMATOSUS,1
TW,TENDERNESS,1
TW,THYROTOXIC CRISIS,1
TW,TORSADE DE POINTES,1
TW,TRAUMATIC ARTHROPATHY,1
TW,TREATMENT NONCOMPLIANCE,1
TW,TREMOR,1
TW,TRICUSPID VALVE INCOMPETENCE,1
TW,URINARY CASTS PRESENT,1
TW,URINARY RETENTION,1
TW,URINE ANALYSIS ABNORMAL,1
TW,URINE OSMOLARITY INCREASED,1
TW,UROSEPSIS,1
TW,VENTRICULAR FIBRILLATION,1
TW,VIRAL INFECTION,1
TW,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
TW,VISION BLURRED,1
TW,VITREOUS HAEMORRHAGE,1
TW,WHITE BLOOD CELL COUNT INCREASED,1
TW,WOUND,1
TW,WOUND HAEMORRHAGE,1
TW,WOUND INFECTION,1
TW,WOUND SECRETION,1
TW,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
TH,CARDIAC FAILURE CONGESTIVE,5
TH,ANAEMIA,4
TH,PNEUMONIA,4
TH,SEPSIS,4
TH,ANAPHYLACTIC SHOCK,3
TH,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,3
TH,SEPTIC SHOCK,3
TH,THROMBOCYTOPENIA,3
TH,GASTROINTESTINAL STROMAL TUMOUR,2
TH,GOUTY ARTHRITIS,2
TH,HEPATIC FUNCTION ABNORMAL,2
TH,MALIGNANT NEOPLASM PROGRESSION,2
TH,PYREXIA,2
TH,RENAL FAILURE ACUTE,2
TH,RESPIRATORY DEPRESSION,2
TH,RESPIRATORY FAILURE,2
TH,RIGHT VENTRICULAR FAILURE,2
TH,VENTRICULAR TACHYCARDIA,2
TH,ABASIA,1
TH,ACUTE KIDNEY INJURY,1
TH,ACUTE PULMONARY OEDEMA,1
TH,ACUTE RESPIRATORY FAILURE,1
TH,ANTERIOR CHAMBER DISORDER,1
TH,APHAKIA,1
TH,APLASIA PURE RED CELL,1
TH,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
TH,BLOOD CREATININE INCREASED,1
TH,BLOOD PRESSURE FLUCTUATION,1
TH,CARDIOMEGALY,1
TH,CELLULITIS,1
TH,CEREBROVASCULAR ACCIDENT,1
TH,CHOLECYSTITIS,1
TH,CIRCULATORY COLLAPSE,1
TH,COAGULOPATHY,1
TH,CONCOMITANT DISEASE PROGRESSION,1
TH,CONJUNCTIVAL HAEMORRHAGE,1
TH,CONJUNCTIVAL OEDEMA,1
TH,CORNEAL EPITHELIUM DEFECT,1
TH,CORNEAL OEDEMA,1
TH,DEATH,1
TH,DEEP VEIN THROMBOSIS,1
TH,DEFECT CONDUCTION INTRAVENTRICULAR,1
TH,DEHYDRATION,1
TH,DIARRHOEA,1
TH,DIARRHOEA INFECTIOUS,1
TH,DISEASE PROGRESSION,1
TH,DISSEMINATED INTRAVASCULAR COAGULATION,1
TH,DRUG INEFFECTIVE,1
TH,DUODENAL ULCER HAEMORRHAGE,1
TH,DYSPNOEA,1
TH,ENTEROCOLITIS,1
TH,ERYTHEMA MULTIFORME,1
TH,ESCHERICHIA TEST POSITIVE,1
TH,EXOPHTHALMOS,1
TH,FATIGUE,1
TH,FEBRILE NEUTROPENIA,1
TH,HAEMATOCRIT DECREASED,1
TH,HEADACHE,1
TH,HEPATIC ENCEPHALOPATHY,1
TH,HEPATIC FAILURE,1
TH,HEPATITIS,1
TH,HERPES VIRUS INFECTION,1
TH,HYPERAEMIA,1
TH,HYPHAEMA,1
TH,HYPOKALAEMIA,1
TH,ISCHAEMIC HEPATITIS,1
TH,LEFT VENTRICULAR DYSFUNCTION,1
TH,METABOLIC ACIDOSIS,1
TH,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
TH,NEOPLASM PROGRESSION,1
TH,NEUTROPENIA,1
TH,OEDEMA,1
TH,OEDEMA PERIPHERAL,1
TH,ORTHOPNOEA,1
TH,PANCREATITIS ACUTE,1
TH,PERITONITIS,1
TH,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
TH,PNEUMONIA BACTERIAL,1
TH,PROTEINURIA,1
TH,RASH ERYTHEMATOUS,1
TH,RASH MACULO-PAPULAR,1
TH,RENAL IMPAIRMENT,1
TH,SHOCK,1
TH,SINUSITIS FUNGAL,1
TH,THERAPY NON-RESPONDER,1
TH,TYPE I HYPERSENSITIVITY,1
TH,UNDERDOSE,1
TH,UPPER GASTROINTESTINAL HAEMORRHAGE,1
TH,VERTIGO,1
TH,VISION BLURRED,1
TH,VOMITING,1
TH,WHITE BLOOD CELL COUNT DECREASED,1
TH,WRONG DRUG ADMINISTERED,1
TT,DYSPNOEA,1
TT,METABOLIC ACIDOSIS,1
TT,SHOCK,1
TN,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,4
TN,HYPERSENSITIVITY VASCULITIS,4
TN,CARDIAC ARREST,2
TN,HAEMORRHAGIC NECROTIC PANCREATITIS,2
TN,ABDOMINAL PAIN,1
TN,CHOLESTASIS,1
TN,DRUG HYPERSENSITIVITY,1
TN,ECZEMA,1
TN,FACE OEDEMA,1
TN,GASTROINTESTINAL HAEMORRHAGE,1
TN,LYMPHADENOPATHY,1
TN,MALAISE,1
TN,NECROSIS,1
TN,PANCREATITIS ACUTE,1
TN,PERIVASCULAR DERMATITIS,1
TN,PETECHIAE,1
TN,PYREXIA,1
TN,RASH MACULO-PAPULAR,1
TN,RASH PRURITIC,1
TN,SKIN LESION,1
TN,SKIN OEDEMA,1
TN,VASCULAR PURPURA,1
TR,HYPONATRAEMIA,15
TR,HYPOKALAEMIA,14
TR,CARDIAC FAILURE,13
TR,DYSPNOEA,10
TR,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,10
TR,NEPHROCALCINOSIS,10
TR,OEDEMA PERIPHERAL,10
TR,NAUSEA,9
TR,DRUG INEFFECTIVE,7
TR,HYPOTENSION,7
TR,ABDOMINAL WALL HAEMATOMA,6
TR,CONFUSIONAL STATE,6
TR,GASTROINTESTINAL HAEMORRHAGE,6
TR,INTERNATIONAL NORMALISED RATIO INCREASED,6
TR,VENTRICULAR FIBRILLATION,6
TR,ACUTE KIDNEY INJURY,5
TR,BLOOD CREATININE INCREASED,5
TR,CARDIAC ARREST,5
TR,DEATH,5
TR,MATERNAL EXPOSURE DURING PREGNANCY,5
TR,OVERDOSE,5
TR,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,5
TR,TACHYCARDIA,5
TR,TORSADE DE POINTES,5
TR,VOMITING,5
TR,BLOOD PRESSURE INCREASED,4
TR,CHEST PAIN,4
TR,CHONDROCALCINOSIS PYROPHOSPHATE,4
TR,EXPOSURE DURING PREGNANCY,4
TR,FOETAL EXPOSURE DURING PREGNANCY,4
TR,HALLUCINATION,4
TR,HEADACHE,4
TR,HYPERCALCIURIA,4
TR,LONG QT SYNDROME CONGENITAL,4
TR,MULTI-ORGAN FAILURE,4
TR,MUSCLE HAEMORRHAGE,4
TR,NEPHROTIC SYNDROME,4
TR,NEUTROPENIA,4
TR,PALLOR,4
TR,PULMONARY EMBOLISM,4
TR,PULMONARY OEDEMA,4
TR,RENAL FAILURE,4
TR,RHABDOMYOLYSIS,4
TR,SHOCK HAEMORRHAGIC,4
TR,URINE CALCIUM/CREATININE RATIO INCREASED,4
TR,ARTHRITIS,3
TR,ASCITES,3
TR,ATRIAL THROMBOSIS,3
TR,BLOOD PRESSURE DECREASED,3
TR,BRADYCARDIA,3
TR,C-REACTIVE PROTEIN INCREASED,3
TR,CARDIO-RESPIRATORY ARREST,3
TR,DECREASED APPETITE,3
TR,DIARRHOEA,3
TR,HEPATIC ENZYME INCREASED,3
TR,HEPATITIS TOXIC,3
TR,HYPOCALCAEMIA,3
TR,LETHARGY,3
TR,MYOCARDIAL INFARCTION,3
TR,NORMAL NEWBORN,3
TR,OSTEOPENIA,3
TR,PLEURAL EFFUSION,3
TR,PYREXIA,3
TR,SEIZURE,3
TR,VENTRICULAR TACHYCARDIA,3
TR,VISUAL IMPAIRMENT,3
TR,ABDOMINAL DISTENSION,2
TR,ABDOMINAL PAIN,2
TR,ANAEMIA,2
TR,BLOOD UREA INCREASED,2
TR,CARDIAC VALVE REPLACEMENT COMPLICATION,2
TR,CEREBROVASCULAR ACCIDENT,2
TR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
TR,CONDITION AGGRAVATED,2
TR,DELIRIUM,2
TR,DIABETIC KETOACIDOSIS,2
TR,DISEASE PROGRESSION,2
TR,EOSINOPHILIA,2
TR,ERYTHEMA,2
TR,EYE SWELLING,2
TR,FATIGUE,2
TR,GASTRIC HAEMORRHAGE,2
TR,GENERAL PHYSICAL HEALTH DETERIORATION,2
TR,HAEMOGLOBIN DECREASED,2
TR,HEPATOMEGALY,2
TR,HYPERCALCAEMIA,2
TR,HYPERTENSION,2
TR,ILEUS,2
TR,INCORRECT DOSE ADMINISTERED,2
TR,JOINT SWELLING,2
TR,LEUKOPENIA,2
TR,LOSS OF CONSCIOUSNESS,2
TR,LOW BIRTH WEIGHT BABY,2
TR,MELAENA,2
TR,MEMORY IMPAIRMENT,2
TR,NON-CARDIOGENIC PULMONARY OEDEMA,2
TR,OEDEMA,2
TR,ORTHOPNOEA,2
TR,PAIN,2
TR,PALPITATIONS,2
TR,PNEUMONIA,2
TR,PREMATURE BABY,2
TR,RESPIRATORY DISTRESS,2
TR,RESPIRATORY FAILURE,2
TR,RIGHT VENTRICULAR FAILURE,2
TR,SEPSIS,2
TR,SOMNOLENCE,2
TR,TACHYCARDIA INDUCED CARDIOMYOPATHY,2
TR,TACHYPNOEA,2
TR,THROMBOCYTOPENIA,2
TR,TUMOUR LYSIS SYNDROME,2
TR,URINARY RETENTION,2
TR,URINE OSMOLARITY INCREASED,2
TR,URTICARIAL VASCULITIS,2
TR,WHITE BLOOD CELL COUNT DECREASED,2
TR,WITHDRAWAL SYNDROME,2
TR,ABDOMINAL PAIN UPPER,1
TR,ABORTION SPONTANEOUS,1
TR,ACUTE MOTOR AXONAL NEUROPATHY,1
TR,ACUTE PRERENAL FAILURE,1
TR,ACUTE PROMYELOCYTIC LEUKAEMIA DIFFERENTIATION SYNDROME,1
TR,AGITATION,1
TR,AKATHISIA,1
TR,ALANINE AMINOTRANSFERASE ABNORMAL,1
TR,ALANINE AMINOTRANSFERASE INCREASED,1
TR,ALTERED STATE OF CONSCIOUSNESS,1
TR,ASPARTATE AMINOTRANSFERASE ABNORMAL,1
TR,ASPARTATE AMINOTRANSFERASE INCREASED,1
TR,ASTHENIA,1
TR,ASTHMA,1
TR,ATRIAL FIBRILLATION,1
TR,ATRIAL FLUTTER,1
TR,ATRIAL SEPTAL DEFECT,1
TR,BACTERIAL INFECTION,1
TR,BILIRUBIN CONJUGATED INCREASED,1
TR,BLINDNESS,1
TR,BLOOD BILIRUBIN INCREASED,1
TR,BLOOD CREATINE INCREASED,1
TR,BLOOD LACTATE DEHYDROGENASE INCREASED,1
TR,BLOOD OSMOLARITY DECREASED,1
TR,BLOOD PARATHYROID HORMONE INCREASED,1
TR,BLOOD SODIUM DECREASED,1
TR,BONE MARROW FAILURE,1
TR,BRADYKINESIA,1
TR,BREAST SWELLING,1
TR,BUDD-CHIARI SYNDROME,1
TR,CARDIAC DISORDER,1
TR,CARDIAC FAILURE CHRONIC,1
TR,CARDIAC FAILURE CONGESTIVE,1
TR,CATHETER SITE SCAB,1
TR,CEREBRAL HAEMORRHAGE,1
TR,CEREBRAL INFARCTION,1
TR,CEREBROVASCULAR DISORDER,1
TR,CHOLELITHIASIS,1
TR,CHOROIDAL HAEMORRHAGE,1
TR,CHRONIC HEPATITIS,1
TR,CHVOSTEK^S SIGN,1
TR,COMA,1
TR,COMPUTERISED TOMOGRAM ABNORMAL,1
TR,CONJUNCTIVAL HAEMORRHAGE,1
TR,CONTUSION,1
TR,COUGH,1
TR,CRYPTOCOCCAL CUTANEOUS INFECTION,1
TR,CYANOSIS,1
TR,DEEP VEIN THROMBOSIS,1
TR,DEHYDRATION,1
TR,DEMENTIA,1
TR,DEMENTIA WITH LEWY BODIES,1
TR,DERMATOPHYTOSIS,1
TR,DEVICE RELATED INFECTION,1
TR,DIABETES MELLITUS,1
TR,DIFFUSE LARGE B-CELL LYMPHOMA,1
TR,DISORIENTATION,1
TR,DIZZINESS,1
TR,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
TR,DRUG ERUPTION,1
TR,DRUG-INDUCED LIVER INJURY,1
TR,DYSPNOEA EXERTIONAL,1
TR,ELECTROCARDIOGRAM QT PROLONGED,1
TR,ENCEPHALOPATHY,1
TR,EPISTAXIS,1
TR,EXCHANGE BLOOD TRANSFUSION,1
TR,EYE HAEMORRHAGE,1
TR,EYE MOVEMENT DISORDER,1
TR,FEBRILE NEUTROPENIA,1
TR,FEMUR FRACTURE,1
TR,FLUSHING,1
TR,FOETAL DISTRESS SYNDROME,1
TR,GALLBLADDER DISORDER,1
TR,GENERAL PHYSICAL CONDITION ABNORMAL,1
TR,GENERALISED ERYTHEMA,1
TR,GLOMERULAR FILTRATION RATE DECREASED,1
TR,HAEMODYNAMIC INSTABILITY,1
TR,HAEMOLYSIS,1
TR,HAEMORRHOIDAL HAEMORRHAGE,1
TR,HAEMOTHORAX,1
TR,HALLUCINATION_ VISUAL,1
TR,HEART RATE INCREASED,1
TR,HEPATIC CONGESTION,1
TR,HEPATIC FAILURE,1
TR,HEPATIC VEIN DILATATION,1
TR,HEPATITIS C,1
TR,HEPATITIS CHOLESTATIC,1
TR,HEPATORENAL SYNDROME,1
TR,HERNIA REPAIR,1
TR,HYPERBILIRUBINAEMIA,1
TR,HYPERHIDROSIS,1
TR,HYPERKERATOSIS,1
TR,HYPERSENSITIVITY,1
TR,HYPERSOMNIA,1
TR,HYPERVENTILATION,1
TR,HYPOALBUMINAEMIA,1
TR,HYPOMAGNESAEMIA,1
TR,HYPOXIA,1
TR,IMMUNOSUPPRESSANT DRUG LEVEL DECREASED,1
TR,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,1
TR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
TR,INCARCERATED HERNIA,1
TR,INTESTINAL HAEMORRHAGE,1
TR,INTESTINAL METASTASIS,1
TR,INTRA-ABDOMINAL FLUID COLLECTION,1
TR,JOINT EFFUSION,1
TR,KAPOSI^S SARCOMA,1
TR,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
TR,LEUKOCYTOSIS,1
TR,LIP INJURY,1
TR,LIVER DISORDER,1
TR,LIVER FUNCTION TEST ABNORMAL,1
TR,LOCAL SWELLING,1
TR,LOW CARDIAC OUTPUT SYNDROME,1
TR,LUNG DISORDER,1
TR,LYMPHOMA,1
TR,MALIGNANT NEOPLASM PROGRESSION,1
TR,MEDICATION ERROR,1
TR,METABOLIC ENCEPHALOPATHY,1
TR,MITRAL VALVE INCOMPETENCE,1
TR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
TR,MUSCLE CONTRACTIONS INVOLUNTARY,1
TR,NASOPHARYNGITIS,1
TR,NEONATAL ANURIA,1
TR,NEONATAL MULTI-ORGAN FAILURE,1
TR,NEOPLASM PROGRESSION,1
TR,NODAL RHYTHM,1
TR,OLIGURIA,1
TR,ORAL MUCOSAL ERYTHEMA,1
TR,OROPHARYNGEAL PAIN,1
TR,ORTHOSTATIC HYPOTENSION,1
TR,OSTEOPOROSIS,1
TR,OVARIAN HYPERSTIMULATION SYNDROME,1
TR,OXYGEN SATURATION DECREASED,1
TR,PAIN IN EXTREMITY,1
TR,PAPULE,1
TR,PERICARDIAL EFFUSION,1
TR,PERIPHERAL SWELLING,1
TR,PERSONALITY DISORDER,1
TR,PHARYNGITIS,1
TR,POLYCYTHAEMIA,1
TR,POTENTIATING DRUG INTERACTION,1
TR,PREMATURE DELIVERY,1
TR,PREMATURE LABOUR,1
TR,PRODUCT QUALITY ISSUE,1
TR,PRODUCT USE IN UNAPPROVED INDICATION,1
TR,PROSTATE CANCER METASTATIC,1
TR,PRURITUS,1
TR,PULMONARY HAEMORRHAGE,1
TR,PULMONARY HYPERTENSION,1
TR,PULMONARY SEPSIS,1
TR,PURPURA,1
TR,QUALITY OF LIFE DECREASED,1
TR,RASH MACULO-PAPULAR,1
TR,RENAL CELL CARCINOMA,1
TR,RENAL CYST,1
TR,RENAL FAILURE ACUTE,1
TR,RENAL FAILURE NEONATAL,1
TR,RENAL IMPAIRMENT,1
TR,RESPIRATORY ARREST,1
TR,RESPIRATORY DISORDER,1
TR,RESPIRATORY RATE DECREASED,1
TR,RHONCHI,1
TR,RICHTER^S SYNDROME,1
TR,RIGHT-TO-LEFT CARDIAC SHUNT,1
TR,SEPSIS NEONATAL,1
TR,SHOCK,1
TR,SINUS TACHYCARDIA,1
TR,SKIN IRRITATION,1
TR,SKIN LESION,1
TR,SKIN MASS,1
TR,SKIN NECROSIS,1
TR,STOMA SITE DISCHARGE,1
TR,STOMATITIS,1
TR,SUBARACHNOID HAEMORRHAGE,1
TR,SUDDEN CARDIAC DEATH,1
TR,SUDDEN DEATH,1
TR,SUPRAVENTRICULAR TACHYCARDIA,1
TR,SUSPECTED COUNTERFEIT PRODUCT,1
TR,SYNCOPE,1
TR,SYNOVITIS,1
TR,TENDERNESS,1
TR,TETANY,1
TR,TONGUE OEDEMA,1
TR,TRANSFUSION,1
TR,TRANSPLANT REJECTION,1
TR,TRAUMATIC HAEMATOMA,1
TR,TROUSSEAU^S SIGN,1
TR,ULTRAFILTRATION FAILURE,1
TR,UNRESPONSIVE TO STIMULI,1
TR,UPPER RESPIRATORY TRACT INFECTION,1
TR,URINARY TRACT INFECTION,1
TR,URINE OUTPUT DECREASED,1
TR,URINE SODIUM INCREASED,1
TR,VENTRICULAR ARRHYTHMIA,1
TR,VOCAL CORD PARALYSIS,1
TR,WALKING DISTANCE TEST ABNORMAL,1
UG,ABDOMINAL PAIN UPPER,1
UG,CARDIAC FAILURE CONGESTIVE,1
UG,CARDIOMEGALY,1
UG,CARDIOTHORACIC RATIO,1
UG,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
UG,COUGH,1
UG,CREPITATIONS,1
UG,DRUG DOSE OMISSION,1
UG,DYSPNOEA,1
UG,ELECTROCARDIOGRAM ST-T CHANGE,1
UG,FLUID RETENTION,1
UG,GOUTY ARTHRITIS,1
UG,HAEMOPTYSIS,1
UG,HEART SOUNDS ABNORMAL,1
UG,HEPATOMEGALY,1
UG,LEFT VENTRICULAR DYSFUNCTION,1
UG,LEFT VENTRICULAR HYPERTROPHY,1
UG,LOW DENSITY LIPOPROTEIN INCREASED,1
UG,MALIGNANT HYPERTENSION,1
UG,MUSCULAR WEAKNESS,1
UG,PERICARDIAL EFFUSION,1
UG,PNEUMONIA,1
UG,PULSE VOLUME DECREASED,1
UG,SINUS TACHYCARDIA,1
UG,TREATMENT NONCOMPLIANCE,1
UA,GASTRIC HAEMORRHAGE,2
UA,HYPERAEMIA,2
UA,LYMPHOPENIA,2
UA,ACUTE CORONARY SYNDROME,1
UA,ANAEMIA,1
UA,ANAPHYLACTIC SHOCK,1
UA,ASCITES,1
UA,ASPHYXIA,1
UA,ASTHENIA,1
UA,ATRIAL FIBRILLATION,1
UA,BLOOD PRESSURE DECREASED,1
UA,BLOOD URINE PRESENT,1
UA,BRONCHITIS,1
UA,CARDIAC ARREST,1
UA,CARDIAC FAILURE,1
UA,CARDIAC FAILURE CHRONIC,1
UA,CYANOSIS,1
UA,DEATH,1
UA,DYSPNOEA,1
UA,FACE OEDEMA,1
UA,FATIGUE,1
UA,FEMORAL HERNIA,1
UA,GENERAL PHYSICAL HEALTH DETERIORATION,1
UA,HAEMORRHOIDAL HAEMORRHAGE,1
UA,HEPATIC CIRRHOSIS,1
UA,HEPATOTOXICITY,1
UA,HYPOTENSION,1
UA,LOSS OF CONSCIOUSNESS,1
UA,OEDEMA GENITAL,1
UA,PLEURAL EFFUSION,1
UA,PRURITUS,1
UA,PULMONARY ARTERY THROMBOSIS,1
UA,PULMONARY OEDEMA,1
UA,PULSE ABNORMAL,1
UA,RESPIRATORY ARREST,1
UA,THROMBOCYTOPENIA,1
UA,ULCER,1
UA,VENTRICULAR EXTRASYSTOLES,1
AE,HYPERBILIRUBINAEMIA,3
AE,ACUTE KIDNEY INJURY,2
AE,ASTHENIA,2
AE,CARDIAC FAILURE,2
AE,PRURITUS,2
AE,ANAEMIA,1
AE,BACK PAIN,1
AE,BLOOD CREATININE INCREASED,1
AE,BLOOD UREA INCREASED,1
AE,CARDIAC FAILURE CONGESTIVE,1
AE,CHEST PAIN,1
AE,DEATH,1
AE,DIARRHOEA,1
AE,DYSPNOEA,1
AE,EXCORIATION,1
AE,FATIGUE,1
AE,HAEMATEMESIS,1
AE,HEPATIC ENCEPHALOPATHY,1
AE,HYPONATRAEMIA,1
AE,LOWER RESPIRATORY TRACT INFECTION,1
AE,MALAISE,1
AE,OCULAR ICTERUS,1
AE,OEDEMA PERIPHERAL,1
AE,OESOPHAGEAL VARICES HAEMORRHAGE,1
AE,OSTEOPOROTIC FRACTURE,1
AE,PAIN IN EXTREMITY,1
AE,PEMPHIGOID,1
AE,PLATELET COUNT DECREASED,1
AE,PNEUMONIA,1
AE,PYREXIA,1
AE,RHABDOMYOLYSIS,1
AE,SKIN HYPERPIGMENTATION,1
AE,THROMBOCYTOPENIA,1
AE,UPPER GASTROINTESTINAL HAEMORRHAGE,1
AE,URINE OUTPUT DECREASED,1
AE,VOMITING,1
AE,WHITE BLOOD CELL COUNT DECREASED,1
GB,ACUTE KIDNEY INJURY,573
GB,DYSPNOEA,541
GB,MALAISE,426
GB,CONFUSIONAL STATE,331
GB,FALL,325
GB,HYPOTENSION,273
GB,DIARRHOEA,271
GB,DIZZINESS,265
GB,VOMITING,238
GB,HYPONATRAEMIA,227
GB,NAUSEA,196
GB,RENAL FAILURE ACUTE,189
GB,INTERNATIONAL NORMALISED RATIO INCREASED,188
GB,HYPERKALAEMIA,181
GB,FATIGUE,178
GB,LOWER RESPIRATORY TRACT INFECTION,176
GB,GASTROINTESTINAL HAEMORRHAGE,169
GB,RENAL IMPAIRMENT,166
GB,ATRIAL FIBRILLATION,161
GB,BRADYCARDIA,154
GB,PNEUMONIA,153
GB,SEPSIS,149
GB,OEDEMA PERIPHERAL,146
GB,SOMNOLENCE,143
GB,LIVER FUNCTION TEST ABNORMAL,141
GB,ANAEMIA,140
GB,CHEST PAIN,134
GB,RASH,130
GB,DECREASED APPETITE,127
GB,CARDIAC FAILURE,125
GB,DEATH,123
GB,HEADACHE,122
GB,LETHARGY,122
GB,TREMOR,122
GB,TOXICITY TO VARIOUS AGENTS,121
GB,DEHYDRATION,118
GB,MELAENA,115
GB,HALLUCINATION,113
GB,ABDOMINAL PAIN,112
GB,PERIPHERAL SWELLING,112
GB,PYREXIA,109
GB,SYNCOPE,105
GB,THROMBOCYTOPENIA,104
GB,CONTUSION,103
GB,MYALGIA,101
GB,PAIN,101
GB,URINARY TRACT INFECTION,101
GB,AGITATION,99
GB,CONDITION AGGRAVATED,96
GB,PAIN IN EXTREMITY,96
GB,PRURITUS,96
GB,ASTHENIA,95
GB,ARTHRALGIA,93
GB,COUGH,92
GB,UPPER GASTROINTESTINAL HAEMORRHAGE,92
GB,HAEMOGLOBIN DECREASED,91
GB,DRUG INEFFECTIVE,89
GB,RECTAL HAEMORRHAGE,86
GB,CARDIAC ARREST,85
GB,HAEMATEMESIS,85
GB,BALANCE DISORDER,84
GB,NEUTROPENIA,81
GB,SWELLING FACE,81
GB,ANGIOEDEMA,79
GB,SEIZURE,79
GB,OEDEMA,78
GB,CIRCULATORY COLLAPSE,75
GB,RENAL FAILURE,72
GB,RHABDOMYOLYSIS,72
GB,ELECTROCARDIOGRAM QT PROLONGED,70
GB,FAECES DISCOLOURED,70
GB,GENERAL PHYSICAL HEALTH DETERIORATION,69
GB,SWOLLEN TONGUE,69
GB,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,68
GB,CEREBROVASCULAR ACCIDENT,67
GB,INSOMNIA,67
GB,CONSTIPATION,66
GB,GASTRITIS,65
GB,HYPOCALCAEMIA,65
GB,RESPIRATORY FAILURE,64
GB,LOSS OF CONSCIOUSNESS,63
GB,BLOOD CREATINE PHOSPHOKINASE INCREASED,62
GB,BLOOD CREATININE INCREASED,61
GB,MUSCULAR WEAKNESS,61
GB,HAEMORRHAGE,60
GB,PULMONARY EMBOLISM,60
GB,HYPERTENSION,59
GB,HYPOMAGNESAEMIA,59
GB,INFECTION,59
GB,PALPITATIONS,59
GB,FEELING ABNORMAL,58
GB,HYPOKALAEMIA,58
GB,TACHYCARDIA,58
GB,PRESYNCOPE,56
GB,EPISTAXIS,55
GB,JOINT SWELLING,55
GB,BACK PAIN,54
GB,UNRESPONSIVE TO STIMULI,54
GB,CELLULITIS,52
GB,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,52
GB,LIP SWELLING,52
GB,RASH ERYTHEMATOUS,52
GB,GLOMERULAR FILTRATION RATE DECREASED,51
GB,DYSPHAGIA,50
GB,DYSPNOEA EXERTIONAL,50
GB,MOBILITY DECREASED,50
GB,PARAESTHESIA,50
GB,WHEEZING,50
GB,HYPERHIDROSIS,49
GB,MUSCLE SPASMS,49
GB,DYSARTHRIA,48
GB,ORTHOSTATIC HYPOTENSION,48
GB,MYOCARDIAL INFARCTION,47
GB,PULMONARY OEDEMA,47
GB,BLISTER,46
GB,DELIRIUM,45
GB,MYOSITIS,45
GB,ABDOMINAL PAIN UPPER,44
GB,PLEURAL EFFUSION,44
GB,URINE OUTPUT DECREASED,44
GB,DYSKINESIA,43
GB,CEREBRAL HAEMORRHAGE,41
GB,DRUG PRESCRIBING ERROR,41
GB,FEELING HOT,41
GB,HYPERSENSITIVITY,41
GB,PALLOR,41
GB,PLATELET COUNT DECREASED,41
GB,PSORIASIS,41
GB,VENTRICULAR TACHYCARDIA,41
GB,ANAPHYLACTIC REACTION,40
GB,NEUROPATHY PERIPHERAL,40
GB,RASH GENERALISED,40
GB,OESOPHAGITIS,39
GB,URTICARIA,39
GB,AGGRESSION,38
GB,PANCYTOPENIA,38
GB,CARDIAC FAILURE CONGESTIVE,37
GB,SKIN EXFOLIATION,37
GB,ANGINA PECTORIS,36
GB,DEPRESSION,36
GB,FEBRILE NEUTROPENIA,36
GB,JAUNDICE,36
GB,ALANINE AMINOTRANSFERASE INCREASED,35
GB,ERYTHEMA,35
GB,HAEMORRHAGE INTRACRANIAL,35
GB,WHITE BLOOD CELL COUNT INCREASED,35
GB,CLOSTRIDIUM DIFFICILE INFECTION,34
GB,GASTRIC ULCER,34
GB,HYPOGLYCAEMIA,34
GB,RASH PRURITIC,34
GB,SWELLING,34
GB,URINARY RETENTION,34
GB,ABNORMAL LOSS OF WEIGHT,33
GB,C-REACTIVE PROTEIN INCREASED,33
GB,DISORIENTATION,33
GB,FLUID RETENTION,33
GB,GAIT DISTURBANCE,33
GB,NEUTROPENIC SEPSIS,33
GB,SKIN ULCER,33
GB,ACUTE MYOCARDIAL INFARCTION,32
GB,ALOPECIA,32
GB,VISION BLURRED,32
GB,DRY MOUTH,31
GB,FLUID OVERLOAD,31
GB,HYPOPHAGIA,31
GB,MOUTH ULCERATION,31
GB,OXYGEN SATURATION DECREASED,31
GB,SEDATION,31
GB,DRUG-INDUCED LIVER INJURY,30
GB,HAEMOPTYSIS,30
GB,HYPOAESTHESIA,30
GB,INFLUENZA LIKE ILLNESS,30
GB,TREATMENT FAILURE,30
GB,DRUG ERUPTION,29
GB,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,29
GB,HAEMATURIA,29
GB,INTENTIONAL OVERDOSE,29
GB,PRURITUS GENERALISED,29
GB,PULMONARY FIBROSIS,29
GB,SEPTIC SHOCK,29
GB,SLEEP DISORDER,29
GB,CHILLS,28
GB,HEPATIC FUNCTION ABNORMAL,28
GB,LOCAL SWELLING,28
GB,ACUTE CORONARY SYNDROME,27
GB,LEUKOPENIA,27
GB,MUSCULOSKELETAL STIFFNESS,27
GB,NIGHTMARE,27
GB,UROSEPSIS,27
GB,ASCITES,26
GB,DEPRESSED MOOD,26
GB,HAEMATOMA,26
GB,HEMIPARESIS,26
GB,HYPOXIA,26
GB,LEFT VENTRICULAR DYSFUNCTION,26
GB,LIVER DISORDER,26
GB,MUSCLE TWITCHING,26
GB,PNEUMONITIS,26
GB,STEVENS-JOHNSON SYNDROME,26
GB,APHASIA,25
GB,BLOOD LACTIC ACID INCREASED,25
GB,CHEST DISCOMFORT,25
GB,CHRONIC KIDNEY DISEASE,25
GB,HOT FLUSH,25
GB,HYPERGLYCAEMIA,25
GB,IRON DEFICIENCY ANAEMIA,25
GB,LUNG INFECTION,25
GB,OROPHARYNGEAL PAIN,25
GB,WEIGHT DECREASED,25
GB,ANXIETY,24
GB,MEDICATION ERROR,24
GB,MYOPATHY,24
GB,RALES,24
GB,MYOCARDIAL ISCHAEMIA,23
GB,OVERDOSE,23
GB,PERITONITIS,23
GB,RASH MACULO-PAPULAR,23
GB,TRANSIENT ISCHAEMIC ATTACK,23
GB,BLOOD PRESSURE DECREASED,22
GB,CHOLECYSTITIS,22
GB,DERMATITIS EXFOLIATIVE,22
GB,HEART RATE DECREASED,22
GB,HEART RATE INCREASED,22
GB,LACTIC ACIDOSIS,22
GB,PRODUCTIVE COUGH,22
GB,SKIN DISCOLOURATION,22
GB,TUBULOINTERSTITIAL NEPHRITIS,22
GB,WEIGHT INCREASED,22
GB,BLOOD URINE PRESENT,21
GB,CARDIO-RESPIRATORY ARREST,21
GB,CONTRAINDICATED PRODUCT ADMINISTERED,21
GB,DEEP VEIN THROMBOSIS,21
GB,EXFOLIATIVE RASH,21
GB,NEUTROPHIL COUNT INCREASED,21
GB,POTENTIATING DRUG INTERACTION,21
GB,RESTLESS LEGS SYNDROME,21
GB,ABDOMINAL DISTENSION,20
GB,BLOOD ALKALINE PHOSPHATASE INCREASED,20
GB,BLOOD POTASSIUM INCREASED,20
GB,COMA SCALE ABNORMAL,20
GB,DIABETIC KETOACIDOSIS,20
GB,FEMORAL NECK FRACTURE,20
GB,HAEMARTHROSIS,20
GB,HEPATIC FAILURE,20
GB,METABOLIC ACIDOSIS,20
GB,NEUROLEPTIC MALIGNANT SYNDROME,20
GB,SINUS BRADYCARDIA,20
GB,THROMBOCYTOSIS,20
GB,URINARY INCONTINENCE,20
GB,BLOOD BILIRUBIN INCREASED,19
GB,CONVULSION,19
GB,ECZEMA,19
GB,FEMUR FRACTURE,19
GB,GLASSY EYES,19
GB,GOUT,19
GB,HYPOTHYROIDISM,19
GB,MULTI-ORGAN FAILURE,19
GB,MUSCULOSKELETAL PAIN,19
GB,PARALYSIS,19
GB,STARING,19
GB,AMNESIA,18
GB,ASTHMA,18
GB,ATRIOVENTRICULAR BLOCK FIRST DEGREE,18
GB,BLOOD GLUCOSE INCREASED,18
GB,BURNING SENSATION,18
GB,DRUG INTOLERANCE,18
GB,INCORRECT DOSE ADMINISTERED,18
GB,INTERSTITIAL LUNG DISEASE,18
GB,LIVER FUNCTION TEST INCREASED,18
GB,MEMORY IMPAIRMENT,18
GB,PHARYNGEAL OEDEMA,18
GB,RASH MACULAR,18
GB,TOXIC EPIDERMAL NECROLYSIS,18
GB,TRANSAMINASES INCREASED,18
GB,TREATMENT NONCOMPLIANCE,18
GB,VENTRICULAR FIBRILLATION,18
GB,ACCIDENTAL OVERDOSE,17
GB,AUTONOMIC NERVOUS SYSTEM IMBALANCE,17
GB,COAGULATION TIME PROLONGED,17
GB,COLD SWEAT,17
GB,DISCOMFORT,17
GB,DRUG DOSE OMISSION,17
GB,DRY SKIN,17
GB,EOSINOPHILIA,17
GB,HYPERCALCAEMIA,17
GB,PAIN OF SKIN,17
GB,PANCREATITIS ACUTE,17
GB,RENAL DISORDER,17
GB,SUICIDAL IDEATION,17
GB,VISUAL IMPAIRMENT,17
GB,BLOOD UREA INCREASED,16
GB,CATATONIA,16
GB,CLOSTRIDIUM DIFFICILE COLITIS,16
GB,HIATUS HERNIA,16
GB,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,16
GB,PRODUCT USE ISSUE,16
GB,PULMONARY HYPERTENSION,16
GB,SKIN FISSURES,16
GB,SKIN TIGHTNESS,16
GB,SPINAL CORD COMPRESSION,16
GB,SUBDURAL HAEMATOMA,16
GB,SUICIDE ATTEMPT,16
GB,ABDOMINAL DISCOMFORT,15
GB,ABDOMINAL SEPSIS,15
GB,BLOOD CHOLESTEROL INCREASED,15
GB,BODY TEMPERATURE INCREASED,15
GB,EXTRADURAL HAEMATOMA,15
GB,EYE PAIN,15
GB,HALLUCINATION_ VISUAL,15
GB,HYPERCHOLESTEROLAEMIA,15
GB,LARGE INTESTINE POLYP,15
GB,MUCOSAL DRYNESS,15
GB,MUSCLE RIGIDITY,15
GB,PERIPHERAL ISCHAEMIA,15
GB,PETECHIAE,15
GB,RESTLESSNESS,15
GB,SUBDURAL HAEMORRHAGE,15
GB,TACHYARRHYTHMIA,15
GB,THIRST,15
GB,VERTIGO,15
GB,ABNORMAL BEHAVIOUR,14
GB,CARDIOGENIC SHOCK,14
GB,COAGULOPATHY,14
GB,DIVERTICULITIS,14
GB,DRUG HYPERSENSITIVITY,14
GB,ESSENTIAL HYPERTENSION,14
GB,FAECAL INCONTINENCE,14
GB,FEEDING DISORDER,14
GB,HEMIPLEGIA,14
GB,IMPAIRED HEALING,14
GB,INFLAMMATORY MARKER INCREASED,14
GB,ISCHAEMIC STROKE,14
GB,LYMPHOEDEMA,14
GB,ORAL MUCOSAL BLISTERING,14
GB,PNEUMONIA ASPIRATION,14
GB,PSYCHOTIC DISORDER,14
GB,RESPIRATORY TRACT INFECTION,14
GB,SPINAL PAIN,14
GB,ARRHYTHMIA,13
GB,ATRIAL FLUTTER,13
GB,ATRIOVENTRICULAR BLOCK,13
GB,ATRIOVENTRICULAR BLOCK COMPLETE,13
GB,BEDRIDDEN,13
GB,BLOOD CREATINE INCREASED,13
GB,BLOOD ELECTROLYTES ABNORMAL,13
GB,CARDIAC OUTPUT DECREASED,13
GB,CHOLELITHIASIS,13
GB,COMA,13
GB,COMMUNICATION DISORDER,13
GB,COORDINATION ABNORMAL,13
GB,DRUG DISPENSING ERROR,13
GB,EJECTION FRACTION DECREASED,13
GB,EXERCISE TOLERANCE DECREASED,13
GB,EYE SWELLING,13
GB,FACIAL PARALYSIS,13
GB,FAILURE TO ANASTOMOSE,13
GB,HYDROCEPHALUS,13
GB,IMMUNE THROMBOCYTOPENIC PURPURA,13
GB,INCONTINENCE,13
GB,INFECTED SKIN ULCER,13
GB,KIDNEY INFECTION,13
GB,MUSCLE ATROPHY,13
GB,OESOPHAGEAL ULCER,13
GB,ORAL PAIN,13
GB,PULMONARY CONGESTION,13
GB,PURPURA,13
GB,RESPIRATORY DISTRESS,13
GB,RETCHING,13
GB,THROMBOSIS,13
GB,TONGUE COATED,13
GB,TONGUE DRY,13
GB,VISUAL ACUITY REDUCED,13
GB,ANAL INCONTINENCE,12
GB,BLOOD PRESSURE FLUCTUATION,12
GB,BLOOD SODIUM DECREASED,12
GB,CHOREA,12
GB,COATING IN MOUTH,12
GB,DERMATITIS,12
GB,DISEASE PROGRESSION,12
GB,DUODENAL ULCER,12
GB,EATING DISORDER,12
GB,EXTENSOR PLANTAR RESPONSE,12
GB,FEELING COLD,12
GB,FLUID INTAKE REDUCED,12
GB,FRUSTRATION,12
GB,GASTRIC HAEMORRHAGE,12
GB,GASTROENTERITIS,12
GB,HYPOKINESIA,12
GB,HYPORESPONSIVE TO STIMULI,12
GB,IRON DEFICIENCY,12
GB,LARGE INTESTINAL ULCER,12
GB,MENTAL STATUS CHANGES,12
GB,METABOLIC ALKALOSIS,12
GB,MOUTH SWELLING,12
GB,MUSCLE SPASTICITY,12
GB,OCULOGYRIC CRISIS,12
GB,OPISTHOTONUS,12
GB,SALIVARY HYPERSECRETION,12
GB,SINUS NODE DYSFUNCTION,12
GB,SPEECH DISORDER,12
GB,STOMATITIS,12
GB,STUPOR,12
GB,TROPONIN T INCREASED,12
GB,WEIGHT LOSS POOR,12
GB,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,12
GB,ABDOMINAL WALL HAEMATOMA,11
GB,ALVEOLITIS ALLERGIC,11
GB,BLINDNESS,11
GB,BLOOD POTASSIUM DECREASED,11
GB,BLOOD PRESSURE INCREASED,11
GB,DRUG LEVEL INCREASED,11
GB,DYSGEUSIA,11
GB,EPILEPSY,11
GB,EXCORIATION,11
GB,FACE OEDEMA,11
GB,GAMMA-GLUTAMYLTRANSFERASE INCREASED,11
GB,GASTRIC DISORDER,11
GB,HEAD INJURY,11
GB,HEPATIC CIRRHOSIS,11
GB,HEPATIC ENCEPHALOPATHY,11
GB,INHIBITORY DRUG INTERACTION,11
GB,LIVER INJURY,11
GB,LOW DENSITY LIPOPROTEIN INCREASED,11
GB,MOOD ALTERED,11
GB,MUSCULOSKELETAL CHEST PAIN,11
GB,NECK PAIN,11
GB,NECROSIS,11
GB,NEPHROPATHY TOXIC,11
GB,NEURALGIA,11
GB,NIGHT SWEATS,11
GB,OBSTRUCTIVE AIRWAYS DISORDER,11
GB,PERIPHERAL COLDNESS,11
GB,PLATELET COUNT INCREASED,11
GB,PNEUMOCYSTIS JIROVECII PNEUMONIA,11
GB,PRODUCT QUALITY ISSUE,11
GB,RENAL PAIN,11
GB,RHEUMATOID ARTHRITIS,11
GB,TENDONITIS,11
GB,VENTRICULAR DYSFUNCTION,11
GB,ABNORMAL DREAMS,10
GB,ANGER,10
GB,AXONAL NEUROPATHY,10
GB,BRAIN HERNIATION,10
GB,BRONCHOSPASM,10
GB,CARDIAC DISORDER,10
GB,DECUBITUS ULCER,10
GB,DEPRESSED LEVEL OF CONSCIOUSNESS,10
GB,DERMATITIS ALLERGIC,10
GB,ELECTROCARDIOGRAM ABNORMAL,10
GB,ENDOCARDITIS,10
GB,EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS,10
GB,ERYTHEMA MULTIFORME,10
GB,EYE MOVEMENT DISORDER,10
GB,GYNAECOMASTIA,10
GB,HEPATITIS,10
GB,HEPATOTOXICITY,10
GB,HYPERTHERMIA,10
GB,HYPOPHOSPHATAEMIA,10
GB,INTESTINAL DILATATION,10
GB,LIMB DISCOMFORT,10
GB,LYMPHOMA,10
GB,MULTIPLE ORGAN DYSFUNCTION SYNDROME,10
GB,NEOPLASM MALIGNANT,10
GB,NEPHROPATHY,10
GB,RESPIRATORY RATE INCREASED,10
GB,SPLENIC RUPTURE,10
GB,TENDON PAIN,10
GB,UPPER RESPIRATORY TRACT INFECTION,10
GB,WEIGHT BEARING DIFFICULTY,10
GB,ABDOMINAL PAIN LOWER,9
GB,ACIDOSIS,9
GB,ACQUIRED HAEMOPHILIA,9
GB,AORTIC STENOSIS,9
GB,ASPARTATE AMINOTRANSFERASE INCREASED,9
GB,ATRIOVENTRICULAR BLOCK SECOND DEGREE,9
GB,BARRETT^S OESOPHAGUS,9
GB,BLISTER RUPTURE,9
GB,BLOOD CALCIUM DECREASED,9
GB,BLOOD GLUCOSE ABNORMAL,9
GB,C-REACTIVE PROTEIN DECREASED,9
GB,CANDIDA INFECTION,9
GB,CONGESTIVE CARDIOMYOPATHY,9
GB,DYSPEPSIA,9
GB,EYE HAEMORRHAGE,9
GB,FURUNCLE,9
GB,HYPERVOLAEMIA,9
GB,HYPOMANIA,9
GB,HYPOPERFUSION,9
GB,IMPAIRED QUALITY OF LIFE,9
GB,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,9
GB,INTESTINAL ISCHAEMIA,9
GB,LUNG DISORDER,9
GB,MALNUTRITION,9
GB,MEGACOLON,9
GB,ORAL CANDIDIASIS,9
GB,OSTEONECROSIS OF JAW,9
GB,PARAESTHESIA ORAL,9
GB,PLEURITIC PAIN,9
GB,POLYARTHRITIS,9
GB,PROCEDURAL HAEMORRHAGE,9
GB,RIB FRACTURE,9
GB,SCAB,9
GB,SENSORY LOSS,9
GB,SINUS ARREST,9
GB,SKIN DISORDER,9
GB,SKIN IRRITATION,9
GB,TINNITUS,9
GB,ABNORMAL WEIGHT GAIN,8
GB,ALVEOLITIS,8
GB,AUTOIMMUNE HAEMOLYTIC ANAEMIA,8
GB,BRONCHIECTASIS,8
GB,BUNDLE BRANCH BLOCK LEFT,8
GB,BURNING FEET SYNDROME,8
GB,CARDIOMEGALY,8
GB,CHROMATURIA,8
GB,COLON CANCER,8
GB,CONCOMITANT DISEASE PROGRESSION,8
GB,DELUSION,8
GB,DIABETES MELLITUS,8
GB,DIVERTICULUM,8
GB,DIZZINESS POSTURAL,8
GB,DYSURIA,8
GB,EMOTIONAL DISTRESS,8
GB,ESCHERICHIA SEPSIS,8
GB,FLUSHING,8
GB,FREQUENT BOWEL MOVEMENTS,8
GB,HAEMORRHOIDS,8
GB,INCREASED UPPER AIRWAY SECRETION,8
GB,LIMB INJURY,8
GB,LYMPHOCYTIC INFILTRATION,8
GB,MASS,8
GB,MYOCLONUS,8
GB,ORTHOPNOEA,8
GB,PANCREATITIS,8
GB,PARAKERATOSIS,8
GB,PERICARDIAL EFFUSION,8
GB,RENAL FAILURE CHRONIC,8
GB,RESPIRATORY ARREST,8
GB,RESPIRATORY DEPRESSION,8
GB,SENSORY DISTURBANCE,8
GB,SKIN LESION,8
GB,SKIN REACTION,8
GB,STAPHYLOCOCCAL INFECTION,8
GB,WHITE BLOOD CELL COUNT DECREASED,8
GB,ABDOMINAL SYMPTOM,7
GB,ACUTE HEPATIC FAILURE,7
GB,ACUTE PULMONARY OEDEMA,7
GB,ADDISON^S DISEASE,7
GB,BONE PAIN,7
GB,BREAST PAIN,7
GB,BRONCHOPULMONARY ASPERGILLOSIS,7
GB,CALCIPHYLAXIS,7
GB,CARDIAC FAILURE ACUTE,7
GB,CLONIC CONVULSION,7
GB,COGNITIVE DISORDER,7
GB,DRUG MONITORING PROCEDURE NOT PERFORMED,7
GB,ELECTROLYTE DEPLETION,7
GB,ENCEPHALOPATHY,7
GB,EYE DISORDER,7
GB,FLATULENCE,7
GB,HAEMORRHAGIC STROKE,7
GB,HEART RATE IRREGULAR,7
GB,HYPERSOMNIA,7
GB,HYPOACUSIS,7
GB,HYPOTHERMIA,7
GB,IRRITABILITY,7
GB,JAUNDICE CHOLESTATIC,7
GB,LACERATION,7
GB,LOCALISED OEDEMA,7
GB,LOSS OF CONTROL OF LEGS,7
GB,LUNG NEOPLASM MALIGNANT,7
GB,METHAEMOGLOBINAEMIA,7
GB,MUSCLE HAEMORRHAGE,7
GB,NEUTROPHIL COUNT DECREASED,7
GB,NITRITE URINE PRESENT,7
GB,OPHTHALMOPLEGIA,7
GB,OPTIC ISCHAEMIC NEUROPATHY,7
GB,PERIPHERAL VASCULAR DISORDER,7
GB,POOR QUALITY SLEEP,7
GB,PROCTALGIA,7
GB,PRODUCT USE IN UNAPPROVED INDICATION,7
GB,RIGHT VENTRICULAR FAILURE,7
GB,SINUS TACHYCARDIA,7
GB,SKIN NECROSIS,7
GB,SUBARACHNOID HAEMORRHAGE,7
GB,TEARFULNESS,7
GB,TENDERNESS,7
GB,TENDON RUPTURE,7
GB,THERAPEUTIC RESPONSE DECREASED,7
GB,THROAT TIGHTNESS,7
GB,TONGUE BLISTERING,7
GB,ULCER,7
GB,VAGINAL HAEMORRHAGE,7
GB,ABDOMINAL TENDERNESS,6
GB,AORTIC ANEURYSM,6
GB,ATYPICAL FEMUR FRACTURE,6
GB,BASAL CELL CARCINOMA,6
GB,BLADDER CANCER,6
GB,BLEEDING TIME PROLONGED,6
GB,BLOOD FOLLICLE STIMULATING HORMONE INCREASED,6
GB,BLOOD LUTEINISING HORMONE INCREASED,6
GB,BRONCHITIS,6
GB,CATARACT,6
GB,COLITIS,6
GB,CYSTITIS,6
GB,DIABETES MELLITUS INADEQUATE CONTROL,6
GB,DIABETIC KETOACIDOTIC HYPERGLYCAEMIC COMA,6
GB,DUODENAL ULCER HAEMORRHAGE,6
GB,DYSPNOEA AT REST,6
GB,DYSPNOEA PAROXYSMAL NOCTURNAL,6
GB,DYSSTASIA,6
GB,EMPHYSEMA,6
GB,EOSINOPHIL COUNT INCREASED,6
GB,GASTROINTESTINAL CARCINOMA,6
GB,GASTROINTESTINAL DISORDER,6
GB,GASTROINTESTINAL ULCER,6
GB,GINGIVAL BLEEDING,6
GB,GLAUCOMA,6
GB,HEART VALVE REPLACEMENT,6
GB,HEPATITIS ACUTE,6
GB,HEPATORENAL SYNDROME,6
GB,HICCUPS,6
GB,ILL-DEFINED DISORDER,6
GB,INAPPROPRIATE AFFECT,6
GB,INCREASED TENDENCY TO BRUISE,6
GB,INFLAMMATION,6
GB,INFLUENZA,6
GB,INTESTINAL PERFORATION,6
GB,JOINT STIFFNESS,6
GB,LIP BLISTER,6
GB,LOWER GASTROINTESTINAL HAEMORRHAGE,6
GB,LUPUS-LIKE SYNDROME,6
GB,LYMPHADENOPATHY,6
GB,MICROCYTIC ANAEMIA,6
GB,MIGRAINE,6
GB,MUCOSAL ULCERATION,6
GB,NYSTAGMUS,6
GB,OBESITY,6
GB,OLIGURIA,6
GB,OSTEOPOROTIC FRACTURE,6
GB,PERITONITIS BACTERIAL,6
GB,PRESCRIBED UNDERDOSE,6
GB,PRODUCT SUBSTITUTION ISSUE,6
GB,PROTEINURIA,6
GB,RASH PAPULAR,6
GB,RHINORRHOEA,6
GB,SECRETION DISCHARGE,6
GB,SEROTONIN SYNDROME,6
GB,SHOCK,6
GB,SKIN INFECTION,6
GB,SMALL CELL CARCINOMA,6
GB,SMALL INTESTINAL OBSTRUCTION,6
GB,SPINAL COLUMN STENOSIS,6
GB,SQUAMOUS CELL CARCINOMA,6
GB,STRESS FRACTURE,6
GB,SUPRAPUBIC PAIN,6
GB,TONGUE OEDEMA,6
GB,TRANSFUSION,6
GB,TRAUMATIC LUNG INJURY,6
GB,UNEVALUABLE EVENT,6
GB,VARICES OESOPHAGEAL,6
GB,VASCULITIC RASH,6
GB,VENTRICULAR EXTRASYSTOLES,6
GB,WOUND,6
GB,WRONG DRUG ADMINISTERED,6
GB,WRONG TECHNIQUE IN DRUG USAGE PROCESS,6
GB,ABNORMAL SLEEP-RELATED EVENT,5
GB,ADRENAL MASS,5
GB,ADVERSE DRUG REACTION,5
GB,ARTHROPATHY,5
GB,ASPIRATION,5
GB,BLINDNESS UNILATERAL,5
GB,BLOOD CHLORIDE DECREASED,5
GB,C-REACTIVE PROTEIN ABNORMAL,5
GB,CARDIAC FAILURE CHRONIC,5
GB,CATHETER SITE CELLULITIS,5
GB,CELLULITIS ORBITAL,5
GB,CEREBELLAR HAEMORRHAGE,5
GB,CEREBRAL INFARCTION,5
GB,CIRCUMORAL OEDEMA,5
GB,CONVERSION DISORDER,5
GB,CROHN^S DISEASE,5
GB,DEFAECATION URGENCY,5
GB,DIFFUSE LARGE B-CELL LYMPHOMA,5
GB,DRUG ADMINISTRATION ERROR,5
GB,DRUG DOSE TITRATION NOT PERFORMED,5
GB,DUODENAL ULCER PERFORATION,5
GB,EMPYEMA,5
GB,ENCEPHALITIS,5
GB,ENERGY INCREASED,5
GB,EXTREMITY CONTRACTURE,5
GB,EYE PRURITUS,5
GB,EYELID OEDEMA,5
GB,GASTROINTESTINAL STOMA COMPLICATION,5
GB,GASTROOESOPHAGEAL REFLUX DISEASE,5
GB,GIARDIASIS,5
GB,GLOSSODYNIA,5
GB,HAEMOLYTIC URAEMIC SYNDROME,5
GB,HAND DEFORMITY,5
GB,HEPATIC NECROSIS,5
GB,HIP FRACTURE,5
GB,HYPERTONIA,5
GB,HYPERVENTILATION,5
GB,HYPOPNOEA,5
GB,IMMOBILE,5
GB,INCORRECT DOSAGE ADMINISTERED,5
GB,INJECTION SITE HAEMORRHAGE,5
GB,INTERNATIONAL NORMALISED RATIO DECREASED,5
GB,LEFT VENTRICULAR FAILURE,5
GB,LICHEN SCLEROSUS,5
GB,LOCALISED INFECTION,5
GB,MEDICATION MONITORING ERROR,5
GB,MENTAL DISORDER,5
GB,MENTAL IMPAIRMENT,5
GB,METASTASES TO LIVER,5
GB,MICTURITION URGENCY,5
GB,MITRAL VALVE INCOMPETENCE,5
GB,NEUTROPHILIA,5
GB,PANCREATIC CARCINOMA METASTATIC,5
GB,PERIORBITAL OEDEMA,5
GB,PLASMA CELL MYELOMA,5
GB,PNEUMONIA CYTOMEGALOVIRAL,5
GB,PNEUMOTHORAX,5
GB,POLLAKIURIA,5
GB,POOR QUALITY DRUG ADMINISTERED,5
GB,PULSELESS ELECTRICAL ACTIVITY,5
GB,RENAL TUBULAR NECROSIS,5
GB,RESPIRATORY DISORDER,5
GB,RIGHT VENTRICULAR DYSFUNCTION,5
GB,SALIVARY GLAND CANCER STAGE IV,5
GB,SCAPULA FRACTURE,5
GB,SLE ARTHRITIS,5
GB,SLEEP TALKING,5
GB,SNEEZING,5
GB,STAPHYLOCOCCAL BACTERAEMIA,5
GB,STATUS EPILEPTICUS,5
GB,SURGERY,5
GB,THERAPEUTIC RESPONSE UNEXPECTED,5
GB,THINKING ABNORMAL,5
GB,THYROIDITIS,5
GB,TONSILLAR ULCER,5
GB,TOOTH LOSS,5
GB,TROPONIN INCREASED,5
GB,VASCULITIS,5
GB,WITHDRAWAL SYNDROME,5
GB,WOUND SECRETION,5
GB,ACCIDENTAL EXPOSURE TO PRODUCT,4
GB,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,4
GB,ACUTE RESPIRATORY DISTRESS SYNDROME,4
GB,ACUTE RESPIRATORY FAILURE,4
GB,ADVERSE EVENT,4
GB,AGRANULOCYTOSIS,4
GB,AMYLASE INCREASED,4
GB,ANGLE CLOSURE GLAUCOMA,4
GB,ANTIPSYCHOTIC DRUG LEVEL INCREASED,4
GB,AORTIC VALVE INCOMPETENCE,4
GB,APPENDICITIS PERFORATED,4
GB,APPLICATION SITE RASH,4
GB,ARTHRITIS,4
GB,ATHETOSIS,4
GB,BILIARY SEPSIS,4
GB,BRAIN INJURY,4
GB,CEREBRAL ISCHAEMIA,4
GB,CHRONIC GASTROINTESTINAL BLEEDING,4
GB,COLONIC PSEUDO-OBSTRUCTION,4
GB,CONJUNCTIVAL HAEMORRHAGE,4
GB,CONTRAINDICATED DRUG ADMINISTERED,4
GB,CREPITATIONS,4
GB,DEAFNESS,4
GB,DERMATITIS BULLOUS,4
GB,DIVERTICULUM INTESTINAL HAEMORRHAGIC,4
GB,DRUG EFFECT INCOMPLETE,4
GB,DRUG WITHDRAWAL SYNDROME,4
GB,EAR DISCOMFORT,4
GB,ESCHERICHIA INFECTION,4
GB,ESCHERICHIA URINARY TRACT INFECTION,4
GB,EXPIRED DRUG ADMINISTERED,4
GB,FEELING OF BODY TEMPERATURE CHANGE,4
GB,FORCED VITAL CAPACITY DECREASED,4
GB,GASTROENTERITIS VIRAL,4
GB,GASTROINTESTINAL INFLAMMATION,4
GB,GASTROINTESTINAL WALL THICKENING,4
GB,GINGIVAL SWELLING,4
GB,GLOMERULAR FILTRATION RATE ABNORMAL,4
GB,HAEMATOCHEZIA,4
GB,HAEMODYNAMIC INSTABILITY,4
GB,HEPATIC ENZYME ABNORMAL,4
GB,HEPATIC ENZYME INCREASED,4
GB,HEPATOCELLULAR CARCINOMA,4
GB,HOMICIDAL IDEATION,4
GB,HYPERBILIRUBINAEMIA,4
GB,HYPOAESTHESIA ORAL,4
GB,INCORRECT PRODUCT STORAGE,4
GB,INCORRECT ROUTE OF DRUG ADMINISTRATION,4
GB,INJECTION SITE PAIN,4
GB,INTERNATIONAL NORMALISED RATIO ABNORMAL,4
GB,LARGE INTESTINE PERFORATION,4
GB,LICHENOID KERATOSIS,4
GB,LUNG CONSOLIDATION,4
GB,MOOD SWINGS,4
GB,MOVEMENT DISORDER,4
GB,NEEDLE ISSUE,4
GB,NEOPLASM PROGRESSION,4
GB,NO ADVERSE EVENT,4
GB,OROPHARYNGEAL SWELLING,4
GB,OTITIS EXTERNA,4
GB,PARANOIA,4
GB,PARKINSONISM,4
GB,PERIPHERAL EMBOLISM,4
GB,PERIRENAL HAEMATOMA,4
GB,PERSONALITY CHANGE,4
GB,PHOTOSENSITIVITY REACTION,4
GB,POLYURIA,4
GB,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,4
GB,PSEUDOMONAS INFECTION,4
GB,PULMONARY CAVITATION,4
GB,RASH VESICULAR,4
GB,RENAL INJURY,4
GB,RESPIRATORY ALKALOSIS,4
GB,RETINAL VEIN OCCLUSION,4
GB,RHINALGIA,4
GB,SKIN BURNING SENSATION,4
GB,SKIN HAEMORRHAGE,4
GB,SKIN HYPERPIGMENTATION,4
GB,SKIN SWELLING,4
GB,SKIN TURGOR DECREASED,4
GB,SOCIAL AVOIDANT BEHAVIOUR,4
GB,SPUTUM DISCOLOURED,4
GB,SUNBURN,4
GB,TERMINAL STATE,4
GB,TRIFASCICULAR BLOCK,4
GB,URINARY BLADDER HAEMORRHAGE,4
GB,URINE FLOW DECREASED,4
GB,VITAMIN B12 DECREASED,4
GB,ABASIA,3
GB,ACTIVITIES OF DAILY LIVING IMPAIRED,3
GB,ACUTE MYELOID LEUKAEMIA,3
GB,ADVERSE REACTION,3
GB,ALCOHOLIC LIVER DISEASE,3
GB,ANAPHYLACTIC SHOCK,3
GB,ANAPHYLACTOID REACTION,3
GB,AORTIC VALVE DISEASE MIXED,3
GB,APPLICATION SITE BURN,3
GB,ARTERIOSCLEROSIS CORONARY ARTERY,3
GB,ARTHRITIS BACTERIAL,3
GB,ASTHMA EXERCISE INDUCED,3
GB,BACTERAEMIA,3
GB,BACTERIAL SEPSIS,3
GB,BENIGN BREAST NEOPLASM,3
GB,BLADDER NEOPLASM,3
GB,BLOOD CREATININE ABNORMAL,3
GB,BLOOD MAGNESIUM DECREASED,3
GB,BLOOD PRESSURE ABNORMAL,3
GB,BLOOD SODIUM INCREASED,3
GB,BODY TEMPERATURE FLUCTUATION,3
GB,BONE MARROW FAILURE,3
GB,BRADYARRHYTHMIA,3
GB,BRAIN OEDEMA,3
GB,BREAST CANCER,3
GB,BREAST CANCER METASTATIC,3
GB,BREATH ODOUR,3
GB,BRONCHOPNEUMONIA,3
GB,BUNDLE BRANCH BLOCK RIGHT,3
GB,CARDIAC VALVE DISEASE,3
GB,CARDIOMYOPATHY,3
GB,CATHETER SITE RASH,3
GB,CEREBROVASCULAR DISORDER,3
GB,CREATININE RENAL CLEARANCE DECREASED,3
GB,CUTANEOUS VASCULITIS,3
GB,DEMENTIA,3
GB,DEVICE RELATED INFECTION,3
GB,DEVICE RELATED SEPSIS,3
GB,DIASTOLIC DYSFUNCTION,3
GB,DIPLOPIA,3
GB,DISTURBANCE IN ATTENTION,3
GB,DUODENITIS,3
GB,ELECTROCARDIOGRAM CHANGE,3
GB,ELECTROCARDIOGRAM QRS COMPLEX SHORTENED,3
GB,EMBOLISM,3
GB,END STAGE RENAL DISEASE,3
GB,ENDOPHTHALMITIS,3
GB,ERECTILE DYSFUNCTION,3
GB,EROSIVE DUODENITIS,3
GB,FAECALOMA,3
GB,FOETAL EXPOSURE DURING PREGNANCY,3
GB,GASTRIC PERFORATION,3
GB,GASTROINTESTINAL MOTILITY DISORDER,3
GB,GENERALISED TONIC-CLONIC SEIZURE,3
GB,GLUCOSE TOLERANCE IMPAIRED,3
GB,HAEMATOCRIT DECREASED,3
GB,HAEMOLYSIS,3
GB,HEPATIC STEATOSIS,3
GB,HERPES ZOSTER,3
GB,HOSPITALISATION,3
GB,HYDRONEPHROSIS,3
GB,HYPERNATRAEMIA,3
GB,HYPERTENSIVE HEART DISEASE,3
GB,HYPONATRAEMIC SEIZURE,3
GB,HYPOVENTILATION,3
GB,IDIOPATHIC PULMONARY FIBROSIS,3
GB,IMPAIRED DRIVING ABILITY,3
GB,INAPPROPRIATE PRESCRIBING,3
GB,INCREASED APPETITE,3
GB,INFECTIVE EXACERBATION OF BRONCHIECTASIS,3
GB,INFREQUENT BOWEL MOVEMENTS,3
GB,INFUSION SITE PAIN,3
GB,INGUINAL HERNIA,3
GB,INTRA-ABDOMINAL HAEMATOMA,3
GB,INTRAVENTRICULAR HAEMORRHAGE,3
GB,INVASIVE DUCTAL BREAST CARCINOMA,3
GB,LABYRINTHITIS,3
GB,LEUKAEMIA,3
GB,LOBAR PNEUMONIA,3
GB,LOWER RESPIRATORY TRACT INFECTION BACTERIAL,3
GB,LYMPHOCYTE COUNT DECREASED,3
GB,MALIGNANT NEOPLASM PROGRESSION,3
GB,MANTLE CELL LYMPHOMA,3
GB,MOUTH HAEMORRHAGE,3
GB,MYELOFIBROSIS,3
GB,MYOCARDITIS,3
GB,NASOPHARYNGITIS,3
GB,NEPHROLITHIASIS,3
GB,NEPHROTIC SYNDROME,3
GB,NERVE INJURY,3
GB,NON-CARDIAC CHEST PAIN,3
GB,NON-HODGKIN^S LYMPHOMA,3
GB,NON-SMALL CELL LUNG CANCER,3
GB,NORMOCHROMIC NORMOCYTIC ANAEMIA,3
GB,OEDEMA MOUTH,3
GB,OESOPHAGEAL DISCOMFORT,3
GB,OESOPHAGEAL HAEMORRHAGE,3
GB,ONYCHOLYSIS,3
GB,OSTEOARTHRITIS,3
GB,OSTEONECROSIS,3
GB,OSTEOPOROSIS,3
GB,PAIN IN JAW,3
GB,PARKINSON^S DISEASE,3
GB,PEMPHIGOID,3
GB,PEMPHIGUS,3
GB,PENIS DISORDER,3
GB,PHLEBITIS,3
GB,PLASMACYTOMA,3
GB,POOR VENOUS ACCESS,3
GB,PREMATURE BABY,3
GB,PREMATURE DELIVERY,3
GB,PRESCRIBED OVERDOSE,3
GB,PROSTATE CANCER,3
GB,PROTHROMBIN TIME PROLONGED,3
GB,PSYCHIATRIC SYMPTOM,3
GB,PULMONARY ARTERIAL HYPERTENSION,3
GB,PULMONARY MASS,3
GB,PULMONARY TOXICITY,3
GB,PUSTULAR PSORIASIS,3
GB,PYELONEPHRITIS,3
GB,PYODERMA GANGRENOSUM,3
GB,RENAL ARTERY STENOSIS,3
GB,RENAL FUNCTION TEST ABNORMAL,3
GB,RETINAL EXUDATES,3
GB,RETINAL HAEMORRHAGE,3
GB,RETINAL VEIN THROMBOSIS,3
GB,RETROPERITONEAL HAEMATOMA,3
GB,SENSATION OF PRESSURE,3
GB,SKIN ATROPHY,3
GB,SKIN EROSION,3
GB,SKIN ODOUR ABNORMAL,3
GB,SKIN SENSITISATION,3
GB,SKIN ULCER HAEMORRHAGE,3
GB,SLEEP APNOEA SYNDROME,3
GB,SOMNAMBULISM,3
GB,SPINAL OSTEOARTHRITIS,3
GB,STRIDOR,3
GB,SUDDEN DEATH,3
GB,SUPERIOR VENA CAVA OCCLUSION,3
GB,SUPRAVENTRICULAR TACHYARRHYTHMIA,3
GB,TACHYPNOEA,3
GB,TENDON DISCOMFORT,3
GB,TESTICULAR SWELLING,3
GB,TETANY,3
GB,THERAPY CHANGE,3
GB,THYROIDITIS ACUTE,3
GB,TORSADE DE POINTES,3
GB,TYPE 2 DIABETES MELLITUS,3
GB,ULCER HAEMORRHAGE,3
GB,URINARY HESITATION,3
GB,VAGINAL DISCHARGE,3
GB,VESTIBULAR NEURONITIS,3
GB,VIITH NERVE PARALYSIS,3
GB,VIRAL INFECTION,3
GB,VITAMIN D DECREASED,3
GB,WOUND INFECTION,3
GB,ABSCESS LIMB,2
GB,ACUTE INTERSTITIAL PNEUMONITIS,2
GB,ACUTE LEFT VENTRICULAR FAILURE,2
GB,ACUTE LEUKAEMIA,2
GB,AGEUSIA,2
GB,AKATHISIA,2
GB,ANAL HAEMORRHAGE,2
GB,ANAL ULCER HAEMORRHAGE,2
US,DYSPNOEA,6372
US,FATIGUE,4722
US,CARDIAC FAILURE CONGESTIVE,4641
US,DIARRHOEA,4106
US,NAUSEA,3886
US,DEATH,3510
US,PNEUMONIA,3415
US,DRUG INEFFECTIVE,3381
US,FALL,3234
US,DIZZINESS,3089
US,GASTROINTESTINAL HAEMORRHAGE,2975
US,ASTHENIA,2964
US,HEADACHE,2838
US,PAIN,2768
US,MALAISE,2464
US,MYOCARDIAL INFARCTION,2461
US,ANAEMIA,2374
US,PERIPHERAL SWELLING,2244
US,OEDEMA PERIPHERAL,2163
US,VOMITING,2138
US,WEIGHT DECREASED,2091
US,PAIN IN EXTREMITY,2073
US,DRUG DOSE OMISSION,2016
US,COUGH,1969
US,HYPOTENSION,1905
US,ARTHRALGIA,1868
US,CONSTIPATION,1748
US,RASH,1710
US,BACK PAIN,1707
US,WEIGHT INCREASED,1698
US,CHEST PAIN,1666
US,FLUID RETENTION,1602
US,DECREASED APPETITE,1550
US,ATRIAL FIBRILLATION,1548
US,HYPERTENSION,1416
US,PYREXIA,1387
US,CEREBROVASCULAR ACCIDENT,1383
US,GAIT DISTURBANCE,1370
US,INSOMNIA,1360
US,ACUTE KIDNEY INJURY,1334
US,URINARY TRACT INFECTION,1334
US,PRURITUS,1309
US,DEHYDRATION,1273
US,MUSCLE SPASMS,1223
US,OEDEMA,1219
US,FEELING ABNORMAL,1182
US,CONDITION AGGRAVATED,1161
US,RENAL FAILURE,1138
US,EPISTAXIS,1116
US,ANXIETY,1100
US,ABDOMINAL PAIN,1094
US,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1074
US,DEPRESSION,1052
US,ABDOMINAL PAIN UPPER,1042
US,CONTUSION,1029
US,BLOOD GLUCOSE INCREASED,990
US,HAEMOGLOBIN DECREASED,932
US,ABDOMINAL DISCOMFORT,917
US,SEPSIS,884
US,CONFUSIONAL STATE,881
US,PRODUCT USE ISSUE,881
US,SWELLING,862
US,PLEURAL EFFUSION,860
US,NASOPHARYNGITIS,858
US,HYPOAESTHESIA,856
US,RESPIRATORY FAILURE,853
US,CORONARY ARTERY DISEASE,850
US,BRONCHITIS,845
US,JOINT SWELLING,840
US,SOMNOLENCE,839
US,CARDIAC DISORDER,828
US,MYALGIA,820
US,ABDOMINAL DISTENSION,806
US,SYNCOPE,806
US,DRUG HYPERSENSITIVITY,802
US,CELLULITIS,793
US,TREMOR,785
US,PRODUCT QUALITY ISSUE,779
US,MUSCULAR WEAKNESS,775
US,NEUROPATHY PERIPHERAL,765
US,BLOOD PRESSURE INCREASED,748
US,MEMORY IMPAIRMENT,741
US,HAEMORRHAGE,739
US,CARDIAC FAILURE,735
US,RECTAL HAEMORRHAGE,735
US,LOSS OF CONSCIOUSNESS,728
US,ALOPECIA,716
US,VISION BLURRED,698
US,PULMONARY OEDEMA,690
US,GASTROOESOPHAGEAL REFLUX DISEASE,685
US,PARAESTHESIA,685
US,SINUSITIS,684
US,PLATELET COUNT DECREASED,680
US,HAEMORRHAGIC ANAEMIA,666
US,INFLUENZA,644
US,NASAL CONGESTION,637
US,PALPITATIONS,630
US,THROMBOSIS,625
US,CHEST DISCOMFORT,623
US,DISEASE PROGRESSION,623
US,ARTHRITIS,621
US,PULMONARY HYPERTENSION,620
US,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,614
US,INFECTION,612
US,DYSPHAGIA,606
US,DYSPEPSIA,605
US,BALANCE DISORDER,604
US,DYSPNOEA EXERTIONAL,599
US,INCORRECT DOSE ADMINISTERED,593
US,UPPER GASTROINTESTINAL HAEMORRHAGE,590
US,HEART RATE INCREASED,581
US,RENAL FAILURE ACUTE,579
US,THROMBOCYTOPENIA,574
US,OXYGEN SATURATION DECREASED,572
US,DEEP VEIN THROMBOSIS,567
US,ERYTHEMA,562
US,INJECTION SITE PAIN,562
US,DIABETES MELLITUS,561
US,CHILLS,559
US,ACUTE MYOCARDIAL INFARCTION,558
US,PULMONARY EMBOLISM,557
US,CARDIAC ARREST,556
US,VISUAL IMPAIRMENT,543
US,HOSPITALISATION,541
US,HYPOXIA,537
US,WHITE BLOOD CELL COUNT DECREASED,530
US,FLUID OVERLOAD,528
US,BLOOD CREATININE INCREASED,523
US,DRY MOUTH,519
US,HYPERSENSITIVITY,519
US,OROPHARYNGEAL PAIN,514
US,HYPERHIDROSIS,513
US,DYSGEUSIA,512
US,COAGULOPATHY,508
US,INTENTIONAL PRODUCT MISUSE,508
US,FLUSHING,502
US,ASTHMA,501
US,RENAL IMPAIRMENT,496
US,BLOOD PRESSURE DECREASED,486
US,MUSCULOSKELETAL PAIN,483
US,UNEVALUABLE EVENT,483
US,BLOOD POTASSIUM DECREASED,480
US,OSTEOARTHRITIS,475
US,CATARACT,474
US,DYSPHONIA,466
US,PULMONARY ARTERIAL HYPERTENSION,464
US,ACUTE RESPIRATORY FAILURE,450
US,HAEMATURIA,450
US,HYPOKALAEMIA,449
US,PRODUCTIVE COUGH,446
US,WHEEZING,439
US,PAIN IN JAW,419
US,PLASMA CELL MYELOMA,414
US,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,413
US,HAEMOPTYSIS,404
US,RENAL DISORDER,398
US,ASCITES,397
US,LOWER GASTROINTESTINAL HAEMORRHAGE,396
US,RHINORRHOEA,396
US,NECK PAIN,391
US,TOXICITY TO VARIOUS AGENTS,386
US,HAEMATOCHEZIA,384
US,DRY SKIN,383
US,BLISTER,380
US,MALIGNANT NEOPLASM PROGRESSION,375
US,PERICARDIAL EFFUSION,373
US,SEIZURE,373
US,UPPER RESPIRATORY TRACT INFECTION,373
US,OSTEOPOROSIS,371
US,URTICARIA,366
US,LOCAL SWELLING,363
US,MENTAL STATUS CHANGES,362
US,FLATULENCE,361
US,INTERNAL HAEMORRHAGE,361
US,PSORIASIS,361
US,HYPERKALAEMIA,357
US,AMNESIA,356
US,PANCYTOPENIA,355
US,NEUTROPENIA,354
US,MUSCULOSKELETAL STIFFNESS,353
US,BURNING SENSATION,350
US,GOUT,348
US,SWELLING FACE,345
US,HERPES ZOSTER,344
US,BLOOD GLUCOSE DECREASED,341
US,TACHYCARDIA,338
US,HIP FRACTURE,337
US,RHEUMATOID ARTHRITIS,336
US,INJURY,335
US,POLLAKIURIA,331
US,BONE PAIN,329
US,COMPLETED SUICIDE,326
US,LETHARGY,326
US,STOMATITIS,325
US,LUNG DISORDER,324
US,INTERNATIONAL NORMALISED RATIO INCREASED,323
US,ARTHROPATHY,320
US,CHRONIC KIDNEY DISEASE,319
US,DRUG INTOLERANCE,319
US,HYPONATRAEMIA,318
US,SLEEP APNOEA SYNDROME,317
US,ARRHYTHMIA,312
US,GENERAL PHYSICAL HEALTH DETERIORATION,312
US,TRANSIENT ISCHAEMIC ATTACK,310
US,HALLUCINATION,309
US,OVERDOSE,307
US,HEAD INJURY,301
US,THERAPEUTIC RESPONSE UNEXPECTED,301
US,HAEMATOMA,299
US,ABASIA,298
US,HOT FLUSH,297
US,INFLUENZA LIKE ILLNESS,294
US,SKIN DISCOLOURATION,288
US,STAPHYLOCOCCAL INFECTION,287
US,MIGRAINE,282
US,SEPTIC SHOCK,281
US,MOBILITY DECREASED,280
US,RIB FRACTURE,277
US,CARDIO-RESPIRATORY ARREST,273
US,SKIN ULCER,273
US,SKIN EXFOLIATION,272
US,RED BLOOD CELL COUNT DECREASED,269
US,UNDERDOSE,267
US,ADVERSE EVENT,265
US,DYSURIA,264
US,CEREBRAL HAEMORRHAGE,263
US,DRUG EFFECT INCOMPLETE,263
US,CARDIOMYOPATHY,262
US,CLOSTRIDIUM DIFFICILE INFECTION,262
US,ADVERSE DRUG REACTION,261
US,RIGHT VENTRICULAR FAILURE,261
US,HYPOACUSIS,257
US,NERVOUSNESS,257
US,TREATMENT NONCOMPLIANCE,256
US,FULL BLOOD COUNT DECREASED,255
US,PRODUCT USE IN UNAPPROVED INDICATION,255
US,SLEEP DISORDER,255
US,ANGINA PECTORIS,254
US,CYSTITIS,253
US,NEPHROLITHIASIS,253
US,URINARY INCONTINENCE,252
US,ORAL PAIN,250
US,BRADYCARDIA,249
US,THERAPY CESSATION,249
US,HEPATIC CIRRHOSIS,248
US,RASH PRURITIC,248
US,RESPIRATORY DISTRESS,248
US,FEELING HOT,246
US,HEART RATE DECREASED,245
US,STRESS,245
US,BONE DISORDER,242
US,DRUG EFFECT DECREASED,240
US,BLOOD CHOLESTEROL INCREASED,239
US,PANCREATITIS,239
US,TYPE 2 DIABETES MELLITUS,238
US,GASTROINTESTINAL DISORDER,237
US,IMPAIRED HEALING,237
US,CHOLELITHIASIS,236
US,LOCALISED INFECTION,236
US,WHITE BLOOD CELL COUNT INCREASED,233
US,BLOOD POTASSIUM INCREASED,232
US,BODY HEIGHT DECREASED,231
US,INTERVERTEBRAL DISC PROTRUSION,231
US,DRUG ADMINISTRATION ERROR,229
US,HEPATIC ENZYME INCREASED,228
US,DIVERTICULITIS,227
US,VISUAL ACUITY REDUCED,226
US,URINARY RETENTION,225
US,HYPOGLYCAEMIA,224
US,MULTIPLE SCLEROSIS RELAPSE,224
US,OSTEOMYELITIS,222
US,GASTRITIS,220
US,CORONARY ARTERY BYPASS,219
US,INJECTION SITE BRUISING,219
US,IRON DEFICIENCY ANAEMIA,219
US,TRANSFUSION,219
US,HAEMORRHOIDS,217
US,DEVICE RELATED INFECTION,216
US,LIMB DISCOMFORT,215
US,SPEECH DISORDER,214
US,OSTEONECROSIS OF JAW,213
US,PRESYNCOPE,213
US,HYPERSOMNIA,212
US,HYPOTHYROIDISM,212
US,ATELECTASIS,211
US,EMOTIONAL DISTRESS,209
US,INTERVERTEBRAL DISC DEGENERATION,209
US,CARDIOMEGALY,208
US,HIATUS HERNIA,208
US,ROAD TRAFFIC ACCIDENT,207
US,LIMB INJURY,204
US,VERTIGO,204
US,THROAT IRRITATION,203
US,SPINAL OSTEOARTHRITIS,201
US,INTENTIONAL PRODUCT USE ISSUE,199
US,BLOOD COUNT ABNORMAL,198
US,BLOOD URINE PRESENT,197
US,HYPERLIPIDAEMIA,196
US,JOINT INJURY,195
US,VENTRICULAR TACHYCARDIA,195
US,FUNGAL INFECTION,194
US,UPPER LIMB FRACTURE,192
US,WOUND,192
US,WRONG TECHNIQUE IN DRUG USAGE PROCESS,191
US,INJECTION SITE ERYTHEMA,190
US,LIVER FUNCTION TEST ABNORMAL,190
US,ASPARTATE AMINOTRANSFERASE INCREASED,189
US,DYSSTASIA,189
US,PULMONARY MASS,189
US,DEVICE MALFUNCTION,188
US,HEPATIC FAILURE,188
US,INJECTION SITE HAEMORRHAGE,188
US,NO ADVERSE EVENT,188
US,FOOT FRACTURE,187
US,HYPOPHAGIA,187
US,LACERATION,187
US,LYMPHADENOPATHY,185
US,HEART RATE IRREGULAR,184
US,LEUKOCYTOSIS,184
US,DISORIENTATION,183
US,FAECES DISCOLOURED,183
US,HYPERGLYCAEMIA,183
US,LUNG NEOPLASM MALIGNANT,183
US,SUBDURAL HAEMATOMA,183
US,DRY EYE,182
US,OSTEOPENIA,181
US,HAEMATEMESIS,180
US,FIBROMYALGIA,179
US,GASTRIC DISORDER,179
US,HAEMATOCRIT DECREASED,178
US,INCORRECT DRUG ADMINISTRATION DURATION,178
US,BLOOD UREA INCREASED,176
US,DISCOMFORT,175
US,ACTIVITIES OF DAILY LIVING IMPAIRED,174
US,TINNITUS,174
US,AGITATION,173
US,DRUG PRESCRIBING ERROR,172
US,CORONARY ARTERY OCCLUSION,171
US,SINUS DISORDER,171
US,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,170
US,LOWER LIMB FRACTURE,170
US,CORONARY ARTERIAL STENT INSERTION,168
US,INTESTINAL OBSTRUCTION,168
US,MALABSORPTION,168
US,GENERALISED OEDEMA,165
US,LIVER DISORDER,165
US,PRURITUS GENERALISED,164
US,DYSARTHRIA,163
US,ATRIAL FLUTTER,162
US,BLOOD SODIUM DECREASED,162
US,DEAFNESS,162
US,VIRAL INFECTION,162
US,HAEMORRHAGE INTRACRANIAL,161
US,MITRAL VALVE INCOMPETENCE,160
US,NIGHT SWEATS,160
US,SKIN LESION,160
US,NEOPLASM MALIGNANT,159
US,SPINAL FRACTURE,159
US,COLITIS,158
US,DIVERTICULUM,158
US,ENCEPHALOPATHY,158
US,VAGINAL HAEMORRHAGE,158
US,BLOOD BILIRUBIN INCREASED,156
US,MELAENA,156
US,ANKLE FRACTURE,154
US,DYSKINESIA,154
US,OBESITY,154
US,RENAL FAILURE CHRONIC,154
US,RESPIRATORY DISORDER,154
US,DISTURBANCE IN ATTENTION,153
US,NEURALGIA,153
US,ARTERIOSCLEROSIS,152
US,CANDIDA INFECTION,152
US,MUSCULOSKELETAL CHEST PAIN,152
US,PULMONARY CONGESTION,152
US,SPLENOMEGALY,152
US,BLOOD PRESSURE ABNORMAL,151
US,DEPRESSED MOOD,151
US,SURGERY,151
US,FEELING COLD,150
US,RESTLESS LEGS SYNDROME,150
US,THERAPEUTIC RESPONSE DECREASED,150
US,EYE SWELLING,149
US,FEMUR FRACTURE,149
US,LACRIMATION INCREASED,149
US,LUNG INFECTION,149
US,ALANINE AMINOTRANSFERASE INCREASED,148
US,FEBRILE NEUTROPENIA,148
US,UNRESPONSIVE TO STIMULI,148
US,IRRITABILITY,147
US,SKIN DISORDER,146
US,DEMENTIA,145
US,ROTATOR CUFF SYNDROME,145
US,MEDICATION ERROR,144
US,DEVICE ISSUE,143
US,BLINDNESS,142
US,CLOSTRIDIUM DIFFICILE COLITIS,142
US,EYE PAIN,142
US,PULMONARY FIBROSIS,142
US,RETCHING,142
US,HERNIA,141
US,AGEUSIA,140
US,BREAST CANCER,140
US,EAR PAIN,140
US,EYE DISORDER,140
US,RASH GENERALISED,140
US,LABORATORY TEST ABNORMAL,137
US,ECCHYMOSIS,136
US,LUNG INFILTRATION,136
US,OCULAR HYPERAEMIA,136
US,ARTERIOSCLEROSIS CORONARY ARTERY,135
US,GASTRIC ULCER,135
US,CONVULSION,134
US,NEOPLASM PROGRESSION,134
US,VITAMIN D DEFICIENCY,134
US,MYOCARDIAL ISCHAEMIA,133
US,SUICIDAL IDEATION,133
US,EMPHYSEMA,132
US,GALLBLADDER DISORDER,132
US,GASTROENTERITIS VIRAL,132
US,RASH ERYTHEMATOUS,132
US,DRUG WITHDRAWAL SYNDROME,131
US,EJECTION FRACTION DECREASED,131
US,HAEMORRHAGIC STROKE,131
US,MUSCULOSKELETAL DISCOMFORT,131
US,PRE-EXISTING CONDITION IMPROVED,131
US,COGNITIVE DISORDER,130
US,INCORRECT ROUTE OF DRUG ADMINISTRATION,130
US,PROSTATIC SPECIFIC ANTIGEN INCREASED,130
US,URINE OUTPUT DECREASED,130
US,BACK DISORDER,129
US,METABOLIC ACIDOSIS,129
US,EATING DISORDER,128
US,INCREASED TENDENCY TO BRUISE,128
US,JOINT STIFFNESS,128
US,AMMONIA INCREASED,127
US,DELIRIUM,127
US,METASTASES TO BONE,127
US,PNEUMONITIS,127
US,SWOLLEN TONGUE,127
US,ILL-DEFINED DISORDER,126
US,PNEUMONIA ASPIRATION,126
US,RASH MACULAR,126
US,PANIC ATTACK,125
US,SYSTEMIC LUPUS ERYTHEMATOSUS,124
US,KNEE ARTHROPLASTY,123
US,RESPIRATORY TRACT INFECTION,123
US,CARPAL TUNNEL SYNDROME,122
US,DECUBITUS ULCER,122
US,INJECTION SITE PRURITUS,122
US,INTERSTITIAL LUNG DISEASE,122
US,MYELODYSPLASTIC SYNDROME,122
US,ORTHOSTATIC HYPOTENSION,122
US,APHASIA,121
US,BLOOD ALKALINE PHOSPHATASE INCREASED,121
US,GLAUCOMA,121
US,PERIPHERAL VASCULAR DISORDER,121
US,BLOOD MAGNESIUM DECREASED,120
US,DIPLOPIA,120
US,EXOSTOSIS,120
US,EYE IRRITATION,120
US,GLOSSODYNIA,120
US,CARDIOGENIC SHOCK,119
US,CRYING,119
US,HEPATIC ENCEPHALOPATHY,119
US,SINUS CONGESTION,119
US,TOOTH DISORDER,119
US,TRICUSPID VALVE INCOMPETENCE,119
US,ANGINA UNSTABLE,118
US,KIDNEY INFECTION,118
US,LYMPHOEDEMA,118
US,MULTI-ORGAN FAILURE,118
US,ABNORMAL BEHAVIOUR,117
US,GLYCOSYLATED HAEMOGLOBIN INCREASED,117
US,ISCHAEMIC CARDIOMYOPATHY,117
US,TENDERNESS,117
US,CHROMATURIA,116
US,DENTAL CARIES,116
US,ELECTROCARDIOGRAM QT PROLONGED,116
US,LARGE INTESTINE POLYP,116
US,COMA,115
US,CROHN^S DISEASE,115
US,EAR INFECTION,115
US,TOOTHACHE,115
US,MOVEMENT DISORDER,114
US,PNEUMOTHORAX,114
US,DIZZINESS POSTURAL,113
US,SPINAL COLUMN STENOSIS,113
US,BLOOD PRESSURE FLUCTUATION,112
US,HYPOCALCAEMIA,112
US,INTENTIONAL DRUG MISUSE,112
US,MASS,111
US,LIP SWELLING,110
US,DIALYSIS,109
US,GINGIVAL BLEEDING,109
US,IRRITABLE BOWEL SYNDROME,109
US,LEUKOPENIA,109
US,WEIGHT FLUCTUATION,109
US,ANAPHYLACTIC REACTION,108
US,FEEDING DISORDER,108
US,HYPOMAGNESAEMIA,108
US,MULTIPLE FRACTURES,108
US,SPINAL COMPRESSION FRACTURE,108
US,ACNE,107
US,END STAGE RENAL DISEASE,107
US,EXPIRED PRODUCT ADMINISTERED,107
US,PULMONARY THROMBOSIS,107
US,SCIATICA,107
US,RESPIRATORY TRACT CONGESTION,106
US,SKIN CANCER,106
US,SNEEZING,106
US,THINKING ABNORMAL,106
US,THYROID DISORDER,106
US,WRIST FRACTURE,106
US,DIABETIC NEUROPATHY,105
US,MACULAR DEGENERATION,105
US,PSORIATIC ARTHROPATHY,105
US,HEPATIC STEATOSIS,104
US,MALNUTRITION,104
US,PHARYNGEAL OEDEMA,104
US,INFLAMMATION,103
US,THROAT TIGHTNESS,103
US,TOOTH LOSS,103
US,BACTERAEMIA,102
US,BASAL CELL CARCINOMA,102
US,BLOOD IRON DECREASED,102
US,CARDIOVASCULAR DISORDER,102
US,CHOKING,102
US,MULTIPLE SCLEROSIS,101
US,RENAL CYST,101
US,TOOTH FRACTURE,101
US,EYE HAEMORRHAGE,100
US,HYPERCALCAEMIA,100
US,SHOCK HAEMORRHAGIC,100
US,STENT PLACEMENT,100
US,ISCHAEMIC STROKE,98
US,LACTIC ACIDOSIS,98
US,METASTASES TO LIVER,98
US,RESTLESSNESS,98
US,ULCER,98
US,CARDIAC MURMUR,97
US,CARDIAC OPERATION,97
US,EYE PRURITUS,97
US,POST PROCEDURAL HAEMORRHAGE,97
US,SUPRAVENTRICULAR TACHYCARDIA,97
US,PALLOR,96
US,BACK INJURY,95
US,ERUCTATION,95
US,HEAD DISCOMFORT,95
US,MENTAL DISORDER,95
US,RHABDOMYOLYSIS,95
US,SCOLIOSIS,95
US,SMALL INTESTINAL OBSTRUCTION,95
US,THERAPY NON-RESPONDER,95
US,INFUSION RELATED REACTION,94
US,JAUNDICE,94
US,MENTAL IMPAIRMENT,94
US,MUSCLE TIGHTNESS,94
US,ORAL CANDIDIASIS,94
US,PRESCRIBED UNDERDOSE,94
US,CARDIAC PACEMAKER INSERTION,93
US,FREQUENT BOWEL MOVEMENTS,93
US,MUSCULOSKELETAL DISORDER,93
US,PULMONARY HAEMORRHAGE,93
US,ANHEDONIA,92
US,ELECTROLYTE IMBALANCE,92
US,MICTURITION URGENCY,92
US,MUCOSAL INFLAMMATION,92
US,NO THERAPEUTIC RESPONSE,92
US,PANCREATITIS ACUTE,92
US,BONE LESION,91
US,HAEMORRHOIDAL HAEMORRHAGE,91
US,RESPIRATORY ARREST,90
US,ABSCESS,89
US,CARDIAC FAILURE ACUTE,89
US,SECRETION DISCHARGE,89
US,ABNORMAL LOSS OF WEIGHT,88
US,BLOOD CALCIUM DECREASED,88
US,BLOOD GLUCOSE ABNORMAL,88
US,INCONTINENCE,88
US,SEASONAL ALLERGY,88
US,FEELING JITTERY,87
US,FOOT DEFORMITY,87
US,JOINT DISLOCATION,87
US,NERVE COMPRESSION,87
US,ORTHOPNOEA,87
US,GLOMERULAR FILTRATION RATE DECREASED,86
US,LEFT VENTRICULAR DYSFUNCTION,86
US,MOUTH HAEMORRHAGE,86
US,CARDIAC VALVE DISEASE,85
US,GASTROENTERITIS,85
US,INJECTION SITE REACTION,85
US,WITHDRAWAL SYNDROME,85
US,BLOOD TRIGLYCERIDES INCREASED,84
US,COMPRESSION FRACTURE,84
US,DIVERTICULUM INTESTINAL HAEMORRHAGIC,84
US,DRUG DISPENSING ERROR,84
US,OSTEOSCLEROSIS,84
US,SHOCK,84
US,SPUTUM DISCOLOURED,84
US,GASTRIC ULCER HAEMORRHAGE,83
US,HAIR TEXTURE ABNORMAL,83
US,HYPOAESTHESIA ORAL,83
US,HYPOVOLAEMIA,83
US,IMPAIRED GASTRIC EMPTYING,83
US,INCREASED APPETITE,83
US,INFUSION SITE PAIN,83
US,JOINT RANGE OF MOTION DECREASED,83
US,LARYNGITIS,83
US,LIGAMENT SPRAIN,83
US,PROTEINURIA,83
US,VENTRICULAR FIBRILLATION,83
US,AORTIC STENOSIS,82
US,HEMIPARESIS,82
US,MULTIPLE ORGAN DYSFUNCTION SYNDROME,82
US,NIGHTMARE,82
US,NODULE,82
US,POST PROCEDURAL COMPLICATION,82
US,WOUND INFECTION,82
US,CATHETERISATION CARDIAC,81
US,DEVICE DISLOCATION,81
US,ESSENTIAL HYPERTENSION,81
US,OESOPHAGITIS,81
US,POOR QUALITY SLEEP,81
US,PROSTATE CANCER,81
US,TOOTH ABSCESS,81
US,ULCER HAEMORRHAGE,81
US,UROSEPSIS,81
US,VITAMIN D DECREASED,81
US,BURSITIS,80
US,DEPRESSED LEVEL OF CONSCIOUSNESS,80
US,FLANK PAIN,80
US,MUSCLE TWITCHING,80
US,PATHOLOGICAL FRACTURE,80
US,WALKING AID USER,80
US,DEFORMITY,79
US,GROIN PAIN,79
US,NEUTROPHIL COUNT DECREASED,79
US,NOCTURIA,79
US,SKIN IRRITATION,79
US,APHONIA,78
US,ARTERIAL OCCLUSIVE DISEASE,78
US,PARKINSON^S DISEASE,78
US,BACTERIAL INFECTION,77
US,DIABETES MELLITUS INADEQUATE CONTROL,77
US,MOUTH ULCERATION,77
US,PLATELET COUNT INCREASED,77
US,PURULENT DISCHARGE,77
US,SINUS TACHYCARDIA,77
US,SUBARACHNOID HAEMORRHAGE,77
US,TOOTH INFECTION,77
US,UPPER-AIRWAY COUGH SYNDROME,77
US,BLOOD GLUCOSE FLUCTUATION,76
US,DECREASED INTEREST,76
US,FAILURE TO THRIVE,76
US,INJECTION SITE SWELLING,76
US,METASTASES TO LUNG,76
US,NERVOUS SYSTEM DISORDER,76
US,ORAL DISCOMFORT,76
US,PRESCRIBED OVERDOSE,76
US,PRODUCT SUBSTITUTION ISSUE,76
US,RASH PAPULAR,76
US,TROPONIN INCREASED,76
US,VIRAL UPPER RESPIRATORY TRACT INFECTION,76
US,HAIR COLOUR CHANGES,75
US,PETECHIAE,75
US,SKIN HAEMORRHAGE,75
US,TREATMENT FAILURE,75
US,VASCULAR GRAFT,75
US,ASPIRATION,74
US,BODY TEMPERATURE INCREASED,74
US,DIASTOLIC DYSFUNCTION,74
US,EXTRA DOSE ADMINISTERED,74
US,HEARING IMPAIRED,74
US,HEPATOMEGALY,74
US,LIVER FUNCTION TEST INCREASED,74
US,NERVE INJURY,74
US,ORAL MUCOSAL BLISTERING,74
US,PRODUCT ADHESION ISSUE,74
US,SCAR,74
US,HEPATITIS C,73
US,MUSCLE ATROPHY,73
US,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,73
US,COLD SWEAT,72
US,DERMATITIS,72
US,LOWER RESPIRATORY TRACT INFECTION,72
US,PELVIC FRACTURE,72
US,POLYP,72
US,THIRST,72
US,TUBULOINTERSTITIAL NEPHRITIS,72
US,ABNORMAL DREAMS,71
US,ACCIDENTAL OVERDOSE,71
US,DISABILITY,71
US,MEDICATION RESIDUE PRESENT,71
US,VITREOUS FLOATERS,71
US,ACUTE RESPIRATORY DISTRESS SYNDROME,70
US,ANGIOEDEMA,70
US,EXPOSED BONE IN JAW,70
US,GAIT INABILITY,70
US,OSTEOLYSIS,70
US,BLINDNESS UNILATERAL,69
US,CEREBRAL INFARCTION,69
US,DEVICE USE ERROR,69
US,EAR DISCOMFORT,69
US,HYPOKINESIA,69
US,INJECTION SITE MASS,69
US,JOINT EFFUSION,69
US,MUSCLE STRAIN,69
US,BLOOD ALBUMIN DECREASED,68
US,BLOOD CALCIUM INCREASED,68
US,DIVERTICULUM INTESTINAL,68
US,FEAR,68
US,RALES,68
US,RENAL TUBULAR NECROSIS,68
US,ABDOMINAL PAIN LOWER,67
US,GASTRIC HAEMORRHAGE,67
US,LUMBAR SPINAL STENOSIS,67
US,TRANSAMINASES INCREASED,67
US,AORTIC ANEURYSM,66
US,CONTRAINDICATED PRODUCT ADMINISTERED,66
US,CYST,66
US,DRY THROAT,66
US,HYPERCHOLESTEROLAEMIA,66
US,MUSCLE SPASTICITY,66
US,PRODUCT PHYSICAL ISSUE,66
US,RENAL HAEMORRHAGE,66
US,TENDONITIS,66
US,ACUTE CORONARY SYNDROME,65
US,ADRENAL INSUFFICIENCY,65
US,BREATH SOUNDS ABNORMAL,65
US,FRACTURE,65
US,PERIPHERAL COLDNESS,65
US,SLUGGISHNESS,65
US,BLOOD TEST ABNORMAL,64
US,CARDIAC FAILURE CHRONIC,64
US,EXPOSURE DURING PREGNANCY,64
US,HAEMORRHAGIC ARTERIOVENOUS MALFORMATION,64
US,MOOD SWINGS,64
US,PSYCHOTIC DISORDER,64
US,DIABETIC KETOACIDOSIS,63
US,MOOD ALTERED,63
US,POLYURIA,63
US,SEDATION,63
US,WOUND COMPLICATION,63
US,ANAL INCONTINENCE,62
US,BRAIN NATRIURETIC PEPTIDE INCREASED,62
US,CATHETER SITE INFECTION,62
US,CYTOPENIA,62
US,EXERCISE TOLERANCE DECREASED,62
US,GINGIVAL PAIN,62
US,HEPATIC CANCER,62
US,INTESTINAL PERFORATION,62
US,LEFT VENTRICULAR HYPERTROPHY,62
US,PAIN OF SKIN,62
US,PANCREATIC CARCINOMA METASTATIC,62
US,RENAL INJURY,62
US,SCAB,62
US,SKIN BURNING SENSATION,62
US,AGGRESSION,61
US,AORTIC ARTERIOSCLEROSIS,61
US,CHOLECYSTECTOMY,61
US,DEVICE LEAKAGE,61
US,HOSPICE CARE,61
US,PANCREATIC CARCINOMA,61
US,PHOTOPHOBIA,61
US,SINUS BRADYCARDIA,61
US,SPINAL PAIN,61
US,TORSADE DE POINTES,61
US,VENTRICULAR EXTRASYSTOLES,61
US,APPLICATION SITE ERYTHEMA,60
US,BLADDER CANCER,60
US,COLITIS ISCHAEMIC,60
US,FACIAL PAIN,60
US,INTERNATIONAL NORMALISED RATIO ABNORMAL,60
US,OXYGEN CONSUMPTION INCREASED,60
US,PROTHROMBIN TIME PROLONGED,60
US,RHINITIS ALLERGIC,60
US,SECOND PRIMARY MALIGNANCY,60
US,SQUAMOUS CELL CARCINOMA OF SKIN,60
US,APPLICATION SITE PAIN,59
US,COLON CANCER,59
US,OSTEONECROSIS,59
US,PERITONITIS,59
US,AORTIC VALVE INCOMPETENCE,58
US,EMOTIONAL DISORDER,58
US,EYE INFECTION,58
US,FIBULA FRACTURE,58
US,HAND FRACTURE,58
US,HIP ARTHROPLASTY,58
US,HUMERUS FRACTURE,58
US,ORAL DISORDER,58
US,PERITONITIS BACTERIAL,58
US,PULMONARY ARTERIAL PRESSURE INCREASED,58
US,SKIN INFECTION,58
US,BLADDER DISORDER,57
US,COLITIS ULCERATIVE,57
US,ERECTILE DYSFUNCTION,57
US,HAEMORRHAGIC DIATHESIS,57
US,MULTIPLE ALLERGIES,57
US,PARAESTHESIA ORAL,57
US,PARALYSIS,57
US,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,57
US,PRIMARY SEQUESTRUM,57
US,WOUND HAEMORRHAGE,57
US,ABDOMINAL HERNIA,56
US,ATAXIA,56
US,BEDRIDDEN,56
US,BRAIN INJURY,56
US,CONCUSSION,56
US,DEVICE OCCLUSION,56
US,DRUG DEPENDENCE,56
US,LOCALISED OEDEMA,56
US,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,56
US,MIDDLE INSOMNIA,56
US,ONYCHOMYCOSIS,56
US,PROCEDURAL PAIN,56
US,SQUAMOUS CELL CARCINOMA,56
US,TACHYPNOEA,56
US,WOUND SECRETION,56
US,ACUTE MYELOID LEUKAEMIA,55
US,APPETITE DISORDER,55
US,BONE DENSITY DECREASED,55
US,COMPLICATION ASSOCIATED WITH DEVICE,55
US,CYANOSIS,55
US,GOITRE,55
US,ANGER,54
US,BLOOD BLISTER,54
US,BLOOD PRESSURE SYSTOLIC INCREASED,54
US,COORDINATION ABNORMAL,54
US,ILEUS,54
US,INCORRECT PRODUCT STORAGE,54
US,LYMPHOCYTE COUNT DECREASED,54
US,NEPHROPATHY,54
US,RENAL CANCER,54
US,BOWEL MOVEMENT IRREGULARITY,53
US,BRONCHOSPASM,53
US,DERMATITIS CONTACT,53
US,HUNGER,53
US,HYDRONEPHROSIS,53
US,LEFT VENTRICULAR FAILURE,53
US,LUNG TRANSPLANT,53
US,NEPHROGENIC SYSTEMIC FIBROSIS,53
US,PERICARDIAL HAEMORRHAGE,53
US,APPLICATION SITE PRURITUS,52
US,CARDIAC FLUTTER,52
US,DECREASED ACTIVITY,52
US,DEVICE FAILURE,52
US,PHOTOSENSITIVITY REACTION,52
US,PULSELESS ELECTRICAL ACTIVITY,52
US,SPINAL DISORDER,52
US,CATARACT OPERATION,51
US,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,51
US,DYSLIPIDAEMIA,51
US,GANGRENE,51
US,INTERNATIONAL NORMALISED RATIO DECREASED,51
US,KYPHOSIS,51
US,METASTASES TO SPINE,51
US,PERONEAL NERVE PALSY,51
US,RHINITIS,51
US,SENSORY DISTURBANCE,51
US,ACUTE HEPATIC FAILURE,50
US,ATRIOVENTRICULAR BLOCK,50
US,BLOOD DISORDER,50
US,HAEMOTHORAX,50
US,HICCUPS,50
US,IMMUNE SYSTEM DISORDER,50
US,IMPAIRED WORK ABILITY,50
US,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,50
US,LYMPHOMA,50
US,METASTASES TO CENTRAL NERVOUS SYSTEM,50
US,ORAL HERPES,50
US,PNEUMONIA BACTERIAL,50
US,PRODUCT TASTE ABNORMAL,50
US,RESPIRATORY SYNCYTIAL VIRUS INFECTION,50
US,SKIN FISSURES,50
US,TIBIA FRACTURE,50
US,WHEELCHAIR USER,50
US,BARRETT^S OESOPHAGUS,49
US,BONE LOSS,49
US,BREAST PAIN,49
US,CHOLECYSTITIS,49
US,FAECAL INCONTINENCE,49
US,HEART VALVE INCOMPETENCE,49
US,OLIGURIA,49
US,PARANASAL SINUS HYPERSECRETION,49
US,RASH MACULO-PAPULAR,49
US,SCRATCH,49
US,APHAGIA,48
US,BLOOD URIC ACID INCREASED,48
US,CEREBRAL ATROPHY,48
US,CONCOMITANT DISEASE AGGRAVATED,48
US,DISEASE RECURRENCE,48
US,DRUG-INDUCED LIVER INJURY,48
US,FACE OEDEMA,48
US,HAEMARTHROSIS,48
US,HAIR DISORDER,48
US,HYPERKERATOSIS,48
US,NON-CARDIAC CHEST PAIN,48
US,PARANOIA,48
US,PERIPHERAL VENOUS DISEASE,48
US,PROTEIN TOTAL DECREASED,48
US,SENSORY LOSS,48
US,UMBILICAL HERNIA,48
US,CARDIAC TAMPONADE,47
US,ECZEMA,47
US,INCOHERENT,47
US,INTERNATIONAL NORMALISED RATIO FLUCTUATION,47
US,INVESTIGATION,47
US,PHARYNGITIS,47
US,TOOTH EXTRACTION,47
US,VARICOSE VEIN,47
US,AORTIC CALCIFICATION,46
US,CONGESTIVE CARDIOMYOPATHY,46
US,DEMENTIA ALZHEIMER^S TYPE,46
US,DISSEMINATED INTRAVASCULAR COAGULATION,46
US,IMMUNODEFICIENCY,46
US,MEDICAL DEVICE COMPLICATION,46
US,TEMPERATURE INTOLERANCE,46
US,ARTHRITIS INFECTIVE,45
US,BENIGN PROSTATIC HYPERPLASIA,45
US,COR PULMONALE,45
US,EMBOLIC STROKE,45
US,HYPERAESTHESIA,45
US,HYPERTHYROIDISM,45
US,MALIGNANT MELANOMA,45
US,ONYCHOCLASIS,45
US,POOR PERIPHERAL CIRCULATION,45
US,RENAL PAIN,45
US,SCLERODERMA,45
US,SKIN ABRASION,45
US,SYNOVITIS,45
US,TENDON RUPTURE,45
US,ANGIOPATHY,44
US,BIPOLAR DISORDER,44
US,BREAST CANCER METASTATIC,44
US,BRONCHITIS CHRONIC,44
US,CAROTID ARTERY STENOSIS,44
US,CHRONIC RESPIRATORY FAILURE,44
US,DELUSION,44
US,ELECTROCARDIOGRAM ABNORMAL,44
US,IMPAIRED DRIVING ABILITY,44
US,INCREASED UPPER AIRWAY SECRETION,44
US,MENISCUS INJURY,44
US,PSEUDOMONAS INFECTION,44
US,QUALITY OF LIFE DECREASED,44
US,RADICULOPATHY,44
US,SUDDEN CARDIAC DEATH,44
US,THYROID NEOPLASM,44
US,VERTEBRAL FORAMINAL STENOSIS,44
US,ARTHROPOD BITE,43
US,CATHETER SITE HAEMORRHAGE,43
US,CENTRAL VENOUS CATHETERISATION,43
US,EYELID OEDEMA,43
US,FACIAL BONES FRACTURE,43
US,FUNGAL SKIN INFECTION,43
US,HALLUCINATION_ VISUAL,43
US,HYPOVOLAEMIC SHOCK,43
US,INJECTION SITE RASH,43
US,INTERVERTEBRAL DISC SPACE NARROWING,43
US,JAW DISORDER,43
US,METASTASES TO LYMPH NODES,43
US,PEPTIC ULCER,43
US,POSTOPERATIVE WOUND INFECTION,43
US,SPINAL OPERATION,43
US,STAPHYLOCOCCAL SEPSIS,43
US,VASCULAR CALCIFICATION,43
US,ANEURYSM,42
US,AZOTAEMIA,42
US,BLOOD CHOLESTEROL ABNORMAL,42
US,BLOOD CREATINE PHOSPHOKINASE INCREASED,42
US,BLOOD POTASSIUM ABNORMAL,42
US,GASTRITIS EROSIVE,42
US,GASTROINTESTINAL INFECTION,42
US,GENERALISED TONIC-CLONIC SEIZURE,42
US,HYPOALBUMINAEMIA,42
US,INFUSION SITE ERYTHEMA,42
US,MATERNAL EXPOSURE DURING PREGNANCY,42
US,MENORRHAGIA,42
US,NASAL DISCOMFORT,42
US,PHYSICAL DISABILITY,42
US,SKIN ATROPHY,42
US,SKIN WARM,42
US,TONGUE DISORDER,42
US,ACCIDENTAL EXPOSURE TO PRODUCT,41
US,BONE MARROW FAILURE,41
US,CAROTID ARTERY OCCLUSION,41
US,CENTRAL NERVOUS SYSTEM LESION,41
US,CONJUNCTIVITIS,41
US,FISTULA,41
US,HAEMOGLOBIN ABNORMAL,41
US,HEART RATE ABNORMAL,41
US,HEPATITIS,41
US,HYPERBILIRUBINAEMIA,41
US,HYPERTENSIVE CRISIS,41
US,INTENTIONAL OVERDOSE,41
US,METABOLIC ENCEPHALOPATHY,41
US,MYOPATHY,41
US,SPONDYLOLISTHESIS,41
UM,DRUG INEFFECTIVE,1
UM,FATIGUE,1
UM,FRUSTRATION TOLERANCE DECREASED,1
UM,NEGATIVE THOUGHTS,1
UY,PRODUCT USE ISSUE,3
UY,BRONCHOSPASM,2
UY,CARDIAC FAILURE,2
UY,CONDITION AGGRAVATED,2
UY,NAUSEA,2
UY,OEDEMA PERIPHERAL,2
UY,RENAL FAILURE,2
UY,RIGHT VENTRICULAR FAILURE,2
UY,SUDDEN DEATH,2
UY,VAGINAL HAEMORRHAGE,2
UY,ABDOMINAL DISTENSION,1
UY,ACNE,1
UY,ANURIA,1
UY,ARTHRALGIA,1
UY,CEREBROVASCULAR ACCIDENT,1
UY,DRUG DOSE OMISSION,1
UY,DYSPNOEA,1
UY,DYSPNOEA EXERTIONAL,1
UY,FLUID RETENTION,1
UY,GASTRIC ULCER,1
UY,GASTROINTESTINAL HAEMORRHAGE,1
UY,GENERALISED OEDEMA,1
UY,HAEMOPTYSIS,1
UY,HEMIPLEGIA,1
UY,HYPERHIDROSIS,1
UY,HYPOCHROMIC ANAEMIA,1
UY,HYPOTENSION,1
UY,INTRACARDIAC THROMBUS,1
UY,JOINT SWELLING,1
UY,METRORRHAGIA,1
UY,OROPHARYNGEAL PAIN,1
UY,PAIN,1
UY,PAIN OF SKIN,1
UY,PERICARDIAL EFFUSION,1
UY,PERIPHERAL SWELLING,1
UY,POLYARTHRITIS,1
UY,PULMONARY ARTERIAL HYPERTENSION,1
UY,PYREXIA,1
UY,RASH MACULAR,1
UY,RHEUMATOID ARTHRITIS,1
UY,SKIN BURNING SENSATION,1
UY,SUBCUTANEOUS HAEMATOMA,1
UY,SYNCOPE,1
UY,SYSTEMIC LUPUS ERYTHEMATOSUS,1
UY,TACHYCARDIA,1
UY,THROMBOSIS,1
UY,TONSILLITIS STREPTOCOCCAL,1
UY,URINARY TRACT INFECTION,1
UY,UTERINE HAEMORRHAGE,1
UY,VOMITING,1
UY,WEIGHT DECREASED,1
VE,DYSPNOEA,6
VE,DEATH,5
VE,FATIGUE,4
VE,MALAISE,3
VE,ABDOMINAL DISTENSION,2
VE,ANGINA PECTORIS,2
VE,ARTHRALGIA,2
VE,CONSTIPATION,2
VE,INFLUENZA,2
VE,MYOCARDIAL INFARCTION,2
VE,NAUSEA,2
VE,PAIN,2
VE,PRODUCT USE ISSUE,2
VE,PRODUCTIVE COUGH,2
VE,PULMONARY OEDEMA,2
VE,RESPIRATORY ARREST,2
VE,THROMBOSIS,2
VE,VOMITING,2
VE,ABDOMINAL PAIN,1
VE,ABDOMINAL PAIN UPPER,1
VE,ABDOMINAL SEPSIS,1
VE,ASCITES,1
VE,ASPHYXIA,1
VE,ASTHMATIC CRISIS,1
VE,BIFASCICULAR BLOCK,1
VE,BLOOD CHOLESTEROL INCREASED,1
VE,BLOOD POTASSIUM DECREASED,1
VE,BLOOD PRESSURE DECREASED,1
VE,BONE FISSURE,1
VE,BRONCHOSPASM,1
VE,CARDIAC DISORDER,1
VE,CARDIAC FAILURE,1
VE,CARDIAC FAILURE CONGESTIVE,1
VE,CARDIAC VALVE DISEASE,1
VE,CARDIOMEGALY,1
VE,CHEST PAIN,1
VE,CHILLS,1
VE,CHOKING,1
VE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
VE,CONVULSION,1
VE,DEPRESSED MOOD,1
VE,DIARRHOEA,1
VE,DISEASE RECURRENCE,1
VE,DYSGEUSIA,1
VE,DYSPEPSIA,1
VE,DYSPNOEA PAROXYSMAL NOCTURNAL,1
VE,DYSSTASIA,1
VE,DYSURIA,1
VE,ERYTHEMA,1
VE,EXERCISE TOLERANCE DECREASED,1
VE,FALL,1
VE,FEELING ABNORMAL,1
VE,FINGERPRINT LOSS,1
VE,FLATULENCE,1
VE,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,1
VE,GAIT DISTURBANCE,1
VE,GASTRIC DISORDER,1
VE,GENERALISED TONIC-CLONIC SEIZURE,1
VE,GRIP STRENGTH DECREASED,1
VE,HEPATIC FAILURE,1
VE,HEPATIC NEOPLASM,1
VE,HIATUS HERNIA,1
VE,HYPERAESTHESIA,1
VE,HYPERTENSION,1
VE,HYPERTENSIVE CRISIS,1
VE,HYPOACUSIS,1
VE,HYPOAESTHESIA,1
VE,HYPOGLYCAEMIA,1
VE,HYPOTENSION,1
VE,INFARCTION,1
VE,INFECTION,1
VE,INFLAMMATION,1
VE,INSOMNIA,1
VE,IRRITABLE BOWEL SYNDROME,1
VE,ISCHAEMIC STROKE,1
VE,LARGE INTESTINAL HAEMORRHAGE,1
VE,LIMB DISCOMFORT,1
VE,LUNG INFECTION,1
VE,MEMORY IMPAIRMENT,1
VE,MICTURITION DISORDER,1
VE,MOUTH ULCERATION,1
VE,MOVEMENT DISORDER,1
VE,MUSCLE SPASMS,1
VE,MUSCULOSKELETAL DISCOMFORT,1
VE,MYALGIA,1
VE,NEOPLASM,1
VE,NEUROPATHY PERIPHERAL,1
VE,NONINFECTIVE GINGIVITIS,1
VE,OEDEMA MOUTH,1
VE,OEDEMA PERIPHERAL,1
VE,ORAL PAIN,1
VE,OSTEOPENIA,1
VE,OSTEOPOROSIS,1
VE,PAIN OF SKIN,1
VE,PERIPHERAL SWELLING,1
VE,PRESYNCOPE,1
VE,PROTEIN-LOSING GASTROENTEROPATHY,1
VE,PULMONARY CALCIFICATION,1
VE,PULMONARY HYPERTENSION,1
VE,RASH GENERALISED,1
VE,RASH PAPULAR,1
VE,RECTAL HAEMORRHAGE,1
VE,SEIZURE,1
VE,SKIN DISCOLOURATION,1
VE,SKIN DISORDER,1
VE,SKIN EXFOLIATION,1
VE,SOMATIC SYMPTOM DISORDER,1
VE,SOMNOLENCE,1
VE,STOMATITIS,1
VE,SWELLING,1
VE,SYNCOPE,1
VE,VIRAL INFECTION,1
VE,VISUAL IMPAIRMENT,1
VN,BLOOD CREATININE INCREASED,2
VN,END STAGE RENAL DISEASE,2
VN,CARDIAC FAILURE,1
VN,CHRONIC KIDNEY DISEASE,1
VN,HYPOGLYCAEMIA,1
VN,SMALL INTESTINAL ULCER HAEMORRHAGE,1
VN,URINARY TRACT INFECTION,1
VI,DRY SKIN,1
VI,MALIGNANT NEOPLASM PROGRESSION,1
VI,RASH PAPULAR,1
ZW,BRADYCARDIA FOETAL,2
ZW,FOETAL EXPOSURE DURING PREGNANCY,2
ZW,COR PULMONALE,1
ZW,DRUG INEFFECTIVE,1
ZW,EXPOSURE DURING PREGNANCY,1
ZW,LIVE BIRTH,1
ZW,LOW BIRTH WEIGHT BABY,1
